{"idB": "1006281_12_item1_p0_s1", "idA": "1006281_11_item1_p0_s0", "sentA": "Using our ProCellEx system, we are developing a pipeline of proprietary and biosimilar or generic versions of recombinant therapeutic proteins based on our plant cell-based expression technology that target large, established pharmaceutical markets and that rely upon known biological mechanisms of action.", "sentB": "Using our ProCellEx system, we are developing a pipeline of proprietary and biosimilar versions of recombinant therapeutic proteins based on our plant cell-based expression technology that target large, established pharmaceutical markets and that rely upon known biological mechanisms of action.", "type": 2, "words": ["<tag1>", "Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary", "and", "biosimilar", "or", "generic", "versions", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "plant", "cell-based", "expression", "technology", "that", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag2>", "Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary", "and", "biosimilar", "versions", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "plant", "cell-based", "expression", "technology", "that", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag3>"], "wordsA": ["Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary", "and", "biosimilar", "or", "generic", "versions", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "plant", "cell-based", "expression", "technology", "that", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "wordsB": ["Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary", "and", "biosimilar", "versions", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "plant", "cell-based", "expression", "technology", "that", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p165_s1", "idA": "1006281_11_item1_p100_s1", "sentA": "Zavesca has been approved by the FDA for use in the United States as an oral treatment.", "sentB": "A paper entitled: Adaptive Alternative Splicing Correlates with Less Environmental Risk of Parkinsonism, has been published in the Journal of Neurodegenerative Diseases (Neurodegener Dis. 2012;9(2):87-98.", "type": 2, "words": ["<tag1>", "Zavesca", "has", "been", "approved", "by", "the", "FDA", "for", "use", "in", "the", "United", "States", "as", "an", "oral", "treatment.", "<tag2>", "A", "paper", "entitled:", "Adaptive", "Alternative", "Splicing", "Correlates", "with", "Less", "Environmental", "Risk", "of", "Parkinsonism,", "has", "been", "published", "in", "the", "Journal", "of", "Neurodegenerative", "Diseases", "(Neurodegener", "Dis.", "2012;9(2):87-98.", "<tag3>"], "wordsA": ["Zavesca", "has", "been", "approved", "by", "the", "FDA", "for", "use", "in", "the", "United", "States", "as", "an", "oral", "treatment."], "wordsB": ["A", "paper", "entitled:", "Adaptive", "Alternative", "Splicing", "Correlates", "with", "Less", "Environmental", "Risk", "of", "Parkinsonism,", "has", "been", "published", "in", "the", "Journal", "of", "Neurodegenerative", "Diseases", "(Neurodegener", "Dis.", "2012;9(2):87-98."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p234_s0", "idA": "1006281_11_item1_p100_s1", "sentA": "Zavesca has been approved by the FDA for use in the United States as an oral treatment.", "sentB": "In March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act, or collectively, PPACA, became law in the United States.", "type": 2, "words": ["<tag1>", "Zavesca", "has", "been", "approved", "by", "the", "FDA", "for", "use", "in", "the", "United", "States", "as", "an", "oral", "treatment.", "<tag2>", "In", "March", "2010,", "the", "Patient", "Protection", "and", "Affordable", "Care", "Act,", "as", "amended", "by", "the", "Health", "Care", "and", "Education", "Affordability", "Reconciliation", "Act,", "or", "collectively,", "PPACA,", "became", "law", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["Zavesca", "has", "been", "approved", "by", "the", "FDA", "for", "use", "in", "the", "United", "States", "as", "an", "oral", "treatment."], "wordsB": ["In", "March", "2010,", "the", "Patient", "Protection", "and", "Affordable", "Care", "Act,", "as", "amended", "by", "the", "Health", "Care", "and", "Education", "Affordability", "Reconciliation", "Act,", "or", "collectively,", "PPACA,", "became", "law", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p179_s1", "idA": "1006281_11_item1_p100_s3", "sentA": "As a result, Zavesca s use has been extremely limited.", "sentB": "As a result, Pfizer recorded an allowance for sales returns.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "Zavesca", "s", "use", "has", "been", "extremely", "limited.", "<tag2>", "As", "a", "result,", "Pfizer", "recorded", "an", "allowance", "for", "sales", "returns.", "<tag3>"], "wordsA": ["As", "a", "result,", "Zavesca", "s", "use", "has", "been", "extremely", "limited."], "wordsB": ["As", "a", "result,", "Pfizer", "recorded", "an", "allowance", "for", "sales", "returns."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p23_s1", "idA": "1006281_11_item1_p100_s3", "sentA": "As a result, Zavesca s use has been extremely limited.", "sentB": "As a result, Pfizer recorded an allowance for sales return.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "Zavesca", "s", "use", "has", "been", "extremely", "limited.", "<tag2>", "As", "a", "result,", "Pfizer", "recorded", "an", "allowance", "for", "sales", "return.", "<tag3>"], "wordsA": ["As", "a", "result,", "Zavesca", "s", "use", "has", "been", "extremely", "limited."], "wordsB": ["As", "a", "result,", "Pfizer", "recorded", "an", "allowance", "for", "sales", "return."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p117_s4", "idA": "1006281_11_item1_p100_s4", "sentA": "Actelion has reported sales of Zavesca of approximately CHF 68.7 million (approximately $72.0 million) in 2010.", "sentB": "Actelion has reported sales of Zavesca of approximately CHF 68.4 million (approximately $74.4 million) in 2011.", "type": 2, "words": ["<tag1>", "Actelion", "has", "reported", "sales", "of", "Zavesca", "of", "approximately", "CHF", "68.7", "million", "(approximately", "$72.0", "million)", "in", "2010.", "<tag2>", "Actelion", "has", "reported", "sales", "of", "Zavesca", "of", "approximately", "CHF", "68.4", "million", "(approximately", "$74.4", "million)", "in", "2011.", "<tag3>"], "wordsA": ["Actelion", "has", "reported", "sales", "of", "Zavesca", "of", "approximately", "CHF", "68.7", "million", "(approximately", "$72.0", "million)", "in", "2010."], "wordsB": ["Actelion", "has", "reported", "sales", "of", "Zavesca", "of", "approximately", "CHF", "68.4", "million", "(approximately", "$74.4", "million)", "in", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p118_s0", "idA": "1006281_11_item1_p101_s0", "sentA": "We believe the clinical development path for taliglucerase alfa will be similar to that followed by the existing enzyme replacement therapy currently on the market.", "sentB": "We believe the clinical development and regulatory path for taliglucerase alfa will be similar to that followed by the existing enzyme replacement therapy currently on the market.", "type": 2, "words": ["<tag1>", "We", "believe", "the", "clinical", "development", "path", "for", "taliglucerase", "alfa", "will", "be", "similar", "to", "that", "followed", "by", "the", "existing", "enzyme", "replacement", "therapy", "currently", "on", "the", "market.", "<tag2>", "We", "believe", "the", "clinical", "development", "and", "regulatory", "path", "for", "taliglucerase", "alfa", "will", "be", "similar", "to", "that", "followed", "by", "the", "existing", "enzyme", "replacement", "therapy", "currently", "on", "the", "market.", "<tag3>"], "wordsA": ["We", "believe", "the", "clinical", "development", "path", "for", "taliglucerase", "alfa", "will", "be", "similar", "to", "that", "followed", "by", "the", "existing", "enzyme", "replacement", "therapy", "currently", "on", "the", "market."], "wordsB": ["We", "believe", "the", "clinical", "development", "and", "regulatory", "path", "for", "taliglucerase", "alfa", "will", "be", "similar", "to", "that", "followed", "by", "the", "existing", "enzyme", "replacement", "therapy", "currently", "on", "the", "market."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p129_s2", "idA": "1006281_11_item1_p101_s2", "sentA": "The phase III clinical trial was successfully completed in September 2009 and we announced positive top-line results from the trial in October 2009 and full study results in February 2010.", "sentB": "We successfully completed the trial in September 2009 and announced positive top-line results of the trial in October 2009 and full study results in February 2010.", "type": 2, "words": ["<tag1>", "The", "phase", "III", "clinical", "trial", "was", "successfully", "completed", "in", "September", "2009", "and", "we", "announced", "positive", "top-line", "results", "from", "the", "trial", "in", "October", "2009", "and", "full", "study", "results", "in", "February", "2010.", "<tag2>", "We", "successfully", "completed", "the", "trial", "in", "September", "2009", "and", "announced", "positive", "top-line", "results", "of", "the", "trial", "in", "October", "2009", "and", "full", "study", "results", "in", "February", "2010.", "<tag3>"], "wordsA": ["The", "phase", "III", "clinical", "trial", "was", "successfully", "completed", "in", "September", "2009", "and", "we", "announced", "positive", "top-line", "results", "from", "the", "trial", "in", "October", "2009", "and", "full", "study", "results", "in", "February", "2010."], "wordsB": ["We", "successfully", "completed", "the", "trial", "in", "September", "2009", "and", "announced", "positive", "top-line", "results", "of", "the", "trial", "in", "October", "2009", "and", "full", "study", "results", "in", "February", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p130_s2", "idA": "1006281_11_item1_p102_s0", "sentA": "in liver size and increase in platelet count at the 60 U/kg dose.", "sentB": "Accordingly, the extension trial included two treatment groups; one treated with a 60 U/kg dose and the other with a 30 U/kg dose.", "type": 2, "words": ["<tag1>", "in", "liver", "size", "and", "increase", "in", "platelet", "count", "at", "the", "60", "U/kg", "dose.", "<tag2>", "Accordingly,", "the", "extension", "trial", "included", "two", "treatment", "groups;", "one", "treated", "with", "a", "60", "U/kg", "dose", "and", "the", "other", "with", "a", "30", "U/kg", "dose.", "<tag3>"], "wordsA": ["in", "liver", "size", "and", "increase", "in", "platelet", "count", "at", "the", "60", "U/kg", "dose."], "wordsB": ["Accordingly,", "the", "extension", "trial", "included", "two", "treatment", "groups;", "one", "treated", "with", "a", "60", "U/kg", "dose", "and", "the", "other", "with", "a", "30", "U/kg", "dose."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p142_s1", "idA": "1006281_11_item1_p102_s0", "sentA": "in liver size and increase in platelet count at the 60 U/kg dose.", "sentB": "In addition, one patient in the 60 U/kg dose group experienced a hypersensitivity reaction during month 10 of treatment.", "type": 2, "words": ["<tag1>", "in", "liver", "size", "and", "increase", "in", "platelet", "count", "at", "the", "60", "U/kg", "dose.", "<tag2>", "In", "addition,", "one", "patient", "in", "the", "60", "U/kg", "dose", "group", "experienced", "a", "hypersensitivity", "reaction", "during", "month", "10", "of", "treatment.", "<tag3>"], "wordsA": ["in", "liver", "size", "and", "increase", "in", "platelet", "count", "at", "the", "60", "U/kg", "dose."], "wordsB": ["In", "addition,", "one", "patient", "in", "the", "60", "U/kg", "dose", "group", "experienced", "a", "hypersensitivity", "reaction", "during", "month", "10", "of", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p139_s1", "idA": "1006281_11_item1_p102_s2", "sentA": "However, the lower dose group did not meet the secondary endpoint relating to platelet count.", "sentB": "Accordingly, the lower dose group did not meet the secondary endpoint relating to platelet count.", "type": 2, "words": ["<tag1>", "However,", "the", "lower", "dose", "group", "did", "not", "meet", "the", "secondary", "endpoint", "relating", "to", "platelet", "count.", "<tag2>", "Accordingly,", "the", "lower", "dose", "group", "did", "not", "meet", "the", "secondary", "endpoint", "relating", "to", "platelet", "count.", "<tag3>"], "wordsA": ["However,", "the", "lower", "dose", "group", "did", "not", "meet", "the", "secondary", "endpoint", "relating", "to", "platelet", "count."], "wordsB": ["Accordingly,", "the", "lower", "dose", "group", "did", "not", "meet", "the", "secondary", "endpoint", "relating", "to", "platelet", "count."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p119_s0", "idA": "1006281_11_item1_p106_s0", "sentA": "We completed a phase I clinical trial of taliglucerase alfa in June 2006.", "sentB": "After completion of laboratory testing and preclinical studies of taliglucerase alfa, we commenced a phase I clinical trial which was completed in June 2006 .", "type": 2, "words": ["<tag1>", "We", "completed", "a", "phase", "I", "clinical", "trial", "of", "taliglucerase", "alfa", "in", "June", "2006.", "<tag2>", "After", "completion", "of", "laboratory", "testing", "and", "preclinical", "studies", "of", "taliglucerase", "alfa,", "we", "commenced", "a", "phase", "I", "clinical", "trial", "which", "was", "completed", "in", "June", "2006", ".", "<tag3>"], "wordsA": ["We", "completed", "a", "phase", "I", "clinical", "trial", "of", "taliglucerase", "alfa", "in", "June", "2006."], "wordsB": ["After", "completion", "of", "laboratory", "testing", "and", "preclinical", "studies", "of", "taliglucerase", "alfa,", "we", "commenced", "a", "phase", "I", "clinical", "trial", "which", "was", "completed", "in", "June", "2006", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p173_s3", "idA": "1006281_11_item1_p106_s0", "sentA": "We completed a phase I clinical trial of taliglucerase alfa in June 2006.", "sentB": "We intend to plan a phase I clinical trial of oral glucocerebrosidase in healthy individuals who are carriers of Gaucher disease and who show reduced enzymatic activity at baseline based on the final results of the animal studies.", "type": 2, "words": ["<tag1>", "We", "completed", "a", "phase", "I", "clinical", "trial", "of", "taliglucerase", "alfa", "in", "June", "2006.", "<tag2>", "We", "intend", "to", "plan", "a", "phase", "I", "clinical", "trial", "of", "oral", "glucocerebrosidase", "in", "healthy", "individuals", "who", "are", "carriers", "of", "Gaucher", "disease", "and", "who", "show", "reduced", "enzymatic", "activity", "at", "baseline", "based", "on", "the", "final", "results", "of", "the", "animal", "studies.", "<tag3>"], "wordsA": ["We", "completed", "a", "phase", "I", "clinical", "trial", "of", "taliglucerase", "alfa", "in", "June", "2006."], "wordsB": ["We", "intend", "to", "plan", "a", "phase", "I", "clinical", "trial", "of", "oral", "glucocerebrosidase", "in", "healthy", "individuals", "who", "are", "carriers", "of", "Gaucher", "disease", "and", "who", "show", "reduced", "enzymatic", "activity", "at", "baseline", "based", "on", "the", "final", "results", "of", "the", "animal", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p123_s0", "idA": "1006281_11_item1_p106_s1", "sentA": "The phase I clinical trial was a single-center, non-randomized, open label, dose ranging study designed to evaluate the safety and pharmacokinetics of taliglucerase alfa in healthy subjects.", "sentB": "The phase I clinical trial, which we completed in June 2006, was a single-center, non-randomized, open label, dose ranging study designed to evaluate the safety and pharmacokinetics of taliglucerase alfa in healthy subjects.", "type": 2, "words": ["<tag1>", "The", "phase", "I", "clinical", "trial", "was", "a", "single-center,", "non-randomized,", "open", "label,", "dose", "ranging", "study", "designed", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "taliglucerase", "alfa", "in", "healthy", "subjects.", "<tag2>", "The", "phase", "I", "clinical", "trial,", "which", "we", "completed", "in", "June", "2006,", "was", "a", "single-center,", "non-randomized,", "open", "label,", "dose", "ranging", "study", "designed", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "taliglucerase", "alfa", "in", "healthy", "subjects.", "<tag3>"], "wordsA": ["The", "phase", "I", "clinical", "trial", "was", "a", "single-center,", "non-randomized,", "open", "label,", "dose", "ranging", "study", "designed", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "taliglucerase", "alfa", "in", "healthy", "subjects."], "wordsB": ["The", "phase", "I", "clinical", "trial,", "which", "we", "completed", "in", "June", "2006,", "was", "a", "single-center,", "non-randomized,", "open", "label,", "dose", "ranging", "study", "designed", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "taliglucerase", "alfa", "in", "healthy", "subjects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p123_s1", "idA": "1006281_11_item1_p106_s2", "sentA": "The trial was conducted on healthy subjects over a four-week period in which subjects received three single escalating doses of taliglucerase alfa administered as intravenous infusions.", "sentB": "The trial was conducted on healthy subjects over a four-week period in which subjects received three single escalating doses of taliglucerase alfa administered via intravenous infusions.", "type": 2, "words": ["<tag1>", "The", "trial", "was", "conducted", "on", "healthy", "subjects", "over", "a", "four-week", "period", "in", "which", "subjects", "received", "three", "single", "escalating", "doses", "of", "taliglucerase", "alfa", "administered", "as", "intravenous", "infusions.", "<tag2>", "The", "trial", "was", "conducted", "on", "healthy", "subjects", "over", "a", "four-week", "period", "in", "which", "subjects", "received", "three", "single", "escalating", "doses", "of", "taliglucerase", "alfa", "administered", "via", "intravenous", "infusions.", "<tag3>"], "wordsA": ["The", "trial", "was", "conducted", "on", "healthy", "subjects", "over", "a", "four-week", "period", "in", "which", "subjects", "received", "three", "single", "escalating", "doses", "of", "taliglucerase", "alfa", "administered", "as", "intravenous", "infusions."], "wordsB": ["The", "trial", "was", "conducted", "on", "healthy", "subjects", "over", "a", "four-week", "period", "in", "which", "subjects", "received", "three", "single", "escalating", "doses", "of", "taliglucerase", "alfa", "administered", "via", "intravenous", "infusions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p168_s1", "idA": "1006281_11_item1_p10_s0", "sentA": "Taliglucerase alfa has an amino acid, glycan and three-dimensional structure that is very similar to Cerezyme, which is a mammalian cell expressed version of the same protein.", "sentB": "Our pr-antiTNF product candidate has an amino acid sequence that is similar to Enbrel which is one of the treatments for patients of those diseases.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "has", "an", "amino", "acid,", "glycan", "and", "three-dimensional", "structure", "that", "is", "very", "similar", "to", "Cerezyme,", "which", "is", "a", "mammalian", "cell", "expressed", "version", "of", "the", "same", "protein.", "<tag2>", "Our", "pr-antiTNF", "product", "candidate", "has", "an", "amino", "acid", "sequence", "that", "is", "similar", "to", "Enbrel", "which", "is", "one", "of", "the", "treatments", "for", "patients", "of", "those", "diseases.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "has", "an", "amino", "acid,", "glycan", "and", "three-dimensional", "structure", "that", "is", "very", "similar", "to", "Cerezyme,", "which", "is", "a", "mammalian", "cell", "expressed", "version", "of", "the", "same", "protein."], "wordsB": ["Our", "pr-antiTNF", "product", "candidate", "has", "an", "amino", "acid", "sequence", "that", "is", "similar", "to", "Enbrel", "which", "is", "one", "of", "the", "treatments", "for", "patients", "of", "those", "diseases."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p34_s0", "idA": "1006281_11_item1_p10_s0", "sentA": "Taliglucerase alfa has an amino acid, glycan and three-dimensional structure that is very similar to Cerezyme, which is a mammalian cell expressed version of the same protein.", "sentB": "Our pr-antiTNF product candidate has an amino acid sequence that is similar to Enbrel which is one of the treatments for patients of those diseases.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "has", "an", "amino", "acid,", "glycan", "and", "three-dimensional", "structure", "that", "is", "very", "similar", "to", "Cerezyme,", "which", "is", "a", "mammalian", "cell", "expressed", "version", "of", "the", "same", "protein.", "<tag2>", "Our", "pr-antiTNF", "product", "candidate", "has", "an", "amino", "acid", "sequence", "that", "is", "similar", "to", "Enbrel", "which", "is", "one", "of", "the", "treatments", "for", "patients", "of", "those", "diseases.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "has", "an", "amino", "acid,", "glycan", "and", "three-dimensional", "structure", "that", "is", "very", "similar", "to", "Cerezyme,", "which", "is", "a", "mammalian", "cell", "expressed", "version", "of", "the", "same", "protein."], "wordsB": ["Our", "pr-antiTNF", "product", "candidate", "has", "an", "amino", "acid", "sequence", "that", "is", "similar", "to", "Enbrel", "which", "is", "one", "of", "the", "treatments", "for", "patients", "of", "those", "diseases."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p18_s1", "idA": "1006281_11_item1_p10_s2", "sentA": "Under our SPA, the switch-over study is not a prerequisite for approval of taliglucerase alfa by the FDA.", "sentB": "The FDA did not originally require our switch-over study in the SPA as a prerequisite for approval of taliglucerase alfa.", "type": 2, "words": ["<tag1>", "Under", "our", "SPA,", "the", "switch-over", "study", "is", "not", "a", "prerequisite", "for", "approval", "of", "taliglucerase", "alfa", "by", "the", "FDA.", "<tag2>", "The", "FDA", "did", "not", "originally", "require", "our", "switch-over", "study", "in", "the", "SPA", "as", "a", "prerequisite", "for", "approval", "of", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["Under", "our", "SPA,", "the", "switch-over", "study", "is", "not", "a", "prerequisite", "for", "approval", "of", "taliglucerase", "alfa", "by", "the", "FDA."], "wordsB": ["The", "FDA", "did", "not", "originally", "require", "our", "switch-over", "study", "in", "the", "SPA", "as", "a", "prerequisite", "for", "approval", "of", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p15_s0", "idA": "1006281_11_item1_p10_s3", "sentA": "In December 2009, we filed a proposed pediatric investigation plan to the Pediatric Committee of the EMEA which was approved during the first quarter of 2010 and have since initiated the study.", "sentB": "In December 2009, we filed a proposed pediatric investigation plan to the Pediatric Committee of the EMA, which was approved during the first quarter of 2010.", "type": 2, "words": ["<tag1>", "In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010", "and", "have", "since", "initiated", "the", "study.", "<tag2>", "In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMA,", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010.", "<tag3>"], "wordsA": ["In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010", "and", "have", "since", "initiated", "the", "study."], "wordsB": ["In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMA,", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p15_s1", "idA": "1006281_11_item1_p10_s3", "sentA": "In December 2009, we filed a proposed pediatric investigation plan to the Pediatric Committee of the EMEA which was approved during the first quarter of 2010 and have since initiated the study.", "sentB": "We have since initiated the pediatric study and have enrolled all of the na ve pediatric patients required according to the study protocol.", "type": 2, "words": ["<tag1>", "In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010", "and", "have", "since", "initiated", "the", "study.", "<tag2>", "We", "have", "since", "initiated", "the", "pediatric", "study", "and", "have", "enrolled", "all", "of", "the", "na", "ve", "pediatric", "patients", "required", "according", "to", "the", "study", "protocol.", "<tag3>"], "wordsA": ["In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010", "and", "have", "since", "initiated", "the", "study."], "wordsB": ["We", "have", "since", "initiated", "the", "pediatric", "study", "and", "have", "enrolled", "all", "of", "the", "na", "ve", "pediatric", "patients", "required", "according", "to", "the", "study", "protocol."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p89_s0", "idA": "1006281_11_item1_p10_s3", "sentA": "In December 2009, we filed a proposed pediatric investigation plan to the Pediatric Committee of the EMEA which was approved during the first quarter of 2010 and have since initiated the study.", "sentB": "In addition, in December 2009, we filed a proposed pediatric investigation plan to the Pediatric Committee of the EMA, which was approved during the first quarter of 2010.", "type": 2, "words": ["<tag1>", "In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010", "and", "have", "since", "initiated", "the", "study.", "<tag2>", "In", "addition,", "in", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMA,", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010.", "<tag3>"], "wordsA": ["In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010", "and", "have", "since", "initiated", "the", "study."], "wordsB": ["In", "addition,", "in", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMA,", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p89_s1", "idA": "1006281_11_item1_p10_s3", "sentA": "In December 2009, we filed a proposed pediatric investigation plan to the Pediatric Committee of the EMEA which was approved during the first quarter of 2010 and have since initiated the study.", "sentB": "We have since initiated the pediatric study and have enrolled all of the na ve pediatric patients required according to the study protocol.", "type": 2, "words": ["<tag1>", "In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010", "and", "have", "since", "initiated", "the", "study.", "<tag2>", "We", "have", "since", "initiated", "the", "pediatric", "study", "and", "have", "enrolled", "all", "of", "the", "na", "ve", "pediatric", "patients", "required", "according", "to", "the", "study", "protocol.", "<tag3>"], "wordsA": ["In", "December", "2009,", "we", "filed", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA", "which", "was", "approved", "during", "the", "first", "quarter", "of", "2010", "and", "have", "since", "initiated", "the", "study."], "wordsB": ["We", "have", "since", "initiated", "the", "pediatric", "study", "and", "have", "enrolled", "all", "of", "the", "na", "ve", "pediatric", "patients", "required", "according", "to", "the", "study", "protocol."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p126_s0", "idA": "1006281_11_item1_p110_s0", "sentA": "Further, no neutralizing antibodies or adverse immunological responses were detected in any of the subjects treated in the phase I clinical trial.", "sentB": "Further, as in the laboratory and preclinical testing phase, no neutralizing antibodies or adverse immunological responses were detected in any of the subjects treated in the phase I clinical trial.", "type": 2, "words": ["<tag1>", "Further,", "no", "neutralizing", "antibodies", "or", "adverse", "immunological", "responses", "were", "detected", "in", "any", "of", "the", "subjects", "treated", "in", "the", "phase", "I", "clinical", "trial.", "<tag2>", "Further,", "as", "in", "the", "laboratory", "and", "preclinical", "testing", "phase,", "no", "neutralizing", "antibodies", "or", "adverse", "immunological", "responses", "were", "detected", "in", "any", "of", "the", "subjects", "treated", "in", "the", "phase", "I", "clinical", "trial.", "<tag3>"], "wordsA": ["Further,", "no", "neutralizing", "antibodies", "or", "adverse", "immunological", "responses", "were", "detected", "in", "any", "of", "the", "subjects", "treated", "in", "the", "phase", "I", "clinical", "trial."], "wordsB": ["Further,", "as", "in", "the", "laboratory", "and", "preclinical", "testing", "phase,", "no", "neutralizing", "antibodies", "or", "adverse", "immunological", "responses", "were", "detected", "in", "any", "of", "the", "subjects", "treated", "in", "the", "phase", "I", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p136_s1", "idA": "1006281_11_item1_p110_s0", "sentA": "Further, no neutralizing antibodies or adverse immunological responses were detected in any of the subjects treated in the phase I clinical trial.", "sentB": "These improvements continued in the extension trial.", "type": 2, "words": ["<tag1>", "Further,", "no", "neutralizing", "antibodies", "or", "adverse", "immunological", "responses", "were", "detected", "in", "any", "of", "the", "subjects", "treated", "in", "the", "phase", "I", "clinical", "trial.", "<tag2>", "These", "improvements", "continued", "in", "the", "extension", "trial.", "<tag3>"], "wordsA": ["Further,", "no", "neutralizing", "antibodies", "or", "adverse", "immunological", "responses", "were", "detected", "in", "any", "of", "the", "subjects", "treated", "in", "the", "phase", "I", "clinical", "trial."], "wordsB": ["These", "improvements", "continued", "in", "the", "extension", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p119_s1", "idA": "1006281_11_item1_p111_s0", "sentA": "After the conclusion of the phase I clinical trial and discussions with the FDA, we applied to commence a pivotal phase III clinical trial of taliglucerase alfa without the requirement to first complete a phase II clinical trial.", "sentB": "After the conclusion of the phase I clinical trial and discussions with the FDA, we proceeded directly with a pivotal phase III clinical trial of taliglucerase alfa without undergoing a phase II clinical trial.", "type": 2, "words": ["<tag1>", "After", "the", "conclusion", "of", "the", "phase", "I", "clinical", "trial", "and", "discussions", "with", "the", "FDA,", "we", "applied", "to", "commence", "a", "pivotal", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa", "without", "the", "requirement", "to", "first", "complete", "a", "phase", "II", "clinical", "trial.", "<tag2>", "After", "the", "conclusion", "of", "the", "phase", "I", "clinical", "trial", "and", "discussions", "with", "the", "FDA,", "we", "proceeded", "directly", "with", "a", "pivotal", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa", "without", "undergoing", "a", "phase", "II", "clinical", "trial.", "<tag3>"], "wordsA": ["After", "the", "conclusion", "of", "the", "phase", "I", "clinical", "trial", "and", "discussions", "with", "the", "FDA,", "we", "applied", "to", "commence", "a", "pivotal", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa", "without", "the", "requirement", "to", "first", "complete", "a", "phase", "II", "clinical", "trial."], "wordsB": ["After", "the", "conclusion", "of", "the", "phase", "I", "clinical", "trial", "and", "discussions", "with", "the", "FDA,", "we", "proceeded", "directly", "with", "a", "pivotal", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa", "without", "undergoing", "a", "phase", "II", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p34_s2", "idA": "1006281_11_item1_p111_s0", "sentA": "After the conclusion of the phase I clinical trial and discussions with the FDA, we applied to commence a pivotal phase III clinical trial of taliglucerase alfa without the requirement to first complete a phase II clinical trial.", "sentB": "Based on our pre IND meeting with the FDA held in December 2011, we believe we may submit an IND around year end and, if approved, commence a phase I clinical trial shortly thereafter with no need for an external partner.", "type": 2, "words": ["<tag1>", "After", "the", "conclusion", "of", "the", "phase", "I", "clinical", "trial", "and", "discussions", "with", "the", "FDA,", "we", "applied", "to", "commence", "a", "pivotal", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa", "without", "the", "requirement", "to", "first", "complete", "a", "phase", "II", "clinical", "trial.", "<tag2>", "Based", "on", "our", "pre", "IND", "meeting", "with", "the", "FDA", "held", "in", "December", "2011,", "we", "believe", "we", "may", "submit", "an", "IND", "around", "year", "end", "and,", "if", "approved,", "commence", "a", "phase", "I", "clinical", "trial", "shortly", "thereafter", "with", "no", "need", "for", "an", "external", "partner.", "<tag3>"], "wordsA": ["After", "the", "conclusion", "of", "the", "phase", "I", "clinical", "trial", "and", "discussions", "with", "the", "FDA,", "we", "applied", "to", "commence", "a", "pivotal", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa", "without", "the", "requirement", "to", "first", "complete", "a", "phase", "II", "clinical", "trial."], "wordsB": ["Based", "on", "our", "pre", "IND", "meeting", "with", "the", "FDA", "held", "in", "December", "2011,", "we", "believe", "we", "may", "submit", "an", "IND", "around", "year", "end", "and,", "if", "approved,", "commence", "a", "phase", "I", "clinical", "trial", "shortly", "thereafter", "with", "no", "need", "for", "an", "external", "partner."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p15_s3", "idA": "1006281_11_item1_p112_s0", "sentA": "phase III clinical trial for taliglucerase alfa.", "sentB": "Patients in the extension trial and the switchover trial are still being treated with taliglucerase alfa.", "type": 2, "words": ["<tag1>", "phase", "III", "clinical", "trial", "for", "taliglucerase", "alfa.", "<tag2>", "Patients", "in", "the", "extension", "trial", "and", "the", "switchover", "trial", "are", "still", "being", "treated", "with", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["phase", "III", "clinical", "trial", "for", "taliglucerase", "alfa."], "wordsB": ["Patients", "in", "the", "extension", "trial", "and", "the", "switchover", "trial", "are", "still", "being", "treated", "with", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p21_s5", "idA": "1006281_11_item1_p112_s0", "sentA": "phase III clinical trial for taliglucerase alfa.", "sentB": "Hundreds of patients, in the aggregate, have been treated with taliglucerase alfa.", "type": 2, "words": ["<tag1>", "phase", "III", "clinical", "trial", "for", "taliglucerase", "alfa.", "<tag2>", "Hundreds", "of", "patients,", "in", "the", "aggregate,", "have", "been", "treated", "with", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["phase", "III", "clinical", "trial", "for", "taliglucerase", "alfa."], "wordsB": ["Hundreds", "of", "patients,", "in", "the", "aggregate,", "have", "been", "treated", "with", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p88_s8", "idA": "1006281_11_item1_p112_s0", "sentA": "phase III clinical trial for taliglucerase alfa.", "sentB": "Patients in the extension trial and the switchover trial are still being treated with taliglucerase alfa.", "type": 2, "words": ["<tag1>", "phase", "III", "clinical", "trial", "for", "taliglucerase", "alfa.", "<tag2>", "Patients", "in", "the", "extension", "trial", "and", "the", "switchover", "trial", "are", "still", "being", "treated", "with", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["phase", "III", "clinical", "trial", "for", "taliglucerase", "alfa."], "wordsB": ["Patients", "in", "the", "extension", "trial", "and", "the", "switchover", "trial", "are", "still", "being", "treated", "with", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p137_s0", "idA": "1006281_11_item1_p112_s1", "sentA": "In July 2007, we reached an agreement with the FDA on the design that we submitted in the SPA request and in the third quarter of 2007 we initiated enrollment and treatment of naive patients in the phase III clinical trial.", "sentB": "In the phase III clinical trial, patients in both dosage groups demonstrated mean increases in hemoglobin from baseline; mean increases from 11.4 g/DL to 13.6 g/DL (p 0.0001) (22.2%) in the 60 U/kg group and from 12.2 g/DL to 14.0 g/DL (p 0.0010) (14.8%).", "type": 2, "words": ["<tag1>", "In", "July", "2007,", "we", "reached", "an", "agreement", "with", "the", "FDA", "on", "the", "design", "that", "we", "submitted", "in", "the", "SPA", "request", "and", "in", "the", "third", "quarter", "of", "2007", "we", "initiated", "enrollment", "and", "treatment", "of", "naive", "patients", "in", "the", "phase", "III", "clinical", "trial.", "<tag2>", "In", "the", "phase", "III", "clinical", "trial,", "patients", "in", "both", "dosage", "groups", "demonstrated", "mean", "increases", "in", "hemoglobin", "from", "baseline;", "mean", "increases", "from", "11.4", "g/DL", "to", "13.6", "g/DL", "(p", "0.0001)", "(22.2%)", "in", "the", "60", "U/kg", "group", "and", "from", "12.2", "g/DL", "to", "14.0", "g/DL", "(p", "0.0010)", "(14.8%).", "<tag3>"], "wordsA": ["In", "July", "2007,", "we", "reached", "an", "agreement", "with", "the", "FDA", "on", "the", "design", "that", "we", "submitted", "in", "the", "SPA", "request", "and", "in", "the", "third", "quarter", "of", "2007", "we", "initiated", "enrollment", "and", "treatment", "of", "naive", "patients", "in", "the", "phase", "III", "clinical", "trial."], "wordsB": ["In", "the", "phase", "III", "clinical", "trial,", "patients", "in", "both", "dosage", "groups", "demonstrated", "mean", "increases", "in", "hemoglobin", "from", "baseline;", "mean", "increases", "from", "11.4", "g/DL", "to", "13.6", "g/DL", "(p", "0.0001)", "(22.2%)", "in", "the", "60", "U/kg", "group", "and", "from", "12.2", "g/DL", "to", "14.0", "g/DL", "(p", "0.0010)", "(14.8%)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p119_s3", "idA": "1006281_11_item1_p113_s2", "sentA": "The primary endpoint of the study was a 20% mean reduction from baseline in spleen volume after nine months, as measured by MRI.", "sentB": "This study was summarized in a recent publication in BLOOD, the Journal of the American Hematological Society (Zimran, et .", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "of", "the", "study", "was", "a", "20%", "mean", "reduction", "from", "baseline", "in", "spleen", "volume", "after", "nine", "months,", "as", "measured", "by", "MRI.", "<tag2>", "This", "study", "was", "summarized", "in", "a", "recent", "publication", "in", "BLOOD,", "the", "Journal", "of", "the", "American", "Hematological", "Society", "(Zimran,", "et", ".", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "of", "the", "study", "was", "a", "20%", "mean", "reduction", "from", "baseline", "in", "spleen", "volume", "after", "nine", "months,", "as", "measured", "by", "MRI."], "wordsB": ["This", "study", "was", "summarized", "in", "a", "recent", "publication", "in", "BLOOD,", "the", "Journal", "of", "the", "American", "Hematological", "Society", "(Zimran,", "et", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p129_s0", "idA": "1006281_11_item1_p114_s0", "sentA": "Patients enrolled in the trial were treated in 11 centers throughout Europe, Israel, North America, South America and South Africa.", "sentB": "Patients enrolled in the trial were treated in 11 selected leading medical centers throughout Europe, Israel, North America, South America and South Africa.", "type": 2, "words": ["<tag1>", "Patients", "enrolled", "in", "the", "trial", "were", "treated", "in", "11", "centers", "throughout", "Europe,", "Israel,", "North", "America,", "South", "America", "and", "South", "Africa.", "<tag2>", "Patients", "enrolled", "in", "the", "trial", "were", "treated", "in", "11", "selected", "leading", "medical", "centers", "throughout", "Europe,", "Israel,", "North", "America,", "South", "America", "and", "South", "Africa.", "<tag3>"], "wordsA": ["Patients", "enrolled", "in", "the", "trial", "were", "treated", "in", "11", "centers", "throughout", "Europe,", "Israel,", "North", "America,", "South", "America", "and", "South", "Africa."], "wordsB": ["Patients", "enrolled", "in", "the", "trial", "were", "treated", "in", "11", "selected", "leading", "medical", "centers", "throughout", "Europe,", "Israel,", "North", "America,", "South", "America", "and", "South", "Africa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p131_s0", "idA": "1006281_11_item1_p114_s0", "sentA": "Patients enrolled in the trial were treated in 11 centers throughout Europe, Israel, North America, South America and South Africa.", "sentB": "Twenty-six patients were enrolled in the extension trial which was performed in centers throughout Europe, Israel, North America, South America and South Africa.", "type": 2, "words": ["<tag1>", "Patients", "enrolled", "in", "the", "trial", "were", "treated", "in", "11", "centers", "throughout", "Europe,", "Israel,", "North", "America,", "South", "America", "and", "South", "Africa.", "<tag2>", "Twenty-six", "patients", "were", "enrolled", "in", "the", "extension", "trial", "which", "was", "performed", "in", "centers", "throughout", "Europe,", "Israel,", "North", "America,", "South", "America", "and", "South", "Africa.", "<tag3>"], "wordsA": ["Patients", "enrolled", "in", "the", "trial", "were", "treated", "in", "11", "centers", "throughout", "Europe,", "Israel,", "North", "America,", "South", "America", "and", "South", "Africa."], "wordsB": ["Twenty-six", "patients", "were", "enrolled", "in", "the", "extension", "trial", "which", "was", "performed", "in", "centers", "throughout", "Europe,", "Israel,", "North", "America,", "South", "America", "and", "South", "Africa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p130_s0", "idA": "1006281_11_item1_p114_s2", "sentA": "During the third quarter of 2008, we initiated a double blind, follow-on extension study as part of our phase III clinical trial in which patients that successfully completed treatment in the trial were given the opportunity to continue to be treated with taliglucerase alfa at the same dose that they received in the trial.", "sentB": "During the third quarter of 2008 , we initiated a double blind, follow-on extension study as part of our phase III clinical trial.", "type": 2, "words": ["<tag1>", "During", "the", "third", "quarter", "of", "2008,", "we", "initiated", "a", "double", "blind,", "follow-on", "extension", "study", "as", "part", "of", "our", "phase", "III", "clinical", "trial", "in", "which", "patients", "that", "successfully", "completed", "treatment", "in", "the", "trial", "were", "given", "the", "opportunity", "to", "continue", "to", "be", "treated", "with", "taliglucerase", "alfa", "at", "the", "same", "dose", "that", "they", "received", "in", "the", "trial.", "<tag2>", "During", "the", "third", "quarter", "of", "2008", ",", "we", "initiated", "a", "double", "blind,", "follow-on", "extension", "study", "as", "part", "of", "our", "phase", "III", "clinical", "trial.", "<tag3>"], "wordsA": ["During", "the", "third", "quarter", "of", "2008,", "we", "initiated", "a", "double", "blind,", "follow-on", "extension", "study", "as", "part", "of", "our", "phase", "III", "clinical", "trial", "in", "which", "patients", "that", "successfully", "completed", "treatment", "in", "the", "trial", "were", "given", "the", "opportunity", "to", "continue", "to", "be", "treated", "with", "taliglucerase", "alfa", "at", "the", "same", "dose", "that", "they", "received", "in", "the", "trial."], "wordsB": ["During", "the", "third", "quarter", "of", "2008", ",", "we", "initiated", "a", "double", "blind,", "follow-on", "extension", "study", "as", "part", "of", "our", "phase", "III", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p132_s2", "idA": "1006281_11_item1_p114_s6", "sentA": "Due to the shortage of Cerezyme in 2009, after fully enrolling the 15 patients, we extended the trial to include up to 30 patients in total.", "sentB": "Due to the shortage of Cerezyme in 2009, after fully enrolling 15 patients, we extended the trial to include additional patients.", "type": 2, "words": ["<tag1>", "Due", "to", "the", "shortage", "of", "Cerezyme", "in", "2009,", "after", "fully", "enrolling", "the", "15", "patients,", "we", "extended", "the", "trial", "to", "include", "up", "to", "30", "patients", "in", "total.", "<tag2>", "Due", "to", "the", "shortage", "of", "Cerezyme", "in", "2009,", "after", "fully", "enrolling", "15", "patients,", "we", "extended", "the", "trial", "to", "include", "additional", "patients.", "<tag3>"], "wordsA": ["Due", "to", "the", "shortage", "of", "Cerezyme", "in", "2009,", "after", "fully", "enrolling", "the", "15", "patients,", "we", "extended", "the", "trial", "to", "include", "up", "to", "30", "patients", "in", "total."], "wordsB": ["Due", "to", "the", "shortage", "of", "Cerezyme", "in", "2009,", "after", "fully", "enrolling", "15", "patients,", "we", "extended", "the", "trial", "to", "include", "additional", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p134_s1", "idA": "1006281_11_item1_p114_s7", "sentA": "We successfully completed the phase III clinical trial in September 2009.", "sentB": "According to the data, after 24 months (nine months in the phase III clinical trial and 15 months in the extension trial), patients continued to demonstrate a significant improvement in all parameters with a similar safety profile as seen in the phase III clinical trial.", "type": 2, "words": ["<tag1>", "We", "successfully", "completed", "the", "phase", "III", "clinical", "trial", "in", "September", "2009.", "<tag2>", "According", "to", "the", "data,", "after", "24", "months", "(nine", "months", "in", "the", "phase", "III", "clinical", "trial", "and", "15", "months", "in", "the", "extension", "trial),", "patients", "continued", "to", "demonstrate", "a", "significant", "improvement", "in", "all", "parameters", "with", "a", "similar", "safety", "profile", "as", "seen", "in", "the", "phase", "III", "clinical", "trial.", "<tag3>"], "wordsA": ["We", "successfully", "completed", "the", "phase", "III", "clinical", "trial", "in", "September", "2009."], "wordsB": ["According", "to", "the", "data,", "after", "24", "months", "(nine", "months", "in", "the", "phase", "III", "clinical", "trial", "and", "15", "months", "in", "the", "extension", "trial),", "patients", "continued", "to", "demonstrate", "a", "significant", "improvement", "in", "all", "parameters", "with", "a", "similar", "safety", "profile", "as", "seen", "in", "the", "phase", "III", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p13_s1", "idA": "1006281_11_item1_p114_s7", "sentA": "We successfully completed the phase III clinical trial in September 2009.", "sentB": "According to the data, after 24 months, patients continued to demonstrate statistically significant improvement in all parameters with a similar safety profile as seen in the phase III clinical trial.", "type": 2, "words": ["<tag1>", "We", "successfully", "completed", "the", "phase", "III", "clinical", "trial", "in", "September", "2009.", "<tag2>", "According", "to", "the", "data,", "after", "24", "months,", "patients", "continued", "to", "demonstrate", "statistically", "significant", "improvement", "in", "all", "parameters", "with", "a", "similar", "safety", "profile", "as", "seen", "in", "the", "phase", "III", "clinical", "trial.", "<tag3>"], "wordsA": ["We", "successfully", "completed", "the", "phase", "III", "clinical", "trial", "in", "September", "2009."], "wordsB": ["According", "to", "the", "data,", "after", "24", "months,", "patients", "continued", "to", "demonstrate", "statistically", "significant", "improvement", "in", "all", "parameters", "with", "a", "similar", "safety", "profile", "as", "seen", "in", "the", "phase", "III", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p85_s1", "idA": "1006281_11_item1_p114_s7", "sentA": "We successfully completed the phase III clinical trial in September 2009.", "sentB": "According to the data, after 24 months, patients continued to demonstrate a significant improvement in all parameters with a similar safety profile as seen in the phase III clinical trial.", "type": 2, "words": ["<tag1>", "We", "successfully", "completed", "the", "phase", "III", "clinical", "trial", "in", "September", "2009.", "<tag2>", "According", "to", "the", "data,", "after", "24", "months,", "patients", "continued", "to", "demonstrate", "a", "significant", "improvement", "in", "all", "parameters", "with", "a", "similar", "safety", "profile", "as", "seen", "in", "the", "phase", "III", "clinical", "trial.", "<tag3>"], "wordsA": ["We", "successfully", "completed", "the", "phase", "III", "clinical", "trial", "in", "September", "2009."], "wordsB": ["According", "to", "the", "data,", "after", "24", "months,", "patients", "continued", "to", "demonstrate", "a", "significant", "improvement", "in", "all", "parameters", "with", "a", "similar", "safety", "profile", "as", "seen", "in", "the", "phase", "III", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p20_s2", "idA": "1006281_11_item1_p115_s1", "sentA": "The treatment protocol was approved by the FDA in August 2009.", "sentB": "The treatment protocol was approved by the FDA in August 2009, and we are continuing to treat patients in the United States under this protocol.", "type": 2, "words": ["<tag1>", "The", "treatment", "protocol", "was", "approved", "by", "the", "FDA", "in", "August", "2009.", "<tag2>", "The", "treatment", "protocol", "was", "approved", "by", "the", "FDA", "in", "August", "2009,", "and", "we", "are", "continuing", "to", "treat", "patients", "in", "the", "United", "States", "under", "this", "protocol.", "<tag3>"], "wordsA": ["The", "treatment", "protocol", "was", "approved", "by", "the", "FDA", "in", "August", "2009."], "wordsB": ["The", "treatment", "protocol", "was", "approved", "by", "the", "FDA", "in", "August", "2009,", "and", "we", "are", "continuing", "to", "treat", "patients", "in", "the", "United", "States", "under", "this", "protocol."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p79_s0", "idA": "1006281_11_item1_p115_s3", "sentA": "In January 2010, the Committee for Orphan Medicinal Products (COMP) of the EMEA, after reviewing all relevant clinical data, recommended that the European Commission grant Orphan Drug designation to taliglucerase alfa for the treatment of Gaucher disease.", "sentB": "In January 2010, COMP, after reviewing all relevant clinical data, recommended that the European Commission grant orphan drug designation to taliglucerase alfa for the treatment of Gaucher disease and in March 2010, the European Commission granted orphan designation to taliglucerase alfa.", "type": 2, "words": ["<tag1>", "In", "January", "2010,", "the", "Committee", "for", "Orphan", "Medicinal", "Products", "(COMP)", "of", "the", "EMEA,", "after", "reviewing", "all", "relevant", "clinical", "data,", "recommended", "that", "the", "European", "Commission", "grant", "Orphan", "Drug", "designation", "to", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "In", "January", "2010,", "COMP,", "after", "reviewing", "all", "relevant", "clinical", "data,", "recommended", "that", "the", "European", "Commission", "grant", "orphan", "drug", "designation", "to", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease", "and", "in", "March", "2010,", "the", "European", "Commission", "granted", "orphan", "designation", "to", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["In", "January", "2010,", "the", "Committee", "for", "Orphan", "Medicinal", "Products", "(COMP)", "of", "the", "EMEA,", "after", "reviewing", "all", "relevant", "clinical", "data,", "recommended", "that", "the", "European", "Commission", "grant", "Orphan", "Drug", "designation", "to", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["In", "January", "2010,", "COMP,", "after", "reviewing", "all", "relevant", "clinical", "data,", "recommended", "that", "the", "European", "Commission", "grant", "orphan", "drug", "designation", "to", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease", "and", "in", "March", "2010,", "the", "European", "Commission", "granted", "orphan", "designation", "to", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p8_s0", "idA": "1006281_11_item1_p115_s3", "sentA": "In January 2010, the Committee for Orphan Medicinal Products (COMP) of the EMEA, after reviewing all relevant clinical data, recommended that the European Commission grant Orphan Drug designation to taliglucerase alfa for the treatment of Gaucher disease.", "sentB": "In January 2010, the EMA's Committee for Orphan Medicinal Products, or COMP, after reviewing all relevant clinical data, recommended that the European Commission grant orphan drug designation to taliglucerase alfa for the treatment of Gaucher disease and in March 2010, the European Commission granted orphan designation to taliglucerase alfa.", "type": 2, "words": ["<tag1>", "In", "January", "2010,", "the", "Committee", "for", "Orphan", "Medicinal", "Products", "(COMP)", "of", "the", "EMEA,", "after", "reviewing", "all", "relevant", "clinical", "data,", "recommended", "that", "the", "European", "Commission", "grant", "Orphan", "Drug", "designation", "to", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "In", "January", "2010,", "the", "EMA's", "Committee", "for", "Orphan", "Medicinal", "Products,", "or", "COMP,", "after", "reviewing", "all", "relevant", "clinical", "data,", "recommended", "that", "the", "European", "Commission", "grant", "orphan", "drug", "designation", "to", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease", "and", "in", "March", "2010,", "the", "European", "Commission", "granted", "orphan", "designation", "to", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["In", "January", "2010,", "the", "Committee", "for", "Orphan", "Medicinal", "Products", "(COMP)", "of", "the", "EMEA,", "after", "reviewing", "all", "relevant", "clinical", "data,", "recommended", "that", "the", "European", "Commission", "grant", "Orphan", "Drug", "designation", "to", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["In", "January", "2010,", "the", "EMA's", "Committee", "for", "Orphan", "Medicinal", "Products,", "or", "COMP,", "after", "reviewing", "all", "relevant", "clinical", "data,", "recommended", "that", "the", "European", "Commission", "grant", "orphan", "drug", "designation", "to", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease", "and", "in", "March", "2010,", "the", "European", "Commission", "granted", "orphan", "designation", "to", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p119_s2", "idA": "1006281_11_item1_p117_s0", "sentA": "We reported positive top line results of our phase III clinical trial of taliglucerase alfa in October 2009 and full study results in February 2010.", "sentB": "We reported positive top-line results of the phase III clinical trial in October 2009 and full study results in February 2010.", "type": 2, "words": ["<tag1>", "We", "reported", "positive", "top", "line", "results", "of", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa", "in", "October", "2009", "and", "full", "study", "results", "in", "February", "2010.", "<tag2>", "We", "reported", "positive", "top-line", "results", "of", "the", "phase", "III", "clinical", "trial", "in", "October", "2009", "and", "full", "study", "results", "in", "February", "2010.", "<tag3>"], "wordsA": ["We", "reported", "positive", "top", "line", "results", "of", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa", "in", "October", "2009", "and", "full", "study", "results", "in", "February", "2010."], "wordsB": ["We", "reported", "positive", "top-line", "results", "of", "the", "phase", "III", "clinical", "trial", "in", "October", "2009", "and", "full", "study", "results", "in", "February", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p133_s1", "idA": "1006281_11_item1_p117_s1", "sentA": "In the clinical trial, taliglucerase alfa significantly reduced mean spleen volume after nine months compared with baseline in both treatment groups.", "sentB": "In the clinical trial, taliglucerase alfa significantly reduced mean spleen volume after nine months compared with baseline in both treatment groups, thereby meeting the trial's primary endpoint of reduced mean spleen volume after nine months.", "type": 2, "words": ["<tag1>", "In", "the", "clinical", "trial,", "taliglucerase", "alfa", "significantly", "reduced", "mean", "spleen", "volume", "after", "nine", "months", "compared", "with", "baseline", "in", "both", "treatment", "groups.", "<tag2>", "In", "the", "clinical", "trial,", "taliglucerase", "alfa", "significantly", "reduced", "mean", "spleen", "volume", "after", "nine", "months", "compared", "with", "baseline", "in", "both", "treatment", "groups,", "thereby", "meeting", "the", "trial's", "primary", "endpoint", "of", "reduced", "mean", "spleen", "volume", "after", "nine", "months.", "<tag3>"], "wordsA": ["In", "the", "clinical", "trial,", "taliglucerase", "alfa", "significantly", "reduced", "mean", "spleen", "volume", "after", "nine", "months", "compared", "with", "baseline", "in", "both", "treatment", "groups."], "wordsB": ["In", "the", "clinical", "trial,", "taliglucerase", "alfa", "significantly", "reduced", "mean", "spleen", "volume", "after", "nine", "months", "compared", "with", "baseline", "in", "both", "treatment", "groups,", "thereby", "meeting", "the", "trial's", "primary", "endpoint", "of", "reduced", "mean", "spleen", "volume", "after", "nine", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p135_s0", "idA": "1006281_11_item1_p117_s2", "sentA": "The 60 U/kg group demonstrated a statistically significant mean reduction in spleen volume of 38.0% (p 0.0001) and the 30 U/kg group demonstrated a significant mean reduction in spleen volume of 26.9% (p 0.0001).", "sentB": "In the phase III clinical trial, the 60 U/kg group demonstrated a statistically significant mean reduction in spleen volume of 38.0% (p 0.0001) and the 30 U/kg group demonstrated a significant mean reduction in spleen volume of 26.9% (p 0.0001).", "type": 2, "words": ["<tag1>", "The", "60", "U/kg", "group", "demonstrated", "a", "statistically", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "38.0%", "(p", "0.0001)", "and", "the", "30", "U/kg", "group", "demonstrated", "a", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "26.9%", "(p", "0.0001).", "<tag2>", "In", "the", "phase", "III", "clinical", "trial,", "the", "60", "U/kg", "group", "demonstrated", "a", "statistically", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "38.0%", "(p", "0.0001)", "and", "the", "30", "U/kg", "group", "demonstrated", "a", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "26.9%", "(p", "0.0001).", "<tag3>"], "wordsA": ["The", "60", "U/kg", "group", "demonstrated", "a", "statistically", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "38.0%", "(p", "0.0001)", "and", "the", "30", "U/kg", "group", "demonstrated", "a", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "26.9%", "(p", "0.0001)."], "wordsB": ["In", "the", "phase", "III", "clinical", "trial,", "the", "60", "U/kg", "group", "demonstrated", "a", "statistically", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "38.0%", "(p", "0.0001)", "and", "the", "30", "U/kg", "group", "demonstrated", "a", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "26.9%", "(p", "0.0001)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p135_s2", "idA": "1006281_11_item1_p117_s2", "sentA": "The 60 U/kg group demonstrated a statistically significant mean reduction in spleen volume of 38.0% (p 0.0001) and the 30 U/kg group demonstrated a significant mean reduction in spleen volume of 26.9% (p 0.0001).", "sentB": "Patients treated with taliglucerase alfa in the extension trial continued to demonstrate a statistically significant reduction in mean spleen volume after 24 months, compared with baseline, in both treatment groups; reductions of 54.0% (p 0.0001) in the 60 U/kg group and of 41.0% (p 0.0001) in the 30 U/kg group.", "type": 2, "words": ["<tag1>", "The", "60", "U/kg", "group", "demonstrated", "a", "statistically", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "38.0%", "(p", "0.0001)", "and", "the", "30", "U/kg", "group", "demonstrated", "a", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "26.9%", "(p", "0.0001).", "<tag2>", "Patients", "treated", "with", "taliglucerase", "alfa", "in", "the", "extension", "trial", "continued", "to", "demonstrate", "a", "statistically", "significant", "reduction", "in", "mean", "spleen", "volume", "after", "24", "months,", "compared", "with", "baseline,", "in", "both", "treatment", "groups;", "reductions", "of", "54.0%", "(p", "0.0001)", "in", "the", "60", "U/kg", "group", "and", "of", "41.0%", "(p", "0.0001)", "in", "the", "30", "U/kg", "group.", "<tag3>"], "wordsA": ["The", "60", "U/kg", "group", "demonstrated", "a", "statistically", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "38.0%", "(p", "0.0001)", "and", "the", "30", "U/kg", "group", "demonstrated", "a", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "26.9%", "(p", "0.0001)."], "wordsB": ["Patients", "treated", "with", "taliglucerase", "alfa", "in", "the", "extension", "trial", "continued", "to", "demonstrate", "a", "statistically", "significant", "reduction", "in", "mean", "spleen", "volume", "after", "24", "months,", "compared", "with", "baseline,", "in", "both", "treatment", "groups;", "reductions", "of", "54.0%", "(p", "0.0001)", "in", "the", "60", "U/kg", "group", "and", "of", "41.0%", "(p", "0.0001)", "in", "the", "30", "U/kg", "group."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p137_s1", "idA": "1006281_11_item1_p117_s2", "sentA": "The 60 U/kg group demonstrated a statistically significant mean reduction in spleen volume of 38.0% (p 0.0001) and the 30 U/kg group demonstrated a significant mean reduction in spleen volume of 26.9% (p 0.0001).", "sentB": "In the extension trial, statistically significant mean increases in hemoglobin concentration were also demonstrated by both groups; mean increases from baseline (from 11.6 g/DL to 13.9 g/DL (p 0.0020)) (19.8%) in the 60 U/kg group and mean increases from baseline (from 12.4 g/DL to 13.6 g/DL (p 0.0314)) (9.7%) in the 30 U/kg group.", "type": 2, "words": ["<tag1>", "The", "60", "U/kg", "group", "demonstrated", "a", "statistically", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "38.0%", "(p", "0.0001)", "and", "the", "30", "U/kg", "group", "demonstrated", "a", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "26.9%", "(p", "0.0001).", "<tag2>", "In", "the", "extension", "trial,", "statistically", "significant", "mean", "increases", "in", "hemoglobin", "concentration", "were", "also", "demonstrated", "by", "both", "groups;", "mean", "increases", "from", "baseline", "(from", "11.6", "g/DL", "to", "13.9", "g/DL", "(p", "0.0020))", "(19.8%)", "in", "the", "60", "U/kg", "group", "and", "mean", "increases", "from", "baseline", "(from", "12.4", "g/DL", "to", "13.6", "g/DL", "(p", "0.0314))", "(9.7%)", "in", "the", "30", "U/kg", "group.", "<tag3>"], "wordsA": ["The", "60", "U/kg", "group", "demonstrated", "a", "statistically", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "38.0%", "(p", "0.0001)", "and", "the", "30", "U/kg", "group", "demonstrated", "a", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "26.9%", "(p", "0.0001)."], "wordsB": ["In", "the", "extension", "trial,", "statistically", "significant", "mean", "increases", "in", "hemoglobin", "concentration", "were", "also", "demonstrated", "by", "both", "groups;", "mean", "increases", "from", "baseline", "(from", "11.6", "g/DL", "to", "13.9", "g/DL", "(p", "0.0020))", "(19.8%)", "in", "the", "60", "U/kg", "group", "and", "mean", "increases", "from", "baseline", "(from", "12.4", "g/DL", "to", "13.6", "g/DL", "(p", "0.0314))", "(9.7%)", "in", "the", "30", "U/kg", "group."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p138_s0", "idA": "1006281_11_item1_p117_s2", "sentA": "The 60 U/kg group demonstrated a statistically significant mean reduction in spleen volume of 38.0% (p 0.0001) and the 30 U/kg group demonstrated a significant mean reduction in spleen volume of 26.9% (p 0.0001).", "sentB": "In the phase III clinical trial, patients in both dosage groups demonstrated mean increases in liver volume; reductions of 11.1% (p 0.0001) in the 60 U/kg group and of 10.48% (p 0.0041) in the 30 U/kg group.", "type": 2, "words": ["<tag1>", "The", "60", "U/kg", "group", "demonstrated", "a", "statistically", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "38.0%", "(p", "0.0001)", "and", "the", "30", "U/kg", "group", "demonstrated", "a", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "26.9%", "(p", "0.0001).", "<tag2>", "In", "the", "phase", "III", "clinical", "trial,", "patients", "in", "both", "dosage", "groups", "demonstrated", "mean", "increases", "in", "liver", "volume;", "reductions", "of", "11.1%", "(p", "0.0001)", "in", "the", "60", "U/kg", "group", "and", "of", "10.48%", "(p", "0.0041)", "in", "the", "30", "U/kg", "group.", "<tag3>"], "wordsA": ["The", "60", "U/kg", "group", "demonstrated", "a", "statistically", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "38.0%", "(p", "0.0001)", "and", "the", "30", "U/kg", "group", "demonstrated", "a", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "26.9%", "(p", "0.0001)."], "wordsB": ["In", "the", "phase", "III", "clinical", "trial,", "patients", "in", "both", "dosage", "groups", "demonstrated", "mean", "increases", "in", "liver", "volume;", "reductions", "of", "11.1%", "(p", "0.0001)", "in", "the", "60", "U/kg", "group", "and", "of", "10.48%", "(p", "0.0041)", "in", "the", "30", "U/kg", "group."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p138_s1", "idA": "1006281_11_item1_p117_s2", "sentA": "The 60 U/kg group demonstrated a statistically significant mean reduction in spleen volume of 38.0% (p 0.0001) and the 30 U/kg group demonstrated a significant mean reduction in spleen volume of 26.9% (p 0.0001).", "sentB": "In the extension trial, both groups demonstrated statistically significant mean reductions in liver volume; reductions of 17.5% (p 0.0003) in the 60 U/kg group and of 20.6% (p 0.0001) in the 30 U/kg group; patients with Hepatomegaly demonstrated a reduction in liver volume of 25.2% (p 0.0001).", "type": 2, "words": ["<tag1>", "The", "60", "U/kg", "group", "demonstrated", "a", "statistically", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "38.0%", "(p", "0.0001)", "and", "the", "30", "U/kg", "group", "demonstrated", "a", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "26.9%", "(p", "0.0001).", "<tag2>", "In", "the", "extension", "trial,", "both", "groups", "demonstrated", "statistically", "significant", "mean", "reductions", "in", "liver", "volume;", "reductions", "of", "17.5%", "(p", "0.0003)", "in", "the", "60", "U/kg", "group", "and", "of", "20.6%", "(p", "0.0001)", "in", "the", "30", "U/kg", "group;", "patients", "with", "Hepatomegaly", "demonstrated", "a", "reduction", "in", "liver", "volume", "of", "25.2%", "(p", "0.0001).", "<tag3>"], "wordsA": ["The", "60", "U/kg", "group", "demonstrated", "a", "statistically", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "38.0%", "(p", "0.0001)", "and", "the", "30", "U/kg", "group", "demonstrated", "a", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "26.9%", "(p", "0.0001)."], "wordsB": ["In", "the", "extension", "trial,", "both", "groups", "demonstrated", "statistically", "significant", "mean", "reductions", "in", "liver", "volume;", "reductions", "of", "17.5%", "(p", "0.0003)", "in", "the", "60", "U/kg", "group", "and", "of", "20.6%", "(p", "0.0001)", "in", "the", "30", "U/kg", "group;", "patients", "with", "Hepatomegaly", "demonstrated", "a", "reduction", "in", "liver", "volume", "of", "25.2%", "(p", "0.0001)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p139_s2", "idA": "1006281_11_item1_p117_s2", "sentA": "The 60 U/kg group demonstrated a statistically significant mean reduction in spleen volume of 38.0% (p 0.0001) and the 30 U/kg group demonstrated a significant mean reduction in spleen volume of 26.9% (p 0.0001).", "sentB": "However, in the extension trial, both groups demonstrated statistically significant mean increases in platelet count for both groups; increases from 69,043 to 141,071 (p 0.0016) in the 60 U/kg group and from 64,900 to 93,333 (p 0.0105) in the 30 U/kg group.", "type": 2, "words": ["<tag1>", "The", "60", "U/kg", "group", "demonstrated", "a", "statistically", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "38.0%", "(p", "0.0001)", "and", "the", "30", "U/kg", "group", "demonstrated", "a", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "26.9%", "(p", "0.0001).", "<tag2>", "However,", "in", "the", "extension", "trial,", "both", "groups", "demonstrated", "statistically", "significant", "mean", "increases", "in", "platelet", "count", "for", "both", "groups;", "increases", "from", "69,043", "to", "141,071", "(p", "0.0016)", "in", "the", "60", "U/kg", "group", "and", "from", "64,900", "to", "93,333", "(p", "0.0105)", "in", "the", "30", "U/kg", "group.", "<tag3>"], "wordsA": ["The", "60", "U/kg", "group", "demonstrated", "a", "statistically", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "38.0%", "(p", "0.0001)", "and", "the", "30", "U/kg", "group", "demonstrated", "a", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "26.9%", "(p", "0.0001)."], "wordsB": ["However,", "in", "the", "extension", "trial,", "both", "groups", "demonstrated", "statistically", "significant", "mean", "increases", "in", "platelet", "count", "for", "both", "groups;", "increases", "from", "69,043", "to", "141,071", "(p", "0.0016)", "in", "the", "60", "U/kg", "group", "and", "from", "64,900", "to", "93,333", "(p", "0.0105)", "in", "the", "30", "U/kg", "group."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p140_s2", "idA": "1006281_11_item1_p117_s2", "sentA": "The 60 U/kg group demonstrated a statistically significant mean reduction in spleen volume of 38.0% (p 0.0001) and the 30 U/kg group demonstrated a significant mean reduction in spleen volume of 26.9% (p 0.0001).", "sentB": "In the extension trial, statistically significant mean reductions in chitotriosidase activity were demonstrated by both groups; a reduction of 76% (p 0.0001)) in the 60 U/kg group and of 61% (p 0.0001) in the 30 U/kg group.", "type": 2, "words": ["<tag1>", "The", "60", "U/kg", "group", "demonstrated", "a", "statistically", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "38.0%", "(p", "0.0001)", "and", "the", "30", "U/kg", "group", "demonstrated", "a", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "26.9%", "(p", "0.0001).", "<tag2>", "In", "the", "extension", "trial,", "statistically", "significant", "mean", "reductions", "in", "chitotriosidase", "activity", "were", "demonstrated", "by", "both", "groups;", "a", "reduction", "of", "76%", "(p", "0.0001))", "in", "the", "60", "U/kg", "group", "and", "of", "61%", "(p", "0.0001)", "in", "the", "30", "U/kg", "group.", "<tag3>"], "wordsA": ["The", "60", "U/kg", "group", "demonstrated", "a", "statistically", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "38.0%", "(p", "0.0001)", "and", "the", "30", "U/kg", "group", "demonstrated", "a", "significant", "mean", "reduction", "in", "spleen", "volume", "of", "26.9%", "(p", "0.0001)."], "wordsB": ["In", "the", "extension", "trial,", "statistically", "significant", "mean", "reductions", "in", "chitotriosidase", "activity", "were", "demonstrated", "by", "both", "groups;", "a", "reduction", "of", "76%", "(p", "0.0001))", "in", "the", "60", "U/kg", "group", "and", "of", "61%", "(p", "0.0001)", "in", "the", "30", "U/kg", "group."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p136_s0", "idA": "1006281_11_item1_p118_s0", "sentA": "Statistically significant improvements were also observed for the secondary endpoints after nine months when compared to baseline for the 60 U/kg dose.", "sentB": "In the phase III clinical trial, statistically significant improvements were also observed for the secondary endpoints, including increase in hemoglobin level, decrease in liver size and increase in platelet count, after nine months when compared to baseline for the 60 U/kg dose.", "type": 2, "words": ["<tag1>", "Statistically", "significant", "improvements", "were", "also", "observed", "for", "the", "secondary", "endpoints", "after", "nine", "months", "when", "compared", "to", "baseline", "for", "the", "60", "U/kg", "dose.", "<tag2>", "In", "the", "phase", "III", "clinical", "trial,", "statistically", "significant", "improvements", "were", "also", "observed", "for", "the", "secondary", "endpoints,", "including", "increase", "in", "hemoglobin", "level,", "decrease", "in", "liver", "size", "and", "increase", "in", "platelet", "count,", "after", "nine", "months", "when", "compared", "to", "baseline", "for", "the", "60", "U/kg", "dose.", "<tag3>"], "wordsA": ["Statistically", "significant", "improvements", "were", "also", "observed", "for", "the", "secondary", "endpoints", "after", "nine", "months", "when", "compared", "to", "baseline", "for", "the", "60", "U/kg", "dose."], "wordsB": ["In", "the", "phase", "III", "clinical", "trial,", "statistically", "significant", "improvements", "were", "also", "observed", "for", "the", "secondary", "endpoints,", "including", "increase", "in", "hemoglobin", "level,", "decrease", "in", "liver", "size", "and", "increase", "in", "platelet", "count,", "after", "nine", "months", "when", "compared", "to", "baseline", "for", "the", "60", "U/kg", "dose."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p137_s2", "idA": "1006281_11_item1_p118_s1", "sentA": "Patients demonstrated a mean increase in hemoglobin of 2.2 g/dL or 22.2% (p 0.0001), a mean decrease in liver volume of 11.1% (p 0.0001) and a mean elevation in platelet count of 41,494 ml or 72.1% (p=0.0031).", "sentB": "Anemic patients demonstrated a mean increase from baseline in hemoglobin concentration (from 9.5 g/DL to 12.9 g/DL (p 0.0013) (35.8%)).", "type": 2, "words": ["<tag1>", "Patients", "demonstrated", "a", "mean", "increase", "in", "hemoglobin", "of", "2.2", "g/dL", "or", "22.2%", "(p", "0.0001),", "a", "mean", "decrease", "in", "liver", "volume", "of", "11.1%", "(p", "0.0001)", "and", "a", "mean", "elevation", "in", "platelet", "count", "of", "41,494", "ml", "or", "72.1%", "(p=0.0031).", "<tag2>", "Anemic", "patients", "demonstrated", "a", "mean", "increase", "from", "baseline", "in", "hemoglobin", "concentration", "(from", "9.5", "g/DL", "to", "12.9", "g/DL", "(p", "0.0013)", "(35.8%)).", "<tag3>"], "wordsA": ["Patients", "demonstrated", "a", "mean", "increase", "in", "hemoglobin", "of", "2.2", "g/dL", "or", "22.2%", "(p", "0.0001),", "a", "mean", "decrease", "in", "liver", "volume", "of", "11.1%", "(p", "0.0001)", "and", "a", "mean", "elevation", "in", "platelet", "count", "of", "41,494", "ml", "or", "72.1%", "(p=0.0031)."], "wordsB": ["Anemic", "patients", "demonstrated", "a", "mean", "increase", "from", "baseline", "in", "hemoglobin", "concentration", "(from", "9.5", "g/DL", "to", "12.9", "g/DL", "(p", "0.0013)", "(35.8%))."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p139_s0", "idA": "1006281_11_item1_p118_s1", "sentA": "Patients demonstrated a mean increase in hemoglobin of 2.2 g/dL or 22.2% (p 0.0001), a mean decrease in liver volume of 11.1% (p 0.0001) and a mean elevation in platelet count of 41,494 ml or 72.1% (p=0.0031).", "sentB": "In the phase III clinical trial, patients in both dosage groups demonstrated mean increases in platelet count; an increase in platelet count of 41,494 ml or 72.1% (p=0.0031) in the 60 U/kg group and a nominal increase of 11,427 ml or 13.7% (p=0.0460) in the 30 U/kg group.", "type": 2, "words": ["<tag1>", "Patients", "demonstrated", "a", "mean", "increase", "in", "hemoglobin", "of", "2.2", "g/dL", "or", "22.2%", "(p", "0.0001),", "a", "mean", "decrease", "in", "liver", "volume", "of", "11.1%", "(p", "0.0001)", "and", "a", "mean", "elevation", "in", "platelet", "count", "of", "41,494", "ml", "or", "72.1%", "(p=0.0031).", "<tag2>", "In", "the", "phase", "III", "clinical", "trial,", "patients", "in", "both", "dosage", "groups", "demonstrated", "mean", "increases", "in", "platelet", "count;", "an", "increase", "in", "platelet", "count", "of", "41,494", "ml", "or", "72.1%", "(p=0.0031)", "in", "the", "60", "U/kg", "group", "and", "a", "nominal", "increase", "of", "11,427", "ml", "or", "13.7%", "(p=0.0460)", "in", "the", "30", "U/kg", "group.", "<tag3>"], "wordsA": ["Patients", "demonstrated", "a", "mean", "increase", "in", "hemoglobin", "of", "2.2", "g/dL", "or", "22.2%", "(p", "0.0001),", "a", "mean", "decrease", "in", "liver", "volume", "of", "11.1%", "(p", "0.0001)", "and", "a", "mean", "elevation", "in", "platelet", "count", "of", "41,494", "ml", "or", "72.1%", "(p=0.0031)."], "wordsB": ["In", "the", "phase", "III", "clinical", "trial,", "patients", "in", "both", "dosage", "groups", "demonstrated", "mean", "increases", "in", "platelet", "count;", "an", "increase", "in", "platelet", "count", "of", "41,494", "ml", "or", "72.1%", "(p=0.0031)", "in", "the", "60", "U/kg", "group", "and", "a", "nominal", "increase", "of", "11,427", "ml", "or", "13.7%", "(p=0.0460)", "in", "the", "30", "U/kg", "group."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p140_s0", "idA": "1006281_11_item1_p119_s0", "sentA": "Thirty patients in the trial had Chitotriosidase measurements, a biomarker for clinical symptoms of Gaucher disease.", "sentB": "Last, 30 patients in the phase III clinical trial had chitotriosidase measurements, a biomarker for clinical symptoms of Gaucher disease.", "type": 2, "words": ["<tag1>", "Thirty", "patients", "in", "the", "trial", "had", "Chitotriosidase", "measurements,", "a", "biomarker", "for", "clinical", "symptoms", "of", "Gaucher", "disease.", "<tag2>", "Last,", "30", "patients", "in", "the", "phase", "III", "clinical", "trial", "had", "chitotriosidase", "measurements,", "a", "biomarker", "for", "clinical", "symptoms", "of", "Gaucher", "disease.", "<tag3>"], "wordsA": ["Thirty", "patients", "in", "the", "trial", "had", "Chitotriosidase", "measurements,", "a", "biomarker", "for", "clinical", "symptoms", "of", "Gaucher", "disease."], "wordsB": ["Last,", "30", "patients", "in", "the", "phase", "III", "clinical", "trial", "had", "chitotriosidase", "measurements,", "a", "biomarker", "for", "clinical", "symptoms", "of", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p141_s0", "idA": "1006281_11_item1_p120_s0", "sentA": "The safety analysis for both treatment groups showed that taliglucerase alfa was well tolerated and no serious or severe adverse events were reported.", "sentB": "The safety analysis for both treatment groups in the phase III clinical trial showed that taliglucerase alfa was well tolerated and no serious or severe adverse events were reported.", "type": 2, "words": ["<tag1>", "The", "safety", "analysis", "for", "both", "treatment", "groups", "showed", "that", "taliglucerase", "alfa", "was", "well", "tolerated", "and", "no", "serious", "or", "severe", "adverse", "events", "were", "reported.", "<tag2>", "The", "safety", "analysis", "for", "both", "treatment", "groups", "in", "the", "phase", "III", "clinical", "trial", "showed", "that", "taliglucerase", "alfa", "was", "well", "tolerated", "and", "no", "serious", "or", "severe", "adverse", "events", "were", "reported.", "<tag3>"], "wordsA": ["The", "safety", "analysis", "for", "both", "treatment", "groups", "showed", "that", "taliglucerase", "alfa", "was", "well", "tolerated", "and", "no", "serious", "or", "severe", "adverse", "events", "were", "reported."], "wordsB": ["The", "safety", "analysis", "for", "both", "treatment", "groups", "in", "the", "phase", "III", "clinical", "trial", "showed", "that", "taliglucerase", "alfa", "was", "well", "tolerated", "and", "no", "serious", "or", "severe", "adverse", "events", "were", "reported."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p141_s4", "idA": "1006281_11_item1_p120_s0", "sentA": "The safety analysis for both treatment groups showed that taliglucerase alfa was well tolerated and no serious or severe adverse events were reported.", "sentB": "The safety analysis in the extension trial for both treatment groups also demonstrates that taliglucerase alfa was well tolerated, and no drug related serious adverse events were reported.", "type": 2, "words": ["<tag1>", "The", "safety", "analysis", "for", "both", "treatment", "groups", "showed", "that", "taliglucerase", "alfa", "was", "well", "tolerated", "and", "no", "serious", "or", "severe", "adverse", "events", "were", "reported.", "<tag2>", "The", "safety", "analysis", "in", "the", "extension", "trial", "for", "both", "treatment", "groups", "also", "demonstrates", "that", "taliglucerase", "alfa", "was", "well", "tolerated,", "and", "no", "drug", "related", "serious", "adverse", "events", "were", "reported.", "<tag3>"], "wordsA": ["The", "safety", "analysis", "for", "both", "treatment", "groups", "showed", "that", "taliglucerase", "alfa", "was", "well", "tolerated", "and", "no", "serious", "or", "severe", "adverse", "events", "were", "reported."], "wordsB": ["The", "safety", "analysis", "in", "the", "extension", "trial", "for", "both", "treatment", "groups", "also", "demonstrates", "that", "taliglucerase", "alfa", "was", "well", "tolerated,", "and", "no", "drug", "related", "serious", "adverse", "events", "were", "reported."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p14_s2", "idA": "1006281_11_item1_p120_s0", "sentA": "The safety analysis for both treatment groups showed that taliglucerase alfa was well tolerated and no serious or severe adverse events were reported.", "sentB": "The safety analysis of the switchover trial demonstrated that taliglucerase alfa was well tolerated, and no drug-related serious adverse events were reported.", "type": 2, "words": ["<tag1>", "The", "safety", "analysis", "for", "both", "treatment", "groups", "showed", "that", "taliglucerase", "alfa", "was", "well", "tolerated", "and", "no", "serious", "or", "severe", "adverse", "events", "were", "reported.", "<tag2>", "The", "safety", "analysis", "of", "the", "switchover", "trial", "demonstrated", "that", "taliglucerase", "alfa", "was", "well", "tolerated,", "and", "no", "drug-related", "serious", "adverse", "events", "were", "reported.", "<tag3>"], "wordsA": ["The", "safety", "analysis", "for", "both", "treatment", "groups", "showed", "that", "taliglucerase", "alfa", "was", "well", "tolerated", "and", "no", "serious", "or", "severe", "adverse", "events", "were", "reported."], "wordsB": ["The", "safety", "analysis", "of", "the", "switchover", "trial", "demonstrated", "that", "taliglucerase", "alfa", "was", "well", "tolerated,", "and", "no", "drug-related", "serious", "adverse", "events", "were", "reported."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p88_s7", "idA": "1006281_11_item1_p120_s0", "sentA": "The safety analysis for both treatment groups showed that taliglucerase alfa was well tolerated and no serious or severe adverse events were reported.", "sentB": "The safety analysis of the switchover trial demonstrated that taliglucerase alfa was well tolerated, and no drug related serious adverse events were reported.", "type": 2, "words": ["<tag1>", "The", "safety", "analysis", "for", "both", "treatment", "groups", "showed", "that", "taliglucerase", "alfa", "was", "well", "tolerated", "and", "no", "serious", "or", "severe", "adverse", "events", "were", "reported.", "<tag2>", "The", "safety", "analysis", "of", "the", "switchover", "trial", "demonstrated", "that", "taliglucerase", "alfa", "was", "well", "tolerated,", "and", "no", "drug", "related", "serious", "adverse", "events", "were", "reported.", "<tag3>"], "wordsA": ["The", "safety", "analysis", "for", "both", "treatment", "groups", "showed", "that", "taliglucerase", "alfa", "was", "well", "tolerated", "and", "no", "serious", "or", "severe", "adverse", "events", "were", "reported."], "wordsB": ["The", "safety", "analysis", "of", "the", "switchover", "trial", "demonstrated", "that", "taliglucerase", "alfa", "was", "well", "tolerated,", "and", "no", "drug", "related", "serious", "adverse", "events", "were", "reported."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p142_s0", "idA": "1006281_11_item1_p120_s1", "sentA": "Two patients in the trial developed antibodies to taliglucerase alfa and no patients developed neutralizing antibodies.", "sentB": "Two patients who participated in the extension trial developed neutralizing IgG antibodies that were determined to be positive in an in vitro assay, but were determined to be negative in a cell-based assay.", "type": 2, "words": ["<tag1>", "Two", "patients", "in", "the", "trial", "developed", "antibodies", "to", "taliglucerase", "alfa", "and", "no", "patients", "developed", "neutralizing", "antibodies.", "<tag2>", "Two", "patients", "who", "participated", "in", "the", "extension", "trial", "developed", "neutralizing", "IgG", "antibodies", "that", "were", "determined", "to", "be", "positive", "in", "an", "in", "vitro", "assay,", "but", "were", "determined", "to", "be", "negative", "in", "a", "cell-based", "assay.", "<tag3>"], "wordsA": ["Two", "patients", "in", "the", "trial", "developed", "antibodies", "to", "taliglucerase", "alfa", "and", "no", "patients", "developed", "neutralizing", "antibodies."], "wordsB": ["Two", "patients", "who", "participated", "in", "the", "extension", "trial", "developed", "neutralizing", "IgG", "antibodies", "that", "were", "determined", "to", "be", "positive", "in", "an", "in", "vitro", "assay,", "but", "were", "determined", "to", "be", "negative", "in", "a", "cell-based", "assay."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p143_s0", "idA": "1006281_11_item1_p121_s0", "sentA": "Most adverse events were considered unrelated to taliglucerase alfa.", "sentB": "In the phase III clinical trial, most adverse events were considered unrelated to taliglucerase alfa.", "type": 2, "words": ["<tag1>", "Most", "adverse", "events", "were", "considered", "unrelated", "to", "taliglucerase", "alfa.", "<tag2>", "In", "the", "phase", "III", "clinical", "trial,", "most", "adverse", "events", "were", "considered", "unrelated", "to", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["Most", "adverse", "events", "were", "considered", "unrelated", "to", "taliglucerase", "alfa."], "wordsB": ["In", "the", "phase", "III", "clinical", "trial,", "most", "adverse", "events", "were", "considered", "unrelated", "to", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p120_s0", "idA": "1006281_11_item1_p122_s0", "sentA": "In November 2010, we announced positive preliminary data from the first 15 patients that completed our switchover trial of taliglucerase alfa.", "sentB": "In February 2012, we announced positive results from our extension study in na ve patients and from our switchover study.", "type": 2, "words": ["<tag1>", "In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "our", "switchover", "trial", "of", "taliglucerase", "alfa.", "<tag2>", "In", "February", "2012,", "we", "announced", "positive", "results", "from", "our", "extension", "study", "in", "na", "ve", "patients", "and", "from", "our", "switchover", "study.", "<tag3>"], "wordsA": ["In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "our", "switchover", "trial", "of", "taliglucerase", "alfa."], "wordsB": ["In", "February", "2012,", "we", "announced", "positive", "results", "from", "our", "extension", "study", "in", "na", "ve", "patients", "and", "from", "our", "switchover", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p144_s0", "idA": "1006281_11_item1_p122_s0", "sentA": "In November 2010, we announced positive preliminary data from the first 15 patients that completed our switchover trial of taliglucerase alfa.", "sentB": "In November 2010, we announced positive preliminary data from the first 15 patients that completed our switchover trial of taliglucerase alfa, and in February 2012 we reported full results from the trial.", "type": 2, "words": ["<tag1>", "In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "our", "switchover", "trial", "of", "taliglucerase", "alfa.", "<tag2>", "In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "our", "switchover", "trial", "of", "taliglucerase", "alfa,", "and", "in", "February", "2012", "we", "reported", "full", "results", "from", "the", "trial.", "<tag3>"], "wordsA": ["In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "our", "switchover", "trial", "of", "taliglucerase", "alfa."], "wordsB": ["In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "our", "switchover", "trial", "of", "taliglucerase", "alfa,", "and", "in", "February", "2012", "we", "reported", "full", "results", "from", "the", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p145_s0", "idA": "1006281_11_item1_p123_s2", "sentA": "The safety analysis from the interim report (n=25, as performed at the time of data lock) demonstrates that taliglucerase alfa was well tolerated and no drug related severe adverse events were reported.", "sentB": "The safety analysis presented for the switchover trial demonstrates that taliglucerase alfa was well tolerated, and no drug related serious adverse events were reported.", "type": 2, "words": ["<tag1>", "The", "safety", "analysis", "from", "the", "interim", "report", "(n=25,", "as", "performed", "at", "the", "time", "of", "data", "lock)", "demonstrates", "that", "taliglucerase", "alfa", "was", "well", "tolerated", "and", "no", "drug", "related", "severe", "adverse", "events", "were", "reported.", "<tag2>", "The", "safety", "analysis", "presented", "for", "the", "switchover", "trial", "demonstrates", "that", "taliglucerase", "alfa", "was", "well", "tolerated,", "and", "no", "drug", "related", "serious", "adverse", "events", "were", "reported.", "<tag3>"], "wordsA": ["The", "safety", "analysis", "from", "the", "interim", "report", "(n=25,", "as", "performed", "at", "the", "time", "of", "data", "lock)", "demonstrates", "that", "taliglucerase", "alfa", "was", "well", "tolerated", "and", "no", "drug", "related", "severe", "adverse", "events", "were", "reported."], "wordsB": ["The", "safety", "analysis", "presented", "for", "the", "switchover", "trial", "demonstrates", "that", "taliglucerase", "alfa", "was", "well", "tolerated,", "and", "no", "drug", "related", "serious", "adverse", "events", "were", "reported."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p146_s0", "idA": "1006281_11_item1_p124_s0", "sentA": "We are developing other recombinant therapeutic proteins to be expressed by our ProCellEx protein expression system, with an emphasis on treatments for which there are large, established pharmaceutical markets and where our proprietary protein expression system enables us to develop and commercialize recombinant proteins that are patent-protected and therapeutically equivalent or superior to the existing treatments.", "sentB": "We are developing other innovative recombinant therapeutic proteins to be expressed by our ProCellEx protein expression system, with an emphasis on treatments for which there are large, established pharmaceutical markets and where our proprietary protein expression system enables us to develop and commercialize recombinant proteins that are patent-protected and therapeutically equivalent or superior to the existing treatments.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "other", "recombinant", "therapeutic", "proteins", "to", "be", "expressed", "by", "our", "ProCellEx", "protein", "expression", "system,", "with", "an", "emphasis", "on", "treatments", "for", "which", "there", "are", "large,", "established", "pharmaceutical", "markets", "and", "where", "our", "proprietary", "protein", "expression", "system", "enables", "us", "to", "develop", "and", "commercialize", "recombinant", "proteins", "that", "are", "patent-protected", "and", "therapeutically", "equivalent", "or", "superior", "to", "the", "existing", "treatments.", "<tag2>", "We", "are", "developing", "other", "innovative", "recombinant", "therapeutic", "proteins", "to", "be", "expressed", "by", "our", "ProCellEx", "protein", "expression", "system,", "with", "an", "emphasis", "on", "treatments", "for", "which", "there", "are", "large,", "established", "pharmaceutical", "markets", "and", "where", "our", "proprietary", "protein", "expression", "system", "enables", "us", "to", "develop", "and", "commercialize", "recombinant", "proteins", "that", "are", "patent-protected", "and", "therapeutically", "equivalent", "or", "superior", "to", "the", "existing", "treatments.", "<tag3>"], "wordsA": ["We", "are", "developing", "other", "recombinant", "therapeutic", "proteins", "to", "be", "expressed", "by", "our", "ProCellEx", "protein", "expression", "system,", "with", "an", "emphasis", "on", "treatments", "for", "which", "there", "are", "large,", "established", "pharmaceutical", "markets", "and", "where", "our", "proprietary", "protein", "expression", "system", "enables", "us", "to", "develop", "and", "commercialize", "recombinant", "proteins", "that", "are", "patent-protected", "and", "therapeutically", "equivalent", "or", "superior", "to", "the", "existing", "treatments."], "wordsB": ["We", "are", "developing", "other", "innovative", "recombinant", "therapeutic", "proteins", "to", "be", "expressed", "by", "our", "ProCellEx", "protein", "expression", "system,", "with", "an", "emphasis", "on", "treatments", "for", "which", "there", "are", "large,", "established", "pharmaceutical", "markets", "and", "where", "our", "proprietary", "protein", "expression", "system", "enables", "us", "to", "develop", "and", "commercialize", "recombinant", "proteins", "that", "are", "patent-protected", "and", "therapeutically", "equivalent", "or", "superior", "to", "the", "existing", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p149_s4", "idA": "1006281_11_item1_p124_s3", "sentA": "We are also conducting initial research programs in the fields of monoclonal antibodies, cytokines and vaccines.", "sentB": "Last, we are conducting research programs in the fields of enzymes, monoclonal antibodies, cytokines and vaccines.", "type": 2, "words": ["<tag1>", "We", "are", "also", "conducting", "initial", "research", "programs", "in", "the", "fields", "of", "monoclonal", "antibodies,", "cytokines", "and", "vaccines.", "<tag2>", "Last,", "we", "are", "conducting", "research", "programs", "in", "the", "fields", "of", "enzymes,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines.", "<tag3>"], "wordsA": ["We", "are", "also", "conducting", "initial", "research", "programs", "in", "the", "fields", "of", "monoclonal", "antibodies,", "cytokines", "and", "vaccines."], "wordsB": ["Last,", "we", "are", "conducting", "research", "programs", "in", "the", "fields", "of", "enzymes,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p154_s1", "idA": "1006281_11_item1_p129_s1", "sentA": "Fabrazyme, made by Genzyme, was approved for the treatment of Fabry disease in the European Union in 2001 and the United States in 2003.", "sentB": "Fabrazyme, made by Genzyme (acquired by Sanofi), was approved for the treatment of Fabry disease in the European Union in 2001 and the United States in 2003.", "type": 2, "words": ["<tag1>", "Fabrazyme,", "made", "by", "Genzyme,", "was", "approved", "for", "the", "treatment", "of", "Fabry", "disease", "in", "the", "European", "Union", "in", "2001", "and", "the", "United", "States", "in", "2003.", "<tag2>", "Fabrazyme,", "made", "by", "Genzyme", "(acquired", "by", "Sanofi),", "was", "approved", "for", "the", "treatment", "of", "Fabry", "disease", "in", "the", "European", "Union", "in", "2001", "and", "the", "United", "States", "in", "2003.", "<tag3>"], "wordsA": ["Fabrazyme,", "made", "by", "Genzyme,", "was", "approved", "for", "the", "treatment", "of", "Fabry", "disease", "in", "the", "European", "Union", "in", "2001", "and", "the", "United", "States", "in", "2003."], "wordsB": ["Fabrazyme,", "made", "by", "Genzyme", "(acquired", "by", "Sanofi),", "was", "approved", "for", "the", "treatment", "of", "Fabry", "disease", "in", "the", "European", "Union", "in", "2001", "and", "the", "United", "States", "in", "2003."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p154_s2", "idA": "1006281_11_item1_p129_s2", "sentA": "Genzyme reported $188 million in worldwide sales of Fabrazyme in 2010, compared to $431 million in 2009.", "sentB": "Sanofi reported 109 million (approximately $143.2 million) in worldwide sales of Fabrazyme in 2011, a growth of 9.4% compared to 2010.", "type": 2, "words": ["<tag1>", "Genzyme", "reported", "$188", "million", "in", "worldwide", "sales", "of", "Fabrazyme", "in", "2010,", "compared", "to", "$431", "million", "in", "2009.", "<tag2>", "Sanofi", "reported", "109", "million", "(approximately", "$143.2", "million)", "in", "worldwide", "sales", "of", "Fabrazyme", "in", "2011,", "a", "growth", "of", "9.4%", "compared", "to", "2010.", "<tag3>"], "wordsA": ["Genzyme", "reported", "$188", "million", "in", "worldwide", "sales", "of", "Fabrazyme", "in", "2010,", "compared", "to", "$431", "million", "in", "2009."], "wordsB": ["Sanofi", "reported", "109", "million", "(approximately", "$143.2", "million)", "in", "worldwide", "sales", "of", "Fabrazyme", "in", "2011,", "a", "growth", "of", "9.4%", "compared", "to", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p155_s0", "idA": "1006281_11_item1_p129_s3", "sentA": "According to Genzyme, it suffered a temporary interruption in production of Fabrazyme in 2009 associated with the remediation of a contamination in one of its manufacturing facilities, and, as a result, shipments of Fabrazyme were limited during the second half of 2009.", "sentB": "According to Genzyme, supplies of Fabrazyme have also been affected by the production interruptions that have occurred since 2009.", "type": 2, "words": ["<tag1>", "According", "to", "Genzyme,", "it", "suffered", "a", "temporary", "interruption", "in", "production", "of", "Fabrazyme", "in", "2009", "associated", "with", "the", "remediation", "of", "a", "contamination", "in", "one", "of", "its", "manufacturing", "facilities,", "and,", "as", "a", "result,", "shipments", "of", "Fabrazyme", "were", "limited", "during", "the", "second", "half", "of", "2009.", "<tag2>", "According", "to", "Genzyme,", "supplies", "of", "Fabrazyme", "have", "also", "been", "affected", "by", "the", "production", "interruptions", "that", "have", "occurred", "since", "2009.", "<tag3>"], "wordsA": ["According", "to", "Genzyme,", "it", "suffered", "a", "temporary", "interruption", "in", "production", "of", "Fabrazyme", "in", "2009", "associated", "with", "the", "remediation", "of", "a", "contamination", "in", "one", "of", "its", "manufacturing", "facilities,", "and,", "as", "a", "result,", "shipments", "of", "Fabrazyme", "were", "limited", "during", "the", "second", "half", "of", "2009."], "wordsB": ["According", "to", "Genzyme,", "supplies", "of", "Fabrazyme", "have", "also", "been", "affected", "by", "the", "production", "interruptions", "that", "have", "occurred", "since", "2009."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p155_s1", "idA": "1006281_11_item1_p129_s4", "sentA": "The other approved drug for the treatment of Fabry disease in the European Union is Replagal, which is sold by Shire plc.", "sentB": "The other approved drug for the treatment of Fabry disease in the European Union is Replagal, which is sold by Shire.", "type": 2, "words": ["<tag1>", "The", "other", "approved", "drug", "for", "the", "treatment", "of", "Fabry", "disease", "in", "the", "European", "Union", "is", "Replagal,", "which", "is", "sold", "by", "Shire", "plc.", "<tag2>", "The", "other", "approved", "drug", "for", "the", "treatment", "of", "Fabry", "disease", "in", "the", "European", "Union", "is", "Replagal,", "which", "is", "sold", "by", "Shire.", "<tag3>"], "wordsA": ["The", "other", "approved", "drug", "for", "the", "treatment", "of", "Fabry", "disease", "in", "the", "European", "Union", "is", "Replagal,", "which", "is", "sold", "by", "Shire", "plc."], "wordsB": ["The", "other", "approved", "drug", "for", "the", "treatment", "of", "Fabry", "disease", "in", "the", "European", "Union", "is", "Replagal,", "which", "is", "sold", "by", "Shire."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p155_s2", "idA": "1006281_11_item1_p129_s5", "sentA": "Shire reported $351 million in sales of Replagal in 2009.", "sentB": "Shire reported $475.2 million in sales of Replagal in 2011, compared to $351.3 million in sales of Replagal in 2010.", "type": 2, "words": ["<tag1>", "Shire", "reported", "$351", "million", "in", "sales", "of", "Replagal", "in", "2009.", "<tag2>", "Shire", "reported", "$475.2", "million", "in", "sales", "of", "Replagal", "in", "2011,", "compared", "to", "$351.3", "million", "in", "sales", "of", "Replagal", "in", "2010.", "<tag3>"], "wordsA": ["Shire", "reported", "$351", "million", "in", "sales", "of", "Replagal", "in", "2009."], "wordsB": ["Shire", "reported", "$475.2", "million", "in", "sales", "of", "Replagal", "in", "2011,", "compared", "to", "$351.3", "million", "in", "sales", "of", "Replagal", "in", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p156_s3", "idA": "1006281_11_item1_p129_s6", "sentA": "According to public reports by Shire, it filed a BLA with the FDA for Replagal in the United States in December 2009.", "sentB": "According to public reports by Shire, it submitted a a rolling BLA with the FDA for Replagal in the United States in November 2011, which the FDA has accepted and a priority review.", "type": 2, "words": ["<tag1>", "According", "to", "public", "reports", "by", "Shire,", "it", "filed", "a", "BLA", "with", "the", "FDA", "for", "Replagal", "in", "the", "United", "States", "in", "December", "2009.", "<tag2>", "According", "to", "public", "reports", "by", "Shire,", "it", "submitted", "a", "a", "rolling", "BLA", "with", "the", "FDA", "for", "Replagal", "in", "the", "United", "States", "in", "November", "2011,", "which", "the", "FDA", "has", "accepted", "and", "a", "priority", "review.", "<tag3>"], "wordsA": ["According", "to", "public", "reports", "by", "Shire,", "it", "filed", "a", "BLA", "with", "the", "FDA", "for", "Replagal", "in", "the", "United", "States", "in", "December", "2009."], "wordsB": ["According", "to", "public", "reports", "by", "Shire,", "it", "submitted", "a", "a", "rolling", "BLA", "with", "the", "FDA", "for", "Replagal", "in", "the", "United", "States", "in", "November", "2011,", "which", "the", "FDA", "has", "accepted", "and", "a", "priority", "review."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p166_s0", "idA": "1006281_11_item1_p129_s6", "sentA": "According to public reports by Shire, it filed a BLA with the FDA for Replagal in the United States in December 2009.", "sentB": "We recently filed a joint PCT patent application entitled: Methods for Treating or Preventing Parkinson's Disease, with the Hebrew University.", "type": 2, "words": ["<tag1>", "According", "to", "public", "reports", "by", "Shire,", "it", "filed", "a", "BLA", "with", "the", "FDA", "for", "Replagal", "in", "the", "United", "States", "in", "December", "2009.", "<tag2>", "We", "recently", "filed", "a", "joint", "PCT", "patent", "application", "entitled:", "Methods", "for", "Treating", "or", "Preventing", "Parkinson's", "Disease,", "with", "the", "Hebrew", "University.", "<tag3>"], "wordsA": ["According", "to", "public", "reports", "by", "Shire,", "it", "filed", "a", "BLA", "with", "the", "FDA", "for", "Replagal", "in", "the", "United", "States", "in", "December", "2009."], "wordsB": ["We", "recently", "filed", "a", "joint", "PCT", "patent", "application", "entitled:", "Methods", "for", "Treating", "or", "Preventing", "Parkinson's", "Disease,", "with", "the", "Hebrew", "University."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p156_s1", "idA": "1006281_11_item1_p129_s7", "sentA": "Shire subsequently received Fast Track designation for Replagal and withdrew its December 2009 BLA in favor of a rolling BLA submission.", "sentB": "Shire subsequently received Fast Track designation for Replagal, withdrew the BLA in 2010 and in October 2010, initiated a rolling BLA submission.", "type": 2, "words": ["<tag1>", "Shire", "subsequently", "received", "Fast", "Track", "designation", "for", "Replagal", "and", "withdrew", "its", "December", "2009", "BLA", "in", "favor", "of", "a", "rolling", "BLA", "submission.", "<tag2>", "Shire", "subsequently", "received", "Fast", "Track", "designation", "for", "Replagal,", "withdrew", "the", "BLA", "in", "2010", "and", "in", "October", "2010,", "initiated", "a", "rolling", "BLA", "submission.", "<tag3>"], "wordsA": ["Shire", "subsequently", "received", "Fast", "Track", "designation", "for", "Replagal", "and", "withdrew", "its", "December", "2009", "BLA", "in", "favor", "of", "a", "rolling", "BLA", "submission."], "wordsB": ["Shire", "subsequently", "received", "Fast", "Track", "designation", "for", "Replagal,", "withdrew", "the", "BLA", "in", "2010", "and", "in", "October", "2010,", "initiated", "a", "rolling", "BLA", "submission."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p156_s2", "idA": "1006281_11_item1_p129_s8", "sentA": "Shire has reported that it withdrew that filing in August 2010 in order to update the filing with additional clinical information.", "sentB": "Shire has reported that it withdrew the December 2009 filing in August 2010 in order to update the filing with additional clinical information.", "type": 2, "words": ["<tag1>", "Shire", "has", "reported", "that", "it", "withdrew", "that", "filing", "in", "August", "2010", "in", "order", "to", "update", "the", "filing", "with", "additional", "clinical", "information.", "<tag2>", "Shire", "has", "reported", "that", "it", "withdrew", "the", "December", "2009", "filing", "in", "August", "2010", "in", "order", "to", "update", "the", "filing", "with", "additional", "clinical", "information.", "<tag3>"], "wordsA": ["Shire", "has", "reported", "that", "it", "withdrew", "that", "filing", "in", "August", "2010", "in", "order", "to", "update", "the", "filing", "with", "additional", "clinical", "information."], "wordsB": ["Shire", "has", "reported", "that", "it", "withdrew", "the", "December", "2009", "filing", "in", "August", "2010", "in", "order", "to", "update", "the", "filing", "with", "additional", "clinical", "information."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p157_s0", "idA": "1006281_11_item1_p130_s0", "sentA": "We are currently in the animal evaluation testing phase of the development of PRX-102, which tests are based on a well established mouse model for Fabry disease.", "sentB": "We completed the animal evaluation testing phase of the development of PRX-102, which tests are based on a well established mouse model for Fabry disease.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "in", "the", "animal", "evaluation", "testing", "phase", "of", "the", "development", "of", "PRX-102,", "which", "tests", "are", "based", "on", "a", "well", "established", "mouse", "model", "for", "Fabry", "disease.", "<tag2>", "We", "completed", "the", "animal", "evaluation", "testing", "phase", "of", "the", "development", "of", "PRX-102,", "which", "tests", "are", "based", "on", "a", "well", "established", "mouse", "model", "for", "Fabry", "disease.", "<tag3>"], "wordsA": ["We", "are", "currently", "in", "the", "animal", "evaluation", "testing", "phase", "of", "the", "development", "of", "PRX-102,", "which", "tests", "are", "based", "on", "a", "well", "established", "mouse", "model", "for", "Fabry", "disease."], "wordsB": ["We", "completed", "the", "animal", "evaluation", "testing", "phase", "of", "the", "development", "of", "PRX-102,", "which", "tests", "are", "based", "on", "a", "well", "established", "mouse", "model", "for", "Fabry", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p165_s2", "idA": "1006281_11_item1_p130_s0", "sentA": "We are currently in the animal evaluation testing phase of the development of PRX-102, which tests are based on a well established mouse model for Fabry disease.", "sentB": "The research includes an investigation of the effect of PRX-105 on alternative splicing patterns in the striatum, which may confer protection in Parkinson's disease.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "in", "the", "animal", "evaluation", "testing", "phase", "of", "the", "development", "of", "PRX-102,", "which", "tests", "are", "based", "on", "a", "well", "established", "mouse", "model", "for", "Fabry", "disease.", "<tag2>", "The", "research", "includes", "an", "investigation", "of", "the", "effect", "of", "PRX-105", "on", "alternative", "splicing", "patterns", "in", "the", "striatum,", "which", "may", "confer", "protection", "in", "Parkinson's", "disease.", "<tag3>"], "wordsA": ["We", "are", "currently", "in", "the", "animal", "evaluation", "testing", "phase", "of", "the", "development", "of", "PRX-102,", "which", "tests", "are", "based", "on", "a", "well", "established", "mouse", "model", "for", "Fabry", "disease."], "wordsB": ["The", "research", "includes", "an", "investigation", "of", "the", "effect", "of", "PRX-105", "on", "alternative", "splicing", "patterns", "in", "the", "striatum,", "which", "may", "confer", "protection", "in", "Parkinson's", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p157_s2", "idA": "1006281_11_item1_p131_s0", "sentA": "enzyme s activity and stability resulting in prolonged activity profiles and enhanced bioavailability in animals.", "sentB": "Chemical modifications made to PRX-102 improved the enzyme s activity and stability resulting in prolonged activity profiles and enhanced bioavailability in animals.", "type": 2, "words": ["<tag1>", "enzyme", "s", "activity", "and", "stability", "resulting", "in", "prolonged", "activity", "profiles", "and", "enhanced", "bioavailability", "in", "animals.", "<tag2>", "Chemical", "modifications", "made", "to", "PRX-102", "improved", "the", "enzyme", "s", "activity", "and", "stability", "resulting", "in", "prolonged", "activity", "profiles", "and", "enhanced", "bioavailability", "in", "animals.", "<tag3>"], "wordsA": ["enzyme", "s", "activity", "and", "stability", "resulting", "in", "prolonged", "activity", "profiles", "and", "enhanced", "bioavailability", "in", "animals."], "wordsB": ["Chemical", "modifications", "made", "to", "PRX-102", "improved", "the", "enzyme", "s", "activity", "and", "stability", "resulting", "in", "prolonged", "activity", "profiles", "and", "enhanced", "bioavailability", "in", "animals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p32_s2", "idA": "1006281_11_item1_p132_s0", "sentA": "We held a pre-IND meeting with the FDA in 2010 regarding PRX-102, and we expect to file an IND with the FDA within the next 12 months.", "sentB": "In December 2011 we held a pre-IND meeting with respect to PRX-106 and we expect to submit an IND around the fourth quarter of 2012.", "type": 2, "words": ["<tag1>", "We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "2010", "regarding", "PRX-102,", "and", "we", "expect", "to", "file", "an", "IND", "with", "the", "FDA", "within", "the", "next", "12", "months.", "<tag2>", "In", "December", "2011", "we", "held", "a", "pre-IND", "meeting", "with", "respect", "to", "PRX-106", "and", "we", "expect", "to", "submit", "an", "IND", "around", "the", "fourth", "quarter", "of", "2012.", "<tag3>"], "wordsA": ["We", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "in", "2010", "regarding", "PRX-102,", "and", "we", "expect", "to", "file", "an", "IND", "with", "the", "FDA", "within", "the", "next", "12", "months."], "wordsB": ["In", "December", "2011", "we", "held", "a", "pre-IND", "meeting", "with", "respect", "to", "PRX-106", "and", "we", "expect", "to", "submit", "an", "IND", "around", "the", "fourth", "quarter", "of", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p159_s1", "idA": "1006281_11_item1_p133_s1", "sentA": "Based on our experience with taliglucerase alfa, the experience of other companies developing enzyme replacement therapies for Fabry disease and the pre IND meeting we held with FDA in 2010, we have reason to believe that, if favorable data is accumulated in preclinical and phase I/II clinical trials, the FDA may allow us to proceed directly with a pivotal phase III clinical trial.", "sentB": "Based on the pre IND meeting we held with FDA in 2010, the experience with taliglucerase alfa and the experience of other companies developing enzyme replacement therapies for Fabry disease, we have reason to believe that, if favorable data is accumulated in preclinical and phase I/II clinical trials, the FDA may allow us to proceed directly with a pivotal phase III clinical trial.", "type": 2, "words": ["<tag1>", "Based", "on", "our", "experience", "with", "taliglucerase", "alfa,", "the", "experience", "of", "other", "companies", "developing", "enzyme", "replacement", "therapies", "for", "Fabry", "disease", "and", "the", "pre", "IND", "meeting", "we", "held", "with", "FDA", "in", "2010,", "we", "have", "reason", "to", "believe", "that,", "if", "favorable", "data", "is", "accumulated", "in", "preclinical", "and", "phase", "I/II", "clinical", "trials,", "the", "FDA", "may", "allow", "us", "to", "proceed", "directly", "with", "a", "pivotal", "phase", "III", "clinical", "trial.", "<tag2>", "Based", "on", "the", "pre", "IND", "meeting", "we", "held", "with", "FDA", "in", "2010,", "the", "experience", "with", "taliglucerase", "alfa", "and", "the", "experience", "of", "other", "companies", "developing", "enzyme", "replacement", "therapies", "for", "Fabry", "disease,", "we", "have", "reason", "to", "believe", "that,", "if", "favorable", "data", "is", "accumulated", "in", "preclinical", "and", "phase", "I/II", "clinical", "trials,", "the", "FDA", "may", "allow", "us", "to", "proceed", "directly", "with", "a", "pivotal", "phase", "III", "clinical", "trial.", "<tag3>"], "wordsA": ["Based", "on", "our", "experience", "with", "taliglucerase", "alfa,", "the", "experience", "of", "other", "companies", "developing", "enzyme", "replacement", "therapies", "for", "Fabry", "disease", "and", "the", "pre", "IND", "meeting", "we", "held", "with", "FDA", "in", "2010,", "we", "have", "reason", "to", "believe", "that,", "if", "favorable", "data", "is", "accumulated", "in", "preclinical", "and", "phase", "I/II", "clinical", "trials,", "the", "FDA", "may", "allow", "us", "to", "proceed", "directly", "with", "a", "pivotal", "phase", "III", "clinical", "trial."], "wordsB": ["Based", "on", "the", "pre", "IND", "meeting", "we", "held", "with", "FDA", "in", "2010,", "the", "experience", "with", "taliglucerase", "alfa", "and", "the", "experience", "of", "other", "companies", "developing", "enzyme", "replacement", "therapies", "for", "Fabry", "disease,", "we", "have", "reason", "to", "believe", "that,", "if", "favorable", "data", "is", "accumulated", "in", "preclinical", "and", "phase", "I/II", "clinical", "trials,", "the", "FDA", "may", "allow", "us", "to", "proceed", "directly", "with", "a", "pivotal", "phase", "III", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p160_s2", "idA": "1006281_11_item1_p136_s0", "sentA": "In addition, early animal studies demonstrated that the acetylcholinesterase expressed in our ProCellEx protein expression system was able to successfully treat animals exposed to the nerve gas agent analogues, both when injected with our acetylcholinesterase product candidate immediately before exposure or when injected after exposure.", "sentB": "To date, our in vitro experiments of PRX-105 have shown that the acetylcholinesterase enzyme expressed in our ProCellEx protein expression system demonstrates promising biological activity on biochemical and cellular levels.", "type": 2, "words": ["<tag1>", "In", "addition,", "early", "animal", "studies", "demonstrated", "that", "the", "acetylcholinesterase", "expressed", "in", "our", "ProCellEx", "protein", "expression", "system", "was", "able", "to", "successfully", "treat", "animals", "exposed", "to", "the", "nerve", "gas", "agent", "analogues,", "both", "when", "injected", "with", "our", "acetylcholinesterase", "product", "candidate", "immediately", "before", "exposure", "or", "when", "injected", "after", "exposure.", "<tag2>", "To", "date,", "our", "in", "vitro", "experiments", "of", "PRX-105", "have", "shown", "that", "the", "acetylcholinesterase", "enzyme", "expressed", "in", "our", "ProCellEx", "protein", "expression", "system", "demonstrates", "promising", "biological", "activity", "on", "biochemical", "and", "cellular", "levels.", "<tag3>"], "wordsA": ["In", "addition,", "early", "animal", "studies", "demonstrated", "that", "the", "acetylcholinesterase", "expressed", "in", "our", "ProCellEx", "protein", "expression", "system", "was", "able", "to", "successfully", "treat", "animals", "exposed", "to", "the", "nerve", "gas", "agent", "analogues,", "both", "when", "injected", "with", "our", "acetylcholinesterase", "product", "candidate", "immediately", "before", "exposure", "or", "when", "injected", "after", "exposure."], "wordsB": ["To", "date,", "our", "in", "vitro", "experiments", "of", "PRX-105", "have", "shown", "that", "the", "acetylcholinesterase", "enzyme", "expressed", "in", "our", "ProCellEx", "protein", "expression", "system", "demonstrates", "promising", "biological", "activity", "on", "biochemical", "and", "cellular", "levels."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p164_s1", "idA": "1006281_11_item1_p139_s1", "sentA": "We anticipate applying for specific grants during 2011 to support the further development of our acetylcholinesterase program.", "sentB": "We anticipate applying for specific U.S. grants during 2012 to support the further development of our acetylcholinesterase program.", "type": 2, "words": ["<tag1>", "We", "anticipate", "applying", "for", "specific", "grants", "during", "2011", "to", "support", "the", "further", "development", "of", "our", "acetylcholinesterase", "program.", "<tag2>", "We", "anticipate", "applying", "for", "specific", "U.S.", "grants", "during", "2012", "to", "support", "the", "further", "development", "of", "our", "acetylcholinesterase", "program.", "<tag3>"], "wordsA": ["We", "anticipate", "applying", "for", "specific", "grants", "during", "2011", "to", "support", "the", "further", "development", "of", "our", "acetylcholinesterase", "program."], "wordsB": ["We", "anticipate", "applying", "for", "specific", "U.S.", "grants", "during", "2012", "to", "support", "the", "further", "development", "of", "our", "acetylcholinesterase", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p19_s0", "idA": "1006281_11_item1_p13_s0", "sentA": "On November 30, 2009, Protalix Ltd., our wholly-owned subsidiary, and Pfizer Inc., or Pfizer, entered into an exclusive license and supply agreement pursuant to which Pfizer was granted an exclusive, worldwide license to develop and commercialize taliglucerase alfa.", "sentB": "On November 30, 2009, Protalix Ltd., our wholly-owned subsidiary, and Pfizer entered into an exclusive license and supply agreement, which we refer to as the Pfizer Agreement, pursuant to which Pfizer was granted an exclusive, worldwide license to develop and commercialize taliglucerase alfa.", "type": 2, "words": ["<tag1>", "On", "November", "30,", "2009,", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer", "Inc.,", "or", "Pfizer,", "entered", "into", "an", "exclusive", "license", "and", "supply", "agreement", "pursuant", "to", "which", "Pfizer", "was", "granted", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa.", "<tag2>", "On", "November", "30,", "2009,", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer", "entered", "into", "an", "exclusive", "license", "and", "supply", "agreement,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement,", "pursuant", "to", "which", "Pfizer", "was", "granted", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["On", "November", "30,", "2009,", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer", "Inc.,", "or", "Pfizer,", "entered", "into", "an", "exclusive", "license", "and", "supply", "agreement", "pursuant", "to", "which", "Pfizer", "was", "granted", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa."], "wordsB": ["On", "November", "30,", "2009,", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer", "entered", "into", "an", "exclusive", "license", "and", "supply", "agreement,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement,", "pursuant", "to", "which", "Pfizer", "was", "granted", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p19_s2", "idA": "1006281_11_item1_p13_s2", "sentA": "In connection with the execution of the Pfizer agreement, Pfizer made an upfront payment to Protalix Ltd. of $60.0 million in connection with the execution of the agreement and subsequently paid Protalix Ltd. an additional $5.0 million upon its filing of a proposed pediatric investigation plan to the Pediatric Committee of the EMEA.", "sentB": "In connection with the execution of the Pfizer Agreement, Pfizer made an upfront payment to Protalix Ltd. of $60.0 million in connection with the execution of the agreement and subsequently paid Protalix Ltd. an additional $5.0 million upon its filing of a proposed pediatric investigation plan to the Pediatric Committee of the EMA.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "the", "execution", "of", "the", "Pfizer", "agreement,", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "its", "filing", "of", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA.", "<tag2>", "In", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement,", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "its", "filing", "of", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMA.", "<tag3>"], "wordsA": ["In", "connection", "with", "the", "execution", "of", "the", "Pfizer", "agreement,", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "its", "filing", "of", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA."], "wordsB": ["In", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement,", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "its", "filing", "of", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p19_s4", "idA": "1006281_11_item1_p13_s4", "sentA": "Pfizer and Protalix Ltd. will also share future revenues and expenses for the development and commercialization of taliglucerase alfa on a 60% and 40% basis, respectively, and have also agreed to a specific allocation of the responsibilities for the continued development efforts for taliglucerase alfa.", "sentB": "According to the Pfizer Agreement, Pfizer and Protalix Ltd. are required to share future revenues and expenses for the development and commercialization of taliglucerase alfa on a 60% and 40% basis, respectively, and have agreed to a specific allocation of the responsibilities for the continued development efforts for taliglucerase alfa.", "type": 2, "words": ["<tag1>", "Pfizer", "and", "Protalix", "Ltd.", "will", "also", "share", "future", "revenues", "and", "expenses", "for", "the", "development", "and", "commercialization", "of", "taliglucerase", "alfa", "on", "a", "60%", "and", "40%", "basis,", "respectively,", "and", "have", "also", "agreed", "to", "a", "specific", "allocation", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa.", "<tag2>", "According", "to", "the", "Pfizer", "Agreement,", "Pfizer", "and", "Protalix", "Ltd.", "are", "required", "to", "share", "future", "revenues", "and", "expenses", "for", "the", "development", "and", "commercialization", "of", "taliglucerase", "alfa", "on", "a", "60%", "and", "40%", "basis,", "respectively,", "and", "have", "agreed", "to", "a", "specific", "allocation", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["Pfizer", "and", "Protalix", "Ltd.", "will", "also", "share", "future", "revenues", "and", "expenses", "for", "the", "development", "and", "commercialization", "of", "taliglucerase", "alfa", "on", "a", "60%", "and", "40%", "basis,", "respectively,", "and", "have", "also", "agreed", "to", "a", "specific", "allocation", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa."], "wordsB": ["According", "to", "the", "Pfizer", "Agreement,", "Pfizer", "and", "Protalix", "Ltd.", "are", "required", "to", "share", "future", "revenues", "and", "expenses", "for", "the", "development", "and", "commercialization", "of", "taliglucerase", "alfa", "on", "a", "60%", "and", "40%", "basis,", "respectively,", "and", "have", "agreed", "to", "a", "specific", "allocation", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p167_s0", "idA": "1006281_11_item1_p140_s0", "sentA": "In September 2009, we announced preliminary preclinical data regarding an antiTNF (Tumor, Necrosis Factor) protein that we are expressing through our proprietary ProCellEx system.", "sentB": "pr-antiTNF is an antiTNF (Tumor, Necrosis Factor) protein that we are expressing through our proprietary ProCellEx system.", "type": 2, "words": ["<tag1>", "In", "September", "2009,", "we", "announced", "preliminary", "preclinical", "data", "regarding", "an", "antiTNF", "(Tumor,", "Necrosis", "Factor)", "protein", "that", "we", "are", "expressing", "through", "our", "proprietary", "ProCellEx", "system.", "<tag2>", "pr-antiTNF", "is", "an", "antiTNF", "(Tumor,", "Necrosis", "Factor)", "protein", "that", "we", "are", "expressing", "through", "our", "proprietary", "ProCellEx", "system.", "<tag3>"], "wordsA": ["In", "September", "2009,", "we", "announced", "preliminary", "preclinical", "data", "regarding", "an", "antiTNF", "(Tumor,", "Necrosis", "Factor)", "protein", "that", "we", "are", "expressing", "through", "our", "proprietary", "ProCellEx", "system."], "wordsB": ["pr-antiTNF", "is", "an", "antiTNF", "(Tumor,", "Necrosis", "Factor)", "protein", "that", "we", "are", "expressing", "through", "our", "proprietary", "ProCellEx", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p169_s0", "idA": "1006281_11_item1_p142_s0", "sentA": "Amgen Inc. reported total sales of Enbrel of $3.5 billion in the United States and Canada for 2010 and Pfizer has reported total sales of Enbrel outside of the United States and Canada of $865.0 million for 2010.", "sentB": "Amgen Inc. reported total sales of Enbrel of $3.7 billion in the United States and Canada for 2011 and Pfizer has reported total sales of Enbrel outside of the United States and Canada of $3.7 billion for 2011.", "type": 2, "words": ["<tag1>", "Amgen", "Inc.", "reported", "total", "sales", "of", "Enbrel", "of", "$3.5", "billion", "in", "the", "United", "States", "and", "Canada", "for", "2010", "and", "Pfizer", "has", "reported", "total", "sales", "of", "Enbrel", "outside", "of", "the", "United", "States", "and", "Canada", "of", "$865.0", "million", "for", "2010.", "<tag2>", "Amgen", "Inc.", "reported", "total", "sales", "of", "Enbrel", "of", "$3.7", "billion", "in", "the", "United", "States", "and", "Canada", "for", "2011", "and", "Pfizer", "has", "reported", "total", "sales", "of", "Enbrel", "outside", "of", "the", "United", "States", "and", "Canada", "of", "$3.7", "billion", "for", "2011.", "<tag3>"], "wordsA": ["Amgen", "Inc.", "reported", "total", "sales", "of", "Enbrel", "of", "$3.5", "billion", "in", "the", "United", "States", "and", "Canada", "for", "2010", "and", "Pfizer", "has", "reported", "total", "sales", "of", "Enbrel", "outside", "of", "the", "United", "States", "and", "Canada", "of", "$865.0", "million", "for", "2010."], "wordsB": ["Amgen", "Inc.", "reported", "total", "sales", "of", "Enbrel", "of", "$3.7", "billion", "in", "the", "United", "States", "and", "Canada", "for", "2011", "and", "Pfizer", "has", "reported", "total", "sales", "of", "Enbrel", "outside", "of", "the", "United", "States", "and", "Canada", "of", "$3.7", "billion", "for", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p174_s2", "idA": "1006281_11_item1_p145_s2", "sentA": "In connection with the execution of the Pfizer agreement, Pfizer made an upfront payment to Protalix Ltd. of $60.0 million in connection with the execution of the agreement and subsequently paid to Protalix Ltd. an additional $5.0 million upon our filing of a proposed pediatric investigation plan to the Pediatric Committee of the EMEA.", "sentB": "In connection with the execution of the Pfizer Agreement, Pfizer made an upfront payment to Protalix Ltd. of $60.0 million in connection with the execution of the agreement and subsequently paid to Protalix Ltd. an additional $5.0 million upon our filing of a proposed pediatric investigation plan to the Pediatric Committee of the EMA.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "the", "execution", "of", "the", "Pfizer", "agreement,", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "our", "filing", "of", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA.", "<tag2>", "In", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement,", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "our", "filing", "of", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMA.", "<tag3>"], "wordsA": ["In", "connection", "with", "the", "execution", "of", "the", "Pfizer", "agreement,", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "our", "filing", "of", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMEA."], "wordsB": ["In", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement,", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "to", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "our", "filing", "of", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p177_s2", "idA": "1006281_11_item1_p148_s2", "sentA": "We are also required to pay a royalty equal to 3% of the revenues of taliglucerase alfa Pizer records under the Pfizer agreement to the OCS.", "sentB": "We are also required to pay a royalty equal to 3% of the revenues of taliglucerase alfa Pfizer records under the Pfizer Agreement to the OCS.", "type": 2, "words": ["<tag1>", "We", "are", "also", "required", "to", "pay", "a", "royalty", "equal", "to", "3%", "of", "the", "revenues", "of", "taliglucerase", "alfa", "Pizer", "records", "under", "the", "Pfizer", "agreement", "to", "the", "OCS.", "<tag2>", "We", "are", "also", "required", "to", "pay", "a", "royalty", "equal", "to", "3%", "of", "the", "revenues", "of", "taliglucerase", "alfa", "Pfizer", "records", "under", "the", "Pfizer", "Agreement", "to", "the", "OCS.", "<tag3>"], "wordsA": ["We", "are", "also", "required", "to", "pay", "a", "royalty", "equal", "to", "3%", "of", "the", "revenues", "of", "taliglucerase", "alfa", "Pizer", "records", "under", "the", "Pfizer", "agreement", "to", "the", "OCS."], "wordsB": ["We", "are", "also", "required", "to", "pay", "a", "royalty", "equal", "to", "3%", "of", "the", "revenues", "of", "taliglucerase", "alfa", "Pfizer", "records", "under", "the", "Pfizer", "Agreement", "to", "the", "OCS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p5_s9", "idA": "1006281_11_item1_p14_s1", "sentA": "The treatment protocol was approved by the FDA in August 2009.", "sentB": "No additional data was requested by the FDA in the notification, nor were we notified of any specific deficiency in the taliglucerase alfa NDA.", "type": 2, "words": ["<tag1>", "The", "treatment", "protocol", "was", "approved", "by", "the", "FDA", "in", "August", "2009.", "<tag2>", "No", "additional", "data", "was", "requested", "by", "the", "FDA", "in", "the", "notification,", "nor", "were", "we", "notified", "of", "any", "specific", "deficiency", "in", "the", "taliglucerase", "alfa", "NDA.", "<tag3>"], "wordsA": ["The", "treatment", "protocol", "was", "approved", "by", "the", "FDA", "in", "August", "2009."], "wordsB": ["No", "additional", "data", "was", "requested", "by", "the", "FDA", "in", "the", "notification,", "nor", "were", "we", "notified", "of", "any", "specific", "deficiency", "in", "the", "taliglucerase", "alfa", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p64_s10", "idA": "1006281_11_item1_p14_s1", "sentA": "The treatment protocol was approved by the FDA in August 2009.", "sentB": "No additional data was requested by the FDA in the notification, nor were we notified of any specific deficiency in the taliglucerase alfa NDA.", "type": 2, "words": ["<tag1>", "The", "treatment", "protocol", "was", "approved", "by", "the", "FDA", "in", "August", "2009.", "<tag2>", "No", "additional", "data", "was", "requested", "by", "the", "FDA", "in", "the", "notification,", "nor", "were", "we", "notified", "of", "any", "specific", "deficiency", "in", "the", "taliglucerase", "alfa", "NDA.", "<tag3>"], "wordsA": ["The", "treatment", "protocol", "was", "approved", "by", "the", "FDA", "in", "August", "2009."], "wordsB": ["No", "additional", "data", "was", "requested", "by", "the", "FDA", "in", "the", "notification,", "nor", "were", "we", "notified", "of", "any", "specific", "deficiency", "in", "the", "taliglucerase", "alfa", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p75_s9", "idA": "1006281_11_item1_p14_s1", "sentA": "The treatment protocol was approved by the FDA in August 2009.", "sentB": "No additional data was requested by the FDA in the notification, nor were we notified of any specific deficiency in the taliglucerase alfa NDA.", "type": 2, "words": ["<tag1>", "The", "treatment", "protocol", "was", "approved", "by", "the", "FDA", "in", "August", "2009.", "<tag2>", "No", "additional", "data", "was", "requested", "by", "the", "FDA", "in", "the", "notification,", "nor", "were", "we", "notified", "of", "any", "specific", "deficiency", "in", "the", "taliglucerase", "alfa", "NDA.", "<tag3>"], "wordsA": ["The", "treatment", "protocol", "was", "approved", "by", "the", "FDA", "in", "August", "2009."], "wordsB": ["No", "additional", "data", "was", "requested", "by", "the", "FDA", "in", "the", "notification,", "nor", "were", "we", "notified", "of", "any", "specific", "deficiency", "in", "the", "taliglucerase", "alfa", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p183_s1", "idA": "1006281_11_item1_p152_s1", "sentA": "Under the terms of the agreement, Yeda agreed to use its technology to design a next generation of glucoceribrosidase (GCD) for the treatment of Gaucher disease that can be expressed using our ProCellEx protein expression system and that may have certain benefits over the first generation treatments used today.", "sentB": "Under the terms of the agreement, Yeda agreed to use its technology to design a next generation of glucocerebrosidase (GCD) for the treatment of Gaucher disease that can be expressed using our ProCellEx protein expression system and that may have certain benefits over the first generation treatments used today.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "of", "the", "agreement,", "Yeda", "agreed", "to", "use", "its", "technology", "to", "design", "a", "next", "generation", "of", "glucoceribrosidase", "(GCD)", "for", "the", "treatment", "of", "Gaucher", "disease", "that", "can", "be", "expressed", "using", "our", "ProCellEx", "protein", "expression", "system", "and", "that", "may", "have", "certain", "benefits", "over", "the", "first", "generation", "treatments", "used", "today.", "<tag2>", "Under", "the", "terms", "of", "the", "agreement,", "Yeda", "agreed", "to", "use", "its", "technology", "to", "design", "a", "next", "generation", "of", "glucocerebrosidase", "(GCD)", "for", "the", "treatment", "of", "Gaucher", "disease", "that", "can", "be", "expressed", "using", "our", "ProCellEx", "protein", "expression", "system", "and", "that", "may", "have", "certain", "benefits", "over", "the", "first", "generation", "treatments", "used", "today.", "<tag3>"], "wordsA": ["Under", "the", "terms", "of", "the", "agreement,", "Yeda", "agreed", "to", "use", "its", "technology", "to", "design", "a", "next", "generation", "of", "glucoceribrosidase", "(GCD)", "for", "the", "treatment", "of", "Gaucher", "disease", "that", "can", "be", "expressed", "using", "our", "ProCellEx", "protein", "expression", "system", "and", "that", "may", "have", "certain", "benefits", "over", "the", "first", "generation", "treatments", "used", "today."], "wordsB": ["Under", "the", "terms", "of", "the", "agreement,", "Yeda", "agreed", "to", "use", "its", "technology", "to", "design", "a", "next", "generation", "of", "glucocerebrosidase", "(GCD)", "for", "the", "treatment", "of", "Gaucher", "disease", "that", "can", "be", "expressed", "using", "our", "ProCellEx", "protein", "expression", "system", "and", "that", "may", "have", "certain", "benefits", "over", "the", "first", "generation", "treatments", "used", "today."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p183_s2", "idA": "1006281_11_item1_p153_s0", "sentA": "The technology licensed from Yeda provides a methodology for the rational design of an improved drug for the treatment of Gaucher disease by enzyme replacement therapy, based on the three-dimensional crystal structure of glucoceribrosidase (GCD) that was solved by scientists from the Weizmann Institute of Science.", "sentB": "The technology licensed from Yeda provides a methodology for the rational design of an improved drug for the treatment of Gaucher disease by enzyme replacement therapy, based on the three-dimensional crystal structure of glucocerebrosidase that was solved by scientists from the Weizmann Institute of Science.", "type": 2, "words": ["<tag1>", "The", "technology", "licensed", "from", "Yeda", "provides", "a", "methodology", "for", "the", "rational", "design", "of", "an", "improved", "drug", "for", "the", "treatment", "of", "Gaucher", "disease", "by", "enzyme", "replacement", "therapy,", "based", "on", "the", "three-dimensional", "crystal", "structure", "of", "glucoceribrosidase", "(GCD)", "that", "was", "solved", "by", "scientists", "from", "the", "Weizmann", "Institute", "of", "Science.", "<tag2>", "The", "technology", "licensed", "from", "Yeda", "provides", "a", "methodology", "for", "the", "rational", "design", "of", "an", "improved", "drug", "for", "the", "treatment", "of", "Gaucher", "disease", "by", "enzyme", "replacement", "therapy,", "based", "on", "the", "three-dimensional", "crystal", "structure", "of", "glucocerebrosidase", "that", "was", "solved", "by", "scientists", "from", "the", "Weizmann", "Institute", "of", "Science.", "<tag3>"], "wordsA": ["The", "technology", "licensed", "from", "Yeda", "provides", "a", "methodology", "for", "the", "rational", "design", "of", "an", "improved", "drug", "for", "the", "treatment", "of", "Gaucher", "disease", "by", "enzyme", "replacement", "therapy,", "based", "on", "the", "three-dimensional", "crystal", "structure", "of", "glucoceribrosidase", "(GCD)", "that", "was", "solved", "by", "scientists", "from", "the", "Weizmann", "Institute", "of", "Science."], "wordsB": ["The", "technology", "licensed", "from", "Yeda", "provides", "a", "methodology", "for", "the", "rational", "design", "of", "an", "improved", "drug", "for", "the", "treatment", "of", "Gaucher", "disease", "by", "enzyme", "replacement", "therapy,", "based", "on", "the", "three-dimensional", "crystal", "structure", "of", "glucocerebrosidase", "that", "was", "solved", "by", "scientists", "from", "the", "Weizmann", "Institute", "of", "Science."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p183_s3", "idA": "1006281_11_item1_p153_s1", "sentA": "Yeda has granted us an exclusive worldwide license to use their technology and discoveries for the development, production and sale of enzymatically active mutations of glucoceribrosidase (GCD) and derivatives thereof for the treatment of Gaucher disease.", "sentB": "Yeda has granted us an exclusive worldwide license to use their technology and discoveries for the development, production and sale of enzymatically active mutations of glucocerebrosidase (GCD) and derivatives thereof for the treatment of Gaucher disease.", "type": 2, "words": ["<tag1>", "Yeda", "has", "granted", "us", "an", "exclusive", "worldwide", "license", "to", "use", "their", "technology", "and", "discoveries", "for", "the", "development,", "production", "and", "sale", "of", "enzymatically", "active", "mutations", "of", "glucoceribrosidase", "(GCD)", "and", "derivatives", "thereof", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "Yeda", "has", "granted", "us", "an", "exclusive", "worldwide", "license", "to", "use", "their", "technology", "and", "discoveries", "for", "the", "development,", "production", "and", "sale", "of", "enzymatically", "active", "mutations", "of", "glucocerebrosidase", "(GCD)", "and", "derivatives", "thereof", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag3>"], "wordsA": ["Yeda", "has", "granted", "us", "an", "exclusive", "worldwide", "license", "to", "use", "their", "technology", "and", "discoveries", "for", "the", "development,", "production", "and", "sale", "of", "enzymatically", "active", "mutations", "of", "glucoceribrosidase", "(GCD)", "and", "derivatives", "thereof", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["Yeda", "has", "granted", "us", "an", "exclusive", "worldwide", "license", "to", "use", "their", "technology", "and", "discoveries", "for", "the", "development,", "production", "and", "sale", "of", "enzymatically", "active", "mutations", "of", "glucocerebrosidase", "(GCD)", "and", "derivatives", "thereof", "for", "the", "treatment", "of", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p184_s3", "idA": "1006281_11_item1_p154_s3", "sentA": "In addition, we are obligated to make an annual non-refundable license fee of $10,000 during the term of the agreement, commencing on the fifth anniversary of the execution of the agreement until, and including, the 19th anniversary thereof.", "sentB": "In addition, we are obligated to make an annual non-refundable license fee of $10,000 during the term of the agreement, commencing on the fifth anniversary of the execution of the agreement until, and including, the 19 th anniversary thereof.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "are", "obligated", "to", "make", "an", "annual", "non-refundable", "license", "fee", "of", "$10,000", "during", "the", "term", "of", "the", "agreement,", "commencing", "on", "the", "fifth", "anniversary", "of", "the", "execution", "of", "the", "agreement", "until,", "and", "including,", "the", "19th", "anniversary", "thereof.", "<tag2>", "In", "addition,", "we", "are", "obligated", "to", "make", "an", "annual", "non-refundable", "license", "fee", "of", "$10,000", "during", "the", "term", "of", "the", "agreement,", "commencing", "on", "the", "fifth", "anniversary", "of", "the", "execution", "of", "the", "agreement", "until,", "and", "including,", "the", "19", "th", "anniversary", "thereof.", "<tag3>"], "wordsA": ["In", "addition,", "we", "are", "obligated", "to", "make", "an", "annual", "non-refundable", "license", "fee", "of", "$10,000", "during", "the", "term", "of", "the", "agreement,", "commencing", "on", "the", "fifth", "anniversary", "of", "the", "execution", "of", "the", "agreement", "until,", "and", "including,", "the", "19th", "anniversary", "thereof."], "wordsB": ["In", "addition,", "we", "are", "obligated", "to", "make", "an", "annual", "non-refundable", "license", "fee", "of", "$10,000", "during", "the", "term", "of", "the", "agreement,", "commencing", "on", "the", "fifth", "anniversary", "of", "the", "execution", "of", "the", "agreement", "until,", "and", "including,", "the", "19", "th", "anniversary", "thereof."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p184_s4", "idA": "1006281_11_item1_p155_s0", "sentA": "also obligated to make royalty payments equal to varying low, single-digit percentages of net sales of products under the agreement.", "sentB": "We are also obligated to make royalty payments equal to varying low, single-digit percentages of net sales of products under the agreement.", "type": 2, "words": ["<tag1>", "also", "obligated", "to", "make", "royalty", "payments", "equal", "to", "varying", "low,", "single-digit", "percentages", "of", "net", "sales", "of", "products", "under", "the", "agreement.", "<tag2>", "We", "are", "also", "obligated", "to", "make", "royalty", "payments", "equal", "to", "varying", "low,", "single-digit", "percentages", "of", "net", "sales", "of", "products", "under", "the", "agreement.", "<tag3>"], "wordsA": ["also", "obligated", "to", "make", "royalty", "payments", "equal", "to", "varying", "low,", "single-digit", "percentages", "of", "net", "sales", "of", "products", "under", "the", "agreement."], "wordsB": ["We", "are", "also", "obligated", "to", "make", "royalty", "payments", "equal", "to", "varying", "low,", "single-digit", "percentages", "of", "net", "sales", "of", "products", "under", "the", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p146_s3", "idA": "1006281_11_item1_p158_s1", "sentA": "At the end of the first quarter of 2011, we held 20 granted patents and 84 pending patent applications with respect to various compositions, methods of production and methods of use relating to our ProCellEx protein expression system and our proprietary product pipeline.", "sentB": "We participated in a pre IND meeting with respect to one of the undisclosed product candidates in the first quarter of 2012 and a pre IND meeting for the second candidate is planned for later this year.", "type": 2, "words": ["<tag1>", "At", "the", "end", "of", "the", "first", "quarter", "of", "2011,", "we", "held", "20", "granted", "patents", "and", "84", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline.", "<tag2>", "We", "participated", "in", "a", "pre", "IND", "meeting", "with", "respect", "to", "one", "of", "the", "undisclosed", "product", "candidates", "in", "the", "first", "quarter", "of", "2012", "and", "a", "pre", "IND", "meeting", "for", "the", "second", "candidate", "is", "planned", "for", "later", "this", "year.", "<tag3>"], "wordsA": ["At", "the", "end", "of", "the", "first", "quarter", "of", "2011,", "we", "held", "20", "granted", "patents", "and", "84", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline."], "wordsB": ["We", "participated", "in", "a", "pre", "IND", "meeting", "with", "respect", "to", "one", "of", "the", "undisclosed", "product", "candidates", "in", "the", "first", "quarter", "of", "2012", "and", "a", "pre", "IND", "meeting", "for", "the", "second", "candidate", "is", "planned", "for", "later", "this", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p188_s1", "idA": "1006281_11_item1_p158_s1", "sentA": "At the end of the first quarter of 2011, we held 20 granted patents and 84 pending patent applications with respect to various compositions, methods of production and methods of use relating to our ProCellEx protein expression system and our proprietary product pipeline.", "sentB": "As of December 31, 2011, we hold, or have license rights to, 31 patents and 81 pending patent applications with respect to various compositions, methods of production and methods of use relating to our ProCellEx protein expression system and our proprietary product pipeline.", "type": 2, "words": ["<tag1>", "At", "the", "end", "of", "the", "first", "quarter", "of", "2011,", "we", "held", "20", "granted", "patents", "and", "84", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline.", "<tag2>", "As", "of", "December", "31,", "2011,", "we", "hold,", "or", "have", "license", "rights", "to,", "31", "patents", "and", "81", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline.", "<tag3>"], "wordsA": ["At", "the", "end", "of", "the", "first", "quarter", "of", "2011,", "we", "held", "20", "granted", "patents", "and", "84", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline."], "wordsB": ["As", "of", "December", "31,", "2011,", "we", "hold,", "or", "have", "license", "rights", "to,", "31", "patents", "and", "81", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p22_s1", "idA": "1006281_11_item1_p158_s1", "sentA": "At the end of the first quarter of 2011, we held 20 granted patents and 84 pending patent applications with respect to various compositions, methods of production and methods of use relating to our ProCellEx protein expression system and our proprietary product pipeline.", "sentB": "During the first quarter of 2011, we and Pfizer supplied the remaining products deliverable under the short-term supply agreement.", "type": 2, "words": ["<tag1>", "At", "the", "end", "of", "the", "first", "quarter", "of", "2011,", "we", "held", "20", "granted", "patents", "and", "84", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline.", "<tag2>", "During", "the", "first", "quarter", "of", "2011,", "we", "and", "Pfizer", "supplied", "the", "remaining", "products", "deliverable", "under", "the", "short-term", "supply", "agreement.", "<tag3>"], "wordsA": ["At", "the", "end", "of", "the", "first", "quarter", "of", "2011,", "we", "held", "20", "granted", "patents", "and", "84", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline."], "wordsB": ["During", "the", "first", "quarter", "of", "2011,", "we", "and", "Pfizer", "supplied", "the", "remaining", "products", "deliverable", "under", "the", "short-term", "supply", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p188_s2", "idA": "1006281_11_item1_p158_s2", "sentA": "At the end of the first quarter of 2011 we also held one joint patent with a third party and held licensed rights to six patents and seven patent applications.", "sentB": "As of December 31, 2011, we also hold, with a third party, one joint patent and one joint patent application, and licensed rights to six patents and seven patent applications.", "type": 2, "words": ["<tag1>", "At", "the", "end", "of", "the", "first", "quarter", "of", "2011", "we", "also", "held", "one", "joint", "patent", "with", "a", "third", "party", "and", "held", "licensed", "rights", "to", "six", "patents", "and", "seven", "patent", "applications.", "<tag2>", "As", "of", "December", "31,", "2011,", "we", "also", "hold,", "with", "a", "third", "party,", "one", "joint", "patent", "and", "one", "joint", "patent", "application,", "and", "licensed", "rights", "to", "six", "patents", "and", "seven", "patent", "applications.", "<tag3>"], "wordsA": ["At", "the", "end", "of", "the", "first", "quarter", "of", "2011", "we", "also", "held", "one", "joint", "patent", "with", "a", "third", "party", "and", "held", "licensed", "rights", "to", "six", "patents", "and", "seven", "patent", "applications."], "wordsB": ["As", "of", "December", "31,", "2011,", "we", "also", "hold,", "with", "a", "third", "party,", "one", "joint", "patent", "and", "one", "joint", "patent", "application,", "and", "licensed", "rights", "to", "six", "patents", "and", "seven", "patent", "applications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p21_s4", "idA": "1006281_11_item1_p15_s0", "sentA": "The Orphan Drug designation in the United States for taliglucerase alfa for the treatment of Gaucher disease provides special status to taliglucerase alfa provided that it meets certain criteria.", "sentB": "In addition to the United States and France, taliglucerase alfa is currently being provided to Gaucher disease patients under special access agreements or Named Patient provisions in Brazil and in other countries.", "type": 2, "words": ["<tag1>", "The", "Orphan", "Drug", "designation", "in", "the", "United", "States", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease", "provides", "special", "status", "to", "taliglucerase", "alfa", "provided", "that", "it", "meets", "certain", "criteria.", "<tag2>", "In", "addition", "to", "the", "United", "States", "and", "France,", "taliglucerase", "alfa", "is", "currently", "being", "provided", "to", "Gaucher", "disease", "patients", "under", "special", "access", "agreements", "or", "Named", "Patient", "provisions", "in", "Brazil", "and", "in", "other", "countries.", "<tag3>"], "wordsA": ["The", "Orphan", "Drug", "designation", "in", "the", "United", "States", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease", "provides", "special", "status", "to", "taliglucerase", "alfa", "provided", "that", "it", "meets", "certain", "criteria."], "wordsB": ["In", "addition", "to", "the", "United", "States", "and", "France,", "taliglucerase", "alfa", "is", "currently", "being", "provided", "to", "Gaucher", "disease", "patients", "under", "special", "access", "agreements", "or", "Named", "Patient", "provisions", "in", "Brazil", "and", "in", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p190_s0", "idA": "1006281_11_item1_p160_s0", "sentA": "As of December 31, 2010, our patent portfolio consists of several patent families (consisting of patents and/or patent applications) covering our technology, protein expression methodologies and system and product candidates, as follows:", "sentB": "As of December 31, 2011, our patent portfolio consists of several patent families (consisting of patents and/or patent applications) covering our technology, protein expression methodologies and system and product candidates, as follows:", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2010,", "our", "patent", "portfolio", "consists", "of", "several", "patent", "families", "(consisting", "of", "patents", "and/or", "patent", "applications)", "covering", "our", "technology,", "protein", "expression", "methodologies", "and", "system", "and", "product", "candidates,", "as", "follows:", "<tag2>", "As", "of", "December", "31,", "2011,", "our", "patent", "portfolio", "consists", "of", "several", "patent", "families", "(consisting", "of", "patents", "and/or", "patent", "applications)", "covering", "our", "technology,", "protein", "expression", "methodologies", "and", "system", "and", "product", "candidates,", "as", "follows:", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2010,", "our", "patent", "portfolio", "consists", "of", "several", "patent", "families", "(consisting", "of", "patents", "and/or", "patent", "applications)", "covering", "our", "technology,", "protein", "expression", "methodologies", "and", "system", "and", "product", "candidates,", "as", "follows:"], "wordsB": ["As", "of", "December", "31,", "2011,", "our", "patent", "portfolio", "consists", "of", "several", "patent", "families", "(consisting", "of", "patents", "and/or", "patent", "applications)", "covering", "our", "technology,", "protein", "expression", "methodologies", "and", "system", "and", "product", "candidates,", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p191_s0", "idA": "1006281_11_item1_p161_s0", "sentA": "With respect to our ProCellEx protein expression system, we have been issued, and hold licensed rights to, patents in the United States, the European Union, Israel, Canada, the Czech Republic, Hungary, Japan, Poland, Mexico, Hong Kong and India, and to 10 pending patent applications.", "sentB": "With respect to our ProCellEx protein expression system, we have been issued, and hold licensed rights to, patents in the United States, Australia, the European Union, Israel, Canada, the Czech Republic, Hungary, Japan, Poland, Mexico, Hong Kong and India, and to eight pending patent applications.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "have", "been", "issued,", "and", "hold", "licensed", "rights", "to,", "patents", "in", "the", "United", "States,", "the", "European", "Union,", "Israel,", "Canada,", "the", "Czech", "Republic,", "Hungary,", "Japan,", "Poland,", "Mexico,", "Hong", "Kong", "and", "India,", "and", "to", "10", "pending", "patent", "applications.", "<tag2>", "With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "have", "been", "issued,", "and", "hold", "licensed", "rights", "to,", "patents", "in", "the", "United", "States,", "Australia,", "the", "European", "Union,", "Israel,", "Canada,", "the", "Czech", "Republic,", "Hungary,", "Japan,", "Poland,", "Mexico,", "Hong", "Kong", "and", "India,", "and", "to", "eight", "pending", "patent", "applications.", "<tag3>"], "wordsA": ["With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "have", "been", "issued,", "and", "hold", "licensed", "rights", "to,", "patents", "in", "the", "United", "States,", "the", "European", "Union,", "Israel,", "Canada,", "the", "Czech", "Republic,", "Hungary,", "Japan,", "Poland,", "Mexico,", "Hong", "Kong", "and", "India,", "and", "to", "10", "pending", "patent", "applications."], "wordsB": ["With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "have", "been", "issued,", "and", "hold", "licensed", "rights", "to,", "patents", "in", "the", "United", "States,", "Australia,", "the", "European", "Union,", "Israel,", "Canada,", "the", "Czech", "Republic,", "Hungary,", "Japan,", "Poland,", "Mexico,", "Hong", "Kong", "and", "India,", "and", "to", "eight", "pending", "patent", "applications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p193_s0", "idA": "1006281_11_item1_p163_s0", "sentA": "We hold a patent family containing five granted patents in India, South Africa, Russia, Australia and the Ukraine, and 36 patent applications, relating to the production of glycosylated lysosomal proteins in our plant culture platform, particularly proteins having a terminal mannose glycosylation, including taliglucerase alfa.", "sentB": "We hold a patent family containing nine granted patents in India, South Africa, Russia, Australia, China, the United States and the Ukraine, and 35 patent applications, relating to the production of glycosylated lysosomal proteins in our plant culture platform, particularly proteins having a terminal mannose glycosylation, including taliglucerase alfa.", "type": 2, "words": ["<tag1>", "We", "hold", "a", "patent", "family", "containing", "five", "granted", "patents", "in", "India,", "South", "Africa,", "Russia,", "Australia", "and", "the", "Ukraine,", "and", "36", "patent", "applications,", "relating", "to", "the", "production", "of", "glycosylated", "lysosomal", "proteins", "in", "our", "plant", "culture", "platform,", "particularly", "proteins", "having", "a", "terminal", "mannose", "glycosylation,", "including", "taliglucerase", "alfa.", "<tag2>", "We", "hold", "a", "patent", "family", "containing", "nine", "granted", "patents", "in", "India,", "South", "Africa,", "Russia,", "Australia,", "China,", "the", "United", "States", "and", "the", "Ukraine,", "and", "35", "patent", "applications,", "relating", "to", "the", "production", "of", "glycosylated", "lysosomal", "proteins", "in", "our", "plant", "culture", "platform,", "particularly", "proteins", "having", "a", "terminal", "mannose", "glycosylation,", "including", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["We", "hold", "a", "patent", "family", "containing", "five", "granted", "patents", "in", "India,", "South", "Africa,", "Russia,", "Australia", "and", "the", "Ukraine,", "and", "36", "patent", "applications,", "relating", "to", "the", "production", "of", "glycosylated", "lysosomal", "proteins", "in", "our", "plant", "culture", "platform,", "particularly", "proteins", "having", "a", "terminal", "mannose", "glycosylation,", "including", "taliglucerase", "alfa."], "wordsB": ["We", "hold", "a", "patent", "family", "containing", "nine", "granted", "patents", "in", "India,", "South", "Africa,", "Russia,", "Australia,", "China,", "the", "United", "States", "and", "the", "Ukraine,", "and", "35", "patent", "applications,", "relating", "to", "the", "production", "of", "glycosylated", "lysosomal", "proteins", "in", "our", "plant", "culture", "platform,", "particularly", "proteins", "having", "a", "terminal", "mannose", "glycosylation,", "including", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p193_s1", "idA": "1006281_11_item1_p163_s1", "sentA": "The issued patents and any patents to issue in the future based on pending patent applications in this patent family are expected to expire in 2024.", "sentB": "The issued patents and any patents to issue in the future based on pending patent applications in this patent family are expected to expire in 2024 and 2028.", "type": 2, "words": ["<tag1>", "The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "pending", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2024.", "<tag2>", "The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "pending", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2024", "and", "2028.", "<tag3>"], "wordsA": ["The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "pending", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2024."], "wordsB": ["The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "pending", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2024", "and", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p194_s0", "idA": "1006281_11_item1_p164_s0", "sentA": "We hold a patent family containing one granted and three pending patent applications relating to a system and method for production of antibodies in a plant cell culture, and antibodies produced in such a system.", "sentB": "We hold a patent family containing two granted and two pending patent applications relating to a system and method for production of antibodies in a plant cell culture, and antibodies produced in such a system.", "type": 2, "words": ["<tag1>", "We", "hold", "a", "patent", "family", "containing", "one", "granted", "and", "three", "pending", "patent", "applications", "relating", "to", "a", "system", "and", "method", "for", "production", "of", "antibodies", "in", "a", "plant", "cell", "culture,", "and", "antibodies", "produced", "in", "such", "a", "system.", "<tag2>", "We", "hold", "a", "patent", "family", "containing", "two", "granted", "and", "two", "pending", "patent", "applications", "relating", "to", "a", "system", "and", "method", "for", "production", "of", "antibodies", "in", "a", "plant", "cell", "culture,", "and", "antibodies", "produced", "in", "such", "a", "system.", "<tag3>"], "wordsA": ["We", "hold", "a", "patent", "family", "containing", "one", "granted", "and", "three", "pending", "patent", "applications", "relating", "to", "a", "system", "and", "method", "for", "production", "of", "antibodies", "in", "a", "plant", "cell", "culture,", "and", "antibodies", "produced", "in", "such", "a", "system."], "wordsB": ["We", "hold", "a", "patent", "family", "containing", "two", "granted", "and", "two", "pending", "patent", "applications", "relating", "to", "a", "system", "and", "method", "for", "production", "of", "antibodies", "in", "a", "plant", "cell", "culture,", "and", "antibodies", "produced", "in", "such", "a", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p195_s0", "idA": "1006281_11_item1_p165_s0", "sentA": "We hold a patent family containing one issued patent in South Africa and 12 pending patent applications relating to a new method for delivering active recombinant proteins systemically through oral administration of transgenic plant cells.", "sentB": "We hold a patent family containing two issued patent in South Africa and Singapore and 12 pending patent applications relating to a new method for delivering active recombinant proteins systemically through oral administration of transgenic plant cells.", "type": 2, "words": ["<tag1>", "We", "hold", "a", "patent", "family", "containing", "one", "issued", "patent", "in", "South", "Africa", "and", "12", "pending", "patent", "applications", "relating", "to", "a", "new", "method", "for", "delivering", "active", "recombinant", "proteins", "systemically", "through", "oral", "administration", "of", "transgenic", "plant", "cells.", "<tag2>", "We", "hold", "a", "patent", "family", "containing", "two", "issued", "patent", "in", "South", "Africa", "and", "Singapore", "and", "12", "pending", "patent", "applications", "relating", "to", "a", "new", "method", "for", "delivering", "active", "recombinant", "proteins", "systemically", "through", "oral", "administration", "of", "transgenic", "plant", "cells.", "<tag3>"], "wordsA": ["We", "hold", "a", "patent", "family", "containing", "one", "issued", "patent", "in", "South", "Africa", "and", "12", "pending", "patent", "applications", "relating", "to", "a", "new", "method", "for", "delivering", "active", "recombinant", "proteins", "systemically", "through", "oral", "administration", "of", "transgenic", "plant", "cells."], "wordsB": ["We", "hold", "a", "patent", "family", "containing", "two", "issued", "patent", "in", "South", "Africa", "and", "Singapore", "and", "12", "pending", "patent", "applications", "relating", "to", "a", "new", "method", "for", "delivering", "active", "recombinant", "proteins", "systemically", "through", "oral", "administration", "of", "transgenic", "plant", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p196_s0", "idA": "1006281_11_item1_p166_s0", "sentA": "We hold a patent family containing seven pending patent applications relating to saccharide containing protein conjugates.", "sentB": "We hold a patent family containing one granted patent in South Africa and six pending patent applications relating to saccharide containing protein conjugates.", "type": 2, "words": ["<tag1>", "We", "hold", "a", "patent", "family", "containing", "seven", "pending", "patent", "applications", "relating", "to", "saccharide", "containing", "protein", "conjugates.", "<tag2>", "We", "hold", "a", "patent", "family", "containing", "one", "granted", "patent", "in", "South", "Africa", "and", "six", "pending", "patent", "applications", "relating", "to", "saccharide", "containing", "protein", "conjugates.", "<tag3>"], "wordsA": ["We", "hold", "a", "patent", "family", "containing", "seven", "pending", "patent", "applications", "relating", "to", "saccharide", "containing", "protein", "conjugates."], "wordsB": ["We", "hold", "a", "patent", "family", "containing", "one", "granted", "patent", "in", "South", "Africa", "and", "six", "pending", "patent", "applications", "relating", "to", "saccharide", "containing", "protein", "conjugates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p198_s1", "idA": "1006281_11_item1_p168_s1", "sentA": "We also hold the licensed rights from Yeda to one granted and two pending patent applications with respect to the research and development of the glucocerebrosidase (GCD) protein.", "sentB": "We also hold the licensed rights from Yeda to one granted and two pending patent applications with respect to the research and development of the glucocerebrosidase protein which are expected to expire in 2024.", "type": 2, "words": ["<tag1>", "We", "also", "hold", "the", "licensed", "rights", "from", "Yeda", "to", "one", "granted", "and", "two", "pending", "patent", "applications", "with", "respect", "to", "the", "research", "and", "development", "of", "the", "glucocerebrosidase", "(GCD)", "protein.", "<tag2>", "We", "also", "hold", "the", "licensed", "rights", "from", "Yeda", "to", "one", "granted", "and", "two", "pending", "patent", "applications", "with", "respect", "to", "the", "research", "and", "development", "of", "the", "glucocerebrosidase", "protein", "which", "are", "expected", "to", "expire", "in", "2024.", "<tag3>"], "wordsA": ["We", "also", "hold", "the", "licensed", "rights", "from", "Yeda", "to", "one", "granted", "and", "two", "pending", "patent", "applications", "with", "respect", "to", "the", "research", "and", "development", "of", "the", "glucocerebrosidase", "(GCD)", "protein."], "wordsB": ["We", "also", "hold", "the", "licensed", "rights", "from", "Yeda", "to", "one", "granted", "and", "two", "pending", "patent", "applications", "with", "respect", "to", "the", "research", "and", "development", "of", "the", "glucocerebrosidase", "protein", "which", "are", "expected", "to", "expire", "in", "2024."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p200_s0", "idA": "1006281_11_item1_p170_s1", "sentA": "We are aware, for example, of U.S. patents, and corresponding international counterparts of such patents, owned by third parties that contain claims covering methods of producing GCD.", "sentB": "We are aware of U.S. patents, and corresponding international counterparts of such patents, owned by third parties that contain claims covering methods of producing GCD.", "type": 2, "words": ["<tag1>", "We", "are", "aware,", "for", "example,", "of", "U.S.", "patents,", "and", "corresponding", "international", "counterparts", "of", "such", "patents,", "owned", "by", "third", "parties", "that", "contain", "claims", "covering", "methods", "of", "producing", "GCD.", "<tag2>", "We", "are", "aware", "of", "U.S.", "patents,", "and", "corresponding", "international", "counterparts", "of", "such", "patents,", "owned", "by", "third", "parties", "that", "contain", "claims", "covering", "methods", "of", "producing", "GCD.", "<tag3>"], "wordsA": ["We", "are", "aware,", "for", "example,", "of", "U.S.", "patents,", "and", "corresponding", "international", "counterparts", "of", "such", "patents,", "owned", "by", "third", "parties", "that", "contain", "claims", "covering", "methods", "of", "producing", "GCD."], "wordsB": ["We", "are", "aware", "of", "U.S.", "patents,", "and", "corresponding", "international", "counterparts", "of", "such", "patents,", "owned", "by", "third", "parties", "that", "contain", "claims", "covering", "methods", "of", "producing", "GCD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p202_s2", "idA": "1006281_11_item1_p173_s0", "sentA": "with certain events relating to a wind up or bankruptcy, if we make a general assignment for the benefit of our creditors, or if we cease to conduct operations for a certain period.", "sentB": "Further, Icon may terminate the agreement in connection with certain events relating to a wind up or bankruptcy, if we make a general assignment for the benefit of our creditors, or if we cease to conduct operations for a certain period.", "type": 2, "words": ["<tag1>", "with", "certain", "events", "relating", "to", "a", "wind", "up", "or", "bankruptcy,", "if", "we", "make", "a", "general", "assignment", "for", "the", "benefit", "of", "our", "creditors,", "or", "if", "we", "cease", "to", "conduct", "operations", "for", "a", "certain", "period.", "<tag2>", "Further,", "Icon", "may", "terminate", "the", "agreement", "in", "connection", "with", "certain", "events", "relating", "to", "a", "wind", "up", "or", "bankruptcy,", "if", "we", "make", "a", "general", "assignment", "for", "the", "benefit", "of", "our", "creditors,", "or", "if", "we", "cease", "to", "conduct", "operations", "for", "a", "certain", "period.", "<tag3>"], "wordsA": ["with", "certain", "events", "relating", "to", "a", "wind", "up", "or", "bankruptcy,", "if", "we", "make", "a", "general", "assignment", "for", "the", "benefit", "of", "our", "creditors,", "or", "if", "we", "cease", "to", "conduct", "operations", "for", "a", "certain", "period."], "wordsB": ["Further,", "Icon", "may", "terminate", "the", "agreement", "in", "connection", "with", "certain", "events", "relating", "to", "a", "wind", "up", "or", "bankruptcy,", "if", "we", "make", "a", "general", "assignment", "for", "the", "benefit", "of", "our", "creditors,", "or", "if", "we", "cease", "to", "conduct", "operations", "for", "a", "certain", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p202_s4", "idA": "1006281_11_item1_p173_s2", "sentA": "Notwithstanding the termination date of the agreement, our obligation to pay royalties under the agreement to Icon may expire prior to the termination of this agreement, subject to certain conditions.", "sentB": "Notwithstanding the termination date of the agreement, our obligation to pay royalties to Icon under the agreement may expire prior to the termination of the agreement, subject to certain conditions.", "type": 2, "words": ["<tag1>", "Notwithstanding", "the", "termination", "date", "of", "the", "agreement,", "our", "obligation", "to", "pay", "royalties", "under", "the", "agreement", "to", "Icon", "may", "expire", "prior", "to", "the", "termination", "of", "this", "agreement,", "subject", "to", "certain", "conditions.", "<tag2>", "Notwithstanding", "the", "termination", "date", "of", "the", "agreement,", "our", "obligation", "to", "pay", "royalties", "to", "Icon", "under", "the", "agreement", "may", "expire", "prior", "to", "the", "termination", "of", "the", "agreement,", "subject", "to", "certain", "conditions.", "<tag3>"], "wordsA": ["Notwithstanding", "the", "termination", "date", "of", "the", "agreement,", "our", "obligation", "to", "pay", "royalties", "under", "the", "agreement", "to", "Icon", "may", "expire", "prior", "to", "the", "termination", "of", "this", "agreement,", "subject", "to", "certain", "conditions."], "wordsB": ["Notwithstanding", "the", "termination", "date", "of", "the", "agreement,", "our", "obligation", "to", "pay", "royalties", "to", "Icon", "under", "the", "agreement", "may", "expire", "prior", "to", "the", "termination", "of", "the", "agreement,", "subject", "to", "certain", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p203_s1", "idA": "1006281_11_item1_p174_s1", "sentA": "As consideration for the license, we made a one-time license fee payment to Virginia Tech within 10 days of the effective date of the agreement, and we are obligated to make royalty payments equal to varying low, single-digit percentages of net sales of licensed products by Protalix Ltd., its subsidiaries and/or their affiliates.", "sentB": "As consideration for the license, we made a one-time license fee payment to Virginia Tech, and we are obligated to make royalty payments equal to varying low, single-digit percentages of net sales of licensed products by Protalix Ltd., its subsidiaries and/or their affiliates.", "type": 2, "words": ["<tag1>", "As", "consideration", "for", "the", "license,", "we", "made", "a", "one-time", "license", "fee", "payment", "to", "Virginia", "Tech", "within", "10", "days", "of", "the", "effective", "date", "of", "the", "agreement,", "and", "we", "are", "obligated", "to", "make", "royalty", "payments", "equal", "to", "varying", "low,", "single-digit", "percentages", "of", "net", "sales", "of", "licensed", "products", "by", "Protalix", "Ltd.,", "its", "subsidiaries", "and/or", "their", "affiliates.", "<tag2>", "As", "consideration", "for", "the", "license,", "we", "made", "a", "one-time", "license", "fee", "payment", "to", "Virginia", "Tech,", "and", "we", "are", "obligated", "to", "make", "royalty", "payments", "equal", "to", "varying", "low,", "single-digit", "percentages", "of", "net", "sales", "of", "licensed", "products", "by", "Protalix", "Ltd.,", "its", "subsidiaries", "and/or", "their", "affiliates.", "<tag3>"], "wordsA": ["As", "consideration", "for", "the", "license,", "we", "made", "a", "one-time", "license", "fee", "payment", "to", "Virginia", "Tech", "within", "10", "days", "of", "the", "effective", "date", "of", "the", "agreement,", "and", "we", "are", "obligated", "to", "make", "royalty", "payments", "equal", "to", "varying", "low,", "single-digit", "percentages", "of", "net", "sales", "of", "licensed", "products", "by", "Protalix", "Ltd.,", "its", "subsidiaries", "and/or", "their", "affiliates."], "wordsB": ["As", "consideration", "for", "the", "license,", "we", "made", "a", "one-time", "license", "fee", "payment", "to", "Virginia", "Tech,", "and", "we", "are", "obligated", "to", "make", "royalty", "payments", "equal", "to", "varying", "low,", "single-digit", "percentages", "of", "net", "sales", "of", "licensed", "products", "by", "Protalix", "Ltd.,", "its", "subsidiaries", "and/or", "their", "affiliates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p165_s0", "idA": "1006281_11_item1_p174_s3", "sentA": "In addition, we are obligated to make milestone payments equal to $150,000, in aggregate, upon the achievement of certain milestones.", "sentB": "In addition, we are researching other indications for which PRX-105 may serve as a therapy.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "are", "obligated", "to", "make", "milestone", "payments", "equal", "to", "$150,000,", "in", "aggregate,", "upon", "the", "achievement", "of", "certain", "milestones.", "<tag2>", "In", "addition,", "we", "are", "researching", "other", "indications", "for", "which", "PRX-105", "may", "serve", "as", "a", "therapy.", "<tag3>"], "wordsA": ["In", "addition,", "we", "are", "obligated", "to", "make", "milestone", "payments", "equal", "to", "$150,000,", "in", "aggregate,", "upon", "the", "achievement", "of", "certain", "milestones."], "wordsB": ["In", "addition,", "we", "are", "researching", "other", "indications", "for", "which", "PRX-105", "may", "serve", "as", "a", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p206_s2", "idA": "1006281_11_item1_p176_s4", "sentA": "We intend to use our current manufacturing space to produce all of the taliglucerase alfa we need in the near future, included the taliglucerase alfa to be purchased by Pfizer.", "sentB": "We use our current facility, which has approximately 20,000 sq/ft of clean rooms built according to industry standards, to develop, process and manufacture taliglucerase alfa and other recombinant proteins We intend to use our current manufacturing space to produce all of the taliglucerase alfa we need in the near future, included the taliglucerase alfa to be purchased by Pfizer.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "use", "our", "current", "manufacturing", "space", "to", "produce", "all", "of", "the", "taliglucerase", "alfa", "we", "need", "in", "the", "near", "future,", "included", "the", "taliglucerase", "alfa", "to", "be", "purchased", "by", "Pfizer.", "<tag2>", "We", "use", "our", "current", "facility,", "which", "has", "approximately", "20,000", "sq/ft", "of", "clean", "rooms", "built", "according", "to", "industry", "standards,", "to", "develop,", "process", "and", "manufacture", "taliglucerase", "alfa", "and", "other", "recombinant", "proteins", "We", "intend", "to", "use", "our", "current", "manufacturing", "space", "to", "produce", "all", "of", "the", "taliglucerase", "alfa", "we", "need", "in", "the", "near", "future,", "included", "the", "taliglucerase", "alfa", "to", "be", "purchased", "by", "Pfizer.", "<tag3>"], "wordsA": ["We", "intend", "to", "use", "our", "current", "manufacturing", "space", "to", "produce", "all", "of", "the", "taliglucerase", "alfa", "we", "need", "in", "the", "near", "future,", "included", "the", "taliglucerase", "alfa", "to", "be", "purchased", "by", "Pfizer."], "wordsB": ["We", "use", "our", "current", "facility,", "which", "has", "approximately", "20,000", "sq/ft", "of", "clean", "rooms", "built", "according", "to", "industry", "standards,", "to", "develop,", "process", "and", "manufacture", "taliglucerase", "alfa", "and", "other", "recombinant", "proteins", "We", "intend", "to", "use", "our", "current", "manufacturing", "space", "to", "produce", "all", "of", "the", "taliglucerase", "alfa", "we", "need", "in", "the", "near", "future,", "included", "the", "taliglucerase", "alfa", "to", "be", "purchased", "by", "Pfizer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p206_s3", "idA": "1006281_11_item1_p176_s5", "sentA": "Current capacity of our facility can serve approximately 20% of the Gaucher disease patients that are currently under treatment.", "sentB": "Current capacity of our facility can serve approximately 30% of the Gaucher disease patients that are currently under treatment.", "type": 2, "words": ["<tag1>", "Current", "capacity", "of", "our", "facility", "can", "serve", "approximately", "20%", "of", "the", "Gaucher", "disease", "patients", "that", "are", "currently", "under", "treatment.", "<tag2>", "Current", "capacity", "of", "our", "facility", "can", "serve", "approximately", "30%", "of", "the", "Gaucher", "disease", "patients", "that", "are", "currently", "under", "treatment.", "<tag3>"], "wordsA": ["Current", "capacity", "of", "our", "facility", "can", "serve", "approximately", "20%", "of", "the", "Gaucher", "disease", "patients", "that", "are", "currently", "under", "treatment."], "wordsB": ["Current", "capacity", "of", "our", "facility", "can", "serve", "approximately", "30%", "of", "the", "Gaucher", "disease", "patients", "that", "are", "currently", "under", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p214_s3", "idA": "1006281_11_item1_p176_s5", "sentA": "Current capacity of our facility can serve approximately 20% of the Gaucher disease patients that are currently under treatment.", "sentB": "Amicus Therapeutics reports that it has suspended its development of its Gaucher disease treatment.", "type": 2, "words": ["<tag1>", "Current", "capacity", "of", "our", "facility", "can", "serve", "approximately", "20%", "of", "the", "Gaucher", "disease", "patients", "that", "are", "currently", "under", "treatment.", "<tag2>", "Amicus", "Therapeutics", "reports", "that", "it", "has", "suspended", "its", "development", "of", "its", "Gaucher", "disease", "treatment.", "<tag3>"], "wordsA": ["Current", "capacity", "of", "our", "facility", "can", "serve", "approximately", "20%", "of", "the", "Gaucher", "disease", "patients", "that", "are", "currently", "under", "treatment."], "wordsB": ["Amicus", "Therapeutics", "reports", "that", "it", "has", "suspended", "its", "development", "of", "its", "Gaucher", "disease", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p206_s5", "idA": "1006281_11_item1_p176_s7", "sentA": "Total expected cost for such expansion is currently estimated to be approximately $25 million and the process is expected to be completed during 2012.", "sentB": "Total expected cost for such expansion is currently estimated to be approximately $25 million and the process is expected to be completed during 2013.", "type": 2, "words": ["<tag1>", "Total", "expected", "cost", "for", "such", "expansion", "is", "currently", "estimated", "to", "be", "approximately", "$25", "million", "and", "the", "process", "is", "expected", "to", "be", "completed", "during", "2012.", "<tag2>", "Total", "expected", "cost", "for", "such", "expansion", "is", "currently", "estimated", "to", "be", "approximately", "$25", "million", "and", "the", "process", "is", "expected", "to", "be", "completed", "during", "2013.", "<tag3>"], "wordsA": ["Total", "expected", "cost", "for", "such", "expansion", "is", "currently", "estimated", "to", "be", "approximately", "$25", "million", "and", "the", "process", "is", "expected", "to", "be", "completed", "during", "2012."], "wordsB": ["Total", "expected", "cost", "for", "such", "expansion", "is", "currently", "estimated", "to", "be", "approximately", "$25", "million", "and", "the", "process", "is", "expected", "to", "be", "completed", "during", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p209_s0", "idA": "1006281_11_item1_p177_s1", "sentA": "In addition, we have engaged a contract manufacturer in Europe to act as an additional source of fill and finish activities for taliglucerase alfa.", "sentB": "We have engaged a contract manufacturer in Europe to act as an additional source of fill and finish activities for taliglucerase alfa.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "have", "engaged", "a", "contract", "manufacturer", "in", "Europe", "to", "act", "as", "an", "additional", "source", "of", "fill", "and", "finish", "activities", "for", "taliglucerase", "alfa.", "<tag2>", "We", "have", "engaged", "a", "contract", "manufacturer", "in", "Europe", "to", "act", "as", "an", "additional", "source", "of", "fill", "and", "finish", "activities", "for", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["In", "addition,", "we", "have", "engaged", "a", "contract", "manufacturer", "in", "Europe", "to", "act", "as", "an", "additional", "source", "of", "fill", "and", "finish", "activities", "for", "taliglucerase", "alfa."], "wordsB": ["We", "have", "engaged", "a", "contract", "manufacturer", "in", "Europe", "to", "act", "as", "an", "additional", "source", "of", "fill", "and", "finish", "activities", "for", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p210_s1", "idA": "1006281_11_item1_p178_s1", "sentA": "Our facility is located in a Zone A location, and, therefore, our income from the Approved Enterprise will be tax exempt in Israel for a period of 10 years commencing with the year in which we first generate taxable income from the relevant Approved Enterprise.", "sentB": "Our facility is located in a Zone A location, and, therefore, our income from the Approved Enterprise will be tax exempt in Israel for a 10-year period commencing with the year in which we first generate taxable income from the relevant Approved Enterprise.", "type": 2, "words": ["<tag1>", "Our", "facility", "is", "located", "in", "a", "Zone", "A", "location,", "and,", "therefore,", "our", "income", "from", "the", "Approved", "Enterprise", "will", "be", "tax", "exempt", "in", "Israel", "for", "a", "period", "of", "10", "years", "commencing", "with", "the", "year", "in", "which", "we", "first", "generate", "taxable", "income", "from", "the", "relevant", "Approved", "Enterprise.", "<tag2>", "Our", "facility", "is", "located", "in", "a", "Zone", "A", "location,", "and,", "therefore,", "our", "income", "from", "the", "Approved", "Enterprise", "will", "be", "tax", "exempt", "in", "Israel", "for", "a", "10-year", "period", "commencing", "with", "the", "year", "in", "which", "we", "first", "generate", "taxable", "income", "from", "the", "relevant", "Approved", "Enterprise.", "<tag3>"], "wordsA": ["Our", "facility", "is", "located", "in", "a", "Zone", "A", "location,", "and,", "therefore,", "our", "income", "from", "the", "Approved", "Enterprise", "will", "be", "tax", "exempt", "in", "Israel", "for", "a", "period", "of", "10", "years", "commencing", "with", "the", "year", "in", "which", "we", "first", "generate", "taxable", "income", "from", "the", "relevant", "Approved", "Enterprise."], "wordsB": ["Our", "facility", "is", "located", "in", "a", "Zone", "A", "location,", "and,", "therefore,", "our", "income", "from", "the", "Approved", "Enterprise", "will", "be", "tax", "exempt", "in", "Israel", "for", "a", "10-year", "period", "commencing", "with", "the", "year", "in", "which", "we", "first", "generate", "taxable", "income", "from", "the", "relevant", "Approved", "Enterprise."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p254_s1", "idA": "1006281_11_item1_p178_s1", "sentA": "Our facility is located in a Zone A location, and, therefore, our income from the Approved Enterprise will be tax exempt in Israel for a period of 10 years commencing with the year in which we first generate taxable income from the relevant Approved Enterprise.", "sentB": "Under the terms of its Approved Enterprise program, the facility is located in a top priority location, or Zone A, and, therefore, the income from that Approved Enterprise will be tax exempt in Israel for a period of 10 years, commencing with the year in which taxable income is first generated from the relevant Approved Enterprise.", "type": 2, "words": ["<tag1>", "Our", "facility", "is", "located", "in", "a", "Zone", "A", "location,", "and,", "therefore,", "our", "income", "from", "the", "Approved", "Enterprise", "will", "be", "tax", "exempt", "in", "Israel", "for", "a", "period", "of", "10", "years", "commencing", "with", "the", "year", "in", "which", "we", "first", "generate", "taxable", "income", "from", "the", "relevant", "Approved", "Enterprise.", "<tag2>", "Under", "the", "terms", "of", "its", "Approved", "Enterprise", "program,", "the", "facility", "is", "located", "in", "a", "top", "priority", "location,", "or", "Zone", "A,", "and,", "therefore,", "the", "income", "from", "that", "Approved", "Enterprise", "will", "be", "tax", "exempt", "in", "Israel", "for", "a", "period", "of", "10", "years,", "commencing", "with", "the", "year", "in", "which", "taxable", "income", "is", "first", "generated", "from", "the", "relevant", "Approved", "Enterprise.", "<tag3>"], "wordsA": ["Our", "facility", "is", "located", "in", "a", "Zone", "A", "location,", "and,", "therefore,", "our", "income", "from", "the", "Approved", "Enterprise", "will", "be", "tax", "exempt", "in", "Israel", "for", "a", "period", "of", "10", "years", "commencing", "with", "the", "year", "in", "which", "we", "first", "generate", "taxable", "income", "from", "the", "relevant", "Approved", "Enterprise."], "wordsB": ["Under", "the", "terms", "of", "its", "Approved", "Enterprise", "program,", "the", "facility", "is", "located", "in", "a", "top", "priority", "location,", "or", "Zone", "A,", "and,", "therefore,", "the", "income", "from", "that", "Approved", "Enterprise", "will", "be", "tax", "exempt", "in", "Israel", "for", "a", "period", "of", "10", "years,", "commencing", "with", "the", "year", "in", "which", "taxable", "income", "is", "first", "generated", "from", "the", "relevant", "Approved", "Enterprise."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p210_s3", "idA": "1006281_11_item1_p179_s0", "sentA": "example, by future acquisitions, such increased activities generally may not be eligible for inclusion in Israeli tax benefit programs.", "sentB": "To remain eligible for these tax benefits, we must continue to meet certain conditions, and if we increase our activities outside of Israel, for example, by future acquisitions, such increased activities generally may not be eligible for inclusion in Israeli tax benefit programs.", "type": 2, "words": ["<tag1>", "example,", "by", "future", "acquisitions,", "such", "increased", "activities", "generally", "may", "not", "be", "eligible", "for", "inclusion", "in", "Israeli", "tax", "benefit", "programs.", "<tag2>", "To", "remain", "eligible", "for", "these", "tax", "benefits,", "we", "must", "continue", "to", "meet", "certain", "conditions,", "and", "if", "we", "increase", "our", "activities", "outside", "of", "Israel,", "for", "example,", "by", "future", "acquisitions,", "such", "increased", "activities", "generally", "may", "not", "be", "eligible", "for", "inclusion", "in", "Israeli", "tax", "benefit", "programs.", "<tag3>"], "wordsA": ["example,", "by", "future", "acquisitions,", "such", "increased", "activities", "generally", "may", "not", "be", "eligible", "for", "inclusion", "in", "Israeli", "tax", "benefit", "programs."], "wordsB": ["To", "remain", "eligible", "for", "these", "tax", "benefits,", "we", "must", "continue", "to", "meet", "certain", "conditions,", "and", "if", "we", "increase", "our", "activities", "outside", "of", "Israel,", "for", "example,", "by", "future", "acquisitions,", "such", "increased", "activities", "generally", "may", "not", "be", "eligible", "for", "inclusion", "in", "Israeli", "tax", "benefit", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p11_s3", "idA": "1006281_11_item1_p17_s2", "sentA": "This ATU allows patients with Gaucher disease in France to receive treatment with taliglucerase alfa before marketing authorization for the product is granted in the European Union.", "sentB": "The IMB certificate is accepted by all health authorities in the European Union under the European Union's centralized marketing authorization procedure, and by authorities of several other countries that recognize EU certification.", "type": 2, "words": ["<tag1>", "This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union.", "<tag2>", "The", "IMB", "certificate", "is", "accepted", "by", "all", "health", "authorities", "in", "the", "European", "Union", "under", "the", "European", "Union's", "centralized", "marketing", "authorization", "procedure,", "and", "by", "authorities", "of", "several", "other", "countries", "that", "recognize", "EU", "certification.", "<tag3>"], "wordsA": ["This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union."], "wordsB": ["The", "IMB", "certificate", "is", "accepted", "by", "all", "health", "authorities", "in", "the", "European", "Union", "under", "the", "European", "Union's", "centralized", "marketing", "authorization", "procedure,", "and", "by", "authorities", "of", "several", "other", "countries", "that", "recognize", "EU", "certification."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p208_s3", "idA": "1006281_11_item1_p17_s2", "sentA": "This ATU allows patients with Gaucher disease in France to receive treatment with taliglucerase alfa before marketing authorization for the product is granted in the European Union.", "sentB": "The IMB certificate is accepted by all health authorities in the European Union under the European Union's centralized marketing authorization procedure, and by authorities of several other countries that recognize EU certification.", "type": 2, "words": ["<tag1>", "This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union.", "<tag2>", "The", "IMB", "certificate", "is", "accepted", "by", "all", "health", "authorities", "in", "the", "European", "Union", "under", "the", "European", "Union's", "centralized", "marketing", "authorization", "procedure,", "and", "by", "authorities", "of", "several", "other", "countries", "that", "recognize", "EU", "certification.", "<tag3>"], "wordsA": ["This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union."], "wordsB": ["The", "IMB", "certificate", "is", "accepted", "by", "all", "health", "authorities", "in", "the", "European", "Union", "under", "the", "European", "Union's", "centralized", "marketing", "authorization", "procedure,", "and", "by", "authorities", "of", "several", "other", "countries", "that", "recognize", "EU", "certification."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p21_s2", "idA": "1006281_11_item1_p17_s2", "sentA": "This ATU allows patients with Gaucher disease in France to receive treatment with taliglucerase alfa before marketing authorization for the product is granted in the European Union.", "sentB": "This ATU allows Gaucher disease patients in France to receive treatment with taliglucerase alfa before marketing authorization for the product is granted in the European Union.", "type": 2, "words": ["<tag1>", "This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union.", "<tag2>", "This", "ATU", "allows", "Gaucher", "disease", "patients", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union.", "<tag3>"], "wordsA": ["This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union."], "wordsB": ["This", "ATU", "allows", "Gaucher", "disease", "patients", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p6_s2", "idA": "1006281_11_item1_p17_s2", "sentA": "This ATU allows patients with Gaucher disease in France to receive treatment with taliglucerase alfa before marketing authorization for the product is granted in the European Union.", "sentB": "Among the topics currently in discussion, is the orphan drug designation and exclusivity granted by the EMA/European Commission to VPRIV, Shire plc's, or Shire's, Gaucher disease treatment, which could prevent the marketing authorization of taliglucerase alfa in the European Union for a 10-year market exclusivity period commencing as of the August 2010 marketing authorization of VPRIV in the European Union.", "type": 2, "words": ["<tag1>", "This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union.", "<tag2>", "Among", "the", "topics", "currently", "in", "discussion,", "is", "the", "orphan", "drug", "designation", "and", "exclusivity", "granted", "by", "the", "EMA/European", "Commission", "to", "VPRIV,", "Shire", "plc's,", "or", "Shire's,", "Gaucher", "disease", "treatment,", "which", "could", "prevent", "the", "marketing", "authorization", "of", "taliglucerase", "alfa", "in", "the", "European", "Union", "for", "a", "10-year", "market", "exclusivity", "period", "commencing", "as", "of", "the", "August", "2010", "marketing", "authorization", "of", "VPRIV", "in", "the", "European", "Union.", "<tag3>"], "wordsA": ["This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union."], "wordsB": ["Among", "the", "topics", "currently", "in", "discussion,", "is", "the", "orphan", "drug", "designation", "and", "exclusivity", "granted", "by", "the", "EMA/European", "Commission", "to", "VPRIV,", "Shire", "plc's,", "or", "Shire's,", "Gaucher", "disease", "treatment,", "which", "could", "prevent", "the", "marketing", "authorization", "of", "taliglucerase", "alfa", "in", "the", "European", "Union", "for", "a", "10-year", "market", "exclusivity", "period", "commencing", "as", "of", "the", "August", "2010", "marketing", "authorization", "of", "VPRIV", "in", "the", "European", "Union."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p77_s1", "idA": "1006281_11_item1_p17_s2", "sentA": "This ATU allows patients with Gaucher disease in France to receive treatment with taliglucerase alfa before marketing authorization for the product is granted in the European Union.", "sentB": "Among the topics currently in discussion, is the orphan drug designation and exclusivity granted by the EMA/European Commission to VPRIV, which could prevent the marketing authorization of taliglucerase alfa in the European Union for a 10-year market exclusivity period commencing as of the August 2010 marketing authorization of VPRIV in the European Union.", "type": 2, "words": ["<tag1>", "This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union.", "<tag2>", "Among", "the", "topics", "currently", "in", "discussion,", "is", "the", "orphan", "drug", "designation", "and", "exclusivity", "granted", "by", "the", "EMA/European", "Commission", "to", "VPRIV,", "which", "could", "prevent", "the", "marketing", "authorization", "of", "taliglucerase", "alfa", "in", "the", "European", "Union", "for", "a", "10-year", "market", "exclusivity", "period", "commencing", "as", "of", "the", "August", "2010", "marketing", "authorization", "of", "VPRIV", "in", "the", "European", "Union.", "<tag3>"], "wordsA": ["This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union."], "wordsB": ["Among", "the", "topics", "currently", "in", "discussion,", "is", "the", "orphan", "drug", "designation", "and", "exclusivity", "granted", "by", "the", "EMA/European", "Commission", "to", "VPRIV,", "which", "could", "prevent", "the", "marketing", "authorization", "of", "taliglucerase", "alfa", "in", "the", "European", "Union", "for", "a", "10-year", "market", "exclusivity", "period", "commencing", "as", "of", "the", "August", "2010", "marketing", "authorization", "of", "VPRIV", "in", "the", "European", "Union."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p87_s2", "idA": "1006281_11_item1_p17_s2", "sentA": "This ATU allows patients with Gaucher disease in France to receive treatment with taliglucerase alfa before marketing authorization for the product is granted in the European Union.", "sentB": "The IMB certificate is accepted by all health authorities in the European Union under the European Union's centralized marketing authorization procedure, and by authorities of several other countries that recognize EU certification.", "type": 2, "words": ["<tag1>", "This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union.", "<tag2>", "The", "IMB", "certificate", "is", "accepted", "by", "all", "health", "authorities", "in", "the", "European", "Union", "under", "the", "European", "Union's", "centralized", "marketing", "authorization", "procedure,", "and", "by", "authorities", "of", "several", "other", "countries", "that", "recognize", "EU", "certification.", "<tag3>"], "wordsA": ["This", "ATU", "allows", "patients", "with", "Gaucher", "disease", "in", "France", "to", "receive", "treatment", "with", "taliglucerase", "alfa", "before", "marketing", "authorization", "for", "the", "product", "is", "granted", "in", "the", "European", "Union."], "wordsB": ["The", "IMB", "certificate", "is", "accepted", "by", "all", "health", "authorities", "in", "the", "European", "Union", "under", "the", "European", "Union's", "centralized", "marketing", "authorization", "procedure,", "and", "by", "authorities", "of", "several", "other", "countries", "that", "recognize", "EU", "certification."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p272_s1", "idA": "1006281_11_item1_p180_s0", "sentA": "In addition, our technology is subject to certain restrictions with respect to the transfer of technology and manufacturing rights.", "sentB": "The technology is, however, subject to transfer of technology and manufacturing rights restrictions as described above.", "type": 2, "words": ["<tag1>", "In", "addition,", "our", "technology", "is", "subject", "to", "certain", "restrictions", "with", "respect", "to", "the", "transfer", "of", "technology", "and", "manufacturing", "rights.", "<tag2>", "The", "technology", "is,", "however,", "subject", "to", "transfer", "of", "technology", "and", "manufacturing", "rights", "restrictions", "as", "described", "above.", "<tag3>"], "wordsA": ["In", "addition,", "our", "technology", "is", "subject", "to", "certain", "restrictions", "with", "respect", "to", "the", "transfer", "of", "technology", "and", "manufacturing", "rights."], "wordsB": ["The", "technology", "is,", "however,", "subject", "to", "transfer", "of", "technology", "and", "manufacturing", "rights", "restrictions", "as", "described", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p214_s0", "idA": "1006281_11_item1_p184_s0", "sentA": "We specifically face competition from companies with approved treatments of Gaucher disease, including Genzyme, which recently announced a proposed merger into Sanofi Aventis, and to a much lesser extent, Actelion.", "sentB": "We specifically face competition from companies with approved treatments of Gaucher disease, including Genzyme, which was recently acquired by Sanofi, and to a much lesser extent, Actelion.", "type": 2, "words": ["<tag1>", "We", "specifically", "face", "competition", "from", "companies", "with", "approved", "treatments", "of", "Gaucher", "disease,", "including", "Genzyme,", "which", "recently", "announced", "a", "proposed", "merger", "into", "Sanofi", "Aventis,", "and", "to", "a", "much", "lesser", "extent,", "Actelion.", "<tag2>", "We", "specifically", "face", "competition", "from", "companies", "with", "approved", "treatments", "of", "Gaucher", "disease,", "including", "Genzyme,", "which", "was", "recently", "acquired", "by", "Sanofi,", "and", "to", "a", "much", "lesser", "extent,", "Actelion.", "<tag3>"], "wordsA": ["We", "specifically", "face", "competition", "from", "companies", "with", "approved", "treatments", "of", "Gaucher", "disease,", "including", "Genzyme,", "which", "recently", "announced", "a", "proposed", "merger", "into", "Sanofi", "Aventis,", "and", "to", "a", "much", "lesser", "extent,", "Actelion."], "wordsB": ["We", "specifically", "face", "competition", "from", "companies", "with", "approved", "treatments", "of", "Gaucher", "disease,", "including", "Genzyme,", "which", "was", "recently", "acquired", "by", "Sanofi,", "and", "to", "a", "much", "lesser", "extent,", "Actelion."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p214_s1", "idA": "1006281_11_item1_p185_s0", "sentA": "In February 2010, the FDA approved VPRIV, Shire s enzyme replacement therapy for the treatment of Gaucher disease and the European Commission granted marketing authorization to VPRIV in August 2010.", "sentB": "In addition, in February 2010, the FDA approved VPRIV, Shire s enzyme replacement therapy for the treatment of Gaucher disease and the European Commission granted marketing authorization to VPRIV in August 2010.", "type": 2, "words": ["<tag1>", "In", "February", "2010,", "the", "FDA", "approved", "VPRIV,", "Shire", "s", "enzyme", "replacement", "therapy", "for", "the", "treatment", "of", "Gaucher", "disease", "and", "the", "European", "Commission", "granted", "marketing", "authorization", "to", "VPRIV", "in", "August", "2010.", "<tag2>", "In", "addition,", "in", "February", "2010,", "the", "FDA", "approved", "VPRIV,", "Shire", "s", "enzyme", "replacement", "therapy", "for", "the", "treatment", "of", "Gaucher", "disease", "and", "the", "European", "Commission", "granted", "marketing", "authorization", "to", "VPRIV", "in", "August", "2010.", "<tag3>"], "wordsA": ["In", "February", "2010,", "the", "FDA", "approved", "VPRIV,", "Shire", "s", "enzyme", "replacement", "therapy", "for", "the", "treatment", "of", "Gaucher", "disease", "and", "the", "European", "Commission", "granted", "marketing", "authorization", "to", "VPRIV", "in", "August", "2010."], "wordsB": ["In", "addition,", "in", "February", "2010,", "the", "FDA", "approved", "VPRIV,", "Shire", "s", "enzyme", "replacement", "therapy", "for", "the", "treatment", "of", "Gaucher", "disease", "and", "the", "European", "Commission", "granted", "marketing", "authorization", "to", "VPRIV", "in", "August", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p214_s2", "idA": "1006281_11_item1_p185_s1", "sentA": "In addition, we are aware of other early clinical stage, experimental, small molecule, oral drugs which are being developed for the treatment of Gaucher disease by Genzyme and Amicus Therapeutics, which according to public filings by Amicus Therapeutics has been suspended.", "sentB": "In addition, we are aware of other early clinical stage, experimental, small molecule, oral drugs which are being developed for the treatment of Gaucher disease by Genzyme and Amicus Therapeutics.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "are", "aware", "of", "other", "early", "clinical", "stage,", "experimental,", "small", "molecule,", "oral", "drugs", "which", "are", "being", "developed", "for", "the", "treatment", "of", "Gaucher", "disease", "by", "Genzyme", "and", "Amicus", "Therapeutics,", "which", "according", "to", "public", "filings", "by", "Amicus", "Therapeutics", "has", "been", "suspended.", "<tag2>", "In", "addition,", "we", "are", "aware", "of", "other", "early", "clinical", "stage,", "experimental,", "small", "molecule,", "oral", "drugs", "which", "are", "being", "developed", "for", "the", "treatment", "of", "Gaucher", "disease", "by", "Genzyme", "and", "Amicus", "Therapeutics.", "<tag3>"], "wordsA": ["In", "addition,", "we", "are", "aware", "of", "other", "early", "clinical", "stage,", "experimental,", "small", "molecule,", "oral", "drugs", "which", "are", "being", "developed", "for", "the", "treatment", "of", "Gaucher", "disease", "by", "Genzyme", "and", "Amicus", "Therapeutics,", "which", "according", "to", "public", "filings", "by", "Amicus", "Therapeutics", "has", "been", "suspended."], "wordsB": ["In", "addition,", "we", "are", "aware", "of", "other", "early", "clinical", "stage,", "experimental,", "small", "molecule,", "oral", "drugs", "which", "are", "being", "developed", "for", "the", "treatment", "of", "Gaucher", "disease", "by", "Genzyme", "and", "Amicus", "Therapeutics."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p215_s3", "idA": "1006281_11_item1_p187_s0", "sentA": "Other companies are developing alternate plant-based technologies, include Biolex, Inc., Chlorogen, Inc., Greenovation Biotech GmbH, and Symbiosys, none of which are cell-based.", "sentB": "Other companies are developing alternate plant-based technologies, include Biolex, Inc., Chlorogen, Inc., iBIO, Medicago, Greenovation Biotech GmbH, and Symbiosys, none of which are cell-based.", "type": 2, "words": ["<tag1>", "Other", "companies", "are", "developing", "alternate", "plant-based", "technologies,", "include", "Biolex,", "Inc.,", "Chlorogen,", "Inc.,", "Greenovation", "Biotech", "GmbH,", "and", "Symbiosys,", "none", "of", "which", "are", "cell-based.", "<tag2>", "Other", "companies", "are", "developing", "alternate", "plant-based", "technologies,", "include", "Biolex,", "Inc.,", "Chlorogen,", "Inc.,", "iBIO,", "Medicago,", "Greenovation", "Biotech", "GmbH,", "and", "Symbiosys,", "none", "of", "which", "are", "cell-based.", "<tag3>"], "wordsA": ["Other", "companies", "are", "developing", "alternate", "plant-based", "technologies,", "include", "Biolex,", "Inc.,", "Chlorogen,", "Inc.,", "Greenovation", "Biotech", "GmbH,", "and", "Symbiosys,", "none", "of", "which", "are", "cell-based."], "wordsB": ["Other", "companies", "are", "developing", "alternate", "plant-based", "technologies,", "include", "Biolex,", "Inc.,", "Chlorogen,", "Inc.,", "iBIO,", "Medicago,", "Greenovation", "Biotech", "GmbH,", "and", "Symbiosys,", "none", "of", "which", "are", "cell-based."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p6_s4", "idA": "1006281_11_item1_p193_s0", "sentA": "Delays or terminations could result from a number of factors, including stringent enrollment criteria, slow rate of enrollment, size of patient population, having to compete with other clinical trials for eligible patients, geographical considerations and others.", "sentB": "The EU orphan drug regulation provides for the possibility of such a challenge, and for an exception to this exclusivity to be granted, based on a number of factors, including contribution to patient care, clinical, supply, capacity and others.", "type": 2, "words": ["<tag1>", "Delays", "or", "terminations", "could", "result", "from", "a", "number", "of", "factors,", "including", "stringent", "enrollment", "criteria,", "slow", "rate", "of", "enrollment,", "size", "of", "patient", "population,", "having", "to", "compete", "with", "other", "clinical", "trials", "for", "eligible", "patients,", "geographical", "considerations", "and", "others.", "<tag2>", "The", "EU", "orphan", "drug", "regulation", "provides", "for", "the", "possibility", "of", "such", "a", "challenge,", "and", "for", "an", "exception", "to", "this", "exclusivity", "to", "be", "granted,", "based", "on", "a", "number", "of", "factors,", "including", "contribution", "to", "patient", "care,", "clinical,", "supply,", "capacity", "and", "others.", "<tag3>"], "wordsA": ["Delays", "or", "terminations", "could", "result", "from", "a", "number", "of", "factors,", "including", "stringent", "enrollment", "criteria,", "slow", "rate", "of", "enrollment,", "size", "of", "patient", "population,", "having", "to", "compete", "with", "other", "clinical", "trials", "for", "eligible", "patients,", "geographical", "considerations", "and", "others."], "wordsB": ["The", "EU", "orphan", "drug", "regulation", "provides", "for", "the", "possibility", "of", "such", "a", "challenge,", "and", "for", "an", "exception", "to", "this", "exclusivity", "to", "be", "granted,", "based", "on", "a", "number", "of", "factors,", "including", "contribution", "to", "patient", "care,", "clinical,", "supply,", "capacity", "and", "others."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p77_s3", "idA": "1006281_11_item1_p193_s0", "sentA": "Delays or terminations could result from a number of factors, including stringent enrollment criteria, slow rate of enrollment, size of patient population, having to compete with other clinical trials for eligible patients, geographical considerations and others.", "sentB": "The EU orphan drug regulation provides for the possibility of such a challenge, and for an exception to this exclusivity to be granted, based on a number of factors, including contribution to patient care, clinical, supply, capacity and others.", "type": 2, "words": ["<tag1>", "Delays", "or", "terminations", "could", "result", "from", "a", "number", "of", "factors,", "including", "stringent", "enrollment", "criteria,", "slow", "rate", "of", "enrollment,", "size", "of", "patient", "population,", "having", "to", "compete", "with", "other", "clinical", "trials", "for", "eligible", "patients,", "geographical", "considerations", "and", "others.", "<tag2>", "The", "EU", "orphan", "drug", "regulation", "provides", "for", "the", "possibility", "of", "such", "a", "challenge,", "and", "for", "an", "exception", "to", "this", "exclusivity", "to", "be", "granted,", "based", "on", "a", "number", "of", "factors,", "including", "contribution", "to", "patient", "care,", "clinical,", "supply,", "capacity", "and", "others.", "<tag3>"], "wordsA": ["Delays", "or", "terminations", "could", "result", "from", "a", "number", "of", "factors,", "including", "stringent", "enrollment", "criteria,", "slow", "rate", "of", "enrollment,", "size", "of", "patient", "population,", "having", "to", "compete", "with", "other", "clinical", "trials", "for", "eligible", "patients,", "geographical", "considerations", "and", "others."], "wordsB": ["The", "EU", "orphan", "drug", "regulation", "provides", "for", "the", "possibility", "of", "such", "a", "challenge,", "and", "for", "an", "exception", "to", "this", "exclusivity", "to", "be", "granted,", "based", "on", "a", "number", "of", "factors,", "including", "contribution", "to", "patient", "care,", "clinical,", "supply,", "capacity", "and", "others."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p224_s1", "idA": "1006281_11_item1_p197_s1", "sentA": "Assuming that the clinical data support the product s safety and effectiveness for its intended use, a New Drug Application (NDA) is submitted to the FDA for its review.", "sentB": "Assuming that the clinical data support the product s safety and effectiveness for its intended use, an NDA is submitted to the FDA for its review.", "type": 2, "words": ["<tag1>", "Assuming", "that", "the", "clinical", "data", "support", "the", "product", "s", "safety", "and", "effectiveness", "for", "its", "intended", "use,", "a", "New", "Drug", "Application", "(NDA)", "is", "submitted", "to", "the", "FDA", "for", "its", "review.", "<tag2>", "Assuming", "that", "the", "clinical", "data", "support", "the", "product", "s", "safety", "and", "effectiveness", "for", "its", "intended", "use,", "an", "NDA", "is", "submitted", "to", "the", "FDA", "for", "its", "review.", "<tag3>"], "wordsA": ["Assuming", "that", "the", "clinical", "data", "support", "the", "product", "s", "safety", "and", "effectiveness", "for", "its", "intended", "use,", "a", "New", "Drug", "Application", "(NDA)", "is", "submitted", "to", "the", "FDA", "for", "its", "review."], "wordsB": ["Assuming", "that", "the", "clinical", "data", "support", "the", "product", "s", "safety", "and", "effectiveness", "for", "its", "intended", "use,", "an", "NDA", "is", "submitted", "to", "the", "FDA", "for", "its", "review."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p172_s0", "idA": "1006281_11_item1_p198_s1", "sentA": "In September 2009, we received orphan drug designation for taliglucerase alfa for the treatment of Gaucher disease.", "sentB": "We are developing an orally delivered glucocerebrosidase (GCD) enzyme for the potential treatment of Gaucher disease.", "type": 2, "words": ["<tag1>", "In", "September", "2009,", "we", "received", "orphan", "drug", "designation", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "We", "are", "developing", "an", "orally", "delivered", "glucocerebrosidase", "(GCD)", "enzyme", "for", "the", "potential", "treatment", "of", "Gaucher", "disease.", "<tag3>"], "wordsA": ["In", "September", "2009,", "we", "received", "orphan", "drug", "designation", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["We", "are", "developing", "an", "orally", "delivered", "glucocerebrosidase", "(GCD)", "enzyme", "for", "the", "potential", "treatment", "of", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p179_s0", "idA": "1006281_11_item1_p19_s1", "sentA": "Revenue generated from the Ministry of Health of Brazil will be recorded by Pfizer and we are entitled to our share of the revenue in accordance with the terms and conditions of the Pfizer agreement.", "sentB": "During the second and fourth quarters of 2011, the Ministry of Health of Brazil requested that Pfizer consider the replacement of certain vials that might expire during 2012.", "type": 2, "words": ["<tag1>", "Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "will", "be", "recorded", "by", "Pfizer", "and", "we", "are", "entitled", "to", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "agreement.", "<tag2>", "During", "the", "second", "and", "fourth", "quarters", "of", "2011,", "the", "Ministry", "of", "Health", "of", "Brazil", "requested", "that", "Pfizer", "consider", "the", "replacement", "of", "certain", "vials", "that", "might", "expire", "during", "2012.", "<tag3>"], "wordsA": ["Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "will", "be", "recorded", "by", "Pfizer", "and", "we", "are", "entitled", "to", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "agreement."], "wordsB": ["During", "the", "second", "and", "fourth", "quarters", "of", "2011,", "the", "Ministry", "of", "Health", "of", "Brazil", "requested", "that", "Pfizer", "consider", "the", "replacement", "of", "certain", "vials", "that", "might", "expire", "during", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p22_s2", "idA": "1006281_11_item1_p19_s1", "sentA": "Revenue generated from the Ministry of Health of Brazil will be recorded by Pfizer and we are entitled to our share of the revenue in accordance with the terms and conditions of the Pfizer agreement.", "sentB": "Revenue generated from the Ministry of Health of Brazil was recorded by Pfizer, and we recorded our share of the revenue in accordance with the terms and conditions of the Pfizer Agreement.", "type": 2, "words": ["<tag1>", "Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "will", "be", "recorded", "by", "Pfizer", "and", "we", "are", "entitled", "to", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "agreement.", "<tag2>", "Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "was", "recorded", "by", "Pfizer,", "and", "we", "recorded", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement.", "<tag3>"], "wordsA": ["Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "will", "be", "recorded", "by", "Pfizer", "and", "we", "are", "entitled", "to", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "agreement."], "wordsB": ["Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "was", "recorded", "by", "Pfizer,", "and", "we", "recorded", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p23_s0", "idA": "1006281_11_item1_p19_s1", "sentA": "Revenue generated from the Ministry of Health of Brazil will be recorded by Pfizer and we are entitled to our share of the revenue in accordance with the terms and conditions of the Pfizer agreement.", "sentB": "During the second quarter of 2011, the Ministry of Health of Brazil requested that Pfizer consider the replacement of certain vials that might expire during 2012.", "type": 2, "words": ["<tag1>", "Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "will", "be", "recorded", "by", "Pfizer", "and", "we", "are", "entitled", "to", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "agreement.", "<tag2>", "During", "the", "second", "quarter", "of", "2011,", "the", "Ministry", "of", "Health", "of", "Brazil", "requested", "that", "Pfizer", "consider", "the", "replacement", "of", "certain", "vials", "that", "might", "expire", "during", "2012.", "<tag3>"], "wordsA": ["Revenue", "generated", "from", "the", "Ministry", "of", "Health", "of", "Brazil", "will", "be", "recorded", "by", "Pfizer", "and", "we", "are", "entitled", "to", "our", "share", "of", "the", "revenue", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "agreement."], "wordsB": ["During", "the", "second", "quarter", "of", "2011,", "the", "Ministry", "of", "Health", "of", "Brazil", "requested", "that", "Pfizer", "consider", "the", "replacement", "of", "certain", "vials", "that", "might", "expire", "during", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p156_s4", "idA": "1006281_11_item1_p201_s0", "sentA": "The FDA has a fast track program that is intended to expedite or facilitate the process for reviewing new drugs and biological products that meet certain criteria.", "sentB": "The FDA has assigned Replagal an action date of May 17, 2012.", "type": 2, "words": ["<tag1>", "The", "FDA", "has", "a", "fast", "track", "program", "that", "is", "intended", "to", "expedite", "or", "facilitate", "the", "process", "for", "reviewing", "new", "drugs", "and", "biological", "products", "that", "meet", "certain", "criteria.", "<tag2>", "The", "FDA", "has", "assigned", "Replagal", "an", "action", "date", "of", "May", "17,", "2012.", "<tag3>"], "wordsA": ["The", "FDA", "has", "a", "fast", "track", "program", "that", "is", "intended", "to", "expedite", "or", "facilitate", "the", "process", "for", "reviewing", "new", "drugs", "and", "biological", "products", "that", "meet", "certain", "criteria."], "wordsB": ["The", "FDA", "has", "assigned", "Replagal", "an", "action", "date", "of", "May", "17,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p228_s1", "idA": "1006281_11_item1_p202_s0", "sentA": "eligible for fast track designation if they are intended to treat a serious or life-threatening condition and demonstrate the potential to address unmet medical needs for the condition.", "sentB": "Specifically, new drugs and biological products are eligible for fast track designation if they are intended to treat a serious or life-threatening condition and demonstrate the potential to address unmet medical needs for the condition.", "type": 2, "words": ["<tag1>", "eligible", "for", "fast", "track", "designation", "if", "they", "are", "intended", "to", "treat", "a", "serious", "or", "life-threatening", "condition", "and", "demonstrate", "the", "potential", "to", "address", "unmet", "medical", "needs", "for", "the", "condition.", "<tag2>", "Specifically,", "new", "drugs", "and", "biological", "products", "are", "eligible", "for", "fast", "track", "designation", "if", "they", "are", "intended", "to", "treat", "a", "serious", "or", "life-threatening", "condition", "and", "demonstrate", "the", "potential", "to", "address", "unmet", "medical", "needs", "for", "the", "condition.", "<tag3>"], "wordsA": ["eligible", "for", "fast", "track", "designation", "if", "they", "are", "intended", "to", "treat", "a", "serious", "or", "life-threatening", "condition", "and", "demonstrate", "the", "potential", "to", "address", "unmet", "medical", "needs", "for", "the", "condition."], "wordsB": ["Specifically,", "new", "drugs", "and", "biological", "products", "are", "eligible", "for", "fast", "track", "designation", "if", "they", "are", "intended", "to", "treat", "a", "serious", "or", "life-threatening", "condition", "and", "demonstrate", "the", "potential", "to", "address", "unmet", "medical", "needs", "for", "the", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p20_s0", "idA": "1006281_11_item1_p204_s0", "sentA": "None of our products under development has been approved for marketing in the United States or elsewhere.", "sentB": "Although taliglucerase alfa has not yet been approved for commercial sale, patients are being treated with taliglucerase alfa, both in the framework of our clinical trials and related studies and in compassionate use programs, special access agreements, named patient provisions and other programs designed to ensure that treatments are available to Gaucher patients in light of recent shortages of approved treatments.", "type": 2, "words": ["<tag1>", "None", "of", "our", "products", "under", "development", "has", "been", "approved", "for", "marketing", "in", "the", "United", "States", "or", "elsewhere.", "<tag2>", "Although", "taliglucerase", "alfa", "has", "not", "yet", "been", "approved", "for", "commercial", "sale,", "patients", "are", "being", "treated", "with", "taliglucerase", "alfa,", "both", "in", "the", "framework", "of", "our", "clinical", "trials", "and", "related", "studies", "and", "in", "compassionate", "use", "programs,", "special", "access", "agreements,", "named", "patient", "provisions", "and", "other", "programs", "designed", "to", "ensure", "that", "treatments", "are", "available", "to", "Gaucher", "patients", "in", "light", "of", "recent", "shortages", "of", "approved", "treatments.", "<tag3>"], "wordsA": ["None", "of", "our", "products", "under", "development", "has", "been", "approved", "for", "marketing", "in", "the", "United", "States", "or", "elsewhere."], "wordsB": ["Although", "taliglucerase", "alfa", "has", "not", "yet", "been", "approved", "for", "commercial", "sale,", "patients", "are", "being", "treated", "with", "taliglucerase", "alfa,", "both", "in", "the", "framework", "of", "our", "clinical", "trials", "and", "related", "studies", "and", "in", "compassionate", "use", "programs,", "special", "access", "agreements,", "named", "patient", "provisions", "and", "other", "programs", "designed", "to", "ensure", "that", "treatments", "are", "available", "to", "Gaucher", "patients", "in", "light", "of", "recent", "shortages", "of", "approved", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p15_s2", "idA": "1006281_11_item1_p205_s1", "sentA": "All of the aforementioned are agencies within the Department of Health and Human Services (HHS).", "sentB": "All of the enrolled patients are in the final stages of pediatric patient treatment.", "type": 2, "words": ["<tag1>", "All", "of", "the", "aforementioned", "are", "agencies", "within", "the", "Department", "of", "Health", "and", "Human", "Services", "(HHS).", "<tag2>", "All", "of", "the", "enrolled", "patients", "are", "in", "the", "final", "stages", "of", "pediatric", "patient", "treatment.", "<tag3>"], "wordsA": ["All", "of", "the", "aforementioned", "are", "agencies", "within", "the", "Department", "of", "Health", "and", "Human", "Services", "(HHS)."], "wordsB": ["All", "of", "the", "enrolled", "patients", "are", "in", "the", "final", "stages", "of", "pediatric", "patient", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p89_s2", "idA": "1006281_11_item1_p205_s1", "sentA": "All of the aforementioned are agencies within the Department of Health and Human Services (HHS).", "sentB": "All of the enrolled patients are in the final stages of pediatric patient treatment.", "type": 2, "words": ["<tag1>", "All", "of", "the", "aforementioned", "are", "agencies", "within", "the", "Department", "of", "Health", "and", "Human", "Services", "(HHS).", "<tag2>", "All", "of", "the", "enrolled", "patients", "are", "in", "the", "final", "stages", "of", "pediatric", "patient", "treatment.", "<tag3>"], "wordsA": ["All", "of", "the", "aforementioned", "are", "agencies", "within", "the", "Department", "of", "Health", "and", "Human", "Services", "(HHS)."], "wordsB": ["All", "of", "the", "enrolled", "patients", "are", "in", "the", "final", "stages", "of", "pediatric", "patient", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p112_s0", "idA": "1006281_11_item1_p20_s1", "sentA": "The annual worldwide sales of Cerezyme were approximately $722.0 million in 2010, compared with $793.0 million for the previous year, according to public reports by Genzyme.", "sentB": "According to public reports by Sanofi, consolidated sales of Cerezyme from April 1, 2011 through the end of the year were 441.0 million (or $579.6 million), a growth of 11.1% compared to the same period in 2010.", "type": 2, "words": ["<tag1>", "The", "annual", "worldwide", "sales", "of", "Cerezyme", "were", "approximately", "$722.0", "million", "in", "2010,", "compared", "with", "$793.0", "million", "for", "the", "previous", "year,", "according", "to", "public", "reports", "by", "Genzyme.", "<tag2>", "According", "to", "public", "reports", "by", "Sanofi,", "consolidated", "sales", "of", "Cerezyme", "from", "April", "1,", "2011", "through", "the", "end", "of", "the", "year", "were", "441.0", "million", "(or", "$579.6", "million),", "a", "growth", "of", "11.1%", "compared", "to", "the", "same", "period", "in", "2010.", "<tag3>"], "wordsA": ["The", "annual", "worldwide", "sales", "of", "Cerezyme", "were", "approximately", "$722.0", "million", "in", "2010,", "compared", "with", "$793.0", "million", "for", "the", "previous", "year,", "according", "to", "public", "reports", "by", "Genzyme."], "wordsB": ["According", "to", "public", "reports", "by", "Sanofi,", "consolidated", "sales", "of", "Cerezyme", "from", "April", "1,", "2011", "through", "the", "end", "of", "the", "year", "were", "441.0", "million", "(or", "$579.6", "million),", "a", "growth", "of", "11.1%", "compared", "to", "the", "same", "period", "in", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p26_s1", "idA": "1006281_11_item1_p20_s1", "sentA": "The annual worldwide sales of Cerezyme were approximately $722.0 million in 2010, compared with $793.0 million for the previous year, according to public reports by Genzyme.", "sentB": "According to public reports by Sanofi, consolidated sales of Cerezyme from April 1, 2011 through the end of the year were 441.0 million (or $579.6 million), a growth of 11.1% compared to the same period in 2010.", "type": 2, "words": ["<tag1>", "The", "annual", "worldwide", "sales", "of", "Cerezyme", "were", "approximately", "$722.0", "million", "in", "2010,", "compared", "with", "$793.0", "million", "for", "the", "previous", "year,", "according", "to", "public", "reports", "by", "Genzyme.", "<tag2>", "According", "to", "public", "reports", "by", "Sanofi,", "consolidated", "sales", "of", "Cerezyme", "from", "April", "1,", "2011", "through", "the", "end", "of", "the", "year", "were", "441.0", "million", "(or", "$579.6", "million),", "a", "growth", "of", "11.1%", "compared", "to", "the", "same", "period", "in", "2010.", "<tag3>"], "wordsA": ["The", "annual", "worldwide", "sales", "of", "Cerezyme", "were", "approximately", "$722.0", "million", "in", "2010,", "compared", "with", "$793.0", "million", "for", "the", "previous", "year,", "according", "to", "public", "reports", "by", "Genzyme."], "wordsB": ["According", "to", "public", "reports", "by", "Sanofi,", "consolidated", "sales", "of", "Cerezyme", "from", "April", "1,", "2011", "through", "the", "end", "of", "the", "year", "were", "441.0", "million", "(or", "$579.6", "million),", "a", "growth", "of", "11.1%", "compared", "to", "the", "same", "period", "in", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p113_s0", "idA": "1006281_11_item1_p20_s2", "sentA": "According to Genzyme, it suffered a temporary interruption in production of Cerezyme in 2009 associated with the remediation of a contamination in one of its manufacturing facilities, and, as a result, shipments of Cerezyme were limited.", "sentB": "According to Genzyme, it has suffered interruptions and other limitations in its Cerezyme production and release since September 2009 and, as a result, Cerezyme supplies have been limited.", "type": 2, "words": ["<tag1>", "According", "to", "Genzyme,", "it", "suffered", "a", "temporary", "interruption", "in", "production", "of", "Cerezyme", "in", "2009", "associated", "with", "the", "remediation", "of", "a", "contamination", "in", "one", "of", "its", "manufacturing", "facilities,", "and,", "as", "a", "result,", "shipments", "of", "Cerezyme", "were", "limited.", "<tag2>", "According", "to", "Genzyme,", "it", "has", "suffered", "interruptions", "and", "other", "limitations", "in", "its", "Cerezyme", "production", "and", "release", "since", "September", "2009", "and,", "as", "a", "result,", "Cerezyme", "supplies", "have", "been", "limited.", "<tag3>"], "wordsA": ["According", "to", "Genzyme,", "it", "suffered", "a", "temporary", "interruption", "in", "production", "of", "Cerezyme", "in", "2009", "associated", "with", "the", "remediation", "of", "a", "contamination", "in", "one", "of", "its", "manufacturing", "facilities,", "and,", "as", "a", "result,", "shipments", "of", "Cerezyme", "were", "limited."], "wordsB": ["According", "to", "Genzyme,", "it", "has", "suffered", "interruptions", "and", "other", "limitations", "in", "its", "Cerezyme", "production", "and", "release", "since", "September", "2009", "and,", "as", "a", "result,", "Cerezyme", "supplies", "have", "been", "limited."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p27_s0", "idA": "1006281_11_item1_p20_s2", "sentA": "According to Genzyme, it suffered a temporary interruption in production of Cerezyme in 2009 associated with the remediation of a contamination in one of its manufacturing facilities, and, as a result, shipments of Cerezyme were limited.", "sentB": "According to Genzyme, it has suffered interruptions and other limitations in its Cerezyme production and release since September 2009 and, as a result, Cerezyme supplies have been limited.", "type": 2, "words": ["<tag1>", "According", "to", "Genzyme,", "it", "suffered", "a", "temporary", "interruption", "in", "production", "of", "Cerezyme", "in", "2009", "associated", "with", "the", "remediation", "of", "a", "contamination", "in", "one", "of", "its", "manufacturing", "facilities,", "and,", "as", "a", "result,", "shipments", "of", "Cerezyme", "were", "limited.", "<tag2>", "According", "to", "Genzyme,", "it", "has", "suffered", "interruptions", "and", "other", "limitations", "in", "its", "Cerezyme", "production", "and", "release", "since", "September", "2009", "and,", "as", "a", "result,", "Cerezyme", "supplies", "have", "been", "limited.", "<tag3>"], "wordsA": ["According", "to", "Genzyme,", "it", "suffered", "a", "temporary", "interruption", "in", "production", "of", "Cerezyme", "in", "2009", "associated", "with", "the", "remediation", "of", "a", "contamination", "in", "one", "of", "its", "manufacturing", "facilities,", "and,", "as", "a", "result,", "shipments", "of", "Cerezyme", "were", "limited."], "wordsB": ["According", "to", "Genzyme,", "it", "has", "suffered", "interruptions", "and", "other", "limitations", "in", "its", "Cerezyme", "production", "and", "release", "since", "September", "2009", "and,", "as", "a", "result,", "Cerezyme", "supplies", "have", "been", "limited."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p114_s0", "idA": "1006281_11_item1_p20_s3", "sentA": "Shire reported annual worldwide sales of VPRIV of approximately $143.0 million in 2010.", "sentB": "Shire reported annual worldwide sales of VPRIV of approximately $256 million in 2011, a growth of 79% compared to the same period in 2010 (VPRIV was approved for sale in the United States in February 2010 and in the European Union in August 2010).", "type": 2, "words": ["<tag1>", "Shire", "reported", "annual", "worldwide", "sales", "of", "VPRIV", "of", "approximately", "$143.0", "million", "in", "2010.", "<tag2>", "Shire", "reported", "annual", "worldwide", "sales", "of", "VPRIV", "of", "approximately", "$256", "million", "in", "2011,", "a", "growth", "of", "79%", "compared", "to", "the", "same", "period", "in", "2010", "(VPRIV", "was", "approved", "for", "sale", "in", "the", "United", "States", "in", "February", "2010", "and", "in", "the", "European", "Union", "in", "August", "2010).", "<tag3>"], "wordsA": ["Shire", "reported", "annual", "worldwide", "sales", "of", "VPRIV", "of", "approximately", "$143.0", "million", "in", "2010."], "wordsB": ["Shire", "reported", "annual", "worldwide", "sales", "of", "VPRIV", "of", "approximately", "$256", "million", "in", "2011,", "a", "growth", "of", "79%", "compared", "to", "the", "same", "period", "in", "2010", "(VPRIV", "was", "approved", "for", "sale", "in", "the", "United", "States", "in", "February", "2010", "and", "in", "the", "European", "Union", "in", "August", "2010)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p28_s0", "idA": "1006281_11_item1_p20_s3", "sentA": "Shire reported annual worldwide sales of VPRIV of approximately $143.0 million in 2010.", "sentB": "Shire reported annual worldwide sales of VPRIV of approximately $256 million in 2011, a growth of 79% compared to the same period in 2010 (VPRIV was approved for sale in the United States in February 2010 and in the European Union in August 2010).", "type": 2, "words": ["<tag1>", "Shire", "reported", "annual", "worldwide", "sales", "of", "VPRIV", "of", "approximately", "$143.0", "million", "in", "2010.", "<tag2>", "Shire", "reported", "annual", "worldwide", "sales", "of", "VPRIV", "of", "approximately", "$256", "million", "in", "2011,", "a", "growth", "of", "79%", "compared", "to", "the", "same", "period", "in", "2010", "(VPRIV", "was", "approved", "for", "sale", "in", "the", "United", "States", "in", "February", "2010", "and", "in", "the", "European", "Union", "in", "August", "2010).", "<tag3>"], "wordsA": ["Shire", "reported", "annual", "worldwide", "sales", "of", "VPRIV", "of", "approximately", "$143.0", "million", "in", "2010."], "wordsB": ["Shire", "reported", "annual", "worldwide", "sales", "of", "VPRIV", "of", "approximately", "$256", "million", "in", "2011,", "a", "growth", "of", "79%", "compared", "to", "the", "same", "period", "in", "2010", "(VPRIV", "was", "approved", "for", "sale", "in", "the", "United", "States", "in", "February", "2010", "and", "in", "the", "European", "Union", "in", "August", "2010)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p238_s2", "idA": "1006281_11_item1_p210_s2", "sentA": "In order to obtain an authorization, an application must be made to the competent authority of the member state concerned or in a centralized procedure to the EMEA.", "sentB": "In order to obtain an authorization, an application must be made to the competent authority of the member state concerned or in a centralized procedure to the EMA.", "type": 2, "words": ["<tag1>", "In", "order", "to", "obtain", "an", "authorization,", "an", "application", "must", "be", "made", "to", "the", "competent", "authority", "of", "the", "member", "state", "concerned", "or", "in", "a", "centralized", "procedure", "to", "the", "EMEA.", "<tag2>", "In", "order", "to", "obtain", "an", "authorization,", "an", "application", "must", "be", "made", "to", "the", "competent", "authority", "of", "the", "member", "state", "concerned", "or", "in", "a", "centralized", "procedure", "to", "the", "EMA.", "<tag3>"], "wordsA": ["In", "order", "to", "obtain", "an", "authorization,", "an", "application", "must", "be", "made", "to", "the", "competent", "authority", "of", "the", "member", "state", "concerned", "or", "in", "a", "centralized", "procedure", "to", "the", "EMEA."], "wordsB": ["In", "order", "to", "obtain", "an", "authorization,", "an", "application", "must", "be", "made", "to", "the", "competent", "authority", "of", "the", "member", "state", "concerned", "or", "in", "a", "centralized", "procedure", "to", "the", "EMA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p239_s0", "idA": "1006281_11_item1_p211_s0", "sentA": "On January 2010, the Committee for Orphan Medicinal Products (COMP) of the EMEA recommended that the European Commission grant orphan drug designation to taliglucerase alfa.", "sentB": "On January 2010, the Committee for Orphan Medicinal Products (COMP) of the EMA recommended that the European Commission grant orphan drug designation to taliglucerase alfa.", "type": 2, "words": ["<tag1>", "On", "January", "2010,", "the", "Committee", "for", "Orphan", "Medicinal", "Products", "(COMP)", "of", "the", "EMEA", "recommended", "that", "the", "European", "Commission", "grant", "orphan", "drug", "designation", "to", "taliglucerase", "alfa.", "<tag2>", "On", "January", "2010,", "the", "Committee", "for", "Orphan", "Medicinal", "Products", "(COMP)", "of", "the", "EMA", "recommended", "that", "the", "European", "Commission", "grant", "orphan", "drug", "designation", "to", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["On", "January", "2010,", "the", "Committee", "for", "Orphan", "Medicinal", "Products", "(COMP)", "of", "the", "EMEA", "recommended", "that", "the", "European", "Commission", "grant", "orphan", "drug", "designation", "to", "taliglucerase", "alfa."], "wordsB": ["On", "January", "2010,", "the", "Committee", "for", "Orphan", "Medicinal", "Products", "(COMP)", "of", "the", "EMA", "recommended", "that", "the", "European", "Commission", "grant", "orphan", "drug", "designation", "to", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p6_s3", "idA": "1006281_11_item1_p211_s0", "sentA": "On January 2010, the Committee for Orphan Medicinal Products (COMP) of the EMEA recommended that the European Commission grant orphan drug designation to taliglucerase alfa.", "sentB": "As part of the MAA procedure, Pfizer, with our cooperation, is challenging VPRIV's orphan market protection with respect to taliglucerase alfa pursuant to the EU orphan drug regulation.", "type": 2, "words": ["<tag1>", "On", "January", "2010,", "the", "Committee", "for", "Orphan", "Medicinal", "Products", "(COMP)", "of", "the", "EMEA", "recommended", "that", "the", "European", "Commission", "grant", "orphan", "drug", "designation", "to", "taliglucerase", "alfa.", "<tag2>", "As", "part", "of", "the", "MAA", "procedure,", "Pfizer,", "with", "our", "cooperation,", "is", "challenging", "VPRIV's", "orphan", "market", "protection", "with", "respect", "to", "taliglucerase", "alfa", "pursuant", "to", "the", "EU", "orphan", "drug", "regulation.", "<tag3>"], "wordsA": ["On", "January", "2010,", "the", "Committee", "for", "Orphan", "Medicinal", "Products", "(COMP)", "of", "the", "EMEA", "recommended", "that", "the", "European", "Commission", "grant", "orphan", "drug", "designation", "to", "taliglucerase", "alfa."], "wordsB": ["As", "part", "of", "the", "MAA", "procedure,", "Pfizer,", "with", "our", "cooperation,", "is", "challenging", "VPRIV's", "orphan", "market", "protection", "with", "respect", "to", "taliglucerase", "alfa", "pursuant", "to", "the", "EU", "orphan", "drug", "regulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p77_s2", "idA": "1006281_11_item1_p211_s0", "sentA": "On January 2010, the Committee for Orphan Medicinal Products (COMP) of the EMEA recommended that the European Commission grant orphan drug designation to taliglucerase alfa.", "sentB": "As part of the MAA procedure, Pfizer, with our cooperation, is challenging VPRIV's orphan market protection with respect to taliglucerase alfa pursuant to the EU orphan drug regulation.", "type": 2, "words": ["<tag1>", "On", "January", "2010,", "the", "Committee", "for", "Orphan", "Medicinal", "Products", "(COMP)", "of", "the", "EMEA", "recommended", "that", "the", "European", "Commission", "grant", "orphan", "drug", "designation", "to", "taliglucerase", "alfa.", "<tag2>", "As", "part", "of", "the", "MAA", "procedure,", "Pfizer,", "with", "our", "cooperation,", "is", "challenging", "VPRIV's", "orphan", "market", "protection", "with", "respect", "to", "taliglucerase", "alfa", "pursuant", "to", "the", "EU", "orphan", "drug", "regulation.", "<tag3>"], "wordsA": ["On", "January", "2010,", "the", "Committee", "for", "Orphan", "Medicinal", "Products", "(COMP)", "of", "the", "EMEA", "recommended", "that", "the", "European", "Commission", "grant", "orphan", "drug", "designation", "to", "taliglucerase", "alfa."], "wordsB": ["As", "part", "of", "the", "MAA", "procedure,", "Pfizer,", "with", "our", "cooperation,", "is", "challenging", "VPRIV's", "orphan", "market", "protection", "with", "respect", "to", "taliglucerase", "alfa", "pursuant", "to", "the", "EU", "orphan", "drug", "regulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p88_s6", "idA": "1006281_11_item1_p211_s0", "sentA": "On January 2010, the Committee for Orphan Medicinal Products (COMP) of the EMEA recommended that the European Commission grant orphan drug designation to taliglucerase alfa.", "sentB": "The results of the switchover trial, which were announced in February 2012, demonstrate that over the nine-month treatment period, patients remained stable with regard to spleen volume, liver volume, platelet count and hemoglobin concentration, the efficacy endpoints of the switchover trial, after switching from imiglucerase to taliglucerase alfa.", "type": 2, "words": ["<tag1>", "On", "January", "2010,", "the", "Committee", "for", "Orphan", "Medicinal", "Products", "(COMP)", "of", "the", "EMEA", "recommended", "that", "the", "European", "Commission", "grant", "orphan", "drug", "designation", "to", "taliglucerase", "alfa.", "<tag2>", "The", "results", "of", "the", "switchover", "trial,", "which", "were", "announced", "in", "February", "2012,", "demonstrate", "that", "over", "the", "nine-month", "treatment", "period,", "patients", "remained", "stable", "with", "regard", "to", "spleen", "volume,", "liver", "volume,", "platelet", "count", "and", "hemoglobin", "concentration,", "the", "efficacy", "endpoints", "of", "the", "switchover", "trial,", "after", "switching", "from", "imiglucerase", "to", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["On", "January", "2010,", "the", "Committee", "for", "Orphan", "Medicinal", "Products", "(COMP)", "of", "the", "EMEA", "recommended", "that", "the", "European", "Commission", "grant", "orphan", "drug", "designation", "to", "taliglucerase", "alfa."], "wordsB": ["The", "results", "of", "the", "switchover", "trial,", "which", "were", "announced", "in", "February", "2012,", "demonstrate", "that", "over", "the", "nine-month", "treatment", "period,", "patients", "remained", "stable", "with", "regard", "to", "spleen", "volume,", "liver", "volume,", "platelet", "count", "and", "hemoglobin", "concentration,", "the", "efficacy", "endpoints", "of", "the", "switchover", "trial,", "after", "switching", "from", "imiglucerase", "to", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p244_s0", "idA": "1006281_11_item1_p213_s0", "sentA": "Generally, Israeli companies are subject to corporate tax at the rate of 25% on taxable income and are subject to real capital gains tax at a rate of 25% on capital gains (other than gains derived from the sale of listed securities that are taxed at the prevailing corporate tax rates) derived after January 1, 2003.", "sentB": "Capital gains on the sale of assets are subject to capital gains tax according to the corporate tax rate in effect for the year the assets are sold.", "type": 2, "words": ["<tag1>", "Generally,", "Israeli", "companies", "are", "subject", "to", "corporate", "tax", "at", "the", "rate", "of", "25%", "on", "taxable", "income", "and", "are", "subject", "to", "real", "capital", "gains", "tax", "at", "a", "rate", "of", "25%", "on", "capital", "gains", "(other", "than", "gains", "derived", "from", "the", "sale", "of", "listed", "securities", "that", "are", "taxed", "at", "the", "prevailing", "corporate", "tax", "rates)", "derived", "after", "January", "1,", "2003.", "<tag2>", "Capital", "gains", "on", "the", "sale", "of", "assets", "are", "subject", "to", "capital", "gains", "tax", "according", "to", "the", "corporate", "tax", "rate", "in", "effect", "for", "the", "year", "the", "assets", "are", "sold.", "<tag3>"], "wordsA": ["Generally,", "Israeli", "companies", "are", "subject", "to", "corporate", "tax", "at", "the", "rate", "of", "25%", "on", "taxable", "income", "and", "are", "subject", "to", "real", "capital", "gains", "tax", "at", "a", "rate", "of", "25%", "on", "capital", "gains", "(other", "than", "gains", "derived", "from", "the", "sale", "of", "listed", "securities", "that", "are", "taxed", "at", "the", "prevailing", "corporate", "tax", "rates)", "derived", "after", "January", "1,", "2003."], "wordsB": ["Capital", "gains", "on", "the", "sale", "of", "assets", "are", "subject", "to", "capital", "gains", "tax", "according", "to", "the", "corporate", "tax", "rate", "in", "effect", "for", "the", "year", "the", "assets", "are", "sold."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p243_s0", "idA": "1006281_11_item1_p213_s3", "sentA": "As discussed below, the corporate tax rate may be less for income derived from an Approved Enterprise.", "sentB": "On December 5, 2011, the Tax Burden Distribution Law was officially published, discontinuing a previously approved gradual decrease in corporate tax provided in the 2009 amendment, and setting the corporate tax rate in Israel for 2012 and thereafter to 25%.", "type": 2, "words": ["<tag1>", "As", "discussed", "below,", "the", "corporate", "tax", "rate", "may", "be", "less", "for", "income", "derived", "from", "an", "Approved", "Enterprise.", "<tag2>", "On", "December", "5,", "2011,", "the", "Tax", "Burden", "Distribution", "Law", "was", "officially", "published,", "discontinuing", "a", "previously", "approved", "gradual", "decrease", "in", "corporate", "tax", "provided", "in", "the", "2009", "amendment,", "and", "setting", "the", "corporate", "tax", "rate", "in", "Israel", "for", "2012", "and", "thereafter", "to", "25%.", "<tag3>"], "wordsA": ["As", "discussed", "below,", "the", "corporate", "tax", "rate", "may", "be", "less", "for", "income", "derived", "from", "an", "Approved", "Enterprise."], "wordsB": ["On", "December", "5,", "2011,", "the", "Tax", "Burden", "Distribution", "Law", "was", "officially", "published,", "discontinuing", "a", "previously", "approved", "gradual", "decrease", "in", "corporate", "tax", "provided", "in", "the", "2009", "amendment,", "and", "setting", "the", "corporate", "tax", "rate", "in", "Israel", "for", "2012", "and", "thereafter", "to", "25%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p246_s0", "idA": "1006281_11_item1_p215_s0", "sentA": "The Law for the Encouragement of Capital Investments, 1959, known as the Investment Law, provides certain incentives for capital investments in a production facility (or other eligible assets).", "sentB": "The Law for the Encouragement of Capital Investments, 1959, or the Investment Law, provides certain incentives for capital investments in a production facility (or other eligible assets).", "type": 2, "words": ["<tag1>", "The", "Law", "for", "the", "Encouragement", "of", "Capital", "Investments,", "1959,", "known", "as", "the", "Investment", "Law,", "provides", "certain", "incentives", "for", "capital", "investments", "in", "a", "production", "facility", "(or", "other", "eligible", "assets).", "<tag2>", "The", "Law", "for", "the", "Encouragement", "of", "Capital", "Investments,", "1959,", "or", "the", "Investment", "Law,", "provides", "certain", "incentives", "for", "capital", "investments", "in", "a", "production", "facility", "(or", "other", "eligible", "assets).", "<tag3>"], "wordsA": ["The", "Law", "for", "the", "Encouragement", "of", "Capital", "Investments,", "1959,", "known", "as", "the", "Investment", "Law,", "provides", "certain", "incentives", "for", "capital", "investments", "in", "a", "production", "facility", "(or", "other", "eligible", "assets)."], "wordsB": ["The", "Law", "for", "the", "Encouragement", "of", "Capital", "Investments,", "1959,", "or", "the", "Investment", "Law,", "provides", "certain", "incentives", "for", "capital", "investments", "in", "a", "production", "facility", "(or", "other", "eligible", "assets)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p246_s1", "idA": "1006281_11_item1_p216_s0", "sentA": "investment program that is implemented in accordance with the provisions of the Investment Law, referred to as an Approved Enterprise, is entitled to benefits.", "sentB": "Generally, an investment program that is implemented in accordance with the provisions of the Investment Law, referred to as an Approved Enterprise, is entitled to benefits.", "type": 2, "words": ["<tag1>", "investment", "program", "that", "is", "implemented", "in", "accordance", "with", "the", "provisions", "of", "the", "Investment", "Law,", "referred", "to", "as", "an", "Approved", "Enterprise,", "is", "entitled", "to", "benefits.", "<tag2>", "Generally,", "an", "investment", "program", "that", "is", "implemented", "in", "accordance", "with", "the", "provisions", "of", "the", "Investment", "Law,", "referred", "to", "as", "an", "Approved", "Enterprise,", "is", "entitled", "to", "benefits.", "<tag3>"], "wordsA": ["investment", "program", "that", "is", "implemented", "in", "accordance", "with", "the", "provisions", "of", "the", "Investment", "Law,", "referred", "to", "as", "an", "Approved", "Enterprise,", "is", "entitled", "to", "benefits."], "wordsB": ["Generally,", "an", "investment", "program", "that", "is", "implemented", "in", "accordance", "with", "the", "provisions", "of", "the", "Investment", "Law,", "referred", "to", "as", "an", "Approved", "Enterprise,", "is", "entitled", "to", "benefits."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p234_s2", "idA": "1006281_11_item1_p217_s2", "sentA": "If any new benefits are granted to Protalix Ltd. in the future, Protalix Ltd. will be subject to the provisions of the amended Investment Law with respect to these new benefits.", "sentB": "Key provisions of PPACA specific to the pharmaceutical industry, among others, include the following:", "type": 2, "words": ["<tag1>", "If", "any", "new", "benefits", "are", "granted", "to", "Protalix", "Ltd.", "in", "the", "future,", "Protalix", "Ltd.", "will", "be", "subject", "to", "the", "provisions", "of", "the", "amended", "Investment", "Law", "with", "respect", "to", "these", "new", "benefits.", "<tag2>", "Key", "provisions", "of", "PPACA", "specific", "to", "the", "pharmaceutical", "industry,", "among", "others,", "include", "the", "following:", "<tag3>"], "wordsA": ["If", "any", "new", "benefits", "are", "granted", "to", "Protalix", "Ltd.", "in", "the", "future,", "Protalix", "Ltd.", "will", "be", "subject", "to", "the", "provisions", "of", "the", "amended", "Investment", "Law", "with", "respect", "to", "these", "new", "benefits."], "wordsB": ["Key", "provisions", "of", "PPACA", "specific", "to", "the", "pharmaceutical", "industry,", "among", "others,", "include", "the", "following:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p241_s1", "idA": "1006281_11_item1_p217_s2", "sentA": "If any new benefits are granted to Protalix Ltd. in the future, Protalix Ltd. will be subject to the provisions of the amended Investment Law with respect to these new benefits.", "sentB": "According to the provisions of the Law for Amending the Israel Income Tax Ordinance, 2005, corporate tax rates will be gradually lowered, resulting in a corporate tax rate for 2009 and thereafter: 2009 26% and for 2010 and thereafter 25%.", "type": 2, "words": ["<tag1>", "If", "any", "new", "benefits", "are", "granted", "to", "Protalix", "Ltd.", "in", "the", "future,", "Protalix", "Ltd.", "will", "be", "subject", "to", "the", "provisions", "of", "the", "amended", "Investment", "Law", "with", "respect", "to", "these", "new", "benefits.", "<tag2>", "According", "to", "the", "provisions", "of", "the", "Law", "for", "Amending", "the", "Israel", "Income", "Tax", "Ordinance,", "2005,", "corporate", "tax", "rates", "will", "be", "gradually", "lowered,", "resulting", "in", "a", "corporate", "tax", "rate", "for", "2009", "and", "thereafter:", "2009", "26%", "and", "for", "2010", "and", "thereafter", "25%.", "<tag3>"], "wordsA": ["If", "any", "new", "benefits", "are", "granted", "to", "Protalix", "Ltd.", "in", "the", "future,", "Protalix", "Ltd.", "will", "be", "subject", "to", "the", "provisions", "of", "the", "amended", "Investment", "Law", "with", "respect", "to", "these", "new", "benefits."], "wordsB": ["According", "to", "the", "provisions", "of", "the", "Law", "for", "Amending", "the", "Israel", "Income", "Tax", "Ordinance,", "2005,", "corporate", "tax", "rates", "will", "be", "gradually", "lowered,", "resulting", "in", "a", "corporate", "tax", "rate", "for", "2009", "and", "thereafter:", "2009", "26%", "and", "for", "2010", "and", "thereafter", "25%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p263_s3", "idA": "1006281_11_item1_p217_s2", "sentA": "If any new benefits are granted to Protalix Ltd. in the future, Protalix Ltd. will be subject to the provisions of the amended Investment Law with respect to these new benefits.", "sentB": "As of December 31, 2011, Protalix Ltd. either paid or accrued royalties payable of $2.8 million and Protalix Ltd. s contingent liability to the OCS with respect to grants received was approximately $19.8 million.", "type": 2, "words": ["<tag1>", "If", "any", "new", "benefits", "are", "granted", "to", "Protalix", "Ltd.", "in", "the", "future,", "Protalix", "Ltd.", "will", "be", "subject", "to", "the", "provisions", "of", "the", "amended", "Investment", "Law", "with", "respect", "to", "these", "new", "benefits.", "<tag2>", "As", "of", "December", "31,", "2011,", "Protalix", "Ltd.", "either", "paid", "or", "accrued", "royalties", "payable", "of", "$2.8", "million", "and", "Protalix", "Ltd.", "s", "contingent", "liability", "to", "the", "OCS", "with", "respect", "to", "grants", "received", "was", "approximately", "$19.8", "million.", "<tag3>"], "wordsA": ["If", "any", "new", "benefits", "are", "granted", "to", "Protalix", "Ltd.", "in", "the", "future,", "Protalix", "Ltd.", "will", "be", "subject", "to", "the", "provisions", "of", "the", "amended", "Investment", "Law", "with", "respect", "to", "these", "new", "benefits."], "wordsB": ["As", "of", "December", "31,", "2011,", "Protalix", "Ltd.", "either", "paid", "or", "accrued", "royalties", "payable", "of", "$2.8", "million", "and", "Protalix", "Ltd.", "s", "contingent", "liability", "to", "the", "OCS", "with", "respect", "to", "grants", "received", "was", "approximately", "$19.8", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p146_s2", "idA": "1006281_11_item1_p21_s1", "sentA": "Our product pipeline currently includes, among other candidates, (1) PRX-102, a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans, (2) PRX-105, a plant cell expressed pegylated recombinant acetylcholinesterase product candidate for biodefense and other indications, (3) pr-antiTNF, a plant cell expressed recombinant fusion protein made from the soluble form of the human TNF receptor (TNFR) and an antibody portion, which is being developed as a treatment of certain immune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing, spondylitis, psoriatic arthritis and plaque psoriasis, (4) an orally administrated glucocerebrosidase enzyme for treating Gaucher patients utilizing the oral delivery of the recombinant enzyme produced within carrot cells and (5) additional undisclosed therapeutic proteins, all of which are currently being evaluated in animal studies.", "sentB": "We have identified several product candidates oriented towards specialty disease and therapeutic market segments, including: (1) PRX-102, a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans; (2) PRX-105, a plant cell expressed pegylated recombinant acetylcholinesterase product candidate for biodefense and other indications; (3) PRX-106, or pr-antiTNF, a plant cell expressed recombinant fusion protein made from the soluble form of the human TNF receptor (TNFR) and an antibody portion, which is being developed as a treatment of certain immune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing, spondylitis, psoriatic arthritis and plaque psoriasis; (4) an orally administrated glucocerebrosidase enzyme for treating Gaucher disease patients utilizing the oral delivery of the recombinant enzyme produced within carrot cells; and (5) two additional undisclosed therapeutic proteins, both of which are being evaluated in animal studies.", "type": 2, "words": ["<tag1>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates,", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications,", "(3)", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "juvenile", "idiopathic", "arthritis,", "ankylosing,", "spondylitis,", "psoriatic", "arthritis", "and", "plaque", "psoriasis,", "(4)", "an", "orally", "administrated", "glucocerebrosidase", "enzyme", "for", "treating", "Gaucher", "patients", "utilizing", "the", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells", "and", "(5)", "additional", "undisclosed", "therapeutic", "proteins,", "all", "of", "which", "are", "currently", "being", "evaluated", "in", "animal", "studies.", "<tag2>", "We", "have", "identified", "several", "product", "candidates", "oriented", "towards", "specialty", "disease", "and", "therapeutic", "market", "segments,", "including:", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans;", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications;", "(3)", "PRX-106,", "or", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "juvenile", "idiopathic", "arthritis,", "ankylosing,", "spondylitis,", "psoriatic", "arthritis", "and", "plaque", "psoriasis;", "(4)", "an", "orally", "administrated", "glucocerebrosidase", "enzyme", "for", "treating", "Gaucher", "disease", "patients", "utilizing", "the", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells;", "and", "(5)", "two", "additional", "undisclosed", "therapeutic", "proteins,", "both", "of", "which", "are", "being", "evaluated", "in", "animal", "studies.", "<tag3>"], "wordsA": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates,", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications,", "(3)", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "juvenile", "idiopathic", "arthritis,", "ankylosing,", "spondylitis,", "psoriatic", "arthritis", "and", "plaque", "psoriasis,", "(4)", "an", "orally", "administrated", "glucocerebrosidase", "enzyme", "for", "treating", "Gaucher", "patients", "utilizing", "the", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells", "and", "(5)", "additional", "undisclosed", "therapeutic", "proteins,", "all", "of", "which", "are", "currently", "being", "evaluated", "in", "animal", "studies."], "wordsB": ["We", "have", "identified", "several", "product", "candidates", "oriented", "towards", "specialty", "disease", "and", "therapeutic", "market", "segments,", "including:", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans;", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications;", "(3)", "PRX-106,", "or", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "juvenile", "idiopathic", "arthritis,", "ankylosing,", "spondylitis,", "psoriatic", "arthritis", "and", "plaque", "psoriasis;", "(4)", "an", "orally", "administrated", "glucocerebrosidase", "enzyme", "for", "treating", "Gaucher", "disease", "patients", "utilizing", "the", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells;", "and", "(5)", "two", "additional", "undisclosed", "therapeutic", "proteins,", "both", "of", "which", "are", "being", "evaluated", "in", "animal", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p29_s1", "idA": "1006281_11_item1_p21_s1", "sentA": "Our product pipeline currently includes, among other candidates, (1) PRX-102, a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans, (2) PRX-105, a plant cell expressed pegylated recombinant acetylcholinesterase product candidate for biodefense and other indications, (3) pr-antiTNF, a plant cell expressed recombinant fusion protein made from the soluble form of the human TNF receptor (TNFR) and an antibody portion, which is being developed as a treatment of certain immune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing, spondylitis, psoriatic arthritis and plaque psoriasis, (4) an orally administrated glucocerebrosidase enzyme for treating Gaucher patients utilizing the oral delivery of the recombinant enzyme produced within carrot cells and (5) additional undisclosed therapeutic proteins, all of which are currently being evaluated in animal studies.", "sentB": "Our product pipeline currently includes, among other candidates: (1) PRX-102, a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans; (2) PRX-105, a plant cell expressed pegylated recombinant acetylcholinesterase product candidate for biodefense and other indications; (3) PRX-106, or pr-antiTNF, a plant cell expressed recombinant fusion protein made from the soluble form of the human TNF receptor (TNFR) and an antibody portion, which is being developed as a treatment of certain immune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, spondylitis, psoriatic arthritis and plaque psoriasis; (4) an orally-administered glucocerebrosidase enzyme for the treatment of Gaucher disease patients utilizing oral delivery of the recombinant enzyme produced within carrot cells; and (5) two additional undisclosed therapeutic proteins, both of which are being evaluated in animal studies.", "type": 2, "words": ["<tag1>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates,", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications,", "(3)", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "juvenile", "idiopathic", "arthritis,", "ankylosing,", "spondylitis,", "psoriatic", "arthritis", "and", "plaque", "psoriasis,", "(4)", "an", "orally", "administrated", "glucocerebrosidase", "enzyme", "for", "treating", "Gaucher", "patients", "utilizing", "the", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells", "and", "(5)", "additional", "undisclosed", "therapeutic", "proteins,", "all", "of", "which", "are", "currently", "being", "evaluated", "in", "animal", "studies.", "<tag2>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans;", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications;", "(3)", "PRX-106,", "or", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "juvenile", "idiopathic", "arthritis,", "spondylitis,", "psoriatic", "arthritis", "and", "plaque", "psoriasis;", "(4)", "an", "orally-administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "disease", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells;", "and", "(5)", "two", "additional", "undisclosed", "therapeutic", "proteins,", "both", "of", "which", "are", "being", "evaluated", "in", "animal", "studies.", "<tag3>"], "wordsA": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates,", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications,", "(3)", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "juvenile", "idiopathic", "arthritis,", "ankylosing,", "spondylitis,", "psoriatic", "arthritis", "and", "plaque", "psoriasis,", "(4)", "an", "orally", "administrated", "glucocerebrosidase", "enzyme", "for", "treating", "Gaucher", "patients", "utilizing", "the", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells", "and", "(5)", "additional", "undisclosed", "therapeutic", "proteins,", "all", "of", "which", "are", "currently", "being", "evaluated", "in", "animal", "studies."], "wordsB": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "(1)", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans;", "(2)", "PRX-105,", "a", "plant", "cell", "expressed", "pegylated", "recombinant", "acetylcholinesterase", "product", "candidate", "for", "biodefense", "and", "other", "indications;", "(3)", "PRX-106,", "or", "pr-antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "made", "from", "the", "soluble", "form", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "as", "a", "treatment", "of", "certain", "immune", "diseases", "such", "as", "rheumatoid", "arthritis,", "juvenile", "idiopathic", "arthritis,", "spondylitis,", "psoriatic", "arthritis", "and", "plaque", "psoriasis;", "(4)", "an", "orally-administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "disease", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "enzyme", "produced", "within", "carrot", "cells;", "and", "(5)", "two", "additional", "undisclosed", "therapeutic", "proteins,", "both", "of", "which", "are", "being", "evaluated", "in", "animal", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p261_s1", "idA": "1006281_11_item1_p232_s1", "sentA": "In addition, it is possible that Protalix Ltd. may not be able to operate in a way that maximizes utilization of the benefits under the Investment Law.", "sentB": "In addition, it is possible that Protalix Ltd. may not be able to operate in a manner that maximizes utilization of the potential benefits available under the Investment Law.", "type": 2, "words": ["<tag1>", "In", "addition,", "it", "is", "possible", "that", "Protalix", "Ltd.", "may", "not", "be", "able", "to", "operate", "in", "a", "way", "that", "maximizes", "utilization", "of", "the", "benefits", "under", "the", "Investment", "Law.", "<tag2>", "In", "addition,", "it", "is", "possible", "that", "Protalix", "Ltd.", "may", "not", "be", "able", "to", "operate", "in", "a", "manner", "that", "maximizes", "utilization", "of", "the", "potential", "benefits", "available", "under", "the", "Investment", "Law.", "<tag3>"], "wordsA": ["In", "addition,", "it", "is", "possible", "that", "Protalix", "Ltd.", "may", "not", "be", "able", "to", "operate", "in", "a", "way", "that", "maximizes", "utilization", "of", "the", "benefits", "under", "the", "Investment", "Law."], "wordsB": ["In", "addition,", "it", "is", "possible", "that", "Protalix", "Ltd.", "may", "not", "be", "able", "to", "operate", "in", "a", "manner", "that", "maximizes", "utilization", "of", "the", "potential", "benefits", "available", "under", "the", "Investment", "Law."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p262_s0", "idA": "1006281_11_item1_p233_s0", "sentA": "From time to time, the Israeli Government has discussed reducing the benefits available to companies under the Investment Law.", "sentB": "From time to time, the Israeli Government has considered reducing the benefits available to companies under the Investment Law.", "type": 2, "words": ["<tag1>", "From", "time", "to", "time,", "the", "Israeli", "Government", "has", "discussed", "reducing", "the", "benefits", "available", "to", "companies", "under", "the", "Investment", "Law.", "<tag2>", "From", "time", "to", "time,", "the", "Israeli", "Government", "has", "considered", "reducing", "the", "benefits", "available", "to", "companies", "under", "the", "Investment", "Law.", "<tag3>"], "wordsA": ["From", "time", "to", "time,", "the", "Israeli", "Government", "has", "discussed", "reducing", "the", "benefits", "available", "to", "companies", "under", "the", "Investment", "Law."], "wordsB": ["From", "time", "to", "time,", "the", "Israeli", "Government", "has", "considered", "reducing", "the", "benefits", "available", "to", "companies", "under", "the", "Investment", "Law."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p263_s0", "idA": "1006281_11_item1_p234_s0", "sentA": "In the past, Protalix Ltd. received grants from the Office of the Chief Scientist of the Israeli Ministry of Industry, Trade and Labor, the OCS, for the financing of a portion of its research and development expenditures in Israel.", "sentB": "To date, Protalix Ltd. has received grants from the Office of the Chief Scientist of the Israeli Ministry of Industry, Trade and Labor, the OCS, for the financing of a portion of its research and development expenditures in Israel.", "type": 2, "words": ["<tag1>", "In", "the", "past,", "Protalix", "Ltd.", "received", "grants", "from", "the", "Office", "of", "the", "Chief", "Scientist", "of", "the", "Israeli", "Ministry", "of", "Industry,", "Trade", "and", "Labor,", "the", "OCS,", "for", "the", "financing", "of", "a", "portion", "of", "its", "research", "and", "development", "expenditures", "in", "Israel.", "<tag2>", "To", "date,", "Protalix", "Ltd.", "has", "received", "grants", "from", "the", "Office", "of", "the", "Chief", "Scientist", "of", "the", "Israeli", "Ministry", "of", "Industry,", "Trade", "and", "Labor,", "the", "OCS,", "for", "the", "financing", "of", "a", "portion", "of", "its", "research", "and", "development", "expenditures", "in", "Israel.", "<tag3>"], "wordsA": ["In", "the", "past,", "Protalix", "Ltd.", "received", "grants", "from", "the", "Office", "of", "the", "Chief", "Scientist", "of", "the", "Israeli", "Ministry", "of", "Industry,", "Trade", "and", "Labor,", "the", "OCS,", "for", "the", "financing", "of", "a", "portion", "of", "its", "research", "and", "development", "expenditures", "in", "Israel."], "wordsB": ["To", "date,", "Protalix", "Ltd.", "has", "received", "grants", "from", "the", "Office", "of", "the", "Chief", "Scientist", "of", "the", "Israeli", "Ministry", "of", "Industry,", "Trade", "and", "Labor,", "the", "OCS,", "for", "the", "financing", "of", "a", "portion", "of", "its", "research", "and", "development", "expenditures", "in", "Israel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p263_s1", "idA": "1006281_11_item1_p235_s0", "sentA": "continuing operations totaling approximately $21.5 million, measured from inception.", "sentB": "As of December 31, 2011, the OCS approved grants in respect of Protalix Ltd. s continuing operations totaling approximately $23.9 million, measured from inception.", "type": 2, "words": ["<tag1>", "continuing", "operations", "totaling", "approximately", "$21.5", "million,", "measured", "from", "inception.", "<tag2>", "As", "of", "December", "31,", "2011,", "the", "OCS", "approved", "grants", "in", "respect", "of", "Protalix", "Ltd.", "s", "continuing", "operations", "totaling", "approximately", "$23.9", "million,", "measured", "from", "inception.", "<tag3>"], "wordsA": ["continuing", "operations", "totaling", "approximately", "$21.5", "million,", "measured", "from", "inception."], "wordsB": ["As", "of", "December", "31,", "2011,", "the", "OCS", "approved", "grants", "in", "respect", "of", "Protalix", "Ltd.", "s", "continuing", "operations", "totaling", "approximately", "$23.9", "million,", "measured", "from", "inception."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p149_s0", "idA": "1006281_11_item1_p23_s0", "sentA": "In December 2010 we held a pre-investigational new drug, or IND, meeting with the FDA with respect to PRX-102.", "sentB": "In December 2010, we held a pre- IND meeting with the FDA with respect to PRX-102.", "type": 2, "words": ["<tag1>", "In", "December", "2010", "we", "held", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102.", "<tag2>", "In", "December", "2010,", "we", "held", "a", "pre-", "IND", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102.", "<tag3>"], "wordsA": ["In", "December", "2010", "we", "held", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102."], "wordsB": ["In", "December", "2010,", "we", "held", "a", "pre-", "IND", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p149_s2", "idA": "1006281_11_item1_p23_s0", "sentA": "In December 2010 we held a pre-investigational new drug, or IND, meeting with the FDA with respect to PRX-102.", "sentB": "In December 2011 we held a pre IND meeting with respect to PRX 106 and we expect to submit an IND around the fourth quarter of 2012.", "type": 2, "words": ["<tag1>", "In", "December", "2010", "we", "held", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102.", "<tag2>", "In", "December", "2011", "we", "held", "a", "pre", "IND", "meeting", "with", "respect", "to", "PRX", "106", "and", "we", "expect", "to", "submit", "an", "IND", "around", "the", "fourth", "quarter", "of", "2012.", "<tag3>"], "wordsA": ["In", "December", "2010", "we", "held", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102."], "wordsB": ["In", "December", "2011", "we", "held", "a", "pre", "IND", "meeting", "with", "respect", "to", "PRX", "106", "and", "we", "expect", "to", "submit", "an", "IND", "around", "the", "fourth", "quarter", "of", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p161_s3", "idA": "1006281_11_item1_p23_s0", "sentA": "In December 2010 we held a pre-investigational new drug, or IND, meeting with the FDA with respect to PRX-102.", "sentB": "In December 2010, we held a pre-investigational new drug, or IND, meeting with the FDA with respect to PRX-105.", "type": 2, "words": ["<tag1>", "In", "December", "2010", "we", "held", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102.", "<tag2>", "In", "December", "2010,", "we", "held", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-105.", "<tag3>"], "wordsA": ["In", "December", "2010", "we", "held", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102."], "wordsB": ["In", "December", "2010,", "we", "held", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-105."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p171_s3", "idA": "1006281_11_item1_p23_s0", "sentA": "In December 2010 we held a pre-investigational new drug, or IND, meeting with the FDA with respect to PRX-102.", "sentB": "In December 2011, we held a pre IND meeting with respect to pr-antiTNF, and we expect to submit an IND around year end.", "type": 2, "words": ["<tag1>", "In", "December", "2010", "we", "held", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102.", "<tag2>", "In", "December", "2011,", "we", "held", "a", "pre", "IND", "meeting", "with", "respect", "to", "pr-antiTNF,", "and", "we", "expect", "to", "submit", "an", "IND", "around", "year", "end.", "<tag3>"], "wordsA": ["In", "December", "2010", "we", "held", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102."], "wordsB": ["In", "December", "2011,", "we", "held", "a", "pre", "IND", "meeting", "with", "respect", "to", "pr-antiTNF,", "and", "we", "expect", "to", "submit", "an", "IND", "around", "year", "end."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p29_s2", "idA": "1006281_11_item1_p23_s0", "sentA": "In December 2010 we held a pre-investigational new drug, or IND, meeting with the FDA with respect to PRX-102.", "sentB": "We participated in a pre-investigational new drug, or IND, meeting with respect to one of the undisclosed product candidates in the first quarter of 2012 and a pre-IND meeting for the second candidate is planned for later this year.", "type": 2, "words": ["<tag1>", "In", "December", "2010", "we", "held", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102.", "<tag2>", "We", "participated", "in", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "respect", "to", "one", "of", "the", "undisclosed", "product", "candidates", "in", "the", "first", "quarter", "of", "2012", "and", "a", "pre-IND", "meeting", "for", "the", "second", "candidate", "is", "planned", "for", "later", "this", "year.", "<tag3>"], "wordsA": ["In", "December", "2010", "we", "held", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102."], "wordsB": ["We", "participated", "in", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "respect", "to", "one", "of", "the", "undisclosed", "product", "candidates", "in", "the", "first", "quarter", "of", "2012", "and", "a", "pre-IND", "meeting", "for", "the", "second", "candidate", "is", "planned", "for", "later", "this", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p32_s0", "idA": "1006281_11_item1_p23_s0", "sentA": "In December 2010 we held a pre-investigational new drug, or IND, meeting with the FDA with respect to PRX-102.", "sentB": "In December 2010, we held a pre-IND meeting with the FDA with respect to PRX-102.", "type": 2, "words": ["<tag1>", "In", "December", "2010", "we", "held", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102.", "<tag2>", "In", "December", "2010,", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102.", "<tag3>"], "wordsA": ["In", "December", "2010", "we", "held", "a", "pre-investigational", "new", "drug,", "or", "IND,", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102."], "wordsB": ["In", "December", "2010,", "we", "held", "a", "pre-IND", "meeting", "with", "the", "FDA", "with", "respect", "to", "PRX-102."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p149_s1", "idA": "1006281_11_item1_p23_s1", "sentA": "We expect to submit an IND to the FDA within the next 12 months in connection with an anticipated phase I/II study of PRX-102 and to initiate the trial once approved, if at all.", "sentB": "We completed preclinical trials in small and large animals with respect to PRX-102, and we expect to submit an IND to the FDA during the second quarter of 2012 in connection with an anticipated phase I/II clinical study of PX-102 in Fabry patients, and to initiate the trial once the IND is approved, if at all.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "within", "the", "next", "12", "months", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "study", "of", "PRX-102", "and", "to", "initiate", "the", "trial", "once", "approved,", "if", "at", "all.", "<tag2>", "We", "completed", "preclinical", "trials", "in", "small", "and", "large", "animals", "with", "respect", "to", "PRX-102,", "and", "we", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "during", "the", "second", "quarter", "of", "2012", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "clinical", "study", "of", "PX-102", "in", "Fabry", "patients,", "and", "to", "initiate", "the", "trial", "once", "the", "IND", "is", "approved,", "if", "at", "all.", "<tag3>"], "wordsA": ["We", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "within", "the", "next", "12", "months", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "study", "of", "PRX-102", "and", "to", "initiate", "the", "trial", "once", "approved,", "if", "at", "all."], "wordsB": ["We", "completed", "preclinical", "trials", "in", "small", "and", "large", "animals", "with", "respect", "to", "PRX-102,", "and", "we", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "during", "the", "second", "quarter", "of", "2012", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "clinical", "study", "of", "PX-102", "in", "Fabry", "patients,", "and", "to", "initiate", "the", "trial", "once", "the", "IND", "is", "approved,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p158_s0", "idA": "1006281_11_item1_p23_s1", "sentA": "We expect to submit an IND to the FDA within the next 12 months in connection with an anticipated phase I/II study of PRX-102 and to initiate the trial once approved, if at all.", "sentB": "We currently expect to submit an IND to the FDA during the second quarter of 2012 in connection with an anticipated phase I/II clinical study of PRX-102 and to initiate the trial once the IND is approved, if at all.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "within", "the", "next", "12", "months", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "study", "of", "PRX-102", "and", "to", "initiate", "the", "trial", "once", "approved,", "if", "at", "all.", "<tag2>", "We", "currently", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "during", "the", "second", "quarter", "of", "2012", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "clinical", "study", "of", "PRX-102", "and", "to", "initiate", "the", "trial", "once", "the", "IND", "is", "approved,", "if", "at", "all.", "<tag3>"], "wordsA": ["We", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "within", "the", "next", "12", "months", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "study", "of", "PRX-102", "and", "to", "initiate", "the", "trial", "once", "approved,", "if", "at", "all."], "wordsB": ["We", "currently", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "during", "the", "second", "quarter", "of", "2012", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "clinical", "study", "of", "PRX-102", "and", "to", "initiate", "the", "trial", "once", "the", "IND", "is", "approved,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p32_s1", "idA": "1006281_11_item1_p23_s1", "sentA": "We expect to submit an IND to the FDA within the next 12 months in connection with an anticipated phase I/II study of PRX-102 and to initiate the trial once approved, if at all.", "sentB": "We completed preclinical trials in small and large animals with respect to PRX-102, and we expect to submit an IND to the FDA during the second quarter of 2012 in connection with an anticipated phase I/II clinical study of PRX-102 in Fabry patients, and to initiate the trial once the IND is approved, if at all.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "within", "the", "next", "12", "months", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "study", "of", "PRX-102", "and", "to", "initiate", "the", "trial", "once", "approved,", "if", "at", "all.", "<tag2>", "We", "completed", "preclinical", "trials", "in", "small", "and", "large", "animals", "with", "respect", "to", "PRX-102,", "and", "we", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "during", "the", "second", "quarter", "of", "2012", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "clinical", "study", "of", "PRX-102", "in", "Fabry", "patients,", "and", "to", "initiate", "the", "trial", "once", "the", "IND", "is", "approved,", "if", "at", "all.", "<tag3>"], "wordsA": ["We", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "within", "the", "next", "12", "months", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "study", "of", "PRX-102", "and", "to", "initiate", "the", "trial", "once", "approved,", "if", "at", "all."], "wordsB": ["We", "completed", "preclinical", "trials", "in", "small", "and", "large", "animals", "with", "respect", "to", "PRX-102,", "and", "we", "expect", "to", "submit", "an", "IND", "to", "the", "FDA", "during", "the", "second", "quarter", "of", "2012", "in", "connection", "with", "an", "anticipated", "phase", "I/II", "clinical", "study", "of", "PRX-102", "in", "Fabry", "patients,", "and", "to", "initiate", "the", "trial", "once", "the", "IND", "is", "approved,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p267_s0", "idA": "1006281_11_item1_p240_s0", "sentA": "In March 2005, an amendment to the Research Law was enacted.", "sentB": "In March 2005, Research Law was amended.", "type": 2, "words": ["<tag1>", "In", "March", "2005,", "an", "amendment", "to", "the", "Research", "Law", "was", "enacted.", "<tag2>", "In", "March", "2005,", "Research", "Law", "was", "amended.", "<tag3>"], "wordsA": ["In", "March", "2005,", "an", "amendment", "to", "the", "Research", "Law", "was", "enacted."], "wordsB": ["In", "March", "2005,", "Research", "Law", "was", "amended."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p5_s1", "idA": "1006281_11_item1_p244_s0", "sentA": "Another provision in the amendment concerns the transfer of manufacturing rights.", "sentB": "The FDA did not request additional clinical studies in the CRL.", "type": 2, "words": ["<tag1>", "Another", "provision", "in", "the", "amendment", "concerns", "the", "transfer", "of", "manufacturing", "rights.", "<tag2>", "The", "FDA", "did", "not", "request", "additional", "clinical", "studies", "in", "the", "CRL.", "<tag3>"], "wordsA": ["Another", "provision", "in", "the", "amendment", "concerns", "the", "transfer", "of", "manufacturing", "rights."], "wordsB": ["The", "FDA", "did", "not", "request", "additional", "clinical", "studies", "in", "the", "CRL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p75_s1", "idA": "1006281_11_item1_p244_s0", "sentA": "Another provision in the amendment concerns the transfer of manufacturing rights.", "sentB": "The FDA did not request additional clinical studies in the CRL.", "type": 2, "words": ["<tag1>", "Another", "provision", "in", "the", "amendment", "concerns", "the", "transfer", "of", "manufacturing", "rights.", "<tag2>", "The", "FDA", "did", "not", "request", "additional", "clinical", "studies", "in", "the", "CRL.", "<tag3>"], "wordsA": ["Another", "provision", "in", "the", "amendment", "concerns", "the", "transfer", "of", "manufacturing", "rights."], "wordsB": ["The", "FDA", "did", "not", "request", "additional", "clinical", "studies", "in", "the", "CRL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p241_s0", "idA": "1006281_11_item1_p248_s0", "sentA": "Protalix Ltd. is taxed in Israel under the Income Tax Law (Inflationary Adjustments), 1985, generally referred to as the Inflationary Adjustments Law.", "sentB": "Protalix Ltd.'s income, other than income from Approved Enterprises, is taxed in Israel at the regular rate.", "type": 2, "words": ["<tag1>", "Protalix", "Ltd.", "is", "taxed", "in", "Israel", "under", "the", "Income", "Tax", "Law", "(Inflationary", "Adjustments),", "1985,", "generally", "referred", "to", "as", "the", "Inflationary", "Adjustments", "Law.", "<tag2>", "Protalix", "Ltd.'s", "income,", "other", "than", "income", "from", "Approved", "Enterprises,", "is", "taxed", "in", "Israel", "at", "the", "regular", "rate.", "<tag3>"], "wordsA": ["Protalix", "Ltd.", "is", "taxed", "in", "Israel", "under", "the", "Income", "Tax", "Law", "(Inflationary", "Adjustments),", "1985,", "generally", "referred", "to", "as", "the", "Inflationary", "Adjustments", "Law."], "wordsB": ["Protalix", "Ltd.'s", "income,", "other", "than", "income", "from", "Approved", "Enterprises,", "is", "taxed", "in", "Israel", "at", "the", "regular", "rate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p274_s0", "idA": "1006281_11_item1_p248_s0", "sentA": "Protalix Ltd. is taxed in Israel under the Income Tax Law (Inflationary Adjustments), 1985, generally referred to as the Inflationary Adjustments Law.", "sentB": "Protalix Ltd. is subject to Israel's Income Tax Law (Inflationary Adjustments), 1985, or the Inflationary Adjustments Law.", "type": 2, "words": ["<tag1>", "Protalix", "Ltd.", "is", "taxed", "in", "Israel", "under", "the", "Income", "Tax", "Law", "(Inflationary", "Adjustments),", "1985,", "generally", "referred", "to", "as", "the", "Inflationary", "Adjustments", "Law.", "<tag2>", "Protalix", "Ltd.", "is", "subject", "to", "Israel's", "Income", "Tax", "Law", "(Inflationary", "Adjustments),", "1985,", "or", "the", "Inflationary", "Adjustments", "Law.", "<tag3>"], "wordsA": ["Protalix", "Ltd.", "is", "taxed", "in", "Israel", "under", "the", "Income", "Tax", "Law", "(Inflationary", "Adjustments),", "1985,", "generally", "referred", "to", "as", "the", "Inflationary", "Adjustments", "Law."], "wordsB": ["Protalix", "Ltd.", "is", "subject", "to", "Israel's", "Income", "Tax", "Law", "(Inflationary", "Adjustments),", "1985,", "or", "the", "Inflationary", "Adjustments", "Law."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p33_s1", "idA": "1006281_11_item1_p25_s2", "sentA": "In addition we are continuously evaluating potential strategic marketing partnerships.", "sentB": "In addition, we are continuously evaluating potential strategic marketing partnerships.", "type": 2, "words": ["<tag1>", "In", "addition", "we", "are", "continuously", "evaluating", "potential", "strategic", "marketing", "partnerships.", "<tag2>", "In", "addition,", "we", "are", "continuously", "evaluating", "potential", "strategic", "marketing", "partnerships.", "<tag3>"], "wordsA": ["In", "addition", "we", "are", "continuously", "evaluating", "potential", "strategic", "marketing", "partnerships."], "wordsB": ["In", "addition,", "we", "are", "continuously", "evaluating", "potential", "strategic", "marketing", "partnerships."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p285_s1", "idA": "1006281_11_item1_p260_s1", "sentA": "However, the amount of such deductible expenditures is reduced by the sum of any funds received through government grants for the finance of such scientific research and development projects.", "sentB": "These expenditures must relate to scientific research and development projects and must be approved by the OCS.", "type": 2, "words": ["<tag1>", "However,", "the", "amount", "of", "such", "deductible", "expenditures", "is", "reduced", "by", "the", "sum", "of", "any", "funds", "received", "through", "government", "grants", "for", "the", "finance", "of", "such", "scientific", "research", "and", "development", "projects.", "<tag2>", "These", "expenditures", "must", "relate", "to", "scientific", "research", "and", "development", "projects", "and", "must", "be", "approved", "by", "the", "OCS.", "<tag3>"], "wordsA": ["However,", "the", "amount", "of", "such", "deductible", "expenditures", "is", "reduced", "by", "the", "sum", "of", "any", "funds", "received", "through", "government", "grants", "for", "the", "finance", "of", "such", "scientific", "research", "and", "development", "projects."], "wordsB": ["These", "expenditures", "must", "relate", "to", "scientific", "research", "and", "development", "projects", "and", "must", "be", "approved", "by", "the", "OCS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p286_s0", "idA": "1006281_11_item1_p261_s0", "sentA": "As of December 31, 2010, we had 240 employees, of who 35 have an M.D. or a Ph.D. in their respective scientific fields.", "sentB": "As of December 31, 2011, we had 235 employees, of whom 34 have an M.D. or a Ph.D. in their respective scientific fields.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2010,", "we", "had", "240", "employees,", "of", "who", "35", "have", "an", "M.D.", "or", "a", "Ph.D.", "in", "their", "respective", "scientific", "fields.", "<tag2>", "As", "of", "December", "31,", "2011,", "we", "had", "235", "employees,", "of", "whom", "34", "have", "an", "M.D.", "or", "a", "Ph.D.", "in", "their", "respective", "scientific", "fields.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2010,", "we", "had", "240", "employees,", "of", "who", "35", "have", "an", "M.D.", "or", "a", "Ph.D.", "in", "their", "respective", "scientific", "fields."], "wordsB": ["As", "of", "December", "31,", "2011,", "we", "had", "235", "employees,", "of", "whom", "34", "have", "an", "M.D.", "or", "a", "Ph.D.", "in", "their", "respective", "scientific", "fields."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p293_s0", "idA": "1006281_11_item1_p268_s0", "sentA": "We make available on our website, free of charge, our Securities and Exchange Commission, or the Commission, filings, including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to these reports, as soon as reasonably practicable after we electronically file these documents with, or furnish them to, the Commission.", "sentB": "We make available on our website, free of charge, our Commission, filings, including our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to these reports, as soon as reasonably practicable after we electronically file these documents with, or furnish them to, the Commission.", "type": 2, "words": ["<tag1>", "We", "make", "available", "on", "our", "website,", "free", "of", "charge,", "our", "Securities", "and", "Exchange", "Commission,", "or", "the", "Commission,", "filings,", "including", "our", "Annual", "Report", "on", "Form", "10-K,", "Quarterly", "Reports", "on", "Form", "10-Q,", "Current", "Reports", "on", "Form", "8-K", "and", "any", "amendments", "to", "these", "reports,", "as", "soon", "as", "reasonably", "practicable", "after", "we", "electronically", "file", "these", "documents", "with,", "or", "furnish", "them", "to,", "the", "Commission.", "<tag2>", "We", "make", "available", "on", "our", "website,", "free", "of", "charge,", "our", "Commission,", "filings,", "including", "our", "Annual", "Reports", "on", "Form", "10-K,", "Quarterly", "Reports", "on", "Form", "10-Q,", "Current", "Reports", "on", "Form", "8-K", "and", "any", "amendments", "to", "these", "reports,", "as", "soon", "as", "reasonably", "practicable", "after", "we", "electronically", "file", "these", "documents", "with,", "or", "furnish", "them", "to,", "the", "Commission.", "<tag3>"], "wordsA": ["We", "make", "available", "on", "our", "website,", "free", "of", "charge,", "our", "Securities", "and", "Exchange", "Commission,", "or", "the", "Commission,", "filings,", "including", "our", "Annual", "Report", "on", "Form", "10-K,", "Quarterly", "Reports", "on", "Form", "10-Q,", "Current", "Reports", "on", "Form", "8-K", "and", "any", "amendments", "to", "these", "reports,", "as", "soon", "as", "reasonably", "practicable", "after", "we", "electronically", "file", "these", "documents", "with,", "or", "furnish", "them", "to,", "the", "Commission."], "wordsB": ["We", "make", "available", "on", "our", "website,", "free", "of", "charge,", "our", "Commission,", "filings,", "including", "our", "Annual", "Reports", "on", "Form", "10-K,", "Quarterly", "Reports", "on", "Form", "10-Q,", "Current", "Reports", "on", "Form", "8-K", "and", "any", "amendments", "to", "these", "reports,", "as", "soon", "as", "reasonably", "practicable", "after", "we", "electronically", "file", "these", "documents", "with,", "or", "furnish", "them", "to,", "the", "Commission."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p294_s0", "idA": "1006281_11_item1_p269_s0", "sentA": "We are also listed on the Tel Aviv Stock Exchange and, accordingly, we submit copies of all our filings with the Commission to the Israeli Securities Authority and the Tel Aviv Stock Exchange.", "sentB": "We are also listed on the Tel Aviv Stock Exchange, or the TASE, and, accordingly, we submit copies of all our filings with the Commission to the Israeli Securities Authority and the TASE.", "type": 2, "words": ["<tag1>", "We", "are", "also", "listed", "on", "the", "Tel", "Aviv", "Stock", "Exchange", "and,", "accordingly,", "we", "submit", "copies", "of", "all", "our", "filings", "with", "the", "Commission", "to", "the", "Israeli", "Securities", "Authority", "and", "the", "Tel", "Aviv", "Stock", "Exchange.", "<tag2>", "We", "are", "also", "listed", "on", "the", "Tel", "Aviv", "Stock", "Exchange,", "or", "the", "TASE,", "and,", "accordingly,", "we", "submit", "copies", "of", "all", "our", "filings", "with", "the", "Commission", "to", "the", "Israeli", "Securities", "Authority", "and", "the", "TASE.", "<tag3>"], "wordsA": ["We", "are", "also", "listed", "on", "the", "Tel", "Aviv", "Stock", "Exchange", "and,", "accordingly,", "we", "submit", "copies", "of", "all", "our", "filings", "with", "the", "Commission", "to", "the", "Israeli", "Securities", "Authority", "and", "the", "Tel", "Aviv", "Stock", "Exchange."], "wordsB": ["We", "are", "also", "listed", "on", "the", "Tel", "Aviv", "Stock", "Exchange,", "or", "the", "TASE,", "and,", "accordingly,", "we", "submit", "copies", "of", "all", "our", "filings", "with", "the", "Commission", "to", "the", "Israeli", "Securities", "Authority", "and", "the", "TASE."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p35_s1", "idA": "1006281_11_item1_p26_s1", "sentA": "Through our ProCellEx protein expression system, we can develop highly complex recombinant therapeutic proteins all the way to the scale-up of a purified product produced in compliance with current good manufacturing practices, or cGMP.", "sentB": "Through our ProCellEx protein expression system, we can develop highly complex recombinant therapeutic proteins all the way to the scale-up of a purified product produced in compliance with current.", "type": 2, "words": ["<tag1>", "Through", "our", "ProCellEx", "protein", "expression", "system,", "we", "can", "develop", "highly", "complex", "recombinant", "therapeutic", "proteins", "all", "the", "way", "to", "the", "scale-up", "of", "a", "purified", "product", "produced", "in", "compliance", "with", "current", "good", "manufacturing", "practices,", "or", "cGMP.", "<tag2>", "Through", "our", "ProCellEx", "protein", "expression", "system,", "we", "can", "develop", "highly", "complex", "recombinant", "therapeutic", "proteins", "all", "the", "way", "to", "the", "scale-up", "of", "a", "purified", "product", "produced", "in", "compliance", "with", "current.", "<tag3>"], "wordsA": ["Through", "our", "ProCellEx", "protein", "expression", "system,", "we", "can", "develop", "highly", "complex", "recombinant", "therapeutic", "proteins", "all", "the", "way", "to", "the", "scale-up", "of", "a", "purified", "product", "produced", "in", "compliance", "with", "current", "good", "manufacturing", "practices,", "or", "cGMP."], "wordsB": ["Through", "our", "ProCellEx", "protein", "expression", "system,", "we", "can", "develop", "highly", "complex", "recombinant", "therapeutic", "proteins", "all", "the", "way", "to", "the", "scale-up", "of", "a", "purified", "product", "produced", "in", "compliance", "with", "current."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p55_s5", "idA": "1006281_11_item1_p26_s6", "sentA": "We have filed for United States and international composition of matter patents for taliglucerase alfa.", "sentB": "We have filed for United States and international composition of matter patents for taliglucerase alfa, PRX-102 and certain of our other product candidates.", "type": 2, "words": ["<tag1>", "We", "have", "filed", "for", "United", "States", "and", "international", "composition", "of", "matter", "patents", "for", "taliglucerase", "alfa.", "<tag2>", "We", "have", "filed", "for", "United", "States", "and", "international", "composition", "of", "matter", "patents", "for", "taliglucerase", "alfa,", "PRX-102", "and", "certain", "of", "our", "other", "product", "candidates.", "<tag3>"], "wordsA": ["We", "have", "filed", "for", "United", "States", "and", "international", "composition", "of", "matter", "patents", "for", "taliglucerase", "alfa."], "wordsB": ["We", "have", "filed", "for", "United", "States", "and", "international", "composition", "of", "matter", "patents", "for", "taliglucerase", "alfa,", "PRX-102", "and", "certain", "of", "our", "other", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p294_s1", "idA": "1006281_11_item1_p270_s0", "sentA": "retrieved electronically through the Tel Aviv Stock Exchange s internet messaging system (www.maya.tase.co.il) and through the MAGNA distribution site of the Israeli Securities Authority (www.magna.isa.gov.il).", "sentB": "Such copies can be retrieved electronically through the TASE s internet messaging system (www.maya.tase.co.il) and through the MAGNA distribution site of the Israeli Securities Authority (www.magna.isa.gov.il).", "type": 2, "words": ["<tag1>", "retrieved", "electronically", "through", "the", "Tel", "Aviv", "Stock", "Exchange", "s", "internet", "messaging", "system", "(www.maya.tase.co.il)", "and", "through", "the", "MAGNA", "distribution", "site", "of", "the", "Israeli", "Securities", "Authority", "(www.magna.isa.gov.il).", "<tag2>", "Such", "copies", "can", "be", "retrieved", "electronically", "through", "the", "TASE", "s", "internet", "messaging", "system", "(www.maya.tase.co.il)", "and", "through", "the", "MAGNA", "distribution", "site", "of", "the", "Israeli", "Securities", "Authority", "(www.magna.isa.gov.il).", "<tag3>"], "wordsA": ["retrieved", "electronically", "through", "the", "Tel", "Aviv", "Stock", "Exchange", "s", "internet", "messaging", "system", "(www.maya.tase.co.il)", "and", "through", "the", "MAGNA", "distribution", "site", "of", "the", "Israeli", "Securities", "Authority", "(www.magna.isa.gov.il)."], "wordsB": ["Such", "copies", "can", "be", "retrieved", "electronically", "through", "the", "TASE", "s", "internet", "messaging", "system", "(www.maya.tase.co.il)", "and", "through", "the", "MAGNA", "distribution", "site", "of", "the", "Israeli", "Securities", "Authority", "(www.magna.isa.gov.il)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p295_s1", "idA": "1006281_11_item1_p271_s1", "sentA": "Each of these documents is also available in print to any shareholder who requests a copy by addressing a request to:", "sentB": "Each of these documents is also available in print, free of charge, to any shareholder who requests a copy by addressing a request to:", "type": 2, "words": ["<tag1>", "Each", "of", "these", "documents", "is", "also", "available", "in", "print", "to", "any", "shareholder", "who", "requests", "a", "copy", "by", "addressing", "a", "request", "to:", "<tag2>", "Each", "of", "these", "documents", "is", "also", "available", "in", "print,", "free", "of", "charge,", "to", "any", "shareholder", "who", "requests", "a", "copy", "by", "addressing", "a", "request", "to:", "<tag3>"], "wordsA": ["Each", "of", "these", "documents", "is", "also", "available", "in", "print", "to", "any", "shareholder", "who", "requests", "a", "copy", "by", "addressing", "a", "request", "to:"], "wordsB": ["Each", "of", "these", "documents", "is", "also", "available", "in", "print,", "free", "of", "charge,", "to", "any", "shareholder", "who", "requests", "a", "copy", "by", "addressing", "a", "request", "to:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p37_s0", "idA": "1006281_11_item1_p28_s0", "sentA": "We have successfully demonstrated the feasibility of our ProCellEx system through clinical and preclinical studies performed by us to date including the positive efficacy and safety data in our phase III study for taliglucerase alfa, preclinical results in well-known models in our enzyme for Fabry disease and pr-antiTNF, and extensive animal studies for our acetylcholinesterase enzyme, and by expressing, on an exploratory, research scale, many additional complex therapeutic proteins belonging to different drug classes, such as enzymes, hormones, monoclonal antibodies, cytokines and vaccines.", "sentB": "We have successfully demonstrated the feasibility of our ProCellEx system through: the clinical and preclinical studies performed by us to date, including the positive efficacy and safety data in our phase III study for taliglucerase alfa, our switchover study and our extension study; preclinical results in well-known models in our enzyme for each of Fabry disease and pr-antiTNF; extensive animal studies for our acetylcholinesterase enzyme; and by expressing, on an exploratory, research scale, many additional complex therapeutic proteins belonging to different drug classes, such as enzymes, hormones, monoclonal antibodies, cytokines and vaccines.", "type": 2, "words": ["<tag1>", "We", "have", "successfully", "demonstrated", "the", "feasibility", "of", "our", "ProCellEx", "system", "through", "clinical", "and", "preclinical", "studies", "performed", "by", "us", "to", "date", "including", "the", "positive", "efficacy", "and", "safety", "data", "in", "our", "phase", "III", "study", "for", "taliglucerase", "alfa,", "preclinical", "results", "in", "well-known", "models", "in", "our", "enzyme", "for", "Fabry", "disease", "and", "pr-antiTNF,", "and", "extensive", "animal", "studies", "for", "our", "acetylcholinesterase", "enzyme,", "and", "by", "expressing,", "on", "an", "exploratory,", "research", "scale,", "many", "additional", "complex", "therapeutic", "proteins", "belonging", "to", "different", "drug", "classes,", "such", "as", "enzymes,", "hormones,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines.", "<tag2>", "We", "have", "successfully", "demonstrated", "the", "feasibility", "of", "our", "ProCellEx", "system", "through:", "the", "clinical", "and", "preclinical", "studies", "performed", "by", "us", "to", "date,", "including", "the", "positive", "efficacy", "and", "safety", "data", "in", "our", "phase", "III", "study", "for", "taliglucerase", "alfa,", "our", "switchover", "study", "and", "our", "extension", "study;", "preclinical", "results", "in", "well-known", "models", "in", "our", "enzyme", "for", "each", "of", "Fabry", "disease", "and", "pr-antiTNF;", "extensive", "animal", "studies", "for", "our", "acetylcholinesterase", "enzyme;", "and", "by", "expressing,", "on", "an", "exploratory,", "research", "scale,", "many", "additional", "complex", "therapeutic", "proteins", "belonging", "to", "different", "drug", "classes,", "such", "as", "enzymes,", "hormones,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines.", "<tag3>"], "wordsA": ["We", "have", "successfully", "demonstrated", "the", "feasibility", "of", "our", "ProCellEx", "system", "through", "clinical", "and", "preclinical", "studies", "performed", "by", "us", "to", "date", "including", "the", "positive", "efficacy", "and", "safety", "data", "in", "our", "phase", "III", "study", "for", "taliglucerase", "alfa,", "preclinical", "results", "in", "well-known", "models", "in", "our", "enzyme", "for", "Fabry", "disease", "and", "pr-antiTNF,", "and", "extensive", "animal", "studies", "for", "our", "acetylcholinesterase", "enzyme,", "and", "by", "expressing,", "on", "an", "exploratory,", "research", "scale,", "many", "additional", "complex", "therapeutic", "proteins", "belonging", "to", "different", "drug", "classes,", "such", "as", "enzymes,", "hormones,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines."], "wordsB": ["We", "have", "successfully", "demonstrated", "the", "feasibility", "of", "our", "ProCellEx", "system", "through:", "the", "clinical", "and", "preclinical", "studies", "performed", "by", "us", "to", "date,", "including", "the", "positive", "efficacy", "and", "safety", "data", "in", "our", "phase", "III", "study", "for", "taliglucerase", "alfa,", "our", "switchover", "study", "and", "our", "extension", "study;", "preclinical", "results", "in", "well-known", "models", "in", "our", "enzyme", "for", "each", "of", "Fabry", "disease", "and", "pr-antiTNF;", "extensive", "animal", "studies", "for", "our", "acetylcholinesterase", "enzyme;", "and", "by", "expressing,", "on", "an", "exploratory,", "research", "scale,", "many", "additional", "complex", "therapeutic", "proteins", "belonging", "to", "different", "drug", "classes,", "such", "as", "enzymes,", "hormones,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p38_s4", "idA": "1006281_11_item1_p31_s0", "sentA": "under which we have agreed to collaborate on several matters.", "sentB": "We entered into an agreement with Teva in September 2006 under which we have agreed to collaborate on several matters.", "type": 2, "words": ["<tag1>", "under", "which", "we", "have", "agreed", "to", "collaborate", "on", "several", "matters.", "<tag2>", "We", "entered", "into", "an", "agreement", "with", "Teva", "in", "September", "2006", "under", "which", "we", "have", "agreed", "to", "collaborate", "on", "several", "matters.", "<tag3>"], "wordsA": ["under", "which", "we", "have", "agreed", "to", "collaborate", "on", "several", "matters."], "wordsB": ["We", "entered", "into", "an", "agreement", "with", "Teva", "in", "September", "2006", "under", "which", "we", "have", "agreed", "to", "collaborate", "on", "several", "matters."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p166_s1", "idA": "1006281_11_item1_p31_s2", "sentA": "Other elements of our collaboration with Teva are currently ongoing.", "sentB": "These filings are part of our continuing collaboration with Yissum.", "type": 2, "words": ["<tag1>", "Other", "elements", "of", "our", "collaboration", "with", "Teva", "are", "currently", "ongoing.", "<tag2>", "These", "filings", "are", "part", "of", "our", "continuing", "collaboration", "with", "Yissum.", "<tag3>"], "wordsA": ["Other", "elements", "of", "our", "collaboration", "with", "Teva", "are", "currently", "ongoing."], "wordsB": ["These", "filings", "are", "part", "of", "our", "continuing", "collaboration", "with", "Yissum."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p38_s6", "idA": "1006281_11_item1_p31_s2", "sentA": "Other elements of our collaboration with Teva are currently ongoing.", "sentB": "Other elements of our collaboration with Teva, as well as the exploration of new collaborations, are currently ongoing.", "type": 2, "words": ["<tag1>", "Other", "elements", "of", "our", "collaboration", "with", "Teva", "are", "currently", "ongoing.", "<tag2>", "Other", "elements", "of", "our", "collaboration", "with", "Teva,", "as", "well", "as", "the", "exploration", "of", "new", "collaborations,", "are", "currently", "ongoing.", "<tag3>"], "wordsA": ["Other", "elements", "of", "our", "collaboration", "with", "Teva", "are", "currently", "ongoing."], "wordsB": ["Other", "elements", "of", "our", "collaboration", "with", "Teva,", "as", "well", "as", "the", "exploration", "of", "new", "collaborations,", "are", "currently", "ongoing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p41_s1", "idA": "1006281_11_item1_p38_s2", "sentA": "Accordingly, such systems cannot be used to produce glycoproteins or other complex proteins and, therefore, bacterial and yeast cell-based systems are limited to the expression of the most basic, simple proteins, such as insulin and growth hormones.", "sentB": "Mammalian cell-based systems were first introduced in the late 1980s and are currently used to produce many of the biotechnology industry s largest and most successful therapeutic proteins, including Epogen , Neupogen , Cerezyme, Rituxan , Enbrel, Neulasta , Remicade and Herceptin .", "type": 2, "words": ["<tag1>", "Accordingly,", "such", "systems", "cannot", "be", "used", "to", "produce", "glycoproteins", "or", "other", "complex", "proteins", "and,", "therefore,", "bacterial", "and", "yeast", "cell-based", "systems", "are", "limited", "to", "the", "expression", "of", "the", "most", "basic,", "simple", "proteins,", "such", "as", "insulin", "and", "growth", "hormones.", "<tag2>", "Mammalian", "cell-based", "systems", "were", "first", "introduced", "in", "the", "late", "1980s", "and", "are", "currently", "used", "to", "produce", "many", "of", "the", "biotechnology", "industry", "s", "largest", "and", "most", "successful", "therapeutic", "proteins,", "including", "Epogen", ",", "Neupogen", ",", "Cerezyme,", "Rituxan", ",", "Enbrel,", "Neulasta", ",", "Remicade", "and", "Herceptin", ".", "<tag3>"], "wordsA": ["Accordingly,", "such", "systems", "cannot", "be", "used", "to", "produce", "glycoproteins", "or", "other", "complex", "proteins", "and,", "therefore,", "bacterial", "and", "yeast", "cell-based", "systems", "are", "limited", "to", "the", "expression", "of", "the", "most", "basic,", "simple", "proteins,", "such", "as", "insulin", "and", "growth", "hormones."], "wordsB": ["Mammalian", "cell-based", "systems", "were", "first", "introduced", "in", "the", "late", "1980s", "and", "are", "currently", "used", "to", "produce", "many", "of", "the", "biotechnology", "industry", "s", "largest", "and", "most", "successful", "therapeutic", "proteins,", "including", "Epogen", ",", "Neupogen", ",", "Cerezyme,", "Rituxan", ",", "Enbrel,", "Neulasta", ",", "Remicade", "and", "Herceptin", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p3_s0", "idA": "1006281_11_item1_p3_s0", "sentA": "Taliglucerase alfa is our proprietary recombinant form of glucocerebrosidase (GCD), an enzyme naturally found in human cells that is mutated or deficient in patients with Gaucher disease.", "sentB": "Gaucher disease patients suffer from mutations in or deficiencies of GCD, which is an enzyme that is naturally found in human cells.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "is", "our", "proprietary", "recombinant", "form", "of", "glucocerebrosidase", "(GCD),", "an", "enzyme", "naturally", "found", "in", "human", "cells", "that", "is", "mutated", "or", "deficient", "in", "patients", "with", "Gaucher", "disease.", "<tag2>", "Gaucher", "disease", "patients", "suffer", "from", "mutations", "in", "or", "deficiencies", "of", "GCD,", "which", "is", "an", "enzyme", "that", "is", "naturally", "found", "in", "human", "cells.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "is", "our", "proprietary", "recombinant", "form", "of", "glucocerebrosidase", "(GCD),", "an", "enzyme", "naturally", "found", "in", "human", "cells", "that", "is", "mutated", "or", "deficient", "in", "patients", "with", "Gaucher", "disease."], "wordsB": ["Gaucher", "disease", "patients", "suffer", "from", "mutations", "in", "or", "deficiencies", "of", "GCD,", "which", "is", "an", "enzyme", "that", "is", "naturally", "found", "in", "human", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p4_s0", "idA": "1006281_11_item1_p3_s1", "sentA": "In July 2007, we reached an agreement with the U.S. Food and Drug Administration, or the FDA, on the final design of our pivotal phase III clinical trial of taliglucerase alfa through the FDA s special protocol assessment (SPA) process.", "sentB": "The U.S. Food and Drug Administration, or the FDA, has granted taliglucerase alfa a Prescription Drug User Fee Act (PDUFA) date of May 1, 2012.", "type": 2, "words": ["<tag1>", "In", "July", "2007,", "we", "reached", "an", "agreement", "with", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "on", "the", "final", "design", "of", "our", "pivotal", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa", "through", "the", "FDA", "s", "special", "protocol", "assessment", "(SPA)", "process.", "<tag2>", "The", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "has", "granted", "taliglucerase", "alfa", "a", "Prescription", "Drug", "User", "Fee", "Act", "(PDUFA)", "date", "of", "May", "1,", "2012.", "<tag3>"], "wordsA": ["In", "July", "2007,", "we", "reached", "an", "agreement", "with", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "on", "the", "final", "design", "of", "our", "pivotal", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa", "through", "the", "FDA", "s", "special", "protocol", "assessment", "(SPA)", "process."], "wordsB": ["The", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "has", "granted", "taliglucerase", "alfa", "a", "Prescription", "Drug", "User", "Fee", "Act", "(PDUFA)", "date", "of", "May", "1,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p132_s5", "idA": "1006281_11_item1_p3_s2", "sentA": "The phase III clinical trial was completed in September 2009 and, on October 15, 2009, we announced positive top-line results from the trial.", "sentB": "In February 2012 we reported full results from the trial.", "type": 2, "words": ["<tag1>", "The", "phase", "III", "clinical", "trial", "was", "completed", "in", "September", "2009", "and,", "on", "October", "15,", "2009,", "we", "announced", "positive", "top-line", "results", "from", "the", "trial.", "<tag2>", "In", "February", "2012", "we", "reported", "full", "results", "from", "the", "trial.", "<tag3>"], "wordsA": ["The", "phase", "III", "clinical", "trial", "was", "completed", "in", "September", "2009", "and,", "on", "October", "15,", "2009,", "we", "announced", "positive", "top-line", "results", "from", "the", "trial."], "wordsB": ["In", "February", "2012", "we", "reported", "full", "results", "from", "the", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p88_s3", "idA": "1006281_11_item1_p3_s2", "sentA": "The phase III clinical trial was completed in September 2009 and, on October 15, 2009, we announced positive top-line results from the trial.", "sentB": "In August 2011, we announced top-line results from the switch-over trial.", "type": 2, "words": ["<tag1>", "The", "phase", "III", "clinical", "trial", "was", "completed", "in", "September", "2009", "and,", "on", "October", "15,", "2009,", "we", "announced", "positive", "top-line", "results", "from", "the", "trial.", "<tag2>", "In", "August", "2011,", "we", "announced", "top-line", "results", "from", "the", "switch-over", "trial.", "<tag3>"], "wordsA": ["The", "phase", "III", "clinical", "trial", "was", "completed", "in", "September", "2009", "and,", "on", "October", "15,", "2009,", "we", "announced", "positive", "top-line", "results", "from", "the", "trial."], "wordsB": ["In", "August", "2011,", "we", "announced", "top-line", "results", "from", "the", "switch-over", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p4_s1", "idA": "1006281_11_item1_p3_s3", "sentA": "On December 9, 2009, we filed our New Drug Application (NDA) for taliglucerase alfa, and in January 2010 the FDA requested additional data regarding the Chemistry, Manufacturing and Controls (CMC) section of our NDA.", "sentB": "We first filed a New Drug Application, or NDA, for taliglucerase alfa with the FDA on December 9, 2009, and on February 25, 2011, the FDA issued a complete response letter, or CRL, indicating that the FDA's review was complete but questions remain that preclude the approval of the NDA in its then-current form.", "type": 2, "words": ["<tag1>", "On", "December", "9,", "2009,", "we", "filed", "our", "New", "Drug", "Application", "(NDA)", "for", "taliglucerase", "alfa,", "and", "in", "January", "2010", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "our", "NDA.", "<tag2>", "We", "first", "filed", "a", "New", "Drug", "Application,", "or", "NDA,", "for", "taliglucerase", "alfa", "with", "the", "FDA", "on", "December", "9,", "2009,", "and", "on", "February", "25,", "2011,", "the", "FDA", "issued", "a", "complete", "response", "letter,", "or", "CRL,", "indicating", "that", "the", "FDA's", "review", "was", "complete", "but", "questions", "remain", "that", "preclude", "the", "approval", "of", "the", "NDA", "in", "its", "then-current", "form.", "<tag3>"], "wordsA": ["On", "December", "9,", "2009,", "we", "filed", "our", "New", "Drug", "Application", "(NDA)", "for", "taliglucerase", "alfa,", "and", "in", "January", "2010", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "our", "NDA."], "wordsB": ["We", "first", "filed", "a", "New", "Drug", "Application,", "or", "NDA,", "for", "taliglucerase", "alfa", "with", "the", "FDA", "on", "December", "9,", "2009,", "and", "on", "February", "25,", "2011,", "the", "FDA", "issued", "a", "complete", "response", "letter,", "or", "CRL,", "indicating", "that", "the", "FDA's", "review", "was", "complete", "but", "questions", "remain", "that", "preclude", "the", "approval", "of", "the", "NDA", "in", "its", "then-current", "form."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p46_s1", "idA": "1006281_11_item1_p42_s0", "sentA": "manufacturing processes in order to address these potential hazards, thereby increasing the cost and time demands of such expression systems.", "sentB": "The FDA and other regulatory authorities require viral inactivation and other rigorous and detailed procedures for mammalian cell-based manufacturing processes in order to address these potential hazards, thereby increasing the cost and time demands of such expression systems.", "type": 2, "words": ["<tag1>", "manufacturing", "processes", "in", "order", "to", "address", "these", "potential", "hazards,", "thereby", "increasing", "the", "cost", "and", "time", "demands", "of", "such", "expression", "systems.", "<tag2>", "The", "FDA", "and", "other", "regulatory", "authorities", "require", "viral", "inactivation", "and", "other", "rigorous", "and", "detailed", "procedures", "for", "mammalian", "cell-based", "manufacturing", "processes", "in", "order", "to", "address", "these", "potential", "hazards,", "thereby", "increasing", "the", "cost", "and", "time", "demands", "of", "such", "expression", "systems.", "<tag3>"], "wordsA": ["manufacturing", "processes", "in", "order", "to", "address", "these", "potential", "hazards,", "thereby", "increasing", "the", "cost", "and", "time", "demands", "of", "such", "expression", "systems."], "wordsB": ["The", "FDA", "and", "other", "regulatory", "authorities", "require", "viral", "inactivation", "and", "other", "rigorous", "and", "detailed", "procedures", "for", "mammalian", "cell-based", "manufacturing", "processes", "in", "order", "to", "address", "these", "potential", "hazards,", "thereby", "increasing", "the", "cost", "and", "time", "demands", "of", "such", "expression", "systems."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p48_s0", "idA": "1006281_11_item1_p44_s0", "sentA": "ProCellEx is our proprietary production system that we have developed based on our plant cell culture technology for the development, expression and manufacture of recombinant proteins.", "sentB": "ProCellEx is our proprietary production system.", "type": 2, "words": ["<tag1>", "ProCellEx", "is", "our", "proprietary", "production", "system", "that", "we", "have", "developed", "based", "on", "our", "plant", "cell", "culture", "technology", "for", "the", "development,", "expression", "and", "manufacture", "of", "recombinant", "proteins.", "<tag2>", "ProCellEx", "is", "our", "proprietary", "production", "system.", "<tag3>"], "wordsA": ["ProCellEx", "is", "our", "proprietary", "production", "system", "that", "we", "have", "developed", "based", "on", "our", "plant", "cell", "culture", "technology", "for", "the", "development,", "expression", "and", "manufacture", "of", "recombinant", "proteins."], "wordsB": ["ProCellEx", "is", "our", "proprietary", "production", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p48_s1", "idA": "1006281_11_item1_p44_s0", "sentA": "ProCellEx is our proprietary production system that we have developed based on our plant cell culture technology for the development, expression and manufacture of recombinant proteins.", "sentB": "We have developed ProCellEx based on our plant cell culture technology for the development, expression and manufacture of recombinant proteins.", "type": 2, "words": ["<tag1>", "ProCellEx", "is", "our", "proprietary", "production", "system", "that", "we", "have", "developed", "based", "on", "our", "plant", "cell", "culture", "technology", "for", "the", "development,", "expression", "and", "manufacture", "of", "recombinant", "proteins.", "<tag2>", "We", "have", "developed", "ProCellEx", "based", "on", "our", "plant", "cell", "culture", "technology", "for", "the", "development,", "expression", "and", "manufacture", "of", "recombinant", "proteins.", "<tag3>"], "wordsA": ["ProCellEx", "is", "our", "proprietary", "production", "system", "that", "we", "have", "developed", "based", "on", "our", "plant", "cell", "culture", "technology", "for", "the", "development,", "expression", "and", "manufacture", "of", "recombinant", "proteins."], "wordsB": ["We", "have", "developed", "ProCellEx", "based", "on", "our", "plant", "cell", "culture", "technology", "for", "the", "development,", "expression", "and", "manufacture", "of", "recombinant", "proteins."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p173_s1", "idA": "1006281_11_item1_p45_s2", "sentA": "Our bioreactors are well-suited for plant cell growth using a simple, inexpensive, chemically-defined growth medium as a catalyst for growth.", "sentB": "The plant cell itself serves as a delivery vehicle to transport the enzyme in active form to the bloodstream.", "type": 2, "words": ["<tag1>", "Our", "bioreactors", "are", "well-suited", "for", "plant", "cell", "growth", "using", "a", "simple,", "inexpensive,", "chemically-defined", "growth", "medium", "as", "a", "catalyst", "for", "growth.", "<tag2>", "The", "plant", "cell", "itself", "serves", "as", "a", "delivery", "vehicle", "to", "transport", "the", "enzyme", "in", "active", "form", "to", "the", "bloodstream.", "<tag3>"], "wordsA": ["Our", "bioreactors", "are", "well-suited", "for", "plant", "cell", "growth", "using", "a", "simple,", "inexpensive,", "chemically-defined", "growth", "medium", "as", "a", "catalyst", "for", "growth."], "wordsB": ["The", "plant", "cell", "itself", "serves", "as", "a", "delivery", "vehicle", "to", "transport", "the", "enzyme", "in", "active", "form", "to", "the", "bloodstream."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p51_s2", "idA": "1006281_11_item1_p47_s2", "sentA": "In collaboration with Israel s Weizmann Institute of Science, we have demonstrated that the three-dimensional structure of a protein expressed in our proprietary plant cell-based expression system retains the same three-dimensional structure as exhibited by the mammalian cell-based expressed version of the same protein.", "sentB": "In collaboration with the Weizmann Institute of Science, we have demonstrated that the three-dimensional structure of a protein expressed in our proprietary plant cell-based expression system retains the same three-dimensional structure as exhibited by the mammalian cell-based expressed version of the same protein.", "type": 2, "words": ["<tag1>", "In", "collaboration", "with", "Israel", "s", "Weizmann", "Institute", "of", "Science,", "we", "have", "demonstrated", "that", "the", "three-dimensional", "structure", "of", "a", "protein", "expressed", "in", "our", "proprietary", "plant", "cell-based", "expression", "system", "retains", "the", "same", "three-dimensional", "structure", "as", "exhibited", "by", "the", "mammalian", "cell-based", "expressed", "version", "of", "the", "same", "protein.", "<tag2>", "In", "collaboration", "with", "the", "Weizmann", "Institute", "of", "Science,", "we", "have", "demonstrated", "that", "the", "three-dimensional", "structure", "of", "a", "protein", "expressed", "in", "our", "proprietary", "plant", "cell-based", "expression", "system", "retains", "the", "same", "three-dimensional", "structure", "as", "exhibited", "by", "the", "mammalian", "cell-based", "expressed", "version", "of", "the", "same", "protein.", "<tag3>"], "wordsA": ["In", "collaboration", "with", "Israel", "s", "Weizmann", "Institute", "of", "Science,", "we", "have", "demonstrated", "that", "the", "three-dimensional", "structure", "of", "a", "protein", "expressed", "in", "our", "proprietary", "plant", "cell-based", "expression", "system", "retains", "the", "same", "three-dimensional", "structure", "as", "exhibited", "by", "the", "mammalian", "cell-based", "expressed", "version", "of", "the", "same", "protein."], "wordsB": ["In", "collaboration", "with", "the", "Weizmann", "Institute", "of", "Science,", "we", "have", "demonstrated", "that", "the", "three-dimensional", "structure", "of", "a", "protein", "expressed", "in", "our", "proprietary", "plant", "cell-based", "expression", "system", "retains", "the", "same", "three-dimensional", "structure", "as", "exhibited", "by", "the", "mammalian", "cell-based", "expressed", "version", "of", "the", "same", "protein."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p6_s0", "idA": "1006281_11_item1_p4_s0", "sentA": "and a Marketing Authorization Application (MAA) to each of the European Medicines Agency, or the EMEA, and ANVISA, the National Sanitary Vigilance Agency, an agency of the Brazilian Ministry of Health, or the ANVISA, for taliglucerase alfa for the treatment of Gaucher disease.", "sentB": "In the fourth quarter of 2010, Pfizer, our commercialization partner, filed, with our cooperation, a Marketing Authorization Application, or MAA, for taliglucerase alfa with the European Medicines Agency, or EMA.", "type": 2, "words": ["<tag1>", "and", "a", "Marketing", "Authorization", "Application", "(MAA)", "to", "each", "of", "the", "European", "Medicines", "Agency,", "or", "the", "EMEA,", "and", "ANVISA,", "the", "National", "Sanitary", "Vigilance", "Agency,", "an", "agency", "of", "the", "Brazilian", "Ministry", "of", "Health,", "or", "the", "ANVISA,", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "In", "the", "fourth", "quarter", "of", "2010,", "Pfizer,", "our", "commercialization", "partner,", "filed,", "with", "our", "cooperation,", "a", "Marketing", "Authorization", "Application,", "or", "MAA,", "for", "taliglucerase", "alfa", "with", "the", "European", "Medicines", "Agency,", "or", "EMA.", "<tag3>"], "wordsA": ["and", "a", "Marketing", "Authorization", "Application", "(MAA)", "to", "each", "of", "the", "European", "Medicines", "Agency,", "or", "the", "EMEA,", "and", "ANVISA,", "the", "National", "Sanitary", "Vigilance", "Agency,", "an", "agency", "of", "the", "Brazilian", "Ministry", "of", "Health,", "or", "the", "ANVISA,", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["In", "the", "fourth", "quarter", "of", "2010,", "Pfizer,", "our", "commercialization", "partner,", "filed,", "with", "our", "cooperation,", "a", "Marketing", "Authorization", "Application,", "or", "MAA,", "for", "taliglucerase", "alfa", "with", "the", "European", "Medicines", "Agency,", "or", "EMA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p9_s0", "idA": "1006281_11_item1_p4_s0", "sentA": "and a Marketing Authorization Application (MAA) to each of the European Medicines Agency, or the EMEA, and ANVISA, the National Sanitary Vigilance Agency, an agency of the Brazilian Ministry of Health, or the ANVISA, for taliglucerase alfa for the treatment of Gaucher disease.", "sentB": "In addition, marketing applications have been submitted for taliglucerase alfa with each of the Israeli Ministry of Health, or Israeli MOH, the National Sanitary Vigilance Agency, or ANVISA, an agency of the Ministry of Health of Brazil, and the Australian Therapeutic Goods Administration, or Australian TGA.", "type": 2, "words": ["<tag1>", "and", "a", "Marketing", "Authorization", "Application", "(MAA)", "to", "each", "of", "the", "European", "Medicines", "Agency,", "or", "the", "EMEA,", "and", "ANVISA,", "the", "National", "Sanitary", "Vigilance", "Agency,", "an", "agency", "of", "the", "Brazilian", "Ministry", "of", "Health,", "or", "the", "ANVISA,", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "In", "addition,", "marketing", "applications", "have", "been", "submitted", "for", "taliglucerase", "alfa", "with", "each", "of", "the", "Israeli", "Ministry", "of", "Health,", "or", "Israeli", "MOH,", "the", "National", "Sanitary", "Vigilance", "Agency,", "or", "ANVISA,", "an", "agency", "of", "the", "Ministry", "of", "Health", "of", "Brazil,", "and", "the", "Australian", "Therapeutic", "Goods", "Administration,", "or", "Australian", "TGA.", "<tag3>"], "wordsA": ["and", "a", "Marketing", "Authorization", "Application", "(MAA)", "to", "each", "of", "the", "European", "Medicines", "Agency,", "or", "the", "EMEA,", "and", "ANVISA,", "the", "National", "Sanitary", "Vigilance", "Agency,", "an", "agency", "of", "the", "Brazilian", "Ministry", "of", "Health,", "or", "the", "ANVISA,", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["In", "addition,", "marketing", "applications", "have", "been", "submitted", "for", "taliglucerase", "alfa", "with", "each", "of", "the", "Israeli", "Ministry", "of", "Health,", "or", "Israeli", "MOH,", "the", "National", "Sanitary", "Vigilance", "Agency,", "or", "ANVISA,", "an", "agency", "of", "the", "Ministry", "of", "Health", "of", "Brazil,", "and", "the", "Australian", "Therapeutic", "Goods", "Administration,", "or", "Australian", "TGA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p55_s0", "idA": "1006281_11_item1_p50_s0", "sentA": "sale are not protected by patents that cover the compound and are available for use in the public domain.", "sentB": "Certain biotherapeutic proteins available for commercial sale are not protected by patents that cover the compound and are available for use in the public domain.", "type": 2, "words": ["<tag1>", "sale", "are", "not", "protected", "by", "patents", "that", "cover", "the", "compound", "and", "are", "available", "for", "use", "in", "the", "public", "domain.", "<tag2>", "Certain", "biotherapeutic", "proteins", "available", "for", "commercial", "sale", "are", "not", "protected", "by", "patents", "that", "cover", "the", "compound", "and", "are", "available", "for", "use", "in", "the", "public", "domain.", "<tag3>"], "wordsA": ["sale", "are", "not", "protected", "by", "patents", "that", "cover", "the", "compound", "and", "are", "available", "for", "use", "in", "the", "public", "domain."], "wordsB": ["Certain", "biotherapeutic", "proteins", "available", "for", "commercial", "sale", "are", "not", "protected", "by", "patents", "that", "cover", "the", "compound", "and", "are", "available", "for", "use", "in", "the", "public", "domain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p173_s0", "idA": "1006281_11_item1_p52_s0", "sentA": "Plant cells have a number of dynamic qualities that make them well-suited for the production of therapeutic proteins.", "sentB": "Plant cells have the unique attribute of a cellulose cell wall which makes them resistant to enzyme degradation when passing through the digestive tract.", "type": 2, "words": ["<tag1>", "Plant", "cells", "have", "a", "number", "of", "dynamic", "qualities", "that", "make", "them", "well-suited", "for", "the", "production", "of", "therapeutic", "proteins.", "<tag2>", "Plant", "cells", "have", "the", "unique", "attribute", "of", "a", "cellulose", "cell", "wall", "which", "makes", "them", "resistant", "to", "enzyme", "degradation", "when", "passing", "through", "the", "digestive", "tract.", "<tag3>"], "wordsA": ["Plant", "cells", "have", "a", "number", "of", "dynamic", "qualities", "that", "make", "them", "well-suited", "for", "the", "production", "of", "therapeutic", "proteins."], "wordsB": ["Plant", "cells", "have", "the", "unique", "attribute", "of", "a", "cellulose", "cell", "wall", "which", "makes", "them", "resistant", "to", "enzyme", "degradation", "when", "passing", "through", "the", "digestive", "tract."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p58_s4", "idA": "1006281_11_item1_p53_s4", "sentA": "In addition, the production process of our ProCellEx protein expression system is void of any mammalian components which are susceptible to the transmission of prions, such as those related to bovine spongiform encephalopathy (commonly known as mad-cow disease ).", "sentB": "In addition, t he production process of our ProCellEx protein expression system is void of any mammalian components which are susceptible to the transmission of prions, such as those related to bovine spongiform encephalopathy (commonly known as mad-cow disease ).", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "production", "process", "of", "our", "ProCellEx", "protein", "expression", "system", "is", "void", "of", "any", "mammalian", "components", "which", "are", "susceptible", "to", "the", "transmission", "of", "prions,", "such", "as", "those", "related", "to", "bovine", "spongiform", "encephalopathy", "(commonly", "known", "as", "mad-cow", "disease", ").", "<tag2>", "In", "addition,", "t", "he", "production", "process", "of", "our", "ProCellEx", "protein", "expression", "system", "is", "void", "of", "any", "mammalian", "components", "which", "are", "susceptible", "to", "the", "transmission", "of", "prions,", "such", "as", "those", "related", "to", "bovine", "spongiform", "encephalopathy", "(commonly", "known", "as", "mad-cow", "disease", ").", "<tag3>"], "wordsA": ["In", "addition,", "the", "production", "process", "of", "our", "ProCellEx", "protein", "expression", "system", "is", "void", "of", "any", "mammalian", "components", "which", "are", "susceptible", "to", "the", "transmission", "of", "prions,", "such", "as", "those", "related", "to", "bovine", "spongiform", "encephalopathy", "(commonly", "known", "as", "mad-cow", "disease", ")."], "wordsB": ["In", "addition,", "t", "he", "production", "process", "of", "our", "ProCellEx", "protein", "expression", "system", "is", "void", "of", "any", "mammalian", "components", "which", "are", "susceptible", "to", "the", "transmission", "of", "prions,", "such", "as", "those", "related", "to", "bovine", "spongiform", "encephalopathy", "(commonly", "known", "as", "mad-cow", "disease", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p61_s0", "idA": "1006281_11_item1_p56_s0", "sentA": "Unlike bacterial and yeast cell-based systems, which are unable to produce complex proteins, our ProCellEx protein expression system is able to produce a broad array of complex glycosilated proteins.", "sentB": "Our ProCellEx protein expression system is able to produce a broad array of complex glycosilated proteins, which differentiates our system from bacterial and yeast cell-based systems which are unable to produce complex proteins.", "type": 2, "words": ["<tag1>", "Unlike", "bacterial", "and", "yeast", "cell-based", "systems,", "which", "are", "unable", "to", "produce", "complex", "proteins,", "our", "ProCellEx", "protein", "expression", "system", "is", "able", "to", "produce", "a", "broad", "array", "of", "complex", "glycosilated", "proteins.", "<tag2>", "Our", "ProCellEx", "protein", "expression", "system", "is", "able", "to", "produce", "a", "broad", "array", "of", "complex", "glycosilated", "proteins,", "which", "differentiates", "our", "system", "from", "bacterial", "and", "yeast", "cell-based", "systems", "which", "are", "unable", "to", "produce", "complex", "proteins.", "<tag3>"], "wordsA": ["Unlike", "bacterial", "and", "yeast", "cell-based", "systems,", "which", "are", "unable", "to", "produce", "complex", "proteins,", "our", "ProCellEx", "protein", "expression", "system", "is", "able", "to", "produce", "a", "broad", "array", "of", "complex", "glycosilated", "proteins."], "wordsB": ["Our", "ProCellEx", "protein", "expression", "system", "is", "able", "to", "produce", "a", "broad", "array", "of", "complex", "glycosilated", "proteins,", "which", "differentiates", "our", "system", "from", "bacterial", "and", "yeast", "cell-based", "systems", "which", "are", "unable", "to", "produce", "complex", "proteins."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p0_s0", "idA": "1006281_11_item1_p57_s0", "sentA": "Our goal is to become a leading fully integrated biopharmaceutical company focused on the development and commercialization of proprietary and biosimilar or generic versions of recombinant therapeutic proteins.", "sentB": "We are a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on our proprietary ProCellEx protein expression system, or ProCellEx.", "type": 2, "words": ["<tag1>", "Our", "goal", "is", "to", "become", "a", "leading", "fully", "integrated", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "proprietary", "and", "biosimilar", "or", "generic", "versions", "of", "recombinant", "therapeutic", "proteins.", "<tag2>", "We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "proprietary", "ProCellEx", "protein", "expression", "system,", "or", "ProCellEx.", "<tag3>"], "wordsA": ["Our", "goal", "is", "to", "become", "a", "leading", "fully", "integrated", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "proprietary", "and", "biosimilar", "or", "generic", "versions", "of", "recombinant", "therapeutic", "proteins."], "wordsB": ["We", "are", "a", "biopharmaceutical", "company", "focused", "on", "the", "development", "and", "commercialization", "of", "recombinant", "therapeutic", "proteins", "based", "on", "our", "proprietary", "ProCellEx", "protein", "expression", "system,", "or", "ProCellEx."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p63_s2", "idA": "1006281_11_item1_p58_s2", "sentA": "We have begun collaborating with Pfizer to facilitate the transition of certain of our taliglucerase alfa assets to Pfizer s organization.", "sentB": "We have been collaborating with Pfizer to facilitate the transition of certain of our taliglucerase alfa assets to Pfizer s organization.", "type": 2, "words": ["<tag1>", "We", "have", "begun", "collaborating", "with", "Pfizer", "to", "facilitate", "the", "transition", "of", "certain", "of", "our", "taliglucerase", "alfa", "assets", "to", "Pfizer", "s", "organization.", "<tag2>", "We", "have", "been", "collaborating", "with", "Pfizer", "to", "facilitate", "the", "transition", "of", "certain", "of", "our", "taliglucerase", "alfa", "assets", "to", "Pfizer", "s", "organization.", "<tag3>"], "wordsA": ["We", "have", "begun", "collaborating", "with", "Pfizer", "to", "facilitate", "the", "transition", "of", "certain", "of", "our", "taliglucerase", "alfa", "assets", "to", "Pfizer", "s", "organization."], "wordsB": ["We", "have", "been", "collaborating", "with", "Pfizer", "to", "facilitate", "the", "transition", "of", "certain", "of", "our", "taliglucerase", "alfa", "assets", "to", "Pfizer", "s", "organization."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p63_s7", "idA": "1006281_11_item1_p58_s6", "sentA": "We intend to actively participate and provide our expertise in Pfizer s development and commercialization efforts with respect to taligluerase alfa.", "sentB": "We intend to actively participate and provide our expertise in Pfizer s development and commercialization efforts with respect to taliglucerase alfa.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "actively", "participate", "and", "provide", "our", "expertise", "in", "Pfizer", "s", "development", "and", "commercialization", "efforts", "with", "respect", "to", "taligluerase", "alfa.", "<tag2>", "We", "intend", "to", "actively", "participate", "and", "provide", "our", "expertise", "in", "Pfizer", "s", "development", "and", "commercialization", "efforts", "with", "respect", "to", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["We", "intend", "to", "actively", "participate", "and", "provide", "our", "expertise", "in", "Pfizer", "s", "development", "and", "commercialization", "efforts", "with", "respect", "to", "taligluerase", "alfa."], "wordsB": ["We", "intend", "to", "actively", "participate", "and", "provide", "our", "expertise", "in", "Pfizer", "s", "development", "and", "commercialization", "efforts", "with", "respect", "to", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p64_s2", "idA": "1006281_11_item1_p59_s2", "sentA": "We filed an NDA with the FDA in December 2009 and in January 2010, the FDA requested additional data regarding the Chemistry, Manufacturing and Controls (CMC) section of the NDA.", "sentB": "We filed an NDA with the FDA in December 2009 and taliglucerase alfa was originally granted a PDUFA date of February 25, 2011.", "type": 2, "words": ["<tag1>", "We", "filed", "an", "NDA", "with", "the", "FDA", "in", "December", "2009", "and", "in", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA.", "<tag2>", "We", "filed", "an", "NDA", "with", "the", "FDA", "in", "December", "2009", "and", "taliglucerase", "alfa", "was", "originally", "granted", "a", "PDUFA", "date", "of", "February", "25,", "2011.", "<tag3>"], "wordsA": ["We", "filed", "an", "NDA", "with", "the", "FDA", "in", "December", "2009", "and", "in", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA."], "wordsB": ["We", "filed", "an", "NDA", "with", "the", "FDA", "in", "December", "2009", "and", "taliglucerase", "alfa", "was", "originally", "granted", "a", "PDUFA", "date", "of", "February", "25,", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p5_s4", "idA": "1006281_11_item1_p59_s3", "sentA": "We provided the requested data to the FDA in April 2010 and in July 2010 we received notification from the FDA that it had accepted the filing of our NDA and assigned it a PDUFA date of February 25, 2011.", "sentB": "In December 2011, the FDA notified us that it had decided to extend the PDUFA date to May 1, 2012.", "type": 2, "words": ["<tag1>", "We", "provided", "the", "requested", "data", "to", "the", "FDA", "in", "April", "2010", "and", "in", "July", "2010", "we", "received", "notification", "from", "the", "FDA", "that", "it", "had", "accepted", "the", "filing", "of", "our", "NDA", "and", "assigned", "it", "a", "PDUFA", "date", "of", "February", "25,", "2011.", "<tag2>", "In", "December", "2011,", "the", "FDA", "notified", "us", "that", "it", "had", "decided", "to", "extend", "the", "PDUFA", "date", "to", "May", "1,", "2012.", "<tag3>"], "wordsA": ["We", "provided", "the", "requested", "data", "to", "the", "FDA", "in", "April", "2010", "and", "in", "July", "2010", "we", "received", "notification", "from", "the", "FDA", "that", "it", "had", "accepted", "the", "filing", "of", "our", "NDA", "and", "assigned", "it", "a", "PDUFA", "date", "of", "February", "25,", "2011."], "wordsB": ["In", "December", "2011,", "the", "FDA", "notified", "us", "that", "it", "had", "decided", "to", "extend", "the", "PDUFA", "date", "to", "May", "1,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p64_s4", "idA": "1006281_11_item1_p59_s3", "sentA": "We provided the requested data to the FDA in April 2010 and in July 2010 we received notification from the FDA that it had accepted the filing of our NDA and assigned it a PDUFA date of February 25, 2011.", "sentB": "In July 2011 we submitted our reply to the CRL and in August 2011, the FDA notified us that it had established February 1, 2012 as the new PDUFA date.", "type": 2, "words": ["<tag1>", "We", "provided", "the", "requested", "data", "to", "the", "FDA", "in", "April", "2010", "and", "in", "July", "2010", "we", "received", "notification", "from", "the", "FDA", "that", "it", "had", "accepted", "the", "filing", "of", "our", "NDA", "and", "assigned", "it", "a", "PDUFA", "date", "of", "February", "25,", "2011.", "<tag2>", "In", "July", "2011", "we", "submitted", "our", "reply", "to", "the", "CRL", "and", "in", "August", "2011,", "the", "FDA", "notified", "us", "that", "it", "had", "established", "February", "1,", "2012", "as", "the", "new", "PDUFA", "date.", "<tag3>"], "wordsA": ["We", "provided", "the", "requested", "data", "to", "the", "FDA", "in", "April", "2010", "and", "in", "July", "2010", "we", "received", "notification", "from", "the", "FDA", "that", "it", "had", "accepted", "the", "filing", "of", "our", "NDA", "and", "assigned", "it", "a", "PDUFA", "date", "of", "February", "25,", "2011."], "wordsB": ["In", "July", "2011", "we", "submitted", "our", "reply", "to", "the", "CRL", "and", "in", "August", "2011,", "the", "FDA", "notified", "us", "that", "it", "had", "established", "February", "1,", "2012", "as", "the", "new", "PDUFA", "date."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p64_s5", "idA": "1006281_11_item1_p59_s3", "sentA": "We provided the requested data to the FDA in April 2010 and in July 2010 we received notification from the FDA that it had accepted the filing of our NDA and assigned it a PDUFA date of February 25, 2011.", "sentB": "In December 2011, the FDA notified us that it had decided to extend the PDUFA date to May 1, 2012.", "type": 2, "words": ["<tag1>", "We", "provided", "the", "requested", "data", "to", "the", "FDA", "in", "April", "2010", "and", "in", "July", "2010", "we", "received", "notification", "from", "the", "FDA", "that", "it", "had", "accepted", "the", "filing", "of", "our", "NDA", "and", "assigned", "it", "a", "PDUFA", "date", "of", "February", "25,", "2011.", "<tag2>", "In", "December", "2011,", "the", "FDA", "notified", "us", "that", "it", "had", "decided", "to", "extend", "the", "PDUFA", "date", "to", "May", "1,", "2012.", "<tag3>"], "wordsA": ["We", "provided", "the", "requested", "data", "to", "the", "FDA", "in", "April", "2010", "and", "in", "July", "2010", "we", "received", "notification", "from", "the", "FDA", "that", "it", "had", "accepted", "the", "filing", "of", "our", "NDA", "and", "assigned", "it", "a", "PDUFA", "date", "of", "February", "25,", "2011."], "wordsB": ["In", "December", "2011,", "the", "FDA", "notified", "us", "that", "it", "had", "decided", "to", "extend", "the", "PDUFA", "date", "to", "May", "1,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p75_s4", "idA": "1006281_11_item1_p59_s3", "sentA": "We provided the requested data to the FDA in April 2010 and in July 2010 we received notification from the FDA that it had accepted the filing of our NDA and assigned it a PDUFA date of February 25, 2011.", "sentB": "In December 2011, the FDA notified us that it had decided to extend the PDUFA date to May 1, 2012.", "type": 2, "words": ["<tag1>", "We", "provided", "the", "requested", "data", "to", "the", "FDA", "in", "April", "2010", "and", "in", "July", "2010", "we", "received", "notification", "from", "the", "FDA", "that", "it", "had", "accepted", "the", "filing", "of", "our", "NDA", "and", "assigned", "it", "a", "PDUFA", "date", "of", "February", "25,", "2011.", "<tag2>", "In", "December", "2011,", "the", "FDA", "notified", "us", "that", "it", "had", "decided", "to", "extend", "the", "PDUFA", "date", "to", "May", "1,", "2012.", "<tag3>"], "wordsA": ["We", "provided", "the", "requested", "data", "to", "the", "FDA", "in", "April", "2010", "and", "in", "July", "2010", "we", "received", "notification", "from", "the", "FDA", "that", "it", "had", "accepted", "the", "filing", "of", "our", "NDA", "and", "assigned", "it", "a", "PDUFA", "date", "of", "February", "25,", "2011."], "wordsB": ["In", "December", "2011,", "the", "FDA", "notified", "us", "that", "it", "had", "decided", "to", "extend", "the", "PDUFA", "date", "to", "May", "1,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p64_s11", "idA": "1006281_11_item1_p59_s4", "sentA": "In addition, in November 2010 we submitted a marketing application to the Israeli MOH, and with our partner Pfizer, an MAA to each of the EMEA and to ANVISA for taliglucerase alfa.", "sentB": "In addition, in November 2010 we submitted a marketing application to the Israeli MOH, and with our partner Pfizer, an MAA to each of the EMA, ANVISA and the Australian TGA for taliglucerase alfa.", "type": 2, "words": ["<tag1>", "In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH,", "and", "with", "our", "partner", "Pfizer,", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "to", "ANVISA", "for", "taliglucerase", "alfa.", "<tag2>", "In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH,", "and", "with", "our", "partner", "Pfizer,", "an", "MAA", "to", "each", "of", "the", "EMA,", "ANVISA", "and", "the", "Australian", "TGA", "for", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH,", "and", "with", "our", "partner", "Pfizer,", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "to", "ANVISA", "for", "taliglucerase", "alfa."], "wordsB": ["In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH,", "and", "with", "our", "partner", "Pfizer,", "an", "MAA", "to", "each", "of", "the", "EMA,", "ANVISA", "and", "the", "Australian", "TGA", "for", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p80_s0", "idA": "1006281_11_item1_p59_s4", "sentA": "In addition, in November 2010 we submitted a marketing application to the Israeli MOH, and with our partner Pfizer, an MAA to each of the EMEA and to ANVISA for taliglucerase alfa.", "sentB": "In addition, marketing applications for taliglucerase alfa have been submitted with each of the Israeli MOH, ANVISA and the Australian TGA.", "type": 2, "words": ["<tag1>", "In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH,", "and", "with", "our", "partner", "Pfizer,", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "to", "ANVISA", "for", "taliglucerase", "alfa.", "<tag2>", "In", "addition,", "marketing", "applications", "for", "taliglucerase", "alfa", "have", "been", "submitted", "with", "each", "of", "the", "Israeli", "MOH,", "ANVISA", "and", "the", "Australian", "TGA.", "<tag3>"], "wordsA": ["In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH,", "and", "with", "our", "partner", "Pfizer,", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "to", "ANVISA", "for", "taliglucerase", "alfa."], "wordsB": ["In", "addition,", "marketing", "applications", "for", "taliglucerase", "alfa", "have", "been", "submitted", "with", "each", "of", "the", "Israeli", "MOH,", "ANVISA", "and", "the", "Australian", "TGA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p10_s0", "idA": "1006281_11_item1_p5_s0", "sentA": "In February 2010, the Israeli MOH completed a successful good manufacturing practices (GMP) audit of our manufacturing facilities in Carmiel, Israel.", "sentB": "In February 2010, the Israeli MOH completed a successful GMP audit of our manufacturing facilities in Carmiel, Israel.", "type": 2, "words": ["<tag1>", "In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "good", "manufacturing", "practices", "(GMP)", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel.", "<tag2>", "In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "GMP", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel.", "<tag3>"], "wordsA": ["In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "good", "manufacturing", "practices", "(GMP)", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel."], "wordsB": ["In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "GMP", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p11_s1", "idA": "1006281_11_item1_p5_s0", "sentA": "In February 2010, the Israeli MOH completed a successful good manufacturing practices (GMP) audit of our manufacturing facilities in Carmiel, Israel.", "sentB": "In June 2011, ANVISA completed a successful GMP audit of the facility and determined that the facility is acceptable.", "type": 2, "words": ["<tag1>", "In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "good", "manufacturing", "practices", "(GMP)", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel.", "<tag2>", "In", "June", "2011,", "ANVISA", "completed", "a", "successful", "GMP", "audit", "of", "the", "facility", "and", "determined", "that", "the", "facility", "is", "acceptable.", "<tag3>"], "wordsA": ["In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "good", "manufacturing", "practices", "(GMP)", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel."], "wordsB": ["In", "June", "2011,", "ANVISA", "completed", "a", "successful", "GMP", "audit", "of", "the", "facility", "and", "determined", "that", "the", "facility", "is", "acceptable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p207_s0", "idA": "1006281_11_item1_p5_s0", "sentA": "In February 2010, the Israeli MOH completed a successful good manufacturing practices (GMP) audit of our manufacturing facilities in Carmiel, Israel.", "sentB": "In February 2010, the Israeli MOH completed a successful GMP audit of our manufacturing facilities in Carmiel, Israel.", "type": 2, "words": ["<tag1>", "In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "good", "manufacturing", "practices", "(GMP)", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel.", "<tag2>", "In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "GMP", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel.", "<tag3>"], "wordsA": ["In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "good", "manufacturing", "practices", "(GMP)", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel."], "wordsB": ["In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "GMP", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p208_s1", "idA": "1006281_11_item1_p5_s0", "sentA": "In February 2010, the Israeli MOH completed a successful good manufacturing practices (GMP) audit of our manufacturing facilities in Carmiel, Israel.", "sentB": "In June 2011, ANVISA completed a successful GMP audit of the facility and determined that the facility is acceptable.", "type": 2, "words": ["<tag1>", "In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "good", "manufacturing", "practices", "(GMP)", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel.", "<tag2>", "In", "June", "2011,", "ANVISA", "completed", "a", "successful", "GMP", "audit", "of", "the", "facility", "and", "determined", "that", "the", "facility", "is", "acceptable.", "<tag3>"], "wordsA": ["In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "good", "manufacturing", "practices", "(GMP)", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel."], "wordsB": ["In", "June", "2011,", "ANVISA", "completed", "a", "successful", "GMP", "audit", "of", "the", "facility", "and", "determined", "that", "the", "facility", "is", "acceptable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p208_s2", "idA": "1006281_11_item1_p5_s0", "sentA": "In February 2010, the Israeli MOH completed a successful good manufacturing practices (GMP) audit of our manufacturing facilities in Carmiel, Israel.", "sentB": "In December 2011, after the taliglucerase alfa NDA was filed with the EMA, the IMB completed a successful GMP audit of our facility and issued a Certificate of GMP Compliance of a Manufacturer for the facility.", "type": 2, "words": ["<tag1>", "In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "good", "manufacturing", "practices", "(GMP)", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel.", "<tag2>", "In", "December", "2011,", "after", "the", "taliglucerase", "alfa", "NDA", "was", "filed", "with", "the", "EMA,", "the", "IMB", "completed", "a", "successful", "GMP", "audit", "of", "our", "facility", "and", "issued", "a", "Certificate", "of", "GMP", "Compliance", "of", "a", "Manufacturer", "for", "the", "facility.", "<tag3>"], "wordsA": ["In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "good", "manufacturing", "practices", "(GMP)", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel."], "wordsB": ["In", "December", "2011,", "after", "the", "taliglucerase", "alfa", "NDA", "was", "filed", "with", "the", "EMA,", "the", "IMB", "completed", "a", "successful", "GMP", "audit", "of", "our", "facility", "and", "issued", "a", "Certificate", "of", "GMP", "Compliance", "of", "a", "Manufacturer", "for", "the", "facility."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p86_s0", "idA": "1006281_11_item1_p5_s0", "sentA": "In February 2010, the Israeli MOH completed a successful good manufacturing practices (GMP) audit of our manufacturing facilities in Carmiel, Israel.", "sentB": "In February 2010, the Israeli MOH completed a successful good manufacturing practices, or GMP, audit of our manufacturing facilities in Carmiel, Israel.", "type": 2, "words": ["<tag1>", "In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "good", "manufacturing", "practices", "(GMP)", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel.", "<tag2>", "In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "good", "manufacturing", "practices,", "or", "GMP,", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel.", "<tag3>"], "wordsA": ["In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "good", "manufacturing", "practices", "(GMP)", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel."], "wordsB": ["In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "good", "manufacturing", "practices,", "or", "GMP,", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p87_s1", "idA": "1006281_11_item1_p5_s0", "sentA": "In February 2010, the Israeli MOH completed a successful good manufacturing practices (GMP) audit of our manufacturing facilities in Carmiel, Israel.", "sentB": "In June 2011, ANVISA completed a successful GMP audit of the facility and determined that the facility is acceptable and in December 2011, the Irish Medicines Board, or IMB, completed a successful GMP audit of our facility and issued a Certificate of GMP Compliance of a Manufacturer for the facility.", "type": 2, "words": ["<tag1>", "In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "good", "manufacturing", "practices", "(GMP)", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel.", "<tag2>", "In", "June", "2011,", "ANVISA", "completed", "a", "successful", "GMP", "audit", "of", "the", "facility", "and", "determined", "that", "the", "facility", "is", "acceptable", "and", "in", "December", "2011,", "the", "Irish", "Medicines", "Board,", "or", "IMB,", "completed", "a", "successful", "GMP", "audit", "of", "our", "facility", "and", "issued", "a", "Certificate", "of", "GMP", "Compliance", "of", "a", "Manufacturer", "for", "the", "facility.", "<tag3>"], "wordsA": ["In", "February", "2010,", "the", "Israeli", "MOH", "completed", "a", "successful", "good", "manufacturing", "practices", "(GMP)", "audit", "of", "our", "manufacturing", "facilities", "in", "Carmiel,", "Israel."], "wordsB": ["In", "June", "2011,", "ANVISA", "completed", "a", "successful", "GMP", "audit", "of", "the", "facility", "and", "determined", "that", "the", "facility", "is", "acceptable", "and", "in", "December", "2011,", "the", "Irish", "Medicines", "Board,", "or", "IMB,", "completed", "a", "successful", "GMP", "audit", "of", "our", "facility", "and", "issued", "a", "Certificate", "of", "GMP", "Compliance", "of", "a", "Manufacturer", "for", "the", "facility."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p52_s0", "idA": "1006281_11_item1_p5_s1", "sentA": "The audit was performed as part of the Israeli MOH s evaluation of our manufacturing process for taliglucerase alfa.", "sentB": "To date, our manufacturing facility, which uses our ProCellEx system, was determined to be acceptable by each of the FDA, EMA, ANVISA and the Israeli MOH after GMP inspections performed as part of their respective reviews for marketing approval of taliglucerase alfa.", "type": 2, "words": ["<tag1>", "The", "audit", "was", "performed", "as", "part", "of", "the", "Israeli", "MOH", "s", "evaluation", "of", "our", "manufacturing", "process", "for", "taliglucerase", "alfa.", "<tag2>", "To", "date,", "our", "manufacturing", "facility,", "which", "uses", "our", "ProCellEx", "system,", "was", "determined", "to", "be", "acceptable", "by", "each", "of", "the", "FDA,", "EMA,", "ANVISA", "and", "the", "Israeli", "MOH", "after", "GMP", "inspections", "performed", "as", "part", "of", "their", "respective", "reviews", "for", "marketing", "approval", "of", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["The", "audit", "was", "performed", "as", "part", "of", "the", "Israeli", "MOH", "s", "evaluation", "of", "our", "manufacturing", "process", "for", "taliglucerase", "alfa."], "wordsB": ["To", "date,", "our", "manufacturing", "facility,", "which", "uses", "our", "ProCellEx", "system,", "was", "determined", "to", "be", "acceptable", "by", "each", "of", "the", "FDA,", "EMA,", "ANVISA", "and", "the", "Israeli", "MOH", "after", "GMP", "inspections", "performed", "as", "part", "of", "their", "respective", "reviews", "for", "marketing", "approval", "of", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p6_s1", "idA": "1006281_11_item1_p5_s1", "sentA": "The audit was performed as part of the Israeli MOH s evaluation of our manufacturing process for taliglucerase alfa.", "sentB": "As part of its ongoing review of the MAA, the EMA delivered a list of outstanding points to be addressed by the applicant.", "type": 2, "words": ["<tag1>", "The", "audit", "was", "performed", "as", "part", "of", "the", "Israeli", "MOH", "s", "evaluation", "of", "our", "manufacturing", "process", "for", "taliglucerase", "alfa.", "<tag2>", "As", "part", "of", "its", "ongoing", "review", "of", "the", "MAA,", "the", "EMA", "delivered", "a", "list", "of", "outstanding", "points", "to", "be", "addressed", "by", "the", "applicant.", "<tag3>"], "wordsA": ["The", "audit", "was", "performed", "as", "part", "of", "the", "Israeli", "MOH", "s", "evaluation", "of", "our", "manufacturing", "process", "for", "taliglucerase", "alfa."], "wordsB": ["As", "part", "of", "its", "ongoing", "review", "of", "the", "MAA,", "the", "EMA", "delivered", "a", "list", "of", "outstanding", "points", "to", "be", "addressed", "by", "the", "applicant."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p77_s0", "idA": "1006281_11_item1_p5_s1", "sentA": "The audit was performed as part of the Israeli MOH s evaluation of our manufacturing process for taliglucerase alfa.", "sentB": "As part of its ongoing review of the MAA, the EMA delivered a list of outstanding points to be addressed by the applicant.", "type": 2, "words": ["<tag1>", "The", "audit", "was", "performed", "as", "part", "of", "the", "Israeli", "MOH", "s", "evaluation", "of", "our", "manufacturing", "process", "for", "taliglucerase", "alfa.", "<tag2>", "As", "part", "of", "its", "ongoing", "review", "of", "the", "MAA,", "the", "EMA", "delivered", "a", "list", "of", "outstanding", "points", "to", "be", "addressed", "by", "the", "applicant.", "<tag3>"], "wordsA": ["The", "audit", "was", "performed", "as", "part", "of", "the", "Israeli", "MOH", "s", "evaluation", "of", "our", "manufacturing", "process", "for", "taliglucerase", "alfa."], "wordsB": ["As", "part", "of", "its", "ongoing", "review", "of", "the", "MAA,", "the", "EMA", "delivered", "a", "list", "of", "outstanding", "points", "to", "be", "addressed", "by", "the", "applicant."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p78_s0", "idA": "1006281_11_item1_p5_s1", "sentA": "The audit was performed as part of the Israeli MOH s evaluation of our manufacturing process for taliglucerase alfa.", "sentB": "Following the submission of the taliglucerase alfa MAA to the EMA, a GMP audit of our manufacturing facility was performed and it was found compliant with EMA GMP in December 2011.", "type": 2, "words": ["<tag1>", "The", "audit", "was", "performed", "as", "part", "of", "the", "Israeli", "MOH", "s", "evaluation", "of", "our", "manufacturing", "process", "for", "taliglucerase", "alfa.", "<tag2>", "Following", "the", "submission", "of", "the", "taliglucerase", "alfa", "MAA", "to", "the", "EMA,", "a", "GMP", "audit", "of", "our", "manufacturing", "facility", "was", "performed", "and", "it", "was", "found", "compliant", "with", "EMA", "GMP", "in", "December", "2011.", "<tag3>"], "wordsA": ["The", "audit", "was", "performed", "as", "part", "of", "the", "Israeli", "MOH", "s", "evaluation", "of", "our", "manufacturing", "process", "for", "taliglucerase", "alfa."], "wordsB": ["Following", "the", "submission", "of", "the", "taliglucerase", "alfa", "MAA", "to", "the", "EMA,", "a", "GMP", "audit", "of", "our", "manufacturing", "facility", "was", "performed", "and", "it", "was", "found", "compliant", "with", "EMA", "GMP", "in", "December", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p7_s0", "idA": "1006281_11_item1_p5_s1", "sentA": "The audit was performed as part of the Israeli MOH s evaluation of our manufacturing process for taliglucerase alfa.", "sentB": "Following the submission of the taliglucerase alfa MAA to the EMA, a good manufacturing practices, or GMP, audit of our manufacturing facility was performed and it was found compliant with EMA GMP in December 2011.", "type": 2, "words": ["<tag1>", "The", "audit", "was", "performed", "as", "part", "of", "the", "Israeli", "MOH", "s", "evaluation", "of", "our", "manufacturing", "process", "for", "taliglucerase", "alfa.", "<tag2>", "Following", "the", "submission", "of", "the", "taliglucerase", "alfa", "MAA", "to", "the", "EMA,", "a", "good", "manufacturing", "practices,", "or", "GMP,", "audit", "of", "our", "manufacturing", "facility", "was", "performed", "and", "it", "was", "found", "compliant", "with", "EMA", "GMP", "in", "December", "2011.", "<tag3>"], "wordsA": ["The", "audit", "was", "performed", "as", "part", "of", "the", "Israeli", "MOH", "s", "evaluation", "of", "our", "manufacturing", "process", "for", "taliglucerase", "alfa."], "wordsB": ["Following", "the", "submission", "of", "the", "taliglucerase", "alfa", "MAA", "to", "the", "EMA,", "a", "good", "manufacturing", "practices,", "or", "GMP,", "audit", "of", "our", "manufacturing", "facility", "was", "performed", "and", "it", "was", "found", "compliant", "with", "EMA", "GMP", "in", "December", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p12_s1", "idA": "1006281_11_item1_p60_s0", "sentA": "In the third quarter of 2008, we initiated a double blind, follow-on extension study as part of the phase III clinical trial in which patients that successfully completed treatment in the trial were given the opportunity to continue to be treated with taliglucerase alfa at the same dose that they received in the trial.", "sentB": "Eligible patients who completed nine months of treatment in our phase III clinical trial were offered the opportunity to participate in the extension study and continue to receive taliglucerase alfa at the same dose they received in the phase III clinical trial for an additional 15 months in a blinded manner.", "type": 2, "words": ["<tag1>", "In", "the", "third", "quarter", "of", "2008,", "we", "initiated", "a", "double", "blind,", "follow-on", "extension", "study", "as", "part", "of", "the", "phase", "III", "clinical", "trial", "in", "which", "patients", "that", "successfully", "completed", "treatment", "in", "the", "trial", "were", "given", "the", "opportunity", "to", "continue", "to", "be", "treated", "with", "taliglucerase", "alfa", "at", "the", "same", "dose", "that", "they", "received", "in", "the", "trial.", "<tag2>", "Eligible", "patients", "who", "completed", "nine", "months", "of", "treatment", "in", "our", "phase", "III", "clinical", "trial", "were", "offered", "the", "opportunity", "to", "participate", "in", "the", "extension", "study", "and", "continue", "to", "receive", "taliglucerase", "alfa", "at", "the", "same", "dose", "they", "received", "in", "the", "phase", "III", "clinical", "trial", "for", "an", "additional", "15", "months", "in", "a", "blinded", "manner.", "<tag3>"], "wordsA": ["In", "the", "third", "quarter", "of", "2008,", "we", "initiated", "a", "double", "blind,", "follow-on", "extension", "study", "as", "part", "of", "the", "phase", "III", "clinical", "trial", "in", "which", "patients", "that", "successfully", "completed", "treatment", "in", "the", "trial", "were", "given", "the", "opportunity", "to", "continue", "to", "be", "treated", "with", "taliglucerase", "alfa", "at", "the", "same", "dose", "that", "they", "received", "in", "the", "trial."], "wordsB": ["Eligible", "patients", "who", "completed", "nine", "months", "of", "treatment", "in", "our", "phase", "III", "clinical", "trial", "were", "offered", "the", "opportunity", "to", "participate", "in", "the", "extension", "study", "and", "continue", "to", "receive", "taliglucerase", "alfa", "at", "the", "same", "dose", "they", "received", "in", "the", "phase", "III", "clinical", "trial", "for", "an", "additional", "15", "months", "in", "a", "blinded", "manner."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p130_s1", "idA": "1006281_11_item1_p60_s0", "sentA": "In the third quarter of 2008, we initiated a double blind, follow-on extension study as part of the phase III clinical trial in which patients that successfully completed treatment in the trial were given the opportunity to continue to be treated with taliglucerase alfa at the same dose that they received in the trial.", "sentB": "Eligible patients who successfully completed nine months of treatment in our phase III clinical trial were offered the opportunity to participate in the extension study and continue to receive taliglucerase alfa at the same dose they received in the phase III clinical trial for an additional 15 months in a blinded manner.", "type": 2, "words": ["<tag1>", "In", "the", "third", "quarter", "of", "2008,", "we", "initiated", "a", "double", "blind,", "follow-on", "extension", "study", "as", "part", "of", "the", "phase", "III", "clinical", "trial", "in", "which", "patients", "that", "successfully", "completed", "treatment", "in", "the", "trial", "were", "given", "the", "opportunity", "to", "continue", "to", "be", "treated", "with", "taliglucerase", "alfa", "at", "the", "same", "dose", "that", "they", "received", "in", "the", "trial.", "<tag2>", "Eligible", "patients", "who", "successfully", "completed", "nine", "months", "of", "treatment", "in", "our", "phase", "III", "clinical", "trial", "were", "offered", "the", "opportunity", "to", "participate", "in", "the", "extension", "study", "and", "continue", "to", "receive", "taliglucerase", "alfa", "at", "the", "same", "dose", "they", "received", "in", "the", "phase", "III", "clinical", "trial", "for", "an", "additional", "15", "months", "in", "a", "blinded", "manner.", "<tag3>"], "wordsA": ["In", "the", "third", "quarter", "of", "2008,", "we", "initiated", "a", "double", "blind,", "follow-on", "extension", "study", "as", "part", "of", "the", "phase", "III", "clinical", "trial", "in", "which", "patients", "that", "successfully", "completed", "treatment", "in", "the", "trial", "were", "given", "the", "opportunity", "to", "continue", "to", "be", "treated", "with", "taliglucerase", "alfa", "at", "the", "same", "dose", "that", "they", "received", "in", "the", "trial."], "wordsB": ["Eligible", "patients", "who", "successfully", "completed", "nine", "months", "of", "treatment", "in", "our", "phase", "III", "clinical", "trial", "were", "offered", "the", "opportunity", "to", "participate", "in", "the", "extension", "study", "and", "continue", "to", "receive", "taliglucerase", "alfa", "at", "the", "same", "dose", "they", "received", "in", "the", "phase", "III", "clinical", "trial", "for", "an", "additional", "15", "months", "in", "a", "blinded", "manner."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p84_s1", "idA": "1006281_11_item1_p60_s0", "sentA": "In the third quarter of 2008, we initiated a double blind, follow-on extension study as part of the phase III clinical trial in which patients that successfully completed treatment in the trial were given the opportunity to continue to be treated with taliglucerase alfa at the same dose that they received in the trial.", "sentB": "Eligible patients who successfully completed nine months of treatment in our phase III clinical trial were offered the opportunity to participate in the extension study and continue to receive taliglucerase alfa at the same dose they received in the phase III clinical trial for an additional 15 months in a blinded manner.", "type": 2, "words": ["<tag1>", "In", "the", "third", "quarter", "of", "2008,", "we", "initiated", "a", "double", "blind,", "follow-on", "extension", "study", "as", "part", "of", "the", "phase", "III", "clinical", "trial", "in", "which", "patients", "that", "successfully", "completed", "treatment", "in", "the", "trial", "were", "given", "the", "opportunity", "to", "continue", "to", "be", "treated", "with", "taliglucerase", "alfa", "at", "the", "same", "dose", "that", "they", "received", "in", "the", "trial.", "<tag2>", "Eligible", "patients", "who", "successfully", "completed", "nine", "months", "of", "treatment", "in", "our", "phase", "III", "clinical", "trial", "were", "offered", "the", "opportunity", "to", "participate", "in", "the", "extension", "study", "and", "continue", "to", "receive", "taliglucerase", "alfa", "at", "the", "same", "dose", "they", "received", "in", "the", "phase", "III", "clinical", "trial", "for", "an", "additional", "15", "months", "in", "a", "blinded", "manner.", "<tag3>"], "wordsA": ["In", "the", "third", "quarter", "of", "2008,", "we", "initiated", "a", "double", "blind,", "follow-on", "extension", "study", "as", "part", "of", "the", "phase", "III", "clinical", "trial", "in", "which", "patients", "that", "successfully", "completed", "treatment", "in", "the", "trial", "were", "given", "the", "opportunity", "to", "continue", "to", "be", "treated", "with", "taliglucerase", "alfa", "at", "the", "same", "dose", "that", "they", "received", "in", "the", "trial."], "wordsB": ["Eligible", "patients", "who", "successfully", "completed", "nine", "months", "of", "treatment", "in", "our", "phase", "III", "clinical", "trial", "were", "offered", "the", "opportunity", "to", "participate", "in", "the", "extension", "study", "and", "continue", "to", "receive", "taliglucerase", "alfa", "at", "the", "same", "dose", "they", "received", "in", "the", "phase", "III", "clinical", "trial", "for", "an", "additional", "15", "months", "in", "a", "blinded", "manner."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p96_s0", "idA": "1006281_11_item1_p60_s6", "sentA": "We believe that taliglucerase alfa may have cost, efficacy and potency advantages over the currently available enzyme replacement therapy for Gaucher disease and we intend to pursue post-marketing studies to confirm these advantages.", "sentB": "We intend to pursue post-marketing studies to confirm these advantages.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "taliglucerase", "alfa", "may", "have", "cost,", "efficacy", "and", "potency", "advantages", "over", "the", "currently", "available", "enzyme", "replacement", "therapy", "for", "Gaucher", "disease", "and", "we", "intend", "to", "pursue", "post-marketing", "studies", "to", "confirm", "these", "advantages.", "<tag2>", "We", "intend", "to", "pursue", "post-marketing", "studies", "to", "confirm", "these", "advantages.", "<tag3>"], "wordsA": ["We", "believe", "that", "taliglucerase", "alfa", "may", "have", "cost,", "efficacy", "and", "potency", "advantages", "over", "the", "currently", "available", "enzyme", "replacement", "therapy", "for", "Gaucher", "disease", "and", "we", "intend", "to", "pursue", "post-marketing", "studies", "to", "confirm", "these", "advantages."], "wordsB": ["We", "intend", "to", "pursue", "post-marketing", "studies", "to", "confirm", "these", "advantages."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p97_s1", "idA": "1006281_11_item1_p62_s0", "sentA": "with its potentially longer acting profile and more cost-effective development process, may lead to an increase in the number of patients who will be able to have access to and afford such treatment, thereby expanding the size of the market for Gaucher disease treatments.", "sentB": "We believe that the approval of taliglucerase alfa as a treatment for Gaucher disease, if at all, with its potentially longer acting profile and more cost-effective development process, may lead to an increase in the number of patients who will be able to have access to and afford such treatment, thereby expanding the size of the market for Gaucher disease treatments.", "type": 2, "words": ["<tag1>", "with", "its", "potentially", "longer", "acting", "profile", "and", "more", "cost-effective", "development", "process,", "may", "lead", "to", "an", "increase", "in", "the", "number", "of", "patients", "who", "will", "be", "able", "to", "have", "access", "to", "and", "afford", "such", "treatment,", "thereby", "expanding", "the", "size", "of", "the", "market", "for", "Gaucher", "disease", "treatments.", "<tag2>", "We", "believe", "that", "the", "approval", "of", "taliglucerase", "alfa", "as", "a", "treatment", "for", "Gaucher", "disease,", "if", "at", "all,", "with", "its", "potentially", "longer", "acting", "profile", "and", "more", "cost-effective", "development", "process,", "may", "lead", "to", "an", "increase", "in", "the", "number", "of", "patients", "who", "will", "be", "able", "to", "have", "access", "to", "and", "afford", "such", "treatment,", "thereby", "expanding", "the", "size", "of", "the", "market", "for", "Gaucher", "disease", "treatments.", "<tag3>"], "wordsA": ["with", "its", "potentially", "longer", "acting", "profile", "and", "more", "cost-effective", "development", "process,", "may", "lead", "to", "an", "increase", "in", "the", "number", "of", "patients", "who", "will", "be", "able", "to", "have", "access", "to", "and", "afford", "such", "treatment,", "thereby", "expanding", "the", "size", "of", "the", "market", "for", "Gaucher", "disease", "treatments."], "wordsB": ["We", "believe", "that", "the", "approval", "of", "taliglucerase", "alfa", "as", "a", "treatment", "for", "Gaucher", "disease,", "if", "at", "all,", "with", "its", "potentially", "longer", "acting", "profile", "and", "more", "cost-effective", "development", "process,", "may", "lead", "to", "an", "increase", "in", "the", "number", "of", "patients", "who", "will", "be", "able", "to", "have", "access", "to", "and", "afford", "such", "treatment,", "thereby", "expanding", "the", "size", "of", "the", "market", "for", "Gaucher", "disease", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p179_s2", "idA": "1006281_11_item1_p63_s5", "sentA": "We believe our cost-effective technology will be an important asset for the commercialization of such drug candidates.", "sentB": "If and when such vials are replaced, revenues will be recorded upon the supply of such replaced vials, and if it is determined that there is no longer a need for the replacement of vials, the allowance will be reversed and the revenues will be recognized accordingly.", "type": 2, "words": ["<tag1>", "We", "believe", "our", "cost-effective", "technology", "will", "be", "an", "important", "asset", "for", "the", "commercialization", "of", "such", "drug", "candidates.", "<tag2>", "If", "and", "when", "such", "vials", "are", "replaced,", "revenues", "will", "be", "recorded", "upon", "the", "supply", "of", "such", "replaced", "vials,", "and", "if", "it", "is", "determined", "that", "there", "is", "no", "longer", "a", "need", "for", "the", "replacement", "of", "vials,", "the", "allowance", "will", "be", "reversed", "and", "the", "revenues", "will", "be", "recognized", "accordingly.", "<tag3>"], "wordsA": ["We", "believe", "our", "cost-effective", "technology", "will", "be", "an", "important", "asset", "for", "the", "commercialization", "of", "such", "drug", "candidates."], "wordsB": ["If", "and", "when", "such", "vials", "are", "replaced,", "revenues", "will", "be", "recorded", "upon", "the", "supply", "of", "such", "replaced", "vials,", "and", "if", "it", "is", "determined", "that", "there", "is", "no", "longer", "a", "need", "for", "the", "replacement", "of", "vials,", "the", "allowance", "will", "be", "reversed", "and", "the", "revenues", "will", "be", "recognized", "accordingly."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p23_s2", "idA": "1006281_11_item1_p63_s5", "sentA": "We believe our cost-effective technology will be an important asset for the commercialization of such drug candidates.", "sentB": "If and when such vials are replaced, revenues will be recorded upon the supply of such replaced vials, and if it is determined that there is no longer a need for the replacement of vials, the allowance will be reversed and the revenues will be recognized accordingly.", "type": 2, "words": ["<tag1>", "We", "believe", "our", "cost-effective", "technology", "will", "be", "an", "important", "asset", "for", "the", "commercialization", "of", "such", "drug", "candidates.", "<tag2>", "If", "and", "when", "such", "vials", "are", "replaced,", "revenues", "will", "be", "recorded", "upon", "the", "supply", "of", "such", "replaced", "vials,", "and", "if", "it", "is", "determined", "that", "there", "is", "no", "longer", "a", "need", "for", "the", "replacement", "of", "vials,", "the", "allowance", "will", "be", "reversed", "and", "the", "revenues", "will", "be", "recognized", "accordingly.", "<tag3>"], "wordsA": ["We", "believe", "our", "cost-effective", "technology", "will", "be", "an", "important", "asset", "for", "the", "commercialization", "of", "such", "drug", "candidates."], "wordsB": ["If", "and", "when", "such", "vials", "are", "replaced,", "revenues", "will", "be", "recorded", "upon", "the", "supply", "of", "such", "replaced", "vials,", "and", "if", "it", "is", "determined", "that", "there", "is", "no", "longer", "a", "need", "for", "the", "replacement", "of", "vials,", "the", "allowance", "will", "be", "reversed", "and", "the", "revenues", "will", "be", "recognized", "accordingly."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p211_s2", "idA": "1006281_11_item1_p63_s7", "sentA": "Furthermore, established markets already exist for the development of most of our current product candidates.", "sentB": "We have identified additional suppliers for most of the materials required for the production of our product candidates.", "type": 2, "words": ["<tag1>", "Furthermore,", "established", "markets", "already", "exist", "for", "the", "development", "of", "most", "of", "our", "current", "product", "candidates.", "<tag2>", "We", "have", "identified", "additional", "suppliers", "for", "most", "of", "the", "materials", "required", "for", "the", "production", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["Furthermore,", "established", "markets", "already", "exist", "for", "the", "development", "of", "most", "of", "our", "current", "product", "candidates."], "wordsB": ["We", "have", "identified", "additional", "suppliers", "for", "most", "of", "the", "materials", "required", "for", "the", "production", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p220_s1", "idA": "1006281_11_item1_p63_s7", "sentA": "Furthermore, established markets already exist for the development of most of our current product candidates.", "sentB": "Delays or terminations of clinical trials that we undertake would likely impair our development of product candidates.", "type": 2, "words": ["<tag1>", "Furthermore,", "established", "markets", "already", "exist", "for", "the", "development", "of", "most", "of", "our", "current", "product", "candidates.", "<tag2>", "Delays", "or", "terminations", "of", "clinical", "trials", "that", "we", "undertake", "would", "likely", "impair", "our", "development", "of", "product", "candidates.", "<tag3>"], "wordsA": ["Furthermore,", "established", "markets", "already", "exist", "for", "the", "development", "of", "most", "of", "our", "current", "product", "candidates."], "wordsB": ["Delays", "or", "terminations", "of", "clinical", "trials", "that", "we", "undertake", "would", "likely", "impair", "our", "development", "of", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p66_s1", "idA": "1006281_11_item1_p65_s0", "sentA": "We have licensed to Pfizer the right to commercialize taliglucerase worldwide, except in Israel.", "sentB": "We have licensed to Pfizer the right to commercialize taliglucerase alfa worldwide, except in Israel.", "type": 2, "words": ["<tag1>", "We", "have", "licensed", "to", "Pfizer", "the", "right", "to", "commercialize", "taliglucerase", "worldwide,", "except", "in", "Israel.", "<tag2>", "We", "have", "licensed", "to", "Pfizer", "the", "right", "to", "commercialize", "taliglucerase", "alfa", "worldwide,", "except", "in", "Israel.", "<tag3>"], "wordsA": ["We", "have", "licensed", "to", "Pfizer", "the", "right", "to", "commercialize", "taliglucerase", "worldwide,", "except", "in", "Israel."], "wordsB": ["We", "have", "licensed", "to", "Pfizer", "the", "right", "to", "commercialize", "taliglucerase", "alfa", "worldwide,", "except", "in", "Israel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p66_s2", "idA": "1006281_11_item1_p65_s1", "sentA": "We plan to establish our own, internal sales and marketing capabilities for taliglucerase in Israel, and, for our other product candidates, in North America, the European Union and in other significant markets, including Israel.", "sentB": "We plan to establish our own, internal sales and marketing capabilities for taliglucerase alfa in Israel, and, for our other product candidates, in North America, the European Union and in other significant markets, including Israel.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "establish", "our", "own,", "internal", "sales", "and", "marketing", "capabilities", "for", "taliglucerase", "in", "Israel,", "and,", "for", "our", "other", "product", "candidates,", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel.", "<tag2>", "We", "plan", "to", "establish", "our", "own,", "internal", "sales", "and", "marketing", "capabilities", "for", "taliglucerase", "alfa", "in", "Israel,", "and,", "for", "our", "other", "product", "candidates,", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel.", "<tag3>"], "wordsA": ["We", "plan", "to", "establish", "our", "own,", "internal", "sales", "and", "marketing", "capabilities", "for", "taliglucerase", "in", "Israel,", "and,", "for", "our", "other", "product", "candidates,", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel."], "wordsB": ["We", "plan", "to", "establish", "our", "own,", "internal", "sales", "and", "marketing", "capabilities", "for", "taliglucerase", "alfa", "in", "Israel,", "and,", "for", "our", "other", "product", "candidates,", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p66_s3", "idA": "1006281_11_item1_p65_s2", "sentA": "We believe that the focus of our current clinical pipeline on relatively rare genetic disorders with small patient populations and a highly concentrated group of physicians focused on treating patients with such disorders may facilitate our creation of a targeted internal sales force.", "sentB": "We believe that the focus of our current clinical pipeline is mainly on relatively rare genetic disorders with small patient populations and a highly concentrated group of physicians focused on treating patients with such disorders may facilitate our creation of a targeted internal sales force.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "the", "focus", "of", "our", "current", "clinical", "pipeline", "on", "relatively", "rare", "genetic", "disorders", "with", "small", "patient", "populations", "and", "a", "highly", "concentrated", "group", "of", "physicians", "focused", "on", "treating", "patients", "with", "such", "disorders", "may", "facilitate", "our", "creation", "of", "a", "targeted", "internal", "sales", "force.", "<tag2>", "We", "believe", "that", "the", "focus", "of", "our", "current", "clinical", "pipeline", "is", "mainly", "on", "relatively", "rare", "genetic", "disorders", "with", "small", "patient", "populations", "and", "a", "highly", "concentrated", "group", "of", "physicians", "focused", "on", "treating", "patients", "with", "such", "disorders", "may", "facilitate", "our", "creation", "of", "a", "targeted", "internal", "sales", "force.", "<tag3>"], "wordsA": ["We", "believe", "that", "the", "focus", "of", "our", "current", "clinical", "pipeline", "on", "relatively", "rare", "genetic", "disorders", "with", "small", "patient", "populations", "and", "a", "highly", "concentrated", "group", "of", "physicians", "focused", "on", "treating", "patients", "with", "such", "disorders", "may", "facilitate", "our", "creation", "of", "a", "targeted", "internal", "sales", "force."], "wordsB": ["We", "believe", "that", "the", "focus", "of", "our", "current", "clinical", "pipeline", "is", "mainly", "on", "relatively", "rare", "genetic", "disorders", "with", "small", "patient", "populations", "and", "a", "highly", "concentrated", "group", "of", "physicians", "focused", "on", "treating", "patients", "with", "such", "disorders", "may", "facilitate", "our", "creation", "of", "a", "targeted", "internal", "sales", "force."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p69_s1", "idA": "1006281_11_item1_p68_s1", "sentA": "Although programs relating to two proteins to be developed under the agreement were terminated for commercial reasons in 2009, other elements of our collaboration are still ongoing.", "sentB": "Although programs relating to two proteins to be developed under the agreement were terminated for commercial reasons in 2009, other elements of our collaboration are still ongoing and we are exploring other potential ways to collaborate.", "type": 2, "words": ["<tag1>", "Although", "programs", "relating", "to", "two", "proteins", "to", "be", "developed", "under", "the", "agreement", "were", "terminated", "for", "commercial", "reasons", "in", "2009,", "other", "elements", "of", "our", "collaboration", "are", "still", "ongoing.", "<tag2>", "Although", "programs", "relating", "to", "two", "proteins", "to", "be", "developed", "under", "the", "agreement", "were", "terminated", "for", "commercial", "reasons", "in", "2009,", "other", "elements", "of", "our", "collaboration", "are", "still", "ongoing", "and", "we", "are", "exploring", "other", "potential", "ways", "to", "collaborate.", "<tag3>"], "wordsA": ["Although", "programs", "relating", "to", "two", "proteins", "to", "be", "developed", "under", "the", "agreement", "were", "terminated", "for", "commercial", "reasons", "in", "2009,", "other", "elements", "of", "our", "collaboration", "are", "still", "ongoing."], "wordsB": ["Although", "programs", "relating", "to", "two", "proteins", "to", "be", "developed", "under", "the", "agreement", "were", "terminated", "for", "commercial", "reasons", "in", "2009,", "other", "elements", "of", "our", "collaboration", "are", "still", "ongoing", "and", "we", "are", "exploring", "other", "potential", "ways", "to", "collaborate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p69_s2", "idA": "1006281_11_item1_p68_s2", "sentA": "Last, we are in various stages of discussions with a number of multinational pharmaceutical companies regarding additional collaboration agreements.", "sentB": "Last, we are engaged in confidential discussions with a number of multinational pharmaceutical companies to discuss additional potential collaboration arrangements.", "type": 2, "words": ["<tag1>", "Last,", "we", "are", "in", "various", "stages", "of", "discussions", "with", "a", "number", "of", "multinational", "pharmaceutical", "companies", "regarding", "additional", "collaboration", "agreements.", "<tag2>", "Last,", "we", "are", "engaged", "in", "confidential", "discussions", "with", "a", "number", "of", "multinational", "pharmaceutical", "companies", "to", "discuss", "additional", "potential", "collaboration", "arrangements.", "<tag3>"], "wordsA": ["Last,", "we", "are", "in", "various", "stages", "of", "discussions", "with", "a", "number", "of", "multinational", "pharmaceutical", "companies", "regarding", "additional", "collaboration", "agreements."], "wordsB": ["Last,", "we", "are", "engaged", "in", "confidential", "discussions", "with", "a", "number", "of", "multinational", "pharmaceutical", "companies", "to", "discuss", "additional", "potential", "collaboration", "arrangements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p208_s0", "idA": "1006281_11_item1_p6_s0", "sentA": "On February 20, 2011, we received a letter from the FDA notifying us that the FDA had completed its review of the Establishment Inspection Report in connection with the FDA s inspection of our facility in Carmiel, Israel, and that the FDA had classified our facility as acceptable.", "sentB": "On February 20, 2011, we received a letter from the FDA notifying us that the FDA had completed its review of the Establishment Inspection Report in connection with the FDA s inspection of our Carmiel facility and that the FDA had classified our facility as acceptable.", "type": 2, "words": ["<tag1>", "On", "February", "20,", "2011,", "we", "received", "a", "letter", "from", "the", "FDA", "notifying", "us", "that", "the", "FDA", "had", "completed", "its", "review", "of", "the", "Establishment", "Inspection", "Report", "in", "connection", "with", "the", "FDA", "s", "inspection", "of", "our", "facility", "in", "Carmiel,", "Israel,", "and", "that", "the", "FDA", "had", "classified", "our", "facility", "as", "acceptable.", "<tag2>", "On", "February", "20,", "2011,", "we", "received", "a", "letter", "from", "the", "FDA", "notifying", "us", "that", "the", "FDA", "had", "completed", "its", "review", "of", "the", "Establishment", "Inspection", "Report", "in", "connection", "with", "the", "FDA", "s", "inspection", "of", "our", "Carmiel", "facility", "and", "that", "the", "FDA", "had", "classified", "our", "facility", "as", "acceptable.", "<tag3>"], "wordsA": ["On", "February", "20,", "2011,", "we", "received", "a", "letter", "from", "the", "FDA", "notifying", "us", "that", "the", "FDA", "had", "completed", "its", "review", "of", "the", "Establishment", "Inspection", "Report", "in", "connection", "with", "the", "FDA", "s", "inspection", "of", "our", "facility", "in", "Carmiel,", "Israel,", "and", "that", "the", "FDA", "had", "classified", "our", "facility", "as", "acceptable."], "wordsB": ["On", "February", "20,", "2011,", "we", "received", "a", "letter", "from", "the", "FDA", "notifying", "us", "that", "the", "FDA", "had", "completed", "its", "review", "of", "the", "Establishment", "Inspection", "Report", "in", "connection", "with", "the", "FDA", "s", "inspection", "of", "our", "Carmiel", "facility", "and", "that", "the", "FDA", "had", "classified", "our", "facility", "as", "acceptable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p5_s7", "idA": "1006281_11_item1_p6_s0", "sentA": "On February 20, 2011, we received a letter from the FDA notifying us that the FDA had completed its review of the Establishment Inspection Report in connection with the FDA s inspection of our facility in Carmiel, Israel, and that the FDA had classified our facility as acceptable.", "sentB": "As this information was requested and provided within 90 days of the February 1, 2012 PDUFA goal date, the FDA had the option to extend the PDUFA goal date to provide adequate time for the FDA to complete its review.", "type": 2, "words": ["<tag1>", "On", "February", "20,", "2011,", "we", "received", "a", "letter", "from", "the", "FDA", "notifying", "us", "that", "the", "FDA", "had", "completed", "its", "review", "of", "the", "Establishment", "Inspection", "Report", "in", "connection", "with", "the", "FDA", "s", "inspection", "of", "our", "facility", "in", "Carmiel,", "Israel,", "and", "that", "the", "FDA", "had", "classified", "our", "facility", "as", "acceptable.", "<tag2>", "As", "this", "information", "was", "requested", "and", "provided", "within", "90", "days", "of", "the", "February", "1,", "2012", "PDUFA", "goal", "date,", "the", "FDA", "had", "the", "option", "to", "extend", "the", "PDUFA", "goal", "date", "to", "provide", "adequate", "time", "for", "the", "FDA", "to", "complete", "its", "review.", "<tag3>"], "wordsA": ["On", "February", "20,", "2011,", "we", "received", "a", "letter", "from", "the", "FDA", "notifying", "us", "that", "the", "FDA", "had", "completed", "its", "review", "of", "the", "Establishment", "Inspection", "Report", "in", "connection", "with", "the", "FDA", "s", "inspection", "of", "our", "facility", "in", "Carmiel,", "Israel,", "and", "that", "the", "FDA", "had", "classified", "our", "facility", "as", "acceptable."], "wordsB": ["As", "this", "information", "was", "requested", "and", "provided", "within", "90", "days", "of", "the", "February", "1,", "2012", "PDUFA", "goal", "date,", "the", "FDA", "had", "the", "option", "to", "extend", "the", "PDUFA", "goal", "date", "to", "provide", "adequate", "time", "for", "the", "FDA", "to", "complete", "its", "review."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p64_s3", "idA": "1006281_11_item1_p6_s0", "sentA": "On February 20, 2011, we received a letter from the FDA notifying us that the FDA had completed its review of the Establishment Inspection Report in connection with the FDA s inspection of our facility in Carmiel, Israel, and that the FDA had classified our facility as acceptable.", "sentB": "On February 24, 2011, the FDA issued a CRL indicating that the FDA s review was complete but questions remain that preclude the approval of the NDA in its then current form.", "type": 2, "words": ["<tag1>", "On", "February", "20,", "2011,", "we", "received", "a", "letter", "from", "the", "FDA", "notifying", "us", "that", "the", "FDA", "had", "completed", "its", "review", "of", "the", "Establishment", "Inspection", "Report", "in", "connection", "with", "the", "FDA", "s", "inspection", "of", "our", "facility", "in", "Carmiel,", "Israel,", "and", "that", "the", "FDA", "had", "classified", "our", "facility", "as", "acceptable.", "<tag2>", "On", "February", "24,", "2011,", "the", "FDA", "issued", "a", "CRL", "indicating", "that", "the", "FDA", "s", "review", "was", "complete", "but", "questions", "remain", "that", "preclude", "the", "approval", "of", "the", "NDA", "in", "its", "then", "current", "form.", "<tag3>"], "wordsA": ["On", "February", "20,", "2011,", "we", "received", "a", "letter", "from", "the", "FDA", "notifying", "us", "that", "the", "FDA", "had", "completed", "its", "review", "of", "the", "Establishment", "Inspection", "Report", "in", "connection", "with", "the", "FDA", "s", "inspection", "of", "our", "facility", "in", "Carmiel,", "Israel,", "and", "that", "the", "FDA", "had", "classified", "our", "facility", "as", "acceptable."], "wordsB": ["On", "February", "24,", "2011,", "the", "FDA", "issued", "a", "CRL", "indicating", "that", "the", "FDA", "s", "review", "was", "complete", "but", "questions", "remain", "that", "preclude", "the", "approval", "of", "the", "NDA", "in", "its", "then", "current", "form."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p64_s8", "idA": "1006281_11_item1_p6_s0", "sentA": "On February 20, 2011, we received a letter from the FDA notifying us that the FDA had completed its review of the Establishment Inspection Report in connection with the FDA s inspection of our facility in Carmiel, Israel, and that the FDA had classified our facility as acceptable.", "sentB": "As this information was requested and provided within 90 days of the February 1, 2012 PDUFA goal date, the FDA had the option to extend the PDUFA goal date to provide adequate time for the FDA to complete its review.", "type": 2, "words": ["<tag1>", "On", "February", "20,", "2011,", "we", "received", "a", "letter", "from", "the", "FDA", "notifying", "us", "that", "the", "FDA", "had", "completed", "its", "review", "of", "the", "Establishment", "Inspection", "Report", "in", "connection", "with", "the", "FDA", "s", "inspection", "of", "our", "facility", "in", "Carmiel,", "Israel,", "and", "that", "the", "FDA", "had", "classified", "our", "facility", "as", "acceptable.", "<tag2>", "As", "this", "information", "was", "requested", "and", "provided", "within", "90", "days", "of", "the", "February", "1,", "2012", "PDUFA", "goal", "date,", "the", "FDA", "had", "the", "option", "to", "extend", "the", "PDUFA", "goal", "date", "to", "provide", "adequate", "time", "for", "the", "FDA", "to", "complete", "its", "review.", "<tag3>"], "wordsA": ["On", "February", "20,", "2011,", "we", "received", "a", "letter", "from", "the", "FDA", "notifying", "us", "that", "the", "FDA", "had", "completed", "its", "review", "of", "the", "Establishment", "Inspection", "Report", "in", "connection", "with", "the", "FDA", "s", "inspection", "of", "our", "facility", "in", "Carmiel,", "Israel,", "and", "that", "the", "FDA", "had", "classified", "our", "facility", "as", "acceptable."], "wordsB": ["As", "this", "information", "was", "requested", "and", "provided", "within", "90", "days", "of", "the", "February", "1,", "2012", "PDUFA", "goal", "date,", "the", "FDA", "had", "the", "option", "to", "extend", "the", "PDUFA", "goal", "date", "to", "provide", "adequate", "time", "for", "the", "FDA", "to", "complete", "its", "review."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p75_s7", "idA": "1006281_11_item1_p6_s0", "sentA": "On February 20, 2011, we received a letter from the FDA notifying us that the FDA had completed its review of the Establishment Inspection Report in connection with the FDA s inspection of our facility in Carmiel, Israel, and that the FDA had classified our facility as acceptable.", "sentB": "As this information was requested and provided within 90 days of the February 1, 2012 PDUFA goal date, the FDA had the option to extend the PDUFA goal date to provide adequate time for the FDA to complete its review.", "type": 2, "words": ["<tag1>", "On", "February", "20,", "2011,", "we", "received", "a", "letter", "from", "the", "FDA", "notifying", "us", "that", "the", "FDA", "had", "completed", "its", "review", "of", "the", "Establishment", "Inspection", "Report", "in", "connection", "with", "the", "FDA", "s", "inspection", "of", "our", "facility", "in", "Carmiel,", "Israel,", "and", "that", "the", "FDA", "had", "classified", "our", "facility", "as", "acceptable.", "<tag2>", "As", "this", "information", "was", "requested", "and", "provided", "within", "90", "days", "of", "the", "February", "1,", "2012", "PDUFA", "goal", "date,", "the", "FDA", "had", "the", "option", "to", "extend", "the", "PDUFA", "goal", "date", "to", "provide", "adequate", "time", "for", "the", "FDA", "to", "complete", "its", "review.", "<tag3>"], "wordsA": ["On", "February", "20,", "2011,", "we", "received", "a", "letter", "from", "the", "FDA", "notifying", "us", "that", "the", "FDA", "had", "completed", "its", "review", "of", "the", "Establishment", "Inspection", "Report", "in", "connection", "with", "the", "FDA", "s", "inspection", "of", "our", "facility", "in", "Carmiel,", "Israel,", "and", "that", "the", "FDA", "had", "classified", "our", "facility", "as", "acceptable."], "wordsB": ["As", "this", "information", "was", "requested", "and", "provided", "within", "90", "days", "of", "the", "February", "1,", "2012", "PDUFA", "goal", "date,", "the", "FDA", "had", "the", "option", "to", "extend", "the", "PDUFA", "goal", "date", "to", "provide", "adequate", "time", "for", "the", "FDA", "to", "complete", "its", "review."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p234_s1", "idA": "1006281_11_item1_p71_s0", "sentA": "Our management team has extensive experience in the biotechnology and pharmaceutical industry.", "sentB": "PPACA substantially changes the way healthcare is financed by both governmental and private insurers and significantly affects the pharmaceutical industry.", "type": 2, "words": ["<tag1>", "Our", "management", "team", "has", "extensive", "experience", "in", "the", "biotechnology", "and", "pharmaceutical", "industry.", "<tag2>", "PPACA", "substantially", "changes", "the", "way", "healthcare", "is", "financed", "by", "both", "governmental", "and", "private", "insurers", "and", "significantly", "affects", "the", "pharmaceutical", "industry.", "<tag3>"], "wordsA": ["Our", "management", "team", "has", "extensive", "experience", "in", "the", "biotechnology", "and", "pharmaceutical", "industry."], "wordsB": ["PPACA", "substantially", "changes", "the", "way", "healthcare", "is", "financed", "by", "both", "governmental", "and", "private", "insurers", "and", "significantly", "affects", "the", "pharmaceutical", "industry."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p72_s1", "idA": "1006281_11_item1_p72_s0", "sentA": "Chairman of our Board of Directors, Mr. Zeev Bronfeld, is a highly experienced Israeli health care investor.", "sentB": "The Interim Chairman of our Board of Directors, Mr. Zeev Bronfeld, is a highly experienced Israeli health care investor.", "type": 2, "words": ["<tag1>", "Chairman", "of", "our", "Board", "of", "Directors,", "Mr.", "Zeev", "Bronfeld,", "is", "a", "highly", "experienced", "Israeli", "health", "care", "investor.", "<tag2>", "The", "Interim", "Chairman", "of", "our", "Board", "of", "Directors,", "Mr.", "Zeev", "Bronfeld,", "is", "a", "highly", "experienced", "Israeli", "health", "care", "investor.", "<tag3>"], "wordsA": ["Chairman", "of", "our", "Board", "of", "Directors,", "Mr.", "Zeev", "Bronfeld,", "is", "a", "highly", "experienced", "Israeli", "health", "care", "investor."], "wordsB": ["The", "Interim", "Chairman", "of", "our", "Board", "of", "Directors,", "Mr.", "Zeev", "Bronfeld,", "is", "a", "highly", "experienced", "Israeli", "health", "care", "investor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p149_s3", "idA": "1006281_11_item1_p73_s0", "sentA": "Taliglucerase alfa, our lead proprietary product candidate, is a plant cell expressed recombinant glucocerebrosidase enzyme (GCD) for the treatment of Gaucher disease.", "sentB": "We are also conducting pre clinical trials of our orally-administrated glucocerebrosidase enzyme for the treatment of Gaucher disease in small and large animals.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa,", "our", "lead", "proprietary", "product", "candidate,", "is", "a", "plant", "cell", "expressed", "recombinant", "glucocerebrosidase", "enzyme", "(GCD)", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "We", "are", "also", "conducting", "pre", "clinical", "trials", "of", "our", "orally-administrated", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "disease", "in", "small", "and", "large", "animals.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa,", "our", "lead", "proprietary", "product", "candidate,", "is", "a", "plant", "cell", "expressed", "recombinant", "glucocerebrosidase", "enzyme", "(GCD)", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["We", "are", "also", "conducting", "pre", "clinical", "trials", "of", "our", "orally-administrated", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "disease", "in", "small", "and", "large", "animals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p1_s0", "idA": "1006281_11_item1_p73_s0", "sentA": "Taliglucerase alfa, our lead proprietary product candidate, is a plant cell expressed recombinant glucocerebrosidase enzyme (GCD) for the treatment of Gaucher disease.", "sentB": "Taliglucerase alfa, our proprietary, lead product candidate, is a recombinant form of glucocerebrosidase (GCD) that we are developing for the treatment of Gaucher disease using ProCellEx.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa,", "our", "lead", "proprietary", "product", "candidate,", "is", "a", "plant", "cell", "expressed", "recombinant", "glucocerebrosidase", "enzyme", "(GCD)", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "Taliglucerase", "alfa,", "our", "proprietary,", "lead", "product", "candidate,", "is", "a", "recombinant", "form", "of", "glucocerebrosidase", "(GCD)", "that", "we", "are", "developing", "for", "the", "treatment", "of", "Gaucher", "disease", "using", "ProCellEx.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa,", "our", "lead", "proprietary", "product", "candidate,", "is", "a", "plant", "cell", "expressed", "recombinant", "glucocerebrosidase", "enzyme", "(GCD)", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["Taliglucerase", "alfa,", "our", "proprietary,", "lead", "product", "candidate,", "is", "a", "recombinant", "form", "of", "glucocerebrosidase", "(GCD)", "that", "we", "are", "developing", "for", "the", "treatment", "of", "Gaucher", "disease", "using", "ProCellEx."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p32_s3", "idA": "1006281_11_item1_p73_s0", "sentA": "Taliglucerase alfa, our lead proprietary product candidate, is a plant cell expressed recombinant glucocerebrosidase enzyme (GCD) for the treatment of Gaucher disease.", "sentB": "We are also conducting pre-clinical trials of our orally-administrated glucocerebrosidase enzyme for the treatment of Gaucher disease in small and large animals.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa,", "our", "lead", "proprietary", "product", "candidate,", "is", "a", "plant", "cell", "expressed", "recombinant", "glucocerebrosidase", "enzyme", "(GCD)", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "We", "are", "also", "conducting", "pre-clinical", "trials", "of", "our", "orally-administrated", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "disease", "in", "small", "and", "large", "animals.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa,", "our", "lead", "proprietary", "product", "candidate,", "is", "a", "plant", "cell", "expressed", "recombinant", "glucocerebrosidase", "enzyme", "(GCD)", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["We", "are", "also", "conducting", "pre-clinical", "trials", "of", "our", "orally-administrated", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "disease", "in", "small", "and", "large", "animals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p127_s2", "idA": "1006281_11_item1_p73_s1", "sentA": "In July 2007, we reached an agreement with the FDA on the final design of our pivotal phase III clinical trial of taliglucerase alfa through the FDA s special protocol assessment (SPA) process.", "sentB": "We submitted to the FDA a request for a special protocol assessment (SPA) of the final design of our pivotal phase III clinical trial for taliglucerase alfa.", "type": 2, "words": ["<tag1>", "In", "July", "2007,", "we", "reached", "an", "agreement", "with", "the", "FDA", "on", "the", "final", "design", "of", "our", "pivotal", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa", "through", "the", "FDA", "s", "special", "protocol", "assessment", "(SPA)", "process.", "<tag2>", "We", "submitted", "to", "the", "FDA", "a", "request", "for", "a", "special", "protocol", "assessment", "(SPA)", "of", "the", "final", "design", "of", "our", "pivotal", "phase", "III", "clinical", "trial", "for", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["In", "July", "2007,", "we", "reached", "an", "agreement", "with", "the", "FDA", "on", "the", "final", "design", "of", "our", "pivotal", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa", "through", "the", "FDA", "s", "special", "protocol", "assessment", "(SPA)", "process."], "wordsB": ["We", "submitted", "to", "the", "FDA", "a", "request", "for", "a", "special", "protocol", "assessment", "(SPA)", "of", "the", "final", "design", "of", "our", "pivotal", "phase", "III", "clinical", "trial", "for", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p5_s2", "idA": "1006281_11_item1_p73_s3", "sentA": "We submitted an NDA to the FDA in December 2009.", "sentB": "We met with the FDA in May 2011 to clarify the FDA's requests, and in August 2011, we submitted our reply to the CRL.", "type": 2, "words": ["<tag1>", "We", "submitted", "an", "NDA", "to", "the", "FDA", "in", "December", "2009.", "<tag2>", "We", "met", "with", "the", "FDA", "in", "May", "2011", "to", "clarify", "the", "FDA's", "requests,", "and", "in", "August", "2011,", "we", "submitted", "our", "reply", "to", "the", "CRL.", "<tag3>"], "wordsA": ["We", "submitted", "an", "NDA", "to", "the", "FDA", "in", "December", "2009."], "wordsB": ["We", "met", "with", "the", "FDA", "in", "May", "2011", "to", "clarify", "the", "FDA's", "requests,", "and", "in", "August", "2011,", "we", "submitted", "our", "reply", "to", "the", "CRL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p75_s2", "idA": "1006281_11_item1_p73_s3", "sentA": "We submitted an NDA to the FDA in December 2009.", "sentB": "We met with the FDA in May 2011 to clarify the FDA s requests, and in July 2011 we submitted our reply to the CRL.", "type": 2, "words": ["<tag1>", "We", "submitted", "an", "NDA", "to", "the", "FDA", "in", "December", "2009.", "<tag2>", "We", "met", "with", "the", "FDA", "in", "May", "2011", "to", "clarify", "the", "FDA", "s", "requests,", "and", "in", "July", "2011", "we", "submitted", "our", "reply", "to", "the", "CRL.", "<tag3>"], "wordsA": ["We", "submitted", "an", "NDA", "to", "the", "FDA", "in", "December", "2009."], "wordsB": ["We", "met", "with", "the", "FDA", "in", "May", "2011", "to", "clarify", "the", "FDA", "s", "requests,", "and", "in", "July", "2011", "we", "submitted", "our", "reply", "to", "the", "CRL."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p4_s2", "idA": "1006281_11_item1_p73_s4", "sentA": "In January 2010, the FDA requested additional data regarding the Chemistry, Manufacturing and Controls (CMC) section of the NDA.", "sentB": "The main questions raised by the FDA regarding the NDA related to the clinical and chemistry, manufacturing and controls (CMC) sections.", "type": 2, "words": ["<tag1>", "In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA.", "<tag2>", "The", "main", "questions", "raised", "by", "the", "FDA", "regarding", "the", "NDA", "related", "to", "the", "clinical", "and", "chemistry,", "manufacturing", "and", "controls", "(CMC)", "sections.", "<tag3>"], "wordsA": ["In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA."], "wordsB": ["The", "main", "questions", "raised", "by", "the", "FDA", "regarding", "the", "NDA", "related", "to", "the", "clinical", "and", "chemistry,", "manufacturing", "and", "controls", "(CMC)", "sections."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p4_s3", "idA": "1006281_11_item1_p73_s4", "sentA": "In January 2010, the FDA requested additional data regarding the Chemistry, Manufacturing and Controls (CMC) section of the NDA.", "sentB": "In the clinical section of the CRL, the FDA requested additional data from our ongoing switchover trial and our long-term extension trial.", "type": 2, "words": ["<tag1>", "In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA.", "<tag2>", "In", "the", "clinical", "section", "of", "the", "CRL,", "the", "FDA", "requested", "additional", "data", "from", "our", "ongoing", "switchover", "trial", "and", "our", "long-term", "extension", "trial.", "<tag3>"], "wordsA": ["In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA."], "wordsB": ["In", "the", "clinical", "section", "of", "the", "CRL,", "the", "FDA", "requested", "additional", "data", "from", "our", "ongoing", "switchover", "trial", "and", "our", "long-term", "extension", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p5_s0", "idA": "1006281_11_item1_p73_s4", "sentA": "In January 2010, the FDA requested additional data regarding the Chemistry, Manufacturing and Controls (CMC) section of the NDA.", "sentB": "In the CMC section of the CRL, the FDA requested information regarding testing specifications and assay validation.", "type": 2, "words": ["<tag1>", "In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA.", "<tag2>", "In", "the", "CMC", "section", "of", "the", "CRL,", "the", "FDA", "requested", "information", "regarding", "testing", "specifications", "and", "assay", "validation.", "<tag3>"], "wordsA": ["In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA."], "wordsB": ["In", "the", "CMC", "section", "of", "the", "CRL,", "the", "FDA", "requested", "information", "regarding", "testing", "specifications", "and", "assay", "validation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p5_s6", "idA": "1006281_11_item1_p73_s4", "sentA": "In January 2010, the FDA requested additional data regarding the Chemistry, Manufacturing and Controls (CMC) section of the NDA.", "sentB": "The requested information related mainly to the presentation of select data provided in the NDA.", "type": 2, "words": ["<tag1>", "In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA.", "<tag2>", "The", "requested", "information", "related", "mainly", "to", "the", "presentation", "of", "select", "data", "provided", "in", "the", "NDA.", "<tag3>"], "wordsA": ["In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA."], "wordsB": ["The", "requested", "information", "related", "mainly", "to", "the", "presentation", "of", "select", "data", "provided", "in", "the", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p64_s7", "idA": "1006281_11_item1_p73_s4", "sentA": "In January 2010, the FDA requested additional data regarding the Chemistry, Manufacturing and Controls (CMC) section of the NDA.", "sentB": "The requested information related mainly to the presentation of select data provided in the NDA.", "type": 2, "words": ["<tag1>", "In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA.", "<tag2>", "The", "requested", "information", "related", "mainly", "to", "the", "presentation", "of", "select", "data", "provided", "in", "the", "NDA.", "<tag3>"], "wordsA": ["In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA."], "wordsB": ["The", "requested", "information", "related", "mainly", "to", "the", "presentation", "of", "select", "data", "provided", "in", "the", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p73_s4", "idA": "1006281_11_item1_p73_s4", "sentA": "In January 2010, the FDA requested additional data regarding the Chemistry, Manufacturing and Controls (CMC) section of the NDA.", "sentB": "In January 2010, the FDA requested additional data regarding the CMC section of the NDA.", "type": 2, "words": ["<tag1>", "In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA.", "<tag2>", "In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "CMC", "section", "of", "the", "NDA.", "<tag3>"], "wordsA": ["In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA."], "wordsB": ["In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "CMC", "section", "of", "the", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p73_s6", "idA": "1006281_11_item1_p73_s4", "sentA": "In January 2010, the FDA requested additional data regarding the Chemistry, Manufacturing and Controls (CMC) section of the NDA.", "sentB": "On that date, the FDA issued a CRL indicating that the FDA s review was complete but questions remain that preclude the approval of the NDA in its then current form.", "type": 2, "words": ["<tag1>", "In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA.", "<tag2>", "On", "that", "date,", "the", "FDA", "issued", "a", "CRL", "indicating", "that", "the", "FDA", "s", "review", "was", "complete", "but", "questions", "remain", "that", "preclude", "the", "approval", "of", "the", "NDA", "in", "its", "then", "current", "form.", "<tag3>"], "wordsA": ["In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA."], "wordsB": ["On", "that", "date,", "the", "FDA", "issued", "a", "CRL", "indicating", "that", "the", "FDA", "s", "review", "was", "complete", "but", "questions", "remain", "that", "preclude", "the", "approval", "of", "the", "NDA", "in", "its", "then", "current", "form."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p74_s0", "idA": "1006281_11_item1_p73_s4", "sentA": "In January 2010, the FDA requested additional data regarding the Chemistry, Manufacturing and Controls (CMC) section of the NDA.", "sentB": "The main questions raised by the FDA regarding the NDA related to the clinical and CMC sections.", "type": 2, "words": ["<tag1>", "In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA.", "<tag2>", "The", "main", "questions", "raised", "by", "the", "FDA", "regarding", "the", "NDA", "related", "to", "the", "clinical", "and", "CMC", "sections.", "<tag3>"], "wordsA": ["In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA."], "wordsB": ["The", "main", "questions", "raised", "by", "the", "FDA", "regarding", "the", "NDA", "related", "to", "the", "clinical", "and", "CMC", "sections."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p74_s1", "idA": "1006281_11_item1_p73_s4", "sentA": "In January 2010, the FDA requested additional data regarding the Chemistry, Manufacturing and Controls (CMC) section of the NDA.", "sentB": "In the clinical section of the CRL, the FDA requested additional data from our ongoing switchover trial and our long-term extension trial.", "type": 2, "words": ["<tag1>", "In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA.", "<tag2>", "In", "the", "clinical", "section", "of", "the", "CRL,", "the", "FDA", "requested", "additional", "data", "from", "our", "ongoing", "switchover", "trial", "and", "our", "long-term", "extension", "trial.", "<tag3>"], "wordsA": ["In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA."], "wordsB": ["In", "the", "clinical", "section", "of", "the", "CRL,", "the", "FDA", "requested", "additional", "data", "from", "our", "ongoing", "switchover", "trial", "and", "our", "long-term", "extension", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p75_s0", "idA": "1006281_11_item1_p73_s4", "sentA": "In January 2010, the FDA requested additional data regarding the Chemistry, Manufacturing and Controls (CMC) section of the NDA.", "sentB": "In the CMC section of the CRL, the FDA requested information regarding testing specifications and assay validation.", "type": 2, "words": ["<tag1>", "In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA.", "<tag2>", "In", "the", "CMC", "section", "of", "the", "CRL,", "the", "FDA", "requested", "information", "regarding", "testing", "specifications", "and", "assay", "validation.", "<tag3>"], "wordsA": ["In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA."], "wordsB": ["In", "the", "CMC", "section", "of", "the", "CRL,", "the", "FDA", "requested", "information", "regarding", "testing", "specifications", "and", "assay", "validation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p75_s6", "idA": "1006281_11_item1_p73_s4", "sentA": "In January 2010, the FDA requested additional data regarding the Chemistry, Manufacturing and Controls (CMC) section of the NDA.", "sentB": "The requested information related mainly to the presentation of select data provided in the NDA.", "type": 2, "words": ["<tag1>", "In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA.", "<tag2>", "The", "requested", "information", "related", "mainly", "to", "the", "presentation", "of", "select", "data", "provided", "in", "the", "NDA.", "<tag3>"], "wordsA": ["In", "January", "2010,", "the", "FDA", "requested", "additional", "data", "regarding", "the", "Chemistry,", "Manufacturing", "and", "Controls", "(CMC)", "section", "of", "the", "NDA."], "wordsB": ["The", "requested", "information", "related", "mainly", "to", "the", "presentation", "of", "select", "data", "provided", "in", "the", "NDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p5_s3", "idA": "1006281_11_item1_p73_s5", "sentA": "We provided the requested data to the FDA in April 2010 and in July 2010 we received notification from the FDA that it had accepted the filing of our NDA and assigned it a PDUFA date of February 25, 2011.", "sentB": "In August 2011, the FDA notified us that it had accepted for review the resubmission of the taliglucerase alfa NDA, had deemed the resubmission a class 2, or 6-month, response and established February 1, 2012 as the new PDUFA date.", "type": 2, "words": ["<tag1>", "We", "provided", "the", "requested", "data", "to", "the", "FDA", "in", "April", "2010", "and", "in", "July", "2010", "we", "received", "notification", "from", "the", "FDA", "that", "it", "had", "accepted", "the", "filing", "of", "our", "NDA", "and", "assigned", "it", "a", "PDUFA", "date", "of", "February", "25,", "2011.", "<tag2>", "In", "August", "2011,", "the", "FDA", "notified", "us", "that", "it", "had", "accepted", "for", "review", "the", "resubmission", "of", "the", "taliglucerase", "alfa", "NDA,", "had", "deemed", "the", "resubmission", "a", "class", "2,", "or", "6-month,", "response", "and", "established", "February", "1,", "2012", "as", "the", "new", "PDUFA", "date.", "<tag3>"], "wordsA": ["We", "provided", "the", "requested", "data", "to", "the", "FDA", "in", "April", "2010", "and", "in", "July", "2010", "we", "received", "notification", "from", "the", "FDA", "that", "it", "had", "accepted", "the", "filing", "of", "our", "NDA", "and", "assigned", "it", "a", "PDUFA", "date", "of", "February", "25,", "2011."], "wordsB": ["In", "August", "2011,", "the", "FDA", "notified", "us", "that", "it", "had", "accepted", "for", "review", "the", "resubmission", "of", "the", "taliglucerase", "alfa", "NDA,", "had", "deemed", "the", "resubmission", "a", "class", "2,", "or", "6-month,", "response", "and", "established", "February", "1,", "2012", "as", "the", "new", "PDUFA", "date."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p75_s3", "idA": "1006281_11_item1_p73_s5", "sentA": "We provided the requested data to the FDA in April 2010 and in July 2010 we received notification from the FDA that it had accepted the filing of our NDA and assigned it a PDUFA date of February 25, 2011.", "sentB": "In August 2011, the FDA notified us that it had accepted for review the resubmission of the taliglucerase alfa NDA, had deemed the resubmission a class 2, or 6-month, response and established February 1, 2012 as the new PDUFA date.", "type": 2, "words": ["<tag1>", "We", "provided", "the", "requested", "data", "to", "the", "FDA", "in", "April", "2010", "and", "in", "July", "2010", "we", "received", "notification", "from", "the", "FDA", "that", "it", "had", "accepted", "the", "filing", "of", "our", "NDA", "and", "assigned", "it", "a", "PDUFA", "date", "of", "February", "25,", "2011.", "<tag2>", "In", "August", "2011,", "the", "FDA", "notified", "us", "that", "it", "had", "accepted", "for", "review", "the", "resubmission", "of", "the", "taliglucerase", "alfa", "NDA,", "had", "deemed", "the", "resubmission", "a", "class", "2,", "or", "6-month,", "response", "and", "established", "February", "1,", "2012", "as", "the", "new", "PDUFA", "date.", "<tag3>"], "wordsA": ["We", "provided", "the", "requested", "data", "to", "the", "FDA", "in", "April", "2010", "and", "in", "July", "2010", "we", "received", "notification", "from", "the", "FDA", "that", "it", "had", "accepted", "the", "filing", "of", "our", "NDA", "and", "assigned", "it", "a", "PDUFA", "date", "of", "February", "25,", "2011."], "wordsB": ["In", "August", "2011,", "the", "FDA", "notified", "us", "that", "it", "had", "accepted", "for", "review", "the", "resubmission", "of", "the", "taliglucerase", "alfa", "NDA,", "had", "deemed", "the", "resubmission", "a", "class", "2,", "or", "6-month,", "response", "and", "established", "February", "1,", "2012", "as", "the", "new", "PDUFA", "date."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p11_s2", "idA": "1006281_11_item1_p73_s6", "sentA": "In addition, in November 2010 we submitted a marketing application to the Israeli MOH and an MAA to each of the EMEA and ANVISA for taliglucerase alfa for the treatment of Gaucher disease.", "sentB": "In December 2011, following the submission of the taliglucerase alfa MAA to the EMA, the Irish Medicines Board, or IMB, completed a successful GMP audit of our facility and issued a Certificate of GMP Compliance of a Manufacturer for the facility.", "type": 2, "words": ["<tag1>", "In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "In", "December", "2011,", "following", "the", "submission", "of", "the", "taliglucerase", "alfa", "MAA", "to", "the", "EMA,", "the", "Irish", "Medicines", "Board,", "or", "IMB,", "completed", "a", "successful", "GMP", "audit", "of", "our", "facility", "and", "issued", "a", "Certificate", "of", "GMP", "Compliance", "of", "a", "Manufacturer", "for", "the", "facility.", "<tag3>"], "wordsA": ["In", "addition,", "in", "November", "2010", "we", "submitted", "a", "marketing", "application", "to", "the", "Israeli", "MOH", "and", "an", "MAA", "to", "each", "of", "the", "EMEA", "and", "ANVISA", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["In", "December", "2011,", "following", "the", "submission", "of", "the", "taliglucerase", "alfa", "MAA", "to", "the", "EMA,", "the", "Irish", "Medicines", "Board,", "or", "IMB,", "completed", "a", "successful", "GMP", "audit", "of", "our", "facility", "and", "issued", "a", "Certificate", "of", "GMP", "Compliance", "of", "a", "Manufacturer", "for", "the", "facility."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p84_s0", "idA": "1006281_11_item1_p74_s0", "sentA": "During the third quarter of 2008, we initiated a double blind, follow-on extension study as part of our phase III clinical trial of taliglucerase alfa in which patients that successfully completed treatment in the trial were given the opportunity to continue to be treated with taliglucerase alfa at the same dose that they received in the trial.", "sentB": "During the third quarter of 2008 , we initiated a double blind, follow-on extension study as part of our phase III clinical trial of taliglucerase alfa.", "type": 2, "words": ["<tag1>", "During", "the", "third", "quarter", "of", "2008,", "we", "initiated", "a", "double", "blind,", "follow-on", "extension", "study", "as", "part", "of", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa", "in", "which", "patients", "that", "successfully", "completed", "treatment", "in", "the", "trial", "were", "given", "the", "opportunity", "to", "continue", "to", "be", "treated", "with", "taliglucerase", "alfa", "at", "the", "same", "dose", "that", "they", "received", "in", "the", "trial.", "<tag2>", "During", "the", "third", "quarter", "of", "2008", ",", "we", "initiated", "a", "double", "blind,", "follow-on", "extension", "study", "as", "part", "of", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["During", "the", "third", "quarter", "of", "2008,", "we", "initiated", "a", "double", "blind,", "follow-on", "extension", "study", "as", "part", "of", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa", "in", "which", "patients", "that", "successfully", "completed", "treatment", "in", "the", "trial", "were", "given", "the", "opportunity", "to", "continue", "to", "be", "treated", "with", "taliglucerase", "alfa", "at", "the", "same", "dose", "that", "they", "received", "in", "the", "trial."], "wordsB": ["During", "the", "third", "quarter", "of", "2008", ",", "we", "initiated", "a", "double", "blind,", "follow-on", "extension", "study", "as", "part", "of", "our", "phase", "III", "clinical", "trial", "of", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p76_s0", "idA": "1006281_11_item1_p75_s0", "sentA": "In the fourth quarter of 2008 we announced the enrollment of the first patient in a worldwide, multi-center, open-label, switch-over trial which has been reviewed by the FDA and is designed to assess the safety and efficacy of taliglucerase alfa.", "sentB": "In the fourth quarter of 2010, Pfizer, our commercialization partner, filed, with our cooperation, an MAA for taliglucerase alfa with the EMA.", "type": 2, "words": ["<tag1>", "In", "the", "fourth", "quarter", "of", "2008", "we", "announced", "the", "enrollment", "of", "the", "first", "patient", "in", "a", "worldwide,", "multi-center,", "open-label,", "switch-over", "trial", "which", "has", "been", "reviewed", "by", "the", "FDA", "and", "is", "designed", "to", "assess", "the", "safety", "and", "efficacy", "of", "taliglucerase", "alfa.", "<tag2>", "In", "the", "fourth", "quarter", "of", "2010,", "Pfizer,", "our", "commercialization", "partner,", "filed,", "with", "our", "cooperation,", "an", "MAA", "for", "taliglucerase", "alfa", "with", "the", "EMA.", "<tag3>"], "wordsA": ["In", "the", "fourth", "quarter", "of", "2008", "we", "announced", "the", "enrollment", "of", "the", "first", "patient", "in", "a", "worldwide,", "multi-center,", "open-label,", "switch-over", "trial", "which", "has", "been", "reviewed", "by", "the", "FDA", "and", "is", "designed", "to", "assess", "the", "safety", "and", "efficacy", "of", "taliglucerase", "alfa."], "wordsB": ["In", "the", "fourth", "quarter", "of", "2010,", "Pfizer,", "our", "commercialization", "partner,", "filed,", "with", "our", "cooperation,", "an", "MAA", "for", "taliglucerase", "alfa", "with", "the", "EMA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p130_s3", "idA": "1006281_11_item1_p75_s11", "sentA": "One patient developed non-neutralizing IgG antibodies to taliglucerase at the end of the study.", "sentB": "The major endpoints of the study were spleen volume, liver volume, hemoglobin concentration, platelet count, and chitotriosidase activity.", "type": 2, "words": ["<tag1>", "One", "patient", "developed", "non-neutralizing", "IgG", "antibodies", "to", "taliglucerase", "at", "the", "end", "of", "the", "study.", "<tag2>", "The", "major", "endpoints", "of", "the", "study", "were", "spleen", "volume,", "liver", "volume,", "hemoglobin", "concentration,", "platelet", "count,", "and", "chitotriosidase", "activity.", "<tag3>"], "wordsA": ["One", "patient", "developed", "non-neutralizing", "IgG", "antibodies", "to", "taliglucerase", "at", "the", "end", "of", "the", "study."], "wordsB": ["The", "major", "endpoints", "of", "the", "study", "were", "spleen", "volume,", "liver", "volume,", "hemoglobin", "concentration,", "platelet", "count,", "and", "chitotriosidase", "activity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p145_s1", "idA": "1006281_11_item1_p75_s11", "sentA": "One patient developed non-neutralizing IgG antibodies to taliglucerase at the end of the study.", "sentB": "One patient developed neutralizing IgG antibodies that were determined to be positive in an in vitro assay, and were determined to be negative in a cell-based assay.", "type": 2, "words": ["<tag1>", "One", "patient", "developed", "non-neutralizing", "IgG", "antibodies", "to", "taliglucerase", "at", "the", "end", "of", "the", "study.", "<tag2>", "One", "patient", "developed", "neutralizing", "IgG", "antibodies", "that", "were", "determined", "to", "be", "positive", "in", "an", "in", "vitro", "assay,", "and", "were", "determined", "to", "be", "negative", "in", "a", "cell-based", "assay.", "<tag3>"], "wordsA": ["One", "patient", "developed", "non-neutralizing", "IgG", "antibodies", "to", "taliglucerase", "at", "the", "end", "of", "the", "study."], "wordsB": ["One", "patient", "developed", "neutralizing", "IgG", "antibodies", "that", "were", "determined", "to", "be", "positive", "in", "an", "in", "vitro", "assay,", "and", "were", "determined", "to", "be", "negative", "in", "a", "cell-based", "assay."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p88_s2", "idA": "1006281_11_item1_p75_s2", "sentA": "Due to the then shortage of the currently available enzyme replacement therapy for Gaucher disease, after fully enrolling the 15 patients, we extended the trial to include up to 30 patients in total.", "sentB": "Due to the then shortage of the currently available enzyme replacement therapy for Gaucher disease, after fully enrolling 15 patients, we extended the trial to include additional patients.", "type": 2, "words": ["<tag1>", "Due", "to", "the", "then", "shortage", "of", "the", "currently", "available", "enzyme", "replacement", "therapy", "for", "Gaucher", "disease,", "after", "fully", "enrolling", "the", "15", "patients,", "we", "extended", "the", "trial", "to", "include", "up", "to", "30", "patients", "in", "total.", "<tag2>", "Due", "to", "the", "then", "shortage", "of", "the", "currently", "available", "enzyme", "replacement", "therapy", "for", "Gaucher", "disease,", "after", "fully", "enrolling", "15", "patients,", "we", "extended", "the", "trial", "to", "include", "additional", "patients.", "<tag3>"], "wordsA": ["Due", "to", "the", "then", "shortage", "of", "the", "currently", "available", "enzyme", "replacement", "therapy", "for", "Gaucher", "disease,", "after", "fully", "enrolling", "the", "15", "patients,", "we", "extended", "the", "trial", "to", "include", "up", "to", "30", "patients", "in", "total."], "wordsB": ["Due", "to", "the", "then", "shortage", "of", "the", "currently", "available", "enzyme", "replacement", "therapy", "for", "Gaucher", "disease,", "after", "fully", "enrolling", "15", "patients,", "we", "extended", "the", "trial", "to", "include", "additional", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p132_s3", "idA": "1006281_11_item1_p75_s3", "sentA": "In November 2010, we announced positive preliminary data from the first 15 patients that completed the switchover trial.", "sentB": "A total of 26 adult patients were enrolled in the switchover trial.", "type": 2, "words": ["<tag1>", "In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "the", "switchover", "trial.", "<tag2>", "A", "total", "of", "26", "adult", "patients", "were", "enrolled", "in", "the", "switchover", "trial.", "<tag3>"], "wordsA": ["In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "the", "switchover", "trial."], "wordsB": ["A", "total", "of", "26", "adult", "patients", "were", "enrolled", "in", "the", "switchover", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p134_s0", "idA": "1006281_11_item1_p75_s3", "sentA": "In November 2010, we announced positive preliminary data from the first 15 patients that completed the switchover trial.", "sentB": "In February 2012, we announced data from 26 adult patients enrolled in our extension trial.", "type": 2, "words": ["<tag1>", "In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "the", "switchover", "trial.", "<tag2>", "In", "February", "2012,", "we", "announced", "data", "from", "26", "adult", "patients", "enrolled", "in", "our", "extension", "trial.", "<tag3>"], "wordsA": ["In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "the", "switchover", "trial."], "wordsB": ["In", "February", "2012,", "we", "announced", "data", "from", "26", "adult", "patients", "enrolled", "in", "our", "extension", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p13_s0", "idA": "1006281_11_item1_p75_s3", "sentA": "In November 2010, we announced positive preliminary data from the first 15 patients that completed the switchover trial.", "sentB": "In February 2012, we announced data from 26 adult patients enrolled in the trial.", "type": 2, "words": ["<tag1>", "In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "the", "switchover", "trial.", "<tag2>", "In", "February", "2012,", "we", "announced", "data", "from", "26", "adult", "patients", "enrolled", "in", "the", "trial.", "<tag3>"], "wordsA": ["In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "the", "switchover", "trial."], "wordsB": ["In", "February", "2012,", "we", "announced", "data", "from", "26", "adult", "patients", "enrolled", "in", "the", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p18_s2", "idA": "1006281_11_item1_p75_s3", "sentA": "In November 2010, we announced positive preliminary data from the first 15 patients that completed the switchover trial.", "sentB": "However, the FDA requested data from the switchover trial in the CRL which had not been available when the NDA was initially filed.", "type": 2, "words": ["<tag1>", "In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "the", "switchover", "trial.", "<tag2>", "However,", "the", "FDA", "requested", "data", "from", "the", "switchover", "trial", "in", "the", "CRL", "which", "had", "not", "been", "available", "when", "the", "NDA", "was", "initially", "filed.", "<tag3>"], "wordsA": ["In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "the", "switchover", "trial."], "wordsB": ["However,", "the", "FDA", "requested", "data", "from", "the", "switchover", "trial", "in", "the", "CRL", "which", "had", "not", "been", "available", "when", "the", "NDA", "was", "initially", "filed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p85_s0", "idA": "1006281_11_item1_p75_s3", "sentA": "In November 2010, we announced positive preliminary data from the first 15 patients that completed the switchover trial.", "sentB": "In February 2012, we announced data from 26 adult patients enrolled in the trial.", "type": 2, "words": ["<tag1>", "In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "the", "switchover", "trial.", "<tag2>", "In", "February", "2012,", "we", "announced", "data", "from", "26", "adult", "patients", "enrolled", "in", "the", "trial.", "<tag3>"], "wordsA": ["In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "the", "switchover", "trial."], "wordsB": ["In", "February", "2012,", "we", "announced", "data", "from", "26", "adult", "patients", "enrolled", "in", "the", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p88_s4", "idA": "1006281_11_item1_p75_s3", "sentA": "In November 2010, we announced positive preliminary data from the first 15 patients that completed the switchover trial.", "sentB": "A total of 26 adult patients were enrolled in the switchover trial.", "type": 2, "words": ["<tag1>", "In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "the", "switchover", "trial.", "<tag2>", "A", "total", "of", "26", "adult", "patients", "were", "enrolled", "in", "the", "switchover", "trial.", "<tag3>"], "wordsA": ["In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "the", "switchover", "trial."], "wordsB": ["A", "total", "of", "26", "adult", "patients", "were", "enrolled", "in", "the", "switchover", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p144_s1", "idA": "1006281_11_item1_p75_s4", "sentA": "The data indicate that patients can safely be switched to taliglucerase alfa from Cerezyme.", "sentB": "The results of the trial demonstrate that over a nine-month treatment period of the study, patients remained stable with regard to the efficacy endpoints spleen volume, liver volume, platelet count and hemoglobin concentration after switching to taliglucerase alfa from imiglucerase.", "type": 2, "words": ["<tag1>", "The", "data", "indicate", "that", "patients", "can", "safely", "be", "switched", "to", "taliglucerase", "alfa", "from", "Cerezyme.", "<tag2>", "The", "results", "of", "the", "trial", "demonstrate", "that", "over", "a", "nine-month", "treatment", "period", "of", "the", "study,", "patients", "remained", "stable", "with", "regard", "to", "the", "efficacy", "endpoints", "spleen", "volume,", "liver", "volume,", "platelet", "count", "and", "hemoglobin", "concentration", "after", "switching", "to", "taliglucerase", "alfa", "from", "imiglucerase.", "<tag3>"], "wordsA": ["The", "data", "indicate", "that", "patients", "can", "safely", "be", "switched", "to", "taliglucerase", "alfa", "from", "Cerezyme."], "wordsB": ["The", "results", "of", "the", "trial", "demonstrate", "that", "over", "a", "nine-month", "treatment", "period", "of", "the", "study,", "patients", "remained", "stable", "with", "regard", "to", "the", "efficacy", "endpoints", "spleen", "volume,", "liver", "volume,", "platelet", "count", "and", "hemoglobin", "concentration", "after", "switching", "to", "taliglucerase", "alfa", "from", "imiglucerase."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p132_s4", "idA": "1006281_11_item1_p75_s5", "sentA": "every other week) to an equivalent dose using the same number of units of taliglucerase alfa.", "sentB": "Patients enrolled in the trial were switched from imiglucerase (doses ranging from approximately 10-60 U/kg every other week) to an equivalent dose using the same number of units of taliglucerase alfa over a nine-month period.", "type": 2, "words": ["<tag1>", "every", "other", "week)", "to", "an", "equivalent", "dose", "using", "the", "same", "number", "of", "units", "of", "taliglucerase", "alfa.", "<tag2>", "Patients", "enrolled", "in", "the", "trial", "were", "switched", "from", "imiglucerase", "(doses", "ranging", "from", "approximately", "10-60", "U/kg", "every", "other", "week)", "to", "an", "equivalent", "dose", "using", "the", "same", "number", "of", "units", "of", "taliglucerase", "alfa", "over", "a", "nine-month", "period.", "<tag3>"], "wordsA": ["every", "other", "week)", "to", "an", "equivalent", "dose", "using", "the", "same", "number", "of", "units", "of", "taliglucerase", "alfa."], "wordsB": ["Patients", "enrolled", "in", "the", "trial", "were", "switched", "from", "imiglucerase", "(doses", "ranging", "from", "approximately", "10-60", "U/kg", "every", "other", "week)", "to", "an", "equivalent", "dose", "using", "the", "same", "number", "of", "units", "of", "taliglucerase", "alfa", "over", "a", "nine-month", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p5_s5", "idA": "1006281_11_item1_p75_s5", "sentA": "every other week) to an equivalent dose using the same number of units of taliglucerase alfa.", "sentB": "In its notification, the FDA stated that its decision related to certain clinical information regarding taliglucerase alfa we had submitted in November 2011 in response to an FDA request.", "type": 2, "words": ["<tag1>", "every", "other", "week)", "to", "an", "equivalent", "dose", "using", "the", "same", "number", "of", "units", "of", "taliglucerase", "alfa.", "<tag2>", "In", "its", "notification,", "the", "FDA", "stated", "that", "its", "decision", "related", "to", "certain", "clinical", "information", "regarding", "taliglucerase", "alfa", "we", "had", "submitted", "in", "November", "2011", "in", "response", "to", "an", "FDA", "request.", "<tag3>"], "wordsA": ["every", "other", "week)", "to", "an", "equivalent", "dose", "using", "the", "same", "number", "of", "units", "of", "taliglucerase", "alfa."], "wordsB": ["In", "its", "notification,", "the", "FDA", "stated", "that", "its", "decision", "related", "to", "certain", "clinical", "information", "regarding", "taliglucerase", "alfa", "we", "had", "submitted", "in", "November", "2011", "in", "response", "to", "an", "FDA", "request."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p64_s6", "idA": "1006281_11_item1_p75_s5", "sentA": "every other week) to an equivalent dose using the same number of units of taliglucerase alfa.", "sentB": "In its notification, the FDA stated that its decision related to certain clinical information regarding taliglucerase alfa we had submitted in November 2011 in response to an FDA request.", "type": 2, "words": ["<tag1>", "every", "other", "week)", "to", "an", "equivalent", "dose", "using", "the", "same", "number", "of", "units", "of", "taliglucerase", "alfa.", "<tag2>", "In", "its", "notification,", "the", "FDA", "stated", "that", "its", "decision", "related", "to", "certain", "clinical", "information", "regarding", "taliglucerase", "alfa", "we", "had", "submitted", "in", "November", "2011", "in", "response", "to", "an", "FDA", "request.", "<tag3>"], "wordsA": ["every", "other", "week)", "to", "an", "equivalent", "dose", "using", "the", "same", "number", "of", "units", "of", "taliglucerase", "alfa."], "wordsB": ["In", "its", "notification,", "the", "FDA", "stated", "that", "its", "decision", "related", "to", "certain", "clinical", "information", "regarding", "taliglucerase", "alfa", "we", "had", "submitted", "in", "November", "2011", "in", "response", "to", "an", "FDA", "request."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p75_s5", "idA": "1006281_11_item1_p75_s5", "sentA": "every other week) to an equivalent dose using the same number of units of taliglucerase alfa.", "sentB": "In its notification, the FDA stated that its decision related to certain clinical information regarding taliglucerase alfa we had submitted in November 2011 in response to an FDA request.", "type": 2, "words": ["<tag1>", "every", "other", "week)", "to", "an", "equivalent", "dose", "using", "the", "same", "number", "of", "units", "of", "taliglucerase", "alfa.", "<tag2>", "In", "its", "notification,", "the", "FDA", "stated", "that", "its", "decision", "related", "to", "certain", "clinical", "information", "regarding", "taliglucerase", "alfa", "we", "had", "submitted", "in", "November", "2011", "in", "response", "to", "an", "FDA", "request.", "<tag3>"], "wordsA": ["every", "other", "week)", "to", "an", "equivalent", "dose", "using", "the", "same", "number", "of", "units", "of", "taliglucerase", "alfa."], "wordsB": ["In", "its", "notification,", "the", "FDA", "stated", "that", "its", "decision", "related", "to", "certain", "clinical", "information", "regarding", "taliglucerase", "alfa", "we", "had", "submitted", "in", "November", "2011", "in", "response", "to", "an", "FDA", "request."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p88_s5", "idA": "1006281_11_item1_p75_s5", "sentA": "every other week) to an equivalent dose using the same number of units of taliglucerase alfa.", "sentB": "every other week) to an equivalent dose using the same number of units of taliglucerase alfa over a nine-month period.", "type": 2, "words": ["<tag1>", "every", "other", "week)", "to", "an", "equivalent", "dose", "using", "the", "same", "number", "of", "units", "of", "taliglucerase", "alfa.", "<tag2>", "every", "other", "week)", "to", "an", "equivalent", "dose", "using", "the", "same", "number", "of", "units", "of", "taliglucerase", "alfa", "over", "a", "nine-month", "period.", "<tag3>"], "wordsA": ["every", "other", "week)", "to", "an", "equivalent", "dose", "using", "the", "same", "number", "of", "units", "of", "taliglucerase", "alfa."], "wordsB": ["every", "other", "week)", "to", "an", "equivalent", "dose", "using", "the", "same", "number", "of", "units", "of", "taliglucerase", "alfa", "over", "a", "nine-month", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p14_s1", "idA": "1006281_11_item1_p75_s9", "sentA": "There was no evidence of increased safety concerns in patients switched from Cerezyme to taliglucerase alfa and there were no drug related serious adverse events.", "sentB": "The results of the switchover trial demonstrate that over the nine-month treatment period, patients remained stable with regard to spleen volume, liver volume, platelet count and hemoglobin concentration, the efficacy endpoints of the switchover trial, after switching from Cerezyme to taliglucerase alfa.", "type": 2, "words": ["<tag1>", "There", "was", "no", "evidence", "of", "increased", "safety", "concerns", "in", "patients", "switched", "from", "Cerezyme", "to", "taliglucerase", "alfa", "and", "there", "were", "no", "drug", "related", "serious", "adverse", "events.", "<tag2>", "The", "results", "of", "the", "switchover", "trial", "demonstrate", "that", "over", "the", "nine-month", "treatment", "period,", "patients", "remained", "stable", "with", "regard", "to", "spleen", "volume,", "liver", "volume,", "platelet", "count", "and", "hemoglobin", "concentration,", "the", "efficacy", "endpoints", "of", "the", "switchover", "trial,", "after", "switching", "from", "Cerezyme", "to", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["There", "was", "no", "evidence", "of", "increased", "safety", "concerns", "in", "patients", "switched", "from", "Cerezyme", "to", "taliglucerase", "alfa", "and", "there", "were", "no", "drug", "related", "serious", "adverse", "events."], "wordsB": ["The", "results", "of", "the", "switchover", "trial", "demonstrate", "that", "over", "the", "nine-month", "treatment", "period,", "patients", "remained", "stable", "with", "regard", "to", "spleen", "volume,", "liver", "volume,", "platelet", "count", "and", "hemoglobin", "concentration,", "the", "efficacy", "endpoints", "of", "the", "switchover", "trial,", "after", "switching", "from", "Cerezyme", "to", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p91_s0", "idA": "1006281_11_item1_p78_s0", "sentA": "We believe that taliglucerase alfa, if approved, has the potential to offer patients and healthcare payors a more effective and cost efficient treatment of Gaucher disease because of the following features:", "sentB": "We believe that taliglucerase alfa, if approved, has the potential to offer patients and healthcare payors a more effective and cost efficient treatment of Gaucher disease compared to the currently available enzyme replacement therapies because of the following advantages:", "type": 2, "words": ["<tag1>", "We", "believe", "that", "taliglucerase", "alfa,", "if", "approved,", "has", "the", "potential", "to", "offer", "patients", "and", "healthcare", "payors", "a", "more", "effective", "and", "cost", "efficient", "treatment", "of", "Gaucher", "disease", "because", "of", "the", "following", "features:", "<tag2>", "We", "believe", "that", "taliglucerase", "alfa,", "if", "approved,", "has", "the", "potential", "to", "offer", "patients", "and", "healthcare", "payors", "a", "more", "effective", "and", "cost", "efficient", "treatment", "of", "Gaucher", "disease", "compared", "to", "the", "currently", "available", "enzyme", "replacement", "therapies", "because", "of", "the", "following", "advantages:", "<tag3>"], "wordsA": ["We", "believe", "that", "taliglucerase", "alfa,", "if", "approved,", "has", "the", "potential", "to", "offer", "patients", "and", "healthcare", "payors", "a", "more", "effective", "and", "cost", "efficient", "treatment", "of", "Gaucher", "disease", "because", "of", "the", "following", "features:"], "wordsB": ["We", "believe", "that", "taliglucerase", "alfa,", "if", "approved,", "has", "the", "potential", "to", "offer", "patients", "and", "healthcare", "payors", "a", "more", "effective", "and", "cost", "efficient", "treatment", "of", "Gaucher", "disease", "compared", "to", "the", "currently", "available", "enzyme", "replacement", "therapies", "because", "of", "the", "following", "advantages:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p12_s0", "idA": "1006281_11_item1_p7_s0", "sentA": "In addition to our recently completed phase III clinical trial, we initiated a double-blind, follow-on extension study as part of the trial during the second quarter of 2008.", "sentB": "In addition to the completed phase III clinical trial we completed in September 2009, we initiated a double-blind, follow-on extension study as part of the trial during the second quarter of 2008.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "recently", "completed", "phase", "III", "clinical", "trial,", "we", "initiated", "a", "double-blind,", "follow-on", "extension", "study", "as", "part", "of", "the", "trial", "during", "the", "second", "quarter", "of", "2008.", "<tag2>", "In", "addition", "to", "the", "completed", "phase", "III", "clinical", "trial", "we", "completed", "in", "September", "2009,", "we", "initiated", "a", "double-blind,", "follow-on", "extension", "study", "as", "part", "of", "the", "trial", "during", "the", "second", "quarter", "of", "2008.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "recently", "completed", "phase", "III", "clinical", "trial,", "we", "initiated", "a", "double-blind,", "follow-on", "extension", "study", "as", "part", "of", "the", "trial", "during", "the", "second", "quarter", "of", "2008."], "wordsB": ["In", "addition", "to", "the", "completed", "phase", "III", "clinical", "trial", "we", "completed", "in", "September", "2009,", "we", "initiated", "a", "double-blind,", "follow-on", "extension", "study", "as", "part", "of", "the", "trial", "during", "the", "second", "quarter", "of", "2008."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p131_s1", "idA": "1006281_11_item1_p7_s1", "sentA": "We also initiated a home care treatment program for patients enrolled in the extension study and, in December 2008, we initiated a nine-month, worldwide, multi-center, open-label, switch-over clinical study evaluating the safety and efficacy of switching Gaucher patients currently treated under the current standard of care to treatment with taliglucerase alfa.", "sentB": "We have also initiated a home care treatment program for patients enrolled in the extension study.", "type": 2, "words": ["<tag1>", "We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study", "and,", "in", "December", "2008,", "we", "initiated", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "under", "the", "current", "standard", "of", "care", "to", "treatment", "with", "taliglucerase", "alfa.", "<tag2>", "We", "have", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study.", "<tag3>"], "wordsA": ["We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study", "and,", "in", "December", "2008,", "we", "initiated", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "under", "the", "current", "standard", "of", "care", "to", "treatment", "with", "taliglucerase", "alfa."], "wordsB": ["We", "have", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p13_s3", "idA": "1006281_11_item1_p7_s1", "sentA": "We also initiated a home care treatment program for patients enrolled in the extension study and, in December 2008, we initiated a nine-month, worldwide, multi-center, open-label, switch-over clinical study evaluating the safety and efficacy of switching Gaucher patients currently treated under the current standard of care to treatment with taliglucerase alfa.", "sentB": "We have also initiated a home care treatment program for patients enrolled in the extension study.", "type": 2, "words": ["<tag1>", "We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study", "and,", "in", "December", "2008,", "we", "initiated", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "under", "the", "current", "standard", "of", "care", "to", "treatment", "with", "taliglucerase", "alfa.", "<tag2>", "We", "have", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study.", "<tag3>"], "wordsA": ["We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study", "and,", "in", "December", "2008,", "we", "initiated", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "under", "the", "current", "standard", "of", "care", "to", "treatment", "with", "taliglucerase", "alfa."], "wordsB": ["We", "have", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p14_s0", "idA": "1006281_11_item1_p7_s1", "sentA": "We also initiated a home care treatment program for patients enrolled in the extension study and, in December 2008, we initiated a nine-month, worldwide, multi-center, open-label, switch-over clinical study evaluating the safety and efficacy of switching Gaucher patients currently treated under the current standard of care to treatment with taliglucerase alfa.", "sentB": "In the second quarter of 2011, we successfully completed a nine-month, worldwide, multi-center, open-label, switch-over clinical study evaluating the safety and efficacy of switching Gaucher patients currently treated with Cerezyme , which is produced by Genzyme Corporation, or Genzyme (which was acquired by Sanofi-Aventis, or Sanofi, in April 2011), with taliglucerase alfa.", "type": 2, "words": ["<tag1>", "We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study", "and,", "in", "December", "2008,", "we", "initiated", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "under", "the", "current", "standard", "of", "care", "to", "treatment", "with", "taliglucerase", "alfa.", "<tag2>", "In", "the", "second", "quarter", "of", "2011,", "we", "successfully", "completed", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "with", "Cerezyme", ",", "which", "is", "produced", "by", "Genzyme", "Corporation,", "or", "Genzyme", "(which", "was", "acquired", "by", "Sanofi-Aventis,", "or", "Sanofi,", "in", "April", "2011),", "with", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study", "and,", "in", "December", "2008,", "we", "initiated", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "under", "the", "current", "standard", "of", "care", "to", "treatment", "with", "taliglucerase", "alfa."], "wordsB": ["In", "the", "second", "quarter", "of", "2011,", "we", "successfully", "completed", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "with", "Cerezyme", ",", "which", "is", "produced", "by", "Genzyme", "Corporation,", "or", "Genzyme", "(which", "was", "acquired", "by", "Sanofi-Aventis,", "or", "Sanofi,", "in", "April", "2011),", "with", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p85_s3", "idA": "1006281_11_item1_p7_s1", "sentA": "We also initiated a home care treatment program for patients enrolled in the extension study and, in December 2008, we initiated a nine-month, worldwide, multi-center, open-label, switch-over clinical study evaluating the safety and efficacy of switching Gaucher patients currently treated under the current standard of care to treatment with taliglucerase alfa.", "sentB": "We have also initiated a home care treatment program for patients enrolled in the extension study.", "type": 2, "words": ["<tag1>", "We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study", "and,", "in", "December", "2008,", "we", "initiated", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "under", "the", "current", "standard", "of", "care", "to", "treatment", "with", "taliglucerase", "alfa.", "<tag2>", "We", "have", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study.", "<tag3>"], "wordsA": ["We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study", "and,", "in", "December", "2008,", "we", "initiated", "a", "nine-month,", "worldwide,", "multi-center,", "open-label,", "switch-over", "clinical", "study", "evaluating", "the", "safety", "and", "efficacy", "of", "switching", "Gaucher", "patients", "currently", "treated", "under", "the", "current", "standard", "of", "care", "to", "treatment", "with", "taliglucerase", "alfa."], "wordsB": ["We", "have", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p93_s1", "idA": "1006281_11_item1_p80_s0", "sentA": "activity demonstrated in proteins produced through mammalian cell-based expression systems due to its greater glycan efficacy and consistency.", "sentB": "This results in a highly active product that may achieve a desired therapeutic effect more effectively than the activity demonstrated in proteins produced through mammalian cell-based expression systems due to its greater glycan efficacy and consistency.", "type": 2, "words": ["<tag1>", "activity", "demonstrated", "in", "proteins", "produced", "through", "mammalian", "cell-based", "expression", "systems", "due", "to", "its", "greater", "glycan", "efficacy", "and", "consistency.", "<tag2>", "This", "results", "in", "a", "highly", "active", "product", "that", "may", "achieve", "a", "desired", "therapeutic", "effect", "more", "effectively", "than", "the", "activity", "demonstrated", "in", "proteins", "produced", "through", "mammalian", "cell-based", "expression", "systems", "due", "to", "its", "greater", "glycan", "efficacy", "and", "consistency.", "<tag3>"], "wordsA": ["activity", "demonstrated", "in", "proteins", "produced", "through", "mammalian", "cell-based", "expression", "systems", "due", "to", "its", "greater", "glycan", "efficacy", "and", "consistency."], "wordsB": ["This", "results", "in", "a", "highly", "active", "product", "that", "may", "achieve", "a", "desired", "therapeutic", "effect", "more", "effectively", "than", "the", "activity", "demonstrated", "in", "proteins", "produced", "through", "mammalian", "cell-based", "expression", "systems", "due", "to", "its", "greater", "glycan", "efficacy", "and", "consistency."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p172_s1", "idA": "1006281_11_item1_p85_s0", "sentA": "Our oral taliglucerase alfa is a plant cell expressed form of GCD that is naturally encapsulated within carrot cells genetically engineered to express the GCD enzyme.", "sentB": "Oral GCD is a plant cell-expressed form of GCD that is naturally encapsulated within carrot cells that are genetically engineered to express the GCD enzyme.", "type": 2, "words": ["<tag1>", "Our", "oral", "taliglucerase", "alfa", "is", "a", "plant", "cell", "expressed", "form", "of", "GCD", "that", "is", "naturally", "encapsulated", "within", "carrot", "cells", "genetically", "engineered", "to", "express", "the", "GCD", "enzyme.", "<tag2>", "Oral", "GCD", "is", "a", "plant", "cell-expressed", "form", "of", "GCD", "that", "is", "naturally", "encapsulated", "within", "carrot", "cells", "that", "are", "genetically", "engineered", "to", "express", "the", "GCD", "enzyme.", "<tag3>"], "wordsA": ["Our", "oral", "taliglucerase", "alfa", "is", "a", "plant", "cell", "expressed", "form", "of", "GCD", "that", "is", "naturally", "encapsulated", "within", "carrot", "cells", "genetically", "engineered", "to", "express", "the", "GCD", "enzyme."], "wordsB": ["Oral", "GCD", "is", "a", "plant", "cell-expressed", "form", "of", "GCD", "that", "is", "naturally", "encapsulated", "within", "carrot", "cells", "that", "are", "genetically", "engineered", "to", "express", "the", "GCD", "enzyme."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p173_s2", "idA": "1006281_11_item1_p85_s1", "sentA": "Pre-clinical studies of oral taliglucerase alfa demonstrate the stability of the enzyme in the cell and the capacity of the cell s cellulose wall to protect the enzyme against degradation in the digestive tract in an in-vitro model of the stomach and intestines.", "sentB": "We are currently conducting large animal studies of oral GCD to demonstrate the stability of the enzyme in the cell and the capacity of the cellulose wall to protect the enzyme against degradation in the digestive tract in an in vitro model of the stomach and intestines.", "type": 2, "words": ["<tag1>", "Pre-clinical", "studies", "of", "oral", "taliglucerase", "alfa", "demonstrate", "the", "stability", "of", "the", "enzyme", "in", "the", "cell", "and", "the", "capacity", "of", "the", "cell", "s", "cellulose", "wall", "to", "protect", "the", "enzyme", "against", "degradation", "in", "the", "digestive", "tract", "in", "an", "in-vitro", "model", "of", "the", "stomach", "and", "intestines.", "<tag2>", "We", "are", "currently", "conducting", "large", "animal", "studies", "of", "oral", "GCD", "to", "demonstrate", "the", "stability", "of", "the", "enzyme", "in", "the", "cell", "and", "the", "capacity", "of", "the", "cellulose", "wall", "to", "protect", "the", "enzyme", "against", "degradation", "in", "the", "digestive", "tract", "in", "an", "in", "vitro", "model", "of", "the", "stomach", "and", "intestines.", "<tag3>"], "wordsA": ["Pre-clinical", "studies", "of", "oral", "taliglucerase", "alfa", "demonstrate", "the", "stability", "of", "the", "enzyme", "in", "the", "cell", "and", "the", "capacity", "of", "the", "cell", "s", "cellulose", "wall", "to", "protect", "the", "enzyme", "against", "degradation", "in", "the", "digestive", "tract", "in", "an", "in-vitro", "model", "of", "the", "stomach", "and", "intestines."], "wordsB": ["We", "are", "currently", "conducting", "large", "animal", "studies", "of", "oral", "GCD", "to", "demonstrate", "the", "stability", "of", "the", "enzyme", "in", "the", "cell", "and", "the", "capacity", "of", "the", "cellulose", "wall", "to", "protect", "the", "enzyme", "against", "degradation", "in", "the", "digestive", "tract", "in", "an", "in", "vitro", "model", "of", "the", "stomach", "and", "intestines."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p107_s0", "idA": "1006281_11_item1_p93_s0", "sentA": "encoding GCD, a lysosomal enzyme that catalyzes the degradation of the fatty substrate, glucosylceramide (GlcCer).", "sentB": "Gaucher disease is caused by mutations or deficiencies in the gene encoding GCD, a lysosomal enzyme that catalyzes the degradation of the fatty substrate, glucosylceramide (GlcCer).", "type": 2, "words": ["<tag1>", "encoding", "GCD,", "a", "lysosomal", "enzyme", "that", "catalyzes", "the", "degradation", "of", "the", "fatty", "substrate,", "glucosylceramide", "(GlcCer).", "<tag2>", "Gaucher", "disease", "is", "caused", "by", "mutations", "or", "deficiencies", "in", "the", "gene", "encoding", "GCD,", "a", "lysosomal", "enzyme", "that", "catalyzes", "the", "degradation", "of", "the", "fatty", "substrate,", "glucosylceramide", "(GlcCer).", "<tag3>"], "wordsA": ["encoding", "GCD,", "a", "lysosomal", "enzyme", "that", "catalyzes", "the", "degradation", "of", "the", "fatty", "substrate,", "glucosylceramide", "(GlcCer)."], "wordsB": ["Gaucher", "disease", "is", "caused", "by", "mutations", "or", "deficiencies", "in", "the", "gene", "encoding", "GCD,", "a", "lysosomal", "enzyme", "that", "catalyzes", "the", "degradation", "of", "the", "fatty", "substrate,", "glucosylceramide", "(GlcCer)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p165_s4", "idA": "1006281_11_item1_p94_s2", "sentA": "Gaucher cells accumulate in the spleen, liver, lungs, bone marrow and brain.", "sentB": "Furthermore, according to the article, intravenous injection with PRX-105 induced a protective gene expression profile in the striatum of the brain.", "type": 2, "words": ["<tag1>", "Gaucher", "cells", "accumulate", "in", "the", "spleen,", "liver,", "lungs,", "bone", "marrow", "and", "brain.", "<tag2>", "Furthermore,", "according", "to", "the", "article,", "intravenous", "injection", "with", "PRX-105", "induced", "a", "protective", "gene", "expression", "profile", "in", "the", "striatum", "of", "the", "brain.", "<tag3>"], "wordsA": ["Gaucher", "cells", "accumulate", "in", "the", "spleen,", "liver,", "lungs,", "bone", "marrow", "and", "brain."], "wordsB": ["Furthermore,", "according", "to", "the", "article,", "intravenous", "injection", "with", "PRX-105", "induced", "a", "protective", "gene", "expression", "profile", "in", "the", "striatum", "of", "the", "brain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p16_s0", "idA": "1006281_11_item1_p96_s0", "sentA": "The standard of care for Gaucher disease is enzyme replacement therapy using recombinant GCD to replace the mutated or deficient natural GCD enzyme.", "sentB": "The current standard of care for Gaucher patients is enzyme replacement therapy with either Cerezyme or, since its U.S. approval in February 2010, VPRIV.", "type": 2, "words": ["<tag1>", "The", "standard", "of", "care", "for", "Gaucher", "disease", "is", "enzyme", "replacement", "therapy", "using", "recombinant", "GCD", "to", "replace", "the", "mutated", "or", "deficient", "natural", "GCD", "enzyme.", "<tag2>", "The", "current", "standard", "of", "care", "for", "Gaucher", "patients", "is", "enzyme", "replacement", "therapy", "with", "either", "Cerezyme", "or,", "since", "its", "U.S.", "approval", "in", "February", "2010,", "VPRIV.", "<tag3>"], "wordsA": ["The", "standard", "of", "care", "for", "Gaucher", "disease", "is", "enzyme", "replacement", "therapy", "using", "recombinant", "GCD", "to", "replace", "the", "mutated", "or", "deficient", "natural", "GCD", "enzyme."], "wordsB": ["The", "current", "standard", "of", "care", "for", "Gaucher", "patients", "is", "enzyme", "replacement", "therapy", "with", "either", "Cerezyme", "or,", "since", "its", "U.S.", "approval", "in", "February", "2010,", "VPRIV."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p110_s1", "idA": "1006281_11_item1_p96_s1", "sentA": "The latest studies estimate that there are approximately 10,000 patients suffering from Gaucher disease worldwide.", "sentB": "The latest studies estimate that there are approximately 12,000 patients suffering from Gaucher disease worldwide, but only approximately 6,000 patients are undergoing treatment.", "type": 2, "words": ["<tag1>", "The", "latest", "studies", "estimate", "that", "there", "are", "approximately", "10,000", "patients", "suffering", "from", "Gaucher", "disease", "worldwide.", "<tag2>", "The", "latest", "studies", "estimate", "that", "there", "are", "approximately", "12,000", "patients", "suffering", "from", "Gaucher", "disease", "worldwide,", "but", "only", "approximately", "6,000", "patients", "are", "undergoing", "treatment.", "<tag3>"], "wordsA": ["The", "latest", "studies", "estimate", "that", "there", "are", "approximately", "10,000", "patients", "suffering", "from", "Gaucher", "disease", "worldwide."], "wordsB": ["The", "latest", "studies", "estimate", "that", "there", "are", "approximately", "12,000", "patients", "suffering", "from", "Gaucher", "disease", "worldwide,", "but", "only", "approximately", "6,000", "patients", "are", "undergoing", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p111_s1", "idA": "1006281_11_item1_p97_s1", "sentA": "Cerezyme, an enzyme replacement therapy commercialized by Genzyme, and VPRIV, an enzyme replacement therapy commercialized by Shire, are the only recombinant GCDs currently available on the market for the treatment of Gaucher disease.", "sentB": "Cerezyme and VPRIV, enzyme replacement therapies commercialized by Genzyme and Shire, respectively, are the only recombinant GCDs currently available on the market for the treatment of Gaucher disease.", "type": 2, "words": ["<tag1>", "Cerezyme,", "an", "enzyme", "replacement", "therapy", "commercialized", "by", "Genzyme,", "and", "VPRIV,", "an", "enzyme", "replacement", "therapy", "commercialized", "by", "Shire,", "are", "the", "only", "recombinant", "GCDs", "currently", "available", "on", "the", "market", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "Cerezyme", "and", "VPRIV,", "enzyme", "replacement", "therapies", "commercialized", "by", "Genzyme", "and", "Shire,", "respectively,", "are", "the", "only", "recombinant", "GCDs", "currently", "available", "on", "the", "market", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag3>"], "wordsA": ["Cerezyme,", "an", "enzyme", "replacement", "therapy", "commercialized", "by", "Genzyme,", "and", "VPRIV,", "an", "enzyme", "replacement", "therapy", "commercialized", "by", "Shire,", "are", "the", "only", "recombinant", "GCDs", "currently", "available", "on", "the", "market", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["Cerezyme", "and", "VPRIV,", "enzyme", "replacement", "therapies", "commercialized", "by", "Genzyme", "and", "Shire,", "respectively,", "are", "the", "only", "recombinant", "GCDs", "currently", "available", "on", "the", "market", "for", "the", "treatment", "of", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p115_s0", "idA": "1006281_11_item1_p98_s0", "sentA": "Cerezyme is produced through a mammalian cell-based protein expression process in CHO cells.", "sentB": "Cerezyme is produced through a mammalian cell-based protein expression process in CHO cells and VPRIV is produced using a human cancer cell line.", "type": 2, "words": ["<tag1>", "Cerezyme", "is", "produced", "through", "a", "mammalian", "cell-based", "protein", "expression", "process", "in", "CHO", "cells.", "<tag2>", "Cerezyme", "is", "produced", "through", "a", "mammalian", "cell-based", "protein", "expression", "process", "in", "CHO", "cells", "and", "VPRIV", "is", "produced", "using", "a", "human", "cancer", "cell", "line.", "<tag3>"], "wordsA": ["Cerezyme", "is", "produced", "through", "a", "mammalian", "cell-based", "protein", "expression", "process", "in", "CHO", "cells."], "wordsB": ["Cerezyme", "is", "produced", "through", "a", "mammalian", "cell-based", "protein", "expression", "process", "in", "CHO", "cells", "and", "VPRIV", "is", "produced", "using", "a", "human", "cancer", "cell", "line."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p116_s0", "idA": "1006281_11_item1_p99_s0", "sentA": "There are no known severe side effects to the use of Cerezyme and its approved use over the past decade suggests that it is an effective treatment of Gaucher disease.", "sentB": "There are no known severe side effects to the use of Cerezyme or VPRIV, and Cerezyme's approved use over the past decade suggests that it is an effective treatment of Gaucher disease.", "type": 2, "words": ["<tag1>", "There", "are", "no", "known", "severe", "side", "effects", "to", "the", "use", "of", "Cerezyme", "and", "its", "approved", "use", "over", "the", "past", "decade", "suggests", "that", "it", "is", "an", "effective", "treatment", "of", "Gaucher", "disease.", "<tag2>", "There", "are", "no", "known", "severe", "side", "effects", "to", "the", "use", "of", "Cerezyme", "or", "VPRIV,", "and", "Cerezyme's", "approved", "use", "over", "the", "past", "decade", "suggests", "that", "it", "is", "an", "effective", "treatment", "of", "Gaucher", "disease.", "<tag3>"], "wordsA": ["There", "are", "no", "known", "severe", "side", "effects", "to", "the", "use", "of", "Cerezyme", "and", "its", "approved", "use", "over", "the", "past", "decade", "suggests", "that", "it", "is", "an", "effective", "treatment", "of", "Gaucher", "disease."], "wordsB": ["There", "are", "no", "known", "severe", "side", "effects", "to", "the", "use", "of", "Cerezyme", "or", "VPRIV,", "and", "Cerezyme's", "approved", "use", "over", "the", "past", "decade", "suggests", "that", "it", "is", "an", "effective", "treatment", "of", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_12_item1_p116_s1", "idA": "1006281_11_item1_p99_s1", "sentA": "However, Cerezyme is subject to the limitations of most mammalian cell-based therapeutic proteins, including lengthy and costly production processes and contamination risks.", "sentB": "However, Cerezyme and VPRIV are both subject to the limitations of most mammalian cell-based therapeutic proteins, including lengthy and costly production processes and contamination risks.", "type": 2, "words": ["<tag1>", "However,", "Cerezyme", "is", "subject", "to", "the", "limitations", "of", "most", "mammalian", "cell-based", "therapeutic", "proteins,", "including", "lengthy", "and", "costly", "production", "processes", "and", "contamination", "risks.", "<tag2>", "However,", "Cerezyme", "and", "VPRIV", "are", "both", "subject", "to", "the", "limitations", "of", "most", "mammalian", "cell-based", "therapeutic", "proteins,", "including", "lengthy", "and", "costly", "production", "processes", "and", "contamination", "risks.", "<tag3>"], "wordsA": ["However,", "Cerezyme", "is", "subject", "to", "the", "limitations", "of", "most", "mammalian", "cell-based", "therapeutic", "proteins,", "including", "lengthy", "and", "costly", "production", "processes", "and", "contamination", "risks."], "wordsB": ["However,", "Cerezyme", "and", "VPRIV", "are", "both", "subject", "to", "the", "limitations", "of", "most", "mammalian", "cell-based", "therapeutic", "proteins,", "including", "lengthy", "and", "costly", "production", "processes", "and", "contamination", "risks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p0_s1", "idA": "1006281_14_item1_p0_s1", "sentA": "Using our ProCellEx system, we are developing a pipeline of proprietary, biobetter and biosimilar versions of recombinant therapeutic proteins, based on our plant cell-based expression technology, that primarily target large, established pharmaceutical markets and that rely upon known biological mechanisms of action.", "sentB": "Using our ProCellEx system, we are developing a pipeline of proprietary, clinically superior versions of recombinant therapeutic proteins that primarily target large, established pharmaceutical markets and that in most cases rely upon known biological mechanisms of action.", "type": 2, "words": ["<tag1>", "Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary,", "biobetter", "and", "biosimilar", "versions", "of", "recombinant", "therapeutic", "proteins,", "based", "on", "our", "plant", "cell-based", "expression", "technology,", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag2>", "Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "in", "most", "cases", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag3>"], "wordsA": ["Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary,", "biobetter", "and", "biosimilar", "versions", "of", "recombinant", "therapeutic", "proteins,", "based", "on", "our", "plant", "cell-based", "expression", "technology,", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "wordsB": ["Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "in", "most", "cases", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p80_s2", "idA": "1006281_14_item1_p104_s2", "sentA": "Sanofi reported 383 million (approximately $509 million) in worldwide sales of Fabrazyme in 2013, a growth of 39% compared to 2012.", "sentB": "Sanofi reported 460 million (approximately $557 million) in worldwide sales of Fabrazyme in 2014, a growth of 23% compared to 2013.", "type": 2, "words": ["<tag1>", "Sanofi", "reported", "383", "million", "(approximately", "$509", "million)", "in", "worldwide", "sales", "of", "Fabrazyme", "in", "2013,", "a", "growth", "of", "39%", "compared", "to", "2012.", "<tag2>", "Sanofi", "reported", "460", "million", "(approximately", "$557", "million)", "in", "worldwide", "sales", "of", "Fabrazyme", "in", "2014,", "a", "growth", "of", "23%", "compared", "to", "2013.", "<tag3>"], "wordsA": ["Sanofi", "reported", "383", "million", "(approximately", "$509", "million)", "in", "worldwide", "sales", "of", "Fabrazyme", "in", "2013,", "a", "growth", "of", "39%", "compared", "to", "2012."], "wordsB": ["Sanofi", "reported", "460", "million", "(approximately", "$557", "million)", "in", "worldwide", "sales", "of", "Fabrazyme", "in", "2014,", "a", "growth", "of", "23%", "compared", "to", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p81_s1", "idA": "1006281_14_item1_p104_s4", "sentA": "Shire reported $467.9 million in sales of Replagal in 2013, a decline of 6% compared to 2012.", "sentB": "Shire reported $500 million in sales of Replagal in 2014, an increase of 7% compared to 2013.", "type": 2, "words": ["<tag1>", "Shire", "reported", "$467.9", "million", "in", "sales", "of", "Replagal", "in", "2013,", "a", "decline", "of", "6%", "compared", "to", "2012.", "<tag2>", "Shire", "reported", "$500", "million", "in", "sales", "of", "Replagal", "in", "2014,", "an", "increase", "of", "7%", "compared", "to", "2013.", "<tag3>"], "wordsA": ["Shire", "reported", "$467.9", "million", "in", "sales", "of", "Replagal", "in", "2013,", "a", "decline", "of", "6%", "compared", "to", "2012."], "wordsB": ["Shire", "reported", "$500", "million", "in", "sales", "of", "Replagal", "in", "2014,", "an", "increase", "of", "7%", "compared", "to", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p96_s0", "idA": "1006281_14_item1_p106_s0", "sentA": "PRX-102 has demonstrated a significantly longer circular half-life than that of Replagal, over 40 times greater.", "sentB": "PRX-102 has a significantly longer circulatory half-life (T ) of approximately 60 hours, and a substantially higher area under the curve (AUC) of approximately 70,000 ng/mL*hour for the 0.2mg/kg dose, when compared to currently marketed enzyme replacement therapies.", "type": 2, "words": ["<tag1>", "PRX-102", "has", "demonstrated", "a", "significantly", "longer", "circular", "half-life", "than", "that", "of", "Replagal,", "over", "40", "times", "greater.", "<tag2>", "PRX-102", "has", "a", "significantly", "longer", "circulatory", "half-life", "(T", ")", "of", "approximately", "60", "hours,", "and", "a", "substantially", "higher", "area", "under", "the", "curve", "(AUC)", "of", "approximately", "70,000", "ng/mL*hour", "for", "the", "0.2mg/kg", "dose,", "when", "compared", "to", "currently", "marketed", "enzyme", "replacement", "therapies.", "<tag3>"], "wordsA": ["PRX-102", "has", "demonstrated", "a", "significantly", "longer", "circular", "half-life", "than", "that", "of", "Replagal,", "over", "40", "times", "greater."], "wordsB": ["PRX-102", "has", "a", "significantly", "longer", "circulatory", "half-life", "(T", ")", "of", "approximately", "60", "hours,", "and", "a", "substantially", "higher", "area", "under", "the", "curve", "(AUC)", "of", "approximately", "70,000", "ng/mL*hour", "for", "the", "0.2mg/kg", "dose,", "when", "compared", "to", "currently", "marketed", "enzyme", "replacement", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p112_s0", "idA": "1006281_14_item1_p108_s0", "sentA": "In December 2012, the first patient was treated with PRX-102 in our phase I/II clinical trial of Fabry patients.", "sentB": "In February 2015, the last Gaucher patient was treated in our phase IIa clinical trial of oral GCD.", "type": 2, "words": ["<tag1>", "In", "December", "2012,", "the", "first", "patient", "was", "treated", "with", "PRX-102", "in", "our", "phase", "I/II", "clinical", "trial", "of", "Fabry", "patients.", "<tag2>", "In", "February", "2015,", "the", "last", "Gaucher", "patient", "was", "treated", "in", "our", "phase", "IIa", "clinical", "trial", "of", "oral", "GCD.", "<tag3>"], "wordsA": ["In", "December", "2012,", "the", "first", "patient", "was", "treated", "with", "PRX-102", "in", "our", "phase", "I/II", "clinical", "trial", "of", "Fabry", "patients."], "wordsB": ["In", "February", "2015,", "the", "last", "Gaucher", "patient", "was", "treated", "in", "our", "phase", "IIa", "clinical", "trial", "of", "oral", "GCD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p83_s0", "idA": "1006281_14_item1_p108_s0", "sentA": "In December 2012, the first patient was treated with PRX-102 in our phase I/II clinical trial of Fabry patients.", "sentB": "In February 2015, we announced the completion of enrollment in our phase I/II clinical trial in adult Fabry patients.", "type": 2, "words": ["<tag1>", "In", "December", "2012,", "the", "first", "patient", "was", "treated", "with", "PRX-102", "in", "our", "phase", "I/II", "clinical", "trial", "of", "Fabry", "patients.", "<tag2>", "In", "February", "2015,", "we", "announced", "the", "completion", "of", "enrollment", "in", "our", "phase", "I/II", "clinical", "trial", "in", "adult", "Fabry", "patients.", "<tag3>"], "wordsA": ["In", "December", "2012,", "the", "first", "patient", "was", "treated", "with", "PRX-102", "in", "our", "phase", "I/II", "clinical", "trial", "of", "Fabry", "patients."], "wordsB": ["In", "February", "2015,", "we", "announced", "the", "completion", "of", "enrollment", "in", "our", "phase", "I/II", "clinical", "trial", "in", "adult", "Fabry", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p91_s0", "idA": "1006281_14_item1_p108_s0", "sentA": "In December 2012, the first patient was treated with PRX-102 in our phase I/II clinical trial of Fabry patients.", "sentB": "The leading causes for death of Fabry patients include cardiovascular disease and renal failures.", "type": 2, "words": ["<tag1>", "In", "December", "2012,", "the", "first", "patient", "was", "treated", "with", "PRX-102", "in", "our", "phase", "I/II", "clinical", "trial", "of", "Fabry", "patients.", "<tag2>", "The", "leading", "causes", "for", "death", "of", "Fabry", "patients", "include", "cardiovascular", "disease", "and", "renal", "failures.", "<tag3>"], "wordsA": ["In", "December", "2012,", "the", "first", "patient", "was", "treated", "with", "PRX-102", "in", "our", "phase", "I/II", "clinical", "trial", "of", "Fabry", "patients."], "wordsB": ["The", "leading", "causes", "for", "death", "of", "Fabry", "patients", "include", "cardiovascular", "disease", "and", "renal", "failures."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p83_s2", "idA": "1006281_14_item1_p108_s2", "sentA": "The trial is designed to enroll 18 adult Fabry patients, each in one of three dosing groups.", "sentB": "There were 18 adult Fabry patients (11 male and 7 female) enrolled in the trial, each in one of three dosing groups, 0.2 mg/kg, 1mg/kg and 2mg/kg.", "type": 2, "words": ["<tag1>", "The", "trial", "is", "designed", "to", "enroll", "18", "adult", "Fabry", "patients,", "each", "in", "one", "of", "three", "dosing", "groups.", "<tag2>", "There", "were", "18", "adult", "Fabry", "patients", "(11", "male", "and", "7", "female)", "enrolled", "in", "the", "trial,", "each", "in", "one", "of", "three", "dosing", "groups,", "0.2", "mg/kg,", "1mg/kg", "and", "2mg/kg.", "<tag3>"], "wordsA": ["The", "trial", "is", "designed", "to", "enroll", "18", "adult", "Fabry", "patients,", "each", "in", "one", "of", "three", "dosing", "groups."], "wordsB": ["There", "were", "18", "adult", "Fabry", "patients", "(11", "male", "and", "7", "female)", "enrolled", "in", "the", "trial,", "each", "in", "one", "of", "three", "dosing", "groups,", "0.2", "mg/kg,", "1mg/kg", "and", "2mg/kg."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p83_s3", "idA": "1006281_14_item1_p108_s3", "sentA": "Each patient will receive intravenous infusions of PRX-102 every two weeks for 12 weeks.", "sentB": "Each patient receives intravenous infusions of PRX-102 every two weeks for 12 weeks, with a six-month efficacy follow up period.", "type": 2, "words": ["<tag1>", "Each", "patient", "will", "receive", "intravenous", "infusions", "of", "PRX-102", "every", "two", "weeks", "for", "12", "weeks.", "<tag2>", "Each", "patient", "receives", "intravenous", "infusions", "of", "PRX-102", "every", "two", "weeks", "for", "12", "weeks,", "with", "a", "six-month", "efficacy", "follow", "up", "period.", "<tag3>"], "wordsA": ["Each", "patient", "will", "receive", "intravenous", "infusions", "of", "PRX-102", "every", "two", "weeks", "for", "12", "weeks."], "wordsB": ["Each", "patient", "receives", "intravenous", "infusions", "of", "PRX-102", "every", "two", "weeks", "for", "12", "weeks,", "with", "a", "six-month", "efficacy", "follow", "up", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p110_s1", "idA": "1006281_14_item1_p108_s4", "sentA": "After the completion of the protocol, we intend to offer enrolled trial patients the option to continue to receive PRX-102 in an open-label extension study.", "sentB": "Upon reviewing the results of the trial, expected in early 2016, we intend to collaborate with a well-suited partner for further development.", "type": 2, "words": ["<tag1>", "After", "the", "completion", "of", "the", "protocol,", "we", "intend", "to", "offer", "enrolled", "trial", "patients", "the", "option", "to", "continue", "to", "receive", "PRX-102", "in", "an", "open-label", "extension", "study.", "<tag2>", "Upon", "reviewing", "the", "results", "of", "the", "trial,", "expected", "in", "early", "2016,", "we", "intend", "to", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development.", "<tag3>"], "wordsA": ["After", "the", "completion", "of", "the", "protocol,", "we", "intend", "to", "offer", "enrolled", "trial", "patients", "the", "option", "to", "continue", "to", "receive", "PRX-102", "in", "an", "open-label", "extension", "study."], "wordsB": ["Upon", "reviewing", "the", "results", "of", "the", "trial,", "expected", "in", "early", "2016,", "we", "intend", "to", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p17_s1", "idA": "1006281_14_item1_p108_s4", "sentA": "After the completion of the protocol, we intend to offer enrolled trial patients the option to continue to receive PRX-102 in an open-label extension study.", "sentB": "PRX-102 has been the subject of successful proof of concept clinical trials, as described below, and we intend to focus our efforts on a new formulation of the treatment during 2015.", "type": 2, "words": ["<tag1>", "After", "the", "completion", "of", "the", "protocol,", "we", "intend", "to", "offer", "enrolled", "trial", "patients", "the", "option", "to", "continue", "to", "receive", "PRX-102", "in", "an", "open-label", "extension", "study.", "<tag2>", "PRX-102", "has", "been", "the", "subject", "of", "successful", "proof", "of", "concept", "clinical", "trials,", "as", "described", "below,", "and", "we", "intend", "to", "focus", "our", "efforts", "on", "a", "new", "formulation", "of", "the", "treatment", "during", "2015.", "<tag3>"], "wordsA": ["After", "the", "completion", "of", "the", "protocol,", "we", "intend", "to", "offer", "enrolled", "trial", "patients", "the", "option", "to", "continue", "to", "receive", "PRX-102", "in", "an", "open-label", "extension", "study."], "wordsB": ["PRX-102", "has", "been", "the", "subject", "of", "successful", "proof", "of", "concept", "clinical", "trials,", "as", "described", "below,", "and", "we", "intend", "to", "focus", "our", "efforts", "on", "a", "new", "formulation", "of", "the", "treatment", "during", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p22_s4", "idA": "1006281_14_item1_p108_s4", "sentA": "After the completion of the protocol, we intend to offer enrolled trial patients the option to continue to receive PRX-102 in an open-label extension study.", "sentB": "Upon reviewing the results of the trial, expected in early 2016, we intend to collaborate with a well-suited partner for further development.", "type": 2, "words": ["<tag1>", "After", "the", "completion", "of", "the", "protocol,", "we", "intend", "to", "offer", "enrolled", "trial", "patients", "the", "option", "to", "continue", "to", "receive", "PRX-102", "in", "an", "open-label", "extension", "study.", "<tag2>", "Upon", "reviewing", "the", "results", "of", "the", "trial,", "expected", "in", "early", "2016,", "we", "intend", "to", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development.", "<tag3>"], "wordsA": ["After", "the", "completion", "of", "the", "protocol,", "we", "intend", "to", "offer", "enrolled", "trial", "patients", "the", "option", "to", "continue", "to", "receive", "PRX-102", "in", "an", "open-label", "extension", "study."], "wordsB": ["Upon", "reviewing", "the", "results", "of", "the", "trial,", "expected", "in", "early", "2016,", "we", "intend", "to", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p83_s4", "idA": "1006281_14_item1_p108_s4", "sentA": "After the completion of the protocol, we intend to offer enrolled trial patients the option to continue to receive PRX-102 in an open-label extension study.", "sentB": "All patients that completed the trial have opted to continue to receive PRX-102 in an open-label extension trial.", "type": 2, "words": ["<tag1>", "After", "the", "completion", "of", "the", "protocol,", "we", "intend", "to", "offer", "enrolled", "trial", "patients", "the", "option", "to", "continue", "to", "receive", "PRX-102", "in", "an", "open-label", "extension", "study.", "<tag2>", "All", "patients", "that", "completed", "the", "trial", "have", "opted", "to", "continue", "to", "receive", "PRX-102", "in", "an", "open-label", "extension", "trial.", "<tag3>"], "wordsA": ["After", "the", "completion", "of", "the", "protocol,", "we", "intend", "to", "offer", "enrolled", "trial", "patients", "the", "option", "to", "continue", "to", "receive", "PRX-102", "in", "an", "open-label", "extension", "study."], "wordsB": ["All", "patients", "that", "completed", "the", "trial", "have", "opted", "to", "continue", "to", "receive", "PRX-102", "in", "an", "open-label", "extension", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p96_s1", "idA": "1006281_14_item1_p110_s1", "sentA": "Chemical modifications made to PRX-102 improved the enzyme s activity and stability resulting in prolonged activity profiles and enhanced bioavailability in animals.", "sentB": "These enhanced pharmacokinetic benefits are believed to be the result of the chemical modifications made to PRX-102, including cross-linking and covalent bonding to make the enzyme a more stable homo-dimer.", "type": 2, "words": ["<tag1>", "Chemical", "modifications", "made", "to", "PRX-102", "improved", "the", "enzyme", "s", "activity", "and", "stability", "resulting", "in", "prolonged", "activity", "profiles", "and", "enhanced", "bioavailability", "in", "animals.", "<tag2>", "These", "enhanced", "pharmacokinetic", "benefits", "are", "believed", "to", "be", "the", "result", "of", "the", "chemical", "modifications", "made", "to", "PRX-102,", "including", "cross-linking", "and", "covalent", "bonding", "to", "make", "the", "enzyme", "a", "more", "stable", "homo-dimer.", "<tag3>"], "wordsA": ["Chemical", "modifications", "made", "to", "PRX-102", "improved", "the", "enzyme", "s", "activity", "and", "stability", "resulting", "in", "prolonged", "activity", "profiles", "and", "enhanced", "bioavailability", "in", "animals."], "wordsB": ["These", "enhanced", "pharmacokinetic", "benefits", "are", "believed", "to", "be", "the", "result", "of", "the", "chemical", "modifications", "made", "to", "PRX-102,", "including", "cross-linking", "and", "covalent", "bonding", "to", "make", "the", "enzyme", "a", "more", "stable", "homo-dimer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p100_s0", "idA": "1006281_14_item1_p112_s0", "sentA": "Oral GCD is a plant cell-expressed form of GCD that is naturally encapsulated within carrot cells genetically engineered to express the GCD enzyme.", "sentB": "Oral antiTNF is a plant cell-expressed form of the fused protein that is naturally encapsulated within carrot cells genetically engineered to express the enzyme.", "type": 2, "words": ["<tag1>", "Oral", "GCD", "is", "a", "plant", "cell-expressed", "form", "of", "GCD", "that", "is", "naturally", "encapsulated", "within", "carrot", "cells", "genetically", "engineered", "to", "express", "the", "GCD", "enzyme.", "<tag2>", "Oral", "antiTNF", "is", "a", "plant", "cell-expressed", "form", "of", "the", "fused", "protein", "that", "is", "naturally", "encapsulated", "within", "carrot", "cells", "genetically", "engineered", "to", "express", "the", "enzyme.", "<tag3>"], "wordsA": ["Oral", "GCD", "is", "a", "plant", "cell-expressed", "form", "of", "GCD", "that", "is", "naturally", "encapsulated", "within", "carrot", "cells", "genetically", "engineered", "to", "express", "the", "GCD", "enzyme."], "wordsB": ["Oral", "antiTNF", "is", "a", "plant", "cell-expressed", "form", "of", "the", "fused", "protein", "that", "is", "naturally", "encapsulated", "within", "carrot", "cells", "genetically", "engineered", "to", "express", "the", "enzyme."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p101_s0", "idA": "1006281_14_item1_p114_s0", "sentA": "If proven effective, our experimental oral GCD would be the first protein to be administered orally rather than through intravenous therapy.", "sentB": "If proven effective, our experimental oral antiTNF would be the first protein to be administered orally rather than through injectable therapy.", "type": 2, "words": ["<tag1>", "If", "proven", "effective,", "our", "experimental", "oral", "GCD", "would", "be", "the", "first", "protein", "to", "be", "administered", "orally", "rather", "than", "through", "intravenous", "therapy.", "<tag2>", "If", "proven", "effective,", "our", "experimental", "oral", "antiTNF", "would", "be", "the", "first", "protein", "to", "be", "administered", "orally", "rather", "than", "through", "injectable", "therapy.", "<tag3>"], "wordsA": ["If", "proven", "effective,", "our", "experimental", "oral", "GCD", "would", "be", "the", "first", "protein", "to", "be", "administered", "orally", "rather", "than", "through", "intravenous", "therapy."], "wordsB": ["If", "proven", "effective,", "our", "experimental", "oral", "antiTNF", "would", "be", "the", "first", "protein", "to", "be", "administered", "orally", "rather", "than", "through", "injectable", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p112_s1", "idA": "1006281_14_item1_p120_s1", "sentA": "It was an exploratory, open label study to evaluate the safety and pharmacokinetics of oral GCD in Gaucher patients.", "sentB": "The phase IIa clinical trial was a 28-day open-label, sequential dose escalation study to evaluate the safety of PRX-112, and study the dose dependent pharmacokinetics of PRX-112 in na ve adult Gaucher patients.", "type": 2, "words": ["<tag1>", "It", "was", "an", "exploratory,", "open", "label", "study", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "oral", "GCD", "in", "Gaucher", "patients.", "<tag2>", "The", "phase", "IIa", "clinical", "trial", "was", "a", "28-day", "open-label,", "sequential", "dose", "escalation", "study", "to", "evaluate", "the", "safety", "of", "PRX-112,", "and", "study", "the", "dose", "dependent", "pharmacokinetics", "of", "PRX-112", "in", "na", "ve", "adult", "Gaucher", "patients.", "<tag3>"], "wordsA": ["It", "was", "an", "exploratory,", "open", "label", "study", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "oral", "GCD", "in", "Gaucher", "patients."], "wordsB": ["The", "phase", "IIa", "clinical", "trial", "was", "a", "28-day", "open-label,", "sequential", "dose", "escalation", "study", "to", "evaluate", "the", "safety", "of", "PRX-112,", "and", "study", "the", "dose", "dependent", "pharmacokinetics", "of", "PRX-112", "in", "na", "ve", "adult", "Gaucher", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p116_s0", "idA": "1006281_14_item1_p120_s1", "sentA": "It was an exploratory, open label study to evaluate the safety and pharmacokinetics of oral GCD in Gaucher patients.", "sentB": "We completed a phase I clinical trial of oral GCD, which was an exploratory, open label study to evaluate the safety and pharmacokinetics of oral GCD in Gaucher patients.", "type": 2, "words": ["<tag1>", "It", "was", "an", "exploratory,", "open", "label", "study", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "oral", "GCD", "in", "Gaucher", "patients.", "<tag2>", "We", "completed", "a", "phase", "I", "clinical", "trial", "of", "oral", "GCD,", "which", "was", "an", "exploratory,", "open", "label", "study", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "oral", "GCD", "in", "Gaucher", "patients.", "<tag3>"], "wordsA": ["It", "was", "an", "exploratory,", "open", "label", "study", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "oral", "GCD", "in", "Gaucher", "patients."], "wordsB": ["We", "completed", "a", "phase", "I", "clinical", "trial", "of", "oral", "GCD,", "which", "was", "an", "exploratory,", "open", "label", "study", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "oral", "GCD", "in", "Gaucher", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p116_s1", "idA": "1006281_14_item1_p121_s0", "sentA": "Patients receive re-suspended lyophilized carrot cells in a single oral administration during the first segment of the trial and three consecutive daily administrations during the second segment of the trial.", "sentB": "Patients received re-suspended lyophilized carrot cells in a single oral administration during the first segment of the trial and three consecutive daily administrations during the second segment of the trial.", "type": 2, "words": ["<tag1>", "Patients", "receive", "re-suspended", "lyophilized", "carrot", "cells", "in", "a", "single", "oral", "administration", "during", "the", "first", "segment", "of", "the", "trial", "and", "three", "consecutive", "daily", "administrations", "during", "the", "second", "segment", "of", "the", "trial.", "<tag2>", "Patients", "received", "re-suspended", "lyophilized", "carrot", "cells", "in", "a", "single", "oral", "administration", "during", "the", "first", "segment", "of", "the", "trial", "and", "three", "consecutive", "daily", "administrations", "during", "the", "second", "segment", "of", "the", "trial.", "<tag3>"], "wordsA": ["Patients", "receive", "re-suspended", "lyophilized", "carrot", "cells", "in", "a", "single", "oral", "administration", "during", "the", "first", "segment", "of", "the", "trial", "and", "three", "consecutive", "daily", "administrations", "during", "the", "second", "segment", "of", "the", "trial."], "wordsB": ["Patients", "received", "re-suspended", "lyophilized", "carrot", "cells", "in", "a", "single", "oral", "administration", "during", "the", "first", "segment", "of", "the", "trial", "and", "three", "consecutive", "daily", "administrations", "during", "the", "second", "segment", "of", "the", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p114_s0", "idA": "1006281_14_item1_p121_s3", "sentA": "The results demonstrate that oral GCD was well tolerated across all three doses tested.", "sentB": "An initial analysis of the results demonstrates that oral GCD was well tolerated.", "type": 2, "words": ["<tag1>", "The", "results", "demonstrate", "that", "oral", "GCD", "was", "well", "tolerated", "across", "all", "three", "doses", "tested.", "<tag2>", "An", "initial", "analysis", "of", "the", "results", "demonstrates", "that", "oral", "GCD", "was", "well", "tolerated.", "<tag3>"], "wordsA": ["The", "results", "demonstrate", "that", "oral", "GCD", "was", "well", "tolerated", "across", "all", "three", "doses", "tested."], "wordsB": ["An", "initial", "analysis", "of", "the", "results", "demonstrates", "that", "oral", "GCD", "was", "well", "tolerated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p114_s2", "idA": "1006281_14_item1_p121_s5", "sentA": "All adverse reactions were transient in nature, mild and moderate and the patients that experienced the adverse reactions recovered without further events.", "sentB": "Four patients experienced adverse reactions, all of which were transient in nature, mild and moderate and the patients that experienced the adverse reactions recovered without further events.", "type": 2, "words": ["<tag1>", "All", "adverse", "reactions", "were", "transient", "in", "nature,", "mild", "and", "moderate", "and", "the", "patients", "that", "experienced", "the", "adverse", "reactions", "recovered", "without", "further", "events.", "<tag2>", "Four", "patients", "experienced", "adverse", "reactions,", "all", "of", "which", "were", "transient", "in", "nature,", "mild", "and", "moderate", "and", "the", "patients", "that", "experienced", "the", "adverse", "reactions", "recovered", "without", "further", "events.", "<tag3>"], "wordsA": ["All", "adverse", "reactions", "were", "transient", "in", "nature,", "mild", "and", "moderate", "and", "the", "patients", "that", "experienced", "the", "adverse", "reactions", "recovered", "without", "further", "events."], "wordsB": ["Four", "patients", "experienced", "adverse", "reactions,", "all", "of", "which", "were", "transient", "in", "nature,", "mild", "and", "moderate", "and", "the", "patients", "that", "experienced", "the", "adverse", "reactions", "recovered", "without", "further", "events."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p94_s0", "idA": "1006281_14_item1_p121_s5", "sentA": "All adverse reactions were transient in nature, mild and moderate and the patients that experienced the adverse reactions recovered without further events.", "sentB": "PRX-102 was well tolerated, with the majority of events being mild and moderate.", "type": 2, "words": ["<tag1>", "All", "adverse", "reactions", "were", "transient", "in", "nature,", "mild", "and", "moderate", "and", "the", "patients", "that", "experienced", "the", "adverse", "reactions", "recovered", "without", "further", "events.", "<tag2>", "PRX-102", "was", "well", "tolerated,", "with", "the", "majority", "of", "events", "being", "mild", "and", "moderate.", "<tag3>"], "wordsA": ["All", "adverse", "reactions", "were", "transient", "in", "nature,", "mild", "and", "moderate", "and", "the", "patients", "that", "experienced", "the", "adverse", "reactions", "recovered", "without", "further", "events."], "wordsB": ["PRX-102", "was", "well", "tolerated,", "with", "the", "majority", "of", "events", "being", "mild", "and", "moderate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p95_s0", "idA": "1006281_14_item1_p121_s6", "sentA": "One patient experienced nausea related to treatment and two patients experienced mild dizziness and dizziness, which was possibly related to treatment.", "sentB": "Six patients receiving the 0.2mg/kg dose and two patients receiving the 1m/kg dose were evaluated for antibody formation.", "type": 2, "words": ["<tag1>", "One", "patient", "experienced", "nausea", "related", "to", "treatment", "and", "two", "patients", "experienced", "mild", "dizziness", "and", "dizziness,", "which", "was", "possibly", "related", "to", "treatment.", "<tag2>", "Six", "patients", "receiving", "the", "0.2mg/kg", "dose", "and", "two", "patients", "receiving", "the", "1m/kg", "dose", "were", "evaluated", "for", "antibody", "formation.", "<tag3>"], "wordsA": ["One", "patient", "experienced", "nausea", "related", "to", "treatment", "and", "two", "patients", "experienced", "mild", "dizziness", "and", "dizziness,", "which", "was", "possibly", "related", "to", "treatment."], "wordsB": ["Six", "patients", "receiving", "the", "0.2mg/kg", "dose", "and", "two", "patients", "receiving", "the", "1m/kg", "dose", "were", "evaluated", "for", "antibody", "formation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p114_s3", "idA": "1006281_14_item1_p122_s0", "sentA": "Pharmacokinetic (PK) studies revealed that active GCD enzyme was detected in the patients blood circulation, measured in the well-established assay in leucocytes of Gaucher patients, following oral administration of oral GCD.", "sentB": "Active GCD enzyme was detected in the blood circulation of 10 out of the 17 participants in the trial.", "type": 2, "words": ["<tag1>", "Pharmacokinetic", "(PK)", "studies", "revealed", "that", "active", "GCD", "enzyme", "was", "detected", "in", "the", "patients", "blood", "circulation,", "measured", "in", "the", "well-established", "assay", "in", "leucocytes", "of", "Gaucher", "patients,", "following", "oral", "administration", "of", "oral", "GCD.", "<tag2>", "Active", "GCD", "enzyme", "was", "detected", "in", "the", "blood", "circulation", "of", "10", "out", "of", "the", "17", "participants", "in", "the", "trial.", "<tag3>"], "wordsA": ["Pharmacokinetic", "(PK)", "studies", "revealed", "that", "active", "GCD", "enzyme", "was", "detected", "in", "the", "patients", "blood", "circulation,", "measured", "in", "the", "well-established", "assay", "in", "leucocytes", "of", "Gaucher", "patients,", "following", "oral", "administration", "of", "oral", "GCD."], "wordsB": ["Active", "GCD", "enzyme", "was", "detected", "in", "the", "blood", "circulation", "of", "10", "out", "of", "the", "17", "participants", "in", "the", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p114_s4", "idA": "1006281_14_item1_p125_s3", "sentA": "In addition, data from large and small animals demonstrate active absorbance of the protein in the plasma.", "sentB": "In addition, elevated platelet levels were observed in 10 out of the 17 participants in the trial.", "type": 2, "words": ["<tag1>", "In", "addition,", "data", "from", "large", "and", "small", "animals", "demonstrate", "active", "absorbance", "of", "the", "protein", "in", "the", "plasma.", "<tag2>", "In", "addition,", "elevated", "platelet", "levels", "were", "observed", "in", "10", "out", "of", "the", "17", "participants", "in", "the", "trial.", "<tag3>"], "wordsA": ["In", "addition,", "data", "from", "large", "and", "small", "animals", "demonstrate", "active", "absorbance", "of", "the", "protein", "in", "the", "plasma."], "wordsB": ["In", "addition,", "elevated", "platelet", "levels", "were", "observed", "in", "10", "out", "of", "the", "17", "participants", "in", "the", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p102_s0", "idA": "1006281_14_item1_p127_s1", "sentA": "We are developing oral antiTNF an orally-administered treatment for immune mediated disorders using plant cells as a natural capsule for the expressed protein.", "sentB": "We are currently developing oral antiTNF an orally-administered anti inflammatory using plant cells as a natural capsule for the expressed protein.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "oral", "antiTNF", "an", "orally-administered", "treatment", "for", "immune", "mediated", "disorders", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein.", "<tag2>", "We", "are", "currently", "developing", "oral", "antiTNF", "an", "orally-administered", "anti", "inflammatory", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein.", "<tag3>"], "wordsA": ["We", "are", "developing", "oral", "antiTNF", "an", "orally-administered", "treatment", "for", "immune", "mediated", "disorders", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein."], "wordsB": ["We", "are", "currently", "developing", "oral", "antiTNF", "an", "orally-administered", "anti", "inflammatory", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p15_s0", "idA": "1006281_14_item1_p127_s1", "sentA": "We are developing oral antiTNF an orally-administered treatment for immune mediated disorders using plant cells as a natural capsule for the expressed protein.", "sentB": "(2) PRX-106, our oral antiTNF product candidate which is being developed as an orally-delivered anti inflammatory treatment using plant cells as a natural capsule for the expressed protein.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "oral", "antiTNF", "an", "orally-administered", "treatment", "for", "immune", "mediated", "disorders", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein.", "<tag2>", "(2)", "PRX-106,", "our", "oral", "antiTNF", "product", "candidate", "which", "is", "being", "developed", "as", "an", "orally-delivered", "anti", "inflammatory", "treatment", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein.", "<tag3>"], "wordsA": ["We", "are", "developing", "oral", "antiTNF", "an", "orally-administered", "treatment", "for", "immune", "mediated", "disorders", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein."], "wordsB": ["(2)", "PRX-106,", "our", "oral", "antiTNF", "product", "candidate", "which", "is", "being", "developed", "as", "an", "orally-delivered", "anti", "inflammatory", "treatment", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p94_s1", "idA": "1006281_14_item1_p128_s0", "sentA": "Oral antiTNF has an amino acid sequence that is similar to Enbrel which is one of the major treatments for patients of inflammatory diseases.", "sentB": "Only one of the 12 patients evaluated for safety experienced hypersensitivity and discontinued per protocol.", "type": 2, "words": ["<tag1>", "Oral", "antiTNF", "has", "an", "amino", "acid", "sequence", "that", "is", "similar", "to", "Enbrel", "which", "is", "one", "of", "the", "major", "treatments", "for", "patients", "of", "inflammatory", "diseases.", "<tag2>", "Only", "one", "of", "the", "12", "patients", "evaluated", "for", "safety", "experienced", "hypersensitivity", "and", "discontinued", "per", "protocol.", "<tag3>"], "wordsA": ["Oral", "antiTNF", "has", "an", "amino", "acid", "sequence", "that", "is", "similar", "to", "Enbrel", "which", "is", "one", "of", "the", "major", "treatments", "for", "patients", "of", "inflammatory", "diseases."], "wordsB": ["Only", "one", "of", "the", "12", "patients", "evaluated", "for", "safety", "experienced", "hypersensitivity", "and", "discontinued", "per", "protocol."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p104_s1", "idA": "1006281_14_item1_p130_s1", "sentA": "It has an identical amino acid sequence to Enbrel and our in vitro and preclinical animal studies have demonstrated that pr-antiTNF exhibits similar activity to Enbrel.", "sentB": "It has an identical amino acid sequence to Enbrel and our in vitro and preclinical animal studies have demonstrated that pr-antiTNF exhibits similar or better activity to Enbrel.", "type": 2, "words": ["<tag1>", "It", "has", "an", "identical", "amino", "acid", "sequence", "to", "Enbrel", "and", "our", "in", "vitro", "and", "preclinical", "animal", "studies", "have", "demonstrated", "that", "pr-antiTNF", "exhibits", "similar", "activity", "to", "Enbrel.", "<tag2>", "It", "has", "an", "identical", "amino", "acid", "sequence", "to", "Enbrel", "and", "our", "in", "vitro", "and", "preclinical", "animal", "studies", "have", "demonstrated", "that", "pr-antiTNF", "exhibits", "similar", "or", "better", "activity", "to", "Enbrel.", "<tag3>"], "wordsA": ["It", "has", "an", "identical", "amino", "acid", "sequence", "to", "Enbrel", "and", "our", "in", "vitro", "and", "preclinical", "animal", "studies", "have", "demonstrated", "that", "pr-antiTNF", "exhibits", "similar", "activity", "to", "Enbrel."], "wordsB": ["It", "has", "an", "identical", "amino", "acid", "sequence", "to", "Enbrel", "and", "our", "in", "vitro", "and", "preclinical", "animal", "studies", "have", "demonstrated", "that", "pr-antiTNF", "exhibits", "similar", "or", "better", "activity", "to", "Enbrel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p105_s0", "idA": "1006281_14_item1_p132_s0", "sentA": "We are now conducting additional preclinical studies on oral antiTNF for several attractive indications, and we expect to initiate a phase I clinical trial of oral anti TNF for the oral treatment of autoimmune diseases in 2014.", "sentB": "We are now conducting additional preclinical studies on oral antiTNF for several attractive indications, and we plan to initiate clinical efficacy trials of oral anti TNF during 2015.", "type": 2, "words": ["<tag1>", "We", "are", "now", "conducting", "additional", "preclinical", "studies", "on", "oral", "antiTNF", "for", "several", "attractive", "indications,", "and", "we", "expect", "to", "initiate", "a", "phase", "I", "clinical", "trial", "of", "oral", "anti", "TNF", "for", "the", "oral", "treatment", "of", "autoimmune", "diseases", "in", "2014.", "<tag2>", "We", "are", "now", "conducting", "additional", "preclinical", "studies", "on", "oral", "antiTNF", "for", "several", "attractive", "indications,", "and", "we", "plan", "to", "initiate", "clinical", "efficacy", "trials", "of", "oral", "anti", "TNF", "during", "2015.", "<tag3>"], "wordsA": ["We", "are", "now", "conducting", "additional", "preclinical", "studies", "on", "oral", "antiTNF", "for", "several", "attractive", "indications,", "and", "we", "expect", "to", "initiate", "a", "phase", "I", "clinical", "trial", "of", "oral", "anti", "TNF", "for", "the", "oral", "treatment", "of", "autoimmune", "diseases", "in", "2014."], "wordsB": ["We", "are", "now", "conducting", "additional", "preclinical", "studies", "on", "oral", "antiTNF", "for", "several", "attractive", "indications,", "and", "we", "plan", "to", "initiate", "clinical", "efficacy", "trials", "of", "oral", "anti", "TNF", "during", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p106_s0", "idA": "1006281_14_item1_p133_s0", "sentA": "PRX-110 is our plant cell recombinant form of human deoxyribonuclease I (DNase I) that we are developing for the potential treatment of Cystic Fibrosis, to be administered by inhalation.", "sentB": "PRX-110, or AIR DNase, is our plant cell recombinant form of human deoxyribonuclease I (DNase I) that we are developing for the treatment of Cystic Fibrosis, to be administered by inhalation.", "type": 2, "words": ["<tag1>", "PRX-110", "is", "our", "plant", "cell", "recombinant", "form", "of", "human", "deoxyribonuclease", "I", "(DNase", "I)", "that", "we", "are", "developing", "for", "the", "potential", "treatment", "of", "Cystic", "Fibrosis,", "to", "be", "administered", "by", "inhalation.", "<tag2>", "PRX-110,", "or", "AIR", "DNase,", "is", "our", "plant", "cell", "recombinant", "form", "of", "human", "deoxyribonuclease", "I", "(DNase", "I)", "that", "we", "are", "developing", "for", "the", "treatment", "of", "Cystic", "Fibrosis,", "to", "be", "administered", "by", "inhalation.", "<tag3>"], "wordsA": ["PRX-110", "is", "our", "plant", "cell", "recombinant", "form", "of", "human", "deoxyribonuclease", "I", "(DNase", "I)", "that", "we", "are", "developing", "for", "the", "potential", "treatment", "of", "Cystic", "Fibrosis,", "to", "be", "administered", "by", "inhalation."], "wordsB": ["PRX-110,", "or", "AIR", "DNase,", "is", "our", "plant", "cell", "recombinant", "form", "of", "human", "deoxyribonuclease", "I", "(DNase", "I)", "that", "we", "are", "developing", "for", "the", "treatment", "of", "Cystic", "Fibrosis,", "to", "be", "administered", "by", "inhalation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p16_s0", "idA": "1006281_14_item1_p133_s0", "sentA": "PRX-110 is our plant cell recombinant form of human deoxyribonuclease I (DNase I) that we are developing for the potential treatment of Cystic Fibrosis, to be administered by inhalation.", "sentB": "(3) PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1, or DNase, under development for the treatment of cystic fibrosis, to be administered by inhalation.", "type": 2, "words": ["<tag1>", "PRX-110", "is", "our", "plant", "cell", "recombinant", "form", "of", "human", "deoxyribonuclease", "I", "(DNase", "I)", "that", "we", "are", "developing", "for", "the", "potential", "treatment", "of", "Cystic", "Fibrosis,", "to", "be", "administered", "by", "inhalation.", "<tag2>", "(3)", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "or", "DNase,", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation.", "<tag3>"], "wordsA": ["PRX-110", "is", "our", "plant", "cell", "recombinant", "form", "of", "human", "deoxyribonuclease", "I", "(DNase", "I)", "that", "we", "are", "developing", "for", "the", "potential", "treatment", "of", "Cystic", "Fibrosis,", "to", "be", "administered", "by", "inhalation."], "wordsB": ["(3)", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "or", "DNase,", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p107_s0", "idA": "1006281_14_item1_p134_s0", "sentA": "In vitro studies with PRX-110 demonstrated improved enzyme kinetics, less sensitivity to inhibition by actin and improved ex vivo efficacy when compared to Pulmozyme , the only approved form of recombinant DNase I. Preclinical studies of PRX-110 administered by inhalation showed substantial enzymatic activity in lungs.", "sentB": "In vitro studies with PRX-110 demonstrated improved enzyme kinetics, less sensitivity to inhibition by actin and improved ex vivo efficacy when compared to Pulmozyme.", "type": 2, "words": ["<tag1>", "In", "vitro", "studies", "with", "PRX-110", "demonstrated", "improved", "enzyme", "kinetics,", "less", "sensitivity", "to", "inhibition", "by", "actin", "and", "improved", "ex", "vivo", "efficacy", "when", "compared", "to", "Pulmozyme", ",", "the", "only", "approved", "form", "of", "recombinant", "DNase", "I.", "Preclinical", "studies", "of", "PRX-110", "administered", "by", "inhalation", "showed", "substantial", "enzymatic", "activity", "in", "lungs.", "<tag2>", "In", "vitro", "studies", "with", "PRX-110", "demonstrated", "improved", "enzyme", "kinetics,", "less", "sensitivity", "to", "inhibition", "by", "actin", "and", "improved", "ex", "vivo", "efficacy", "when", "compared", "to", "Pulmozyme.", "<tag3>"], "wordsA": ["In", "vitro", "studies", "with", "PRX-110", "demonstrated", "improved", "enzyme", "kinetics,", "less", "sensitivity", "to", "inhibition", "by", "actin", "and", "improved", "ex", "vivo", "efficacy", "when", "compared", "to", "Pulmozyme", ",", "the", "only", "approved", "form", "of", "recombinant", "DNase", "I.", "Preclinical", "studies", "of", "PRX-110", "administered", "by", "inhalation", "showed", "substantial", "enzymatic", "activity", "in", "lungs."], "wordsB": ["In", "vitro", "studies", "with", "PRX-110", "demonstrated", "improved", "enzyme", "kinetics,", "less", "sensitivity", "to", "inhibition", "by", "actin", "and", "improved", "ex", "vivo", "efficacy", "when", "compared", "to", "Pulmozyme."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p108_s0", "idA": "1006281_14_item1_p134_s0", "sentA": "In vitro studies with PRX-110 demonstrated improved enzyme kinetics, less sensitivity to inhibition by actin and improved ex vivo efficacy when compared to Pulmozyme , the only approved form of recombinant DNase I. Preclinical studies of PRX-110 administered by inhalation showed substantial enzymatic activity in lungs.", "sentB": "Preclinical studies of PRX-110 administered by inhalation showed substantial enzymatic activity in lungs.", "type": 2, "words": ["<tag1>", "In", "vitro", "studies", "with", "PRX-110", "demonstrated", "improved", "enzyme", "kinetics,", "less", "sensitivity", "to", "inhibition", "by", "actin", "and", "improved", "ex", "vivo", "efficacy", "when", "compared", "to", "Pulmozyme", ",", "the", "only", "approved", "form", "of", "recombinant", "DNase", "I.", "Preclinical", "studies", "of", "PRX-110", "administered", "by", "inhalation", "showed", "substantial", "enzymatic", "activity", "in", "lungs.", "<tag2>", "Preclinical", "studies", "of", "PRX-110", "administered", "by", "inhalation", "showed", "substantial", "enzymatic", "activity", "in", "lungs.", "<tag3>"], "wordsA": ["In", "vitro", "studies", "with", "PRX-110", "demonstrated", "improved", "enzyme", "kinetics,", "less", "sensitivity", "to", "inhibition", "by", "actin", "and", "improved", "ex", "vivo", "efficacy", "when", "compared", "to", "Pulmozyme", ",", "the", "only", "approved", "form", "of", "recombinant", "DNase", "I.", "Preclinical", "studies", "of", "PRX-110", "administered", "by", "inhalation", "showed", "substantial", "enzymatic", "activity", "in", "lungs."], "wordsB": ["Preclinical", "studies", "of", "PRX-110", "administered", "by", "inhalation", "showed", "substantial", "enzymatic", "activity", "in", "lungs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p120_s2", "idA": "1006281_14_item1_p135_s2", "sentA": "In connection with the execution of the Pfizer Agreement, Pfizer made an upfront payment to Protalix Ltd. of $60.0 million in connection with the execution of the agreement and subsequently paid Protalix Ltd. an additional $5.0 million upon our filing of a proposed pediatric investigation plan to the Pediatric Committee of the EMA.", "sentB": "In connection with the execution of the Pfizer Agreement, Pfizer made an upfront payment to Protalix Ltd. of $60.0 million in connection with the execution of the agreement and subsequently paid Protalix Ltd. an additional $30.0 million milestone payment.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement,", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "our", "filing", "of", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMA.", "<tag2>", "In", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement,", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "Protalix", "Ltd.", "an", "additional", "$30.0", "million", "milestone", "payment.", "<tag3>"], "wordsA": ["In", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement,", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "Protalix", "Ltd.", "an", "additional", "$5.0", "million", "upon", "our", "filing", "of", "a", "proposed", "pediatric", "investigation", "plan", "to", "the", "Pediatric", "Committee", "of", "the", "EMA."], "wordsB": ["In", "connection", "with", "the", "execution", "of", "the", "Pfizer", "Agreement,", "Pfizer", "made", "an", "upfront", "payment", "to", "Protalix", "Ltd.", "of", "$60.0", "million", "in", "connection", "with", "the", "execution", "of", "the", "agreement", "and", "subsequently", "paid", "Protalix", "Ltd.", "an", "additional", "$30.0", "million", "milestone", "payment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p124_s0", "idA": "1006281_14_item1_p141_s0", "sentA": "We entered into the Brazil Agreement with Fiocruz in June 2013, which agreement became effective in January 2014.", "sentB": "We entered into the Brazil Agreement with Fiocruz in June 2013, which became effective in January 2014.", "type": 2, "words": ["<tag1>", "We", "entered", "into", "the", "Brazil", "Agreement", "with", "Fiocruz", "in", "June", "2013,", "which", "agreement", "became", "effective", "in", "January", "2014.", "<tag2>", "We", "entered", "into", "the", "Brazil", "Agreement", "with", "Fiocruz", "in", "June", "2013,", "which", "became", "effective", "in", "January", "2014.", "<tag3>"], "wordsA": ["We", "entered", "into", "the", "Brazil", "Agreement", "with", "Fiocruz", "in", "June", "2013,", "which", "agreement", "became", "effective", "in", "January", "2014."], "wordsB": ["We", "entered", "into", "the", "Brazil", "Agreement", "with", "Fiocruz", "in", "June", "2013,", "which", "became", "effective", "in", "January", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p124_s4", "idA": "1006281_14_item1_p141_s3", "sentA": "Under the agreement, Fiocruz has committed to purchase at least approximately $40 million worth of taliglucerase alfa during the first two years of the term.", "sentB": "Since the agreement went into effect, we have recorded revenues of approximately $3.5 million for sales of taliglucerase alfa to Fiocruz in 2014 and, during the first quarter of 2015, we received a purchase order for approximately $5.7 million of taliglucerase alfa out of which we have delivered approximately $1.7 million of the product.", "type": 2, "words": ["<tag1>", "Under", "the", "agreement,", "Fiocruz", "has", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term.", "<tag2>", "Since", "the", "agreement", "went", "into", "effect,", "we", "have", "recorded", "revenues", "of", "approximately", "$3.5", "million", "for", "sales", "of", "taliglucerase", "alfa", "to", "Fiocruz", "in", "2014", "and,", "during", "the", "first", "quarter", "of", "2015,", "we", "received", "a", "purchase", "order", "for", "approximately", "$5.7", "million", "of", "taliglucerase", "alfa", "out", "of", "which", "we", "have", "delivered", "approximately", "$1.7", "million", "of", "the", "product.", "<tag3>"], "wordsA": ["Under", "the", "agreement,", "Fiocruz", "has", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term."], "wordsB": ["Since", "the", "agreement", "went", "into", "effect,", "we", "have", "recorded", "revenues", "of", "approximately", "$3.5", "million", "for", "sales", "of", "taliglucerase", "alfa", "to", "Fiocruz", "in", "2014", "and,", "during", "the", "first", "quarter", "of", "2015,", "we", "received", "a", "purchase", "order", "for", "approximately", "$5.7", "million", "of", "taliglucerase", "alfa", "out", "of", "which", "we", "have", "delivered", "approximately", "$1.7", "million", "of", "the", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p7_s5", "idA": "1006281_14_item1_p141_s3", "sentA": "Under the agreement, Fiocruz has committed to purchase at least approximately $40 million worth of taliglucerase alfa during the first two years of the term.", "sentB": "Since the agreement went into effect, we have recorded revenues of approximately $3.5 million for sales of taliglucerase alfa to Fiocruz in 2014 and, during the first quarter of 2015, we received a purchase order for approximately $5.7 million of taliglucerase alfa out of which we have delivered approximately $1.7 million of the product.", "type": 2, "words": ["<tag1>", "Under", "the", "agreement,", "Fiocruz", "has", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term.", "<tag2>", "Since", "the", "agreement", "went", "into", "effect,", "we", "have", "recorded", "revenues", "of", "approximately", "$3.5", "million", "for", "sales", "of", "taliglucerase", "alfa", "to", "Fiocruz", "in", "2014", "and,", "during", "the", "first", "quarter", "of", "2015,", "we", "received", "a", "purchase", "order", "for", "approximately", "$5.7", "million", "of", "taliglucerase", "alfa", "out", "of", "which", "we", "have", "delivered", "approximately", "$1.7", "million", "of", "the", "product.", "<tag3>"], "wordsA": ["Under", "the", "agreement,", "Fiocruz", "has", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term."], "wordsB": ["Since", "the", "agreement", "went", "into", "effect,", "we", "have", "recorded", "revenues", "of", "approximately", "$3.5", "million", "for", "sales", "of", "taliglucerase", "alfa", "to", "Fiocruz", "in", "2014", "and,", "during", "the", "first", "quarter", "of", "2015,", "we", "received", "a", "purchase", "order", "for", "approximately", "$5.7", "million", "of", "taliglucerase", "alfa", "out", "of", "which", "we", "have", "delivered", "approximately", "$1.7", "million", "of", "the", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p124_s6", "idA": "1006281_14_item1_p141_s5", "sentA": "Additionally, we are not required to complete the final stage of the technology transfer until Fiocruz purchases at least approximately $280 million worth of taliglucerase alfa.", "sentB": "We are not required to complete the final stage of the technology transfer until Fiocruz purchases at least approximately $280 million worth of taliglucerase alfa.", "type": 2, "words": ["<tag1>", "Additionally,", "we", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa.", "<tag2>", "We", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["Additionally,", "we", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa."], "wordsB": ["We", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p7_s7", "idA": "1006281_14_item1_p141_s5", "sentA": "Additionally, we are not required to complete the final stage of the technology transfer until Fiocruz purchases at least approximately $280 million worth of taliglucerase alfa.", "sentB": "We are not required to complete the final stage of the technology transfer until Fiocruz purchases at least approximately $280 million worth of taliglucerase alfa.", "type": 2, "words": ["<tag1>", "Additionally,", "we", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa.", "<tag2>", "We", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["Additionally,", "we", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa."], "wordsB": ["We", "are", "not", "required", "to", "complete", "the", "final", "stage", "of", "the", "technology", "transfer", "until", "Fiocruz", "purchases", "at", "least", "approximately", "$280", "million", "worth", "of", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p5_s0", "idA": "1006281_14_item1_p142_s3", "sentA": "During such period, Fiocruz will be the sole provider of this important treatment option for Gaucher patients in Brazil and shall pay us a single-digit royalty on net sales.", "sentB": "In September 2014, CONITEC, the National Commission for Incorporation of Technologies in Brazil s Unified Healthcare System, announced that it had decided to give a positive funding recommendation for Uplyso in the treatment of adult patients with types 1 and 3 Gaucher disease, and established that Uplyso will be the first choice for treatment for new adult Gaucher patients in Brazil.", "type": 2, "words": ["<tag1>", "During", "such", "period,", "Fiocruz", "will", "be", "the", "sole", "provider", "of", "this", "important", "treatment", "option", "for", "Gaucher", "patients", "in", "Brazil", "and", "shall", "pay", "us", "a", "single-digit", "royalty", "on", "net", "sales.", "<tag2>", "In", "September", "2014,", "CONITEC,", "the", "National", "Commission", "for", "Incorporation", "of", "Technologies", "in", "Brazil", "s", "Unified", "Healthcare", "System,", "announced", "that", "it", "had", "decided", "to", "give", "a", "positive", "funding", "recommendation", "for", "Uplyso", "in", "the", "treatment", "of", "adult", "patients", "with", "types", "1", "and", "3", "Gaucher", "disease,", "and", "established", "that", "Uplyso", "will", "be", "the", "first", "choice", "for", "treatment", "for", "new", "adult", "Gaucher", "patients", "in", "Brazil.", "<tag3>"], "wordsA": ["During", "such", "period,", "Fiocruz", "will", "be", "the", "sole", "provider", "of", "this", "important", "treatment", "option", "for", "Gaucher", "patients", "in", "Brazil", "and", "shall", "pay", "us", "a", "single-digit", "royalty", "on", "net", "sales."], "wordsB": ["In", "September", "2014,", "CONITEC,", "the", "National", "Commission", "for", "Incorporation", "of", "Technologies", "in", "Brazil", "s", "Unified", "Healthcare", "System,", "announced", "that", "it", "had", "decided", "to", "give", "a", "positive", "funding", "recommendation", "for", "Uplyso", "in", "the", "treatment", "of", "adult", "patients", "with", "types", "1", "and", "3", "Gaucher", "disease,", "and", "established", "that", "Uplyso", "will", "be", "the", "first", "choice", "for", "treatment", "for", "new", "adult", "Gaucher", "patients", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p128_s1", "idA": "1006281_14_item1_p146_s1", "sentA": "As of December 31, 2013, we hold, or have license rights to 49 patents and 89 pending patent applications with respect to various compositions, methods of production and methods of use relating to our ProCellEx protein expression system and our proprietary product pipeline.", "sentB": "As of December 31, 2014, we hold, or have license rights to 64 patents and 95 pending patent applications with respect to various compositions, methods of production and methods of use relating to our ProCellEx protein expression system and our proprietary product pipeline.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2013,", "we", "hold,", "or", "have", "license", "rights", "to", "49", "patents", "and", "89", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline.", "<tag2>", "As", "of", "December", "31,", "2014,", "we", "hold,", "or", "have", "license", "rights", "to", "64", "patents", "and", "95", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2013,", "we", "hold,", "or", "have", "license", "rights", "to", "49", "patents", "and", "89", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline."], "wordsB": ["As", "of", "December", "31,", "2014,", "we", "hold,", "or", "have", "license", "rights", "to", "64", "patents", "and", "95", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p128_s2", "idA": "1006281_14_item1_p146_s2", "sentA": "As of December 31, 2013, we hold, with a third party, one joint patent and one joint patent application, and licensed rights to five patents and six patent applications.", "sentB": "As of December 31, 2014, we hold, with a third party, one joint patent and one joint patent application, and licensed rights to two patents.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2013,", "we", "hold,", "with", "a", "third", "party,", "one", "joint", "patent", "and", "one", "joint", "patent", "application,", "and", "licensed", "rights", "to", "five", "patents", "and", "six", "patent", "applications.", "<tag2>", "As", "of", "December", "31,", "2014,", "we", "hold,", "with", "a", "third", "party,", "one", "joint", "patent", "and", "one", "joint", "patent", "application,", "and", "licensed", "rights", "to", "two", "patents.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2013,", "we", "hold,", "with", "a", "third", "party,", "one", "joint", "patent", "and", "one", "joint", "patent", "application,", "and", "licensed", "rights", "to", "five", "patents", "and", "six", "patent", "applications."], "wordsB": ["As", "of", "December", "31,", "2014,", "we", "hold,", "with", "a", "third", "party,", "one", "joint", "patent", "and", "one", "joint", "patent", "application,", "and", "licensed", "rights", "to", "two", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p130_s0", "idA": "1006281_14_item1_p148_s0", "sentA": "As of December 31, 2013, our patent portfolio consists of several patent families (consisting of patents and/or patent applications) covering our technology, protein expression methodologies and system and product candidates, as follows:", "sentB": "As of December 31, 2014, our patent portfolio consists of several patent families (consisting of patents and/or patent applications) covering our technology, protein expression methodologies and system and product candidates, as follows:", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2013,", "our", "patent", "portfolio", "consists", "of", "several", "patent", "families", "(consisting", "of", "patents", "and/or", "patent", "applications)", "covering", "our", "technology,", "protein", "expression", "methodologies", "and", "system", "and", "product", "candidates,", "as", "follows:", "<tag2>", "As", "of", "December", "31,", "2014,", "our", "patent", "portfolio", "consists", "of", "several", "patent", "families", "(consisting", "of", "patents", "and/or", "patent", "applications)", "covering", "our", "technology,", "protein", "expression", "methodologies", "and", "system", "and", "product", "candidates,", "as", "follows:", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2013,", "our", "patent", "portfolio", "consists", "of", "several", "patent", "families", "(consisting", "of", "patents", "and/or", "patent", "applications)", "covering", "our", "technology,", "protein", "expression", "methodologies", "and", "system", "and", "product", "candidates,", "as", "follows:"], "wordsB": ["As", "of", "December", "31,", "2014,", "our", "patent", "portfolio", "consists", "of", "several", "patent", "families", "(consisting", "of", "patents", "and/or", "patent", "applications)", "covering", "our", "technology,", "protein", "expression", "methodologies", "and", "system", "and", "product", "candidates,", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p131_s0", "idA": "1006281_14_item1_p149_s0", "sentA": "With respect to our ProCellEx protein expression system, we have been issued, and hold licensed rights to, 19 patents in the United States, Australia, the European Union, Israel, Canada, the Czech Republic, Hungary, Japan, Poland, Mexico, Hong Kong, India and Korea, and to three pending patent applications.", "sentB": "With respect to our ProCellEx protein expression system, we have been issued 19 patents in the United States, Australia, the European Union, Israel, Canada, the Czech Republic, Hungary, Japan, Poland, Mexico, Hong Kong, India and Korea, and hold three pending patent applications.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "have", "been", "issued,", "and", "hold", "licensed", "rights", "to,", "19", "patents", "in", "the", "United", "States,", "Australia,", "the", "European", "Union,", "Israel,", "Canada,", "the", "Czech", "Republic,", "Hungary,", "Japan,", "Poland,", "Mexico,", "Hong", "Kong,", "India", "and", "Korea,", "and", "to", "three", "pending", "patent", "applications.", "<tag2>", "With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "have", "been", "issued", "19", "patents", "in", "the", "United", "States,", "Australia,", "the", "European", "Union,", "Israel,", "Canada,", "the", "Czech", "Republic,", "Hungary,", "Japan,", "Poland,", "Mexico,", "Hong", "Kong,", "India", "and", "Korea,", "and", "hold", "three", "pending", "patent", "applications.", "<tag3>"], "wordsA": ["With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "have", "been", "issued,", "and", "hold", "licensed", "rights", "to,", "19", "patents", "in", "the", "United", "States,", "Australia,", "the", "European", "Union,", "Israel,", "Canada,", "the", "Czech", "Republic,", "Hungary,", "Japan,", "Poland,", "Mexico,", "Hong", "Kong,", "India", "and", "Korea,", "and", "to", "three", "pending", "patent", "applications."], "wordsB": ["With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "have", "been", "issued", "19", "patents", "in", "the", "United", "States,", "Australia,", "the", "European", "Union,", "Israel,", "Canada,", "the", "Czech", "Republic,", "Hungary,", "Japan,", "Poland,", "Mexico,", "Hong", "Kong,", "India", "and", "Korea,", "and", "hold", "three", "pending", "patent", "applications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p134_s1", "idA": "1006281_14_item1_p149_s2", "sentA": "Of the issued patents in this family, 13 are expected to expire in 2017 and six are expected to expire in 2025.", "sentB": "The issued patents in this patent family are expected to expire in 2025.", "type": 2, "words": ["<tag1>", "Of", "the", "issued", "patents", "in", "this", "family,", "13", "are", "expected", "to", "expire", "in", "2017", "and", "six", "are", "expected", "to", "expire", "in", "2025.", "<tag2>", "The", "issued", "patents", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2025.", "<tag3>"], "wordsA": ["Of", "the", "issued", "patents", "in", "this", "family,", "13", "are", "expected", "to", "expire", "in", "2017", "and", "six", "are", "expected", "to", "expire", "in", "2025."], "wordsB": ["The", "issued", "patents", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2025."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p48_s0", "idA": "1006281_14_item1_p14_s0", "sentA": "In addition to taliglucerase alfa, we are developing an innovative product pipeline using our ProCellEx protein expression system.", "sentB": "Our ProCellEx protein expression system has internal capabilities developed to improve the biologic dynamics of the expressed protein.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "taliglucerase", "alfa,", "we", "are", "developing", "an", "innovative", "product", "pipeline", "using", "our", "ProCellEx", "protein", "expression", "system.", "<tag2>", "Our", "ProCellEx", "protein", "expression", "system", "has", "internal", "capabilities", "developed", "to", "improve", "the", "biologic", "dynamics", "of", "the", "expressed", "protein.", "<tag3>"], "wordsA": ["In", "addition", "to", "taliglucerase", "alfa,", "we", "are", "developing", "an", "innovative", "product", "pipeline", "using", "our", "ProCellEx", "protein", "expression", "system."], "wordsB": ["Our", "ProCellEx", "protein", "expression", "system", "has", "internal", "capabilities", "developed", "to", "improve", "the", "biologic", "dynamics", "of", "the", "expressed", "protein."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p13_s1", "idA": "1006281_14_item1_p14_s1", "sentA": "Our product pipeline currently includes, among other candidates: PRX-102, a therapeutic protein candidate for the treatment of Fabry disease; PRX-112, an orally administered glucocerebrosidase enzyme for the treatment of Gaucher patients utilizing oral delivery of the recombinant GCD enzyme produced and encapsulated within carrot cells; PRX-106, an oral antiTNF, a plant cell expressed recombinant fusion protein combined of the binding domain of the human TNF receptor (TNFR) and an antibody portion, which is being developed for the treatment of certain immune and inflammatory diseases, such as rheumatoid arthritis, colitis, Crohn s disease, psoriasis and other autoimmune and inflammatory disorders; PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1 under development for the treatment of Cystic Fibrosis, to be administered by inhalation; PRX-107, a proprietary plant cell recombinant human Alpha1-antitrypsin, or AAT, and others.", "sentB": "Our product pipeline currently includes, among other candidates:", "type": 2, "words": ["<tag1>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease;", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells;", "PRX-106,", "an", "oral", "antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "combined", "of", "the", "binding", "domain", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "for", "the", "treatment", "of", "certain", "immune", "and", "inflammatory", "diseases,", "such", "as", "rheumatoid", "arthritis,", "colitis,", "Crohn", "s", "disease,", "psoriasis", "and", "other", "autoimmune", "and", "inflammatory", "disorders;", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1", "under", "development", "for", "the", "treatment", "of", "Cystic", "Fibrosis,", "to", "be", "administered", "by", "inhalation;", "PRX-107,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Alpha1-antitrypsin,", "or", "AAT,", "and", "others.", "<tag2>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "<tag3>"], "wordsA": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease;", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells;", "PRX-106,", "an", "oral", "antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "combined", "of", "the", "binding", "domain", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "for", "the", "treatment", "of", "certain", "immune", "and", "inflammatory", "diseases,", "such", "as", "rheumatoid", "arthritis,", "colitis,", "Crohn", "s", "disease,", "psoriasis", "and", "other", "autoimmune", "and", "inflammatory", "disorders;", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1", "under", "development", "for", "the", "treatment", "of", "Cystic", "Fibrosis,", "to", "be", "administered", "by", "inhalation;", "PRX-107,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Alpha1-antitrypsin,", "or", "AAT,", "and", "others."], "wordsB": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p17_s0", "idA": "1006281_14_item1_p14_s1", "sentA": "Our product pipeline currently includes, among other candidates: PRX-102, a therapeutic protein candidate for the treatment of Fabry disease; PRX-112, an orally administered glucocerebrosidase enzyme for the treatment of Gaucher patients utilizing oral delivery of the recombinant GCD enzyme produced and encapsulated within carrot cells; PRX-106, an oral antiTNF, a plant cell expressed recombinant fusion protein combined of the binding domain of the human TNF receptor (TNFR) and an antibody portion, which is being developed for the treatment of certain immune and inflammatory diseases, such as rheumatoid arthritis, colitis, Crohn s disease, psoriasis and other autoimmune and inflammatory disorders; PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1 under development for the treatment of Cystic Fibrosis, to be administered by inhalation; PRX-107, a proprietary plant cell recombinant human Alpha1-antitrypsin, or AAT, and others.", "sentB": "(4) PRX-112, an orally administered glucocerebrosidase enzyme for the treatment of Gaucher patients utilizing oral delivery of the recombinant GCD enzyme produced and encapsulated within carrot cells.", "type": 2, "words": ["<tag1>", "Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease;", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells;", "PRX-106,", "an", "oral", "antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "combined", "of", "the", "binding", "domain", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "for", "the", "treatment", "of", "certain", "immune", "and", "inflammatory", "diseases,", "such", "as", "rheumatoid", "arthritis,", "colitis,", "Crohn", "s", "disease,", "psoriasis", "and", "other", "autoimmune", "and", "inflammatory", "disorders;", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1", "under", "development", "for", "the", "treatment", "of", "Cystic", "Fibrosis,", "to", "be", "administered", "by", "inhalation;", "PRX-107,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Alpha1-antitrypsin,", "or", "AAT,", "and", "others.", "<tag2>", "(4)", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells.", "<tag3>"], "wordsA": ["Our", "product", "pipeline", "currently", "includes,", "among", "other", "candidates:", "PRX-102,", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease;", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells;", "PRX-106,", "an", "oral", "antiTNF,", "a", "plant", "cell", "expressed", "recombinant", "fusion", "protein", "combined", "of", "the", "binding", "domain", "of", "the", "human", "TNF", "receptor", "(TNFR)", "and", "an", "antibody", "portion,", "which", "is", "being", "developed", "for", "the", "treatment", "of", "certain", "immune", "and", "inflammatory", "diseases,", "such", "as", "rheumatoid", "arthritis,", "colitis,", "Crohn", "s", "disease,", "psoriasis", "and", "other", "autoimmune", "and", "inflammatory", "disorders;", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1", "under", "development", "for", "the", "treatment", "of", "Cystic", "Fibrosis,", "to", "be", "administered", "by", "inhalation;", "PRX-107,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Alpha1-antitrypsin,", "or", "AAT,", "and", "others."], "wordsB": ["(4)", "PRX-112,", "an", "orally", "administered", "glucocerebrosidase", "enzyme", "for", "the", "treatment", "of", "Gaucher", "patients", "utilizing", "oral", "delivery", "of", "the", "recombinant", "GCD", "enzyme", "produced", "and", "encapsulated", "within", "carrot", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p132_s0", "idA": "1006281_14_item1_p150_s0", "sentA": "With respect to our ProCellEx protein expression system, we hold two issued patents and 14 patent applications relating to the large scale production of proteins in cultured plant cells.", "sentB": "With respect to our ProCellEx protein expression system, we hold four issued patents and 13 patent applications relating to the large scale production of proteins in cultured plant cells.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "hold", "two", "issued", "patents", "and", "14", "patent", "applications", "relating", "to", "the", "large", "scale", "production", "of", "proteins", "in", "cultured", "plant", "cells.", "<tag2>", "With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "hold", "four", "issued", "patents", "and", "13", "patent", "applications", "relating", "to", "the", "large", "scale", "production", "of", "proteins", "in", "cultured", "plant", "cells.", "<tag3>"], "wordsA": ["With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "hold", "two", "issued", "patents", "and", "14", "patent", "applications", "relating", "to", "the", "large", "scale", "production", "of", "proteins", "in", "cultured", "plant", "cells."], "wordsB": ["With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "hold", "four", "issued", "patents", "and", "13", "patent", "applications", "relating", "to", "the", "large", "scale", "production", "of", "proteins", "in", "cultured", "plant", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p136_s1", "idA": "1006281_14_item1_p150_s1", "sentA": "The issued patents and any patents to issue in the future based on pending patent applications in this patent family are expected to expire in 2028.", "sentB": "The issued patents and any patents to issue in the future based on the patent applications in this patent family are expected to expire in 2028.", "type": 2, "words": ["<tag1>", "The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "pending", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2028.", "<tag2>", "The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2028.", "<tag3>"], "wordsA": ["The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "pending", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2028."], "wordsB": ["The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p133_s0", "idA": "1006281_14_item1_p151_s0", "sentA": "We hold a patent family containing 16 granted patents in India, South Africa, Russia, Australia, China, the United States, Ukraine, Singapore, Japan, Europe, Hong Kong, Mexico and Korea, and 20 patent applications relating to the production of recombinant glycosylated lysosomal proteins in our plant culture platform, including taliglucerase alfa, and uses of these proteins and of cells containing these proteins for the treatment of lysosomal disorders.", "sentB": "We hold a patent family containing 23 issued patents in India, South Africa, Russian Federation, Australia, China, the United States, Ukraine, Singapore, Japan, Europe, Hong Kong, Mexico, Korea Canada, Brazil and Israel and 13 patent applications relating to the production of recombinant glycosylated lysosomal proteins in our plant culture platform, including taliglucerase alfa, and uses of these proteins and cells containing these proteins for the treatment of lysosomal disorders.", "type": 2, "words": ["<tag1>", "We", "hold", "a", "patent", "family", "containing", "16", "granted", "patents", "in", "India,", "South", "Africa,", "Russia,", "Australia,", "China,", "the", "United", "States,", "Ukraine,", "Singapore,", "Japan,", "Europe,", "Hong", "Kong,", "Mexico", "and", "Korea,", "and", "20", "patent", "applications", "relating", "to", "the", "production", "of", "recombinant", "glycosylated", "lysosomal", "proteins", "in", "our", "plant", "culture", "platform,", "including", "taliglucerase", "alfa,", "and", "uses", "of", "these", "proteins", "and", "of", "cells", "containing", "these", "proteins", "for", "the", "treatment", "of", "lysosomal", "disorders.", "<tag2>", "We", "hold", "a", "patent", "family", "containing", "23", "issued", "patents", "in", "India,", "South", "Africa,", "Russian", "Federation,", "Australia,", "China,", "the", "United", "States,", "Ukraine,", "Singapore,", "Japan,", "Europe,", "Hong", "Kong,", "Mexico,", "Korea", "Canada,", "Brazil", "and", "Israel", "and", "13", "patent", "applications", "relating", "to", "the", "production", "of", "recombinant", "glycosylated", "lysosomal", "proteins", "in", "our", "plant", "culture", "platform,", "including", "taliglucerase", "alfa,", "and", "uses", "of", "these", "proteins", "and", "cells", "containing", "these", "proteins", "for", "the", "treatment", "of", "lysosomal", "disorders.", "<tag3>"], "wordsA": ["We", "hold", "a", "patent", "family", "containing", "16", "granted", "patents", "in", "India,", "South", "Africa,", "Russia,", "Australia,", "China,", "the", "United", "States,", "Ukraine,", "Singapore,", "Japan,", "Europe,", "Hong", "Kong,", "Mexico", "and", "Korea,", "and", "20", "patent", "applications", "relating", "to", "the", "production", "of", "recombinant", "glycosylated", "lysosomal", "proteins", "in", "our", "plant", "culture", "platform,", "including", "taliglucerase", "alfa,", "and", "uses", "of", "these", "proteins", "and", "of", "cells", "containing", "these", "proteins", "for", "the", "treatment", "of", "lysosomal", "disorders."], "wordsB": ["We", "hold", "a", "patent", "family", "containing", "23", "issued", "patents", "in", "India,", "South", "Africa,", "Russian", "Federation,", "Australia,", "China,", "the", "United", "States,", "Ukraine,", "Singapore,", "Japan,", "Europe,", "Hong", "Kong,", "Mexico,", "Korea", "Canada,", "Brazil", "and", "Israel", "and", "13", "patent", "applications", "relating", "to", "the", "production", "of", "recombinant", "glycosylated", "lysosomal", "proteins", "in", "our", "plant", "culture", "platform,", "including", "taliglucerase", "alfa,", "and", "uses", "of", "these", "proteins", "and", "cells", "containing", "these", "proteins", "for", "the", "treatment", "of", "lysosomal", "disorders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p136_s0", "idA": "1006281_14_item1_p154_s0", "sentA": "We hold a patent family containing two granted patents in South Africa and Australia, and five pending patent applications relating to saccharide containing protein conjugates.", "sentB": "We hold a patent family containing three granted patents in the United States, South Africa and Australia, and five pending patent applications relating to saccharide containing protein conjugates.", "type": 2, "words": ["<tag1>", "We", "hold", "a", "patent", "family", "containing", "two", "granted", "patents", "in", "South", "Africa", "and", "Australia,", "and", "five", "pending", "patent", "applications", "relating", "to", "saccharide", "containing", "protein", "conjugates.", "<tag2>", "We", "hold", "a", "patent", "family", "containing", "three", "granted", "patents", "in", "the", "United", "States,", "South", "Africa", "and", "Australia,", "and", "five", "pending", "patent", "applications", "relating", "to", "saccharide", "containing", "protein", "conjugates.", "<tag3>"], "wordsA": ["We", "hold", "a", "patent", "family", "containing", "two", "granted", "patents", "in", "South", "Africa", "and", "Australia,", "and", "five", "pending", "patent", "applications", "relating", "to", "saccharide", "containing", "protein", "conjugates."], "wordsB": ["We", "hold", "a", "patent", "family", "containing", "three", "granted", "patents", "in", "the", "United", "States,", "South", "Africa", "and", "Australia,", "and", "five", "pending", "patent", "applications", "relating", "to", "saccharide", "containing", "protein", "conjugates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p138_s0", "idA": "1006281_14_item1_p156_s0", "sentA": "We hold a patent family containing 14 pending patent applications and one granted patent relating to multimeric protein structures of -galactosidase and to uses thereof in treating Fabry disease.", "sentB": "We hold a patent family containing three granted patents in Europe, New Zealand and South Africa and 16 pending patent applications relating to multimeric protein structures of -galactosidase and to uses thereof in treating Fabry disease.", "type": 2, "words": ["<tag1>", "We", "hold", "a", "patent", "family", "containing", "14", "pending", "patent", "applications", "and", "one", "granted", "patent", "relating", "to", "multimeric", "protein", "structures", "of", "-galactosidase", "and", "to", "uses", "thereof", "in", "treating", "Fabry", "disease.", "<tag2>", "We", "hold", "a", "patent", "family", "containing", "three", "granted", "patents", "in", "Europe,", "New", "Zealand", "and", "South", "Africa", "and", "16", "pending", "patent", "applications", "relating", "to", "multimeric", "protein", "structures", "of", "-galactosidase", "and", "to", "uses", "thereof", "in", "treating", "Fabry", "disease.", "<tag3>"], "wordsA": ["We", "hold", "a", "patent", "family", "containing", "14", "pending", "patent", "applications", "and", "one", "granted", "patent", "relating", "to", "multimeric", "protein", "structures", "of", "-galactosidase", "and", "to", "uses", "thereof", "in", "treating", "Fabry", "disease."], "wordsB": ["We", "hold", "a", "patent", "family", "containing", "three", "granted", "patents", "in", "Europe,", "New", "Zealand", "and", "South", "Africa", "and", "16", "pending", "patent", "applications", "relating", "to", "multimeric", "protein", "structures", "of", "-galactosidase", "and", "to", "uses", "thereof", "in", "treating", "Fabry", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p137_s1", "idA": "1006281_14_item1_p156_s1", "sentA": "The patents to issue in the future based on the patent applications in this patent family are expected to expire in 2031.", "sentB": "The patents to issue in the future based on the patent applications in this patent family, if at all, are expected to expire in 2031.", "type": 2, "words": ["<tag1>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2031.", "<tag2>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2031.", "<tag3>"], "wordsA": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2031."], "wordsB": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2031."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p138_s1", "idA": "1006281_14_item1_p156_s1", "sentA": "The patents to issue in the future based on the patent applications in this patent family are expected to expire in 2031.", "sentB": "The issued patents and any patents to issue in the future based on the patent applications in this patent family are expected to expire in 2031.", "type": 2, "words": ["<tag1>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2031.", "<tag2>", "The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2031.", "<tag3>"], "wordsA": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2031."], "wordsB": ["The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2031."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p139_s1", "idA": "1006281_14_item1_p156_s1", "sentA": "The patents to issue in the future based on the patent applications in this patent family are expected to expire in 2031.", "sentB": "The patents to issue in the future based on the patent applications in this patent family, if at all, are expected to expire in 2031.", "type": 2, "words": ["<tag1>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2031.", "<tag2>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2031.", "<tag3>"], "wordsA": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2031."], "wordsB": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2031."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p140_s1", "idA": "1006281_14_item1_p156_s1", "sentA": "The patents to issue in the future based on the patent applications in this patent family are expected to expire in 2031.", "sentB": "The issued patent and any patent applications to issue in the future based on the patent applications in this patent family, if at all, are expected to expire in 2031.", "type": 2, "words": ["<tag1>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2031.", "<tag2>", "The", "issued", "patent", "and", "any", "patent", "applications", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2031.", "<tag3>"], "wordsA": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2031."], "wordsB": ["The", "issued", "patent", "and", "any", "patent", "applications", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2031."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p141_s0", "idA": "1006281_14_item1_p159_s0", "sentA": "We hold three patent families containing three PCT applications relating to plant recombinant human DNase I and uses in therapy.", "sentB": "We hold three patent families containing eight pending applications relating to plant recombinant human DNase I and uses in therapy.", "type": 2, "words": ["<tag1>", "We", "hold", "three", "patent", "families", "containing", "three", "PCT", "applications", "relating", "to", "plant", "recombinant", "human", "DNase", "I", "and", "uses", "in", "therapy.", "<tag2>", "We", "hold", "three", "patent", "families", "containing", "eight", "pending", "applications", "relating", "to", "plant", "recombinant", "human", "DNase", "I", "and", "uses", "in", "therapy.", "<tag3>"], "wordsA": ["We", "hold", "three", "patent", "families", "containing", "three", "PCT", "applications", "relating", "to", "plant", "recombinant", "human", "DNase", "I", "and", "uses", "in", "therapy."], "wordsB": ["We", "hold", "three", "patent", "families", "containing", "eight", "pending", "applications", "relating", "to", "plant", "recombinant", "human", "DNase", "I", "and", "uses", "in", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p141_s1", "idA": "1006281_14_item1_p159_s1", "sentA": "The patents to issue in the future based on these patent applications are expected to expire in 2033.", "sentB": "The patents to issue in the future based on these patent applications, if at all, are expected to expire in 2033.", "type": 2, "words": ["<tag1>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications", "are", "expected", "to", "expire", "in", "2033.", "<tag2>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2033.", "<tag3>"], "wordsA": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications", "are", "expected", "to", "expire", "in", "2033."], "wordsB": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2033."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p142_s1", "idA": "1006281_14_item1_p159_s1", "sentA": "The patents to issue in the future based on these patent applications are expected to expire in 2033.", "sentB": "The patents to issue in the future based on these patent applications, if at all, are expected to expire in 2034.", "type": 2, "words": ["<tag1>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications", "are", "expected", "to", "expire", "in", "2033.", "<tag2>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2034.", "<tag3>"], "wordsA": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications", "are", "expected", "to", "expire", "in", "2033."], "wordsB": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2034."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p18_s1", "idA": "1006281_14_item1_p15_s1", "sentA": "We have built an internal marketing team designed to serve the Israeli market for taliglucerase alfa and we intend to establish internal commercialization and marketing teams for our other product candidates in North America, the European Union and in other significant markets, including Israel, subject to required marketing approvals, as the need arises.", "sentB": "We have built an internal marketing team designed to serve the Israeli and Brazilian market for taliglucerase alfa and we intend to establish internal commercialization and marketing teams for our other product candidates in North America, the European Union and in other significant markets, including Israel, subject to required marketing approvals, as the need arises.", "type": 2, "words": ["<tag1>", "We", "have", "built", "an", "internal", "marketing", "team", "designed", "to", "serve", "the", "Israeli", "market", "for", "taliglucerase", "alfa", "and", "we", "intend", "to", "establish", "internal", "commercialization", "and", "marketing", "teams", "for", "our", "other", "product", "candidates", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel,", "subject", "to", "required", "marketing", "approvals,", "as", "the", "need", "arises.", "<tag2>", "We", "have", "built", "an", "internal", "marketing", "team", "designed", "to", "serve", "the", "Israeli", "and", "Brazilian", "market", "for", "taliglucerase", "alfa", "and", "we", "intend", "to", "establish", "internal", "commercialization", "and", "marketing", "teams", "for", "our", "other", "product", "candidates", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel,", "subject", "to", "required", "marketing", "approvals,", "as", "the", "need", "arises.", "<tag3>"], "wordsA": ["We", "have", "built", "an", "internal", "marketing", "team", "designed", "to", "serve", "the", "Israeli", "market", "for", "taliglucerase", "alfa", "and", "we", "intend", "to", "establish", "internal", "commercialization", "and", "marketing", "teams", "for", "our", "other", "product", "candidates", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel,", "subject", "to", "required", "marketing", "approvals,", "as", "the", "need", "arises."], "wordsB": ["We", "have", "built", "an", "internal", "marketing", "team", "designed", "to", "serve", "the", "Israeli", "and", "Brazilian", "market", "for", "taliglucerase", "alfa", "and", "we", "intend", "to", "establish", "internal", "commercialization", "and", "marketing", "teams", "for", "our", "other", "product", "candidates", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel,", "subject", "to", "required", "marketing", "approvals,", "as", "the", "need", "arises."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p142_s0", "idA": "1006281_14_item1_p160_s0", "sentA": "We hold patent applications relating to plant recombinant TNF alpha inhibitor polypeptides.", "sentB": "We hold two PCTs and patent applications relating to plant recombinant TNF alpha inhibitor polypeptides.", "type": 2, "words": ["<tag1>", "We", "hold", "patent", "applications", "relating", "to", "plant", "recombinant", "TNF", "alpha", "inhibitor", "polypeptides.", "<tag2>", "We", "hold", "two", "PCTs", "and", "patent", "applications", "relating", "to", "plant", "recombinant", "TNF", "alpha", "inhibitor", "polypeptides.", "<tag3>"], "wordsA": ["We", "hold", "patent", "applications", "relating", "to", "plant", "recombinant", "TNF", "alpha", "inhibitor", "polypeptides."], "wordsB": ["We", "hold", "two", "PCTs", "and", "patent", "applications", "relating", "to", "plant", "recombinant", "TNF", "alpha", "inhibitor", "polypeptides."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p145_s0", "idA": "1006281_14_item1_p163_s0", "sentA": "We co-own a patent application that covers use of plant cells expressing a TNF alpha polypeptide inhibitor in therapy.", "sentB": "We co-own a PCT that covers use of plant cells expressing a TNF alpha polypeptide inhibitor in therapy.", "type": 2, "words": ["<tag1>", "We", "co-own", "a", "patent", "application", "that", "covers", "use", "of", "plant", "cells", "expressing", "a", "TNF", "alpha", "polypeptide", "inhibitor", "in", "therapy.", "<tag2>", "We", "co-own", "a", "PCT", "that", "covers", "use", "of", "plant", "cells", "expressing", "a", "TNF", "alpha", "polypeptide", "inhibitor", "in", "therapy.", "<tag3>"], "wordsA": ["We", "co-own", "a", "patent", "application", "that", "covers", "use", "of", "plant", "cells", "expressing", "a", "TNF", "alpha", "polypeptide", "inhibitor", "in", "therapy."], "wordsB": ["We", "co-own", "a", "PCT", "that", "covers", "use", "of", "plant", "cells", "expressing", "a", "TNF", "alpha", "polypeptide", "inhibitor", "in", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p146_s1", "idA": "1006281_14_item1_p164_s1", "sentA": "The patents to issue in the future based on patent application in this patent family are expected to expire in 2034.", "sentB": "The patents to issue in the future based on patent application in this patent family, if at all, are expected to expire in 2033 and 2035.", "type": 2, "words": ["<tag1>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "patent", "application", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2034.", "<tag2>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "patent", "application", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2033", "and", "2035.", "<tag3>"], "wordsA": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "patent", "application", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2034."], "wordsB": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "patent", "application", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2033", "and", "2035."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p124_s7", "idA": "1006281_14_item1_p168_s1", "sentA": "Icon may terminate the agreement upon written notice to us that we are in material breach of our obligations under the agreement and we are unable to remedy such material breach within 30 days after we receive such notice.", "sentB": "If Fiocruz fails to comply with certain of its purchase commitments under the agreement, we may terminate the agreement, and all of our rights to the technology will be returned.", "type": 2, "words": ["<tag1>", "Icon", "may", "terminate", "the", "agreement", "upon", "written", "notice", "to", "us", "that", "we", "are", "in", "material", "breach", "of", "our", "obligations", "under", "the", "agreement", "and", "we", "are", "unable", "to", "remedy", "such", "material", "breach", "within", "30", "days", "after", "we", "receive", "such", "notice.", "<tag2>", "If", "Fiocruz", "fails", "to", "comply", "with", "certain", "of", "its", "purchase", "commitments", "under", "the", "agreement,", "we", "may", "terminate", "the", "agreement,", "and", "all", "of", "our", "rights", "to", "the", "technology", "will", "be", "returned.", "<tag3>"], "wordsA": ["Icon", "may", "terminate", "the", "agreement", "upon", "written", "notice", "to", "us", "that", "we", "are", "in", "material", "breach", "of", "our", "obligations", "under", "the", "agreement", "and", "we", "are", "unable", "to", "remedy", "such", "material", "breach", "within", "30", "days", "after", "we", "receive", "such", "notice."], "wordsB": ["If", "Fiocruz", "fails", "to", "comply", "with", "certain", "of", "its", "purchase", "commitments", "under", "the", "agreement,", "we", "may", "terminate", "the", "agreement,", "and", "all", "of", "our", "rights", "to", "the", "technology", "will", "be", "returned."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p153_s4", "idA": "1006281_14_item1_p172_s4", "sentA": "In addition, we intend to use our manufacturing space to produce all of the drug substance needed in connection with the clinical trials of PRX-102 and of our oral treatment of Gaucher disease, and potentially for our other product candidates.", "sentB": "In addition, we intend to use our manufacturing space to produce all of the drug substance needed in connection with the clinical trials for our product candidates.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "intend", "to", "use", "our", "manufacturing", "space", "to", "produce", "all", "of", "the", "drug", "substance", "needed", "in", "connection", "with", "the", "clinical", "trials", "of", "PRX-102", "and", "of", "our", "oral", "treatment", "of", "Gaucher", "disease,", "and", "potentially", "for", "our", "other", "product", "candidates.", "<tag2>", "In", "addition,", "we", "intend", "to", "use", "our", "manufacturing", "space", "to", "produce", "all", "of", "the", "drug", "substance", "needed", "in", "connection", "with", "the", "clinical", "trials", "for", "our", "product", "candidates.", "<tag3>"], "wordsA": ["In", "addition,", "we", "intend", "to", "use", "our", "manufacturing", "space", "to", "produce", "all", "of", "the", "drug", "substance", "needed", "in", "connection", "with", "the", "clinical", "trials", "of", "PRX-102", "and", "of", "our", "oral", "treatment", "of", "Gaucher", "disease,", "and", "potentially", "for", "our", "other", "product", "candidates."], "wordsB": ["In", "addition,", "we", "intend", "to", "use", "our", "manufacturing", "space", "to", "produce", "all", "of", "the", "drug", "substance", "needed", "in", "connection", "with", "the", "clinical", "trials", "for", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p153_s5", "idA": "1006281_14_item1_p172_s5", "sentA": "Current capacity of our facility can serve all of our current and expected commercial and clinical needs.", "sentB": "Current capacity of our facility can serve all of our current and expected commercial and clinical needs, and may be sufficient to serve our production needs for the commercialization of PRX-102.", "type": 2, "words": ["<tag1>", "Current", "capacity", "of", "our", "facility", "can", "serve", "all", "of", "our", "current", "and", "expected", "commercial", "and", "clinical", "needs.", "<tag2>", "Current", "capacity", "of", "our", "facility", "can", "serve", "all", "of", "our", "current", "and", "expected", "commercial", "and", "clinical", "needs,", "and", "may", "be", "sufficient", "to", "serve", "our", "production", "needs", "for", "the", "commercialization", "of", "PRX-102.", "<tag3>"], "wordsA": ["Current", "capacity", "of", "our", "facility", "can", "serve", "all", "of", "our", "current", "and", "expected", "commercial", "and", "clinical", "needs."], "wordsB": ["Current", "capacity", "of", "our", "facility", "can", "serve", "all", "of", "our", "current", "and", "expected", "commercial", "and", "clinical", "needs,", "and", "may", "be", "sufficient", "to", "serve", "our", "production", "needs", "for", "the", "commercialization", "of", "PRX-102."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p157_s0", "idA": "1006281_14_item1_p176_s0", "sentA": "We believe that the raw materials that we require throughout the manufacturing process of our current and potential drug product candidates are widely available from numerous suppliers and are generally considered to be generic industrial biological supplies.", "sentB": "We believe that the raw materials that we require throughout the manufacturing process of Elelyso and our current and potential drug product candidates are widely available from numerous suppliers and are generally considered to be generic industrial biological supplies.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "the", "raw", "materials", "that", "we", "require", "throughout", "the", "manufacturing", "process", "of", "our", "current", "and", "potential", "drug", "product", "candidates", "are", "widely", "available", "from", "numerous", "suppliers", "and", "are", "generally", "considered", "to", "be", "generic", "industrial", "biological", "supplies.", "<tag2>", "We", "believe", "that", "the", "raw", "materials", "that", "we", "require", "throughout", "the", "manufacturing", "process", "of", "Elelyso", "and", "our", "current", "and", "potential", "drug", "product", "candidates", "are", "widely", "available", "from", "numerous", "suppliers", "and", "are", "generally", "considered", "to", "be", "generic", "industrial", "biological", "supplies.", "<tag3>"], "wordsA": ["We", "believe", "that", "the", "raw", "materials", "that", "we", "require", "throughout", "the", "manufacturing", "process", "of", "our", "current", "and", "potential", "drug", "product", "candidates", "are", "widely", "available", "from", "numerous", "suppliers", "and", "are", "generally", "considered", "to", "be", "generic", "industrial", "biological", "supplies."], "wordsB": ["We", "believe", "that", "the", "raw", "materials", "that", "we", "require", "throughout", "the", "manufacturing", "process", "of", "Elelyso", "and", "our", "current", "and", "potential", "drug", "product", "candidates", "are", "widely", "available", "from", "numerous", "suppliers", "and", "are", "generally", "considered", "to", "be", "generic", "industrial", "biological", "supplies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p105_s1", "idA": "1006281_14_item1_p177_s2", "sentA": "From time to time, we intend to continue to identify alternative FDA-approved suppliers to ensure the continued supply of necessary raw materials.", "sentB": "Upon reviewing the proof of concept (POC) data, expected in early 2016, we intend to collaborate with a well-suited partner for further development.", "type": 2, "words": ["<tag1>", "From", "time", "to", "time,", "we", "intend", "to", "continue", "to", "identify", "alternative", "FDA-approved", "suppliers", "to", "ensure", "the", "continued", "supply", "of", "necessary", "raw", "materials.", "<tag2>", "Upon", "reviewing", "the", "proof", "of", "concept", "(POC)", "data,", "expected", "in", "early", "2016,", "we", "intend", "to", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development.", "<tag3>"], "wordsA": ["From", "time", "to", "time,", "we", "intend", "to", "continue", "to", "identify", "alternative", "FDA-approved", "suppliers", "to", "ensure", "the", "continued", "supply", "of", "necessary", "raw", "materials."], "wordsB": ["Upon", "reviewing", "the", "proof", "of", "concept", "(POC)", "data,", "expected", "in", "early", "2016,", "we", "intend", "to", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p21_s3", "idA": "1006281_14_item1_p177_s2", "sentA": "From time to time, we intend to continue to identify alternative FDA-approved suppliers to ensure the continued supply of necessary raw materials.", "sentB": "Upon reviewing the proof of concept (POC) data, expected in early 2016, we intend to collaborate with a well-suited partner for further development.", "type": 2, "words": ["<tag1>", "From", "time", "to", "time,", "we", "intend", "to", "continue", "to", "identify", "alternative", "FDA-approved", "suppliers", "to", "ensure", "the", "continued", "supply", "of", "necessary", "raw", "materials.", "<tag2>", "Upon", "reviewing", "the", "proof", "of", "concept", "(POC)", "data,", "expected", "in", "early", "2016,", "we", "intend", "to", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development.", "<tag3>"], "wordsA": ["From", "time", "to", "time,", "we", "intend", "to", "continue", "to", "identify", "alternative", "FDA-approved", "suppliers", "to", "ensure", "the", "continued", "supply", "of", "necessary", "raw", "materials."], "wordsB": ["Upon", "reviewing", "the", "proof", "of", "concept", "(POC)", "data,", "expected", "in", "early", "2016,", "we", "intend", "to", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p160_s3", "idA": "1006281_14_item1_p179_s0", "sentA": "We specifically face competition from companies with approved treatments of Gaucher disease.", "sentB": "In addition, Sanofi has commercialized Cerdelga, a substrate reduction therapy for Gaucher disease.", "type": 2, "words": ["<tag1>", "We", "specifically", "face", "competition", "from", "companies", "with", "approved", "treatments", "of", "Gaucher", "disease.", "<tag2>", "In", "addition,", "Sanofi", "has", "commercialized", "Cerdelga,", "a", "substrate", "reduction", "therapy", "for", "Gaucher", "disease.", "<tag3>"], "wordsA": ["We", "specifically", "face", "competition", "from", "companies", "with", "approved", "treatments", "of", "Gaucher", "disease."], "wordsB": ["In", "addition,", "Sanofi", "has", "commercialized", "Cerdelga,", "a", "substrate", "reduction", "therapy", "for", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p28_s3", "idA": "1006281_14_item1_p17_s3", "sentA": "The IMS Institute for Healthcare Informatics reports that global biologic spending was $157 billion in 2010 ( Report by the IMS Institute for Healthcare Informatics , July 2012).", "sentB": "The IMS Institute for Healthcare Informatics reports that global biologic spending was $169 billion in 2012 and anticipated to reach $221 billion in 2017 ( Report by the IMS Institute for Healthcare Informatics , Nov. 2013).", "type": 2, "words": ["<tag1>", "The", "IMS", "Institute", "for", "Healthcare", "Informatics", "reports", "that", "global", "biologic", "spending", "was", "$157", "billion", "in", "2010", "(", "Report", "by", "the", "IMS", "Institute", "for", "Healthcare", "Informatics", ",", "July", "2012).", "<tag2>", "The", "IMS", "Institute", "for", "Healthcare", "Informatics", "reports", "that", "global", "biologic", "spending", "was", "$169", "billion", "in", "2012", "and", "anticipated", "to", "reach", "$221", "billion", "in", "2017", "(", "Report", "by", "the", "IMS", "Institute", "for", "Healthcare", "Informatics", ",", "Nov.", "2013).", "<tag3>"], "wordsA": ["The", "IMS", "Institute", "for", "Healthcare", "Informatics", "reports", "that", "global", "biologic", "spending", "was", "$157", "billion", "in", "2010", "(", "Report", "by", "the", "IMS", "Institute", "for", "Healthcare", "Informatics", ",", "July", "2012)."], "wordsB": ["The", "IMS", "Institute", "for", "Healthcare", "Informatics", "reports", "that", "global", "biologic", "spending", "was", "$169", "billion", "in", "2012", "and", "anticipated", "to", "reach", "$221", "billion", "in", "2017", "(", "Report", "by", "the", "IMS", "Institute", "for", "Healthcare", "Informatics", ",", "Nov.", "2013)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p164_s1", "idA": "1006281_14_item1_p183_s1", "sentA": "These companies include, among others, Novartis AG/Sandoz Pharmaceuticals, BioGeneriX AG, Stada Arzneimittel AG, BioPartners GmbH and Teva.", "sentB": "These companies include, among others, Novartis AG/Sandoz Pharmaceuticals, BioGeneriX AG, Stada Arzneimittel AG, BioPartners GmbH and Teva Pharmaceutical Industries Ltd. or Teva.", "type": 2, "words": ["<tag1>", "These", "companies", "include,", "among", "others,", "Novartis", "AG/Sandoz", "Pharmaceuticals,", "BioGeneriX", "AG,", "Stada", "Arzneimittel", "AG,", "BioPartners", "GmbH", "and", "Teva.", "<tag2>", "These", "companies", "include,", "among", "others,", "Novartis", "AG/Sandoz", "Pharmaceuticals,", "BioGeneriX", "AG,", "Stada", "Arzneimittel", "AG,", "BioPartners", "GmbH", "and", "Teva", "Pharmaceutical", "Industries", "Ltd.", "or", "Teva.", "<tag3>"], "wordsA": ["These", "companies", "include,", "among", "others,", "Novartis", "AG/Sandoz", "Pharmaceuticals,", "BioGeneriX", "AG,", "Stada", "Arzneimittel", "AG,", "BioPartners", "GmbH", "and", "Teva."], "wordsB": ["These", "companies", "include,", "among", "others,", "Novartis", "AG/Sandoz", "Pharmaceuticals,", "BioGeneriX", "AG,", "Stada", "Arzneimittel", "AG,", "BioPartners", "GmbH", "and", "Teva", "Pharmaceutical", "Industries", "Ltd.", "or", "Teva."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p166_s2", "idA": "1006281_14_item1_p185_s0", "sentA": "Members of our scientific advisory board, who are experts in the fields of plant molecular and cell biology as well as Gaucher disease and various hematological and genetic disorders, consult with our management within their professional areas of expertise; exchange strategic and business development ideas with our management; attend scientific, medical and business meetings with our management, such as meetings with the FDA and comparable foreign regulatory authorities, meetings with strategic or potential strategic partners and other meetings relevant to their areas of expertise; and attend meetings of our scientific advisory board.", "sentB": "Members of our scientific advisory board consult with our management within their professional areas of expertise; exchange strategic and business development ideas with our management; attend scientific, medical and business meetings with our management, such as meetings with the FDA and comparable foreign regulatory authorities, meetings with strategic or potential strategic partners and other meetings relevant to their areas of expertise; and attend meetings of our scientific advisory board.", "type": 2, "words": ["<tag1>", "Members", "of", "our", "scientific", "advisory", "board,", "who", "are", "experts", "in", "the", "fields", "of", "plant", "molecular", "and", "cell", "biology", "as", "well", "as", "Gaucher", "disease", "and", "various", "hematological", "and", "genetic", "disorders,", "consult", "with", "our", "management", "within", "their", "professional", "areas", "of", "expertise;", "exchange", "strategic", "and", "business", "development", "ideas", "with", "our", "management;", "attend", "scientific,", "medical", "and", "business", "meetings", "with", "our", "management,", "such", "as", "meetings", "with", "the", "FDA", "and", "comparable", "foreign", "regulatory", "authorities,", "meetings", "with", "strategic", "or", "potential", "strategic", "partners", "and", "other", "meetings", "relevant", "to", "their", "areas", "of", "expertise;", "and", "attend", "meetings", "of", "our", "scientific", "advisory", "board.", "<tag2>", "Members", "of", "our", "scientific", "advisory", "board", "consult", "with", "our", "management", "within", "their", "professional", "areas", "of", "expertise;", "exchange", "strategic", "and", "business", "development", "ideas", "with", "our", "management;", "attend", "scientific,", "medical", "and", "business", "meetings", "with", "our", "management,", "such", "as", "meetings", "with", "the", "FDA", "and", "comparable", "foreign", "regulatory", "authorities,", "meetings", "with", "strategic", "or", "potential", "strategic", "partners", "and", "other", "meetings", "relevant", "to", "their", "areas", "of", "expertise;", "and", "attend", "meetings", "of", "our", "scientific", "advisory", "board.", "<tag3>"], "wordsA": ["Members", "of", "our", "scientific", "advisory", "board,", "who", "are", "experts", "in", "the", "fields", "of", "plant", "molecular", "and", "cell", "biology", "as", "well", "as", "Gaucher", "disease", "and", "various", "hematological", "and", "genetic", "disorders,", "consult", "with", "our", "management", "within", "their", "professional", "areas", "of", "expertise;", "exchange", "strategic", "and", "business", "development", "ideas", "with", "our", "management;", "attend", "scientific,", "medical", "and", "business", "meetings", "with", "our", "management,", "such", "as", "meetings", "with", "the", "FDA", "and", "comparable", "foreign", "regulatory", "authorities,", "meetings", "with", "strategic", "or", "potential", "strategic", "partners", "and", "other", "meetings", "relevant", "to", "their", "areas", "of", "expertise;", "and", "attend", "meetings", "of", "our", "scientific", "advisory", "board."], "wordsB": ["Members", "of", "our", "scientific", "advisory", "board", "consult", "with", "our", "management", "within", "their", "professional", "areas", "of", "expertise;", "exchange", "strategic", "and", "business", "development", "ideas", "with", "our", "management;", "attend", "scientific,", "medical", "and", "business", "meetings", "with", "our", "management,", "such", "as", "meetings", "with", "the", "FDA", "and", "comparable", "foreign", "regulatory", "authorities,", "meetings", "with", "strategic", "or", "potential", "strategic", "partners", "and", "other", "meetings", "relevant", "to", "their", "areas", "of", "expertise;", "and", "attend", "meetings", "of", "our", "scientific", "advisory", "board."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p166_s0", "idA": "1006281_14_item1_p185_s2", "sentA": "Our scientific advisory board currently includes the following people:", "sentB": "We have reorganized our scientific advisory board by establishing a core team of advisors.", "type": 2, "words": ["<tag1>", "Our", "scientific", "advisory", "board", "currently", "includes", "the", "following", "people:", "<tag2>", "We", "have", "reorganized", "our", "scientific", "advisory", "board", "by", "establishing", "a", "core", "team", "of", "advisors.", "<tag3>"], "wordsA": ["Our", "scientific", "advisory", "board", "currently", "includes", "the", "following", "people:"], "wordsB": ["We", "have", "reorganized", "our", "scientific", "advisory", "board", "by", "establishing", "a", "core", "team", "of", "advisors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p166_s1", "idA": "1006281_14_item1_p185_s2", "sentA": "Our scientific advisory board currently includes the following people:", "sentB": "The scientific advisory board may invite additional experts to attend meetings on a case-by-case basis.", "type": 2, "words": ["<tag1>", "Our", "scientific", "advisory", "board", "currently", "includes", "the", "following", "people:", "<tag2>", "The", "scientific", "advisory", "board", "may", "invite", "additional", "experts", "to", "attend", "meetings", "on", "a", "case-by-case", "basis.", "<tag3>"], "wordsA": ["Our", "scientific", "advisory", "board", "currently", "includes", "the", "following", "people:"], "wordsB": ["The", "scientific", "advisory", "board", "may", "invite", "additional", "experts", "to", "attend", "meetings", "on", "a", "case-by-case", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p29_s1", "idA": "1006281_14_item1_p18_s1", "sentA": "Mammalian cell-based systems were first introduced in the late 1980s and are currently used to produce many of the biotechnology industry s largest and most successful therapeutic proteins, including Epogen , Neupogen , Cerezyme, Rituxan , Enbrel, Neulasta , Remicade and Herceptin .", "sentB": "Mammalian cell-based systems were first introduced in the late 1980s and are currently used to produce many of the biotechnology industry s largest and most successful therapeutic proteins, including Epogen , Neupogen , Cerezyme , Rituxan , Humira , Enbrel , Neulasta , Remicade and Herceptin .", "type": 2, "words": ["<tag1>", "Mammalian", "cell-based", "systems", "were", "first", "introduced", "in", "the", "late", "1980s", "and", "are", "currently", "used", "to", "produce", "many", "of", "the", "biotechnology", "industry", "s", "largest", "and", "most", "successful", "therapeutic", "proteins,", "including", "Epogen", ",", "Neupogen", ",", "Cerezyme,", "Rituxan", ",", "Enbrel,", "Neulasta", ",", "Remicade", "and", "Herceptin", ".", "<tag2>", "Mammalian", "cell-based", "systems", "were", "first", "introduced", "in", "the", "late", "1980s", "and", "are", "currently", "used", "to", "produce", "many", "of", "the", "biotechnology", "industry", "s", "largest", "and", "most", "successful", "therapeutic", "proteins,", "including", "Epogen", ",", "Neupogen", ",", "Cerezyme", ",", "Rituxan", ",", "Humira", ",", "Enbrel", ",", "Neulasta", ",", "Remicade", "and", "Herceptin", ".", "<tag3>"], "wordsA": ["Mammalian", "cell-based", "systems", "were", "first", "introduced", "in", "the", "late", "1980s", "and", "are", "currently", "used", "to", "produce", "many", "of", "the", "biotechnology", "industry", "s", "largest", "and", "most", "successful", "therapeutic", "proteins,", "including", "Epogen", ",", "Neupogen", ",", "Cerezyme,", "Rituxan", ",", "Enbrel,", "Neulasta", ",", "Remicade", "and", "Herceptin", "."], "wordsB": ["Mammalian", "cell-based", "systems", "were", "first", "introduced", "in", "the", "late", "1980s", "and", "are", "currently", "used", "to", "produce", "many", "of", "the", "biotechnology", "industry", "s", "largest", "and", "most", "successful", "therapeutic", "proteins,", "including", "Epogen", ",", "Neupogen", ",", "Cerezyme", ",", "Rituxan", ",", "Humira", ",", "Enbrel", ",", "Neulasta", ",", "Remicade", "and", "Herceptin", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p172_s1", "idA": "1006281_14_item1_p191_s1", "sentA": "Assuming that the clinical data support the product s safety and effectiveness for its intended use, an NDA is submitted to the FDA for its review.", "sentB": "Assuming that the clinical data support the product s safety and effectiveness for its intended use, a new drug application, or NDA, is submitted to the FDA for review.", "type": 2, "words": ["<tag1>", "Assuming", "that", "the", "clinical", "data", "support", "the", "product", "s", "safety", "and", "effectiveness", "for", "its", "intended", "use,", "an", "NDA", "is", "submitted", "to", "the", "FDA", "for", "its", "review.", "<tag2>", "Assuming", "that", "the", "clinical", "data", "support", "the", "product", "s", "safety", "and", "effectiveness", "for", "its", "intended", "use,", "a", "new", "drug", "application,", "or", "NDA,", "is", "submitted", "to", "the", "FDA", "for", "review.", "<tag3>"], "wordsA": ["Assuming", "that", "the", "clinical", "data", "support", "the", "product", "s", "safety", "and", "effectiveness", "for", "its", "intended", "use,", "an", "NDA", "is", "submitted", "to", "the", "FDA", "for", "its", "review."], "wordsB": ["Assuming", "that", "the", "clinical", "data", "support", "the", "product", "s", "safety", "and", "effectiveness", "for", "its", "intended", "use,", "a", "new", "drug", "application,", "or", "NDA,", "is", "submitted", "to", "the", "FDA", "for", "review."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p110_s0", "idA": "1006281_14_item1_p192_s1", "sentA": "In September 2009, we received orphan drug designation for taliglucerase alfa for the treatment of Gaucher disease.", "sentB": "We plan to initiate clinical efficacy trials of AIR DNase for the treatment of Cystic Fibrosis during 2015.", "type": 2, "words": ["<tag1>", "In", "September", "2009,", "we", "received", "orphan", "drug", "designation", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "We", "plan", "to", "initiate", "clinical", "efficacy", "trials", "of", "AIR", "DNase", "for", "the", "treatment", "of", "Cystic", "Fibrosis", "during", "2015.", "<tag3>"], "wordsA": ["In", "September", "2009,", "we", "received", "orphan", "drug", "designation", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["We", "plan", "to", "initiate", "clinical", "efficacy", "trials", "of", "AIR", "DNase", "for", "the", "treatment", "of", "Cystic", "Fibrosis", "during", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p22_s3", "idA": "1006281_14_item1_p192_s1", "sentA": "In September 2009, we received orphan drug designation for taliglucerase alfa for the treatment of Gaucher disease.", "sentB": "We plan to initiate clinical efficacy trials of AIR DNase for the treatment of Cystic Fibrosis (CF) during 2015.", "type": 2, "words": ["<tag1>", "In", "September", "2009,", "we", "received", "orphan", "drug", "designation", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "We", "plan", "to", "initiate", "clinical", "efficacy", "trials", "of", "AIR", "DNase", "for", "the", "treatment", "of", "Cystic", "Fibrosis", "(CF)", "during", "2015.", "<tag3>"], "wordsA": ["In", "September", "2009,", "we", "received", "orphan", "drug", "designation", "for", "taliglucerase", "alfa", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["We", "plan", "to", "initiate", "clinical", "efficacy", "trials", "of", "AIR", "DNase", "for", "the", "treatment", "of", "Cystic", "Fibrosis", "(CF)", "during", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p19_s1", "idA": "1006281_14_item1_p194_s0", "sentA": "If a significant therapeutic advantage over existing treatments is shown in the marketing application, FDA may grant orphan drug approval and provide a seven-year period of marketing exclusivity.", "sentB": "The strategy centers around prioritizing existing and new pipeline candidates to focus on clinically superior products that offer a clear competitive advantage over existing treatments.", "type": 2, "words": ["<tag1>", "If", "a", "significant", "therapeutic", "advantage", "over", "existing", "treatments", "is", "shown", "in", "the", "marketing", "application,", "FDA", "may", "grant", "orphan", "drug", "approval", "and", "provide", "a", "seven-year", "period", "of", "marketing", "exclusivity.", "<tag2>", "The", "strategy", "centers", "around", "prioritizing", "existing", "and", "new", "pipeline", "candidates", "to", "focus", "on", "clinically", "superior", "products", "that", "offer", "a", "clear", "competitive", "advantage", "over", "existing", "treatments.", "<tag3>"], "wordsA": ["If", "a", "significant", "therapeutic", "advantage", "over", "existing", "treatments", "is", "shown", "in", "the", "marketing", "application,", "FDA", "may", "grant", "orphan", "drug", "approval", "and", "provide", "a", "seven-year", "period", "of", "marketing", "exclusivity."], "wordsB": ["The", "strategy", "centers", "around", "prioritizing", "existing", "and", "new", "pipeline", "candidates", "to", "focus", "on", "clinically", "superior", "products", "that", "offer", "a", "clear", "competitive", "advantage", "over", "existing", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p0_s3", "idA": "1006281_14_item1_p1_s1", "sentA": "We believe ProCellEx will enable us to develop proprietary recombinant proteins that are therapeutically equivalent or superior to existing recombinant proteins currently marketed for the same indications.", "sentB": "With our experience, and having successfully developed Elelyso TM , our first drug product, we believe ProCellEx will enable us to develop additional proprietary recombinant proteins that are therapeutically superior to existing recombinant proteins currently marketed for the same indications.", "type": 2, "words": ["<tag1>", "We", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "equivalent", "or", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications.", "<tag2>", "With", "our", "experience,", "and", "having", "successfully", "developed", "Elelyso", "TM", ",", "our", "first", "drug", "product,", "we", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "additional", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications.", "<tag3>"], "wordsA": ["We", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "equivalent", "or", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications."], "wordsB": ["With", "our", "experience,", "and", "having", "successfully", "developed", "Elelyso", "TM", ",", "our", "first", "drug", "product,", "we", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "additional", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p0_s4", "idA": "1006281_14_item1_p1_s3", "sentA": "We are now also applying the unique properties of our ProCellEx system for the oral delivery of therapeutic proteins, with the first two product candidates being glucocerebrosidase and antiTNF fusion protein.", "sentB": "We are now also applying the unique properties of our ProCellEx system for the oral delivery of therapeutic proteins.", "type": 2, "words": ["<tag1>", "We", "are", "now", "also", "applying", "the", "unique", "properties", "of", "our", "ProCellEx", "system", "for", "the", "oral", "delivery", "of", "therapeutic", "proteins,", "with", "the", "first", "two", "product", "candidates", "being", "glucocerebrosidase", "and", "antiTNF", "fusion", "protein.", "<tag2>", "We", "are", "now", "also", "applying", "the", "unique", "properties", "of", "our", "ProCellEx", "system", "for", "the", "oral", "delivery", "of", "therapeutic", "proteins.", "<tag3>"], "wordsA": ["We", "are", "now", "also", "applying", "the", "unique", "properties", "of", "our", "ProCellEx", "system", "for", "the", "oral", "delivery", "of", "therapeutic", "proteins,", "with", "the", "first", "two", "product", "candidates", "being", "glucocerebrosidase", "and", "antiTNF", "fusion", "protein."], "wordsB": ["We", "are", "now", "also", "applying", "the", "unique", "properties", "of", "our", "ProCellEx", "system", "for", "the", "oral", "delivery", "of", "therapeutic", "proteins."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p19_s3", "idA": "1006281_14_item1_p206_s0", "sentA": "The following is a summary of the current principal Israeli tax laws applicable to us and Protalix Ltd., and of the Israeli Government programs from which Protalix Ltd. benefits.", "sentB": "The following highlights the details of the strategic plan.", "type": 2, "words": ["<tag1>", "The", "following", "is", "a", "summary", "of", "the", "current", "principal", "Israeli", "tax", "laws", "applicable", "to", "us", "and", "Protalix", "Ltd.,", "and", "of", "the", "Israeli", "Government", "programs", "from", "which", "Protalix", "Ltd.", "benefits.", "<tag2>", "The", "following", "highlights", "the", "details", "of", "the", "strategic", "plan.", "<tag3>"], "wordsA": ["The", "following", "is", "a", "summary", "of", "the", "current", "principal", "Israeli", "tax", "laws", "applicable", "to", "us", "and", "Protalix", "Ltd.,", "and", "of", "the", "Israeli", "Government", "programs", "from", "which", "Protalix", "Ltd.", "benefits."], "wordsB": ["The", "following", "highlights", "the", "details", "of", "the", "strategic", "plan."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p187_s0", "idA": "1006281_14_item1_p207_s0", "sentA": "The income of Protalix Ltd., other than income from Approved Enterprises, is taxed in Israel at the regular rate.", "sentB": "The income of Protalix Ltd., other than income from Approved Enterprises, is taxed in Israel at the regular rates which were 25% in 2012 and 2013 and 26.5% for 2014 and thereafter.", "type": 2, "words": ["<tag1>", "The", "income", "of", "Protalix", "Ltd.,", "other", "than", "income", "from", "Approved", "Enterprises,", "is", "taxed", "in", "Israel", "at", "the", "regular", "rate.", "<tag2>", "The", "income", "of", "Protalix", "Ltd.,", "other", "than", "income", "from", "Approved", "Enterprises,", "is", "taxed", "in", "Israel", "at", "the", "regular", "rates", "which", "were", "25%", "in", "2012", "and", "2013", "and", "26.5%", "for", "2014", "and", "thereafter.", "<tag3>"], "wordsA": ["The", "income", "of", "Protalix", "Ltd.,", "other", "than", "income", "from", "Approved", "Enterprises,", "is", "taxed", "in", "Israel", "at", "the", "regular", "rate."], "wordsB": ["The", "income", "of", "Protalix", "Ltd.,", "other", "than", "income", "from", "Approved", "Enterprises,", "is", "taxed", "in", "Israel", "at", "the", "regular", "rates", "which", "were", "25%", "in", "2012", "and", "2013", "and", "26.5%", "for", "2014", "and", "thereafter."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p188_s0", "idA": "1006281_14_item1_p211_s0", "sentA": "Capital gains on the sale of assets are subject to capital gain tax according to the corporate tax rate in effect for the year the assets are sold.", "sentB": "Capital gains on the sale of assets are subject to capital gain tax according to the corporate tax rate in effect for the year of selling the assets.", "type": 2, "words": ["<tag1>", "Capital", "gains", "on", "the", "sale", "of", "assets", "are", "subject", "to", "capital", "gain", "tax", "according", "to", "the", "corporate", "tax", "rate", "in", "effect", "for", "the", "year", "the", "assets", "are", "sold.", "<tag2>", "Capital", "gains", "on", "the", "sale", "of", "assets", "are", "subject", "to", "capital", "gain", "tax", "according", "to", "the", "corporate", "tax", "rate", "in", "effect", "for", "the", "year", "of", "selling", "the", "assets.", "<tag3>"], "wordsA": ["Capital", "gains", "on", "the", "sale", "of", "assets", "are", "subject", "to", "capital", "gain", "tax", "according", "to", "the", "corporate", "tax", "rate", "in", "effect", "for", "the", "year", "the", "assets", "are", "sold."], "wordsB": ["Capital", "gains", "on", "the", "sale", "of", "assets", "are", "subject", "to", "capital", "gain", "tax", "according", "to", "the", "corporate", "tax", "rate", "in", "effect", "for", "the", "year", "of", "selling", "the", "assets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p4_s1", "idA": "1006281_14_item1_p212_s0", "sentA": "In addition to the corporate taxes in Israel, we are subject to a withholding tax on the U.S. revenue source portion of the payments made to us for our share of Pfizer s net profits under the Pfizer Agreement.", "sentB": "Prior to the U.S. pediatric approval, Elelyso was approved for pediatric indications in Australia and Canada but in no other jurisdiction.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "corporate", "taxes", "in", "Israel,", "we", "are", "subject", "to", "a", "withholding", "tax", "on", "the", "U.S.", "revenue", "source", "portion", "of", "the", "payments", "made", "to", "us", "for", "our", "share", "of", "Pfizer", "s", "net", "profits", "under", "the", "Pfizer", "Agreement.", "<tag2>", "Prior", "to", "the", "U.S.", "pediatric", "approval,", "Elelyso", "was", "approved", "for", "pediatric", "indications", "in", "Australia", "and", "Canada", "but", "in", "no", "other", "jurisdiction.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "corporate", "taxes", "in", "Israel,", "we", "are", "subject", "to", "a", "withholding", "tax", "on", "the", "U.S.", "revenue", "source", "portion", "of", "the", "payments", "made", "to", "us", "for", "our", "share", "of", "Pfizer", "s", "net", "profits", "under", "the", "Pfizer", "Agreement."], "wordsB": ["Prior", "to", "the", "U.S.", "pediatric", "approval,", "Elelyso", "was", "approved", "for", "pediatric", "indications", "in", "Australia", "and", "Canada", "but", "in", "no", "other", "jurisdiction."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p58_s4", "idA": "1006281_14_item1_p212_s0", "sentA": "In addition to the corporate taxes in Israel, we are subject to a withholding tax on the U.S. revenue source portion of the payments made to us for our share of Pfizer s net profits under the Pfizer Agreement.", "sentB": "Prior to the U.S. pediatric approval, Elelyso was approved for pediatric indications in Australia and Canada but in no other jurisdiction.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "corporate", "taxes", "in", "Israel,", "we", "are", "subject", "to", "a", "withholding", "tax", "on", "the", "U.S.", "revenue", "source", "portion", "of", "the", "payments", "made", "to", "us", "for", "our", "share", "of", "Pfizer", "s", "net", "profits", "under", "the", "Pfizer", "Agreement.", "<tag2>", "Prior", "to", "the", "U.S.", "pediatric", "approval,", "Elelyso", "was", "approved", "for", "pediatric", "indications", "in", "Australia", "and", "Canada", "but", "in", "no", "other", "jurisdiction.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "corporate", "taxes", "in", "Israel,", "we", "are", "subject", "to", "a", "withholding", "tax", "on", "the", "U.S.", "revenue", "source", "portion", "of", "the", "payments", "made", "to", "us", "for", "our", "share", "of", "Pfizer", "s", "net", "profits", "under", "the", "Pfizer", "Agreement."], "wordsB": ["Prior", "to", "the", "U.S.", "pediatric", "approval,", "Elelyso", "was", "approved", "for", "pediatric", "indications", "in", "Australia", "and", "Canada", "but", "in", "no", "other", "jurisdiction."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p88_s1", "idA": "1006281_14_item1_p212_s0", "sentA": "In addition to the corporate taxes in Israel, we are subject to a withholding tax on the U.S. revenue source portion of the payments made to us for our share of Pfizer s net profits under the Pfizer Agreement.", "sentB": "In addition to a 100% reduction in worst pain, all patients also reported a 100% reduction in mean interference, with the exception of one patient who experienced a 33.3% reduction.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "corporate", "taxes", "in", "Israel,", "we", "are", "subject", "to", "a", "withholding", "tax", "on", "the", "U.S.", "revenue", "source", "portion", "of", "the", "payments", "made", "to", "us", "for", "our", "share", "of", "Pfizer", "s", "net", "profits", "under", "the", "Pfizer", "Agreement.", "<tag2>", "In", "addition", "to", "a", "100%", "reduction", "in", "worst", "pain,", "all", "patients", "also", "reported", "a", "100%", "reduction", "in", "mean", "interference,", "with", "the", "exception", "of", "one", "patient", "who", "experienced", "a", "33.3%", "reduction.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "corporate", "taxes", "in", "Israel,", "we", "are", "subject", "to", "a", "withholding", "tax", "on", "the", "U.S.", "revenue", "source", "portion", "of", "the", "payments", "made", "to", "us", "for", "our", "share", "of", "Pfizer", "s", "net", "profits", "under", "the", "Pfizer", "Agreement."], "wordsB": ["In", "addition", "to", "a", "100%", "reduction", "in", "worst", "pain,", "all", "patients", "also", "reported", "a", "100%", "reduction", "in", "mean", "interference,", "with", "the", "exception", "of", "one", "patient", "who", "experienced", "a", "33.3%", "reduction."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p111_s1", "idA": "1006281_14_item1_p215_s1", "sentA": "If any new benefits are granted to Protalix Ltd. in the future, Protalix Ltd. will be subject to the provisions of the amended Investment Law with respect to these new benefits.", "sentB": "In 2015, our focus with respect to oral GCD, will be on improving oral GCD s formulation and delivery in order to transform the product candidate into a commercially viable product.", "type": 2, "words": ["<tag1>", "If", "any", "new", "benefits", "are", "granted", "to", "Protalix", "Ltd.", "in", "the", "future,", "Protalix", "Ltd.", "will", "be", "subject", "to", "the", "provisions", "of", "the", "amended", "Investment", "Law", "with", "respect", "to", "these", "new", "benefits.", "<tag2>", "In", "2015,", "our", "focus", "with", "respect", "to", "oral", "GCD,", "will", "be", "on", "improving", "oral", "GCD", "s", "formulation", "and", "delivery", "in", "order", "to", "transform", "the", "product", "candidate", "into", "a", "commercially", "viable", "product.", "<tag3>"], "wordsA": ["If", "any", "new", "benefits", "are", "granted", "to", "Protalix", "Ltd.", "in", "the", "future,", "Protalix", "Ltd.", "will", "be", "subject", "to", "the", "provisions", "of", "the", "amended", "Investment", "Law", "with", "respect", "to", "these", "new", "benefits."], "wordsB": ["In", "2015,", "our", "focus", "with", "respect", "to", "oral", "GCD,", "will", "be", "on", "improving", "oral", "GCD", "s", "formulation", "and", "delivery", "in", "order", "to", "transform", "the", "product", "candidate", "into", "a", "commercially", "viable", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p85_s0", "idA": "1006281_14_item1_p221_s1", "sentA": "The tax rates and related levels of foreign investments are set forth in the following table:", "sentB": "PRX-102 demonstrated meaningful clinical benefits across the following key disease parameters already in the low dose of 0.2 mg/kg:", "type": 2, "words": ["<tag1>", "The", "tax", "rates", "and", "related", "levels", "of", "foreign", "investments", "are", "set", "forth", "in", "the", "following", "table:", "<tag2>", "PRX-102", "demonstrated", "meaningful", "clinical", "benefits", "across", "the", "following", "key", "disease", "parameters", "already", "in", "the", "low", "dose", "of", "0.2", "mg/kg:", "<tag3>"], "wordsA": ["The", "tax", "rates", "and", "related", "levels", "of", "foreign", "investments", "are", "set", "forth", "in", "the", "following", "table:"], "wordsB": ["PRX-102", "demonstrated", "meaningful", "clinical", "benefits", "across", "the", "following", "key", "disease", "parameters", "already", "in", "the", "low", "dose", "of", "0.2", "mg/kg:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p26_s0", "idA": "1006281_14_item1_p240_s2", "sentA": "For a description of such restrictions, please see Risk Factors Risks Relating to Our Operations in Israel.", "sentB": "We anticipate continuing to increase market share in Israel.", "type": 2, "words": ["<tag1>", "For", "a", "description", "of", "such", "restrictions,", "please", "see", "Risk", "Factors", "Risks", "Relating", "to", "Our", "Operations", "in", "Israel.", "<tag2>", "We", "anticipate", "continuing", "to", "increase", "market", "share", "in", "Israel.", "<tag3>"], "wordsA": ["For", "a", "description", "of", "such", "restrictions,", "please", "see", "Risk", "Factors", "Risks", "Relating", "to", "Our", "Operations", "in", "Israel."], "wordsB": ["We", "anticipate", "continuing", "to", "increase", "market", "share", "in", "Israel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p25_s2", "idA": "1006281_14_item1_p246_s1", "sentA": "It is possible that Protalix Ltd. may fail to qualify or may not continue to qualify as an Industrial Company or that the benefits described above will not be available in the future.", "sentB": "Biosimilars will not be a market on which we focus, and will only be considered in the case of proteins that are highly difficult to express or that represent opportunities for early market entry arising from the intellectual property advantages arising from ProCellEx.", "type": 2, "words": ["<tag1>", "It", "is", "possible", "that", "Protalix", "Ltd.", "may", "fail", "to", "qualify", "or", "may", "not", "continue", "to", "qualify", "as", "an", "Industrial", "Company", "or", "that", "the", "benefits", "described", "above", "will", "not", "be", "available", "in", "the", "future.", "<tag2>", "Biosimilars", "will", "not", "be", "a", "market", "on", "which", "we", "focus,", "and", "will", "only", "be", "considered", "in", "the", "case", "of", "proteins", "that", "are", "highly", "difficult", "to", "express", "or", "that", "represent", "opportunities", "for", "early", "market", "entry", "arising", "from", "the", "intellectual", "property", "advantages", "arising", "from", "ProCellEx.", "<tag3>"], "wordsA": ["It", "is", "possible", "that", "Protalix", "Ltd.", "may", "fail", "to", "qualify", "or", "may", "not", "continue", "to", "qualify", "as", "an", "Industrial", "Company", "or", "that", "the", "benefits", "described", "above", "will", "not", "be", "available", "in", "the", "future."], "wordsB": ["Biosimilars", "will", "not", "be", "a", "market", "on", "which", "we", "focus,", "and", "will", "only", "be", "considered", "in", "the", "case", "of", "proteins", "that", "are", "highly", "difficult", "to", "express", "or", "that", "represent", "opportunities", "for", "early", "market", "entry", "arising", "from", "the", "intellectual", "property", "advantages", "arising", "from", "ProCellEx."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p225_s0", "idA": "1006281_14_item1_p248_s0", "sentA": "As of December 31, 2013, we had 260 employees, of whom 40 have a Ph.D. or an M.D.in their respective scientific fields.", "sentB": "As of December 31, 2014, we had 234 employees, of whom 32 have a Ph.D. or an M.D.in their respective scientific fields.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2013,", "we", "had", "260", "employees,", "of", "whom", "40", "have", "a", "Ph.D.", "or", "an", "M.D.in", "their", "respective", "scientific", "fields.", "<tag2>", "As", "of", "December", "31,", "2014,", "we", "had", "234", "employees,", "of", "whom", "32", "have", "a", "Ph.D.", "or", "an", "M.D.in", "their", "respective", "scientific", "fields.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2013,", "we", "had", "260", "employees,", "of", "whom", "40", "have", "a", "Ph.D.", "or", "an", "M.D.in", "their", "respective", "scientific", "fields."], "wordsB": ["As", "of", "December", "31,", "2014,", "we", "had", "234", "employees,", "of", "whom", "32", "have", "a", "Ph.D.", "or", "an", "M.D.in", "their", "respective", "scientific", "fields."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p20_s3", "idA": "1006281_14_item1_p251_s0", "sentA": "Each of the other trademarks, trade names or service marks appearing in this Annual Report on Form 10-K belongs to its respective holder.", "sentB": "Interim efficacy and safety data from our ongoing phase I/II trial are described in this Annual Report.", "type": 2, "words": ["<tag1>", "Each", "of", "the", "other", "trademarks,", "trade", "names", "or", "service", "marks", "appearing", "in", "this", "Annual", "Report", "on", "Form", "10-K", "belongs", "to", "its", "respective", "holder.", "<tag2>", "Interim", "efficacy", "and", "safety", "data", "from", "our", "ongoing", "phase", "I/II", "trial", "are", "described", "in", "this", "Annual", "Report.", "<tag3>"], "wordsA": ["Each", "of", "the", "other", "trademarks,", "trade", "names", "or", "service", "marks", "appearing", "in", "this", "Annual", "Report", "on", "Form", "10-K", "belongs", "to", "its", "respective", "holder."], "wordsB": ["Interim", "efficacy", "and", "safety", "data", "from", "our", "ongoing", "phase", "I/II", "trial", "are", "described", "in", "this", "Annual", "Report."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p1_s0", "idA": "1006281_14_item1_p2_s0", "sentA": "The following table summarizes our current product and product candidates and their respective stages of development as of December 31, 2013.", "sentB": "The following table summarizes our current product candidates and our current projections regarding their respective stages of clinical development.", "type": 2, "words": ["<tag1>", "The", "following", "table", "summarizes", "our", "current", "product", "and", "product", "candidates", "and", "their", "respective", "stages", "of", "development", "as", "of", "December", "31,", "2013.", "<tag2>", "The", "following", "table", "summarizes", "our", "current", "product", "candidates", "and", "our", "current", "projections", "regarding", "their", "respective", "stages", "of", "clinical", "development.", "<tag3>"], "wordsA": ["The", "following", "table", "summarizes", "our", "current", "product", "and", "product", "candidates", "and", "their", "respective", "stages", "of", "development", "as", "of", "December", "31,", "2013."], "wordsB": ["The", "following", "table", "summarizes", "our", "current", "product", "candidates", "and", "our", "current", "projections", "regarding", "their", "respective", "stages", "of", "clinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p43_s0", "idA": "1006281_14_item1_p32_s0", "sentA": "We have successfully demonstrated the feasibility of our ProCellEx system through: the FDA s approval of taliglucerase alfa; the clinical and preclinical studies we have performed to date, including the positive efficacy and safety data in our phase III study of taliglucerase alfa, our switchover study and our extension study; preclinical results in well-known models in our enzyme for each of Fabry disease and pr-antiTNF; extensive animal studies for our PRX 106 enzyme; and by expressing, on an exploratory, research scale, many additional complex therapeutic proteins belonging to different drug classes, such as enzymes, hormones, monoclonal antibodies, cytokines and vaccines.", "sentB": "We have successfully demonstrated the feasibility of our ProCellEx system through: the FDA s approval of taliglucerase alfa; the clinical and preclinical studies we have performed to date, including the positive efficacy and safety data in our clinical trials for both Elelyso and PRX102 for the treatment of Fabry disease; preclinical results in well-known models in our enzyme for each of Fabry disease, DNase and antiTNF; and by expressing, on an exploratory, research scale, many additional complex therapeutic proteins belonging to different drug classes, such as enzymes, hormones, monoclonal antibodies, cytokines and vaccines.", "type": 2, "words": ["<tag1>", "We", "have", "successfully", "demonstrated", "the", "feasibility", "of", "our", "ProCellEx", "system", "through:", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa;", "the", "clinical", "and", "preclinical", "studies", "we", "have", "performed", "to", "date,", "including", "the", "positive", "efficacy", "and", "safety", "data", "in", "our", "phase", "III", "study", "of", "taliglucerase", "alfa,", "our", "switchover", "study", "and", "our", "extension", "study;", "preclinical", "results", "in", "well-known", "models", "in", "our", "enzyme", "for", "each", "of", "Fabry", "disease", "and", "pr-antiTNF;", "extensive", "animal", "studies", "for", "our", "PRX", "106", "enzyme;", "and", "by", "expressing,", "on", "an", "exploratory,", "research", "scale,", "many", "additional", "complex", "therapeutic", "proteins", "belonging", "to", "different", "drug", "classes,", "such", "as", "enzymes,", "hormones,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines.", "<tag2>", "We", "have", "successfully", "demonstrated", "the", "feasibility", "of", "our", "ProCellEx", "system", "through:", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa;", "the", "clinical", "and", "preclinical", "studies", "we", "have", "performed", "to", "date,", "including", "the", "positive", "efficacy", "and", "safety", "data", "in", "our", "clinical", "trials", "for", "both", "Elelyso", "and", "PRX102", "for", "the", "treatment", "of", "Fabry", "disease;", "preclinical", "results", "in", "well-known", "models", "in", "our", "enzyme", "for", "each", "of", "Fabry", "disease,", "DNase", "and", "antiTNF;", "and", "by", "expressing,", "on", "an", "exploratory,", "research", "scale,", "many", "additional", "complex", "therapeutic", "proteins", "belonging", "to", "different", "drug", "classes,", "such", "as", "enzymes,", "hormones,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines.", "<tag3>"], "wordsA": ["We", "have", "successfully", "demonstrated", "the", "feasibility", "of", "our", "ProCellEx", "system", "through:", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa;", "the", "clinical", "and", "preclinical", "studies", "we", "have", "performed", "to", "date,", "including", "the", "positive", "efficacy", "and", "safety", "data", "in", "our", "phase", "III", "study", "of", "taliglucerase", "alfa,", "our", "switchover", "study", "and", "our", "extension", "study;", "preclinical", "results", "in", "well-known", "models", "in", "our", "enzyme", "for", "each", "of", "Fabry", "disease", "and", "pr-antiTNF;", "extensive", "animal", "studies", "for", "our", "PRX", "106", "enzyme;", "and", "by", "expressing,", "on", "an", "exploratory,", "research", "scale,", "many", "additional", "complex", "therapeutic", "proteins", "belonging", "to", "different", "drug", "classes,", "such", "as", "enzymes,", "hormones,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines."], "wordsB": ["We", "have", "successfully", "demonstrated", "the", "feasibility", "of", "our", "ProCellEx", "system", "through:", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa;", "the", "clinical", "and", "preclinical", "studies", "we", "have", "performed", "to", "date,", "including", "the", "positive", "efficacy", "and", "safety", "data", "in", "our", "clinical", "trials", "for", "both", "Elelyso", "and", "PRX102", "for", "the", "treatment", "of", "Fabry", "disease;", "preclinical", "results", "in", "well-known", "models", "in", "our", "enzyme", "for", "each", "of", "Fabry", "disease,", "DNase", "and", "antiTNF;", "and", "by", "expressing,", "on", "an", "exploratory,", "research", "scale,", "many", "additional", "complex", "therapeutic", "proteins", "belonging", "to", "different", "drug", "classes,", "such", "as", "enzymes,", "hormones,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p109_s1", "idA": "1006281_14_item1_p32_s2", "sentA": "Moreover, several of such proteins demonstrated advantageous biological activity when compared to the biotherapeutics currently available in the market to treat the applicable disease or disorder.", "sentB": "The product candidate has demonstrated improved disease parameters in animal and human models sputum testing when compared to the currently marketed product.", "type": 2, "words": ["<tag1>", "Moreover,", "several", "of", "such", "proteins", "demonstrated", "advantageous", "biological", "activity", "when", "compared", "to", "the", "biotherapeutics", "currently", "available", "in", "the", "market", "to", "treat", "the", "applicable", "disease", "or", "disorder.", "<tag2>", "The", "product", "candidate", "has", "demonstrated", "improved", "disease", "parameters", "in", "animal", "and", "human", "models", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product.", "<tag3>"], "wordsA": ["Moreover,", "several", "of", "such", "proteins", "demonstrated", "advantageous", "biological", "activity", "when", "compared", "to", "the", "biotherapeutics", "currently", "available", "in", "the", "market", "to", "treat", "the", "applicable", "disease", "or", "disorder."], "wordsB": ["The", "product", "candidate", "has", "demonstrated", "improved", "disease", "parameters", "in", "animal", "and", "human", "models", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p22_s2", "idA": "1006281_14_item1_p32_s2", "sentA": "Moreover, several of such proteins demonstrated advantageous biological activity when compared to the biotherapeutics currently available in the market to treat the applicable disease or disorder.", "sentB": "The product candidate has demonstrated improved disease parameters in animal models and human sputum testing when compared to the currently marketed product.", "type": 2, "words": ["<tag1>", "Moreover,", "several", "of", "such", "proteins", "demonstrated", "advantageous", "biological", "activity", "when", "compared", "to", "the", "biotherapeutics", "currently", "available", "in", "the", "market", "to", "treat", "the", "applicable", "disease", "or", "disorder.", "<tag2>", "The", "product", "candidate", "has", "demonstrated", "improved", "disease", "parameters", "in", "animal", "models", "and", "human", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product.", "<tag3>"], "wordsA": ["Moreover,", "several", "of", "such", "proteins", "demonstrated", "advantageous", "biological", "activity", "when", "compared", "to", "the", "biotherapeutics", "currently", "available", "in", "the", "market", "to", "treat", "the", "applicable", "disease", "or", "disorder."], "wordsB": ["The", "product", "candidate", "has", "demonstrated", "improved", "disease", "parameters", "in", "animal", "models", "and", "human", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p25_s0", "idA": "1006281_14_item1_p32_s3", "sentA": "We believe that the FDA s approval of taliglucerase alfa represents a strong proof-of-concept of our ProCellEx system and plant cell-based protein expression technology.", "sentB": "We aim to expand our pipeline by leveraging the advantages of our proprietary ProCellEx protein expression technology.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa", "represents", "a", "strong", "proof-of-concept", "of", "our", "ProCellEx", "system", "and", "plant", "cell-based", "protein", "expression", "technology.", "<tag2>", "We", "aim", "to", "expand", "our", "pipeline", "by", "leveraging", "the", "advantages", "of", "our", "proprietary", "ProCellEx", "protein", "expression", "technology.", "<tag3>"], "wordsA": ["We", "believe", "that", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa", "represents", "a", "strong", "proof-of-concept", "of", "our", "ProCellEx", "system", "and", "plant", "cell-based", "protein", "expression", "technology."], "wordsB": ["We", "aim", "to", "expand", "our", "pipeline", "by", "leveraging", "the", "advantages", "of", "our", "proprietary", "ProCellEx", "protein", "expression", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p44_s0", "idA": "1006281_14_item1_p33_s0", "sentA": "We are also using our ProCellEx system to produce active recombinant proteins systemically through oral administration of plant cells expressing biotherapeutic proteins.", "sentB": "We are also using our ProCellEx system to produce active recombinant proteins through oral administration of plant cells expressing biotherapeutic proteins.", "type": 2, "words": ["<tag1>", "We", "are", "also", "using", "our", "ProCellEx", "system", "to", "produce", "active", "recombinant", "proteins", "systemically", "through", "oral", "administration", "of", "plant", "cells", "expressing", "biotherapeutic", "proteins.", "<tag2>", "We", "are", "also", "using", "our", "ProCellEx", "system", "to", "produce", "active", "recombinant", "proteins", "through", "oral", "administration", "of", "plant", "cells", "expressing", "biotherapeutic", "proteins.", "<tag3>"], "wordsA": ["We", "are", "also", "using", "our", "ProCellEx", "system", "to", "produce", "active", "recombinant", "proteins", "systemically", "through", "oral", "administration", "of", "plant", "cells", "expressing", "biotherapeutic", "proteins."], "wordsB": ["We", "are", "also", "using", "our", "ProCellEx", "system", "to", "produce", "active", "recombinant", "proteins", "through", "oral", "administration", "of", "plant", "cells", "expressing", "biotherapeutic", "proteins."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p57_s3", "idA": "1006281_14_item1_p34_s3", "sentA": "To date we have completed successful preclinical animal studies for oral GCD and oral anti TNF, and a phase I clinical trial of oral GCD in Gaucher patients.", "sentB": "To date we have completed successful preclinical animal studies for oral GCD and oral anti TNF, and early clinical trials of oral GCD in Gaucher patients.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "anti", "TNF,", "and", "a", "phase", "I", "clinical", "trial", "of", "oral", "GCD", "in", "Gaucher", "patients.", "<tag2>", "To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "anti", "TNF,", "and", "early", "clinical", "trials", "of", "oral", "GCD", "in", "Gaucher", "patients.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "anti", "TNF,", "and", "a", "phase", "I", "clinical", "trial", "of", "oral", "GCD", "in", "Gaucher", "patients."], "wordsB": ["To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "anti", "TNF,", "and", "early", "clinical", "trials", "of", "oral", "GCD", "in", "Gaucher", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p46_s0", "idA": "1006281_14_item1_p35_s0", "sentA": "To date, our manufacturing facility, in which we utilize our ProCellEx system, was determined to be acceptable by each of the FDA, EMA, ANVISA, the Israeli MOH, the Australian Therapeutic Goods Administration, or the TGA, and Health Canada, after GMP inspections were performed as part of their respective reviews for marketing approval of taliglucerase alfa.", "sentB": "To date, our manufacturing facility, in which we utilize our ProCellEx system, was determined to be acceptable by each of the FDA, the European Medicines Agency, or the EMA, ANVISA, the Israeli MOH, the Australian Therapeutic Goods Administration, or the TGA, and Health Canada, after GMP inspections were performed as part of their respective reviews for marketing approval of taliglucerase alfa.", "type": 2, "words": ["<tag1>", "To", "date,", "our", "manufacturing", "facility,", "in", "which", "we", "utilize", "our", "ProCellEx", "system,", "was", "determined", "to", "be", "acceptable", "by", "each", "of", "the", "FDA,", "EMA,", "ANVISA,", "the", "Israeli", "MOH,", "the", "Australian", "Therapeutic", "Goods", "Administration,", "or", "the", "TGA,", "and", "Health", "Canada,", "after", "GMP", "inspections", "were", "performed", "as", "part", "of", "their", "respective", "reviews", "for", "marketing", "approval", "of", "taliglucerase", "alfa.", "<tag2>", "To", "date,", "our", "manufacturing", "facility,", "in", "which", "we", "utilize", "our", "ProCellEx", "system,", "was", "determined", "to", "be", "acceptable", "by", "each", "of", "the", "FDA,", "the", "European", "Medicines", "Agency,", "or", "the", "EMA,", "ANVISA,", "the", "Israeli", "MOH,", "the", "Australian", "Therapeutic", "Goods", "Administration,", "or", "the", "TGA,", "and", "Health", "Canada,", "after", "GMP", "inspections", "were", "performed", "as", "part", "of", "their", "respective", "reviews", "for", "marketing", "approval", "of", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["To", "date,", "our", "manufacturing", "facility,", "in", "which", "we", "utilize", "our", "ProCellEx", "system,", "was", "determined", "to", "be", "acceptable", "by", "each", "of", "the", "FDA,", "EMA,", "ANVISA,", "the", "Israeli", "MOH,", "the", "Australian", "Therapeutic", "Goods", "Administration,", "or", "the", "TGA,", "and", "Health", "Canada,", "after", "GMP", "inspections", "were", "performed", "as", "part", "of", "their", "respective", "reviews", "for", "marketing", "approval", "of", "taliglucerase", "alfa."], "wordsB": ["To", "date,", "our", "manufacturing", "facility,", "in", "which", "we", "utilize", "our", "ProCellEx", "system,", "was", "determined", "to", "be", "acceptable", "by", "each", "of", "the", "FDA,", "the", "European", "Medicines", "Agency,", "or", "the", "EMA,", "ANVISA,", "the", "Israeli", "MOH,", "the", "Australian", "Therapeutic", "Goods", "Administration,", "or", "the", "TGA,", "and", "Health", "Canada,", "after", "GMP", "inspections", "were", "performed", "as", "part", "of", "their", "respective", "reviews", "for", "marketing", "approval", "of", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p47_s0", "idA": "1006281_14_item1_p36_s0", "sentA": "We believe that our ProCellEx protein expression system, including our advanced genetic engineering technology and plant cell-based protein expression methods, affords us a number of significant advantages over mammalian, bacterial, yeast and transgenic cell-based expression technologies, including the following:", "sentB": "We intend to continue to leverage the multiple unique advantages of our proprietary ProCellEx protein expression system, including our advanced genetic engineering technology and plant cell-based protein expression methods, to develop our pipeline.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "our", "ProCellEx", "protein", "expression", "system,", "including", "our", "advanced", "genetic", "engineering", "technology", "and", "plant", "cell-based", "protein", "expression", "methods,", "affords", "us", "a", "number", "of", "significant", "advantages", "over", "mammalian,", "bacterial,", "yeast", "and", "transgenic", "cell-based", "expression", "technologies,", "including", "the", "following:", "<tag2>", "We", "intend", "to", "continue", "to", "leverage", "the", "multiple", "unique", "advantages", "of", "our", "proprietary", "ProCellEx", "protein", "expression", "system,", "including", "our", "advanced", "genetic", "engineering", "technology", "and", "plant", "cell-based", "protein", "expression", "methods,", "to", "develop", "our", "pipeline.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "ProCellEx", "protein", "expression", "system,", "including", "our", "advanced", "genetic", "engineering", "technology", "and", "plant", "cell-based", "protein", "expression", "methods,", "affords", "us", "a", "number", "of", "significant", "advantages", "over", "mammalian,", "bacterial,", "yeast", "and", "transgenic", "cell-based", "expression", "technologies,", "including", "the", "following:"], "wordsB": ["We", "intend", "to", "continue", "to", "leverage", "the", "multiple", "unique", "advantages", "of", "our", "proprietary", "ProCellEx", "protein", "expression", "system,", "including", "our", "advanced", "genetic", "engineering", "technology", "and", "plant", "cell-based", "protein", "expression", "methods,", "to", "develop", "our", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p47_s1", "idA": "1006281_14_item1_p36_s0", "sentA": "We believe that our ProCellEx protein expression system, including our advanced genetic engineering technology and plant cell-based protein expression methods, affords us a number of significant advantages over mammalian, bacterial, yeast and transgenic cell-based expression technologies, including the following:", "sentB": "Significant advantages of ProCellEx over mammalian, bacterial, yeast and transgenic cell-based expression technologies, include the following:", "type": 2, "words": ["<tag1>", "We", "believe", "that", "our", "ProCellEx", "protein", "expression", "system,", "including", "our", "advanced", "genetic", "engineering", "technology", "and", "plant", "cell-based", "protein", "expression", "methods,", "affords", "us", "a", "number", "of", "significant", "advantages", "over", "mammalian,", "bacterial,", "yeast", "and", "transgenic", "cell-based", "expression", "technologies,", "including", "the", "following:", "<tag2>", "Significant", "advantages", "of", "ProCellEx", "over", "mammalian,", "bacterial,", "yeast", "and", "transgenic", "cell-based", "expression", "technologies,", "include", "the", "following:", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "ProCellEx", "protein", "expression", "system,", "including", "our", "advanced", "genetic", "engineering", "technology", "and", "plant", "cell-based", "protein", "expression", "methods,", "affords", "us", "a", "number", "of", "significant", "advantages", "over", "mammalian,", "bacterial,", "yeast", "and", "transgenic", "cell-based", "expression", "technologies,", "including", "the", "following:"], "wordsB": ["Significant", "advantages", "of", "ProCellEx", "over", "mammalian,", "bacterial,", "yeast", "and", "transgenic", "cell-based", "expression", "technologies,", "include", "the", "following:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p49_s1", "idA": "1006281_14_item1_p37_s1", "sentA": "We seek to develop recombinant proteins that we believe we can produce and commercialize without infringing upon the method-based patents or other intellectual property rights of third parties.", "sentB": "ProCellEx has the potential to provide workaround manufacturing that does not infringe the method-based patents or other intellectual property rights of third parties.", "type": 2, "words": ["<tag1>", "We", "seek", "to", "develop", "recombinant", "proteins", "that", "we", "believe", "we", "can", "produce", "and", "commercialize", "without", "infringing", "upon", "the", "method-based", "patents", "or", "other", "intellectual", "property", "rights", "of", "third", "parties.", "<tag2>", "ProCellEx", "has", "the", "potential", "to", "provide", "workaround", "manufacturing", "that", "does", "not", "infringe", "the", "method-based", "patents", "or", "other", "intellectual", "property", "rights", "of", "third", "parties.", "<tag3>"], "wordsA": ["We", "seek", "to", "develop", "recombinant", "proteins", "that", "we", "believe", "we", "can", "produce", "and", "commercialize", "without", "infringing", "upon", "the", "method-based", "patents", "or", "other", "intellectual", "property", "rights", "of", "third", "parties."], "wordsB": ["ProCellEx", "has", "the", "potential", "to", "provide", "workaround", "manufacturing", "that", "does", "not", "infringe", "the", "method-based", "patents", "or", "other", "intellectual", "property", "rights", "of", "third", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p50_s5", "idA": "1006281_14_item1_p38_s5", "sentA": "We have filed for United States and international composition of matter patents for taliglucerase alfa, PRX-102 and certain of our other product candidates.", "sentB": "We have filed for U.S. and international composition of matter patents for taliglucerase alfa, PRX-102 and certain of our other product candidates.", "type": 2, "words": ["<tag1>", "We", "have", "filed", "for", "United", "States", "and", "international", "composition", "of", "matter", "patents", "for", "taliglucerase", "alfa,", "PRX-102", "and", "certain", "of", "our", "other", "product", "candidates.", "<tag2>", "We", "have", "filed", "for", "U.S.", "and", "international", "composition", "of", "matter", "patents", "for", "taliglucerase", "alfa,", "PRX-102", "and", "certain", "of", "our", "other", "product", "candidates.", "<tag3>"], "wordsA": ["We", "have", "filed", "for", "United", "States", "and", "international", "composition", "of", "matter", "patents", "for", "taliglucerase", "alfa,", "PRX-102", "and", "certain", "of", "our", "other", "product", "candidates."], "wordsB": ["We", "have", "filed", "for", "U.S.", "and", "international", "composition", "of", "matter", "patents", "for", "taliglucerase", "alfa,", "PRX-102", "and", "certain", "of", "our", "other", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p2_s0", "idA": "1006281_14_item1_p3_s0", "sentA": "On May 1, 2012, the U.S. Food and Drug Administration, or the FDA, approved for sale our first commercial product, taliglucerase alfa for injection, which is being marketed in the United States and Israel under the brand name ELELYSO TM , as an enzyme replacement therapy, or ERT, for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "sentB": "On May 1, 2012, the U.S. Food and Drug Administration, or the FDA, approved for sale our first commercial product, taliglucerase alfa for injection, which is being marketed in the United States and Israel under the brand name Elelyso, as an enzyme replacement therapy, or ERT, for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "type": 2, "words": ["<tag1>", "On", "May", "1,", "2012,", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "ELELYSO", "TM", ",", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag2>", "On", "May", "1,", "2012,", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "Elelyso,", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag3>"], "wordsA": ["On", "May", "1,", "2012,", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "ELELYSO", "TM", ",", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "wordsB": ["On", "May", "1,", "2012,", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "Elelyso,", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p2_s1", "idA": "1006281_14_item1_p3_s1", "sentA": "Subsequently, taliglucerase alfa was approved by the Brazilian National Health Surveillance Agency (Agencia Nacional de Vigilancia Sanitaria, or ANVISA) in March 2013, by the Israeli Ministry of Health, or the Israeli MOH, in September 2012, and by the applicable regulatory authorities in Uruguay, Mexico and Chile.", "sentB": "Subsequently, taliglucerase alfa was approved by the Brazilian National Health Surveillance Agency (Agencia Nacional de Vigilancia Sanitaria, or ANVISA) in March 2013, and by the Israeli Ministry of Health, or the Israeli MOH, in September 2012.", "type": 2, "words": ["<tag1>", "Subsequently,", "taliglucerase", "alfa", "was", "approved", "by", "the", "Brazilian", "National", "Health", "Surveillance", "Agency", "(Agencia", "Nacional", "de", "Vigilancia", "Sanitaria,", "or", "ANVISA)", "in", "March", "2013,", "by", "the", "Israeli", "Ministry", "of", "Health,", "or", "the", "Israeli", "MOH,", "in", "September", "2012,", "and", "by", "the", "applicable", "regulatory", "authorities", "in", "Uruguay,", "Mexico", "and", "Chile.", "<tag2>", "Subsequently,", "taliglucerase", "alfa", "was", "approved", "by", "the", "Brazilian", "National", "Health", "Surveillance", "Agency", "(Agencia", "Nacional", "de", "Vigilancia", "Sanitaria,", "or", "ANVISA)", "in", "March", "2013,", "and", "by", "the", "Israeli", "Ministry", "of", "Health,", "or", "the", "Israeli", "MOH,", "in", "September", "2012.", "<tag3>"], "wordsA": ["Subsequently,", "taliglucerase", "alfa", "was", "approved", "by", "the", "Brazilian", "National", "Health", "Surveillance", "Agency", "(Agencia", "Nacional", "de", "Vigilancia", "Sanitaria,", "or", "ANVISA)", "in", "March", "2013,", "by", "the", "Israeli", "Ministry", "of", "Health,", "or", "the", "Israeli", "MOH,", "in", "September", "2012,", "and", "by", "the", "applicable", "regulatory", "authorities", "in", "Uruguay,", "Mexico", "and", "Chile."], "wordsB": ["Subsequently,", "taliglucerase", "alfa", "was", "approved", "by", "the", "Brazilian", "National", "Health", "Surveillance", "Agency", "(Agencia", "Nacional", "de", "Vigilancia", "Sanitaria,", "or", "ANVISA)", "in", "March", "2013,", "and", "by", "the", "Israeli", "Ministry", "of", "Health,", "or", "the", "Israeli", "MOH,", "in", "September", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p3_s0", "idA": "1006281_14_item1_p3_s2", "sentA": "Taliglucerase alfa will be marketed under the name UPLYSO TM in Brazil and certain other Latin American countries.", "sentB": "Taliglucerase alfa is being marketed under the name Uplyso TM in Brazil and certain other Latin American countries.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "will", "be", "marketed", "under", "the", "name", "UPLYSO", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries.", "<tag2>", "Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "will", "be", "marketed", "under", "the", "name", "UPLYSO", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries."], "wordsB": ["Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p54_s0", "idA": "1006281_14_item1_p40_s1", "sentA": "Plant cells grow rapidly under a variety of conditions and are not as sensitive to temperature, pH and oxygen levels as are mammalian cells.", "sentB": "Plant cells grow rapidly under a variety of conditions and are not as sensitive as mammalian cells are to temperature, pH and oxygen levels.", "type": 2, "words": ["<tag1>", "Plant", "cells", "grow", "rapidly", "under", "a", "variety", "of", "conditions", "and", "are", "not", "as", "sensitive", "to", "temperature,", "pH", "and", "oxygen", "levels", "as", "are", "mammalian", "cells.", "<tag2>", "Plant", "cells", "grow", "rapidly", "under", "a", "variety", "of", "conditions", "and", "are", "not", "as", "sensitive", "as", "mammalian", "cells", "are", "to", "temperature,", "pH", "and", "oxygen", "levels.", "<tag3>"], "wordsA": ["Plant", "cells", "grow", "rapidly", "under", "a", "variety", "of", "conditions", "and", "are", "not", "as", "sensitive", "to", "temperature,", "pH", "and", "oxygen", "levels", "as", "are", "mammalian", "cells."], "wordsB": ["Plant", "cells", "grow", "rapidly", "under", "a", "variety", "of", "conditions", "and", "are", "not", "as", "sensitive", "as", "mammalian", "cells", "are", "to", "temperature,", "pH", "and", "oxygen", "levels."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p54_s1", "idA": "1006281_14_item1_p40_s2", "sentA": "Our ProCellEx system, therefore, requires significantly less upfront capital expenditures as it does not use the highly complex, expensive, stainless steel bioreactors typically used in mammalian cell-based production systems to maintain very specific temperature, pH and oxygen levels.", "sentB": "Our system, therefore, does not require the highly complex, expensive, stainless steel bioreactors typically used in mammalian cell-based production systems to maintain very specific temperature, pH and oxygen levels.", "type": 2, "words": ["<tag1>", "Our", "ProCellEx", "system,", "therefore,", "requires", "significantly", "less", "upfront", "capital", "expenditures", "as", "it", "does", "not", "use", "the", "highly", "complex,", "expensive,", "stainless", "steel", "bioreactors", "typically", "used", "in", "mammalian", "cell-based", "production", "systems", "to", "maintain", "very", "specific", "temperature,", "pH", "and", "oxygen", "levels.", "<tag2>", "Our", "system,", "therefore,", "does", "not", "require", "the", "highly", "complex,", "expensive,", "stainless", "steel", "bioreactors", "typically", "used", "in", "mammalian", "cell-based", "production", "systems", "to", "maintain", "very", "specific", "temperature,", "pH", "and", "oxygen", "levels.", "<tag3>"], "wordsA": ["Our", "ProCellEx", "system,", "therefore,", "requires", "significantly", "less", "upfront", "capital", "expenditures", "as", "it", "does", "not", "use", "the", "highly", "complex,", "expensive,", "stainless", "steel", "bioreactors", "typically", "used", "in", "mammalian", "cell-based", "production", "systems", "to", "maintain", "very", "specific", "temperature,", "pH", "and", "oxygen", "levels."], "wordsB": ["Our", "system,", "therefore,", "does", "not", "require", "the", "highly", "complex,", "expensive,", "stainless", "steel", "bioreactors", "typically", "used", "in", "mammalian", "cell-based", "production", "systems", "to", "maintain", "very", "specific", "temperature,", "pH", "and", "oxygen", "levels."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p48_s1", "idA": "1006281_14_item1_p42_s1", "sentA": "Our ProCellEx protein expression system produces enzymes which have uniform glycosilation patterns and therefore do not require the lengthy and expensive post-expression modifications that are required for certain proteins produced by mammalian cell-based systems, including the proteins for the treatment of Gaucher disease.", "sentB": "For example, the proteins produced through our system have uniform glycosilation patterns and therefore do not require the lengthy and expensive post-expression modifications that are required for certain proteins produced by mammalian cell-based systems.", "type": 2, "words": ["<tag1>", "Our", "ProCellEx", "protein", "expression", "system", "produces", "enzymes", "which", "have", "uniform", "glycosilation", "patterns", "and", "therefore", "do", "not", "require", "the", "lengthy", "and", "expensive", "post-expression", "modifications", "that", "are", "required", "for", "certain", "proteins", "produced", "by", "mammalian", "cell-based", "systems,", "including", "the", "proteins", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "For", "example,", "the", "proteins", "produced", "through", "our", "system", "have", "uniform", "glycosilation", "patterns", "and", "therefore", "do", "not", "require", "the", "lengthy", "and", "expensive", "post-expression", "modifications", "that", "are", "required", "for", "certain", "proteins", "produced", "by", "mammalian", "cell-based", "systems.", "<tag3>"], "wordsA": ["Our", "ProCellEx", "protein", "expression", "system", "produces", "enzymes", "which", "have", "uniform", "glycosilation", "patterns", "and", "therefore", "do", "not", "require", "the", "lengthy", "and", "expensive", "post-expression", "modifications", "that", "are", "required", "for", "certain", "proteins", "produced", "by", "mammalian", "cell-based", "systems,", "including", "the", "proteins", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["For", "example,", "the", "proteins", "produced", "through", "our", "system", "have", "uniform", "glycosilation", "patterns", "and", "therefore", "do", "not", "require", "the", "lengthy", "and", "expensive", "post-expression", "modifications", "that", "are", "required", "for", "certain", "proteins", "produced", "by", "mammalian", "cell-based", "systems."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p51_s0", "idA": "1006281_14_item1_p43_s0", "sentA": "Our ProCellEx protein expression system is able to produce a broad array of complex glycosilated proteins, which differentiates our system from bacterial and yeast cell-based systems which are unable to produce complex proteins.", "sentB": "Our ProCellEx protein expression system is able to produce a broad array of complex glycosilated proteins, which are difficult to produce in other systems, such as bacterial and yeast cell-based systems, as well as CHO (Chinese Hamster Ovary) systems.", "type": 2, "words": ["<tag1>", "Our", "ProCellEx", "protein", "expression", "system", "is", "able", "to", "produce", "a", "broad", "array", "of", "complex", "glycosilated", "proteins,", "which", "differentiates", "our", "system", "from", "bacterial", "and", "yeast", "cell-based", "systems", "which", "are", "unable", "to", "produce", "complex", "proteins.", "<tag2>", "Our", "ProCellEx", "protein", "expression", "system", "is", "able", "to", "produce", "a", "broad", "array", "of", "complex", "glycosilated", "proteins,", "which", "are", "difficult", "to", "produce", "in", "other", "systems,", "such", "as", "bacterial", "and", "yeast", "cell-based", "systems,", "as", "well", "as", "CHO", "(Chinese", "Hamster", "Ovary)", "systems.", "<tag3>"], "wordsA": ["Our", "ProCellEx", "protein", "expression", "system", "is", "able", "to", "produce", "a", "broad", "array", "of", "complex", "glycosilated", "proteins,", "which", "differentiates", "our", "system", "from", "bacterial", "and", "yeast", "cell-based", "systems", "which", "are", "unable", "to", "produce", "complex", "proteins."], "wordsB": ["Our", "ProCellEx", "protein", "expression", "system", "is", "able", "to", "produce", "a", "broad", "array", "of", "complex", "glycosilated", "proteins,", "which", "are", "difficult", "to", "produce", "in", "other", "systems,", "such", "as", "bacterial", "and", "yeast", "cell-based", "systems,", "as", "well", "as", "CHO", "(Chinese", "Hamster", "Ovary)", "systems."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p56_s1", "idA": "1006281_14_item1_p44_s1", "sentA": "We are using our ProCellEx system to produce active recombinant proteins systemically through oral administration of plant cells expressing biotherapeutic proteins.", "sentB": "We are using our ProCellEx system to produce active recombinant proteins through oral administration of plant cells expressing biotherapeutic proteins.", "type": 2, "words": ["<tag1>", "We", "are", "using", "our", "ProCellEx", "system", "to", "produce", "active", "recombinant", "proteins", "systemically", "through", "oral", "administration", "of", "plant", "cells", "expressing", "biotherapeutic", "proteins.", "<tag2>", "We", "are", "using", "our", "ProCellEx", "system", "to", "produce", "active", "recombinant", "proteins", "through", "oral", "administration", "of", "plant", "cells", "expressing", "biotherapeutic", "proteins.", "<tag3>"], "wordsA": ["We", "are", "using", "our", "ProCellEx", "system", "to", "produce", "active", "recombinant", "proteins", "systemically", "through", "oral", "administration", "of", "plant", "cells", "expressing", "biotherapeutic", "proteins."], "wordsB": ["We", "are", "using", "our", "ProCellEx", "system", "to", "produce", "active", "recombinant", "proteins", "through", "oral", "administration", "of", "plant", "cells", "expressing", "biotherapeutic", "proteins."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p45_s3", "idA": "1006281_14_item1_p45_s3", "sentA": "To date we have completed successful preclinical animal studies for oral GCD and oral anti TNF, and a phase I clinical trial of oral GCD in Gaucher patients.", "sentB": "To date we have completed successful preclinical animal studies for oral GCD and oral antiTNF, and in early clinical trials of oral GCD in Gaucher patients.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "anti", "TNF,", "and", "a", "phase", "I", "clinical", "trial", "of", "oral", "GCD", "in", "Gaucher", "patients.", "<tag2>", "To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "antiTNF,", "and", "in", "early", "clinical", "trials", "of", "oral", "GCD", "in", "Gaucher", "patients.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "anti", "TNF,", "and", "a", "phase", "I", "clinical", "trial", "of", "oral", "GCD", "in", "Gaucher", "patients."], "wordsB": ["To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "antiTNF,", "and", "in", "early", "clinical", "trials", "of", "oral", "GCD", "in", "Gaucher", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p26_s1", "idA": "1006281_14_item1_p47_s2", "sentA": "We also intend to continue to work closely with the Israeli HMOs to increase our revenues in our home country.", "sentB": "Additionally, our management intends to continue to work closely with Pfizer, our collaboration partner, and with the Brazilian government, to increase sales globally.", "type": 2, "words": ["<tag1>", "We", "also", "intend", "to", "continue", "to", "work", "closely", "with", "the", "Israeli", "HMOs", "to", "increase", "our", "revenues", "in", "our", "home", "country.", "<tag2>", "Additionally,", "our", "management", "intends", "to", "continue", "to", "work", "closely", "with", "Pfizer,", "our", "collaboration", "partner,", "and", "with", "the", "Brazilian", "government,", "to", "increase", "sales", "globally.", "<tag3>"], "wordsA": ["We", "also", "intend", "to", "continue", "to", "work", "closely", "with", "the", "Israeli", "HMOs", "to", "increase", "our", "revenues", "in", "our", "home", "country."], "wordsB": ["Additionally,", "our", "management", "intends", "to", "continue", "to", "work", "closely", "with", "Pfizer,", "our", "collaboration", "partner,", "and", "with", "the", "Brazilian", "government,", "to", "increase", "sales", "globally."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p20_s0", "idA": "1006281_14_item1_p49_s0", "sentA": "Obtain Regulatory Approval for ELEYSO for the Treatment of Gaucher Disease.", "sentB": "PRX-102 for the Treatment of Fabry disease .", "type": 2, "words": ["<tag1>", "Obtain", "Regulatory", "Approval", "for", "ELEYSO", "for", "the", "Treatment", "of", "Gaucher", "Disease.", "<tag2>", "PRX-102", "for", "the", "Treatment", "of", "Fabry", "disease", ".", "<tag3>"], "wordsA": ["Obtain", "Regulatory", "Approval", "for", "ELEYSO", "for", "the", "Treatment", "of", "Gaucher", "Disease."], "wordsB": ["PRX-102", "for", "the", "Treatment", "of", "Fabry", "disease", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p23_s0", "idA": "1006281_14_item1_p49_s0", "sentA": "Obtain Regulatory Approval for ELEYSO for the Treatment of Gaucher Disease.", "sentB": "Oral GCD (PRX-112) for Gaucher Disease .", "type": 2, "words": ["<tag1>", "Obtain", "Regulatory", "Approval", "for", "ELEYSO", "for", "the", "Treatment", "of", "Gaucher", "Disease.", "<tag2>", "Oral", "GCD", "(PRX-112)", "for", "Gaucher", "Disease", ".", "<tag3>"], "wordsA": ["Obtain", "Regulatory", "Approval", "for", "ELEYSO", "for", "the", "Treatment", "of", "Gaucher", "Disease."], "wordsB": ["Oral", "GCD", "(PRX-112)", "for", "Gaucher", "Disease", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p160_s4", "idA": "1006281_14_item1_p50_s0", "sentA": "ELELYSO has been approved for marketing in the United States, Israel, Brazil, Uruguay, Mexico and Chile.", "sentB": "Cerdelga was approved for marketing by the FDA in August 2014 and by the European Commission in January 2015.", "type": 2, "words": ["<tag1>", "ELELYSO", "has", "been", "approved", "for", "marketing", "in", "the", "United", "States,", "Israel,", "Brazil,", "Uruguay,", "Mexico", "and", "Chile.", "<tag2>", "Cerdelga", "was", "approved", "for", "marketing", "by", "the", "FDA", "in", "August", "2014", "and", "by", "the", "European", "Commission", "in", "January", "2015.", "<tag3>"], "wordsA": ["ELELYSO", "has", "been", "approved", "for", "marketing", "in", "the", "United", "States,", "Israel,", "Brazil,", "Uruguay,", "Mexico", "and", "Chile."], "wordsB": ["Cerdelga", "was", "approved", "for", "marketing", "by", "the", "FDA", "in", "August", "2014", "and", "by", "the", "European", "Commission", "in", "January", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p69_s1", "idA": "1006281_14_item1_p50_s0", "sentA": "ELELYSO has been approved for marketing in the United States, Israel, Brazil, Uruguay, Mexico and Chile.", "sentB": "Cerdelga was approved for marketing by the FDA in August 2014 and by the European Commission in January 2015.", "type": 2, "words": ["<tag1>", "ELELYSO", "has", "been", "approved", "for", "marketing", "in", "the", "United", "States,", "Israel,", "Brazil,", "Uruguay,", "Mexico", "and", "Chile.", "<tag2>", "Cerdelga", "was", "approved", "for", "marketing", "by", "the", "FDA", "in", "August", "2014", "and", "by", "the", "European", "Commission", "in", "January", "2015.", "<tag3>"], "wordsA": ["ELELYSO", "has", "been", "approved", "for", "marketing", "in", "the", "United", "States,", "Israel,", "Brazil,", "Uruguay,", "Mexico", "and", "Chile."], "wordsB": ["Cerdelga", "was", "approved", "for", "marketing", "by", "the", "FDA", "in", "August", "2014", "and", "by", "the", "European", "Commission", "in", "January", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p2_s2", "idA": "1006281_14_item1_p50_s1", "sentA": "In addition, Pfizer has submitted marketing applications to the regulatory authorities of other countries.", "sentB": "It has also been approved by other regulatory agencies for other countries.", "type": 2, "words": ["<tag1>", "In", "addition,", "Pfizer", "has", "submitted", "marketing", "applications", "to", "the", "regulatory", "authorities", "of", "other", "countries.", "<tag2>", "It", "has", "also", "been", "approved", "by", "other", "regulatory", "agencies", "for", "other", "countries.", "<tag3>"], "wordsA": ["In", "addition,", "Pfizer", "has", "submitted", "marketing", "applications", "to", "the", "regulatory", "authorities", "of", "other", "countries."], "wordsB": ["It", "has", "also", "been", "approved", "by", "other", "regulatory", "agencies", "for", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p15_s1", "idA": "1006281_14_item1_p52_s1", "sentA": "We expect to initiate next phase clinical trial of Oral GCD in the second half of 2014.", "sentB": "We expect to initiate a proof of concept efficacy study during 2015.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "initiate", "next", "phase", "clinical", "trial", "of", "Oral", "GCD", "in", "the", "second", "half", "of", "2014.", "<tag2>", "We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015.", "<tag3>"], "wordsA": ["We", "expect", "to", "initiate", "next", "phase", "clinical", "trial", "of", "Oral", "GCD", "in", "the", "second", "half", "of", "2014."], "wordsB": ["We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p16_s1", "idA": "1006281_14_item1_p52_s1", "sentA": "We expect to initiate next phase clinical trial of Oral GCD in the second half of 2014.", "sentB": "We expect to initiate a proof of concept efficacy study during 2015.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "initiate", "next", "phase", "clinical", "trial", "of", "Oral", "GCD", "in", "the", "second", "half", "of", "2014.", "<tag2>", "We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015.", "<tag3>"], "wordsA": ["We", "expect", "to", "initiate", "next", "phase", "clinical", "trial", "of", "Oral", "GCD", "in", "the", "second", "half", "of", "2014."], "wordsB": ["We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p21_s2", "idA": "1006281_14_item1_p52_s1", "sentA": "We expect to initiate next phase clinical trial of Oral GCD in the second half of 2014.", "sentB": "We plan to initiate clinical efficacy trials of Oral Anti-TNF during 2015.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "initiate", "next", "phase", "clinical", "trial", "of", "Oral", "GCD", "in", "the", "second", "half", "of", "2014.", "<tag2>", "We", "plan", "to", "initiate", "clinical", "efficacy", "trials", "of", "Oral", "Anti-TNF", "during", "2015.", "<tag3>"], "wordsA": ["We", "expect", "to", "initiate", "next", "phase", "clinical", "trial", "of", "Oral", "GCD", "in", "the", "second", "half", "of", "2014."], "wordsB": ["We", "plan", "to", "initiate", "clinical", "efficacy", "trials", "of", "Oral", "Anti-TNF", "during", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p20_s2", "idA": "1006281_14_item1_p54_s2", "sentA": "We have built our own, internal marketing team designed to serve the Israeli market for ELELYSO and we intend to establish similar sales and marketing capabilities for our other product candidates in North America, the European Union and in other significant markets, including Israel.", "sentB": "The product candidate remains a key focus for our company, and we intend to aggressively push PRX-102 through clinical development.", "type": 2, "words": ["<tag1>", "We", "have", "built", "our", "own,", "internal", "marketing", "team", "designed", "to", "serve", "the", "Israeli", "market", "for", "ELELYSO", "and", "we", "intend", "to", "establish", "similar", "sales", "and", "marketing", "capabilities", "for", "our", "other", "product", "candidates", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel.", "<tag2>", "The", "product", "candidate", "remains", "a", "key", "focus", "for", "our", "company,", "and", "we", "intend", "to", "aggressively", "push", "PRX-102", "through", "clinical", "development.", "<tag3>"], "wordsA": ["We", "have", "built", "our", "own,", "internal", "marketing", "team", "designed", "to", "serve", "the", "Israeli", "market", "for", "ELELYSO", "and", "we", "intend", "to", "establish", "similar", "sales", "and", "marketing", "capabilities", "for", "our", "other", "product", "candidates", "in", "North", "America,", "the", "European", "Union", "and", "in", "other", "significant", "markets,", "including", "Israel."], "wordsB": ["The", "product", "candidate", "remains", "a", "key", "focus", "for", "our", "company,", "and", "we", "intend", "to", "aggressively", "push", "PRX-102", "through", "clinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p115_s0", "idA": "1006281_14_item1_p55_s2", "sentA": "We intend to focus on product candidates that would be synergistic with our ProCellEx protein expression system and expertise and that represent large potential market opportunities.", "sentB": "We intend to focus our efforts on a new formulation of the treatment during 2015 in order to prepare a viable solution for further clinical development.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "focus", "on", "product", "candidates", "that", "would", "be", "synergistic", "with", "our", "ProCellEx", "protein", "expression", "system", "and", "expertise", "and", "that", "represent", "large", "potential", "market", "opportunities.", "<tag2>", "We", "intend", "to", "focus", "our", "efforts", "on", "a", "new", "formulation", "of", "the", "treatment", "during", "2015", "in", "order", "to", "prepare", "a", "viable", "solution", "for", "further", "clinical", "development.", "<tag3>"], "wordsA": ["We", "intend", "to", "focus", "on", "product", "candidates", "that", "would", "be", "synergistic", "with", "our", "ProCellEx", "protein", "expression", "system", "and", "expertise", "and", "that", "represent", "large", "potential", "market", "opportunities."], "wordsB": ["We", "intend", "to", "focus", "our", "efforts", "on", "a", "new", "formulation", "of", "the", "treatment", "during", "2015", "in", "order", "to", "prepare", "a", "viable", "solution", "for", "further", "clinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p24_s1", "idA": "1006281_14_item1_p55_s2", "sentA": "We intend to focus on product candidates that would be synergistic with our ProCellEx protein expression system and expertise and that represent large potential market opportunities.", "sentB": "In 2015, we intend to focus on improving the product candidate s formulation and delivery in order to transform it into a commercially viable product.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "focus", "on", "product", "candidates", "that", "would", "be", "synergistic", "with", "our", "ProCellEx", "protein", "expression", "system", "and", "expertise", "and", "that", "represent", "large", "potential", "market", "opportunities.", "<tag2>", "In", "2015,", "we", "intend", "to", "focus", "on", "improving", "the", "product", "candidate", "s", "formulation", "and", "delivery", "in", "order", "to", "transform", "it", "into", "a", "commercially", "viable", "product.", "<tag3>"], "wordsA": ["We", "intend", "to", "focus", "on", "product", "candidates", "that", "would", "be", "synergistic", "with", "our", "ProCellEx", "protein", "expression", "system", "and", "expertise", "and", "that", "represent", "large", "potential", "market", "opportunities."], "wordsB": ["In", "2015,", "we", "intend", "to", "focus", "on", "improving", "the", "product", "candidate", "s", "formulation", "and", "delivery", "in", "order", "to", "transform", "it", "into", "a", "commercially", "viable", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p4_s0", "idA": "1006281_14_item1_p61_s1", "sentA": "On May 1, 2012, the FDA approved ELELYSO for injection as an enzyme replacement therapy (ERT) for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "sentB": "In August 2014, the FDA approved Elelyso for injection for pediatric patients and the Israeli MOH approved the pediatric indication in January 2015.", "type": 2, "words": ["<tag1>", "On", "May", "1,", "2012,", "the", "FDA", "approved", "ELELYSO", "for", "injection", "as", "an", "enzyme", "replacement", "therapy", "(ERT)", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag2>", "In", "August", "2014,", "the", "FDA", "approved", "Elelyso", "for", "injection", "for", "pediatric", "patients", "and", "the", "Israeli", "MOH", "approved", "the", "pediatric", "indication", "in", "January", "2015.", "<tag3>"], "wordsA": ["On", "May", "1,", "2012,", "the", "FDA", "approved", "ELELYSO", "for", "injection", "as", "an", "enzyme", "replacement", "therapy", "(ERT)", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "wordsB": ["In", "August", "2014,", "the", "FDA", "approved", "Elelyso", "for", "injection", "for", "pediatric", "patients", "and", "the", "Israeli", "MOH", "approved", "the", "pediatric", "indication", "in", "January", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p58_s3", "idA": "1006281_14_item1_p61_s1", "sentA": "On May 1, 2012, the FDA approved ELELYSO for injection as an enzyme replacement therapy (ERT) for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "sentB": "In August 2014, the FDA approved Elelyso for injection for pediatric patients and the Israeli MOH approved the pediatric indication in January 2015.", "type": 2, "words": ["<tag1>", "On", "May", "1,", "2012,", "the", "FDA", "approved", "ELELYSO", "for", "injection", "as", "an", "enzyme", "replacement", "therapy", "(ERT)", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag2>", "In", "August", "2014,", "the", "FDA", "approved", "Elelyso", "for", "injection", "for", "pediatric", "patients", "and", "the", "Israeli", "MOH", "approved", "the", "pediatric", "indication", "in", "January", "2015.", "<tag3>"], "wordsA": ["On", "May", "1,", "2012,", "the", "FDA", "approved", "ELELYSO", "for", "injection", "as", "an", "enzyme", "replacement", "therapy", "(ERT)", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "wordsB": ["In", "August", "2014,", "the", "FDA", "approved", "Elelyso", "for", "injection", "for", "pediatric", "patients", "and", "the", "Israeli", "MOH", "approved", "the", "pediatric", "indication", "in", "January", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p58_s2", "idA": "1006281_14_item1_p61_s2", "sentA": "It was subsequently approved by the Israeli MOH in September 2012, the Brazilian National Health Surveillance Agency (ANVISA) in March 2013, the Mexican Federal Commission for the Protection against Sanitary Risk (COFEPRIS) in April 2013 and the regulatory authorities of other countries .", "sentB": "It was subsequently approved by the Israeli MOH, ANVISA and the regulatory authorities of other countries .", "type": 2, "words": ["<tag1>", "It", "was", "subsequently", "approved", "by", "the", "Israeli", "MOH", "in", "September", "2012,", "the", "Brazilian", "National", "Health", "Surveillance", "Agency", "(ANVISA)", "in", "March", "2013,", "the", "Mexican", "Federal", "Commission", "for", "the", "Protection", "against", "Sanitary", "Risk", "(COFEPRIS)", "in", "April", "2013", "and", "the", "regulatory", "authorities", "of", "other", "countries", ".", "<tag2>", "It", "was", "subsequently", "approved", "by", "the", "Israeli", "MOH,", "ANVISA", "and", "the", "regulatory", "authorities", "of", "other", "countries", ".", "<tag3>"], "wordsA": ["It", "was", "subsequently", "approved", "by", "the", "Israeli", "MOH", "in", "September", "2012,", "the", "Brazilian", "National", "Health", "Surveillance", "Agency", "(ANVISA)", "in", "March", "2013,", "the", "Mexican", "Federal", "Commission", "for", "the", "Protection", "against", "Sanitary", "Risk", "(COFEPRIS)", "in", "April", "2013", "and", "the", "regulatory", "authorities", "of", "other", "countries", "."], "wordsB": ["It", "was", "subsequently", "approved", "by", "the", "Israeli", "MOH,", "ANVISA", "and", "the", "regulatory", "authorities", "of", "other", "countries", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p67_s1", "idA": "1006281_14_item1_p71_s1", "sentA": "Cerezyme and VPRIV, enzyme replacement therapies commercialized by Genzyme and Shire, respectively, are the only recombinant GCDs currently available on the market for the treatment of Gaucher disease.", "sentB": "Cerezyme and VPRIV , enzyme replacement therapies commercialized by Genzyme Corporation (acquired by Sanofi), or Genzyme, and Shire plc, or Shire, respectively, are the only recombinant GCDs currently available on the market for the treatment of Gaucher disease.", "type": 2, "words": ["<tag1>", "Cerezyme", "and", "VPRIV,", "enzyme", "replacement", "therapies", "commercialized", "by", "Genzyme", "and", "Shire,", "respectively,", "are", "the", "only", "recombinant", "GCDs", "currently", "available", "on", "the", "market", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "Cerezyme", "and", "VPRIV", ",", "enzyme", "replacement", "therapies", "commercialized", "by", "Genzyme", "Corporation", "(acquired", "by", "Sanofi),", "or", "Genzyme,", "and", "Shire", "plc,", "or", "Shire,", "respectively,", "are", "the", "only", "recombinant", "GCDs", "currently", "available", "on", "the", "market", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag3>"], "wordsA": ["Cerezyme", "and", "VPRIV,", "enzyme", "replacement", "therapies", "commercialized", "by", "Genzyme", "and", "Shire,", "respectively,", "are", "the", "only", "recombinant", "GCDs", "currently", "available", "on", "the", "market", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["Cerezyme", "and", "VPRIV", ",", "enzyme", "replacement", "therapies", "commercialized", "by", "Genzyme", "Corporation", "(acquired", "by", "Sanofi),", "or", "Genzyme,", "and", "Shire", "plc,", "or", "Shire,", "respectively,", "are", "the", "only", "recombinant", "GCDs", "currently", "available", "on", "the", "market", "for", "the", "treatment", "of", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p106_s2", "idA": "1006281_14_item1_p72_s0", "sentA": "According to public reports by Sanofi, consolidated sales of Cerezyme during the year ended December 31, 2013 were 688 million (or approximately $950 million), a growth of approximately 14% compared to the same period in 2012.", "sentB": "Currently, Pulmozyme is the only DNase I commercially available, with annual sales of approximately $626 million in sales for 2014, according to public reports by F. Hoffman-La Roche Ltd.", "type": 2, "words": ["<tag1>", "According", "to", "public", "reports", "by", "Sanofi,", "consolidated", "sales", "of", "Cerezyme", "during", "the", "year", "ended", "December", "31,", "2013", "were", "688", "million", "(or", "approximately", "$950", "million),", "a", "growth", "of", "approximately", "14%", "compared", "to", "the", "same", "period", "in", "2012.", "<tag2>", "Currently,", "Pulmozyme", "is", "the", "only", "DNase", "I", "commercially", "available,", "with", "annual", "sales", "of", "approximately", "$626", "million", "in", "sales", "for", "2014,", "according", "to", "public", "reports", "by", "F.", "Hoffman-La", "Roche", "Ltd.", "<tag3>"], "wordsA": ["According", "to", "public", "reports", "by", "Sanofi,", "consolidated", "sales", "of", "Cerezyme", "during", "the", "year", "ended", "December", "31,", "2013", "were", "688", "million", "(or", "approximately", "$950", "million),", "a", "growth", "of", "approximately", "14%", "compared", "to", "the", "same", "period", "in", "2012."], "wordsB": ["Currently,", "Pulmozyme", "is", "the", "only", "DNase", "I", "commercially", "available,", "with", "annual", "sales", "of", "approximately", "$626", "million", "in", "sales", "for", "2014,", "according", "to", "public", "reports", "by", "F.", "Hoffman-La", "Roche", "Ltd."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p68_s0", "idA": "1006281_14_item1_p72_s0", "sentA": "According to public reports by Sanofi, consolidated sales of Cerezyme during the year ended December 31, 2013 were 688 million (or approximately $950 million), a growth of approximately 14% compared to the same period in 2012.", "sentB": "According to public reports by Sanofi, consolidated sales of Cerezyme during the year ended December 31, 2014 were 715 million (or approximately $865 million), a growth of approximately 8% compared to the same period in 2013.", "type": 2, "words": ["<tag1>", "According", "to", "public", "reports", "by", "Sanofi,", "consolidated", "sales", "of", "Cerezyme", "during", "the", "year", "ended", "December", "31,", "2013", "were", "688", "million", "(or", "approximately", "$950", "million),", "a", "growth", "of", "approximately", "14%", "compared", "to", "the", "same", "period", "in", "2012.", "<tag2>", "According", "to", "public", "reports", "by", "Sanofi,", "consolidated", "sales", "of", "Cerezyme", "during", "the", "year", "ended", "December", "31,", "2014", "were", "715", "million", "(or", "approximately", "$865", "million),", "a", "growth", "of", "approximately", "8%", "compared", "to", "the", "same", "period", "in", "2013.", "<tag3>"], "wordsA": ["According", "to", "public", "reports", "by", "Sanofi,", "consolidated", "sales", "of", "Cerezyme", "during", "the", "year", "ended", "December", "31,", "2013", "were", "688", "million", "(or", "approximately", "$950", "million),", "a", "growth", "of", "approximately", "14%", "compared", "to", "the", "same", "period", "in", "2012."], "wordsB": ["According", "to", "public", "reports", "by", "Sanofi,", "consolidated", "sales", "of", "Cerezyme", "during", "the", "year", "ended", "December", "31,", "2014", "were", "715", "million", "(or", "approximately", "$865", "million),", "a", "growth", "of", "approximately", "8%", "compared", "to", "the", "same", "period", "in", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p68_s1", "idA": "1006281_14_item1_p72_s1", "sentA": "Shire reported annual worldwide sales of VPRIV of approximately $343 million in 2013, a growth of 12% compared to VPRIV s sales in 2012.", "sentB": "Shire reported annual worldwide sales of VPRIV of approximately $367 million in 2014, a growth of 7% compared to VPRIV s sales in 2013.", "type": 2, "words": ["<tag1>", "Shire", "reported", "annual", "worldwide", "sales", "of", "VPRIV", "of", "approximately", "$343", "million", "in", "2013,", "a", "growth", "of", "12%", "compared", "to", "VPRIV", "s", "sales", "in", "2012.", "<tag2>", "Shire", "reported", "annual", "worldwide", "sales", "of", "VPRIV", "of", "approximately", "$367", "million", "in", "2014,", "a", "growth", "of", "7%", "compared", "to", "VPRIV", "s", "sales", "in", "2013.", "<tag3>"], "wordsA": ["Shire", "reported", "annual", "worldwide", "sales", "of", "VPRIV", "of", "approximately", "$343", "million", "in", "2013,", "a", "growth", "of", "12%", "compared", "to", "VPRIV", "s", "sales", "in", "2012."], "wordsB": ["Shire", "reported", "annual", "worldwide", "sales", "of", "VPRIV", "of", "approximately", "$367", "million", "in", "2014,", "a", "growth", "of", "7%", "compared", "to", "VPRIV", "s", "sales", "in", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p69_s0", "idA": "1006281_14_item1_p75_s0", "sentA": "Zavesca (miglustat), which is marketed by Actelion Ltd., or Actelion, is a small molecule drug for the treatment of Gaucher disease.", "sentB": "In addition, Cerdelga (eliglustat) is a substrate reduction therapy for Gaucher disease marketed by Sanofi.", "type": 2, "words": ["<tag1>", "Zavesca", "(miglustat),", "which", "is", "marketed", "by", "Actelion", "Ltd.,", "or", "Actelion,", "is", "a", "small", "molecule", "drug", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "In", "addition,", "Cerdelga", "(eliglustat)", "is", "a", "substrate", "reduction", "therapy", "for", "Gaucher", "disease", "marketed", "by", "Sanofi.", "<tag3>"], "wordsA": ["Zavesca", "(miglustat),", "which", "is", "marketed", "by", "Actelion", "Ltd.,", "or", "Actelion,", "is", "a", "small", "molecule", "drug", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["In", "addition,", "Cerdelga", "(eliglustat)", "is", "a", "substrate", "reduction", "therapy", "for", "Gaucher", "disease", "marketed", "by", "Sanofi."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p73_s0", "idA": "1006281_14_item1_p76_s0", "sentA": "Actelion has reported total sales of Zavesca of approximately CHF 96 million (approximately $109 million) in 2013, an increase of approximately 13% compared to sales in 2012.", "sentB": "Actelion has reported total sales of Zavesca of approximately CHF 103 million (approximately $104 million) in 2014, an increase of approximately 8% compared to sales in 2013.", "type": 2, "words": ["<tag1>", "Actelion", "has", "reported", "total", "sales", "of", "Zavesca", "of", "approximately", "CHF", "96", "million", "(approximately", "$109", "million)", "in", "2013,", "an", "increase", "of", "approximately", "13%", "compared", "to", "sales", "in", "2012.", "<tag2>", "Actelion", "has", "reported", "total", "sales", "of", "Zavesca", "of", "approximately", "CHF", "103", "million", "(approximately", "$104", "million)", "in", "2014,", "an", "increase", "of", "approximately", "8%", "compared", "to", "sales", "in", "2013.", "<tag3>"], "wordsA": ["Actelion", "has", "reported", "total", "sales", "of", "Zavesca", "of", "approximately", "CHF", "96", "million", "(approximately", "$109", "million)", "in", "2013,", "an", "increase", "of", "approximately", "13%", "compared", "to", "sales", "in", "2012."], "wordsB": ["Actelion", "has", "reported", "total", "sales", "of", "Zavesca", "of", "approximately", "CHF", "103", "million", "(approximately", "$104", "million)", "in", "2014,", "an", "increase", "of", "approximately", "8%", "compared", "to", "sales", "in", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p92_s0", "idA": "1006281_14_item1_p78_s3", "sentA": "The primary endpoint of the study was a 20% mean reduction from baseline in spleen volume after nine months, as measured by MRI.", "sentB": "All patients that participated in the trial exhibited stable cardiac and kidney function, with favorable trends after only six months, as measured by left ventricular mass (LVM), left ventricular mass index (LVMI), ejection fraction (EF), estimated glomerular filtration rate (eGFR) and urine protein.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "of", "the", "study", "was", "a", "20%", "mean", "reduction", "from", "baseline", "in", "spleen", "volume", "after", "nine", "months,", "as", "measured", "by", "MRI.", "<tag2>", "All", "patients", "that", "participated", "in", "the", "trial", "exhibited", "stable", "cardiac", "and", "kidney", "function,", "with", "favorable", "trends", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI),", "ejection", "fraction", "(EF),", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "of", "the", "study", "was", "a", "20%", "mean", "reduction", "from", "baseline", "in", "spleen", "volume", "after", "nine", "months,", "as", "measured", "by", "MRI."], "wordsB": ["All", "patients", "that", "participated", "in", "the", "trial", "exhibited", "stable", "cardiac", "and", "kidney", "function,", "with", "favorable", "trends", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI),", "ejection", "fraction", "(EF),", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p14_s1", "idA": "1006281_14_item1_p79_s1", "sentA": "Enrollment was completed in the fourth quarter of 2008 and the trial was successfully completed in September 2009.", "sentB": "We expect to report interim efficacy and safety results for the 1 mg/kg dose group of the trial during the third quarter of 2015 and to report final efficacy and safety results for the 0.2mg, 1 mg and 2mg/kg dose groups of the trial during the fourth quarter of 2015.", "type": 2, "words": ["<tag1>", "Enrollment", "was", "completed", "in", "the", "fourth", "quarter", "of", "2008", "and", "the", "trial", "was", "successfully", "completed", "in", "September", "2009.", "<tag2>", "We", "expect", "to", "report", "interim", "efficacy", "and", "safety", "results", "for", "the", "1", "mg/kg", "dose", "group", "of", "the", "trial", "during", "the", "third", "quarter", "of", "2015", "and", "to", "report", "final", "efficacy", "and", "safety", "results", "for", "the", "0.2mg,", "1", "mg", "and", "2mg/kg", "dose", "groups", "of", "the", "trial", "during", "the", "fourth", "quarter", "of", "2015.", "<tag3>"], "wordsA": ["Enrollment", "was", "completed", "in", "the", "fourth", "quarter", "of", "2008", "and", "the", "trial", "was", "successfully", "completed", "in", "September", "2009."], "wordsB": ["We", "expect", "to", "report", "interim", "efficacy", "and", "safety", "results", "for", "the", "1", "mg/kg", "dose", "group", "of", "the", "trial", "during", "the", "third", "quarter", "of", "2015", "and", "to", "report", "final", "efficacy", "and", "safety", "results", "for", "the", "0.2mg,", "1", "mg", "and", "2mg/kg", "dose", "groups", "of", "the", "trial", "during", "the", "fourth", "quarter", "of", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p97_s0", "idA": "1006281_14_item1_p79_s1", "sentA": "Enrollment was completed in the fourth quarter of 2008 and the trial was successfully completed in September 2009.", "sentB": "We expect to report interim results from the 1mg/kg cohort in the third quarter of 2015, and full top-line results from all dosing cohorts in the fourth quarter of 2015.", "type": 2, "words": ["<tag1>", "Enrollment", "was", "completed", "in", "the", "fourth", "quarter", "of", "2008", "and", "the", "trial", "was", "successfully", "completed", "in", "September", "2009.", "<tag2>", "We", "expect", "to", "report", "interim", "results", "from", "the", "1mg/kg", "cohort", "in", "the", "third", "quarter", "of", "2015,", "and", "full", "top-line", "results", "from", "all", "dosing", "cohorts", "in", "the", "fourth", "quarter", "of", "2015.", "<tag3>"], "wordsA": ["Enrollment", "was", "completed", "in", "the", "fourth", "quarter", "of", "2008", "and", "the", "trial", "was", "successfully", "completed", "in", "September", "2009."], "wordsB": ["We", "expect", "to", "report", "interim", "results", "from", "the", "1mg/kg", "cohort", "in", "the", "third", "quarter", "of", "2015,", "and", "full", "top-line", "results", "from", "all", "dosing", "cohorts", "in", "the", "fourth", "quarter", "of", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p97_s1", "idA": "1006281_14_item1_p79_s1", "sentA": "Enrollment was completed in the fourth quarter of 2008 and the trial was successfully completed in September 2009.", "sentB": "We intend to request an end of phase II meeting with the FDA in the fourth quarter of 2015, and anticipate initiating a phase III pivotal trial in early 2016.", "type": 2, "words": ["<tag1>", "Enrollment", "was", "completed", "in", "the", "fourth", "quarter", "of", "2008", "and", "the", "trial", "was", "successfully", "completed", "in", "September", "2009.", "<tag2>", "We", "intend", "to", "request", "an", "end", "of", "phase", "II", "meeting", "with", "the", "FDA", "in", "the", "fourth", "quarter", "of", "2015,", "and", "anticipate", "initiating", "a", "phase", "III", "pivotal", "trial", "in", "early", "2016.", "<tag3>"], "wordsA": ["Enrollment", "was", "completed", "in", "the", "fourth", "quarter", "of", "2008", "and", "the", "trial", "was", "successfully", "completed", "in", "September", "2009."], "wordsB": ["We", "intend", "to", "request", "an", "end", "of", "phase", "II", "meeting", "with", "the", "FDA", "in", "the", "fourth", "quarter", "of", "2015,", "and", "anticipate", "initiating", "a", "phase", "III", "pivotal", "trial", "in", "early", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p6_s1", "idA": "1006281_14_item1_p7_s1", "sentA": "We granted Pfizer an exclusive, worldwide license to develop and commercialize taliglucerase alfa under the Pfizer Agreement, but we retained those rights in Israel and in Brazil.", "sentB": "We granted Pfizer an exclusive, worldwide license to develop and commercialize taliglucerase alfa under the Pfizer Agreement, but we retained those rights in Israel, and later in Brazil.", "type": 2, "words": ["<tag1>", "We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "we", "retained", "those", "rights", "in", "Israel", "and", "in", "Brazil.", "<tag2>", "We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "we", "retained", "those", "rights", "in", "Israel,", "and", "later", "in", "Brazil.", "<tag3>"], "wordsA": ["We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "we", "retained", "those", "rights", "in", "Israel", "and", "in", "Brazil."], "wordsB": ["We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "we", "retained", "those", "rights", "in", "Israel,", "and", "later", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p6_s2", "idA": "1006281_14_item1_p7_s2", "sentA": "We have agreed to a specific allocation between Protalix Ltd. and Pfizer of the responsibilities for the continued development efforts for taliglucerase alfa outside of Israel.", "sentB": "We have agreed to a specific allocation between Protalix Ltd. and Pfizer of the responsibilities for the continued development efforts for taliglucerase alfa outside of Israel and Brazil.", "type": 2, "words": ["<tag1>", "We", "have", "agreed", "to", "a", "specific", "allocation", "between", "Protalix", "Ltd.", "and", "Pfizer", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa", "outside", "of", "Israel.", "<tag2>", "We", "have", "agreed", "to", "a", "specific", "allocation", "between", "Protalix", "Ltd.", "and", "Pfizer", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa", "outside", "of", "Israel", "and", "Brazil.", "<tag3>"], "wordsA": ["We", "have", "agreed", "to", "a", "specific", "allocation", "between", "Protalix", "Ltd.", "and", "Pfizer", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa", "outside", "of", "Israel."], "wordsB": ["We", "have", "agreed", "to", "a", "specific", "allocation", "between", "Protalix", "Ltd.", "and", "Pfizer", "of", "the", "responsibilities", "for", "the", "continued", "development", "efforts", "for", "taliglucerase", "alfa", "outside", "of", "Israel", "and", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p6_s3", "idA": "1006281_14_item1_p7_s3", "sentA": "Since 2013, taliglucerase alfa has been marketed in Israel by Protalix Ltd.", "sentB": "Protalix Ltd. has been marketing taliglucerase alfa in Israel since 2013 and in Brazil since January 2014.", "type": 2, "words": ["<tag1>", "Since", "2013,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "Israel", "by", "Protalix", "Ltd.", "<tag2>", "Protalix", "Ltd.", "has", "been", "marketing", "taliglucerase", "alfa", "in", "Israel", "since", "2013", "and", "in", "Brazil", "since", "January", "2014.", "<tag3>"], "wordsA": ["Since", "2013,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "Israel", "by", "Protalix", "Ltd."], "wordsB": ["Protalix", "Ltd.", "has", "been", "marketing", "taliglucerase", "alfa", "in", "Israel", "since", "2013", "and", "in", "Brazil", "since", "January", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p86_s0", "idA": "1006281_14_item1_p81_s2", "sentA": "We also initiated a home care treatment program for patients enrolled in the extension study.", "sentB": "The interim efficacy analysis includes six patients enrolled in the 0.2mg/kg dose group at six months of treatment (for Gb3 in renal peritubular capillaries n=5).", "type": 2, "words": ["<tag1>", "We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study.", "<tag2>", "The", "interim", "efficacy", "analysis", "includes", "six", "patients", "enrolled", "in", "the", "0.2mg/kg", "dose", "group", "at", "six", "months", "of", "treatment", "(for", "Gb3", "in", "renal", "peritubular", "capillaries", "n=5).", "<tag3>"], "wordsA": ["We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study."], "wordsB": ["The", "interim", "efficacy", "analysis", "includes", "six", "patients", "enrolled", "in", "the", "0.2mg/kg", "dose", "group", "at", "six", "months", "of", "treatment", "(for", "Gb3", "in", "renal", "peritubular", "capillaries", "n=5)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p86_s1", "idA": "1006281_14_item1_p81_s2", "sentA": "We also initiated a home care treatment program for patients enrolled in the extension study.", "sentB": "The interim safety analysis includes 12 patients; six patients enrolled in the 0.2mg/kg dose group and six patients enrolled in the 1mg/kg dose group.", "type": 2, "words": ["<tag1>", "We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study.", "<tag2>", "The", "interim", "safety", "analysis", "includes", "12", "patients;", "six", "patients", "enrolled", "in", "the", "0.2mg/kg", "dose", "group", "and", "six", "patients", "enrolled", "in", "the", "1mg/kg", "dose", "group.", "<tag3>"], "wordsA": ["We", "also", "initiated", "a", "home", "care", "treatment", "program", "for", "patients", "enrolled", "in", "the", "extension", "study."], "wordsB": ["The", "interim", "safety", "analysis", "includes", "12", "patients;", "six", "patients", "enrolled", "in", "the", "0.2mg/kg", "dose", "group", "and", "six", "patients", "enrolled", "in", "the", "1mg/kg", "dose", "group."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p90_s0", "idA": "1006281_14_item1_p85_s1", "sentA": "According to the interim data, after 36 months (nine months in the phase III clinical trial and 27 months in the extension trial), patients continued to demonstrate a significant improvement in all parameters with a similar safety profile as seen in the phase III clinical trial.", "sentB": "A meaningful reduction in the total score of Mainz Severity Score Index (MSSI), which looks at general, neurological, cardiovascular and renal parameters, was also demonstrated, with a reduction in all parameters included in MSSI.", "type": 2, "words": ["<tag1>", "According", "to", "the", "interim", "data,", "after", "36", "months", "(nine", "months", "in", "the", "phase", "III", "clinical", "trial", "and", "27", "months", "in", "the", "extension", "trial),", "patients", "continued", "to", "demonstrate", "a", "significant", "improvement", "in", "all", "parameters", "with", "a", "similar", "safety", "profile", "as", "seen", "in", "the", "phase", "III", "clinical", "trial.", "<tag2>", "A", "meaningful", "reduction", "in", "the", "total", "score", "of", "Mainz", "Severity", "Score", "Index", "(MSSI),", "which", "looks", "at", "general,", "neurological,", "cardiovascular", "and", "renal", "parameters,", "was", "also", "demonstrated,", "with", "a", "reduction", "in", "all", "parameters", "included", "in", "MSSI.", "<tag3>"], "wordsA": ["According", "to", "the", "interim", "data,", "after", "36", "months", "(nine", "months", "in", "the", "phase", "III", "clinical", "trial", "and", "27", "months", "in", "the", "extension", "trial),", "patients", "continued", "to", "demonstrate", "a", "significant", "improvement", "in", "all", "parameters", "with", "a", "similar", "safety", "profile", "as", "seen", "in", "the", "phase", "III", "clinical", "trial."], "wordsB": ["A", "meaningful", "reduction", "in", "the", "total", "score", "of", "Mainz", "Severity", "Score", "Index", "(MSSI),", "which", "looks", "at", "general,", "neurological,", "cardiovascular", "and", "renal", "parameters,", "was", "also", "demonstrated,", "with", "a", "reduction", "in", "all", "parameters", "included", "in", "MSSI."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p89_s3", "idA": "1006281_14_item1_p88_s1", "sentA": "In the extension trial, at 36 months, both groups demonstrated clinically significant mean reductions in liver volume; reductions of 19.0% in the 60 U/kg group and of 21.0% in the 30 U/kg group; patients with Hepatomegaly demonstrated a reduction in liver volume of 30.0% in the 60 U/kg group and of 22.0% in the 30 U/kg group.", "sentB": "All patients demonstrated a reduction in absolute Lyso-Gb3 concentration and all patients demonstrated a reduction in Gb3 except for one patient.", "type": 2, "words": ["<tag1>", "In", "the", "extension", "trial,", "at", "36", "months,", "both", "groups", "demonstrated", "clinically", "significant", "mean", "reductions", "in", "liver", "volume;", "reductions", "of", "19.0%", "in", "the", "60", "U/kg", "group", "and", "of", "21.0%", "in", "the", "30", "U/kg", "group;", "patients", "with", "Hepatomegaly", "demonstrated", "a", "reduction", "in", "liver", "volume", "of", "30.0%", "in", "the", "60", "U/kg", "group", "and", "of", "22.0%", "in", "the", "30", "U/kg", "group.", "<tag2>", "All", "patients", "demonstrated", "a", "reduction", "in", "absolute", "Lyso-Gb3", "concentration", "and", "all", "patients", "demonstrated", "a", "reduction", "in", "Gb3", "except", "for", "one", "patient.", "<tag3>"], "wordsA": ["In", "the", "extension", "trial,", "at", "36", "months,", "both", "groups", "demonstrated", "clinically", "significant", "mean", "reductions", "in", "liver", "volume;", "reductions", "of", "19.0%", "in", "the", "60", "U/kg", "group", "and", "of", "21.0%", "in", "the", "30", "U/kg", "group;", "patients", "with", "Hepatomegaly", "demonstrated", "a", "reduction", "in", "liver", "volume", "of", "30.0%", "in", "the", "60", "U/kg", "group", "and", "of", "22.0%", "in", "the", "30", "U/kg", "group."], "wordsB": ["All", "patients", "demonstrated", "a", "reduction", "in", "absolute", "Lyso-Gb3", "concentration", "and", "all", "patients", "demonstrated", "a", "reduction", "in", "Gb3", "except", "for", "one", "patient."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p124_s3", "idA": "1006281_14_item1_p8_s4", "sentA": "Under the agreement, Fiocruz has committed to purchase at least approximately $40 million worth of taliglucerase alfa during the first two years of the term.", "sentB": "Under the agreement, Fiocruz committed to purchase at least approximately $40 million worth of taliglucerase alfa during the first two years of the term.", "type": 2, "words": ["<tag1>", "Under", "the", "agreement,", "Fiocruz", "has", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term.", "<tag2>", "Under", "the", "agreement,", "Fiocruz", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term.", "<tag3>"], "wordsA": ["Under", "the", "agreement,", "Fiocruz", "has", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term."], "wordsB": ["Under", "the", "agreement,", "Fiocruz", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p7_s4", "idA": "1006281_14_item1_p8_s4", "sentA": "Under the agreement, Fiocruz has committed to purchase at least approximately $40 million worth of taliglucerase alfa during the first two years of the term.", "sentB": "Under the agreement, Fiocruz committed to purchase at least approximately $40 million worth of taliglucerase alfa during the first two years of the term.", "type": 2, "words": ["<tag1>", "Under", "the", "agreement,", "Fiocruz", "has", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term.", "<tag2>", "Under", "the", "agreement,", "Fiocruz", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term.", "<tag3>"], "wordsA": ["Under", "the", "agreement,", "Fiocruz", "has", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term."], "wordsB": ["Under", "the", "agreement,", "Fiocruz", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p87_s0", "idA": "1006281_14_item1_p90_s1", "sentA": "In these patients, chitotriosidase decreased from baseline in both the 30U/kg and 60U/kg groups by 47.3% and 58.4%, respectively.", "sentB": "Based on an analysis of kidney biopsies with randomized blinded scoring, PRX-102 demonstrated a major reduction from baseline in renal peritubular capillary Gb3 using both the quantitative Barisoni Lipid Inclusion Scoring System (BLISS) and the semi quantitative method.", "type": 2, "words": ["<tag1>", "In", "these", "patients,", "chitotriosidase", "decreased", "from", "baseline", "in", "both", "the", "30U/kg", "and", "60U/kg", "groups", "by", "47.3%", "and", "58.4%,", "respectively.", "<tag2>", "Based", "on", "an", "analysis", "of", "kidney", "biopsies", "with", "randomized", "blinded", "scoring,", "PRX-102", "demonstrated", "a", "major", "reduction", "from", "baseline", "in", "renal", "peritubular", "capillary", "Gb3", "using", "both", "the", "quantitative", "Barisoni", "Lipid", "Inclusion", "Scoring", "System", "(BLISS)", "and", "the", "semi", "quantitative", "method.", "<tag3>"], "wordsA": ["In", "these", "patients,", "chitotriosidase", "decreased", "from", "baseline", "in", "both", "the", "30U/kg", "and", "60U/kg", "groups", "by", "47.3%", "and", "58.4%,", "respectively."], "wordsB": ["Based", "on", "an", "analysis", "of", "kidney", "biopsies", "with", "randomized", "blinded", "scoring,", "PRX-102", "demonstrated", "a", "major", "reduction", "from", "baseline", "in", "renal", "peritubular", "capillary", "Gb3", "using", "both", "the", "quantitative", "Barisoni", "Lipid", "Inclusion", "Scoring", "System", "(BLISS)", "and", "the", "semi", "quantitative", "method."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p87_s2", "idA": "1006281_14_item1_p90_s1", "sentA": "In these patients, chitotriosidase decreased from baseline in both the 30U/kg and 60U/kg groups by 47.3% and 58.4%, respectively.", "sentB": "Absolute change from baseline was -4.5, -1.2 and -3.2, respectively.", "type": 2, "words": ["<tag1>", "In", "these", "patients,", "chitotriosidase", "decreased", "from", "baseline", "in", "both", "the", "30U/kg", "and", "60U/kg", "groups", "by", "47.3%", "and", "58.4%,", "respectively.", "<tag2>", "Absolute", "change", "from", "baseline", "was", "-4.5,", "-1.2", "and", "-3.2,", "respectively.", "<tag3>"], "wordsA": ["In", "these", "patients,", "chitotriosidase", "decreased", "from", "baseline", "in", "both", "the", "30U/kg", "and", "60U/kg", "groups", "by", "47.3%", "and", "58.4%,", "respectively."], "wordsB": ["Absolute", "change", "from", "baseline", "was", "-4.5,", "-1.2", "and", "-3.2,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p93_s0", "idA": "1006281_14_item1_p91_s0", "sentA": "The safety analysis for both treatment groups in the phase III clinical trial showed that taliglucerase alfa was well tolerated and no serious or severe adverse events were reported.", "sentB": "The safety analysis for adverse events represents a total of 6.7 patient years.", "type": 2, "words": ["<tag1>", "The", "safety", "analysis", "for", "both", "treatment", "groups", "in", "the", "phase", "III", "clinical", "trial", "showed", "that", "taliglucerase", "alfa", "was", "well", "tolerated", "and", "no", "serious", "or", "severe", "adverse", "events", "were", "reported.", "<tag2>", "The", "safety", "analysis", "for", "adverse", "events", "represents", "a", "total", "of", "6.7", "patient", "years.", "<tag3>"], "wordsA": ["The", "safety", "analysis", "for", "both", "treatment", "groups", "in", "the", "phase", "III", "clinical", "trial", "showed", "that", "taliglucerase", "alfa", "was", "well", "tolerated", "and", "no", "serious", "or", "severe", "adverse", "events", "were", "reported."], "wordsB": ["The", "safety", "analysis", "for", "adverse", "events", "represents", "a", "total", "of", "6.7", "patient", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p95_s2", "idA": "1006281_14_item1_p92_s0", "sentA": "In the phase III clinical trial, no serious related adverse event was reported and most of the adverse events were considered unrelated to taliglucerase alfa.", "sentB": "All adverse events experienced by these patients were deemed by the investigators to be unrelated to PRX-102.", "type": 2, "words": ["<tag1>", "In", "the", "phase", "III", "clinical", "trial,", "no", "serious", "related", "adverse", "event", "was", "reported", "and", "most", "of", "the", "adverse", "events", "were", "considered", "unrelated", "to", "taliglucerase", "alfa.", "<tag2>", "All", "adverse", "events", "experienced", "by", "these", "patients", "were", "deemed", "by", "the", "investigators", "to", "be", "unrelated", "to", "PRX-102.", "<tag3>"], "wordsA": ["In", "the", "phase", "III", "clinical", "trial,", "no", "serious", "related", "adverse", "event", "was", "reported", "and", "most", "of", "the", "adverse", "events", "were", "considered", "unrelated", "to", "taliglucerase", "alfa."], "wordsB": ["All", "adverse", "events", "experienced", "by", "these", "patients", "were", "deemed", "by", "the", "investigators", "to", "be", "unrelated", "to", "PRX-102."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p84_s0", "idA": "1006281_14_item1_p93_s0", "sentA": "In November 2010, we announced positive preliminary data from the first 15 patients that completed our switchover trial of taliglucerase alfa, and in February 2012 we reported full results from 25 adult patients in the trial.", "sentB": "In January and February 2015, we announced positive interim efficacy and safety data from the study.", "type": 2, "words": ["<tag1>", "In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "our", "switchover", "trial", "of", "taliglucerase", "alfa,", "and", "in", "February", "2012", "we", "reported", "full", "results", "from", "25", "adult", "patients", "in", "the", "trial.", "<tag2>", "In", "January", "and", "February", "2015,", "we", "announced", "positive", "interim", "efficacy", "and", "safety", "data", "from", "the", "study.", "<tag3>"], "wordsA": ["In", "November", "2010,", "we", "announced", "positive", "preliminary", "data", "from", "the", "first", "15", "patients", "that", "completed", "our", "switchover", "trial", "of", "taliglucerase", "alfa,", "and", "in", "February", "2012", "we", "reported", "full", "results", "from", "25", "adult", "patients", "in", "the", "trial."], "wordsB": ["In", "January", "and", "February", "2015,", "we", "announced", "positive", "interim", "efficacy", "and", "safety", "data", "from", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p112_s4", "idA": "1006281_14_item1_p95_s0", "sentA": "In July 2012, we announced data from our clinical trial of taliglucerase alfa in pediatric Gaucher patients.", "sentB": "The trial covered 17 na ve adult Gaucher patients.", "type": 2, "words": ["<tag1>", "In", "July", "2012,", "we", "announced", "data", "from", "our", "clinical", "trial", "of", "taliglucerase", "alfa", "in", "pediatric", "Gaucher", "patients.", "<tag2>", "The", "trial", "covered", "17", "na", "ve", "adult", "Gaucher", "patients.", "<tag3>"], "wordsA": ["In", "July", "2012,", "we", "announced", "data", "from", "our", "clinical", "trial", "of", "taliglucerase", "alfa", "in", "pediatric", "Gaucher", "patients."], "wordsB": ["The", "trial", "covered", "17", "na", "ve", "adult", "Gaucher", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p89_s0", "idA": "1006281_14_item1_p95_s2", "sentA": "In addition, significant improvements were also seen in all secondary endpoints.", "sentB": "Reductions of plasma Lyso-Gb3 and plasma Gb3 concentrations were also observed.", "type": 2, "words": ["<tag1>", "In", "addition,", "significant", "improvements", "were", "also", "seen", "in", "all", "secondary", "endpoints.", "<tag2>", "Reductions", "of", "plasma", "Lyso-Gb3", "and", "plasma", "Gb3", "concentrations", "were", "also", "observed.", "<tag3>"], "wordsA": ["In", "addition,", "significant", "improvements", "were", "also", "seen", "in", "all", "secondary", "endpoints."], "wordsB": ["Reductions", "of", "plasma", "Lyso-Gb3", "and", "plasma", "Gb3", "concentrations", "were", "also", "observed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p23_s1", "idA": "1006281_14_item1_p96_s3", "sentA": "This patient continues to receive taliglucerase alfa.", "sentB": "Oral GCD represents a novel mode of administrating taliglucerase alfa.", "type": 2, "words": ["<tag1>", "This", "patient", "continues", "to", "receive", "taliglucerase", "alfa.", "<tag2>", "Oral", "GCD", "represents", "a", "novel", "mode", "of", "administrating", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["This", "patient", "continues", "to", "receive", "taliglucerase", "alfa."], "wordsB": ["Oral", "GCD", "represents", "a", "novel", "mode", "of", "administrating", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p14_s0", "idA": "1006281_14_item1_p98_s0", "sentA": "We are developing PRX-102, our proprietary plant cell expressed chemically modified version of the recombinant alpha-GAL-A protein, a therapeutic enzyme, for the treatment of Fabry disease, a rare genetic lysosomal storage disorder.", "sentB": "(1) PRX-102, or alpha-GAL-A , a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans, currently in an ongoing phase I/II clinical trial.", "type": 2, "words": ["<tag1>", "We", "are", "developing", "PRX-102,", "our", "proprietary", "plant", "cell", "expressed", "chemically", "modified", "version", "of", "the", "recombinant", "alpha-GAL-A", "protein,", "a", "therapeutic", "enzyme,", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare", "genetic", "lysosomal", "storage", "disorder.", "<tag2>", "(1)", "PRX-102,", "or", "alpha-GAL-A", ",", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "currently", "in", "an", "ongoing", "phase", "I/II", "clinical", "trial.", "<tag3>"], "wordsA": ["We", "are", "developing", "PRX-102,", "our", "proprietary", "plant", "cell", "expressed", "chemically", "modified", "version", "of", "the", "recombinant", "alpha-GAL-A", "protein,", "a", "therapeutic", "enzyme,", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare", "genetic", "lysosomal", "storage", "disorder."], "wordsB": ["(1)", "PRX-102,", "or", "alpha-GAL-A", ",", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "currently", "in", "an", "ongoing", "phase", "I/II", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p25_s1", "idA": "1006281_14_item1_p98_s1", "sentA": "We believe that PRX-102 has the potential to be an improved version of the currently marketed Fabry disease enzymes, Fabrazyme and Replagal , with improved activity in the Fabry disease target organs and significantly longer half-life due to higher stability, which together can potentially lead to improved substrate clearance.", "sentB": "The focus is expected to be on biologics with improved clinical profiles than the currently marketed proteins for these indications.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "PRX-102", "has", "the", "potential", "to", "be", "an", "improved", "version", "of", "the", "currently", "marketed", "Fabry", "disease", "enzymes,", "Fabrazyme", "and", "Replagal", ",", "with", "improved", "activity", "in", "the", "Fabry", "disease", "target", "organs", "and", "significantly", "longer", "half-life", "due", "to", "higher", "stability,", "which", "together", "can", "potentially", "lead", "to", "improved", "substrate", "clearance.", "<tag2>", "The", "focus", "is", "expected", "to", "be", "on", "biologics", "with", "improved", "clinical", "profiles", "than", "the", "currently", "marketed", "proteins", "for", "these", "indications.", "<tag3>"], "wordsA": ["We", "believe", "that", "PRX-102", "has", "the", "potential", "to", "be", "an", "improved", "version", "of", "the", "currently", "marketed", "Fabry", "disease", "enzymes,", "Fabrazyme", "and", "Replagal", ",", "with", "improved", "activity", "in", "the", "Fabry", "disease", "target", "organs", "and", "significantly", "longer", "half-life", "due", "to", "higher", "stability,", "which", "together", "can", "potentially", "lead", "to", "improved", "substrate", "clearance."], "wordsB": ["The", "focus", "is", "expected", "to", "be", "on", "biologics", "with", "improved", "clinical", "profiles", "than", "the", "currently", "marketed", "proteins", "for", "these", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_15_item1_p20_s1", "idA": "1006281_14_item1_p99_s0", "sentA": "We believe that the treatment of Fabry disease is a specialty clinical niche with the potential for high growth.", "sentB": "PRX-102 is designed to be an improved enzyme replacement therapy product for the treatment of Fabry disease given its potential for clinically superior outcomes and enhanced safety when compared to currently marketed enzyme replacement therapies.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "the", "treatment", "of", "Fabry", "disease", "is", "a", "specialty", "clinical", "niche", "with", "the", "potential", "for", "high", "growth.", "<tag2>", "PRX-102", "is", "designed", "to", "be", "an", "improved", "enzyme", "replacement", "therapy", "product", "for", "the", "treatment", "of", "Fabry", "disease", "given", "its", "potential", "for", "clinically", "superior", "outcomes", "and", "enhanced", "safety", "when", "compared", "to", "currently", "marketed", "enzyme", "replacement", "therapies.", "<tag3>"], "wordsA": ["We", "believe", "that", "the", "treatment", "of", "Fabry", "disease", "is", "a", "specialty", "clinical", "niche", "with", "the", "potential", "for", "high", "growth."], "wordsB": ["PRX-102", "is", "designed", "to", "be", "an", "improved", "enzyme", "replacement", "therapy", "product", "for", "the", "treatment", "of", "Fabry", "disease", "given", "its", "potential", "for", "clinically", "superior", "outcomes", "and", "enhanced", "safety", "when", "compared", "to", "currently", "marketed", "enzyme", "replacement", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p0_s1", "idA": "1006281_15_item1_p0_s1", "sentA": "Using our ProCellEx system, we are developing a pipeline of proprietary, clinically superior versions of recombinant therapeutic proteins that primarily target large, established pharmaceutical markets and that in most cases rely upon known biological mechanisms of action.", "sentB": "We developed our first commercial drug product, Elelyso TM , using our ProCellEx system and we are now focused on utilizing the system to develop a pipeline of proprietary, clinically superior versions of recombinant therapeutic proteins that primarily target large, established pharmaceutical markets and that in most cases rely upon known biological mechanisms of action.", "type": 2, "words": ["<tag1>", "Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "in", "most", "cases", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag2>", "We", "developed", "our", "first", "commercial", "drug", "product,", "Elelyso", "TM", ",", "using", "our", "ProCellEx", "system", "and", "we", "are", "now", "focused", "on", "utilizing", "the", "system", "to", "develop", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "in", "most", "cases", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag3>"], "wordsA": ["Using", "our", "ProCellEx", "system,", "we", "are", "developing", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "in", "most", "cases", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "wordsB": ["We", "developed", "our", "first", "commercial", "drug", "product,", "Elelyso", "TM", ",", "using", "our", "ProCellEx", "system", "and", "we", "are", "now", "focused", "on", "utilizing", "the", "system", "to", "develop", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "in", "most", "cases", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p0_s2", "idA": "1006281_15_item1_p0_s3", "sentA": "With our experience, and having successfully developed Elelyso TM , our first drug product, we believe ProCellEx will enable us to develop additional proprietary recombinant proteins that are therapeutically superior to existing recombinant proteins currently marketed for the same indications.", "sentB": "With our experience to date, we believe ProCellEx will enable us to develop additional proprietary recombinant proteins that are therapeutically superior to existing recombinant proteins currently marketed for the same indications.", "type": 2, "words": ["<tag1>", "With", "our", "experience,", "and", "having", "successfully", "developed", "Elelyso", "TM", ",", "our", "first", "drug", "product,", "we", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "additional", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications.", "<tag2>", "With", "our", "experience", "to", "date,", "we", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "additional", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications.", "<tag3>"], "wordsA": ["With", "our", "experience,", "and", "having", "successfully", "developed", "Elelyso", "TM", ",", "our", "first", "drug", "product,", "we", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "additional", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications."], "wordsB": ["With", "our", "experience", "to", "date,", "we", "believe", "ProCellEx", "will", "enable", "us", "to", "develop", "additional", "proprietary", "recombinant", "proteins", "that", "are", "therapeutically", "superior", "to", "existing", "recombinant", "proteins", "currently", "marketed", "for", "the", "same", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p93_s0", "idA": "1006281_15_item1_p100_s0", "sentA": "Oral antiTNF is a plant cell-expressed form of the fused protein that is naturally encapsulated within carrot cells genetically engineered to express the enzyme.", "sentB": "OPRX-106 is a plant cell-expressed form of the fused protein that is naturally encapsulated within BY-2 cells genetically engineered to express the enzyme.", "type": 2, "words": ["<tag1>", "Oral", "antiTNF", "is", "a", "plant", "cell-expressed", "form", "of", "the", "fused", "protein", "that", "is", "naturally", "encapsulated", "within", "carrot", "cells", "genetically", "engineered", "to", "express", "the", "enzyme.", "<tag2>", "OPRX-106", "is", "a", "plant", "cell-expressed", "form", "of", "the", "fused", "protein", "that", "is", "naturally", "encapsulated", "within", "BY-2", "cells", "genetically", "engineered", "to", "express", "the", "enzyme.", "<tag3>"], "wordsA": ["Oral", "antiTNF", "is", "a", "plant", "cell-expressed", "form", "of", "the", "fused", "protein", "that", "is", "naturally", "encapsulated", "within", "carrot", "cells", "genetically", "engineered", "to", "express", "the", "enzyme."], "wordsB": ["OPRX-106", "is", "a", "plant", "cell-expressed", "form", "of", "the", "fused", "protein", "that", "is", "naturally", "encapsulated", "within", "BY-2", "cells", "genetically", "engineered", "to", "express", "the", "enzyme."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p95_s0", "idA": "1006281_15_item1_p102_s0", "sentA": "We are currently developing oral antiTNF an orally-administered anti inflammatory using plant cells as a natural capsule for the expressed protein.", "sentB": "We are developing oral antiTNF an orally-administered anti-inflammatory treatment using plant cells as a natural capsule for the expressed protein.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "developing", "oral", "antiTNF", "an", "orally-administered", "anti", "inflammatory", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein.", "<tag2>", "We", "are", "developing", "oral", "antiTNF", "an", "orally-administered", "anti-inflammatory", "treatment", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein.", "<tag3>"], "wordsA": ["We", "are", "currently", "developing", "oral", "antiTNF", "an", "orally-administered", "anti", "inflammatory", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein."], "wordsB": ["We", "are", "developing", "oral", "antiTNF", "an", "orally-administered", "anti-inflammatory", "treatment", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p95_s4", "idA": "1006281_15_item1_p103_s1", "sentA": "Additionally, oral administration of PRX-106 alleviated immune mediated colitis in a well-established mouse model, promoting serum levels of anti-inflammatory IL-10 and regulatory T-cells.", "sentB": "Additionally, oral administration of OPRX-106 alleviated immune mediated colitis in a well-established mouse model, promoting serum levels of anti-inflammatory IL-10 and regulatory T-cells.", "type": 2, "words": ["<tag1>", "Additionally,", "oral", "administration", "of", "PRX-106", "alleviated", "immune", "mediated", "colitis", "in", "a", "well-established", "mouse", "model,", "promoting", "serum", "levels", "of", "anti-inflammatory", "IL-10", "and", "regulatory", "T-cells.", "<tag2>", "Additionally,", "oral", "administration", "of", "OPRX-106", "alleviated", "immune", "mediated", "colitis", "in", "a", "well-established", "mouse", "model,", "promoting", "serum", "levels", "of", "anti-inflammatory", "IL-10", "and", "regulatory", "T-cells.", "<tag3>"], "wordsA": ["Additionally,", "oral", "administration", "of", "PRX-106", "alleviated", "immune", "mediated", "colitis", "in", "a", "well-established", "mouse", "model,", "promoting", "serum", "levels", "of", "anti-inflammatory", "IL-10", "and", "regulatory", "T-cells."], "wordsB": ["Additionally,", "oral", "administration", "of", "OPRX-106", "alleviated", "immune", "mediated", "colitis", "in", "a", "well-established", "mouse", "model,", "promoting", "serum", "levels", "of", "anti-inflammatory", "IL-10", "and", "regulatory", "T-cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p12_s5", "idA": "1006281_15_item1_p105_s1", "sentA": "Upon reviewing the proof of concept (POC) data, expected in early 2016, we intend to collaborate with a well-suited partner for further development.", "sentB": "Upon review of the proof of concept data, we intend to identify and collaborate with a well-suited partner for further development.", "type": 2, "words": ["<tag1>", "Upon", "reviewing", "the", "proof", "of", "concept", "(POC)", "data,", "expected", "in", "early", "2016,", "we", "intend", "to", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development.", "<tag2>", "Upon", "review", "of", "the", "proof", "of", "concept", "data,", "we", "intend", "to", "identify", "and", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development.", "<tag3>"], "wordsA": ["Upon", "reviewing", "the", "proof", "of", "concept", "(POC)", "data,", "expected", "in", "early", "2016,", "we", "intend", "to", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development."], "wordsB": ["Upon", "review", "of", "the", "proof", "of", "concept", "data,", "we", "intend", "to", "identify", "and", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p84_s0", "idA": "1006281_15_item1_p106_s0", "sentA": "PRX-110, or AIR DNase, is our plant cell recombinant form of human deoxyribonuclease I (DNase I) that we are developing for the treatment of Cystic Fibrosis, to be administered by inhalation.", "sentB": "PRX-110, or AIR DNase, is our plant cell recombinant form of human deoxyribonuclease I (DNase I) that we are developing for the treatment of CF to be administered by inhalation.", "type": 2, "words": ["<tag1>", "PRX-110,", "or", "AIR", "DNase,", "is", "our", "plant", "cell", "recombinant", "form", "of", "human", "deoxyribonuclease", "I", "(DNase", "I)", "that", "we", "are", "developing", "for", "the", "treatment", "of", "Cystic", "Fibrosis,", "to", "be", "administered", "by", "inhalation.", "<tag2>", "PRX-110,", "or", "AIR", "DNase,", "is", "our", "plant", "cell", "recombinant", "form", "of", "human", "deoxyribonuclease", "I", "(DNase", "I)", "that", "we", "are", "developing", "for", "the", "treatment", "of", "CF", "to", "be", "administered", "by", "inhalation.", "<tag3>"], "wordsA": ["PRX-110,", "or", "AIR", "DNase,", "is", "our", "plant", "cell", "recombinant", "form", "of", "human", "deoxyribonuclease", "I", "(DNase", "I)", "that", "we", "are", "developing", "for", "the", "treatment", "of", "Cystic", "Fibrosis,", "to", "be", "administered", "by", "inhalation."], "wordsB": ["PRX-110,", "or", "AIR", "DNase,", "is", "our", "plant", "cell", "recombinant", "form", "of", "human", "deoxyribonuclease", "I", "(DNase", "I)", "that", "we", "are", "developing", "for", "the", "treatment", "of", "CF", "to", "be", "administered", "by", "inhalation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p84_s1", "idA": "1006281_15_item1_p106_s1", "sentA": "DNase I cleaves extracellular DNA and thins the thick mucus that accumulates in the lungs of Cystic Fibrosis patients.", "sentB": "DNase I cleaves extracellular DNA and thins the thick mucus that accumulates in the lungs of CF patients.", "type": 2, "words": ["<tag1>", "DNase", "I", "cleaves", "extracellular", "DNA", "and", "thins", "the", "thick", "mucus", "that", "accumulates", "in", "the", "lungs", "of", "Cystic", "Fibrosis", "patients.", "<tag2>", "DNase", "I", "cleaves", "extracellular", "DNA", "and", "thins", "the", "thick", "mucus", "that", "accumulates", "in", "the", "lungs", "of", "CF", "patients.", "<tag3>"], "wordsA": ["DNase", "I", "cleaves", "extracellular", "DNA", "and", "thins", "the", "thick", "mucus", "that", "accumulates", "in", "the", "lungs", "of", "Cystic", "Fibrosis", "patients."], "wordsB": ["DNase", "I", "cleaves", "extracellular", "DNA", "and", "thins", "the", "thick", "mucus", "that", "accumulates", "in", "the", "lungs", "of", "CF", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p84_s2", "idA": "1006281_15_item1_p106_s2", "sentA": "Currently, Pulmozyme is the only DNase I commercially available, with annual sales of approximately $626 million in sales for 2014, according to public reports by F. Hoffman-La Roche Ltd.", "sentB": "Currently, Pulmozyme is the only DNase I commercially available, with annual sales of approximately CHF 652 million (approximately $652 million) in sales for 2015, an increase of 10%, according to public reports by F. Hoffman-La Roche Ltd.", "type": 2, "words": ["<tag1>", "Currently,", "Pulmozyme", "is", "the", "only", "DNase", "I", "commercially", "available,", "with", "annual", "sales", "of", "approximately", "$626", "million", "in", "sales", "for", "2014,", "according", "to", "public", "reports", "by", "F.", "Hoffman-La", "Roche", "Ltd.", "<tag2>", "Currently,", "Pulmozyme", "is", "the", "only", "DNase", "I", "commercially", "available,", "with", "annual", "sales", "of", "approximately", "CHF", "652", "million", "(approximately", "$652", "million)", "in", "sales", "for", "2015,", "an", "increase", "of", "10%,", "according", "to", "public", "reports", "by", "F.", "Hoffman-La", "Roche", "Ltd.", "<tag3>"], "wordsA": ["Currently,", "Pulmozyme", "is", "the", "only", "DNase", "I", "commercially", "available,", "with", "annual", "sales", "of", "approximately", "$626", "million", "in", "sales", "for", "2014,", "according", "to", "public", "reports", "by", "F.", "Hoffman-La", "Roche", "Ltd."], "wordsB": ["Currently,", "Pulmozyme", "is", "the", "only", "DNase", "I", "commercially", "available,", "with", "annual", "sales", "of", "approximately", "CHF", "652", "million", "(approximately", "$652", "million)", "in", "sales", "for", "2015,", "an", "increase", "of", "10%,", "according", "to", "public", "reports", "by", "F.", "Hoffman-La", "Roche", "Ltd."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p88_s0", "idA": "1006281_15_item1_p109_s1", "sentA": "The product candidate has demonstrated improved disease parameters in animal and human models sputum testing when compared to the currently marketed product.", "sentB": "In addition, the product candidate has demonstrated improved disease parameters in human models sputum testing when compared to the currently marketed product.", "type": 2, "words": ["<tag1>", "The", "product", "candidate", "has", "demonstrated", "improved", "disease", "parameters", "in", "animal", "and", "human", "models", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product.", "<tag2>", "In", "addition,", "the", "product", "candidate", "has", "demonstrated", "improved", "disease", "parameters", "in", "human", "models", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product.", "<tag3>"], "wordsA": ["The", "product", "candidate", "has", "demonstrated", "improved", "disease", "parameters", "in", "animal", "and", "human", "models", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product."], "wordsB": ["In", "addition,", "the", "product", "candidate", "has", "demonstrated", "improved", "disease", "parameters", "in", "human", "models", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p102_s0", "idA": "1006281_15_item1_p10_s0", "sentA": "We will pay a fee equal to 5% of the net proceeds generated in Brazil to our agent for services provided in assisting us complete the Brazil Agreement pursuant to an agency agreement between us and the agent.", "sentB": "We have agreed to pay a fee equal to 5% of the net proceeds generated in Brazil to our agent for services provided in assisting us complete the Brazil Agreement pursuant to an agency agreement between us and the agent.", "type": 2, "words": ["<tag1>", "We", "will", "pay", "a", "fee", "equal", "to", "5%", "of", "the", "net", "proceeds", "generated", "in", "Brazil", "to", "our", "agent", "for", "services", "provided", "in", "assisting", "us", "complete", "the", "Brazil", "Agreement", "pursuant", "to", "an", "agency", "agreement", "between", "us", "and", "the", "agent.", "<tag2>", "We", "have", "agreed", "to", "pay", "a", "fee", "equal", "to", "5%", "of", "the", "net", "proceeds", "generated", "in", "Brazil", "to", "our", "agent", "for", "services", "provided", "in", "assisting", "us", "complete", "the", "Brazil", "Agreement", "pursuant", "to", "an", "agency", "agreement", "between", "us", "and", "the", "agent.", "<tag3>"], "wordsA": ["We", "will", "pay", "a", "fee", "equal", "to", "5%", "of", "the", "net", "proceeds", "generated", "in", "Brazil", "to", "our", "agent", "for", "services", "provided", "in", "assisting", "us", "complete", "the", "Brazil", "Agreement", "pursuant", "to", "an", "agency", "agreement", "between", "us", "and", "the", "agent."], "wordsB": ["We", "have", "agreed", "to", "pay", "a", "fee", "equal", "to", "5%", "of", "the", "net", "proceeds", "generated", "in", "Brazil", "to", "our", "agent", "for", "services", "provided", "in", "assisting", "us", "complete", "the", "Brazil", "Agreement", "pursuant", "to", "an", "agency", "agreement", "between", "us", "and", "the", "agent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p11_s4", "idA": "1006281_15_item1_p110_s0", "sentA": "We plan to initiate clinical efficacy trials of AIR DNase for the treatment of Cystic Fibrosis during 2015.", "sentB": "We have commenced a phase I clinical trial of AIR DNase in healthy volunteers and plan to initiate clinical efficacy trials of AIR DNase for the treatment of CF in mid-year, 2016.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "initiate", "clinical", "efficacy", "trials", "of", "AIR", "DNase", "for", "the", "treatment", "of", "Cystic", "Fibrosis", "during", "2015.", "<tag2>", "We", "have", "commenced", "a", "phase", "I", "clinical", "trial", "of", "AIR", "DNase", "in", "healthy", "volunteers", "and", "plan", "to", "initiate", "clinical", "efficacy", "trials", "of", "AIR", "DNase", "for", "the", "treatment", "of", "CF", "in", "mid-year,", "2016.", "<tag3>"], "wordsA": ["We", "plan", "to", "initiate", "clinical", "efficacy", "trials", "of", "AIR", "DNase", "for", "the", "treatment", "of", "Cystic", "Fibrosis", "during", "2015."], "wordsB": ["We", "have", "commenced", "a", "phase", "I", "clinical", "trial", "of", "AIR", "DNase", "in", "healthy", "volunteers", "and", "plan", "to", "initiate", "clinical", "efficacy", "trials", "of", "AIR", "DNase", "for", "the", "treatment", "of", "CF", "in", "mid-year,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p11_s5", "idA": "1006281_15_item1_p110_s1", "sentA": "Upon reviewing the results of the trial, expected in early 2016, we intend to collaborate with a well-suited partner for further development.", "sentB": "Upon review of the results of the trial, we intend to identify and collaborate with a well-suited partner for further development.", "type": 2, "words": ["<tag1>", "Upon", "reviewing", "the", "results", "of", "the", "trial,", "expected", "in", "early", "2016,", "we", "intend", "to", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development.", "<tag2>", "Upon", "review", "of", "the", "results", "of", "the", "trial,", "we", "intend", "to", "identify", "and", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development.", "<tag3>"], "wordsA": ["Upon", "reviewing", "the", "results", "of", "the", "trial,", "expected", "in", "early", "2016,", "we", "intend", "to", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development."], "wordsB": ["Upon", "review", "of", "the", "results", "of", "the", "trial,", "we", "intend", "to", "identify", "and", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p97_s3", "idA": "1006281_15_item1_p113_s0", "sentA": "Subjects receive once daily oral administrations of PRX-112 for five consecutive days at each dose, with a two-day washout period between doses.", "sentB": "Study subjects received daily oral administration for five consecutive days.", "type": 2, "words": ["<tag1>", "Subjects", "receive", "once", "daily", "oral", "administrations", "of", "PRX-112", "for", "five", "consecutive", "days", "at", "each", "dose,", "with", "a", "two-day", "washout", "period", "between", "doses.", "<tag2>", "Study", "subjects", "received", "daily", "oral", "administration", "for", "five", "consecutive", "days.", "<tag3>"], "wordsA": ["Subjects", "receive", "once", "daily", "oral", "administrations", "of", "PRX-112", "for", "five", "consecutive", "days", "at", "each", "dose,", "with", "a", "two-day", "washout", "period", "between", "doses."], "wordsB": ["Study", "subjects", "received", "daily", "oral", "administration", "for", "five", "consecutive", "days."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p12_s3", "idA": "1006281_15_item1_p116_s0", "sentA": "We completed a phase I clinical trial of oral GCD, which was an exploratory, open label study to evaluate the safety and pharmacokinetics of oral GCD in Gaucher patients.", "sentB": "We completed a phase I clinical trial oPRX-106, which demonstrated that the drug was safe and well tolerated, showing biological activity in the gut and inducement of regulatory T cells.", "type": 2, "words": ["<tag1>", "We", "completed", "a", "phase", "I", "clinical", "trial", "of", "oral", "GCD,", "which", "was", "an", "exploratory,", "open", "label", "study", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "oral", "GCD", "in", "Gaucher", "patients.", "<tag2>", "We", "completed", "a", "phase", "I", "clinical", "trial", "oPRX-106,", "which", "demonstrated", "that", "the", "drug", "was", "safe", "and", "well", "tolerated,", "showing", "biological", "activity", "in", "the", "gut", "and", "inducement", "of", "regulatory", "T", "cells.", "<tag3>"], "wordsA": ["We", "completed", "a", "phase", "I", "clinical", "trial", "of", "oral", "GCD,", "which", "was", "an", "exploratory,", "open", "label", "study", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "oral", "GCD", "in", "Gaucher", "patients."], "wordsB": ["We", "completed", "a", "phase", "I", "clinical", "trial", "oPRX-106,", "which", "demonstrated", "that", "the", "drug", "was", "safe", "and", "well", "tolerated,", "showing", "biological", "activity", "in", "the", "gut", "and", "inducement", "of", "regulatory", "T", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p89_s0", "idA": "1006281_15_item1_p116_s0", "sentA": "We completed a phase I clinical trial of oral GCD, which was an exploratory, open label study to evaluate the safety and pharmacokinetics of oral GCD in Gaucher patients.", "sentB": "AIR DNase is the subject of a phase I clinical trial involving 18 healthy volunteers.", "type": 2, "words": ["<tag1>", "We", "completed", "a", "phase", "I", "clinical", "trial", "of", "oral", "GCD,", "which", "was", "an", "exploratory,", "open", "label", "study", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "oral", "GCD", "in", "Gaucher", "patients.", "<tag2>", "AIR", "DNase", "is", "the", "subject", "of", "a", "phase", "I", "clinical", "trial", "involving", "18", "healthy", "volunteers.", "<tag3>"], "wordsA": ["We", "completed", "a", "phase", "I", "clinical", "trial", "of", "oral", "GCD,", "which", "was", "an", "exploratory,", "open", "label", "study", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "oral", "GCD", "in", "Gaucher", "patients."], "wordsB": ["AIR", "DNase", "is", "the", "subject", "of", "a", "phase", "I", "clinical", "trial", "involving", "18", "healthy", "volunteers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p97_s0", "idA": "1006281_15_item1_p116_s0", "sentA": "We completed a phase I clinical trial of oral GCD, which was an exploratory, open label study to evaluate the safety and pharmacokinetics of oral GCD in Gaucher patients.", "sentB": "We have concluded a phase I clinical trial of OPRX-106, which demonstrated that the drug was safe and well tolerated, showing biological activity in the gut and inducement of regulatory T cells.", "type": 2, "words": ["<tag1>", "We", "completed", "a", "phase", "I", "clinical", "trial", "of", "oral", "GCD,", "which", "was", "an", "exploratory,", "open", "label", "study", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "oral", "GCD", "in", "Gaucher", "patients.", "<tag2>", "We", "have", "concluded", "a", "phase", "I", "clinical", "trial", "of", "OPRX-106,", "which", "demonstrated", "that", "the", "drug", "was", "safe", "and", "well", "tolerated,", "showing", "biological", "activity", "in", "the", "gut", "and", "inducement", "of", "regulatory", "T", "cells.", "<tag3>"], "wordsA": ["We", "completed", "a", "phase", "I", "clinical", "trial", "of", "oral", "GCD,", "which", "was", "an", "exploratory,", "open", "label", "study", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "oral", "GCD", "in", "Gaucher", "patients."], "wordsB": ["We", "have", "concluded", "a", "phase", "I", "clinical", "trial", "of", "OPRX-106,", "which", "demonstrated", "that", "the", "drug", "was", "safe", "and", "well", "tolerated,", "showing", "biological", "activity", "in", "the", "gut", "and", "inducement", "of", "regulatory", "T", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p97_s1", "idA": "1006281_15_item1_p116_s2", "sentA": "The primary objective of the trial was to measure the safety of oral GCD in Gaucher patients.", "sentB": "The primary objective of the phase I clinical trial was to test the safety and pharmacokinetics of OPRX-106 in healthy volunteers, with an exploratory objective of analyzing the immunomodulatory effect.", "type": 2, "words": ["<tag1>", "The", "primary", "objective", "of", "the", "trial", "was", "to", "measure", "the", "safety", "of", "oral", "GCD", "in", "Gaucher", "patients.", "<tag2>", "The", "primary", "objective", "of", "the", "phase", "I", "clinical", "trial", "was", "to", "test", "the", "safety", "and", "pharmacokinetics", "of", "OPRX-106", "in", "healthy", "volunteers,", "with", "an", "exploratory", "objective", "of", "analyzing", "the", "immunomodulatory", "effect.", "<tag3>"], "wordsA": ["The", "primary", "objective", "of", "the", "trial", "was", "to", "measure", "the", "safety", "of", "oral", "GCD", "in", "Gaucher", "patients."], "wordsB": ["The", "primary", "objective", "of", "the", "phase", "I", "clinical", "trial", "was", "to", "test", "the", "safety", "and", "pharmacokinetics", "of", "OPRX-106", "in", "healthy", "volunteers,", "with", "an", "exploratory", "objective", "of", "analyzing", "the", "immunomodulatory", "effect."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p79_s3", "idA": "1006281_15_item1_p118_s3", "sentA": "Thus, with a daily oral administration of oral GCD, we expect to achieve a steady state level of active GCD enzyme in the blood circulation of patients similar to the physiological state in healthy individuals.", "sentB": "We anticipate a small sample size of patients will be needed to achieve statistical significance with a study duration of approximately six months.", "type": 2, "words": ["<tag1>", "Thus,", "with", "a", "daily", "oral", "administration", "of", "oral", "GCD,", "we", "expect", "to", "achieve", "a", "steady", "state", "level", "of", "active", "GCD", "enzyme", "in", "the", "blood", "circulation", "of", "patients", "similar", "to", "the", "physiological", "state", "in", "healthy", "individuals.", "<tag2>", "We", "anticipate", "a", "small", "sample", "size", "of", "patients", "will", "be", "needed", "to", "achieve", "statistical", "significance", "with", "a", "study", "duration", "of", "approximately", "six", "months.", "<tag3>"], "wordsA": ["Thus,", "with", "a", "daily", "oral", "administration", "of", "oral", "GCD,", "we", "expect", "to", "achieve", "a", "steady", "state", "level", "of", "active", "GCD", "enzyme", "in", "the", "blood", "circulation", "of", "patients", "similar", "to", "the", "physiological", "state", "in", "healthy", "individuals."], "wordsB": ["We", "anticipate", "a", "small", "sample", "size", "of", "patients", "will", "be", "needed", "to", "achieve", "statistical", "significance", "with", "a", "study", "duration", "of", "approximately", "six", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p3_s3", "idA": "1006281_15_item1_p120_s1", "sentA": "Under the terms and conditions of the Pfizer Agreement, Protalix Ltd. retained the right to commercialize taliglucerase alfa in Israel and Brazil.", "sentB": "As part of the sale, we agreed to transfer our rights to Elelyso in Israel to Pfizer, while gaining full rights to Elelyso in Brazil.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "Protalix", "Ltd.", "retained", "the", "right", "to", "commercialize", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil.", "<tag2>", "As", "part", "of", "the", "sale,", "we", "agreed", "to", "transfer", "our", "rights", "to", "Elelyso", "in", "Israel", "to", "Pfizer,", "while", "gaining", "full", "rights", "to", "Elelyso", "in", "Brazil.", "<tag3>"], "wordsA": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "Protalix", "Ltd.", "retained", "the", "right", "to", "commercialize", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil."], "wordsB": ["As", "part", "of", "the", "sale,", "we", "agreed", "to", "transfer", "our", "rights", "to", "Elelyso", "in", "Israel", "to", "Pfizer,", "while", "gaining", "full", "rights", "to", "Elelyso", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p4_s0", "idA": "1006281_15_item1_p120_s1", "sentA": "Under the terms and conditions of the Pfizer Agreement, Protalix Ltd. retained the right to commercialize taliglucerase alfa in Israel and Brazil.", "sentB": "Under the initial Pfizer Agreement, Pfizer shared revenues and expenses for the development and commercialization of Elelyso with us on a 60%/40% basis globally, excluding Israel and Brazil.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "Protalix", "Ltd.", "retained", "the", "right", "to", "commercialize", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil.", "<tag2>", "Under", "the", "initial", "Pfizer", "Agreement,", "Pfizer", "shared", "revenues", "and", "expenses", "for", "the", "development", "and", "commercialization", "of", "Elelyso", "with", "us", "on", "a", "60%/40%", "basis", "globally,", "excluding", "Israel", "and", "Brazil.", "<tag3>"], "wordsA": ["Under", "the", "terms", "and", "conditions", "of", "the", "Pfizer", "Agreement,", "Protalix", "Ltd.", "retained", "the", "right", "to", "commercialize", "taliglucerase", "alfa", "in", "Israel", "and", "Brazil."], "wordsB": ["Under", "the", "initial", "Pfizer", "Agreement,", "Pfizer", "shared", "revenues", "and", "expenses", "for", "the", "development", "and", "commercialization", "of", "Elelyso", "with", "us", "on", "a", "60%/40%", "basis", "globally,", "excluding", "Israel", "and", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p5_s2", "idA": "1006281_15_item1_p122_s2", "sentA": "The Pfizer Agreement also provides for reimbursement by Pfizer of certain costs to be incurred by Protalix Ltd.", "sentB": "The Amended Pfizer Agreement also includes customary provisions regarding cooperation for regulatory matters, patent enforcement, termination, indemnification and insurance requirements.", "type": 2, "words": ["<tag1>", "The", "Pfizer", "Agreement", "also", "provides", "for", "reimbursement", "by", "Pfizer", "of", "certain", "costs", "to", "be", "incurred", "by", "Protalix", "Ltd.", "<tag2>", "The", "Amended", "Pfizer", "Agreement", "also", "includes", "customary", "provisions", "regarding", "cooperation", "for", "regulatory", "matters,", "patent", "enforcement,", "termination,", "indemnification", "and", "insurance", "requirements.", "<tag3>"], "wordsA": ["The", "Pfizer", "Agreement", "also", "provides", "for", "reimbursement", "by", "Pfizer", "of", "certain", "costs", "to", "be", "incurred", "by", "Protalix", "Ltd."], "wordsB": ["The", "Amended", "Pfizer", "Agreement", "also", "includes", "customary", "provisions", "regarding", "cooperation", "for", "regulatory", "matters,", "patent", "enforcement,", "termination,", "indemnification", "and", "insurance", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p100_s2", "idA": "1006281_15_item1_p124_s7", "sentA": "If Fiocruz fails to comply with certain of its purchase commitments under the agreement, we may terminate the agreement, and all of our rights to the technology will be returned.", "sentB": "We are discussing with Fiocruz potential actions that Fiocruz may take to comply with its purchase obligations and, based on such discussions, we will determine what we believe to be the course of action that is in the best interest of our company.", "type": 2, "words": ["<tag1>", "If", "Fiocruz", "fails", "to", "comply", "with", "certain", "of", "its", "purchase", "commitments", "under", "the", "agreement,", "we", "may", "terminate", "the", "agreement,", "and", "all", "of", "our", "rights", "to", "the", "technology", "will", "be", "returned.", "<tag2>", "We", "are", "discussing", "with", "Fiocruz", "potential", "actions", "that", "Fiocruz", "may", "take", "to", "comply", "with", "its", "purchase", "obligations", "and,", "based", "on", "such", "discussions,", "we", "will", "determine", "what", "we", "believe", "to", "be", "the", "course", "of", "action", "that", "is", "in", "the", "best", "interest", "of", "our", "company.", "<tag3>"], "wordsA": ["If", "Fiocruz", "fails", "to", "comply", "with", "certain", "of", "its", "purchase", "commitments", "under", "the", "agreement,", "we", "may", "terminate", "the", "agreement,", "and", "all", "of", "our", "rights", "to", "the", "technology", "will", "be", "returned."], "wordsB": ["We", "are", "discussing", "with", "Fiocruz", "potential", "actions", "that", "Fiocruz", "may", "take", "to", "comply", "with", "its", "purchase", "obligations", "and,", "based", "on", "such", "discussions,", "we", "will", "determine", "what", "we", "believe", "to", "be", "the", "course", "of", "action", "that", "is", "in", "the", "best", "interest", "of", "our", "company."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p7_s3", "idA": "1006281_15_item1_p124_s7", "sentA": "If Fiocruz fails to comply with certain of its purchase commitments under the agreement, we may terminate the agreement, and all of our rights to the technology will be returned.", "sentB": "We are discussing with Fiocruz potential actions that Fiocruz may take to comply with its purchase obligations and, based on such discussions, we will determine what we believe to be the course of action that is in the best interest of our company.", "type": 2, "words": ["<tag1>", "If", "Fiocruz", "fails", "to", "comply", "with", "certain", "of", "its", "purchase", "commitments", "under", "the", "agreement,", "we", "may", "terminate", "the", "agreement,", "and", "all", "of", "our", "rights", "to", "the", "technology", "will", "be", "returned.", "<tag2>", "We", "are", "discussing", "with", "Fiocruz", "potential", "actions", "that", "Fiocruz", "may", "take", "to", "comply", "with", "its", "purchase", "obligations", "and,", "based", "on", "such", "discussions,", "we", "will", "determine", "what", "we", "believe", "to", "be", "the", "course", "of", "action", "that", "is", "in", "the", "best", "interest", "of", "our", "company.", "<tag3>"], "wordsA": ["If", "Fiocruz", "fails", "to", "comply", "with", "certain", "of", "its", "purchase", "commitments", "under", "the", "agreement,", "we", "may", "terminate", "the", "agreement,", "and", "all", "of", "our", "rights", "to", "the", "technology", "will", "be", "returned."], "wordsB": ["We", "are", "discussing", "with", "Fiocruz", "potential", "actions", "that", "Fiocruz", "may", "take", "to", "comply", "with", "its", "purchase", "obligations", "and,", "based", "on", "such", "discussions,", "we", "will", "determine", "what", "we", "believe", "to", "be", "the", "course", "of", "action", "that", "is", "in", "the", "best", "interest", "of", "our", "company."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p103_s1", "idA": "1006281_15_item1_p128_s1", "sentA": "As of December 31, 2014, we hold, or have license rights to 64 patents and 95 pending patent applications with respect to various compositions, methods of production and methods of use relating to our ProCellEx protein expression system and our proprietary product pipeline.", "sentB": "As of December 31, 2015, we held, or had license rights to, 67 patents and 75 pending patent applications with respect to various compositions, methods of production and methods of use relating to our ProCellEx protein expression system and our proprietary product pipeline.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2014,", "we", "hold,", "or", "have", "license", "rights", "to", "64", "patents", "and", "95", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline.", "<tag2>", "As", "of", "December", "31,", "2015,", "we", "held,", "or", "had", "license", "rights", "to,", "67", "patents", "and", "75", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2014,", "we", "hold,", "or", "have", "license", "rights", "to", "64", "patents", "and", "95", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline."], "wordsB": ["As", "of", "December", "31,", "2015,", "we", "held,", "or", "had", "license", "rights", "to,", "67", "patents", "and", "75", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p103_s2", "idA": "1006281_15_item1_p128_s2", "sentA": "As of December 31, 2014, we hold, with a third party, one joint patent and one joint patent application, and licensed rights to two patents.", "sentB": "As of December 31, 2015, we held, with a third party, one joint patent and one joint patent application, and licensed rights to two patents.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2014,", "we", "hold,", "with", "a", "third", "party,", "one", "joint", "patent", "and", "one", "joint", "patent", "application,", "and", "licensed", "rights", "to", "two", "patents.", "<tag2>", "As", "of", "December", "31,", "2015,", "we", "held,", "with", "a", "third", "party,", "one", "joint", "patent", "and", "one", "joint", "patent", "application,", "and", "licensed", "rights", "to", "two", "patents.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2014,", "we", "hold,", "with", "a", "third", "party,", "one", "joint", "patent", "and", "one", "joint", "patent", "application,", "and", "licensed", "rights", "to", "two", "patents."], "wordsB": ["As", "of", "December", "31,", "2015,", "we", "held,", "with", "a", "third", "party,", "one", "joint", "patent", "and", "one", "joint", "patent", "application,", "and", "licensed", "rights", "to", "two", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p105_s0", "idA": "1006281_15_item1_p130_s0", "sentA": "As of December 31, 2014, our patent portfolio consists of several patent families (consisting of patents and/or patent applications) covering our technology, protein expression methodologies and system and product candidates, as follows:", "sentB": "As of December 31, 2015, our patent portfolio consisted of several patent families (consisting of patents and/or patent applications) covering our technology, protein expression methodologies and system and product candidates, as follows:", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2014,", "our", "patent", "portfolio", "consists", "of", "several", "patent", "families", "(consisting", "of", "patents", "and/or", "patent", "applications)", "covering", "our", "technology,", "protein", "expression", "methodologies", "and", "system", "and", "product", "candidates,", "as", "follows:", "<tag2>", "As", "of", "December", "31,", "2015,", "our", "patent", "portfolio", "consisted", "of", "several", "patent", "families", "(consisting", "of", "patents", "and/or", "patent", "applications)", "covering", "our", "technology,", "protein", "expression", "methodologies", "and", "system", "and", "product", "candidates,", "as", "follows:", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2014,", "our", "patent", "portfolio", "consists", "of", "several", "patent", "families", "(consisting", "of", "patents", "and/or", "patent", "applications)", "covering", "our", "technology,", "protein", "expression", "methodologies", "and", "system", "and", "product", "candidates,", "as", "follows:"], "wordsB": ["As", "of", "December", "31,", "2015,", "our", "patent", "portfolio", "consisted", "of", "several", "patent", "families", "(consisting", "of", "patents", "and/or", "patent", "applications)", "covering", "our", "technology,", "protein", "expression", "methodologies", "and", "system", "and", "product", "candidates,", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p106_s0", "idA": "1006281_15_item1_p131_s0", "sentA": "With respect to our ProCellEx protein expression system, we have been issued 19 patents in the United States, Australia, the European Union, Israel, Canada, the Czech Republic, Hungary, Japan, Poland, Mexico, Hong Kong, India and Korea, and hold three pending patent applications.", "sentB": "With respect to our ProCellEx protein expression system, we held 14 issued patents in the United States, Australia, the European Union, Israel, Canada, Mexico, Hong Kong, India and Korea, and hold one pending patent applications.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "have", "been", "issued", "19", "patents", "in", "the", "United", "States,", "Australia,", "the", "European", "Union,", "Israel,", "Canada,", "the", "Czech", "Republic,", "Hungary,", "Japan,", "Poland,", "Mexico,", "Hong", "Kong,", "India", "and", "Korea,", "and", "hold", "three", "pending", "patent", "applications.", "<tag2>", "With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "held", "14", "issued", "patents", "in", "the", "United", "States,", "Australia,", "the", "European", "Union,", "Israel,", "Canada,", "Mexico,", "Hong", "Kong,", "India", "and", "Korea,", "and", "hold", "one", "pending", "patent", "applications.", "<tag3>"], "wordsA": ["With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "have", "been", "issued", "19", "patents", "in", "the", "United", "States,", "Australia,", "the", "European", "Union,", "Israel,", "Canada,", "the", "Czech", "Republic,", "Hungary,", "Japan,", "Poland,", "Mexico,", "Hong", "Kong,", "India", "and", "Korea,", "and", "hold", "three", "pending", "patent", "applications."], "wordsB": ["With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "held", "14", "issued", "patents", "in", "the", "United", "States,", "Australia,", "the", "European", "Union,", "Israel,", "Canada,", "Mexico,", "Hong", "Kong,", "India", "and", "Korea,", "and", "hold", "one", "pending", "patent", "applications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p106_s2", "idA": "1006281_15_item1_p131_s2", "sentA": "Of the issued patents in this family, 13 are expected to expire in 2017 and six are expected to expire in 2025.", "sentB": "Of the issued patents in this family, seven are expected to expire in 2017 and seven are expected to expire in 2025.", "type": 2, "words": ["<tag1>", "Of", "the", "issued", "patents", "in", "this", "family,", "13", "are", "expected", "to", "expire", "in", "2017", "and", "six", "are", "expected", "to", "expire", "in", "2025.", "<tag2>", "Of", "the", "issued", "patents", "in", "this", "family,", "seven", "are", "expected", "to", "expire", "in", "2017", "and", "seven", "are", "expected", "to", "expire", "in", "2025.", "<tag3>"], "wordsA": ["Of", "the", "issued", "patents", "in", "this", "family,", "13", "are", "expected", "to", "expire", "in", "2017", "and", "six", "are", "expected", "to", "expire", "in", "2025."], "wordsB": ["Of", "the", "issued", "patents", "in", "this", "family,", "seven", "are", "expected", "to", "expire", "in", "2017", "and", "seven", "are", "expected", "to", "expire", "in", "2025."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p107_s0", "idA": "1006281_15_item1_p132_s0", "sentA": "With respect to our ProCellEx protein expression system, we hold four issued patents and 13 patent applications relating to the large scale production of proteins in cultured plant cells.", "sentB": "With respect to our ProCellEx protein expression system, we held six issued patents and eight patent applications relating to the large scale production of proteins in cultured plant cells.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "hold", "four", "issued", "patents", "and", "13", "patent", "applications", "relating", "to", "the", "large", "scale", "production", "of", "proteins", "in", "cultured", "plant", "cells.", "<tag2>", "With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "held", "six", "issued", "patents", "and", "eight", "patent", "applications", "relating", "to", "the", "large", "scale", "production", "of", "proteins", "in", "cultured", "plant", "cells.", "<tag3>"], "wordsA": ["With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "hold", "four", "issued", "patents", "and", "13", "patent", "applications", "relating", "to", "the", "large", "scale", "production", "of", "proteins", "in", "cultured", "plant", "cells."], "wordsB": ["With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "held", "six", "issued", "patents", "and", "eight", "patent", "applications", "relating", "to", "the", "large", "scale", "production", "of", "proteins", "in", "cultured", "plant", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p109_s0", "idA": "1006281_15_item1_p134_s0", "sentA": "We hold a patent family containing four granted patents relating to a system and method for production of antibodies in a plant cell culture, and antibodies produced in such a system.", "sentB": "We held a patent family containing three granted patents relating to a system and method for production of antibodies in a plant cell culture, and antibodies produced in such a system.", "type": 2, "words": ["<tag1>", "We", "hold", "a", "patent", "family", "containing", "four", "granted", "patents", "relating", "to", "a", "system", "and", "method", "for", "production", "of", "antibodies", "in", "a", "plant", "cell", "culture,", "and", "antibodies", "produced", "in", "such", "a", "system.", "<tag2>", "We", "held", "a", "patent", "family", "containing", "three", "granted", "patents", "relating", "to", "a", "system", "and", "method", "for", "production", "of", "antibodies", "in", "a", "plant", "cell", "culture,", "and", "antibodies", "produced", "in", "such", "a", "system.", "<tag3>"], "wordsA": ["We", "hold", "a", "patent", "family", "containing", "four", "granted", "patents", "relating", "to", "a", "system", "and", "method", "for", "production", "of", "antibodies", "in", "a", "plant", "cell", "culture,", "and", "antibodies", "produced", "in", "such", "a", "system."], "wordsB": ["We", "held", "a", "patent", "family", "containing", "three", "granted", "patents", "relating", "to", "a", "system", "and", "method", "for", "production", "of", "antibodies", "in", "a", "plant", "cell", "culture,", "and", "antibodies", "produced", "in", "such", "a", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p110_s0", "idA": "1006281_15_item1_p135_s0", "sentA": "We hold a patent family containing four issued patents in South Africa, Australia and Singapore, and seven pending patent applications relating to a new method for delivering active recombinant proteins systemically through oral administration of transgenic plant cells.", "sentB": "We held a patent family containing three issued patents in South Africa, Australia and Israel, and one pending patent application relating to a new method for delivering active recombinant proteins systemically through oral administration of transgenic plant cells.", "type": 2, "words": ["<tag1>", "We", "hold", "a", "patent", "family", "containing", "four", "issued", "patents", "in", "South", "Africa,", "Australia", "and", "Singapore,", "and", "seven", "pending", "patent", "applications", "relating", "to", "a", "new", "method", "for", "delivering", "active", "recombinant", "proteins", "systemically", "through", "oral", "administration", "of", "transgenic", "plant", "cells.", "<tag2>", "We", "held", "a", "patent", "family", "containing", "three", "issued", "patents", "in", "South", "Africa,", "Australia", "and", "Israel,", "and", "one", "pending", "patent", "application", "relating", "to", "a", "new", "method", "for", "delivering", "active", "recombinant", "proteins", "systemically", "through", "oral", "administration", "of", "transgenic", "plant", "cells.", "<tag3>"], "wordsA": ["We", "hold", "a", "patent", "family", "containing", "four", "issued", "patents", "in", "South", "Africa,", "Australia", "and", "Singapore,", "and", "seven", "pending", "patent", "applications", "relating", "to", "a", "new", "method", "for", "delivering", "active", "recombinant", "proteins", "systemically", "through", "oral", "administration", "of", "transgenic", "plant", "cells."], "wordsB": ["We", "held", "a", "patent", "family", "containing", "three", "issued", "patents", "in", "South", "Africa,", "Australia", "and", "Israel,", "and", "one", "pending", "patent", "application", "relating", "to", "a", "new", "method", "for", "delivering", "active", "recombinant", "proteins", "systemically", "through", "oral", "administration", "of", "transgenic", "plant", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p111_s0", "idA": "1006281_15_item1_p136_s0", "sentA": "We hold a patent family containing three granted patents in the United States, South Africa and Australia, and five pending patent applications relating to saccharide containing protein conjugates.", "sentB": "We held a patent family containing three granted patents in the United States, South Africa and Australia, and two pending patent applications relating to saccharide containing protein conjugates.", "type": 2, "words": ["<tag1>", "We", "hold", "a", "patent", "family", "containing", "three", "granted", "patents", "in", "the", "United", "States,", "South", "Africa", "and", "Australia,", "and", "five", "pending", "patent", "applications", "relating", "to", "saccharide", "containing", "protein", "conjugates.", "<tag2>", "We", "held", "a", "patent", "family", "containing", "three", "granted", "patents", "in", "the", "United", "States,", "South", "Africa", "and", "Australia,", "and", "two", "pending", "patent", "applications", "relating", "to", "saccharide", "containing", "protein", "conjugates.", "<tag3>"], "wordsA": ["We", "hold", "a", "patent", "family", "containing", "three", "granted", "patents", "in", "the", "United", "States,", "South", "Africa", "and", "Australia,", "and", "five", "pending", "patent", "applications", "relating", "to", "saccharide", "containing", "protein", "conjugates."], "wordsB": ["We", "held", "a", "patent", "family", "containing", "three", "granted", "patents", "in", "the", "United", "States,", "South", "Africa", "and", "Australia,", "and", "two", "pending", "patent", "applications", "relating", "to", "saccharide", "containing", "protein", "conjugates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p113_s0", "idA": "1006281_15_item1_p138_s0", "sentA": "We hold a patent family containing three granted patents in Europe, New Zealand and South Africa and 16 pending patent applications relating to multimeric protein structures of -galactosidase and to uses thereof in treating Fabry disease.", "sentB": "We held a patent family containing nine granted patents in Europe, United States, Japan, China, Hong Kong, Singapore, New Zealand and South Africa and 12 pending patent applications relating to multimeric protein structures of -galactosidase and to uses thereof in treating Fabry disease.", "type": 2, "words": ["<tag1>", "We", "hold", "a", "patent", "family", "containing", "three", "granted", "patents", "in", "Europe,", "New", "Zealand", "and", "South", "Africa", "and", "16", "pending", "patent", "applications", "relating", "to", "multimeric", "protein", "structures", "of", "-galactosidase", "and", "to", "uses", "thereof", "in", "treating", "Fabry", "disease.", "<tag2>", "We", "held", "a", "patent", "family", "containing", "nine", "granted", "patents", "in", "Europe,", "United", "States,", "Japan,", "China,", "Hong", "Kong,", "Singapore,", "New", "Zealand", "and", "South", "Africa", "and", "12", "pending", "patent", "applications", "relating", "to", "multimeric", "protein", "structures", "of", "-galactosidase", "and", "to", "uses", "thereof", "in", "treating", "Fabry", "disease.", "<tag3>"], "wordsA": ["We", "hold", "a", "patent", "family", "containing", "three", "granted", "patents", "in", "Europe,", "New", "Zealand", "and", "South", "Africa", "and", "16", "pending", "patent", "applications", "relating", "to", "multimeric", "protein", "structures", "of", "-galactosidase", "and", "to", "uses", "thereof", "in", "treating", "Fabry", "disease."], "wordsB": ["We", "held", "a", "patent", "family", "containing", "nine", "granted", "patents", "in", "Europe,", "United", "States,", "Japan,", "China,", "Hong", "Kong,", "Singapore,", "New", "Zealand", "and", "South", "Africa", "and", "12", "pending", "patent", "applications", "relating", "to", "multimeric", "protein", "structures", "of", "-galactosidase", "and", "to", "uses", "thereof", "in", "treating", "Fabry", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p114_s0", "idA": "1006281_15_item1_p139_s0", "sentA": "We hold a patent family containing two pending patent applications relating to therapeutic proteins with stabilized quaternary structure.", "sentB": "We held a granted patent in Europe relating to therapeutic proteins with stabilized quaternary structure.", "type": 2, "words": ["<tag1>", "We", "hold", "a", "patent", "family", "containing", "two", "pending", "patent", "applications", "relating", "to", "therapeutic", "proteins", "with", "stabilized", "quaternary", "structure.", "<tag2>", "We", "held", "a", "granted", "patent", "in", "Europe", "relating", "to", "therapeutic", "proteins", "with", "stabilized", "quaternary", "structure.", "<tag3>"], "wordsA": ["We", "hold", "a", "patent", "family", "containing", "two", "pending", "patent", "applications", "relating", "to", "therapeutic", "proteins", "with", "stabilized", "quaternary", "structure."], "wordsB": ["We", "held", "a", "granted", "patent", "in", "Europe", "relating", "to", "therapeutic", "proteins", "with", "stabilized", "quaternary", "structure."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p115_s0", "idA": "1006281_15_item1_p140_s0", "sentA": "We hold a patent family containing one granted patent in Europe and two pending patent applications relating to multimeric protein structures of glucocerebrosidase and to uses thereof in treating Gaucher disease.", "sentB": "We held a patent family containing one granted patent in Europe and one pending patent application relating to multimeric protein structures of glucocerebrosidase and to uses thereof in treating Gaucher disease.", "type": 2, "words": ["<tag1>", "We", "hold", "a", "patent", "family", "containing", "one", "granted", "patent", "in", "Europe", "and", "two", "pending", "patent", "applications", "relating", "to", "multimeric", "protein", "structures", "of", "glucocerebrosidase", "and", "to", "uses", "thereof", "in", "treating", "Gaucher", "disease.", "<tag2>", "We", "held", "a", "patent", "family", "containing", "one", "granted", "patent", "in", "Europe", "and", "one", "pending", "patent", "application", "relating", "to", "multimeric", "protein", "structures", "of", "glucocerebrosidase", "and", "to", "uses", "thereof", "in", "treating", "Gaucher", "disease.", "<tag3>"], "wordsA": ["We", "hold", "a", "patent", "family", "containing", "one", "granted", "patent", "in", "Europe", "and", "two", "pending", "patent", "applications", "relating", "to", "multimeric", "protein", "structures", "of", "glucocerebrosidase", "and", "to", "uses", "thereof", "in", "treating", "Gaucher", "disease."], "wordsB": ["We", "held", "a", "patent", "family", "containing", "one", "granted", "patent", "in", "Europe", "and", "one", "pending", "patent", "application", "relating", "to", "multimeric", "protein", "structures", "of", "glucocerebrosidase", "and", "to", "uses", "thereof", "in", "treating", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p117_s0", "idA": "1006281_15_item1_p141_s0", "sentA": "We hold three patent families containing eight pending applications relating to plant recombinant human DNase I and uses in therapy.", "sentB": "We held three patent families containing eight pending applications relating to plant recombinant human DNase I and uses in therapy.", "type": 2, "words": ["<tag1>", "We", "hold", "three", "patent", "families", "containing", "eight", "pending", "applications", "relating", "to", "plant", "recombinant", "human", "DNase", "I", "and", "uses", "in", "therapy.", "<tag2>", "We", "held", "three", "patent", "families", "containing", "eight", "pending", "applications", "relating", "to", "plant", "recombinant", "human", "DNase", "I", "and", "uses", "in", "therapy.", "<tag3>"], "wordsA": ["We", "hold", "three", "patent", "families", "containing", "eight", "pending", "applications", "relating", "to", "plant", "recombinant", "human", "DNase", "I", "and", "uses", "in", "therapy."], "wordsB": ["We", "held", "three", "patent", "families", "containing", "eight", "pending", "applications", "relating", "to", "plant", "recombinant", "human", "DNase", "I", "and", "uses", "in", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p118_s1", "idA": "1006281_15_item1_p141_s1", "sentA": "The patents to issue in the future based on these patent applications, if at all, are expected to expire in 2033.", "sentB": "The patents to issue in the future based on these patent applications, if at all, are expected to expire in 2034/2035.", "type": 2, "words": ["<tag1>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2033.", "<tag2>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2034/2035.", "<tag3>"], "wordsA": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2033."], "wordsB": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2034/2035."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p118_s0", "idA": "1006281_15_item1_p142_s0", "sentA": "We hold two PCTs and patent applications relating to plant recombinant TNF alpha inhibitor polypeptides.", "sentB": "We held three families containing nine patent applications relating to plant recombinant TNF alpha inhibitor polypeptides.", "type": 2, "words": ["<tag1>", "We", "hold", "two", "PCTs", "and", "patent", "applications", "relating", "to", "plant", "recombinant", "TNF", "alpha", "inhibitor", "polypeptides.", "<tag2>", "We", "held", "three", "families", "containing", "nine", "patent", "applications", "relating", "to", "plant", "recombinant", "TNF", "alpha", "inhibitor", "polypeptides.", "<tag3>"], "wordsA": ["We", "hold", "two", "PCTs", "and", "patent", "applications", "relating", "to", "plant", "recombinant", "TNF", "alpha", "inhibitor", "polypeptides."], "wordsB": ["We", "held", "three", "families", "containing", "nine", "patent", "applications", "relating", "to", "plant", "recombinant", "TNF", "alpha", "inhibitor", "polypeptides."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p114_s1", "idA": "1006281_15_item1_p143_s2", "sentA": "This patent was issued in the United States and is expected to expire in 2024.", "sentB": "The patent is expected to expire in 2031.", "type": 2, "words": ["<tag1>", "This", "patent", "was", "issued", "in", "the", "United", "States", "and", "is", "expected", "to", "expire", "in", "2024.", "<tag2>", "The", "patent", "is", "expected", "to", "expire", "in", "2031.", "<tag3>"], "wordsA": ["This", "patent", "was", "issued", "in", "the", "United", "States", "and", "is", "expected", "to", "expire", "in", "2024."], "wordsB": ["The", "patent", "is", "expected", "to", "expire", "in", "2031."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p121_s0", "idA": "1006281_15_item1_p145_s0", "sentA": "We co-own a PCT that covers use of plant cells expressing a TNF alpha polypeptide inhibitor in therapy.", "sentB": "We co-own a patent family containing eight pending applications that covers use of plant cells expressing a TNF alpha polypeptide inhibitor in therapy.", "type": 2, "words": ["<tag1>", "We", "co-own", "a", "PCT", "that", "covers", "use", "of", "plant", "cells", "expressing", "a", "TNF", "alpha", "polypeptide", "inhibitor", "in", "therapy.", "<tag2>", "We", "co-own", "a", "patent", "family", "containing", "eight", "pending", "applications", "that", "covers", "use", "of", "plant", "cells", "expressing", "a", "TNF", "alpha", "polypeptide", "inhibitor", "in", "therapy.", "<tag3>"], "wordsA": ["We", "co-own", "a", "PCT", "that", "covers", "use", "of", "plant", "cells", "expressing", "a", "TNF", "alpha", "polypeptide", "inhibitor", "in", "therapy."], "wordsB": ["We", "co-own", "a", "patent", "family", "containing", "eight", "pending", "applications", "that", "covers", "use", "of", "plant", "cells", "expressing", "a", "TNF", "alpha", "polypeptide", "inhibitor", "in", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p123_s1", "idA": "1006281_15_item1_p148_s1", "sentA": "Under the terms of the agreement, we are also entitled to a non-exclusive worldwide license to make and have made other proteins expressed by using Icon s technology in our technology.", "sentB": "We are also entitled to a non-exclusive worldwide license to make and have made other proteins expressed by using Icon s technology in our technology.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "of", "the", "agreement,", "we", "are", "also", "entitled", "to", "a", "non-exclusive", "worldwide", "license", "to", "make", "and", "have", "made", "other", "proteins", "expressed", "by", "using", "Icon", "s", "technology", "in", "our", "technology.", "<tag2>", "We", "are", "also", "entitled", "to", "a", "non-exclusive", "worldwide", "license", "to", "make", "and", "have", "made", "other", "proteins", "expressed", "by", "using", "Icon", "s", "technology", "in", "our", "technology.", "<tag3>"], "wordsA": ["Under", "the", "terms", "of", "the", "agreement,", "we", "are", "also", "entitled", "to", "a", "non-exclusive", "worldwide", "license", "to", "make", "and", "have", "made", "other", "proteins", "expressed", "by", "using", "Icon", "s", "technology", "in", "our", "technology."], "wordsB": ["We", "are", "also", "entitled", "to", "a", "non-exclusive", "worldwide", "license", "to", "make", "and", "have", "made", "other", "proteins", "expressed", "by", "using", "Icon", "s", "technology", "in", "our", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p4_s1", "idA": "1006281_15_item1_p148_s1", "sentA": "Under the terms of the agreement, we are also entitled to a non-exclusive worldwide license to make and have made other proteins expressed by using Icon s technology in our technology.", "sentB": "Under the Amended Pfizer Agreement, Pfizer is responsible for 100% of expenses, and entitled to all revenues globally for Elelyso, excluding Brazil, where we are responsible for all expenses and retain all revenues.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "of", "the", "agreement,", "we", "are", "also", "entitled", "to", "a", "non-exclusive", "worldwide", "license", "to", "make", "and", "have", "made", "other", "proteins", "expressed", "by", "using", "Icon", "s", "technology", "in", "our", "technology.", "<tag2>", "Under", "the", "Amended", "Pfizer", "Agreement,", "Pfizer", "is", "responsible", "for", "100%", "of", "expenses,", "and", "entitled", "to", "all", "revenues", "globally", "for", "Elelyso,", "excluding", "Brazil,", "where", "we", "are", "responsible", "for", "all", "expenses", "and", "retain", "all", "revenues.", "<tag3>"], "wordsA": ["Under", "the", "terms", "of", "the", "agreement,", "we", "are", "also", "entitled", "to", "a", "non-exclusive", "worldwide", "license", "to", "make", "and", "have", "made", "other", "proteins", "expressed", "by", "using", "Icon", "s", "technology", "in", "our", "technology."], "wordsB": ["Under", "the", "Amended", "Pfizer", "Agreement,", "Pfizer", "is", "responsible", "for", "100%", "of", "expenses,", "and", "entitled", "to", "all", "revenues", "globally", "for", "Elelyso,", "excluding", "Brazil,", "where", "we", "are", "responsible", "for", "all", "expenses", "and", "retain", "all", "revenues."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p10_s1", "idA": "1006281_15_item1_p14_s0", "sentA": "(1) PRX-102, or alpha-GAL-A , a therapeutic protein candidate for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans, currently in an ongoing phase I/II clinical trial.", "sentB": "PRX-102 is currently the subject of an ongoing phase I/II clinical trial and we expect to commence phase III clinical trials of PRX-102 during the first half of 2016.", "type": 2, "words": ["<tag1>", "(1)", "PRX-102,", "or", "alpha-GAL-A", ",", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "currently", "in", "an", "ongoing", "phase", "I/II", "clinical", "trial.", "<tag2>", "PRX-102", "is", "currently", "the", "subject", "of", "an", "ongoing", "phase", "I/II", "clinical", "trial", "and", "we", "expect", "to", "commence", "phase", "III", "clinical", "trials", "of", "PRX-102", "during", "the", "first", "half", "of", "2016.", "<tag3>"], "wordsA": ["(1)", "PRX-102,", "or", "alpha-GAL-A", ",", "a", "therapeutic", "protein", "candidate", "for", "the", "treatment", "of", "Fabry", "disease,", "a", "rare,", "genetic", "lysosomal", "disorder", "in", "humans,", "currently", "in", "an", "ongoing", "phase", "I/II", "clinical", "trial."], "wordsB": ["PRX-102", "is", "currently", "the", "subject", "of", "an", "ongoing", "phase", "I/II", "clinical", "trial", "and", "we", "expect", "to", "commence", "phase", "III", "clinical", "trials", "of", "PRX-102", "during", "the", "first", "half", "of", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p125_s0", "idA": "1006281_15_item1_p150_s0", "sentA": "In January 2005, Protalix Ltd. entered into a license agreement with Virginia Tech University, pursuant to which we received a non-exclusive worldwide license to make, have made, use, sell, offer for sale and import certain of Virginia Tech s patents.", "sentB": "In January 2005, Protalix Ltd. entered into a license agreement with Virginia Tech, pursuant to which we received a non-exclusive worldwide license to make, have made, use, sell, offer for sale and import certain of Virginia Tech s patents.", "type": 2, "words": ["<tag1>", "In", "January", "2005,", "Protalix", "Ltd.", "entered", "into", "a", "license", "agreement", "with", "Virginia", "Tech", "University,", "pursuant", "to", "which", "we", "received", "a", "non-exclusive", "worldwide", "license", "to", "make,", "have", "made,", "use,", "sell,", "offer", "for", "sale", "and", "import", "certain", "of", "Virginia", "Tech", "s", "patents.", "<tag2>", "In", "January", "2005,", "Protalix", "Ltd.", "entered", "into", "a", "license", "agreement", "with", "Virginia", "Tech,", "pursuant", "to", "which", "we", "received", "a", "non-exclusive", "worldwide", "license", "to", "make,", "have", "made,", "use,", "sell,", "offer", "for", "sale", "and", "import", "certain", "of", "Virginia", "Tech", "s", "patents.", "<tag3>"], "wordsA": ["In", "January", "2005,", "Protalix", "Ltd.", "entered", "into", "a", "license", "agreement", "with", "Virginia", "Tech", "University,", "pursuant", "to", "which", "we", "received", "a", "non-exclusive", "worldwide", "license", "to", "make,", "have", "made,", "use,", "sell,", "offer", "for", "sale", "and", "import", "certain", "of", "Virginia", "Tech", "s", "patents."], "wordsB": ["In", "January", "2005,", "Protalix", "Ltd.", "entered", "into", "a", "license", "agreement", "with", "Virginia", "Tech,", "pursuant", "to", "which", "we", "received", "a", "non-exclusive", "worldwide", "license", "to", "make,", "have", "made,", "use,", "sell,", "offer", "for", "sale", "and", "import", "certain", "of", "Virginia", "Tech", "s", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p6_s0", "idA": "1006281_15_item1_p150_s0", "sentA": "In January 2005, Protalix Ltd. entered into a license agreement with Virginia Tech University, pursuant to which we received a non-exclusive worldwide license to make, have made, use, sell, offer for sale and import certain of Virginia Tech s patents.", "sentB": "On October 12, 2015, we also entered into a Stock Purchase Agreement with Pfizer, pursuant to which we issued in a private placement 5,649,079 shares of our common stock for an aggregate purchase price equal to $10.0 million subject to certain other terms set forth in the Stock Purchase Agreement.", "type": 2, "words": ["<tag1>", "In", "January", "2005,", "Protalix", "Ltd.", "entered", "into", "a", "license", "agreement", "with", "Virginia", "Tech", "University,", "pursuant", "to", "which", "we", "received", "a", "non-exclusive", "worldwide", "license", "to", "make,", "have", "made,", "use,", "sell,", "offer", "for", "sale", "and", "import", "certain", "of", "Virginia", "Tech", "s", "patents.", "<tag2>", "On", "October", "12,", "2015,", "we", "also", "entered", "into", "a", "Stock", "Purchase", "Agreement", "with", "Pfizer,", "pursuant", "to", "which", "we", "issued", "in", "a", "private", "placement", "5,649,079", "shares", "of", "our", "common", "stock", "for", "an", "aggregate", "purchase", "price", "equal", "to", "$10.0", "million", "subject", "to", "certain", "other", "terms", "set", "forth", "in", "the", "Stock", "Purchase", "Agreement.", "<tag3>"], "wordsA": ["In", "January", "2005,", "Protalix", "Ltd.", "entered", "into", "a", "license", "agreement", "with", "Virginia", "Tech", "University,", "pursuant", "to", "which", "we", "received", "a", "non-exclusive", "worldwide", "license", "to", "make,", "have", "made,", "use,", "sell,", "offer", "for", "sale", "and", "import", "certain", "of", "Virginia", "Tech", "s", "patents."], "wordsB": ["On", "October", "12,", "2015,", "we", "also", "entered", "into", "a", "Stock", "Purchase", "Agreement", "with", "Pfizer,", "pursuant", "to", "which", "we", "issued", "in", "a", "private", "placement", "5,649,079", "shares", "of", "our", "common", "stock", "for", "an", "aggregate", "purchase", "price", "equal", "to", "$10.0", "million", "subject", "to", "certain", "other", "terms", "set", "forth", "in", "the", "Stock", "Purchase", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p100_s0", "idA": "1006281_15_item1_p152_s2", "sentA": "We have the right to terminate the agreement at any time upon prior written notice delivered an agreed-upon number of days prior to the date of termination.", "sentB": "Since the agreement went into effect, Fiocruz s purchases of taliglucerase alfa have been significantly below certain agreed upon purchase milestones and, accordingly, we have the right to terminate the Brazil Agreement.", "type": 2, "words": ["<tag1>", "We", "have", "the", "right", "to", "terminate", "the", "agreement", "at", "any", "time", "upon", "prior", "written", "notice", "delivered", "an", "agreed-upon", "number", "of", "days", "prior", "to", "the", "date", "of", "termination.", "<tag2>", "Since", "the", "agreement", "went", "into", "effect,", "Fiocruz", "s", "purchases", "of", "taliglucerase", "alfa", "have", "been", "significantly", "below", "certain", "agreed", "upon", "purchase", "milestones", "and,", "accordingly,", "we", "have", "the", "right", "to", "terminate", "the", "Brazil", "Agreement.", "<tag3>"], "wordsA": ["We", "have", "the", "right", "to", "terminate", "the", "agreement", "at", "any", "time", "upon", "prior", "written", "notice", "delivered", "an", "agreed-upon", "number", "of", "days", "prior", "to", "the", "date", "of", "termination."], "wordsB": ["Since", "the", "agreement", "went", "into", "effect,", "Fiocruz", "s", "purchases", "of", "taliglucerase", "alfa", "have", "been", "significantly", "below", "certain", "agreed", "upon", "purchase", "milestones", "and,", "accordingly,", "we", "have", "the", "right", "to", "terminate", "the", "Brazil", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p7_s1", "idA": "1006281_15_item1_p152_s2", "sentA": "We have the right to terminate the agreement at any time upon prior written notice delivered an agreed-upon number of days prior to the date of termination.", "sentB": "Fiocruz s purchases of Uplyso to date have been significantly below certain agreed upon purchase milestones and, accordingly, we have the right to terminate the Brazil Agreement.", "type": 2, "words": ["<tag1>", "We", "have", "the", "right", "to", "terminate", "the", "agreement", "at", "any", "time", "upon", "prior", "written", "notice", "delivered", "an", "agreed-upon", "number", "of", "days", "prior", "to", "the", "date", "of", "termination.", "<tag2>", "Fiocruz", "s", "purchases", "of", "Uplyso", "to", "date", "have", "been", "significantly", "below", "certain", "agreed", "upon", "purchase", "milestones", "and,", "accordingly,", "we", "have", "the", "right", "to", "terminate", "the", "Brazil", "Agreement.", "<tag3>"], "wordsA": ["We", "have", "the", "right", "to", "terminate", "the", "agreement", "at", "any", "time", "upon", "prior", "written", "notice", "delivered", "an", "agreed-upon", "number", "of", "days", "prior", "to", "the", "date", "of", "termination."], "wordsB": ["Fiocruz", "s", "purchases", "of", "Uplyso", "to", "date", "have", "been", "significantly", "below", "certain", "agreed", "upon", "purchase", "milestones", "and,", "accordingly,", "we", "have", "the", "right", "to", "terminate", "the", "Brazil", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p128_s0", "idA": "1006281_15_item1_p153_s0", "sentA": "We are obligated to manufacture all of the taliglucerase alfa drug product needed under the Pfizer Agreement, subject to certain terms and conditions.", "sentB": "We are obligated to manufacture all of the taliglucerase alfa drug product needed under the Amended Pfizer Agreement, subject to certain terms and conditions.", "type": 2, "words": ["<tag1>", "We", "are", "obligated", "to", "manufacture", "all", "of", "the", "taliglucerase", "alfa", "drug", "product", "needed", "under", "the", "Pfizer", "Agreement,", "subject", "to", "certain", "terms", "and", "conditions.", "<tag2>", "We", "are", "obligated", "to", "manufacture", "all", "of", "the", "taliglucerase", "alfa", "drug", "product", "needed", "under", "the", "Amended", "Pfizer", "Agreement,", "subject", "to", "certain", "terms", "and", "conditions.", "<tag3>"], "wordsA": ["We", "are", "obligated", "to", "manufacture", "all", "of", "the", "taliglucerase", "alfa", "drug", "product", "needed", "under", "the", "Pfizer", "Agreement,", "subject", "to", "certain", "terms", "and", "conditions."], "wordsB": ["We", "are", "obligated", "to", "manufacture", "all", "of", "the", "taliglucerase", "alfa", "drug", "product", "needed", "under", "the", "Amended", "Pfizer", "Agreement,", "subject", "to", "certain", "terms", "and", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p3_s4", "idA": "1006281_15_item1_p153_s0", "sentA": "We are obligated to manufacture all of the taliglucerase alfa drug product needed under the Pfizer Agreement, subject to certain terms and conditions.", "sentB": "We will continue to manufacture drug substance for Pfizer, subject to certain terms and conditions.", "type": 2, "words": ["<tag1>", "We", "are", "obligated", "to", "manufacture", "all", "of", "the", "taliglucerase", "alfa", "drug", "product", "needed", "under", "the", "Pfizer", "Agreement,", "subject", "to", "certain", "terms", "and", "conditions.", "<tag2>", "We", "will", "continue", "to", "manufacture", "drug", "substance", "for", "Pfizer,", "subject", "to", "certain", "terms", "and", "conditions.", "<tag3>"], "wordsA": ["We", "are", "obligated", "to", "manufacture", "all", "of", "the", "taliglucerase", "alfa", "drug", "product", "needed", "under", "the", "Pfizer", "Agreement,", "subject", "to", "certain", "terms", "and", "conditions."], "wordsB": ["We", "will", "continue", "to", "manufacture", "drug", "substance", "for", "Pfizer,", "subject", "to", "certain", "terms", "and", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p5_s0", "idA": "1006281_15_item1_p153_s0", "sentA": "We are obligated to manufacture all of the taliglucerase alfa drug product needed under the Pfizer Agreement, subject to certain terms and conditions.", "sentB": "For the first 10-year period after the execution of the Amended Pfizer Agreement, we have agreed to sell drug substance to Pfizer for the production of Elelyso, and Pfizer maintains the right to extend the supply period for up to two additional 30-month periods subject to certain terms and conditions.", "type": 2, "words": ["<tag1>", "We", "are", "obligated", "to", "manufacture", "all", "of", "the", "taliglucerase", "alfa", "drug", "product", "needed", "under", "the", "Pfizer", "Agreement,", "subject", "to", "certain", "terms", "and", "conditions.", "<tag2>", "For", "the", "first", "10-year", "period", "after", "the", "execution", "of", "the", "Amended", "Pfizer", "Agreement,", "we", "have", "agreed", "to", "sell", "drug", "substance", "to", "Pfizer", "for", "the", "production", "of", "Elelyso,", "and", "Pfizer", "maintains", "the", "right", "to", "extend", "the", "supply", "period", "for", "up", "to", "two", "additional", "30-month", "periods", "subject", "to", "certain", "terms", "and", "conditions.", "<tag3>"], "wordsA": ["We", "are", "obligated", "to", "manufacture", "all", "of", "the", "taliglucerase", "alfa", "drug", "product", "needed", "under", "the", "Pfizer", "Agreement,", "subject", "to", "certain", "terms", "and", "conditions."], "wordsB": ["For", "the", "first", "10-year", "period", "after", "the", "execution", "of", "the", "Amended", "Pfizer", "Agreement,", "we", "have", "agreed", "to", "sell", "drug", "substance", "to", "Pfizer", "for", "the", "production", "of", "Elelyso,", "and", "Pfizer", "maintains", "the", "right", "to", "extend", "the", "supply", "period", "for", "up", "to", "two", "additional", "30-month", "periods", "subject", "to", "certain", "terms", "and", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p128_s1", "idA": "1006281_15_item1_p153_s1", "sentA": "Our drug product candidates, including taliglucerase alfa, must be manufactured in a sterile environment and in compliance with cGMPs set by the FDA and other relevant foreign regulatory authorities.", "sentB": "Our drug product candidates, as well as taliglucerase alfa, must be manufactured in a sterile environment and in compliance with cGMPs set by the FDA and other relevant foreign regulatory authorities.", "type": 2, "words": ["<tag1>", "Our", "drug", "product", "candidates,", "including", "taliglucerase", "alfa,", "must", "be", "manufactured", "in", "a", "sterile", "environment", "and", "in", "compliance", "with", "cGMPs", "set", "by", "the", "FDA", "and", "other", "relevant", "foreign", "regulatory", "authorities.", "<tag2>", "Our", "drug", "product", "candidates,", "as", "well", "as", "taliglucerase", "alfa,", "must", "be", "manufactured", "in", "a", "sterile", "environment", "and", "in", "compliance", "with", "cGMPs", "set", "by", "the", "FDA", "and", "other", "relevant", "foreign", "regulatory", "authorities.", "<tag3>"], "wordsA": ["Our", "drug", "product", "candidates,", "including", "taliglucerase", "alfa,", "must", "be", "manufactured", "in", "a", "sterile", "environment", "and", "in", "compliance", "with", "cGMPs", "set", "by", "the", "FDA", "and", "other", "relevant", "foreign", "regulatory", "authorities."], "wordsB": ["Our", "drug", "product", "candidates,", "as", "well", "as", "taliglucerase", "alfa,", "must", "be", "manufactured", "in", "a", "sterile", "environment", "and", "in", "compliance", "with", "cGMPs", "set", "by", "the", "FDA", "and", "other", "relevant", "foreign", "regulatory", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p129_s0", "idA": "1006281_15_item1_p153_s4", "sentA": "In addition, we intend to use our manufacturing space to produce all of the drug substance needed in connection with the clinical trials for our product candidates.", "sentB": "In addition, we are currently producing Fabry drug substance for our planned phase III trial as part of the process of converting our current approved manufacturing facility to an approved multi product facility, thereby introducing potentially significant operational savings.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "intend", "to", "use", "our", "manufacturing", "space", "to", "produce", "all", "of", "the", "drug", "substance", "needed", "in", "connection", "with", "the", "clinical", "trials", "for", "our", "product", "candidates.", "<tag2>", "In", "addition,", "we", "are", "currently", "producing", "Fabry", "drug", "substance", "for", "our", "planned", "phase", "III", "trial", "as", "part", "of", "the", "process", "of", "converting", "our", "current", "approved", "manufacturing", "facility", "to", "an", "approved", "multi", "product", "facility,", "thereby", "introducing", "potentially", "significant", "operational", "savings.", "<tag3>"], "wordsA": ["In", "addition,", "we", "intend", "to", "use", "our", "manufacturing", "space", "to", "produce", "all", "of", "the", "drug", "substance", "needed", "in", "connection", "with", "the", "clinical", "trials", "for", "our", "product", "candidates."], "wordsB": ["In", "addition,", "we", "are", "currently", "producing", "Fabry", "drug", "substance", "for", "our", "planned", "phase", "III", "trial", "as", "part", "of", "the", "process", "of", "converting", "our", "current", "approved", "manufacturing", "facility", "to", "an", "approved", "multi", "product", "facility,", "thereby", "introducing", "potentially", "significant", "operational", "savings."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p129_s1", "idA": "1006281_15_item1_p153_s5", "sentA": "Current capacity of our facility can serve all of our current and expected commercial and clinical needs, and may be sufficient to serve our production needs for the commercialization of PRX-102.", "sentB": "Our facility s current capacity can serve all of our current and expected commercial and clinical needs, and we believe it will be sufficient to serve our production needs for the anticipated commercialization of PRX-102.", "type": 2, "words": ["<tag1>", "Current", "capacity", "of", "our", "facility", "can", "serve", "all", "of", "our", "current", "and", "expected", "commercial", "and", "clinical", "needs,", "and", "may", "be", "sufficient", "to", "serve", "our", "production", "needs", "for", "the", "commercialization", "of", "PRX-102.", "<tag2>", "Our", "facility", "s", "current", "capacity", "can", "serve", "all", "of", "our", "current", "and", "expected", "commercial", "and", "clinical", "needs,", "and", "we", "believe", "it", "will", "be", "sufficient", "to", "serve", "our", "production", "needs", "for", "the", "anticipated", "commercialization", "of", "PRX-102.", "<tag3>"], "wordsA": ["Current", "capacity", "of", "our", "facility", "can", "serve", "all", "of", "our", "current", "and", "expected", "commercial", "and", "clinical", "needs,", "and", "may", "be", "sufficient", "to", "serve", "our", "production", "needs", "for", "the", "commercialization", "of", "PRX-102."], "wordsB": ["Our", "facility", "s", "current", "capacity", "can", "serve", "all", "of", "our", "current", "and", "expected", "commercial", "and", "clinical", "needs,", "and", "we", "believe", "it", "will", "be", "sufficient", "to", "serve", "our", "production", "needs", "for", "the", "anticipated", "commercialization", "of", "PRX-102."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p132_s0", "idA": "1006281_15_item1_p157_s0", "sentA": "We believe that the raw materials that we require throughout the manufacturing process of Elelyso and our current and potential drug product candidates are widely available from numerous suppliers and are generally considered to be generic industrial biological supplies.", "sentB": "We believe that the raw materials that we require throughout the manufacturing process of Elelyso, PRX-102 and our other current and potential drug product candidates are widely available from numerous suppliers and are generally considered to be generic industrial biological supplies.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "the", "raw", "materials", "that", "we", "require", "throughout", "the", "manufacturing", "process", "of", "Elelyso", "and", "our", "current", "and", "potential", "drug", "product", "candidates", "are", "widely", "available", "from", "numerous", "suppliers", "and", "are", "generally", "considered", "to", "be", "generic", "industrial", "biological", "supplies.", "<tag2>", "We", "believe", "that", "the", "raw", "materials", "that", "we", "require", "throughout", "the", "manufacturing", "process", "of", "Elelyso,", "PRX-102", "and", "our", "other", "current", "and", "potential", "drug", "product", "candidates", "are", "widely", "available", "from", "numerous", "suppliers", "and", "are", "generally", "considered", "to", "be", "generic", "industrial", "biological", "supplies.", "<tag3>"], "wordsA": ["We", "believe", "that", "the", "raw", "materials", "that", "we", "require", "throughout", "the", "manufacturing", "process", "of", "Elelyso", "and", "our", "current", "and", "potential", "drug", "product", "candidates", "are", "widely", "available", "from", "numerous", "suppliers", "and", "are", "generally", "considered", "to", "be", "generic", "industrial", "biological", "supplies."], "wordsB": ["We", "believe", "that", "the", "raw", "materials", "that", "we", "require", "throughout", "the", "manufacturing", "process", "of", "Elelyso,", "PRX-102", "and", "our", "other", "current", "and", "potential", "drug", "product", "candidates", "are", "widely", "available", "from", "numerous", "suppliers", "and", "are", "generally", "considered", "to", "be", "generic", "industrial", "biological", "supplies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p12_s2", "idA": "1006281_15_item1_p15_s0", "sentA": "(2) PRX-106, our oral antiTNF product candidate which is being developed as an orally-delivered anti inflammatory treatment using plant cells as a natural capsule for the expressed protein.", "sentB": "It is under development as an orally-delivered anti-inflammatory treatment using plant cells as a natural capsule for the expressed protein.", "type": 2, "words": ["<tag1>", "(2)", "PRX-106,", "our", "oral", "antiTNF", "product", "candidate", "which", "is", "being", "developed", "as", "an", "orally-delivered", "anti", "inflammatory", "treatment", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein.", "<tag2>", "It", "is", "under", "development", "as", "an", "orally-delivered", "anti-inflammatory", "treatment", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein.", "<tag3>"], "wordsA": ["(2)", "PRX-106,", "our", "oral", "antiTNF", "product", "candidate", "which", "is", "being", "developed", "as", "an", "orally-delivered", "anti", "inflammatory", "treatment", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein."], "wordsB": ["It", "is", "under", "development", "as", "an", "orally-delivered", "anti-inflammatory", "treatment", "using", "plant", "cells", "as", "a", "natural", "capsule", "for", "the", "expressed", "protein."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p137_s0", "idA": "1006281_15_item1_p160_s0", "sentA": "We specifically face competition from companies with approved treatments of Gaucher disease.", "sentB": "With respect to PRX-106, we face competition from AbbVie Inc. (Humira ), Johnson Johnson and Merck Co. (Remicade) and Pfizer and Amgen Inc. (Enbrel).", "type": 2, "words": ["<tag1>", "We", "specifically", "face", "competition", "from", "companies", "with", "approved", "treatments", "of", "Gaucher", "disease.", "<tag2>", "With", "respect", "to", "PRX-106,", "we", "face", "competition", "from", "AbbVie", "Inc.", "(Humira", "),", "Johnson", "Johnson", "and", "Merck", "Co.", "(Remicade)", "and", "Pfizer", "and", "Amgen", "Inc.", "(Enbrel).", "<tag3>"], "wordsA": ["We", "specifically", "face", "competition", "from", "companies", "with", "approved", "treatments", "of", "Gaucher", "disease."], "wordsB": ["With", "respect", "to", "PRX-106,", "we", "face", "competition", "from", "AbbVie", "Inc.", "(Humira", "),", "Johnson", "Johnson", "and", "Merck", "Co.", "(Remicade)", "and", "Pfizer", "and", "Amgen", "Inc.", "(Enbrel)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p8_s0", "idA": "1006281_15_item1_p160_s4", "sentA": "Cerdelga was approved for marketing by the FDA in August 2014 and by the European Commission in January 2015.", "sentB": "Our operations are focused on our new strategy for accelerated growth, which was implemented in January 2015.", "type": 2, "words": ["<tag1>", "Cerdelga", "was", "approved", "for", "marketing", "by", "the", "FDA", "in", "August", "2014", "and", "by", "the", "European", "Commission", "in", "January", "2015.", "<tag2>", "Our", "operations", "are", "focused", "on", "our", "new", "strategy", "for", "accelerated", "growth,", "which", "was", "implemented", "in", "January", "2015.", "<tag3>"], "wordsA": ["Cerdelga", "was", "approved", "for", "marketing", "by", "the", "FDA", "in", "August", "2014", "and", "by", "the", "European", "Commission", "in", "January", "2015."], "wordsB": ["Our", "operations", "are", "focused", "on", "our", "new", "strategy", "for", "accelerated", "growth,", "which", "was", "implemented", "in", "January", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p135_s3", "idA": "1006281_15_item1_p162_s0", "sentA": "In addition, we are aware of other clinical stage, early clinical stage and experimental drugs which are being developed for the treatment of Fabry disease by Amicus Therapeutics and other companies.", "sentB": "In addition, we are aware of other clinical stage, early clinical stage and experimental drugs which are being developed for the treatment of Fabry disease by Amicus Therapeutics, Inc. and other companies.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "are", "aware", "of", "other", "clinical", "stage,", "early", "clinical", "stage", "and", "experimental", "drugs", "which", "are", "being", "developed", "for", "the", "treatment", "of", "Fabry", "disease", "by", "Amicus", "Therapeutics", "and", "other", "companies.", "<tag2>", "In", "addition,", "we", "are", "aware", "of", "other", "clinical", "stage,", "early", "clinical", "stage", "and", "experimental", "drugs", "which", "are", "being", "developed", "for", "the", "treatment", "of", "Fabry", "disease", "by", "Amicus", "Therapeutics,", "Inc.", "and", "other", "companies.", "<tag3>"], "wordsA": ["In", "addition,", "we", "are", "aware", "of", "other", "clinical", "stage,", "early", "clinical", "stage", "and", "experimental", "drugs", "which", "are", "being", "developed", "for", "the", "treatment", "of", "Fabry", "disease", "by", "Amicus", "Therapeutics", "and", "other", "companies."], "wordsB": ["In", "addition,", "we", "are", "aware", "of", "other", "clinical", "stage,", "early", "clinical", "stage", "and", "experimental", "drugs", "which", "are", "being", "developed", "for", "the", "treatment", "of", "Fabry", "disease", "by", "Amicus", "Therapeutics,", "Inc.", "and", "other", "companies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p5_s1", "idA": "1006281_15_item1_p165_s0", "sentA": "See Risk Factors Developments by competitors may render our products or technologies obsolete or non-competitive which would have a material adverse effect on our business, results of operations and financial condition.", "sentB": "Any failure to comply with our supply commitments may subject us to substantial financial penalties which will have a material adverse effect on our business, results of operations and financial condition.", "type": 2, "words": ["<tag1>", "See", "Risk", "Factors", "Developments", "by", "competitors", "may", "render", "our", "products", "or", "technologies", "obsolete", "or", "non-competitive", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Any", "failure", "to", "comply", "with", "our", "supply", "commitments", "may", "subject", "us", "to", "substantial", "financial", "penalties", "which", "will", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition.", "<tag3>"], "wordsA": ["See", "Risk", "Factors", "Developments", "by", "competitors", "may", "render", "our", "products", "or", "technologies", "obsolete", "or", "non-competitive", "which", "would", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Any", "failure", "to", "comply", "with", "our", "supply", "commitments", "may", "subject", "us", "to", "substantial", "financial", "penalties", "which", "will", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "results", "of", "operations", "and", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p92_s0", "idA": "1006281_15_item1_p168_s2", "sentA": "Delays or terminations could result from a number of factors, including stringent enrollment criteria, slow rate of enrollment, size of patient population, having to compete with other clinical trials for eligible patients, geographical considerations and others.", "sentB": "antiTNFs are used to treat a number of indications including rheumatoid arthritis, psoriasis, crohn s disease and others.", "type": 2, "words": ["<tag1>", "Delays", "or", "terminations", "could", "result", "from", "a", "number", "of", "factors,", "including", "stringent", "enrollment", "criteria,", "slow", "rate", "of", "enrollment,", "size", "of", "patient", "population,", "having", "to", "compete", "with", "other", "clinical", "trials", "for", "eligible", "patients,", "geographical", "considerations", "and", "others.", "<tag2>", "antiTNFs", "are", "used", "to", "treat", "a", "number", "of", "indications", "including", "rheumatoid", "arthritis,", "psoriasis,", "crohn", "s", "disease", "and", "others.", "<tag3>"], "wordsA": ["Delays", "or", "terminations", "could", "result", "from", "a", "number", "of", "factors,", "including", "stringent", "enrollment", "criteria,", "slow", "rate", "of", "enrollment,", "size", "of", "patient", "population,", "having", "to", "compete", "with", "other", "clinical", "trials", "for", "eligible", "patients,", "geographical", "considerations", "and", "others."], "wordsB": ["antiTNFs", "are", "used", "to", "treat", "a", "number", "of", "indications", "including", "rheumatoid", "arthritis,", "psoriasis,", "crohn", "s", "disease", "and", "others."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p11_s1", "idA": "1006281_15_item1_p16_s0", "sentA": "(3) PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1, or DNase, under development for the treatment of cystic fibrosis, to be administered by inhalation.", "sentB": "AIR DNase, our proprietary plant cell recombinant human Deoxyribonuclease 1, is under development for the treatment of cystic fibrosis (CF), to be administered by inhalation.", "type": 2, "words": ["<tag1>", "(3)", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "or", "DNase,", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation.", "<tag2>", "AIR", "DNase,", "our", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "is", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis", "(CF),", "to", "be", "administered", "by", "inhalation.", "<tag3>"], "wordsA": ["(3)", "PRX-110,", "a", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "or", "DNase,", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis,", "to", "be", "administered", "by", "inhalation."], "wordsB": ["AIR", "DNase,", "our", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "is", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis", "(CF),", "to", "be", "administered", "by", "inhalation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p12_s4", "idA": "1006281_15_item1_p16_s1", "sentA": "We expect to initiate a proof of concept efficacy study during 2015.", "sentB": "We plan to initiate a proof of concept efficacy study for the treatment of ulcerative colitis in mid-year, 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015.", "<tag2>", "We", "plan", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "for", "the", "treatment", "of", "ulcerative", "colitis", "in", "mid-year,", "2016.", "<tag3>"], "wordsA": ["We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015."], "wordsB": ["We", "plan", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "for", "the", "treatment", "of", "ulcerative", "colitis", "in", "mid-year,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p89_s1", "idA": "1006281_15_item1_p16_s1", "sentA": "We expect to initiate a proof of concept efficacy study during 2015.", "sentB": "We anticipate commencing a proof of concept study in mid-2016 which we expect to include 15 to 20 CF patients.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015.", "<tag2>", "We", "anticipate", "commencing", "a", "proof", "of", "concept", "study", "in", "mid-2016", "which", "we", "expect", "to", "include", "15", "to", "20", "CF", "patients.", "<tag3>"], "wordsA": ["We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015."], "wordsB": ["We", "anticipate", "commencing", "a", "proof", "of", "concept", "study", "in", "mid-2016", "which", "we", "expect", "to", "include", "15", "to", "20", "CF", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p98_s0", "idA": "1006281_15_item1_p16_s1", "sentA": "We expect to initiate a proof of concept efficacy study during 2015.", "sentB": "We anticipate commencing a proof of concept study in mid-2016 which we expect to include 20 mild to moderate untreated ulcerative colitis patients .", "type": 2, "words": ["<tag1>", "We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015.", "<tag2>", "We", "anticipate", "commencing", "a", "proof", "of", "concept", "study", "in", "mid-2016", "which", "we", "expect", "to", "include", "20", "mild", "to", "moderate", "untreated", "ulcerative", "colitis", "patients", ".", "<tag3>"], "wordsA": ["We", "expect", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "during", "2015."], "wordsB": ["We", "anticipate", "commencing", "a", "proof", "of", "concept", "study", "in", "mid-2016", "which", "we", "expect", "to", "include", "20", "mild", "to", "moderate", "untreated", "ulcerative", "colitis", "patients", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p147_s1", "idA": "1006281_15_item1_p172_s1", "sentA": "Assuming that the clinical data support the product s safety and effectiveness for its intended use, a new drug application, or NDA, is submitted to the FDA for review.", "sentB": "Assuming that the clinical data support the product s safety and effectiveness for its intended use, a new drug application, or NDA, or a BLA is submitted to the FDA for review.", "type": 2, "words": ["<tag1>", "Assuming", "that", "the", "clinical", "data", "support", "the", "product", "s", "safety", "and", "effectiveness", "for", "its", "intended", "use,", "a", "new", "drug", "application,", "or", "NDA,", "is", "submitted", "to", "the", "FDA", "for", "review.", "<tag2>", "Assuming", "that", "the", "clinical", "data", "support", "the", "product", "s", "safety", "and", "effectiveness", "for", "its", "intended", "use,", "a", "new", "drug", "application,", "or", "NDA,", "or", "a", "BLA", "is", "submitted", "to", "the", "FDA", "for", "review.", "<tag3>"], "wordsA": ["Assuming", "that", "the", "clinical", "data", "support", "the", "product", "s", "safety", "and", "effectiveness", "for", "its", "intended", "use,", "a", "new", "drug", "application,", "or", "NDA,", "is", "submitted", "to", "the", "FDA", "for", "review."], "wordsB": ["Assuming", "that", "the", "clinical", "data", "support", "the", "product", "s", "safety", "and", "effectiveness", "for", "its", "intended", "use,", "a", "new", "drug", "application,", "or", "NDA,", "or", "a", "BLA", "is", "submitted", "to", "the", "FDA", "for", "review."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p151_s1", "idA": "1006281_15_item1_p176_s1", "sentA": "For a fast track product, the FDA may consider for review on a rolling basis sections of the NDA before the complete application is submitted, if the sponsor provides a schedule for the submission of the sections of the NDA, the FDA agrees to accept sections of the NDA as they become available and determines that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the NDA.", "sentB": "For a fast track product, the FDA may consider for review on a rolling basis sections of the NDA or BLA before the complete application is submitted, if the sponsor provides a schedule for the submission of the sections of the NDA, the FDA agrees to accept sections of the NDA or BLA as they become available and determines that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the NDA or BLA.", "type": 2, "words": ["<tag1>", "For", "a", "fast", "track", "product,", "the", "FDA", "may", "consider", "for", "review", "on", "a", "rolling", "basis", "sections", "of", "the", "NDA", "before", "the", "complete", "application", "is", "submitted,", "if", "the", "sponsor", "provides", "a", "schedule", "for", "the", "submission", "of", "the", "sections", "of", "the", "NDA,", "the", "FDA", "agrees", "to", "accept", "sections", "of", "the", "NDA", "as", "they", "become", "available", "and", "determines", "that", "the", "schedule", "is", "acceptable,", "and", "the", "sponsor", "pays", "any", "required", "user", "fees", "upon", "submission", "of", "the", "first", "section", "of", "the", "NDA.", "<tag2>", "For", "a", "fast", "track", "product,", "the", "FDA", "may", "consider", "for", "review", "on", "a", "rolling", "basis", "sections", "of", "the", "NDA", "or", "BLA", "before", "the", "complete", "application", "is", "submitted,", "if", "the", "sponsor", "provides", "a", "schedule", "for", "the", "submission", "of", "the", "sections", "of", "the", "NDA,", "the", "FDA", "agrees", "to", "accept", "sections", "of", "the", "NDA", "or", "BLA", "as", "they", "become", "available", "and", "determines", "that", "the", "schedule", "is", "acceptable,", "and", "the", "sponsor", "pays", "any", "required", "user", "fees", "upon", "submission", "of", "the", "first", "section", "of", "the", "NDA", "or", "BLA.", "<tag3>"], "wordsA": ["For", "a", "fast", "track", "product,", "the", "FDA", "may", "consider", "for", "review", "on", "a", "rolling", "basis", "sections", "of", "the", "NDA", "before", "the", "complete", "application", "is", "submitted,", "if", "the", "sponsor", "provides", "a", "schedule", "for", "the", "submission", "of", "the", "sections", "of", "the", "NDA,", "the", "FDA", "agrees", "to", "accept", "sections", "of", "the", "NDA", "as", "they", "become", "available", "and", "determines", "that", "the", "schedule", "is", "acceptable,", "and", "the", "sponsor", "pays", "any", "required", "user", "fees", "upon", "submission", "of", "the", "first", "section", "of", "the", "NDA."], "wordsB": ["For", "a", "fast", "track", "product,", "the", "FDA", "may", "consider", "for", "review", "on", "a", "rolling", "basis", "sections", "of", "the", "NDA", "or", "BLA", "before", "the", "complete", "application", "is", "submitted,", "if", "the", "sponsor", "provides", "a", "schedule", "for", "the", "submission", "of", "the", "sections", "of", "the", "NDA,", "the", "FDA", "agrees", "to", "accept", "sections", "of", "the", "NDA", "or", "BLA", "as", "they", "become", "available", "and", "determines", "that", "the", "schedule", "is", "acceptable,", "and", "the", "sponsor", "pays", "any", "required", "user", "fees", "upon", "submission", "of", "the", "first", "section", "of", "the", "NDA", "or", "BLA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p164_s0", "idA": "1006281_15_item1_p188_s0", "sentA": "Capital gains on the sale of assets are subject to capital gain tax according to the corporate tax rate in effect for the year of selling the assets.", "sentB": "Capital gains on the sale of assets are subject to capital gain tax according to the corporate tax rate in effect in the year which the assets are sold.", "type": 2, "words": ["<tag1>", "Capital", "gains", "on", "the", "sale", "of", "assets", "are", "subject", "to", "capital", "gain", "tax", "according", "to", "the", "corporate", "tax", "rate", "in", "effect", "for", "the", "year", "of", "selling", "the", "assets.", "<tag2>", "Capital", "gains", "on", "the", "sale", "of", "assets", "are", "subject", "to", "capital", "gain", "tax", "according", "to", "the", "corporate", "tax", "rate", "in", "effect", "in", "the", "year", "which", "the", "assets", "are", "sold.", "<tag3>"], "wordsA": ["Capital", "gains", "on", "the", "sale", "of", "assets", "are", "subject", "to", "capital", "gain", "tax", "according", "to", "the", "corporate", "tax", "rate", "in", "effect", "for", "the", "year", "of", "selling", "the", "assets."], "wordsB": ["Capital", "gains", "on", "the", "sale", "of", "assets", "are", "subject", "to", "capital", "gain", "tax", "according", "to", "the", "corporate", "tax", "rate", "in", "effect", "in", "the", "year", "which", "the", "assets", "are", "sold."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p82_s0", "idA": "1006281_15_item1_p189_s0", "sentA": "In addition to the corporate taxes in Israel, we are subject to a withholding tax on the U.S. revenue source portion of the payments made to us for our share of Pfizer s net profits under the Pfizer Agreement.", "sentB": "In addition to the phase III clinical trial described above, we and the FDA also agreed to a phase III head-to-head superiority trial comparing PRX-102 versus Fabrazyme.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "the", "corporate", "taxes", "in", "Israel,", "we", "are", "subject", "to", "a", "withholding", "tax", "on", "the", "U.S.", "revenue", "source", "portion", "of", "the", "payments", "made", "to", "us", "for", "our", "share", "of", "Pfizer", "s", "net", "profits", "under", "the", "Pfizer", "Agreement.", "<tag2>", "In", "addition", "to", "the", "phase", "III", "clinical", "trial", "described", "above,", "we", "and", "the", "FDA", "also", "agreed", "to", "a", "phase", "III", "head-to-head", "superiority", "trial", "comparing", "PRX-102", "versus", "Fabrazyme.", "<tag3>"], "wordsA": ["In", "addition", "to", "the", "corporate", "taxes", "in", "Israel,", "we", "are", "subject", "to", "a", "withholding", "tax", "on", "the", "U.S.", "revenue", "source", "portion", "of", "the", "payments", "made", "to", "us", "for", "our", "share", "of", "Pfizer", "s", "net", "profits", "under", "the", "Pfizer", "Agreement."], "wordsB": ["In", "addition", "to", "the", "phase", "III", "clinical", "trial", "described", "above,", "we", "and", "the", "FDA", "also", "agreed", "to", "a", "phase", "III", "head-to-head", "superiority", "trial", "comparing", "PRX-102", "versus", "Fabrazyme."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p14_s0", "idA": "1006281_15_item1_p18_s0", "sentA": "Except for the rights to commercialize taliglucerase alfa worldwide (other than Brazil and Israel), which we licensed to Pfizer, we hold the worldwide commercialization rights to all of our proprietary development candidates.", "sentB": "Except for the rights to commercialize taliglucerase alfa worldwide (other than Brazil), which we licensed to Pfizer, we hold the worldwide commercialization rights to all of our proprietary development candidates.", "type": 2, "words": ["<tag1>", "Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Brazil", "and", "Israel),", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "all", "of", "our", "proprietary", "development", "candidates.", "<tag2>", "Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Brazil),", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "all", "of", "our", "proprietary", "development", "candidates.", "<tag3>"], "wordsA": ["Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Brazil", "and", "Israel),", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "all", "of", "our", "proprietary", "development", "candidates."], "wordsB": ["Except", "for", "the", "rights", "to", "commercialize", "taliglucerase", "alfa", "worldwide", "(other", "than", "Brazil),", "which", "we", "licensed", "to", "Pfizer,", "we", "hold", "the", "worldwide", "commercialization", "rights", "to", "all", "of", "our", "proprietary", "development", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p14_s1", "idA": "1006281_15_item1_p18_s2", "sentA": "In addition, we continuously evaluate potential strategic marketing partnerships as well as collaboration programs with biotechnology and pharmaceutical companies and academic research institutes.", "sentB": "We continuously evaluate potential strategic marketing partnerships as well as collaboration programs with biotechnology and pharmaceutical companies and academic research institutes.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "continuously", "evaluate", "potential", "strategic", "marketing", "partnerships", "as", "well", "as", "collaboration", "programs", "with", "biotechnology", "and", "pharmaceutical", "companies", "and", "academic", "research", "institutes.", "<tag2>", "We", "continuously", "evaluate", "potential", "strategic", "marketing", "partnerships", "as", "well", "as", "collaboration", "programs", "with", "biotechnology", "and", "pharmaceutical", "companies", "and", "academic", "research", "institutes.", "<tag3>"], "wordsA": ["In", "addition,", "we", "continuously", "evaluate", "potential", "strategic", "marketing", "partnerships", "as", "well", "as", "collaboration", "programs", "with", "biotechnology", "and", "pharmaceutical", "companies", "and", "academic", "research", "institutes."], "wordsB": ["We", "continuously", "evaluate", "potential", "strategic", "marketing", "partnerships", "as", "well", "as", "collaboration", "programs", "with", "biotechnology", "and", "pharmaceutical", "companies", "and", "academic", "research", "institutes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p6_s1", "idA": "1006281_15_item1_p192_s1", "sentA": "If any new benefits are granted to Protalix Ltd. in the future, Protalix Ltd. will be subject to the provisions of the amended Investment Law with respect to these new benefits.", "sentB": "As part of the Stock Purchase Agreement, Pfizer agreed to a 180-day lock-up with respect to the purchased shares of common stock.", "type": 2, "words": ["<tag1>", "If", "any", "new", "benefits", "are", "granted", "to", "Protalix", "Ltd.", "in", "the", "future,", "Protalix", "Ltd.", "will", "be", "subject", "to", "the", "provisions", "of", "the", "amended", "Investment", "Law", "with", "respect", "to", "these", "new", "benefits.", "<tag2>", "As", "part", "of", "the", "Stock", "Purchase", "Agreement,", "Pfizer", "agreed", "to", "a", "180-day", "lock-up", "with", "respect", "to", "the", "purchased", "shares", "of", "common", "stock.", "<tag3>"], "wordsA": ["If", "any", "new", "benefits", "are", "granted", "to", "Protalix", "Ltd.", "in", "the", "future,", "Protalix", "Ltd.", "will", "be", "subject", "to", "the", "provisions", "of", "the", "amended", "Investment", "Law", "with", "respect", "to", "these", "new", "benefits."], "wordsB": ["As", "part", "of", "the", "Stock", "Purchase", "Agreement,", "Pfizer", "agreed", "to", "a", "180-day", "lock-up", "with", "respect", "to", "the", "purchased", "shares", "of", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p8_s1", "idA": "1006281_15_item1_p19_s1", "sentA": "The strategy centers around prioritizing existing and new pipeline candidates to focus on clinically superior products that offer a clear competitive advantage over existing treatments.", "sentB": "The strategy centers around prioritizing existing and new pipeline candidates to focus on products that offer a clear competitive advantage over existing treatments.", "type": 2, "words": ["<tag1>", "The", "strategy", "centers", "around", "prioritizing", "existing", "and", "new", "pipeline", "candidates", "to", "focus", "on", "clinically", "superior", "products", "that", "offer", "a", "clear", "competitive", "advantage", "over", "existing", "treatments.", "<tag2>", "The", "strategy", "centers", "around", "prioritizing", "existing", "and", "new", "pipeline", "candidates", "to", "focus", "on", "products", "that", "offer", "a", "clear", "competitive", "advantage", "over", "existing", "treatments.", "<tag3>"], "wordsA": ["The", "strategy", "centers", "around", "prioritizing", "existing", "and", "new", "pipeline", "candidates", "to", "focus", "on", "clinically", "superior", "products", "that", "offer", "a", "clear", "competitive", "advantage", "over", "existing", "treatments."], "wordsB": ["The", "strategy", "centers", "around", "prioritizing", "existing", "and", "new", "pipeline", "candidates", "to", "focus", "on", "products", "that", "offer", "a", "clear", "competitive", "advantage", "over", "existing", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p8_s2", "idA": "1006281_15_item1_p19_s2", "sentA": "The strategy was the culmination of two month of intensive review by our management of the company s internal resources and of the markets in which we think we can operate.", "sentB": "The strategy was the culmination of two months of intensive review by our management of the company s internal resources and of the markets in which we think we can operate.", "type": 2, "words": ["<tag1>", "The", "strategy", "was", "the", "culmination", "of", "two", "month", "of", "intensive", "review", "by", "our", "management", "of", "the", "company", "s", "internal", "resources", "and", "of", "the", "markets", "in", "which", "we", "think", "we", "can", "operate.", "<tag2>", "The", "strategy", "was", "the", "culmination", "of", "two", "months", "of", "intensive", "review", "by", "our", "management", "of", "the", "company", "s", "internal", "resources", "and", "of", "the", "markets", "in", "which", "we", "think", "we", "can", "operate.", "<tag3>"], "wordsA": ["The", "strategy", "was", "the", "culmination", "of", "two", "month", "of", "intensive", "review", "by", "our", "management", "of", "the", "company", "s", "internal", "resources", "and", "of", "the", "markets", "in", "which", "we", "think", "we", "can", "operate."], "wordsB": ["The", "strategy", "was", "the", "culmination", "of", "two", "months", "of", "intensive", "review", "by", "our", "management", "of", "the", "company", "s", "internal", "resources", "and", "of", "the", "markets", "in", "which", "we", "think", "we", "can", "operate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p8_s3", "idA": "1006281_15_item1_p19_s3", "sentA": "The following highlights the details of the strategic plan.", "sentB": "The following highlights the details of the strategic plan as it relates to our development of an innovative product pipeline using our ProCellEx protein expression system.", "type": 2, "words": ["<tag1>", "The", "following", "highlights", "the", "details", "of", "the", "strategic", "plan.", "<tag2>", "The", "following", "highlights", "the", "details", "of", "the", "strategic", "plan", "as", "it", "relates", "to", "our", "development", "of", "an", "innovative", "product", "pipeline", "using", "our", "ProCellEx", "protein", "expression", "system.", "<tag3>"], "wordsA": ["The", "following", "highlights", "the", "details", "of", "the", "strategic", "plan."], "wordsB": ["The", "following", "highlights", "the", "details", "of", "the", "strategic", "plan", "as", "it", "relates", "to", "our", "development", "of", "an", "innovative", "product", "pipeline", "using", "our", "ProCellEx", "protein", "expression", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p83_s0", "idA": "1006281_15_item1_p203_s2", "sentA": "Instead, these Approved Enterprises are required to make certain investments as specified in the Investment Law.", "sentB": "Guidance from the official FDA minutes, suggests no additional non-clinical studies are required to support a BLA for PRX-102.", "type": 2, "words": ["<tag1>", "Instead,", "these", "Approved", "Enterprises", "are", "required", "to", "make", "certain", "investments", "as", "specified", "in", "the", "Investment", "Law.", "<tag2>", "Guidance", "from", "the", "official", "FDA", "minutes,", "suggests", "no", "additional", "non-clinical", "studies", "are", "required", "to", "support", "a", "BLA", "for", "PRX-102.", "<tag3>"], "wordsA": ["Instead,", "these", "Approved", "Enterprises", "are", "required", "to", "make", "certain", "investments", "as", "specified", "in", "the", "Investment", "Law."], "wordsB": ["Guidance", "from", "the", "official", "FDA", "minutes,", "suggests", "no", "additional", "non-clinical", "studies", "are", "required", "to", "support", "a", "BLA", "for", "PRX-102."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p183_s0", "idA": "1006281_15_item1_p208_s0", "sentA": "To date, Protalix Ltd. has received grants from the OCS for the financing of a portion of its research and development expenditures in Israel.", "sentB": "To date, Protalix Ltd. has received grants from the Office of the Chief Scientist of Israel s Ministry of Industry, Trade and Labor, or the OCS, for the financing of a portion of its research and development expenditures in Israel.", "type": 2, "words": ["<tag1>", "To", "date,", "Protalix", "Ltd.", "has", "received", "grants", "from", "the", "OCS", "for", "the", "financing", "of", "a", "portion", "of", "its", "research", "and", "development", "expenditures", "in", "Israel.", "<tag2>", "To", "date,", "Protalix", "Ltd.", "has", "received", "grants", "from", "the", "Office", "of", "the", "Chief", "Scientist", "of", "Israel", "s", "Ministry", "of", "Industry,", "Trade", "and", "Labor,", "or", "the", "OCS,", "for", "the", "financing", "of", "a", "portion", "of", "its", "research", "and", "development", "expenditures", "in", "Israel.", "<tag3>"], "wordsA": ["To", "date,", "Protalix", "Ltd.", "has", "received", "grants", "from", "the", "OCS", "for", "the", "financing", "of", "a", "portion", "of", "its", "research", "and", "development", "expenditures", "in", "Israel."], "wordsB": ["To", "date,", "Protalix", "Ltd.", "has", "received", "grants", "from", "the", "Office", "of", "the", "Chief", "Scientist", "of", "Israel", "s", "Ministry", "of", "Industry,", "Trade", "and", "Labor,", "or", "the", "OCS,", "for", "the", "financing", "of", "a", "portion", "of", "its", "research", "and", "development", "expenditures", "in", "Israel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p9_s1", "idA": "1006281_15_item1_p20_s1", "sentA": "PRX-102 is designed to be an improved enzyme replacement therapy product for the treatment of Fabry disease given its potential for clinically superior outcomes and enhanced safety when compared to currently marketed enzyme replacement therapies.", "sentB": "PRX-102, or alpha-GAL-A, is designed to be an improved enzyme replacement therapy product for the treatment of Fabry disease given its potential for clinically superior outcomes and enhanced safety when compared to currently marketed enzyme replacement therapies.", "type": 2, "words": ["<tag1>", "PRX-102", "is", "designed", "to", "be", "an", "improved", "enzyme", "replacement", "therapy", "product", "for", "the", "treatment", "of", "Fabry", "disease", "given", "its", "potential", "for", "clinically", "superior", "outcomes", "and", "enhanced", "safety", "when", "compared", "to", "currently", "marketed", "enzyme", "replacement", "therapies.", "<tag2>", "PRX-102,", "or", "alpha-GAL-A,", "is", "designed", "to", "be", "an", "improved", "enzyme", "replacement", "therapy", "product", "for", "the", "treatment", "of", "Fabry", "disease", "given", "its", "potential", "for", "clinically", "superior", "outcomes", "and", "enhanced", "safety", "when", "compared", "to", "currently", "marketed", "enzyme", "replacement", "therapies.", "<tag3>"], "wordsA": ["PRX-102", "is", "designed", "to", "be", "an", "improved", "enzyme", "replacement", "therapy", "product", "for", "the", "treatment", "of", "Fabry", "disease", "given", "its", "potential", "for", "clinically", "superior", "outcomes", "and", "enhanced", "safety", "when", "compared", "to", "currently", "marketed", "enzyme", "replacement", "therapies."], "wordsB": ["PRX-102,", "or", "alpha-GAL-A,", "is", "designed", "to", "be", "an", "improved", "enzyme", "replacement", "therapy", "product", "for", "the", "treatment", "of", "Fabry", "disease", "given", "its", "potential", "for", "clinically", "superior", "outcomes", "and", "enhanced", "safety", "when", "compared", "to", "currently", "marketed", "enzyme", "replacement", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p10_s0", "idA": "1006281_15_item1_p20_s2", "sentA": "The product candidate remains a key focus for our company, and we intend to aggressively push PRX-102 through clinical development.", "sentB": "The product candidate is a key focus for our company.", "type": 2, "words": ["<tag1>", "The", "product", "candidate", "remains", "a", "key", "focus", "for", "our", "company,", "and", "we", "intend", "to", "aggressively", "push", "PRX-102", "through", "clinical", "development.", "<tag2>", "The", "product", "candidate", "is", "a", "key", "focus", "for", "our", "company.", "<tag3>"], "wordsA": ["The", "product", "candidate", "remains", "a", "key", "focus", "for", "our", "company,", "and", "we", "intend", "to", "aggressively", "push", "PRX-102", "through", "clinical", "development."], "wordsB": ["The", "product", "candidate", "is", "a", "key", "focus", "for", "our", "company."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p10_s2", "idA": "1006281_15_item1_p20_s2", "sentA": "The product candidate remains a key focus for our company, and we intend to aggressively push PRX-102 through clinical development.", "sentB": "We have applied to the FDA for a special protocol assessment (SPA) in connection with our proposed protocol for the trial, and we intend to aggressively push PRX-102 through the anticipated phase III clinical trials.", "type": 2, "words": ["<tag1>", "The", "product", "candidate", "remains", "a", "key", "focus", "for", "our", "company,", "and", "we", "intend", "to", "aggressively", "push", "PRX-102", "through", "clinical", "development.", "<tag2>", "We", "have", "applied", "to", "the", "FDA", "for", "a", "special", "protocol", "assessment", "(SPA)", "in", "connection", "with", "our", "proposed", "protocol", "for", "the", "trial,", "and", "we", "intend", "to", "aggressively", "push", "PRX-102", "through", "the", "anticipated", "phase", "III", "clinical", "trials.", "<tag3>"], "wordsA": ["The", "product", "candidate", "remains", "a", "key", "focus", "for", "our", "company,", "and", "we", "intend", "to", "aggressively", "push", "PRX-102", "through", "clinical", "development."], "wordsB": ["We", "have", "applied", "to", "the", "FDA", "for", "a", "special", "protocol", "assessment", "(SPA)", "in", "connection", "with", "our", "proposed", "protocol", "for", "the", "trial,", "and", "we", "intend", "to", "aggressively", "push", "PRX-102", "through", "the", "anticipated", "phase", "III", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p3_s2", "idA": "1006281_15_item1_p215_s0", "sentA": "in the event of an exchange of know-how such that in exchange for the transfer of know-how outside of Israel, the recipient of the know-how transfers other know-how to the company in Israel in a manner in which the OCS is convinced that the Israeli economy realizes a greater, overall benefit from the exchange of know-how.", "sentB": "Pursuant to the Amended Pfizer Agreement, we sold to Pfizer our share in the collaboration created under the initial Pfizer Agreement for the commercialization of Elelyso in exchange for a cash payment equal to $36.0 million.", "type": 2, "words": ["<tag1>", "in", "the", "event", "of", "an", "exchange", "of", "know-how", "such", "that", "in", "exchange", "for", "the", "transfer", "of", "know-how", "outside", "of", "Israel,", "the", "recipient", "of", "the", "know-how", "transfers", "other", "know-how", "to", "the", "company", "in", "Israel", "in", "a", "manner", "in", "which", "the", "OCS", "is", "convinced", "that", "the", "Israeli", "economy", "realizes", "a", "greater,", "overall", "benefit", "from", "the", "exchange", "of", "know-how.", "<tag2>", "Pursuant", "to", "the", "Amended", "Pfizer", "Agreement,", "we", "sold", "to", "Pfizer", "our", "share", "in", "the", "collaboration", "created", "under", "the", "initial", "Pfizer", "Agreement", "for", "the", "commercialization", "of", "Elelyso", "in", "exchange", "for", "a", "cash", "payment", "equal", "to", "$36.0", "million.", "<tag3>"], "wordsA": ["in", "the", "event", "of", "an", "exchange", "of", "know-how", "such", "that", "in", "exchange", "for", "the", "transfer", "of", "know-how", "outside", "of", "Israel,", "the", "recipient", "of", "the", "know-how", "transfers", "other", "know-how", "to", "the", "company", "in", "Israel", "in", "a", "manner", "in", "which", "the", "OCS", "is", "convinced", "that", "the", "Israeli", "economy", "realizes", "a", "greater,", "overall", "benefit", "from", "the", "exchange", "of", "know-how."], "wordsB": ["Pursuant", "to", "the", "Amended", "Pfizer", "Agreement,", "we", "sold", "to", "Pfizer", "our", "share", "in", "the", "collaboration", "created", "under", "the", "initial", "Pfizer", "Agreement", "for", "the", "commercialization", "of", "Elelyso", "in", "exchange", "for", "a", "cash", "payment", "equal", "to", "$36.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p163_s0", "idA": "1006281_15_item1_p219_s0", "sentA": "We believe that Protalix Ltd. currently qualifies as an Industrial Company within the meaning of the Law for the Encouragement of Industry (Taxes), 1969, or the Industry Encouragement Law.", "sentB": "In January 2016, the Law for the Amendment of the Income Tax Ordinance (No. 216) was published, enacting a reduction of corporate tax rate beginning in 2016 and thereafter, from 26.5% to 25%.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "Protalix", "Ltd.", "currently", "qualifies", "as", "an", "Industrial", "Company", "within", "the", "meaning", "of", "the", "Law", "for", "the", "Encouragement", "of", "Industry", "(Taxes),", "1969,", "or", "the", "Industry", "Encouragement", "Law.", "<tag2>", "In", "January", "2016,", "the", "Law", "for", "the", "Amendment", "of", "the", "Income", "Tax", "Ordinance", "(No.", "216)", "was", "published,", "enacting", "a", "reduction", "of", "corporate", "tax", "rate", "beginning", "in", "2016", "and", "thereafter,", "from", "26.5%", "to", "25%.", "<tag3>"], "wordsA": ["We", "believe", "that", "Protalix", "Ltd.", "currently", "qualifies", "as", "an", "Industrial", "Company", "within", "the", "meaning", "of", "the", "Law", "for", "the", "Encouragement", "of", "Industry", "(Taxes),", "1969,", "or", "the", "Industry", "Encouragement", "Law."], "wordsB": ["In", "January", "2016,", "the", "Law", "for", "the", "Amendment", "of", "the", "Income", "Tax", "Ordinance", "(No.", "216)", "was", "published,", "enacting", "a", "reduction", "of", "corporate", "tax", "rate", "beginning", "in", "2016", "and", "thereafter,", "from", "26.5%", "to", "25%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p12_s0", "idA": "1006281_15_item1_p21_s0", "sentA": "Oral Anti-TNF (PRX-106) Anti Inflammatory .", "sentB": "Oral Anti-TNF (OPRX-106) Anti Inflammatory .", "type": 2, "words": ["<tag1>", "Oral", "Anti-TNF", "(PRX-106)", "Anti", "Inflammatory", ".", "<tag2>", "Oral", "Anti-TNF", "(OPRX-106)", "Anti", "Inflammatory", ".", "<tag3>"], "wordsA": ["Oral", "Anti-TNF", "(PRX-106)", "Anti", "Inflammatory", "."], "wordsB": ["Oral", "Anti-TNF", "(OPRX-106)", "Anti", "Inflammatory", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p200_s0", "idA": "1006281_15_item1_p225_s0", "sentA": "As of December 31, 2014, we had 234 employees, of whom 32 have a Ph.D. or an M.D.in their respective scientific fields.", "sentB": "As of December 31, 2015, we had 223 employees, of whom 29 have a Ph.D. or an M.D.in their respective scientific fields.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2014,", "we", "had", "234", "employees,", "of", "whom", "32", "have", "a", "Ph.D.", "or", "an", "M.D.in", "their", "respective", "scientific", "fields.", "<tag2>", "As", "of", "December", "31,", "2015,", "we", "had", "223", "employees,", "of", "whom", "29", "have", "a", "Ph.D.", "or", "an", "M.D.in", "their", "respective", "scientific", "fields.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2014,", "we", "had", "234", "employees,", "of", "whom", "32", "have", "a", "Ph.D.", "or", "an", "M.D.in", "their", "respective", "scientific", "fields."], "wordsB": ["As", "of", "December", "31,", "2015,", "we", "had", "223", "employees,", "of", "whom", "29", "have", "a", "Ph.D.", "or", "an", "M.D.in", "their", "respective", "scientific", "fields."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p11_s0", "idA": "1006281_15_item1_p22_s0", "sentA": "AIR DNase (PRX-110) for Cystic Fibrosis .", "sentB": "AIR DNase TM (PRX-110) for Cystic Fibrosis .", "type": 2, "words": ["<tag1>", "AIR", "DNase", "(PRX-110)", "for", "Cystic", "Fibrosis", ".", "<tag2>", "AIR", "DNase", "TM", "(PRX-110)", "for", "Cystic", "Fibrosis", ".", "<tag3>"], "wordsA": ["AIR", "DNase", "(PRX-110)", "for", "Cystic", "Fibrosis", "."], "wordsB": ["AIR", "DNase", "TM", "(PRX-110)", "for", "Cystic", "Fibrosis", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p11_s3", "idA": "1006281_15_item1_p22_s2", "sentA": "The product candidate has demonstrated improved disease parameters in animal models and human sputum testing when compared to the currently marketed product.", "sentB": "It has demonstrated improved disease parameters in animal models and human sputum testing when compared to the currently marketed product.", "type": 2, "words": ["<tag1>", "The", "product", "candidate", "has", "demonstrated", "improved", "disease", "parameters", "in", "animal", "models", "and", "human", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product.", "<tag2>", "It", "has", "demonstrated", "improved", "disease", "parameters", "in", "animal", "models", "and", "human", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product.", "<tag3>"], "wordsA": ["The", "product", "candidate", "has", "demonstrated", "improved", "disease", "parameters", "in", "animal", "models", "and", "human", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product."], "wordsB": ["It", "has", "demonstrated", "improved", "disease", "parameters", "in", "animal", "models", "and", "human", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p88_s1", "idA": "1006281_15_item1_p22_s2", "sentA": "The product candidate has demonstrated improved disease parameters in animal models and human sputum testing when compared to the currently marketed product.", "sentB": "In particular, AIR DNase has demonstrated a reduction in mucus viscosity in human sputum sample when compared to the currently marketed product.", "type": 2, "words": ["<tag1>", "The", "product", "candidate", "has", "demonstrated", "improved", "disease", "parameters", "in", "animal", "models", "and", "human", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product.", "<tag2>", "In", "particular,", "AIR", "DNase", "has", "demonstrated", "a", "reduction", "in", "mucus", "viscosity", "in", "human", "sputum", "sample", "when", "compared", "to", "the", "currently", "marketed", "product.", "<tag3>"], "wordsA": ["The", "product", "candidate", "has", "demonstrated", "improved", "disease", "parameters", "in", "animal", "models", "and", "human", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product."], "wordsB": ["In", "particular,", "AIR", "DNase", "has", "demonstrated", "a", "reduction", "in", "mucus", "viscosity", "in", "human", "sputum", "sample", "when", "compared", "to", "the", "currently", "marketed", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p76_s3", "idA": "1006281_15_item1_p27_s0", "sentA": "Recombinant proteins have revolutionized the treatment of a variety of diseases and disorders.", "sentB": "In addition, Fabry patients of the 0.2mg/kg cohort of the PRX-102 trial showed a continuous reduction and durable improvement in Mainz Severity Score Index (MSSI), a tool for disease status evaluation of a variety of signs and symptoms of Fabry disease including cardiovascular, renal and neurological.", "type": 2, "words": ["<tag1>", "Recombinant", "proteins", "have", "revolutionized", "the", "treatment", "of", "a", "variety", "of", "diseases", "and", "disorders.", "<tag2>", "In", "addition,", "Fabry", "patients", "of", "the", "0.2mg/kg", "cohort", "of", "the", "PRX-102", "trial", "showed", "a", "continuous", "reduction", "and", "durable", "improvement", "in", "Mainz", "Severity", "Score", "Index", "(MSSI),", "a", "tool", "for", "disease", "status", "evaluation", "of", "a", "variety", "of", "signs", "and", "symptoms", "of", "Fabry", "disease", "including", "cardiovascular,", "renal", "and", "neurological.", "<tag3>"], "wordsA": ["Recombinant", "proteins", "have", "revolutionized", "the", "treatment", "of", "a", "variety", "of", "diseases", "and", "disorders."], "wordsB": ["In", "addition,", "Fabry", "patients", "of", "the", "0.2mg/kg", "cohort", "of", "the", "PRX-102", "trial", "showed", "a", "continuous", "reduction", "and", "durable", "improvement", "in", "Mainz", "Severity", "Score", "Index", "(MSSI),", "a", "tool", "for", "disease", "status", "evaluation", "of", "a", "variety", "of", "signs", "and", "symptoms", "of", "Fabry", "disease", "including", "cardiovascular,", "renal", "and", "neurological."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p91_s1", "idA": "1006281_15_item1_p29_s1", "sentA": "Mammalian cell-based systems were first introduced in the late 1980s and are currently used to produce many of the biotechnology industry s largest and most successful therapeutic proteins, including Epogen , Neupogen , Cerezyme , Rituxan , Humira , Enbrel , Neulasta , Remicade and Herceptin .", "sentB": "Well-known antiTNF drugs include Humira , Remicade and Enbrel .", "type": 2, "words": ["<tag1>", "Mammalian", "cell-based", "systems", "were", "first", "introduced", "in", "the", "late", "1980s", "and", "are", "currently", "used", "to", "produce", "many", "of", "the", "biotechnology", "industry", "s", "largest", "and", "most", "successful", "therapeutic", "proteins,", "including", "Epogen", ",", "Neupogen", ",", "Cerezyme", ",", "Rituxan", ",", "Humira", ",", "Enbrel", ",", "Neulasta", ",", "Remicade", "and", "Herceptin", ".", "<tag2>", "Well-known", "antiTNF", "drugs", "include", "Humira", ",", "Remicade", "and", "Enbrel", ".", "<tag3>"], "wordsA": ["Mammalian", "cell-based", "systems", "were", "first", "introduced", "in", "the", "late", "1980s", "and", "are", "currently", "used", "to", "produce", "many", "of", "the", "biotechnology", "industry", "s", "largest", "and", "most", "successful", "therapeutic", "proteins,", "including", "Epogen", ",", "Neupogen", ",", "Cerezyme", ",", "Rituxan", ",", "Humira", ",", "Enbrel", ",", "Neulasta", ",", "Remicade", "and", "Herceptin", "."], "wordsB": ["Well-known", "antiTNF", "drugs", "include", "Humira", ",", "Remicade", "and", "Enbrel", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p2_s0", "idA": "1006281_15_item1_p2_s0", "sentA": "On May 1, 2012, the U.S. Food and Drug Administration, or the FDA, approved for sale our first commercial product, taliglucerase alfa for injection, which is being marketed in the United States and Israel under the brand name Elelyso, as an enzyme replacement therapy, or ERT, for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "sentB": "On May 1, 2012, the U.S. Food and Drug Administration, or the FDA, approved for sale our first commercial product, taliglucerase alfa for injection, an enzyme replacement therapy, or ERT, for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "type": 2, "words": ["<tag1>", "On", "May", "1,", "2012,", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "Elelyso,", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag2>", "On", "May", "1,", "2012,", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag3>"], "wordsA": ["On", "May", "1,", "2012,", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "which", "is", "being", "marketed", "in", "the", "United", "States", "and", "Israel", "under", "the", "brand", "name", "Elelyso,", "as", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "wordsB": ["On", "May", "1,", "2012,", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p22_s0", "idA": "1006281_15_item1_p33_s1", "sentA": "CHO cells and other mammalian cells are highly sensitive and can only be grown under near perfect conditions, requiring highly complex, expensive, stainless steel bioreactors which tightly regulate the required temperature, pH and oxygen levels.", "sentB": "CHO (Chinese Hamster Ovary) cells and other mammalian cells are highly sensitive and can only be grown under near perfect conditions, requiring highly complex, expensive, stainless steel bioreactors which tightly regulate the required temperature, pH and oxygen levels.", "type": 2, "words": ["<tag1>", "CHO", "cells", "and", "other", "mammalian", "cells", "are", "highly", "sensitive", "and", "can", "only", "be", "grown", "under", "near", "perfect", "conditions,", "requiring", "highly", "complex,", "expensive,", "stainless", "steel", "bioreactors", "which", "tightly", "regulate", "the", "required", "temperature,", "pH", "and", "oxygen", "levels.", "<tag2>", "CHO", "(Chinese", "Hamster", "Ovary)", "cells", "and", "other", "mammalian", "cells", "are", "highly", "sensitive", "and", "can", "only", "be", "grown", "under", "near", "perfect", "conditions,", "requiring", "highly", "complex,", "expensive,", "stainless", "steel", "bioreactors", "which", "tightly", "regulate", "the", "required", "temperature,", "pH", "and", "oxygen", "levels.", "<tag3>"], "wordsA": ["CHO", "cells", "and", "other", "mammalian", "cells", "are", "highly", "sensitive", "and", "can", "only", "be", "grown", "under", "near", "perfect", "conditions,", "requiring", "highly", "complex,", "expensive,", "stainless", "steel", "bioreactors", "which", "tightly", "regulate", "the", "required", "temperature,", "pH", "and", "oxygen", "levels."], "wordsB": ["CHO", "(Chinese", "Hamster", "Ovary)", "cells", "and", "other", "mammalian", "cells", "are", "highly", "sensitive", "and", "can", "only", "be", "grown", "under", "near", "perfect", "conditions,", "requiring", "highly", "complex,", "expensive,", "stainless", "steel", "bioreactors", "which", "tightly", "regulate", "the", "required", "temperature,", "pH", "and", "oxygen", "levels."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p2_s2", "idA": "1006281_15_item1_p3_s0", "sentA": "Taliglucerase alfa is being marketed under the name Uplyso TM in Brazil and certain other Latin American countries.", "sentB": "Taliglucerase alfa is being marketed under the name Uplyso TM in Brazil and certain other Latin American countries, and as Elelyso in all other territories.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries.", "<tag2>", "Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "and", "as", "Elelyso", "in", "all", "other", "territories.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries."], "wordsB": ["Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "and", "as", "Elelyso", "in", "all", "other", "territories."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p39_s3", "idA": "1006281_15_item1_p42_s1", "sentA": "Moreover, we expect to enjoy method-based patent protection for the proteins we develop using our proprietary ProCellEx protein expression technology, although there can be no assurance that any such patents will be granted.", "sentB": "Moreover, we expect to enjoy method-based patent protection for the proteins we develop using ProCellEx, although there can be no assurance that any such patents will be granted.", "type": 2, "words": ["<tag1>", "Moreover,", "we", "expect", "to", "enjoy", "method-based", "patent", "protection", "for", "the", "proteins", "we", "develop", "using", "our", "proprietary", "ProCellEx", "protein", "expression", "technology,", "although", "there", "can", "be", "no", "assurance", "that", "any", "such", "patents", "will", "be", "granted.", "<tag2>", "Moreover,", "we", "expect", "to", "enjoy", "method-based", "patent", "protection", "for", "the", "proteins", "we", "develop", "using", "ProCellEx,", "although", "there", "can", "be", "no", "assurance", "that", "any", "such", "patents", "will", "be", "granted.", "<tag3>"], "wordsA": ["Moreover,", "we", "expect", "to", "enjoy", "method-based", "patent", "protection", "for", "the", "proteins", "we", "develop", "using", "our", "proprietary", "ProCellEx", "protein", "expression", "technology,", "although", "there", "can", "be", "no", "assurance", "that", "any", "such", "patents", "will", "be", "granted."], "wordsB": ["Moreover,", "we", "expect", "to", "enjoy", "method-based", "patent", "protection", "for", "the", "proteins", "we", "develop", "using", "ProCellEx,", "although", "there", "can", "be", "no", "assurance", "that", "any", "such", "patents", "will", "be", "granted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p32_s0", "idA": "1006281_15_item1_p43_s0", "sentA": "We have successfully demonstrated the feasibility of our ProCellEx system through: the FDA s approval of taliglucerase alfa; the clinical and preclinical studies we have performed to date, including the positive efficacy and safety data in our clinical trials for both Elelyso and PRX102 for the treatment of Fabry disease; preclinical results in well-known models in our enzyme for each of Fabry disease, DNase and antiTNF; and by expressing, on an exploratory, research scale, many additional complex therapeutic proteins belonging to different drug classes, such as enzymes, hormones, monoclonal antibodies, cytokines and vaccines.", "sentB": "We have successfully demonstrated the feasibility of our ProCellEx system through: the FDA s approval of taliglucerase alfa, and its subsequent approval by other regulatory authorities; the clinical and preclinical studies we have performed to date, including the positive efficacy and safety data in our clinical trials for both Elelyso and PRX-102 for the treatment of Fabry disease; preclinical results in well-known models in our enzyme for each of Fabry disease, DNase and antiTNF; and by expressing, on an exploratory, research scale, many additional complex therapeutic proteins belonging to different drug classes, such as enzymes, hormones, monoclonal antibodies, cytokines and vaccines.", "type": 2, "words": ["<tag1>", "We", "have", "successfully", "demonstrated", "the", "feasibility", "of", "our", "ProCellEx", "system", "through:", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa;", "the", "clinical", "and", "preclinical", "studies", "we", "have", "performed", "to", "date,", "including", "the", "positive", "efficacy", "and", "safety", "data", "in", "our", "clinical", "trials", "for", "both", "Elelyso", "and", "PRX102", "for", "the", "treatment", "of", "Fabry", "disease;", "preclinical", "results", "in", "well-known", "models", "in", "our", "enzyme", "for", "each", "of", "Fabry", "disease,", "DNase", "and", "antiTNF;", "and", "by", "expressing,", "on", "an", "exploratory,", "research", "scale,", "many", "additional", "complex", "therapeutic", "proteins", "belonging", "to", "different", "drug", "classes,", "such", "as", "enzymes,", "hormones,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines.", "<tag2>", "We", "have", "successfully", "demonstrated", "the", "feasibility", "of", "our", "ProCellEx", "system", "through:", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa,", "and", "its", "subsequent", "approval", "by", "other", "regulatory", "authorities;", "the", "clinical", "and", "preclinical", "studies", "we", "have", "performed", "to", "date,", "including", "the", "positive", "efficacy", "and", "safety", "data", "in", "our", "clinical", "trials", "for", "both", "Elelyso", "and", "PRX-102", "for", "the", "treatment", "of", "Fabry", "disease;", "preclinical", "results", "in", "well-known", "models", "in", "our", "enzyme", "for", "each", "of", "Fabry", "disease,", "DNase", "and", "antiTNF;", "and", "by", "expressing,", "on", "an", "exploratory,", "research", "scale,", "many", "additional", "complex", "therapeutic", "proteins", "belonging", "to", "different", "drug", "classes,", "such", "as", "enzymes,", "hormones,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines.", "<tag3>"], "wordsA": ["We", "have", "successfully", "demonstrated", "the", "feasibility", "of", "our", "ProCellEx", "system", "through:", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa;", "the", "clinical", "and", "preclinical", "studies", "we", "have", "performed", "to", "date,", "including", "the", "positive", "efficacy", "and", "safety", "data", "in", "our", "clinical", "trials", "for", "both", "Elelyso", "and", "PRX102", "for", "the", "treatment", "of", "Fabry", "disease;", "preclinical", "results", "in", "well-known", "models", "in", "our", "enzyme", "for", "each", "of", "Fabry", "disease,", "DNase", "and", "antiTNF;", "and", "by", "expressing,", "on", "an", "exploratory,", "research", "scale,", "many", "additional", "complex", "therapeutic", "proteins", "belonging", "to", "different", "drug", "classes,", "such", "as", "enzymes,", "hormones,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines."], "wordsB": ["We", "have", "successfully", "demonstrated", "the", "feasibility", "of", "our", "ProCellEx", "system", "through:", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa,", "and", "its", "subsequent", "approval", "by", "other", "regulatory", "authorities;", "the", "clinical", "and", "preclinical", "studies", "we", "have", "performed", "to", "date,", "including", "the", "positive", "efficacy", "and", "safety", "data", "in", "our", "clinical", "trials", "for", "both", "Elelyso", "and", "PRX-102", "for", "the", "treatment", "of", "Fabry", "disease;", "preclinical", "results", "in", "well-known", "models", "in", "our", "enzyme", "for", "each", "of", "Fabry", "disease,", "DNase", "and", "antiTNF;", "and", "by", "expressing,", "on", "an", "exploratory,", "research", "scale,", "many", "additional", "complex", "therapeutic", "proteins", "belonging", "to", "different", "drug", "classes,", "such", "as", "enzymes,", "hormones,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p79_s1", "idA": "1006281_15_item1_p43_s3", "sentA": "We believe that the FDA s approval of taliglucerase alfa represents a strong proof-of-concept of our ProCellEx system and plant cell-based protein expression technology.", "sentB": "Official FDA meeting minutes indicate the FDA s acceptance of our path forward for a phase III clinical trial to support a full BLA approval.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa", "represents", "a", "strong", "proof-of-concept", "of", "our", "ProCellEx", "system", "and", "plant", "cell-based", "protein", "expression", "technology.", "<tag2>", "Official", "FDA", "meeting", "minutes", "indicate", "the", "FDA", "s", "acceptance", "of", "our", "path", "forward", "for", "a", "phase", "III", "clinical", "trial", "to", "support", "a", "full", "BLA", "approval.", "<tag3>"], "wordsA": ["We", "believe", "that", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa", "represents", "a", "strong", "proof-of-concept", "of", "our", "ProCellEx", "system", "and", "plant", "cell-based", "protein", "expression", "technology."], "wordsB": ["Official", "FDA", "meeting", "minutes", "indicate", "the", "FDA", "s", "acceptance", "of", "our", "path", "forward", "for", "a", "phase", "III", "clinical", "trial", "to", "support", "a", "full", "BLA", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p34_s3", "idA": "1006281_15_item1_p45_s3", "sentA": "To date we have completed successful preclinical animal studies for oral GCD and oral antiTNF, and in early clinical trials of oral GCD in Gaucher patients.", "sentB": "To date we have completed successful preclinical animal studies for oral GCD and oral antiTNF, and early clinical trials of oral GCD in Gaucher patients and oral antiTNF in a phase I clinical trial in healthy volunteers.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "antiTNF,", "and", "in", "early", "clinical", "trials", "of", "oral", "GCD", "in", "Gaucher", "patients.", "<tag2>", "To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "antiTNF,", "and", "early", "clinical", "trials", "of", "oral", "GCD", "in", "Gaucher", "patients", "and", "oral", "antiTNF", "in", "a", "phase", "I", "clinical", "trial", "in", "healthy", "volunteers.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "antiTNF,", "and", "in", "early", "clinical", "trials", "of", "oral", "GCD", "in", "Gaucher", "patients."], "wordsB": ["To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "antiTNF,", "and", "early", "clinical", "trials", "of", "oral", "GCD", "in", "Gaucher", "patients", "and", "oral", "antiTNF", "in", "a", "phase", "I", "clinical", "trial", "in", "healthy", "volunteers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p37_s0", "idA": "1006281_15_item1_p48_s0", "sentA": "Our ProCellEx protein expression system has internal capabilities developed to improve the biologic dynamics of the expressed protein.", "sentB": "ProCellEx has internal capabilities developed to improve the biologic dynamics of an expressed protein.", "type": 2, "words": ["<tag1>", "Our", "ProCellEx", "protein", "expression", "system", "has", "internal", "capabilities", "developed", "to", "improve", "the", "biologic", "dynamics", "of", "the", "expressed", "protein.", "<tag2>", "ProCellEx", "has", "internal", "capabilities", "developed", "to", "improve", "the", "biologic", "dynamics", "of", "an", "expressed", "protein.", "<tag3>"], "wordsA": ["Our", "ProCellEx", "protein", "expression", "system", "has", "internal", "capabilities", "developed", "to", "improve", "the", "biologic", "dynamics", "of", "the", "expressed", "protein."], "wordsB": ["ProCellEx", "has", "internal", "capabilities", "developed", "to", "improve", "the", "biologic", "dynamics", "of", "an", "expressed", "protein."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p47_s3", "idA": "1006281_15_item1_p4_s0", "sentA": "In August 2014, the FDA approved Elelyso for injection for pediatric patients and the Israeli MOH approved the pediatric indication in January 2015.", "sentB": "In August 2014, the FDA approved Elelyso for injection for pediatric patients and in other jurisdictions thereafter.", "type": 2, "words": ["<tag1>", "In", "August", "2014,", "the", "FDA", "approved", "Elelyso", "for", "injection", "for", "pediatric", "patients", "and", "the", "Israeli", "MOH", "approved", "the", "pediatric", "indication", "in", "January", "2015.", "<tag2>", "In", "August", "2014,", "the", "FDA", "approved", "Elelyso", "for", "injection", "for", "pediatric", "patients", "and", "in", "other", "jurisdictions", "thereafter.", "<tag3>"], "wordsA": ["In", "August", "2014,", "the", "FDA", "approved", "Elelyso", "for", "injection", "for", "pediatric", "patients", "and", "the", "Israeli", "MOH", "approved", "the", "pediatric", "indication", "in", "January", "2015."], "wordsB": ["In", "August", "2014,", "the", "FDA", "approved", "Elelyso", "for", "injection", "for", "pediatric", "patients", "and", "in", "other", "jurisdictions", "thereafter."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p39_s5", "idA": "1006281_15_item1_p50_s5", "sentA": "We have filed for U.S. and international composition of matter patents for taliglucerase alfa, PRX-102 and certain of our other product candidates.", "sentB": "We have filed for U.S. and international composition of matter patents for PRX-102 and certain of our other product candidates.", "type": 2, "words": ["<tag1>", "We", "have", "filed", "for", "U.S.", "and", "international", "composition", "of", "matter", "patents", "for", "taliglucerase", "alfa,", "PRX-102", "and", "certain", "of", "our", "other", "product", "candidates.", "<tag2>", "We", "have", "filed", "for", "U.S.", "and", "international", "composition", "of", "matter", "patents", "for", "PRX-102", "and", "certain", "of", "our", "other", "product", "candidates.", "<tag3>"], "wordsA": ["We", "have", "filed", "for", "U.S.", "and", "international", "composition", "of", "matter", "patents", "for", "taliglucerase", "alfa,", "PRX-102", "and", "certain", "of", "our", "other", "product", "candidates."], "wordsB": ["We", "have", "filed", "for", "U.S.", "and", "international", "composition", "of", "matter", "patents", "for", "PRX-102", "and", "certain", "of", "our", "other", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p40_s0", "idA": "1006281_15_item1_p51_s0", "sentA": "Our ProCellEx protein expression system is able to produce a broad array of complex glycosilated proteins, which are difficult to produce in other systems, such as bacterial and yeast cell-based systems, as well as CHO (Chinese Hamster Ovary) systems.", "sentB": "ProCellEx is able to produce a broad array of complex glycosilated proteins, which are difficult to produce in other systems, such as bacterial and yeast cell-based systems, as well as CHO systems.", "type": 2, "words": ["<tag1>", "Our", "ProCellEx", "protein", "expression", "system", "is", "able", "to", "produce", "a", "broad", "array", "of", "complex", "glycosilated", "proteins,", "which", "are", "difficult", "to", "produce", "in", "other", "systems,", "such", "as", "bacterial", "and", "yeast", "cell-based", "systems,", "as", "well", "as", "CHO", "(Chinese", "Hamster", "Ovary)", "systems.", "<tag2>", "ProCellEx", "is", "able", "to", "produce", "a", "broad", "array", "of", "complex", "glycosilated", "proteins,", "which", "are", "difficult", "to", "produce", "in", "other", "systems,", "such", "as", "bacterial", "and", "yeast", "cell-based", "systems,", "as", "well", "as", "CHO", "systems.", "<tag3>"], "wordsA": ["Our", "ProCellEx", "protein", "expression", "system", "is", "able", "to", "produce", "a", "broad", "array", "of", "complex", "glycosilated", "proteins,", "which", "are", "difficult", "to", "produce", "in", "other", "systems,", "such", "as", "bacterial", "and", "yeast", "cell-based", "systems,", "as", "well", "as", "CHO", "(Chinese", "Hamster", "Ovary)", "systems."], "wordsB": ["ProCellEx", "is", "able", "to", "produce", "a", "broad", "array", "of", "complex", "glycosilated", "proteins,", "which", "are", "difficult", "to", "produce", "in", "other", "systems,", "such", "as", "bacterial", "and", "yeast", "cell-based", "systems,", "as", "well", "as", "CHO", "systems."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p42_s0", "idA": "1006281_15_item1_p53_s0", "sentA": "Our ProCellEx system entails a lower cost of scale-up and of production.", "sentB": "ProCellEx entails a lower cost of scale-up and of production.", "type": 2, "words": ["<tag1>", "Our", "ProCellEx", "system", "entails", "a", "lower", "cost", "of", "scale-up", "and", "of", "production.", "<tag2>", "ProCellEx", "entails", "a", "lower", "cost", "of", "scale-up", "and", "of", "production.", "<tag3>"], "wordsA": ["Our", "ProCellEx", "system", "entails", "a", "lower", "cost", "of", "scale-up", "and", "of", "production."], "wordsB": ["ProCellEx", "entails", "a", "lower", "cost", "of", "scale-up", "and", "of", "production."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p44_s5", "idA": "1006281_15_item1_p55_s5", "sentA": "These factors further reduce the risks and operating costs of our ProCellEx system compared to mammalian cell-based expression systems.", "sentB": "These factors further reduce the risks and operating costs of ProCellEx compared to mammalian cell-based expression systems.", "type": 2, "words": ["<tag1>", "These", "factors", "further", "reduce", "the", "risks", "and", "operating", "costs", "of", "our", "ProCellEx", "system", "compared", "to", "mammalian", "cell-based", "expression", "systems.", "<tag2>", "These", "factors", "further", "reduce", "the", "risks", "and", "operating", "costs", "of", "ProCellEx", "compared", "to", "mammalian", "cell-based", "expression", "systems.", "<tag3>"], "wordsA": ["These", "factors", "further", "reduce", "the", "risks", "and", "operating", "costs", "of", "our", "ProCellEx", "system", "compared", "to", "mammalian", "cell-based", "expression", "systems."], "wordsB": ["These", "factors", "further", "reduce", "the", "risks", "and", "operating", "costs", "of", "ProCellEx", "compared", "to", "mammalian", "cell-based", "expression", "systems."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p45_s1", "idA": "1006281_15_item1_p56_s1", "sentA": "We are using our ProCellEx system to produce active recombinant proteins through oral administration of plant cells expressing biotherapeutic proteins.", "sentB": "We are using ProCellEx to produce active recombinant proteins through oral administration of plant cells expressing biotherapeutic proteins.", "type": 2, "words": ["<tag1>", "We", "are", "using", "our", "ProCellEx", "system", "to", "produce", "active", "recombinant", "proteins", "through", "oral", "administration", "of", "plant", "cells", "expressing", "biotherapeutic", "proteins.", "<tag2>", "We", "are", "using", "ProCellEx", "to", "produce", "active", "recombinant", "proteins", "through", "oral", "administration", "of", "plant", "cells", "expressing", "biotherapeutic", "proteins.", "<tag3>"], "wordsA": ["We", "are", "using", "our", "ProCellEx", "system", "to", "produce", "active", "recombinant", "proteins", "through", "oral", "administration", "of", "plant", "cells", "expressing", "biotherapeutic", "proteins."], "wordsB": ["We", "are", "using", "ProCellEx", "to", "produce", "active", "recombinant", "proteins", "through", "oral", "administration", "of", "plant", "cells", "expressing", "biotherapeutic", "proteins."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p12_s6", "idA": "1006281_15_item1_p57_s2", "sentA": "If proven effective, this would be the first time an enzyme will be administered orally rather than through intravenous therapy.", "sentB": "If approved, oPRX-106 will be the first ever oral enzyme treatment.", "type": 2, "words": ["<tag1>", "If", "proven", "effective,", "this", "would", "be", "the", "first", "time", "an", "enzyme", "will", "be", "administered", "orally", "rather", "than", "through", "intravenous", "therapy.", "<tag2>", "If", "approved,", "oPRX-106", "will", "be", "the", "first", "ever", "oral", "enzyme", "treatment.", "<tag3>"], "wordsA": ["If", "proven", "effective,", "this", "would", "be", "the", "first", "time", "an", "enzyme", "will", "be", "administered", "orally", "rather", "than", "through", "intravenous", "therapy."], "wordsB": ["If", "approved,", "oPRX-106", "will", "be", "the", "first", "ever", "oral", "enzyme", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p2_s1", "idA": "1006281_15_item1_p58_s2", "sentA": "It was subsequently approved by the Israeli MOH, ANVISA and the regulatory authorities of other countries .", "sentB": "Subsequently, taliglucerase alfa was approved for marketing by the regulatory authorities of other countries.", "type": 2, "words": ["<tag1>", "It", "was", "subsequently", "approved", "by", "the", "Israeli", "MOH,", "ANVISA", "and", "the", "regulatory", "authorities", "of", "other", "countries", ".", "<tag2>", "Subsequently,", "taliglucerase", "alfa", "was", "approved", "for", "marketing", "by", "the", "regulatory", "authorities", "of", "other", "countries.", "<tag3>"], "wordsA": ["It", "was", "subsequently", "approved", "by", "the", "Israeli", "MOH,", "ANVISA", "and", "the", "regulatory", "authorities", "of", "other", "countries", "."], "wordsB": ["Subsequently,", "taliglucerase", "alfa", "was", "approved", "for", "marketing", "by", "the", "regulatory", "authorities", "of", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p52_s0", "idA": "1006281_15_item1_p64_s0", "sentA": "The absence of an active GCD enzyme leads to the accumulation of GlcCer in lysosomes of certain white blood cells called macrophages.", "sentB": "The GlcCer accumulates in lysosomes of certain white blood cells called macrophages which consequently become highly enlarged.", "type": 2, "words": ["<tag1>", "The", "absence", "of", "an", "active", "GCD", "enzyme", "leads", "to", "the", "accumulation", "of", "GlcCer", "in", "lysosomes", "of", "certain", "white", "blood", "cells", "called", "macrophages.", "<tag2>", "The", "GlcCer", "accumulates", "in", "lysosomes", "of", "certain", "white", "blood", "cells", "called", "macrophages", "which", "consequently", "become", "highly", "enlarged.", "<tag3>"], "wordsA": ["The", "absence", "of", "an", "active", "GCD", "enzyme", "leads", "to", "the", "accumulation", "of", "GlcCer", "in", "lysosomes", "of", "certain", "white", "blood", "cells", "called", "macrophages."], "wordsB": ["The", "GlcCer", "accumulates", "in", "lysosomes", "of", "certain", "white", "blood", "cells", "called", "macrophages", "which", "consequently", "become", "highly", "enlarged."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p52_s1", "idA": "1006281_15_item1_p64_s2", "sentA": "Gaucher cells accumulate in the spleen, liver, lungs, bone marrow and brain.", "sentB": "The enlarged cells accumulate in the spleen, liver, lungs, bone marrow and brain.", "type": 2, "words": ["<tag1>", "Gaucher", "cells", "accumulate", "in", "the", "spleen,", "liver,", "lungs,", "bone", "marrow", "and", "brain.", "<tag2>", "The", "enlarged", "cells", "accumulate", "in", "the", "spleen,", "liver,", "lungs,", "bone", "marrow", "and", "brain.", "<tag3>"], "wordsA": ["Gaucher", "cells", "accumulate", "in", "the", "spleen,", "liver,", "lungs,", "bone", "marrow", "and", "brain."], "wordsB": ["The", "enlarged", "cells", "accumulate", "in", "the", "spleen,", "liver,", "lungs,", "bone", "marrow", "and", "brain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p54_s2", "idA": "1006281_15_item1_p67_s1", "sentA": "Cerezyme and VPRIV , enzyme replacement therapies commercialized by Genzyme Corporation (acquired by Sanofi), or Genzyme, and Shire plc, or Shire, respectively, are the only recombinant GCDs currently available on the market for the treatment of Gaucher disease.", "sentB": "Cerezyme and VPRIV are the only other ERTS currently available for the treatment of Gaucher disease.", "type": 2, "words": ["<tag1>", "Cerezyme", "and", "VPRIV", ",", "enzyme", "replacement", "therapies", "commercialized", "by", "Genzyme", "Corporation", "(acquired", "by", "Sanofi),", "or", "Genzyme,", "and", "Shire", "plc,", "or", "Shire,", "respectively,", "are", "the", "only", "recombinant", "GCDs", "currently", "available", "on", "the", "market", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "Cerezyme", "and", "VPRIV", "are", "the", "only", "other", "ERTS", "currently", "available", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag3>"], "wordsA": ["Cerezyme", "and", "VPRIV", ",", "enzyme", "replacement", "therapies", "commercialized", "by", "Genzyme", "Corporation", "(acquired", "by", "Sanofi),", "or", "Genzyme,", "and", "Shire", "plc,", "or", "Shire,", "respectively,", "are", "the", "only", "recombinant", "GCDs", "currently", "available", "on", "the", "market", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["Cerezyme", "and", "VPRIV", "are", "the", "only", "other", "ERTS", "currently", "available", "for", "the", "treatment", "of", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p54_s3", "idA": "1006281_15_item1_p69_s1", "sentA": "Cerdelga was approved for marketing by the FDA in August 2014 and by the European Commission in January 2015.", "sentB": "In addition, Cerdelga (eliglustat) is a substrate reduction therapy for Gaucher disease that was approved for marketing by the FDA in August 2014 and by the European Commission in January 2015.", "type": 2, "words": ["<tag1>", "Cerdelga", "was", "approved", "for", "marketing", "by", "the", "FDA", "in", "August", "2014", "and", "by", "the", "European", "Commission", "in", "January", "2015.", "<tag2>", "In", "addition,", "Cerdelga", "(eliglustat)", "is", "a", "substrate", "reduction", "therapy", "for", "Gaucher", "disease", "that", "was", "approved", "for", "marketing", "by", "the", "FDA", "in", "August", "2014", "and", "by", "the", "European", "Commission", "in", "January", "2015.", "<tag3>"], "wordsA": ["Cerdelga", "was", "approved", "for", "marketing", "by", "the", "FDA", "in", "August", "2014", "and", "by", "the", "European", "Commission", "in", "January", "2015."], "wordsB": ["In", "addition,", "Cerdelga", "(eliglustat)", "is", "a", "substrate", "reduction", "therapy", "for", "Gaucher", "disease", "that", "was", "approved", "for", "marketing", "by", "the", "FDA", "in", "August", "2014", "and", "by", "the", "European", "Commission", "in", "January", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p3_s0", "idA": "1006281_15_item1_p6_s0", "sentA": "Since May 2012, taliglucerase alfa has been marketed in the United States by Pfizer Inc., or Pfizer, our commercialization partner, as provided in the exclusive license and supply agreement by and between Protalix Ltd., our wholly-owned subsidiary, and Pfizer, which we refer to as the Pfizer Agreement.", "sentB": "Since its approval by the FDA, taliglucerase alfa has been marketed mainly in the United States by Pfizer Inc., or Pfizer, as provided in the exclusive license and supply agreement by and between Protalix Ltd., our wholly-owned subsidiary, and Pfizer, which we refer to as the Pfizer Agreement.", "type": 2, "words": ["<tag1>", "Since", "May", "2012,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "the", "United", "States", "by", "Pfizer", "Inc.,", "or", "Pfizer,", "our", "commercialization", "partner,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement.", "<tag2>", "Since", "its", "approval", "by", "the", "FDA,", "taliglucerase", "alfa", "has", "been", "marketed", "mainly", "in", "the", "United", "States", "by", "Pfizer", "Inc.,", "or", "Pfizer,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement.", "<tag3>"], "wordsA": ["Since", "May", "2012,", "taliglucerase", "alfa", "has", "been", "marketed", "in", "the", "United", "States", "by", "Pfizer", "Inc.,", "or", "Pfizer,", "our", "commercialization", "partner,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement."], "wordsB": ["Since", "its", "approval", "by", "the", "FDA,", "taliglucerase", "alfa", "has", "been", "marketed", "mainly", "in", "the", "United", "States", "by", "Pfizer", "Inc.,", "or", "Pfizer,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p100_s1", "idA": "1006281_15_item1_p6_s1", "sentA": "We granted Pfizer an exclusive, worldwide license to develop and commercialize taliglucerase alfa under the Pfizer Agreement, but we retained those rights in Israel, and later in Brazil.", "sentB": "Notwithstanding the low purchase amounts, we are, at this time, continuing to supply Uplyso to Fiocruz under the Brazil Agreement, and patients continue to be treated with Uplyso in Brazil.", "type": 2, "words": ["<tag1>", "We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "we", "retained", "those", "rights", "in", "Israel,", "and", "later", "in", "Brazil.", "<tag2>", "Notwithstanding", "the", "low", "purchase", "amounts,", "we", "are,", "at", "this", "time,", "continuing", "to", "supply", "Uplyso", "to", "Fiocruz", "under", "the", "Brazil", "Agreement,", "and", "patients", "continue", "to", "be", "treated", "with", "Uplyso", "in", "Brazil.", "<tag3>"], "wordsA": ["We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "we", "retained", "those", "rights", "in", "Israel,", "and", "later", "in", "Brazil."], "wordsB": ["Notwithstanding", "the", "low", "purchase", "amounts,", "we", "are,", "at", "this", "time,", "continuing", "to", "supply", "Uplyso", "to", "Fiocruz", "under", "the", "Brazil", "Agreement,", "and", "patients", "continue", "to", "be", "treated", "with", "Uplyso", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p7_s2", "idA": "1006281_15_item1_p6_s1", "sentA": "We granted Pfizer an exclusive, worldwide license to develop and commercialize taliglucerase alfa under the Pfizer Agreement, but we retained those rights in Israel, and later in Brazil.", "sentB": "Notwithstanding the low purchase amounts, we are, at this time, continuing to supply Uplyso to Fiocruz under the Brazil Agreement, and patients continue to be treated with Uplyso in Brazil.", "type": 2, "words": ["<tag1>", "We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "we", "retained", "those", "rights", "in", "Israel,", "and", "later", "in", "Brazil.", "<tag2>", "Notwithstanding", "the", "low", "purchase", "amounts,", "we", "are,", "at", "this", "time,", "continuing", "to", "supply", "Uplyso", "to", "Fiocruz", "under", "the", "Brazil", "Agreement,", "and", "patients", "continue", "to", "be", "treated", "with", "Uplyso", "in", "Brazil.", "<tag3>"], "wordsA": ["We", "granted", "Pfizer", "an", "exclusive,", "worldwide", "license", "to", "develop", "and", "commercialize", "taliglucerase", "alfa", "under", "the", "Pfizer", "Agreement,", "but", "we", "retained", "those", "rights", "in", "Israel,", "and", "later", "in", "Brazil."], "wordsB": ["Notwithstanding", "the", "low", "purchase", "amounts,", "we", "are,", "at", "this", "time,", "continuing", "to", "supply", "Uplyso", "to", "Fiocruz", "under", "the", "Brazil", "Agreement,", "and", "patients", "continue", "to", "be", "treated", "with", "Uplyso", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p54_s4", "idA": "1006281_15_item1_p72_s0", "sentA": "Zavesca (miglustat), which is marketed by Actelion Ltd., or Actelion, is a small molecule drug for the treatment of Gaucher disease.", "sentB": "Finally, Zavesca (miglustat) is a small molecule drug for the treatment of Gaucher disease.", "type": 2, "words": ["<tag1>", "Zavesca", "(miglustat),", "which", "is", "marketed", "by", "Actelion", "Ltd.,", "or", "Actelion,", "is", "a", "small", "molecule", "drug", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "Finally,", "Zavesca", "(miglustat)", "is", "a", "small", "molecule", "drug", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag3>"], "wordsA": ["Zavesca", "(miglustat),", "which", "is", "marketed", "by", "Actelion", "Ltd.,", "or", "Actelion,", "is", "a", "small", "molecule", "drug", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["Finally,", "Zavesca", "(miglustat)", "is", "a", "small", "molecule", "drug", "for", "the", "treatment", "of", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p55_s1", "idA": "1006281_15_item1_p74_s1", "sentA": "We believe that PRX-102 has the potential to be an improved version of the currently marketed Fabry disease enzymes, Fabrazyme and Replagal , with improved activity in the Fabry disease target organs and significantly longer half-life due to higher stability, which together can potentially lead to improved substrate clearance.", "sentB": "We believe that PRX-102 has the potential to be an improved version of the currently marketed Fabry disease enzymes, Fabrazyme and Replagal , with improved activity in the Fabry disease target organs and significantly longer half-life due to higher stability, which together can potentially lead to improved substrate clearance and significantly lower formation of antibodies, as observed in our phase I/II clinical trial in Fabry patients.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "PRX-102", "has", "the", "potential", "to", "be", "an", "improved", "version", "of", "the", "currently", "marketed", "Fabry", "disease", "enzymes,", "Fabrazyme", "and", "Replagal", ",", "with", "improved", "activity", "in", "the", "Fabry", "disease", "target", "organs", "and", "significantly", "longer", "half-life", "due", "to", "higher", "stability,", "which", "together", "can", "potentially", "lead", "to", "improved", "substrate", "clearance.", "<tag2>", "We", "believe", "that", "PRX-102", "has", "the", "potential", "to", "be", "an", "improved", "version", "of", "the", "currently", "marketed", "Fabry", "disease", "enzymes,", "Fabrazyme", "and", "Replagal", ",", "with", "improved", "activity", "in", "the", "Fabry", "disease", "target", "organs", "and", "significantly", "longer", "half-life", "due", "to", "higher", "stability,", "which", "together", "can", "potentially", "lead", "to", "improved", "substrate", "clearance", "and", "significantly", "lower", "formation", "of", "antibodies,", "as", "observed", "in", "our", "phase", "I/II", "clinical", "trial", "in", "Fabry", "patients.", "<tag3>"], "wordsA": ["We", "believe", "that", "PRX-102", "has", "the", "potential", "to", "be", "an", "improved", "version", "of", "the", "currently", "marketed", "Fabry", "disease", "enzymes,", "Fabrazyme", "and", "Replagal", ",", "with", "improved", "activity", "in", "the", "Fabry", "disease", "target", "organs", "and", "significantly", "longer", "half-life", "due", "to", "higher", "stability,", "which", "together", "can", "potentially", "lead", "to", "improved", "substrate", "clearance."], "wordsB": ["We", "believe", "that", "PRX-102", "has", "the", "potential", "to", "be", "an", "improved", "version", "of", "the", "currently", "marketed", "Fabry", "disease", "enzymes,", "Fabrazyme", "and", "Replagal", ",", "with", "improved", "activity", "in", "the", "Fabry", "disease", "target", "organs", "and", "significantly", "longer", "half-life", "due", "to", "higher", "stability,", "which", "together", "can", "potentially", "lead", "to", "improved", "substrate", "clearance", "and", "significantly", "lower", "formation", "of", "antibodies,", "as", "observed", "in", "our", "phase", "I/II", "clinical", "trial", "in", "Fabry", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p56_s0", "idA": "1006281_15_item1_p75_s0", "sentA": "We believe that the treatment of Fabry disease is a specialty clinical niche with the potential for high growth.", "sentB": "We believe that the treatment of Fabry disease is a specialty clinical niche with the potential for high growth as there is a significant unmet medical need for Fabry disease treatments.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "the", "treatment", "of", "Fabry", "disease", "is", "a", "specialty", "clinical", "niche", "with", "the", "potential", "for", "high", "growth.", "<tag2>", "We", "believe", "that", "the", "treatment", "of", "Fabry", "disease", "is", "a", "specialty", "clinical", "niche", "with", "the", "potential", "for", "high", "growth", "as", "there", "is", "a", "significant", "unmet", "medical", "need", "for", "Fabry", "disease", "treatments.", "<tag3>"], "wordsA": ["We", "believe", "that", "the", "treatment", "of", "Fabry", "disease", "is", "a", "specialty", "clinical", "niche", "with", "the", "potential", "for", "high", "growth."], "wordsB": ["We", "believe", "that", "the", "treatment", "of", "Fabry", "disease", "is", "a", "specialty", "clinical", "niche", "with", "the", "potential", "for", "high", "growth", "as", "there", "is", "a", "significant", "unmet", "medical", "need", "for", "Fabry", "disease", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p3_s1", "idA": "1006281_15_item1_p7_s0", "sentA": "On June 18, 2013, we entered into a Supply and Technology Transfer Agreement, or the Brazil Agreement, with Fiocruz, for taliglucerase alfa.", "sentB": "In October 2015, we entered into an Amended and Restated Exclusive License and Supply Agreement, or the Amended Pfizer Agreement, which amends and restates the Pfizer Agreement in its entirety.", "type": 2, "words": ["<tag1>", "On", "June", "18,", "2013,", "we", "entered", "into", "a", "Supply", "and", "Technology", "Transfer", "Agreement,", "or", "the", "Brazil", "Agreement,", "with", "Fiocruz,", "for", "taliglucerase", "alfa.", "<tag2>", "In", "October", "2015,", "we", "entered", "into", "an", "Amended", "and", "Restated", "Exclusive", "License", "and", "Supply", "Agreement,", "or", "the", "Amended", "Pfizer", "Agreement,", "which", "amends", "and", "restates", "the", "Pfizer", "Agreement", "in", "its", "entirety.", "<tag3>"], "wordsA": ["On", "June", "18,", "2013,", "we", "entered", "into", "a", "Supply", "and", "Technology", "Transfer", "Agreement,", "or", "the", "Brazil", "Agreement,", "with", "Fiocruz,", "for", "taliglucerase", "alfa."], "wordsB": ["In", "October", "2015,", "we", "entered", "into", "an", "Amended", "and", "Restated", "Exclusive", "License", "and", "Supply", "Agreement,", "or", "the", "Amended", "Pfizer", "Agreement,", "which", "amends", "and", "restates", "the", "Pfizer", "Agreement", "in", "its", "entirety."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p7_s0", "idA": "1006281_15_item1_p7_s0", "sentA": "On June 18, 2013, we entered into a Supply and Technology Transfer Agreement, or the Brazil Agreement, with Fiocruz, for taliglucerase alfa.", "sentB": "On June 18, 2013, we entered into a Supply and Technology Transfer Agreement, or the Brazil Agreement, with Fiocruz, an arm of the Brazilian Ministry of Health for taliglucerase alfa.", "type": 2, "words": ["<tag1>", "On", "June", "18,", "2013,", "we", "entered", "into", "a", "Supply", "and", "Technology", "Transfer", "Agreement,", "or", "the", "Brazil", "Agreement,", "with", "Fiocruz,", "for", "taliglucerase", "alfa.", "<tag2>", "On", "June", "18,", "2013,", "we", "entered", "into", "a", "Supply", "and", "Technology", "Transfer", "Agreement,", "or", "the", "Brazil", "Agreement,", "with", "Fiocruz,", "an", "arm", "of", "the", "Brazilian", "Ministry", "of", "Health", "for", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["On", "June", "18,", "2013,", "we", "entered", "into", "a", "Supply", "and", "Technology", "Transfer", "Agreement,", "or", "the", "Brazil", "Agreement,", "with", "Fiocruz,", "for", "taliglucerase", "alfa."], "wordsB": ["On", "June", "18,", "2013,", "we", "entered", "into", "a", "Supply", "and", "Technology", "Transfer", "Agreement,", "or", "the", "Brazil", "Agreement,", "with", "Fiocruz,", "an", "arm", "of", "the", "Brazilian", "Ministry", "of", "Health", "for", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p99_s3", "idA": "1006281_15_item1_p7_s4", "sentA": "Under the agreement, Fiocruz committed to purchase at least approximately $40 million worth of taliglucerase alfa during the first two years of the term.", "sentB": "Under the agreement, Fiocruz committed to purchase at least approximately $40 million worth of taliglucerase alfa during the first two years of the term and in subsequent years, at least approximately $40 million worth of taliglucerase alfa per year.", "type": 2, "words": ["<tag1>", "Under", "the", "agreement,", "Fiocruz", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term.", "<tag2>", "Under", "the", "agreement,", "Fiocruz", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term", "and", "in", "subsequent", "years,", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "per", "year.", "<tag3>"], "wordsA": ["Under", "the", "agreement,", "Fiocruz", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term."], "wordsB": ["Under", "the", "agreement,", "Fiocruz", "committed", "to", "purchase", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "during", "the", "first", "two", "years", "of", "the", "term", "and", "in", "subsequent", "years,", "at", "least", "approximately", "$40", "million", "worth", "of", "taliglucerase", "alfa", "per", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p60_s1", "idA": "1006281_15_item1_p80_s1", "sentA": "Fabrazyme, marketed by Genzyme, is approved for the treatment of Fabry disease in the United States and the European Union.", "sentB": "Fabrazyme, marketed by Genzyme Corporation (acquired by Sanofi), is approved for the treatment of Fabry disease in the United States and the European Union.", "type": 2, "words": ["<tag1>", "Fabrazyme,", "marketed", "by", "Genzyme,", "is", "approved", "for", "the", "treatment", "of", "Fabry", "disease", "in", "the", "United", "States", "and", "the", "European", "Union.", "<tag2>", "Fabrazyme,", "marketed", "by", "Genzyme", "Corporation", "(acquired", "by", "Sanofi),", "is", "approved", "for", "the", "treatment", "of", "Fabry", "disease", "in", "the", "United", "States", "and", "the", "European", "Union.", "<tag3>"], "wordsA": ["Fabrazyme,", "marketed", "by", "Genzyme,", "is", "approved", "for", "the", "treatment", "of", "Fabry", "disease", "in", "the", "United", "States", "and", "the", "European", "Union."], "wordsB": ["Fabrazyme,", "marketed", "by", "Genzyme", "Corporation", "(acquired", "by", "Sanofi),", "is", "approved", "for", "the", "treatment", "of", "Fabry", "disease", "in", "the", "United", "States", "and", "the", "European", "Union."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p60_s2", "idA": "1006281_15_item1_p80_s2", "sentA": "Sanofi reported 460 million (approximately $557 million) in worldwide sales of Fabrazyme in 2014, a growth of 23% compared to 2013.", "sentB": "Sanofi reported 592 million (approximately $643 million) in worldwide sales of Fabrazyme in 2015.", "type": 2, "words": ["<tag1>", "Sanofi", "reported", "460", "million", "(approximately", "$557", "million)", "in", "worldwide", "sales", "of", "Fabrazyme", "in", "2014,", "a", "growth", "of", "23%", "compared", "to", "2013.", "<tag2>", "Sanofi", "reported", "592", "million", "(approximately", "$643", "million)", "in", "worldwide", "sales", "of", "Fabrazyme", "in", "2015.", "<tag3>"], "wordsA": ["Sanofi", "reported", "460", "million", "(approximately", "$557", "million)", "in", "worldwide", "sales", "of", "Fabrazyme", "in", "2014,", "a", "growth", "of", "23%", "compared", "to", "2013."], "wordsB": ["Sanofi", "reported", "592", "million", "(approximately", "$643", "million)", "in", "worldwide", "sales", "of", "Fabrazyme", "in", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p61_s1", "idA": "1006281_15_item1_p81_s1", "sentA": "Shire reported $500 million in sales of Replagal in 2014, an increase of 7% compared to 2013.", "sentB": "Shire reported $442 million in sales of Replagal in 2015.", "type": 2, "words": ["<tag1>", "Shire", "reported", "$500", "million", "in", "sales", "of", "Replagal", "in", "2014,", "an", "increase", "of", "7%", "compared", "to", "2013.", "<tag2>", "Shire", "reported", "$442", "million", "in", "sales", "of", "Replagal", "in", "2015.", "<tag3>"], "wordsA": ["Shire", "reported", "$500", "million", "in", "sales", "of", "Replagal", "in", "2014,", "an", "increase", "of", "7%", "compared", "to", "2013."], "wordsB": ["Shire", "reported", "$442", "million", "in", "sales", "of", "Replagal", "in", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p79_s2", "idA": "1006281_15_item1_p83_s1", "sentA": "The phase I/II clinical trial is a worldwide, multi-center, open label, dose ranging study to evaluate the safety, tolerability, pharmacokinetics and exploratory efficacy parameters of PRX-102 in adult Fabry patients.", "sentB": "The intended phase III clinical trial will be a randomized, multi-center, placebo-controlled, safety and efficacy study in treatment-na ve Fabry patients evaluating the 1 mg/kg dose of PRX-102.", "type": 2, "words": ["<tag1>", "The", "phase", "I/II", "clinical", "trial", "is", "a", "worldwide,", "multi-center,", "open", "label,", "dose", "ranging", "study", "to", "evaluate", "the", "safety,", "tolerability,", "pharmacokinetics", "and", "exploratory", "efficacy", "parameters", "of", "PRX-102", "in", "adult", "Fabry", "patients.", "<tag2>", "The", "intended", "phase", "III", "clinical", "trial", "will", "be", "a", "randomized,", "multi-center,", "placebo-controlled,", "safety", "and", "efficacy", "study", "in", "treatment-na", "ve", "Fabry", "patients", "evaluating", "the", "1", "mg/kg", "dose", "of", "PRX-102.", "<tag3>"], "wordsA": ["The", "phase", "I/II", "clinical", "trial", "is", "a", "worldwide,", "multi-center,", "open", "label,", "dose", "ranging", "study", "to", "evaluate", "the", "safety,", "tolerability,", "pharmacokinetics", "and", "exploratory", "efficacy", "parameters", "of", "PRX-102", "in", "adult", "Fabry", "patients."], "wordsB": ["The", "intended", "phase", "III", "clinical", "trial", "will", "be", "a", "randomized,", "multi-center,", "placebo-controlled,", "safety", "and", "efficacy", "study", "in", "treatment-na", "ve", "Fabry", "patients", "evaluating", "the", "1", "mg/kg", "dose", "of", "PRX-102."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p82_s2", "idA": "1006281_15_item1_p83_s3", "sentA": "Each patient receives intravenous infusions of PRX-102 every two weeks for 12 weeks, with a six-month efficacy follow up period.", "sentB": "The trial will enroll patients who are currently treated with Fabrazyme; such patients will be treated with 1mg/kg of PRX-102 for a two-year period.", "type": 2, "words": ["<tag1>", "Each", "patient", "receives", "intravenous", "infusions", "of", "PRX-102", "every", "two", "weeks", "for", "12", "weeks,", "with", "a", "six-month", "efficacy", "follow", "up", "period.", "<tag2>", "The", "trial", "will", "enroll", "patients", "who", "are", "currently", "treated", "with", "Fabrazyme;", "such", "patients", "will", "be", "treated", "with", "1mg/kg", "of", "PRX-102", "for", "a", "two-year", "period.", "<tag3>"], "wordsA": ["Each", "patient", "receives", "intravenous", "infusions", "of", "PRX-102", "every", "two", "weeks", "for", "12", "weeks,", "with", "a", "six-month", "efficacy", "follow", "up", "period."], "wordsB": ["The", "trial", "will", "enroll", "patients", "who", "are", "currently", "treated", "with", "Fabrazyme;", "such", "patients", "will", "be", "treated", "with", "1mg/kg", "of", "PRX-102", "for", "a", "two-year", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p64_s0", "idA": "1006281_15_item1_p85_s0", "sentA": "PRX-102 demonstrated meaningful clinical benefits across the following key disease parameters already in the low dose of 0.2 mg/kg:", "sentB": "PRX-102 demonstrated meaningful clinical benefits across the following key disease parameters already in this low dose, including a major reduction in Gb3 in Renal Peritubular Capillaries, significant improvement in all pain parameters, stabilization of cardiac and kidney function and very low level of antibody formation.", "type": 2, "words": ["<tag1>", "PRX-102", "demonstrated", "meaningful", "clinical", "benefits", "across", "the", "following", "key", "disease", "parameters", "already", "in", "the", "low", "dose", "of", "0.2", "mg/kg:", "<tag2>", "PRX-102", "demonstrated", "meaningful", "clinical", "benefits", "across", "the", "following", "key", "disease", "parameters", "already", "in", "this", "low", "dose,", "including", "a", "major", "reduction", "in", "Gb3", "in", "Renal", "Peritubular", "Capillaries,", "significant", "improvement", "in", "all", "pain", "parameters,", "stabilization", "of", "cardiac", "and", "kidney", "function", "and", "very", "low", "level", "of", "antibody", "formation.", "<tag3>"], "wordsA": ["PRX-102", "demonstrated", "meaningful", "clinical", "benefits", "across", "the", "following", "key", "disease", "parameters", "already", "in", "the", "low", "dose", "of", "0.2", "mg/kg:"], "wordsB": ["PRX-102", "demonstrated", "meaningful", "clinical", "benefits", "across", "the", "following", "key", "disease", "parameters", "already", "in", "this", "low", "dose,", "including", "a", "major", "reduction", "in", "Gb3", "in", "Renal", "Peritubular", "Capillaries,", "significant", "improvement", "in", "all", "pain", "parameters,", "stabilization", "of", "cardiac", "and", "kidney", "function", "and", "very", "low", "level", "of", "antibody", "formation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p65_s0", "idA": "1006281_15_item1_p86_s0", "sentA": "The interim efficacy analysis includes six patients enrolled in the 0.2mg/kg dose group at six months of treatment (for Gb3 in renal peritubular capillaries n=5).", "sentB": "The interim efficacy analysis includes six Fabry patients enrolled in the 0.2mg/kg dose group at six months of treatment (for Gb3 in renal peritubular capillaries n=5).", "type": 2, "words": ["<tag1>", "The", "interim", "efficacy", "analysis", "includes", "six", "patients", "enrolled", "in", "the", "0.2mg/kg", "dose", "group", "at", "six", "months", "of", "treatment", "(for", "Gb3", "in", "renal", "peritubular", "capillaries", "n=5).", "<tag2>", "The", "interim", "efficacy", "analysis", "includes", "six", "Fabry", "patients", "enrolled", "in", "the", "0.2mg/kg", "dose", "group", "at", "six", "months", "of", "treatment", "(for", "Gb3", "in", "renal", "peritubular", "capillaries", "n=5).", "<tag3>"], "wordsA": ["The", "interim", "efficacy", "analysis", "includes", "six", "patients", "enrolled", "in", "the", "0.2mg/kg", "dose", "group", "at", "six", "months", "of", "treatment", "(for", "Gb3", "in", "renal", "peritubular", "capillaries", "n=5)."], "wordsB": ["The", "interim", "efficacy", "analysis", "includes", "six", "Fabry", "patients", "enrolled", "in", "the", "0.2mg/kg", "dose", "group", "at", "six", "months", "of", "treatment", "(for", "Gb3", "in", "renal", "peritubular", "capillaries", "n=5)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p69_s0", "idA": "1006281_15_item1_p86_s0", "sentA": "The interim efficacy analysis includes six patients enrolled in the 0.2mg/kg dose group at six months of treatment (for Gb3 in renal peritubular capillaries n=5).", "sentB": "The interim analysis includes six patients enrolled in the 1mg/kg dose group at six months of treatment.", "type": 2, "words": ["<tag1>", "The", "interim", "efficacy", "analysis", "includes", "six", "patients", "enrolled", "in", "the", "0.2mg/kg", "dose", "group", "at", "six", "months", "of", "treatment", "(for", "Gb3", "in", "renal", "peritubular", "capillaries", "n=5).", "<tag2>", "The", "interim", "analysis", "includes", "six", "patients", "enrolled", "in", "the", "1mg/kg", "dose", "group", "at", "six", "months", "of", "treatment.", "<tag3>"], "wordsA": ["The", "interim", "efficacy", "analysis", "includes", "six", "patients", "enrolled", "in", "the", "0.2mg/kg", "dose", "group", "at", "six", "months", "of", "treatment", "(for", "Gb3", "in", "renal", "peritubular", "capillaries", "n=5)."], "wordsB": ["The", "interim", "analysis", "includes", "six", "patients", "enrolled", "in", "the", "1mg/kg", "dose", "group", "at", "six", "months", "of", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p80_s0", "idA": "1006281_15_item1_p86_s0", "sentA": "The interim efficacy analysis includes six patients enrolled in the 0.2mg/kg dose group at six months of treatment (for Gb3 in renal peritubular capillaries n=5).", "sentB": "In the official FDA meeting minutes, the FDA noted that we reported interim analysis results from the phase I/II clinical trial of PRX-102 that preliminarily show a favorable trend in the severity and frequency of abdominal pain and frequency of diarrhea after six months of treatment with PRX-102.", "type": 2, "words": ["<tag1>", "The", "interim", "efficacy", "analysis", "includes", "six", "patients", "enrolled", "in", "the", "0.2mg/kg", "dose", "group", "at", "six", "months", "of", "treatment", "(for", "Gb3", "in", "renal", "peritubular", "capillaries", "n=5).", "<tag2>", "In", "the", "official", "FDA", "meeting", "minutes,", "the", "FDA", "noted", "that", "we", "reported", "interim", "analysis", "results", "from", "the", "phase", "I/II", "clinical", "trial", "of", "PRX-102", "that", "preliminarily", "show", "a", "favorable", "trend", "in", "the", "severity", "and", "frequency", "of", "abdominal", "pain", "and", "frequency", "of", "diarrhea", "after", "six", "months", "of", "treatment", "with", "PRX-102.", "<tag3>"], "wordsA": ["The", "interim", "efficacy", "analysis", "includes", "six", "patients", "enrolled", "in", "the", "0.2mg/kg", "dose", "group", "at", "six", "months", "of", "treatment", "(for", "Gb3", "in", "renal", "peritubular", "capillaries", "n=5)."], "wordsB": ["In", "the", "official", "FDA", "meeting", "minutes,", "the", "FDA", "noted", "that", "we", "reported", "interim", "analysis", "results", "from", "the", "phase", "I/II", "clinical", "trial", "of", "PRX-102", "that", "preliminarily", "show", "a", "favorable", "trend", "in", "the", "severity", "and", "frequency", "of", "abdominal", "pain", "and", "frequency", "of", "diarrhea", "after", "six", "months", "of", "treatment", "with", "PRX-102."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p76_s2", "idA": "1006281_15_item1_p86_s1", "sentA": "The interim safety analysis includes 12 patients; six patients enrolled in the 0.2mg/kg dose group and six patients enrolled in the 1mg/kg dose group.", "sentB": "Throughout the study, continuous and durable reduction of up to 61.8% of plasma lyso-Gb3 levels from base line was observed in patients in the 0.2mg/kg cohort.", "type": 2, "words": ["<tag1>", "The", "interim", "safety", "analysis", "includes", "12", "patients;", "six", "patients", "enrolled", "in", "the", "0.2mg/kg", "dose", "group", "and", "six", "patients", "enrolled", "in", "the", "1mg/kg", "dose", "group.", "<tag2>", "Throughout", "the", "study,", "continuous", "and", "durable", "reduction", "of", "up", "to", "61.8%", "of", "plasma", "lyso-Gb3", "levels", "from", "base", "line", "was", "observed", "in", "patients", "in", "the", "0.2mg/kg", "cohort.", "<tag3>"], "wordsA": ["The", "interim", "safety", "analysis", "includes", "12", "patients;", "six", "patients", "enrolled", "in", "the", "0.2mg/kg", "dose", "group", "and", "six", "patients", "enrolled", "in", "the", "1mg/kg", "dose", "group."], "wordsB": ["Throughout", "the", "study,", "continuous", "and", "durable", "reduction", "of", "up", "to", "61.8%", "of", "plasma", "lyso-Gb3", "levels", "from", "base", "line", "was", "observed", "in", "patients", "in", "the", "0.2mg/kg", "cohort."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p66_s0", "idA": "1006281_15_item1_p87_s0", "sentA": "Based on an analysis of kidney biopsies with randomized blinded scoring, PRX-102 demonstrated a major reduction from baseline in renal peritubular capillary Gb3 using both the quantitative Barisoni Lipid Inclusion Scoring System (BLISS) and the semi quantitative method.", "sentB": "Based on an analysis of kidney biopsies with randomized blinded scoring, PRX-102 demonstrated a reduction in renal peritubular capillary Gb3 of 82.2% for males and 65.4% for females using a quantitative Barisoni Lipid Inclusion Scoring System (BLISS) for a combined reduction of 75.5%.", "type": 2, "words": ["<tag1>", "Based", "on", "an", "analysis", "of", "kidney", "biopsies", "with", "randomized", "blinded", "scoring,", "PRX-102", "demonstrated", "a", "major", "reduction", "from", "baseline", "in", "renal", "peritubular", "capillary", "Gb3", "using", "both", "the", "quantitative", "Barisoni", "Lipid", "Inclusion", "Scoring", "System", "(BLISS)", "and", "the", "semi", "quantitative", "method.", "<tag2>", "Based", "on", "an", "analysis", "of", "kidney", "biopsies", "with", "randomized", "blinded", "scoring,", "PRX-102", "demonstrated", "a", "reduction", "in", "renal", "peritubular", "capillary", "Gb3", "of", "82.2%", "for", "males", "and", "65.4%", "for", "females", "using", "a", "quantitative", "Barisoni", "Lipid", "Inclusion", "Scoring", "System", "(BLISS)", "for", "a", "combined", "reduction", "of", "75.5%.", "<tag3>"], "wordsA": ["Based", "on", "an", "analysis", "of", "kidney", "biopsies", "with", "randomized", "blinded", "scoring,", "PRX-102", "demonstrated", "a", "major", "reduction", "from", "baseline", "in", "renal", "peritubular", "capillary", "Gb3", "using", "both", "the", "quantitative", "Barisoni", "Lipid", "Inclusion", "Scoring", "System", "(BLISS)", "and", "the", "semi", "quantitative", "method."], "wordsB": ["Based", "on", "an", "analysis", "of", "kidney", "biopsies", "with", "randomized", "blinded", "scoring,", "PRX-102", "demonstrated", "a", "reduction", "in", "renal", "peritubular", "capillary", "Gb3", "of", "82.2%", "for", "males", "and", "65.4%", "for", "females", "using", "a", "quantitative", "Barisoni", "Lipid", "Inclusion", "Scoring", "System", "(BLISS)", "for", "a", "combined", "reduction", "of", "75.5%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p70_s0", "idA": "1006281_15_item1_p87_s0", "sentA": "Based on an analysis of kidney biopsies with randomized blinded scoring, PRX-102 demonstrated a major reduction from baseline in renal peritubular capillary Gb3 using both the quantitative Barisoni Lipid Inclusion Scoring System (BLISS) and the semi quantitative method.", "sentB": "Based on an analysis of kidney biopsies with randomized blinded scoring (n=4), PRX-102 demonstrated a reduction in renal peritubular capillary Gb3 of 86% using a quantitative Barisoni Lipid Inclusion Scoring System (BLISS).", "type": 2, "words": ["<tag1>", "Based", "on", "an", "analysis", "of", "kidney", "biopsies", "with", "randomized", "blinded", "scoring,", "PRX-102", "demonstrated", "a", "major", "reduction", "from", "baseline", "in", "renal", "peritubular", "capillary", "Gb3", "using", "both", "the", "quantitative", "Barisoni", "Lipid", "Inclusion", "Scoring", "System", "(BLISS)", "and", "the", "semi", "quantitative", "method.", "<tag2>", "Based", "on", "an", "analysis", "of", "kidney", "biopsies", "with", "randomized", "blinded", "scoring", "(n=4),", "PRX-102", "demonstrated", "a", "reduction", "in", "renal", "peritubular", "capillary", "Gb3", "of", "86%", "using", "a", "quantitative", "Barisoni", "Lipid", "Inclusion", "Scoring", "System", "(BLISS).", "<tag3>"], "wordsA": ["Based", "on", "an", "analysis", "of", "kidney", "biopsies", "with", "randomized", "blinded", "scoring,", "PRX-102", "demonstrated", "a", "major", "reduction", "from", "baseline", "in", "renal", "peritubular", "capillary", "Gb3", "using", "both", "the", "quantitative", "Barisoni", "Lipid", "Inclusion", "Scoring", "System", "(BLISS)", "and", "the", "semi", "quantitative", "method."], "wordsB": ["Based", "on", "an", "analysis", "of", "kidney", "biopsies", "with", "randomized", "blinded", "scoring", "(n=4),", "PRX-102", "demonstrated", "a", "reduction", "in", "renal", "peritubular", "capillary", "Gb3", "of", "86%", "using", "a", "quantitative", "Barisoni", "Lipid", "Inclusion", "Scoring", "System", "(BLISS)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p95_s3", "idA": "1006281_15_item1_p87_s3", "sentA": "Applying the semi quantitative scoring method, commonly used by approved enzyme replacement therapies, PRX-102 demonstrated a reduction of 69.6% in abnormal capillary score.", "sentB": "In a high fat diet model (NASH), OPRX-106 demonstrated a reduction of liver enzymes, ALT and AST, reduction of serum triglycerides, along with a trend for reduction of liver fat.", "type": 2, "words": ["<tag1>", "Applying", "the", "semi", "quantitative", "scoring", "method,", "commonly", "used", "by", "approved", "enzyme", "replacement", "therapies,", "PRX-102", "demonstrated", "a", "reduction", "of", "69.6%", "in", "abnormal", "capillary", "score.", "<tag2>", "In", "a", "high", "fat", "diet", "model", "(NASH),", "OPRX-106", "demonstrated", "a", "reduction", "of", "liver", "enzymes,", "ALT", "and", "AST,", "reduction", "of", "serum", "triglycerides,", "along", "with", "a", "trend", "for", "reduction", "of", "liver", "fat.", "<tag3>"], "wordsA": ["Applying", "the", "semi", "quantitative", "scoring", "method,", "commonly", "used", "by", "approved", "enzyme", "replacement", "therapies,", "PRX-102", "demonstrated", "a", "reduction", "of", "69.6%", "in", "abnormal", "capillary", "score."], "wordsB": ["In", "a", "high", "fat", "diet", "model", "(NASH),", "OPRX-106", "demonstrated", "a", "reduction", "of", "liver", "enzymes,", "ALT", "and", "AST,", "reduction", "of", "serum", "triglycerides,", "along", "with", "a", "trend", "for", "reduction", "of", "liver", "fat."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p66_s2", "idA": "1006281_15_item1_p88_s0", "sentA": "Using the well-accepted Brief Pain Inventory scale, a 100% reduction in pain at its worst, a 60.0% reduction in mean severity, and 78.8% reduction on mean interference (which includes walking, working, sleeping, enjoyment of life and others) were observed.", "sentB": "Using the well-accepted Brief Pain Inventory scale, a 100% reduction in Worst Pain and an average of 78.8% improvement on patients' Impact On Functioning were observed.", "type": 2, "words": ["<tag1>", "Using", "the", "well-accepted", "Brief", "Pain", "Inventory", "scale,", "a", "100%", "reduction", "in", "pain", "at", "its", "worst,", "a", "60.0%", "reduction", "in", "mean", "severity,", "and", "78.8%", "reduction", "on", "mean", "interference", "(which", "includes", "walking,", "working,", "sleeping,", "enjoyment", "of", "life", "and", "others)", "were", "observed.", "<tag2>", "Using", "the", "well-accepted", "Brief", "Pain", "Inventory", "scale,", "a", "100%", "reduction", "in", "Worst", "Pain", "and", "an", "average", "of", "78.8%", "improvement", "on", "patients'", "Impact", "On", "Functioning", "were", "observed.", "<tag3>"], "wordsA": ["Using", "the", "well-accepted", "Brief", "Pain", "Inventory", "scale,", "a", "100%", "reduction", "in", "pain", "at", "its", "worst,", "a", "60.0%", "reduction", "in", "mean", "severity,", "and", "78.8%", "reduction", "on", "mean", "interference", "(which", "includes", "walking,", "working,", "sleeping,", "enjoyment", "of", "life", "and", "others)", "were", "observed."], "wordsB": ["Using", "the", "well-accepted", "Brief", "Pain", "Inventory", "scale,", "a", "100%", "reduction", "in", "Worst", "Pain", "and", "an", "average", "of", "78.8%", "improvement", "on", "patients'", "Impact", "On", "Functioning", "were", "observed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p71_s1", "idA": "1006281_15_item1_p89_s1", "sentA": "Females (n=2) demonstrated a -2.4 ng/mL mean change in Lyso-Gb3 and a -0.4 g/mL mean change in plasma Gb3.", "sentB": "Males (n=4) demonstrated a -67.5 ng/mL and a -5.3 g/mL change, Females (n=2) demonstrated a -9.2 ng/mL mean change in Lyso-Gb3 and a -0.23 g/mL mean change in plasma Gb3, respectively.", "type": 2, "words": ["<tag1>", "Females", "(n=2)", "demonstrated", "a", "-2.4", "ng/mL", "mean", "change", "in", "Lyso-Gb3", "and", "a", "-0.4", "g/mL", "mean", "change", "in", "plasma", "Gb3.", "<tag2>", "Males", "(n=4)", "demonstrated", "a", "-67.5", "ng/mL", "and", "a", "-5.3", "g/mL", "change,", "Females", "(n=2)", "demonstrated", "a", "-9.2", "ng/mL", "mean", "change", "in", "Lyso-Gb3", "and", "a", "-0.23", "g/mL", "mean", "change", "in", "plasma", "Gb3,", "respectively.", "<tag3>"], "wordsA": ["Females", "(n=2)", "demonstrated", "a", "-2.4", "ng/mL", "mean", "change", "in", "Lyso-Gb3", "and", "a", "-0.4", "g/mL", "mean", "change", "in", "plasma", "Gb3."], "wordsB": ["Males", "(n=4)", "demonstrated", "a", "-67.5", "ng/mL", "and", "a", "-5.3", "g/mL", "change,", "Females", "(n=2)", "demonstrated", "a", "-9.2", "ng/mL", "mean", "change", "in", "Lyso-Gb3", "and", "a", "-0.23", "g/mL", "mean", "change", "in", "plasma", "Gb3,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p66_s3", "idA": "1006281_15_item1_p92_s0", "sentA": "All patients that participated in the trial exhibited stable cardiac and kidney function, with favorable trends after only six months, as measured by left ventricular mass (LVM), left ventricular mass index (LVMI), ejection fraction (EF), estimated glomerular filtration rate (eGFR) and urine protein.", "sentB": "Furthermore, all patients had stable cardiac function, with favorable trends after only six months, as measured by left ventricular mass (LVM), left ventricular mass index (LVMI) and ejection fraction (EF).", "type": 2, "words": ["<tag1>", "All", "patients", "that", "participated", "in", "the", "trial", "exhibited", "stable", "cardiac", "and", "kidney", "function,", "with", "favorable", "trends", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI),", "ejection", "fraction", "(EF),", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein.", "<tag2>", "Furthermore,", "all", "patients", "had", "stable", "cardiac", "function,", "with", "favorable", "trends", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI)", "and", "ejection", "fraction", "(EF).", "<tag3>"], "wordsA": ["All", "patients", "that", "participated", "in", "the", "trial", "exhibited", "stable", "cardiac", "and", "kidney", "function,", "with", "favorable", "trends", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI),", "ejection", "fraction", "(EF),", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein."], "wordsB": ["Furthermore,", "all", "patients", "had", "stable", "cardiac", "function,", "with", "favorable", "trends", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI)", "and", "ejection", "fraction", "(EF)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p66_s4", "idA": "1006281_15_item1_p92_s0", "sentA": "All patients that participated in the trial exhibited stable cardiac and kidney function, with favorable trends after only six months, as measured by left ventricular mass (LVM), left ventricular mass index (LVMI), ejection fraction (EF), estimated glomerular filtration rate (eGFR) and urine protein.", "sentB": "Stable kidney function was also observed, with favorable trends after only six months, as measured by estimated glomerular filtration rate (eGFR) and urine protein.", "type": 2, "words": ["<tag1>", "All", "patients", "that", "participated", "in", "the", "trial", "exhibited", "stable", "cardiac", "and", "kidney", "function,", "with", "favorable", "trends", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI),", "ejection", "fraction", "(EF),", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein.", "<tag2>", "Stable", "kidney", "function", "was", "also", "observed,", "with", "favorable", "trends", "after", "only", "six", "months,", "as", "measured", "by", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein.", "<tag3>"], "wordsA": ["All", "patients", "that", "participated", "in", "the", "trial", "exhibited", "stable", "cardiac", "and", "kidney", "function,", "with", "favorable", "trends", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI),", "ejection", "fraction", "(EF),", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein."], "wordsB": ["Stable", "kidney", "function", "was", "also", "observed,", "with", "favorable", "trends", "after", "only", "six", "months,", "as", "measured", "by", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p72_s0", "idA": "1006281_15_item1_p92_s0", "sentA": "All patients that participated in the trial exhibited stable cardiac and kidney function, with favorable trends after only six months, as measured by left ventricular mass (LVM), left ventricular mass index (LVMI), ejection fraction (EF), estimated glomerular filtration rate (eGFR) and urine protein.", "sentB": "Furthermore, all patients had stable cardiac function after only six months, as measured by left ventricular mass (LVM), left ventricular mass index (LVMI) and ejection fraction (EF).", "type": 2, "words": ["<tag1>", "All", "patients", "that", "participated", "in", "the", "trial", "exhibited", "stable", "cardiac", "and", "kidney", "function,", "with", "favorable", "trends", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI),", "ejection", "fraction", "(EF),", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein.", "<tag2>", "Furthermore,", "all", "patients", "had", "stable", "cardiac", "function", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI)", "and", "ejection", "fraction", "(EF).", "<tag3>"], "wordsA": ["All", "patients", "that", "participated", "in", "the", "trial", "exhibited", "stable", "cardiac", "and", "kidney", "function,", "with", "favorable", "trends", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI),", "ejection", "fraction", "(EF),", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein."], "wordsB": ["Furthermore,", "all", "patients", "had", "stable", "cardiac", "function", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI)", "and", "ejection", "fraction", "(EF)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p72_s1", "idA": "1006281_15_item1_p92_s0", "sentA": "All patients that participated in the trial exhibited stable cardiac and kidney function, with favorable trends after only six months, as measured by left ventricular mass (LVM), left ventricular mass index (LVMI), ejection fraction (EF), estimated glomerular filtration rate (eGFR) and urine protein.", "sentB": "Stable kidney function was also observed, as measured by estimated glomerular filtration rate (eGFR) and urine protein.", "type": 2, "words": ["<tag1>", "All", "patients", "that", "participated", "in", "the", "trial", "exhibited", "stable", "cardiac", "and", "kidney", "function,", "with", "favorable", "trends", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI),", "ejection", "fraction", "(EF),", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein.", "<tag2>", "Stable", "kidney", "function", "was", "also", "observed,", "as", "measured", "by", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein.", "<tag3>"], "wordsA": ["All", "patients", "that", "participated", "in", "the", "trial", "exhibited", "stable", "cardiac", "and", "kidney", "function,", "with", "favorable", "trends", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI),", "ejection", "fraction", "(EF),", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein."], "wordsB": ["Stable", "kidney", "function", "was", "also", "observed,", "as", "measured", "by", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p76_s0", "idA": "1006281_15_item1_p92_s0", "sentA": "All patients that participated in the trial exhibited stable cardiac and kidney function, with favorable trends after only six months, as measured by left ventricular mass (LVM), left ventricular mass index (LVMI), ejection fraction (EF), estimated glomerular filtration rate (eGFR) and urine protein.", "sentB": "On average, patients that participated in the 0.2mg/kg cohort of the PRX-102 phase I/II trial exhibited stability in kidney function with favorable trends shown, as measured by estimated Glomerular filtration rate (eGFR).", "type": 2, "words": ["<tag1>", "All", "patients", "that", "participated", "in", "the", "trial", "exhibited", "stable", "cardiac", "and", "kidney", "function,", "with", "favorable", "trends", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI),", "ejection", "fraction", "(EF),", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein.", "<tag2>", "On", "average,", "patients", "that", "participated", "in", "the", "0.2mg/kg", "cohort", "of", "the", "PRX-102", "phase", "I/II", "trial", "exhibited", "stability", "in", "kidney", "function", "with", "favorable", "trends", "shown,", "as", "measured", "by", "estimated", "Glomerular", "filtration", "rate", "(eGFR).", "<tag3>"], "wordsA": ["All", "patients", "that", "participated", "in", "the", "trial", "exhibited", "stable", "cardiac", "and", "kidney", "function,", "with", "favorable", "trends", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI),", "ejection", "fraction", "(EF),", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein."], "wordsB": ["On", "average,", "patients", "that", "participated", "in", "the", "0.2mg/kg", "cohort", "of", "the", "PRX-102", "phase", "I/II", "trial", "exhibited", "stability", "in", "kidney", "function", "with", "favorable", "trends", "shown,", "as", "measured", "by", "estimated", "Glomerular", "filtration", "rate", "(eGFR)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p74_s0", "idA": "1006281_15_item1_p93_s0", "sentA": "The safety analysis for adverse events represents a total of 6.7 patient years.", "sentB": "The interim safety analysis includes 18 patients enrolled in three dose cohorts of 0.2mg/kg, 1mg/kg and 2mg/kg and represents a total of 15 patient years.", "type": 2, "words": ["<tag1>", "The", "safety", "analysis", "for", "adverse", "events", "represents", "a", "total", "of", "6.7", "patient", "years.", "<tag2>", "The", "interim", "safety", "analysis", "includes", "18", "patients", "enrolled", "in", "three", "dose", "cohorts", "of", "0.2mg/kg,", "1mg/kg", "and", "2mg/kg", "and", "represents", "a", "total", "of", "15", "patient", "years.", "<tag3>"], "wordsA": ["The", "safety", "analysis", "for", "adverse", "events", "represents", "a", "total", "of", "6.7", "patient", "years."], "wordsB": ["The", "interim", "safety", "analysis", "includes", "18", "patients", "enrolled", "in", "three", "dose", "cohorts", "of", "0.2mg/kg,", "1mg/kg", "and", "2mg/kg", "and", "represents", "a", "total", "of", "15", "patient", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p73_s0", "idA": "1006281_15_item1_p94_s0", "sentA": "PRX-102 was well tolerated, with the majority of events being mild and moderate.", "sentB": "PRX-102 was well tolerated, with the majority of adverse events being mild and moderate.", "type": 2, "words": ["<tag1>", "PRX-102", "was", "well", "tolerated,", "with", "the", "majority", "of", "events", "being", "mild", "and", "moderate.", "<tag2>", "PRX-102", "was", "well", "tolerated,", "with", "the", "majority", "of", "adverse", "events", "being", "mild", "and", "moderate.", "<tag3>"], "wordsA": ["PRX-102", "was", "well", "tolerated,", "with", "the", "majority", "of", "events", "being", "mild", "and", "moderate."], "wordsB": ["PRX-102", "was", "well", "tolerated,", "with", "the", "majority", "of", "adverse", "events", "being", "mild", "and", "moderate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p78_s0", "idA": "1006281_15_item1_p94_s0", "sentA": "PRX-102 was well tolerated, with the majority of events being mild and moderate.", "sentB": "In addition, PRX-102 continued to be well tolerated with a favorable safety profile, with the majority of adverse events being mild and moderate in severity with a very low rate of antibody formation.", "type": 2, "words": ["<tag1>", "PRX-102", "was", "well", "tolerated,", "with", "the", "majority", "of", "events", "being", "mild", "and", "moderate.", "<tag2>", "In", "addition,", "PRX-102", "continued", "to", "be", "well", "tolerated", "with", "a", "favorable", "safety", "profile,", "with", "the", "majority", "of", "adverse", "events", "being", "mild", "and", "moderate", "in", "severity", "with", "a", "very", "low", "rate", "of", "antibody", "formation.", "<tag3>"], "wordsA": ["PRX-102", "was", "well", "tolerated,", "with", "the", "majority", "of", "events", "being", "mild", "and", "moderate."], "wordsB": ["In", "addition,", "PRX-102", "continued", "to", "be", "well", "tolerated", "with", "a", "favorable", "safety", "profile,", "with", "the", "majority", "of", "adverse", "events", "being", "mild", "and", "moderate", "in", "severity", "with", "a", "very", "low", "rate", "of", "antibody", "formation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p68_s1", "idA": "1006281_15_item1_p94_s1", "sentA": "Only one of the 12 patients evaluated for safety experienced hypersensitivity and discontinued per protocol.", "sentB": "Only one of the 12 patients evaluated for safety experienced hypersensitivity.", "type": 2, "words": ["<tag1>", "Only", "one", "of", "the", "12", "patients", "evaluated", "for", "safety", "experienced", "hypersensitivity", "and", "discontinued", "per", "protocol.", "<tag2>", "Only", "one", "of", "the", "12", "patients", "evaluated", "for", "safety", "experienced", "hypersensitivity.", "<tag3>"], "wordsA": ["Only", "one", "of", "the", "12", "patients", "evaluated", "for", "safety", "experienced", "hypersensitivity", "and", "discontinued", "per", "protocol."], "wordsB": ["Only", "one", "of", "the", "12", "patients", "evaluated", "for", "safety", "experienced", "hypersensitivity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p73_s1", "idA": "1006281_15_item1_p94_s1", "sentA": "Only one of the 12 patients evaluated for safety experienced hypersensitivity and discontinued per protocol.", "sentB": "Only one of the patients evaluated for safety experienced hypersensitivity, and only three patients, or approximately 19%, developed antibodies.", "type": 2, "words": ["<tag1>", "Only", "one", "of", "the", "12", "patients", "evaluated", "for", "safety", "experienced", "hypersensitivity", "and", "discontinued", "per", "protocol.", "<tag2>", "Only", "one", "of", "the", "patients", "evaluated", "for", "safety", "experienced", "hypersensitivity,", "and", "only", "three", "patients,", "or", "approximately", "19%,", "developed", "antibodies.", "<tag3>"], "wordsA": ["Only", "one", "of", "the", "12", "patients", "evaluated", "for", "safety", "experienced", "hypersensitivity", "and", "discontinued", "per", "protocol."], "wordsB": ["Only", "one", "of", "the", "patients", "evaluated", "for", "safety", "experienced", "hypersensitivity,", "and", "only", "three", "patients,", "or", "approximately", "19%,", "developed", "antibodies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p63_s0", "idA": "1006281_15_item1_p95_s1", "sentA": "Of these eight patients, only two patients, or 33% of the 0.2 mg/kg dose cohort, developed antibodies.", "sentB": "0.2 mg/kg dose six months results:", "type": 2, "words": ["<tag1>", "Of", "these", "eight", "patients,", "only", "two", "patients,", "or", "33%", "of", "the", "0.2", "mg/kg", "dose", "cohort,", "developed", "antibodies.", "<tag2>", "0.2", "mg/kg", "dose", "six", "months", "results:", "<tag3>"], "wordsA": ["Of", "these", "eight", "patients,", "only", "two", "patients,", "or", "33%", "of", "the", "0.2", "mg/kg", "dose", "cohort,", "developed", "antibodies."], "wordsB": ["0.2", "mg/kg", "dose", "six", "months", "results:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p75_s0", "idA": "1006281_15_item1_p95_s1", "sentA": "Of these eight patients, only two patients, or 33% of the 0.2 mg/kg dose cohort, developed antibodies.", "sentB": "0.2 mg/kg dose 12 months results:", "type": 2, "words": ["<tag1>", "Of", "these", "eight", "patients,", "only", "two", "patients,", "or", "33%", "of", "the", "0.2", "mg/kg", "dose", "cohort,", "developed", "antibodies.", "<tag2>", "0.2", "mg/kg", "dose", "12", "months", "results:", "<tag3>"], "wordsA": ["Of", "these", "eight", "patients,", "only", "two", "patients,", "or", "33%", "of", "the", "0.2", "mg/kg", "dose", "cohort,", "developed", "antibodies."], "wordsB": ["0.2", "mg/kg", "dose", "12", "months", "results:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p79_s0", "idA": "1006281_15_item1_p97_s1", "sentA": "We intend to request an end of phase II meeting with the FDA in the fourth quarter of 2015, and anticipate initiating a phase III pivotal trial in early 2016.", "sentB": "We held an End-of-Phase II meeting with the FDA in the last quarter of 2015 to discuss our proposed Biologics License Application, or BLA, plan for PRX-102.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "request", "an", "end", "of", "phase", "II", "meeting", "with", "the", "FDA", "in", "the", "fourth", "quarter", "of", "2015,", "and", "anticipate", "initiating", "a", "phase", "III", "pivotal", "trial", "in", "early", "2016.", "<tag2>", "We", "held", "an", "End-of-Phase", "II", "meeting", "with", "the", "FDA", "in", "the", "last", "quarter", "of", "2015", "to", "discuss", "our", "proposed", "Biologics", "License", "Application,", "or", "BLA,", "plan", "for", "PRX-102.", "<tag3>"], "wordsA": ["We", "intend", "to", "request", "an", "end", "of", "phase", "II", "meeting", "with", "the", "FDA", "in", "the", "fourth", "quarter", "of", "2015,", "and", "anticipate", "initiating", "a", "phase", "III", "pivotal", "trial", "in", "early", "2016."], "wordsB": ["We", "held", "an", "End-of-Phase", "II", "meeting", "with", "the", "FDA", "in", "the", "last", "quarter", "of", "2015", "to", "discuss", "our", "proposed", "Biologics", "License", "Application,", "or", "BLA,", "plan", "for", "PRX-102."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p83_s1", "idA": "1006281_15_item1_p97_s1", "sentA": "We intend to request an end of phase II meeting with the FDA in the fourth quarter of 2015, and anticipate initiating a phase III pivotal trial in early 2016.", "sentB": "We submitted a request for a Special Protocol Assessment (SPA) to the FDA later this year, and expect to commence both phase III trials in early 2016.", "type": 2, "words": ["<tag1>", "We", "intend", "to", "request", "an", "end", "of", "phase", "II", "meeting", "with", "the", "FDA", "in", "the", "fourth", "quarter", "of", "2015,", "and", "anticipate", "initiating", "a", "phase", "III", "pivotal", "trial", "in", "early", "2016.", "<tag2>", "We", "submitted", "a", "request", "for", "a", "Special", "Protocol", "Assessment", "(SPA)", "to", "the", "FDA", "later", "this", "year,", "and", "expect", "to", "commence", "both", "phase", "III", "trials", "in", "early", "2016.", "<tag3>"], "wordsA": ["We", "intend", "to", "request", "an", "end", "of", "phase", "II", "meeting", "with", "the", "FDA", "in", "the", "fourth", "quarter", "of", "2015,", "and", "anticipate", "initiating", "a", "phase", "III", "pivotal", "trial", "in", "early", "2016."], "wordsB": ["We", "submitted", "a", "request", "for", "a", "Special", "Protocol", "Assessment", "(SPA)", "to", "the", "FDA", "later", "this", "year,", "and", "expect", "to", "commence", "both", "phase", "III", "trials", "in", "early", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_16_item1_p90_s0", "idA": "1006281_15_item1_p98_s0", "sentA": "Our oral antiTNF product candidate is a recombinant antiTNF (Tumor, Necrosis Factor) protein that we are expressing through ProCellEx.", "sentB": "OPRX-106, our oral antiTNF product candidate, is a recombinant antiTNF (Tumor, Necrosis Factor) protein that we are expressing through ProCellEx.", "type": 2, "words": ["<tag1>", "Our", "oral", "antiTNF", "product", "candidate", "is", "a", "recombinant", "antiTNF", "(Tumor,", "Necrosis", "Factor)", "protein", "that", "we", "are", "expressing", "through", "ProCellEx.", "<tag2>", "OPRX-106,", "our", "oral", "antiTNF", "product", "candidate,", "is", "a", "recombinant", "antiTNF", "(Tumor,", "Necrosis", "Factor)", "protein", "that", "we", "are", "expressing", "through", "ProCellEx.", "<tag3>"], "wordsA": ["Our", "oral", "antiTNF", "product", "candidate", "is", "a", "recombinant", "antiTNF", "(Tumor,", "Necrosis", "Factor)", "protein", "that", "we", "are", "expressing", "through", "ProCellEx."], "wordsB": ["OPRX-106,", "our", "oral", "antiTNF", "product", "candidate,", "is", "a", "recombinant", "antiTNF", "(Tumor,", "Necrosis", "Factor)", "protein", "that", "we", "are", "expressing", "through", "ProCellEx."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p0_s1", "idA": "1006281_16_item1_p0_s1", "sentA": "We developed our first commercial drug product, Elelyso TM , using our ProCellEx system and we are now focused on utilizing the system to develop a pipeline of proprietary, clinically superior versions of recombinant therapeutic proteins that primarily target large, established pharmaceutical markets and that in most cases rely upon known biological mechanisms of action.", "sentB": "We developed our first commercial drug product, Elelyso , using our ProCellEx system and we are now focused on utilizing the system to develop a pipeline of proprietary, clinically superior versions of recombinant therapeutic proteins that primarily target large, established pharmaceutical markets and that, in most cases, rely upon known biological mechanisms of action.", "type": 2, "words": ["<tag1>", "We", "developed", "our", "first", "commercial", "drug", "product,", "Elelyso", "TM", ",", "using", "our", "ProCellEx", "system", "and", "we", "are", "now", "focused", "on", "utilizing", "the", "system", "to", "develop", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "in", "most", "cases", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag2>", "We", "developed", "our", "first", "commercial", "drug", "product,", "Elelyso", ",", "using", "our", "ProCellEx", "system", "and", "we", "are", "now", "focused", "on", "utilizing", "the", "system", "to", "develop", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that,", "in", "most", "cases,", "rely", "upon", "known", "biological", "mechanisms", "of", "action.", "<tag3>"], "wordsA": ["We", "developed", "our", "first", "commercial", "drug", "product,", "Elelyso", "TM", ",", "using", "our", "ProCellEx", "system", "and", "we", "are", "now", "focused", "on", "utilizing", "the", "system", "to", "develop", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that", "in", "most", "cases", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "wordsB": ["We", "developed", "our", "first", "commercial", "drug", "product,", "Elelyso", ",", "using", "our", "ProCellEx", "system", "and", "we", "are", "now", "focused", "on", "utilizing", "the", "system", "to", "develop", "a", "pipeline", "of", "proprietary,", "clinically", "superior", "versions", "of", "recombinant", "therapeutic", "proteins", "that", "primarily", "target", "large,", "established", "pharmaceutical", "markets", "and", "that,", "in", "most", "cases,", "rely", "upon", "known", "biological", "mechanisms", "of", "action."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p8_s0", "idA": "1006281_16_item1_p101_s3", "sentA": "During such period, Fiocruz will be the sole provider of this important treatment option for Gaucher patients in Brazil and shall pay us a single-digit royalty on net sales.", "sentB": "In December 2016, we received a letter from Fiocruz regarding an order from the Brazilian MoH to purchase alfataliglicerase to treat Gaucher patients in Brazil.", "type": 2, "words": ["<tag1>", "During", "such", "period,", "Fiocruz", "will", "be", "the", "sole", "provider", "of", "this", "important", "treatment", "option", "for", "Gaucher", "patients", "in", "Brazil", "and", "shall", "pay", "us", "a", "single-digit", "royalty", "on", "net", "sales.", "<tag2>", "In", "December", "2016,", "we", "received", "a", "letter", "from", "Fiocruz", "regarding", "an", "order", "from", "the", "Brazilian", "MoH", "to", "purchase", "alfataliglicerase", "to", "treat", "Gaucher", "patients", "in", "Brazil.", "<tag3>"], "wordsA": ["During", "such", "period,", "Fiocruz", "will", "be", "the", "sole", "provider", "of", "this", "important", "treatment", "option", "for", "Gaucher", "patients", "in", "Brazil", "and", "shall", "pay", "us", "a", "single-digit", "royalty", "on", "net", "sales."], "wordsB": ["In", "December", "2016,", "we", "received", "a", "letter", "from", "Fiocruz", "regarding", "an", "order", "from", "the", "Brazilian", "MoH", "to", "purchase", "alfataliglicerase", "to", "treat", "Gaucher", "patients", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p95_s0", "idA": "1006281_16_item1_p101_s3", "sentA": "During such period, Fiocruz will be the sole provider of this important treatment option for Gaucher patients in Brazil and shall pay us a single-digit royalty on net sales.", "sentB": "In December 2016, we received a letter from Fiocruz regarding an order from the Brazilian MoH to purchase alfataliglicerase to treat Gaucher patients in Brazil.", "type": 2, "words": ["<tag1>", "During", "such", "period,", "Fiocruz", "will", "be", "the", "sole", "provider", "of", "this", "important", "treatment", "option", "for", "Gaucher", "patients", "in", "Brazil", "and", "shall", "pay", "us", "a", "single-digit", "royalty", "on", "net", "sales.", "<tag2>", "In", "December", "2016,", "we", "received", "a", "letter", "from", "Fiocruz", "regarding", "an", "order", "from", "the", "Brazilian", "MoH", "to", "purchase", "alfataliglicerase", "to", "treat", "Gaucher", "patients", "in", "Brazil.", "<tag3>"], "wordsA": ["During", "such", "period,", "Fiocruz", "will", "be", "the", "sole", "provider", "of", "this", "important", "treatment", "option", "for", "Gaucher", "patients", "in", "Brazil", "and", "shall", "pay", "us", "a", "single-digit", "royalty", "on", "net", "sales."], "wordsB": ["In", "December", "2016,", "we", "received", "a", "letter", "from", "Fiocruz", "regarding", "an", "order", "from", "the", "Brazilian", "MoH", "to", "purchase", "alfataliglicerase", "to", "treat", "Gaucher", "patients", "in", "Brazil."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p97_s1", "idA": "1006281_16_item1_p103_s1", "sentA": "As of December 31, 2015, we held, or had license rights to, 67 patents and 75 pending patent applications with respect to various compositions, methods of production and methods of use relating to our ProCellEx protein expression system and our proprietary product pipeline.", "sentB": "As of December 31, 2016, we held, or had license rights to, 61 patents and 58 pending patent applications with respect to various compositions, methods of production and methods of use relating to our ProCellEx protein expression system and our proprietary product pipeline.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2015,", "we", "held,", "or", "had", "license", "rights", "to,", "67", "patents", "and", "75", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline.", "<tag2>", "As", "of", "December", "31,", "2016,", "we", "held,", "or", "had", "license", "rights", "to,", "61", "patents", "and", "58", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2015,", "we", "held,", "or", "had", "license", "rights", "to,", "67", "patents", "and", "75", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline."], "wordsB": ["As", "of", "December", "31,", "2016,", "we", "held,", "or", "had", "license", "rights", "to,", "61", "patents", "and", "58", "pending", "patent", "applications", "with", "respect", "to", "various", "compositions,", "methods", "of", "production", "and", "methods", "of", "use", "relating", "to", "our", "ProCellEx", "protein", "expression", "system", "and", "our", "proprietary", "product", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p97_s2", "idA": "1006281_16_item1_p103_s2", "sentA": "As of December 31, 2015, we held, with a third party, one joint patent and one joint patent application, and licensed rights to two patents.", "sentB": "Of the above, one is a joint patent, eight are joint patent applications, and one is a licensed patent application.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2015,", "we", "held,", "with", "a", "third", "party,", "one", "joint", "patent", "and", "one", "joint", "patent", "application,", "and", "licensed", "rights", "to", "two", "patents.", "<tag2>", "Of", "the", "above,", "one", "is", "a", "joint", "patent,", "eight", "are", "joint", "patent", "applications,", "and", "one", "is", "a", "licensed", "patent", "application.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2015,", "we", "held,", "with", "a", "third", "party,", "one", "joint", "patent", "and", "one", "joint", "patent", "application,", "and", "licensed", "rights", "to", "two", "patents."], "wordsB": ["Of", "the", "above,", "one", "is", "a", "joint", "patent,", "eight", "are", "joint", "patent", "applications,", "and", "one", "is", "a", "licensed", "patent", "application."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p100_s0", "idA": "1006281_16_item1_p105_s0", "sentA": "As of December 31, 2015, our patent portfolio consisted of several patent families (consisting of patents and/or patent applications) covering our technology, protein expression methodologies and system and product candidates, as follows:", "sentB": "As of December 31, 2016, our patent portfolio consisted of several patent families (consisting of patents and/or patent applications) covering our technology, protein expression methodologies and system and product candidates, as follows:", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2015,", "our", "patent", "portfolio", "consisted", "of", "several", "patent", "families", "(consisting", "of", "patents", "and/or", "patent", "applications)", "covering", "our", "technology,", "protein", "expression", "methodologies", "and", "system", "and", "product", "candidates,", "as", "follows:", "<tag2>", "As", "of", "December", "31,", "2016,", "our", "patent", "portfolio", "consisted", "of", "several", "patent", "families", "(consisting", "of", "patents", "and/or", "patent", "applications)", "covering", "our", "technology,", "protein", "expression", "methodologies", "and", "system", "and", "product", "candidates,", "as", "follows:", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2015,", "our", "patent", "portfolio", "consisted", "of", "several", "patent", "families", "(consisting", "of", "patents", "and/or", "patent", "applications)", "covering", "our", "technology,", "protein", "expression", "methodologies", "and", "system", "and", "product", "candidates,", "as", "follows:"], "wordsB": ["As", "of", "December", "31,", "2016,", "our", "patent", "portfolio", "consisted", "of", "several", "patent", "families", "(consisting", "of", "patents", "and/or", "patent", "applications)", "covering", "our", "technology,", "protein", "expression", "methodologies", "and", "system", "and", "product", "candidates,", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p101_s0", "idA": "1006281_16_item1_p106_s0", "sentA": "With respect to our ProCellEx protein expression system, we held 14 issued patents in the United States, Australia, the European Union, Israel, Canada, Mexico, Hong Kong, India and Korea, and hold one pending patent applications.", "sentB": "With respect to our ProCellEx protein expression system, we held five issued patents in the United States, Israel and Mexico.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "held", "14", "issued", "patents", "in", "the", "United", "States,", "Australia,", "the", "European", "Union,", "Israel,", "Canada,", "Mexico,", "Hong", "Kong,", "India", "and", "Korea,", "and", "hold", "one", "pending", "patent", "applications.", "<tag2>", "With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "held", "five", "issued", "patents", "in", "the", "United", "States,", "Israel", "and", "Mexico.", "<tag3>"], "wordsA": ["With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "held", "14", "issued", "patents", "in", "the", "United", "States,", "Australia,", "the", "European", "Union,", "Israel,", "Canada,", "Mexico,", "Hong", "Kong,", "India", "and", "Korea,", "and", "hold", "one", "pending", "patent", "applications."], "wordsB": ["With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "held", "five", "issued", "patents", "in", "the", "United", "States,", "Israel", "and", "Mexico."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p101_s2", "idA": "1006281_16_item1_p106_s2", "sentA": "Of the issued patents in this family, seven are expected to expire in 2017 and seven are expected to expire in 2025.", "sentB": "Of the issued patents in this family, four are expected to expire in 2017 and one is expected to expire in 2025.", "type": 2, "words": ["<tag1>", "Of", "the", "issued", "patents", "in", "this", "family,", "seven", "are", "expected", "to", "expire", "in", "2017", "and", "seven", "are", "expected", "to", "expire", "in", "2025.", "<tag2>", "Of", "the", "issued", "patents", "in", "this", "family,", "four", "are", "expected", "to", "expire", "in", "2017", "and", "one", "is", "expected", "to", "expire", "in", "2025.", "<tag3>"], "wordsA": ["Of", "the", "issued", "patents", "in", "this", "family,", "seven", "are", "expected", "to", "expire", "in", "2017", "and", "seven", "are", "expected", "to", "expire", "in", "2025."], "wordsB": ["Of", "the", "issued", "patents", "in", "this", "family,", "four", "are", "expected", "to", "expire", "in", "2017", "and", "one", "is", "expected", "to", "expire", "in", "2025."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p102_s0", "idA": "1006281_16_item1_p107_s0", "sentA": "With respect to our ProCellEx protein expression system, we held six issued patents and eight patent applications relating to the large scale production of proteins in cultured plant cells.", "sentB": "With respect to our ProCellEx protein expression system, we held seven issued patents and seven patent applications relating to the large scale production of proteins in cultured plant cells.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "held", "six", "issued", "patents", "and", "eight", "patent", "applications", "relating", "to", "the", "large", "scale", "production", "of", "proteins", "in", "cultured", "plant", "cells.", "<tag2>", "With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "held", "seven", "issued", "patents", "and", "seven", "patent", "applications", "relating", "to", "the", "large", "scale", "production", "of", "proteins", "in", "cultured", "plant", "cells.", "<tag3>"], "wordsA": ["With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "held", "six", "issued", "patents", "and", "eight", "patent", "applications", "relating", "to", "the", "large", "scale", "production", "of", "proteins", "in", "cultured", "plant", "cells."], "wordsB": ["With", "respect", "to", "our", "ProCellEx", "protein", "expression", "system,", "we", "held", "seven", "issued", "patents", "and", "seven", "patent", "applications", "relating", "to", "the", "large", "scale", "production", "of", "proteins", "in", "cultured", "plant", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p102_s1", "idA": "1006281_16_item1_p107_s1", "sentA": "The issued patents and any patents to issue in the future based on pending patent applications in this patent family are expected to expire in 2028.", "sentB": "The issued patents and any patents to issue in the future based on pending patent applications in this patent family, if at all, are expected to expire in 2028.", "type": 2, "words": ["<tag1>", "The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "pending", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2028.", "<tag2>", "The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "pending", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2028.", "<tag3>"], "wordsA": ["The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "pending", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2028."], "wordsB": ["The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "pending", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p103_s1", "idA": "1006281_16_item1_p108_s1", "sentA": "The issued patents and any patents to issue in the future based on pending patent applications in this patent family are expected to expire in 2024.", "sentB": "The issued patents and any patents to issue in the future based on pending patent applications in this patent family, if at all, are expected to expire in 2024.", "type": 2, "words": ["<tag1>", "The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "pending", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2024.", "<tag2>", "The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "pending", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2024.", "<tag3>"], "wordsA": ["The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "pending", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2024."], "wordsB": ["The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "pending", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2024."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p10_s2", "idA": "1006281_16_item1_p10_s0", "sentA": "The product candidate is a key focus for our company.", "sentB": "The product candidate is a key focus for us.", "type": 2, "words": ["<tag1>", "The", "product", "candidate", "is", "a", "key", "focus", "for", "our", "company.", "<tag2>", "The", "product", "candidate", "is", "a", "key", "focus", "for", "us.", "<tag3>"], "wordsA": ["The", "product", "candidate", "is", "a", "key", "focus", "for", "our", "company."], "wordsB": ["The", "product", "candidate", "is", "a", "key", "focus", "for", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p10_s3", "idA": "1006281_16_item1_p10_s1", "sentA": "PRX-102 is currently the subject of an ongoing phase I/II clinical trial and we expect to commence phase III clinical trials of PRX-102 during the first half of 2016.", "sentB": "We enrolled our first patient in a phase III clinical trial of PRX-102 in the fourth quarter of 2016, and our phase I/II clinical trial is ongoing in an extension period .", "type": 2, "words": ["<tag1>", "PRX-102", "is", "currently", "the", "subject", "of", "an", "ongoing", "phase", "I/II", "clinical", "trial", "and", "we", "expect", "to", "commence", "phase", "III", "clinical", "trials", "of", "PRX-102", "during", "the", "first", "half", "of", "2016.", "<tag2>", "We", "enrolled", "our", "first", "patient", "in", "a", "phase", "III", "clinical", "trial", "of", "PRX-102", "in", "the", "fourth", "quarter", "of", "2016,", "and", "our", "phase", "I/II", "clinical", "trial", "is", "ongoing", "in", "an", "extension", "period", ".", "<tag3>"], "wordsA": ["PRX-102", "is", "currently", "the", "subject", "of", "an", "ongoing", "phase", "I/II", "clinical", "trial", "and", "we", "expect", "to", "commence", "phase", "III", "clinical", "trials", "of", "PRX-102", "during", "the", "first", "half", "of", "2016."], "wordsB": ["We", "enrolled", "our", "first", "patient", "in", "a", "phase", "III", "clinical", "trial", "of", "PRX-102", "in", "the", "fourth", "quarter", "of", "2016,", "and", "our", "phase", "I/II", "clinical", "trial", "is", "ongoing", "in", "an", "extension", "period", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p105_s1", "idA": "1006281_16_item1_p110_s1", "sentA": "The issued patents and any patents to issue in the future based on patent applications in this patent family are expected to expire in 2026.", "sentB": "The issued patents and any patents to issue in the future based on patent applications in this patent family, if at all, are expected to expire in 2026.", "type": 2, "words": ["<tag1>", "The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2026.", "<tag2>", "The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2026.", "<tag3>"], "wordsA": ["The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2026."], "wordsB": ["The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2026."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p106_s1", "idA": "1006281_16_item1_p111_s1", "sentA": "The issued patents and any patents to issue in the future based on the patent applications in this patent family are expected to expire in 2028.", "sentB": "The issued patents and any patents to issue in the future based on the patent applications in this patent family, if at all, are expected to expire in 2028.", "type": 2, "words": ["<tag1>", "The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2028.", "<tag2>", "The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2028.", "<tag3>"], "wordsA": ["The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family", "are", "expected", "to", "expire", "in", "2028."], "wordsB": ["The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2028."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p107_s0", "idA": "1006281_16_item1_p112_s0", "sentA": "We held a patent family containing nine pending patent application relating to Nucleic Acid construct for expression of alpha-galactosidase enzyme in plants and plant cells.", "sentB": "We held a patent family containing one granted patent in Japan and eight pending patent applications relating to Nucleic Acid construct for expression of alpha-galactosidase enzyme in plants and plant cells.", "type": 2, "words": ["<tag1>", "We", "held", "a", "patent", "family", "containing", "nine", "pending", "patent", "application", "relating", "to", "Nucleic", "Acid", "construct", "for", "expression", "of", "alpha-galactosidase", "enzyme", "in", "plants", "and", "plant", "cells.", "<tag2>", "We", "held", "a", "patent", "family", "containing", "one", "granted", "patent", "in", "Japan", "and", "eight", "pending", "patent", "applications", "relating", "to", "Nucleic", "Acid", "construct", "for", "expression", "of", "alpha-galactosidase", "enzyme", "in", "plants", "and", "plant", "cells.", "<tag3>"], "wordsA": ["We", "held", "a", "patent", "family", "containing", "nine", "pending", "patent", "application", "relating", "to", "Nucleic", "Acid", "construct", "for", "expression", "of", "alpha-galactosidase", "enzyme", "in", "plants", "and", "plant", "cells."], "wordsB": ["We", "held", "a", "patent", "family", "containing", "one", "granted", "patent", "in", "Japan", "and", "eight", "pending", "patent", "applications", "relating", "to", "Nucleic", "Acid", "construct", "for", "expression", "of", "alpha-galactosidase", "enzyme", "in", "plants", "and", "plant", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p108_s1", "idA": "1006281_16_item1_p112_s1", "sentA": "The patents to issue in the future based on the patent applications in this patent family, if at all, are expected to expire in 2031.", "sentB": "The issued patents and any patents to issue in the future based on the patent applications in this patent family, if at all, are expected to expire in 2031.", "type": 2, "words": ["<tag1>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2031.", "<tag2>", "The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2031.", "<tag3>"], "wordsA": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2031."], "wordsB": ["The", "issued", "patents", "and", "any", "patents", "to", "issue", "in", "the", "future", "based", "on", "the", "patent", "applications", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2031."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p108_s0", "idA": "1006281_16_item1_p113_s0", "sentA": "We held a patent family containing nine granted patents in Europe, United States, Japan, China, Hong Kong, Singapore, New Zealand and South Africa and 12 pending patent applications relating to multimeric protein structures of -galactosidase and to uses thereof in treating Fabry disease.", "sentB": "We held a patent family containing 13 granted patents in Europe, United States, Australia, Japan, Russian Federation, China, Hong Kong, Singapore, New Zealand and South Africa, and nine pending patent applications relating to multimeric protein structures of -galactosidase and to uses thereof in treating Fabry disease.", "type": 2, "words": ["<tag1>", "We", "held", "a", "patent", "family", "containing", "nine", "granted", "patents", "in", "Europe,", "United", "States,", "Japan,", "China,", "Hong", "Kong,", "Singapore,", "New", "Zealand", "and", "South", "Africa", "and", "12", "pending", "patent", "applications", "relating", "to", "multimeric", "protein", "structures", "of", "-galactosidase", "and", "to", "uses", "thereof", "in", "treating", "Fabry", "disease.", "<tag2>", "We", "held", "a", "patent", "family", "containing", "13", "granted", "patents", "in", "Europe,", "United", "States,", "Australia,", "Japan,", "Russian", "Federation,", "China,", "Hong", "Kong,", "Singapore,", "New", "Zealand", "and", "South", "Africa,", "and", "nine", "pending", "patent", "applications", "relating", "to", "multimeric", "protein", "structures", "of", "-galactosidase", "and", "to", "uses", "thereof", "in", "treating", "Fabry", "disease.", "<tag3>"], "wordsA": ["We", "held", "a", "patent", "family", "containing", "nine", "granted", "patents", "in", "Europe,", "United", "States,", "Japan,", "China,", "Hong", "Kong,", "Singapore,", "New", "Zealand", "and", "South", "Africa", "and", "12", "pending", "patent", "applications", "relating", "to", "multimeric", "protein", "structures", "of", "-galactosidase", "and", "to", "uses", "thereof", "in", "treating", "Fabry", "disease."], "wordsB": ["We", "held", "a", "patent", "family", "containing", "13", "granted", "patents", "in", "Europe,", "United", "States,", "Australia,", "Japan,", "Russian", "Federation,", "China,", "Hong", "Kong,", "Singapore,", "New", "Zealand", "and", "South", "Africa,", "and", "nine", "pending", "patent", "applications", "relating", "to", "multimeric", "protein", "structures", "of", "-galactosidase", "and", "to", "uses", "thereof", "in", "treating", "Fabry", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p109_s0", "idA": "1006281_16_item1_p116_s0", "sentA": "We held two patent families relating to the oral delivery of plant cells comprising recombinant glucocerebrosidase for the treatment of Gaucher disease.", "sentB": "We held one United States patent application relating to the oral delivery of plant cells comprising recombinant glucocerebrosidase for the treatment of Gaucher disease.", "type": 2, "words": ["<tag1>", "We", "held", "two", "patent", "families", "relating", "to", "the", "oral", "delivery", "of", "plant", "cells", "comprising", "recombinant", "glucocerebrosidase", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "We", "held", "one", "United", "States", "patent", "application", "relating", "to", "the", "oral", "delivery", "of", "plant", "cells", "comprising", "recombinant", "glucocerebrosidase", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag3>"], "wordsA": ["We", "held", "two", "patent", "families", "relating", "to", "the", "oral", "delivery", "of", "plant", "cells", "comprising", "recombinant", "glucocerebrosidase", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["We", "held", "one", "United", "States", "patent", "application", "relating", "to", "the", "oral", "delivery", "of", "plant", "cells", "comprising", "recombinant", "glucocerebrosidase", "for", "the", "treatment", "of", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p109_s1", "idA": "1006281_16_item1_p116_s1", "sentA": "The patents to issue in the future based on patent application in this patent family, if at all, are expected to expire in 2033 and 2035.", "sentB": "The patent to issue in the future based on this patent application, if at all, is expected to expire in 2035.", "type": 2, "words": ["<tag1>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "patent", "application", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2033", "and", "2035.", "<tag2>", "The", "patent", "to", "issue", "in", "the", "future", "based", "on", "this", "patent", "application,", "if", "at", "all,", "is", "expected", "to", "expire", "in", "2035.", "<tag3>"], "wordsA": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "patent", "application", "in", "this", "patent", "family,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2033", "and", "2035."], "wordsB": ["The", "patent", "to", "issue", "in", "the", "future", "based", "on", "this", "patent", "application,", "if", "at", "all,", "is", "expected", "to", "expire", "in", "2035."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p111_s0", "idA": "1006281_16_item1_p117_s0", "sentA": "We held three patent families containing eight pending applications relating to plant recombinant human DNase I and uses in therapy.", "sentB": "We held a PCT application relating to chemically modified plant recombinant human DNase I and uses in therapy.", "type": 2, "words": ["<tag1>", "We", "held", "three", "patent", "families", "containing", "eight", "pending", "applications", "relating", "to", "plant", "recombinant", "human", "DNase", "I", "and", "uses", "in", "therapy.", "<tag2>", "We", "held", "a", "PCT", "application", "relating", "to", "chemically", "modified", "plant", "recombinant", "human", "DNase", "I", "and", "uses", "in", "therapy.", "<tag3>"], "wordsA": ["We", "held", "three", "patent", "families", "containing", "eight", "pending", "applications", "relating", "to", "plant", "recombinant", "human", "DNase", "I", "and", "uses", "in", "therapy."], "wordsB": ["We", "held", "a", "PCT", "application", "relating", "to", "chemically", "modified", "plant", "recombinant", "human", "DNase", "I", "and", "uses", "in", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p111_s1", "idA": "1006281_16_item1_p118_s1", "sentA": "The patents to issue in the future based on these patent applications, if at all, are expected to expire in 2034/2035.", "sentB": "The patents to issue in the future based on this patent application, if at all, are expected to expire in 2036.", "type": 2, "words": ["<tag1>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2034/2035.", "<tag2>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "this", "patent", "application,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2036.", "<tag3>"], "wordsA": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2034/2035."], "wordsB": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "this", "patent", "application,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2036."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p114_s1", "idA": "1006281_16_item1_p118_s1", "sentA": "The patents to issue in the future based on these patent applications, if at all, are expected to expire in 2034/2035.", "sentB": "The patents to issue in the future based on these patent applications, if at all, are expected to expire in 2034.", "type": 2, "words": ["<tag1>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2034/2035.", "<tag2>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2034.", "<tag3>"], "wordsA": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2034/2035."], "wordsB": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2034."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p115_s1", "idA": "1006281_16_item1_p118_s1", "sentA": "The patents to issue in the future based on these patent applications, if at all, are expected to expire in 2034/2035.", "sentB": "The patents to issue in the future based on this application, if at all, are expected to expire in 2034.", "type": 2, "words": ["<tag1>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2034/2035.", "<tag2>", "The", "patents", "to", "issue", "in", "the", "future", "based", "on", "this", "application,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2034.", "<tag3>"], "wordsA": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "these", "patent", "applications,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2034/2035."], "wordsB": ["The", "patents", "to", "issue", "in", "the", "future", "based", "on", "this", "application,", "if", "at", "all,", "are", "expected", "to", "expire", "in", "2034."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p11_s0", "idA": "1006281_16_item1_p11_s0", "sentA": "AIR DNase TM (PRX-110) for Cystic Fibrosis .", "sentB": "alidornase alfa (PRX-110) for Cystic Fibrosis .", "type": 2, "words": ["<tag1>", "AIR", "DNase", "TM", "(PRX-110)", "for", "Cystic", "Fibrosis", ".", "<tag2>", "alidornase", "alfa", "(PRX-110)", "for", "Cystic", "Fibrosis", ".", "<tag3>"], "wordsA": ["AIR", "DNase", "TM", "(PRX-110)", "for", "Cystic", "Fibrosis", "."], "wordsB": ["alidornase", "alfa", "(PRX-110)", "for", "Cystic", "Fibrosis", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p11_s1", "idA": "1006281_16_item1_p11_s1", "sentA": "AIR DNase, our proprietary plant cell recombinant human Deoxyribonuclease 1, is under development for the treatment of cystic fibrosis (CF), to be administered by inhalation.", "sentB": "alidornase alfa, our proprietary plant cell recombinant human Deoxyribonuclease 1, is under development for the treatment of cystic fibrosis (CF), to be administered by inhalation.", "type": 2, "words": ["<tag1>", "AIR", "DNase,", "our", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "is", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis", "(CF),", "to", "be", "administered", "by", "inhalation.", "<tag2>", "alidornase", "alfa,", "our", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "is", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis", "(CF),", "to", "be", "administered", "by", "inhalation.", "<tag3>"], "wordsA": ["AIR", "DNase,", "our", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "is", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis", "(CF),", "to", "be", "administered", "by", "inhalation."], "wordsB": ["alidornase", "alfa,", "our", "proprietary", "plant", "cell", "recombinant", "human", "Deoxyribonuclease", "1,", "is", "under", "development", "for", "the", "treatment", "of", "cystic", "fibrosis", "(CF),", "to", "be", "administered", "by", "inhalation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p11_s2", "idA": "1006281_16_item1_p11_s2", "sentA": "AIR DNase has an actin inhibition resistance that is designed to improve lung function and lower the incidence of recurrent infections by enhancing the enzyme s efficacy in patients sputa.", "sentB": "alidornase alfa has an actin inhibition resistance that is designed to improve lung function and lower the incidence of recurrent infections by enhancing the enzyme s efficacy in patients sputa.", "type": 2, "words": ["<tag1>", "AIR", "DNase", "has", "an", "actin", "inhibition", "resistance", "that", "is", "designed", "to", "improve", "lung", "function", "and", "lower", "the", "incidence", "of", "recurrent", "infections", "by", "enhancing", "the", "enzyme", "s", "efficacy", "in", "patients", "sputa.", "<tag2>", "alidornase", "alfa", "has", "an", "actin", "inhibition", "resistance", "that", "is", "designed", "to", "improve", "lung", "function", "and", "lower", "the", "incidence", "of", "recurrent", "infections", "by", "enhancing", "the", "enzyme", "s", "efficacy", "in", "patients", "sputa.", "<tag3>"], "wordsA": ["AIR", "DNase", "has", "an", "actin", "inhibition", "resistance", "that", "is", "designed", "to", "improve", "lung", "function", "and", "lower", "the", "incidence", "of", "recurrent", "infections", "by", "enhancing", "the", "enzyme", "s", "efficacy", "in", "patients", "sputa."], "wordsB": ["alidornase", "alfa", "has", "an", "actin", "inhibition", "resistance", "that", "is", "designed", "to", "improve", "lung", "function", "and", "lower", "the", "incidence", "of", "recurrent", "infections", "by", "enhancing", "the", "enzyme", "s", "efficacy", "in", "patients", "sputa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p76_s0", "idA": "1006281_16_item1_p11_s2", "sentA": "AIR DNase has an actin inhibition resistance that is designed to improve lung function and lower the incidence of recurrent infections by enhancing the enzyme s efficacy in patients sputa.", "sentB": "We designed alidornase alfa, through chemical modification, to be resistant to inhibition by actin so as to improve lung function and lower the incidence of recurrent infections by enhancing the enzyme s efficacy in patients sputa.", "type": 2, "words": ["<tag1>", "AIR", "DNase", "has", "an", "actin", "inhibition", "resistance", "that", "is", "designed", "to", "improve", "lung", "function", "and", "lower", "the", "incidence", "of", "recurrent", "infections", "by", "enhancing", "the", "enzyme", "s", "efficacy", "in", "patients", "sputa.", "<tag2>", "We", "designed", "alidornase", "alfa,", "through", "chemical", "modification,", "to", "be", "resistant", "to", "inhibition", "by", "actin", "so", "as", "to", "improve", "lung", "function", "and", "lower", "the", "incidence", "of", "recurrent", "infections", "by", "enhancing", "the", "enzyme", "s", "efficacy", "in", "patients", "sputa.", "<tag3>"], "wordsA": ["AIR", "DNase", "has", "an", "actin", "inhibition", "resistance", "that", "is", "designed", "to", "improve", "lung", "function", "and", "lower", "the", "incidence", "of", "recurrent", "infections", "by", "enhancing", "the", "enzyme", "s", "efficacy", "in", "patients", "sputa."], "wordsB": ["We", "designed", "alidornase", "alfa,", "through", "chemical", "modification,", "to", "be", "resistant", "to", "inhibition", "by", "actin", "so", "as", "to", "improve", "lung", "function", "and", "lower", "the", "incidence", "of", "recurrent", "infections", "by", "enhancing", "the", "enzyme", "s", "efficacy", "in", "patients", "sputa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p11_s4", "idA": "1006281_16_item1_p11_s4", "sentA": "We have commenced a phase I clinical trial of AIR DNase in healthy volunteers and plan to initiate clinical efficacy trials of AIR DNase for the treatment of CF in mid-year, 2016.", "sentB": "We have commenced a phase IIa clinical trial of alidornase alfa and in January 2017, we announced positive interim results from the phase II clinical trial for the first 13 CF patients enrolled in the study.", "type": 2, "words": ["<tag1>", "We", "have", "commenced", "a", "phase", "I", "clinical", "trial", "of", "AIR", "DNase", "in", "healthy", "volunteers", "and", "plan", "to", "initiate", "clinical", "efficacy", "trials", "of", "AIR", "DNase", "for", "the", "treatment", "of", "CF", "in", "mid-year,", "2016.", "<tag2>", "We", "have", "commenced", "a", "phase", "IIa", "clinical", "trial", "of", "alidornase", "alfa", "and", "in", "January", "2017,", "we", "announced", "positive", "interim", "results", "from", "the", "phase", "II", "clinical", "trial", "for", "the", "first", "13", "CF", "patients", "enrolled", "in", "the", "study.", "<tag3>"], "wordsA": ["We", "have", "commenced", "a", "phase", "I", "clinical", "trial", "of", "AIR", "DNase", "in", "healthy", "volunteers", "and", "plan", "to", "initiate", "clinical", "efficacy", "trials", "of", "AIR", "DNase", "for", "the", "treatment", "of", "CF", "in", "mid-year,", "2016."], "wordsB": ["We", "have", "commenced", "a", "phase", "IIa", "clinical", "trial", "of", "alidornase", "alfa", "and", "in", "January", "2017,", "we", "announced", "positive", "interim", "results", "from", "the", "phase", "II", "clinical", "trial", "for", "the", "first", "13", "CF", "patients", "enrolled", "in", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p80_s0", "idA": "1006281_16_item1_p11_s4", "sentA": "We have commenced a phase I clinical trial of AIR DNase in healthy volunteers and plan to initiate clinical efficacy trials of AIR DNase for the treatment of CF in mid-year, 2016.", "sentB": "In July 2016 we commenced a phase IIa clinical trial of alidornase alfa.", "type": 2, "words": ["<tag1>", "We", "have", "commenced", "a", "phase", "I", "clinical", "trial", "of", "AIR", "DNase", "in", "healthy", "volunteers", "and", "plan", "to", "initiate", "clinical", "efficacy", "trials", "of", "AIR", "DNase", "for", "the", "treatment", "of", "CF", "in", "mid-year,", "2016.", "<tag2>", "In", "July", "2016", "we", "commenced", "a", "phase", "IIa", "clinical", "trial", "of", "alidornase", "alfa.", "<tag3>"], "wordsA": ["We", "have", "commenced", "a", "phase", "I", "clinical", "trial", "of", "AIR", "DNase", "in", "healthy", "volunteers", "and", "plan", "to", "initiate", "clinical", "efficacy", "trials", "of", "AIR", "DNase", "for", "the", "treatment", "of", "CF", "in", "mid-year,", "2016."], "wordsB": ["In", "July", "2016", "we", "commenced", "a", "phase", "IIa", "clinical", "trial", "of", "alidornase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p11_s5", "idA": "1006281_16_item1_p11_s5", "sentA": "Upon review of the results of the trial, we intend to identify and collaborate with a well-suited partner for further development.", "sentB": "Upon review of the final results of the trial, we will consider different collaboration alternatives as part of our further development plans.", "type": 2, "words": ["<tag1>", "Upon", "review", "of", "the", "results", "of", "the", "trial,", "we", "intend", "to", "identify", "and", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development.", "<tag2>", "Upon", "review", "of", "the", "final", "results", "of", "the", "trial,", "we", "will", "consider", "different", "collaboration", "alternatives", "as", "part", "of", "our", "further", "development", "plans.", "<tag3>"], "wordsA": ["Upon", "review", "of", "the", "results", "of", "the", "trial,", "we", "intend", "to", "identify", "and", "collaborate", "with", "a", "well-suited", "partner", "for", "further", "development."], "wordsB": ["Upon", "review", "of", "the", "final", "results", "of", "the", "trial,", "we", "will", "consider", "different", "collaboration", "alternatives", "as", "part", "of", "our", "further", "development", "plans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p115_s0", "idA": "1006281_16_item1_p120_s0", "sentA": "With respect to taliglucerase alfa, we have licensed the rights to two patents from Virginia Tech Intellectual Properties, Inc., or Virginia Tech, that are expected to expire in 2016.", "sentB": "We have licensed the rights to a United States patent application covering oral composition comprising a TNF antagonist.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "taliglucerase", "alfa,", "we", "have", "licensed", "the", "rights", "to", "two", "patents", "from", "Virginia", "Tech", "Intellectual", "Properties,", "Inc.,", "or", "Virginia", "Tech,", "that", "are", "expected", "to", "expire", "in", "2016.", "<tag2>", "We", "have", "licensed", "the", "rights", "to", "a", "United", "States", "patent", "application", "covering", "oral", "composition", "comprising", "a", "TNF", "antagonist.", "<tag3>"], "wordsA": ["With", "respect", "to", "taliglucerase", "alfa,", "we", "have", "licensed", "the", "rights", "to", "two", "patents", "from", "Virginia", "Tech", "Intellectual", "Properties,", "Inc.,", "or", "Virginia", "Tech,", "that", "are", "expected", "to", "expire", "in", "2016."], "wordsB": ["We", "have", "licensed", "the", "rights", "to", "a", "United", "States", "patent", "application", "covering", "oral", "composition", "comprising", "a", "TNF", "antagonist."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p114_s0", "idA": "1006281_16_item1_p121_s0", "sentA": "We co-own a patent family containing eight pending applications that covers use of plant cells expressing a TNF alpha polypeptide inhibitor in therapy.", "sentB": "We co-own and have an exclusive license to a patent family, containing eight pending applications, that covers use of plant cells expressing a TNF alpha polypeptide inhibitor in therapy.", "type": 2, "words": ["<tag1>", "We", "co-own", "a", "patent", "family", "containing", "eight", "pending", "applications", "that", "covers", "use", "of", "plant", "cells", "expressing", "a", "TNF", "alpha", "polypeptide", "inhibitor", "in", "therapy.", "<tag2>", "We", "co-own", "and", "have", "an", "exclusive", "license", "to", "a", "patent", "family,", "containing", "eight", "pending", "applications,", "that", "covers", "use", "of", "plant", "cells", "expressing", "a", "TNF", "alpha", "polypeptide", "inhibitor", "in", "therapy.", "<tag3>"], "wordsA": ["We", "co-own", "a", "patent", "family", "containing", "eight", "pending", "applications", "that", "covers", "use", "of", "plant", "cells", "expressing", "a", "TNF", "alpha", "polypeptide", "inhibitor", "in", "therapy."], "wordsB": ["We", "co-own", "and", "have", "an", "exclusive", "license", "to", "a", "patent", "family,", "containing", "eight", "pending", "applications,", "that", "covers", "use", "of", "plant", "cells", "expressing", "a", "TNF", "alpha", "polypeptide", "inhibitor", "in", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p62_s1", "idA": "1006281_16_item1_p128_s4", "sentA": "In addition, we intend to use our manufacturing space to produce all of the drug substance needed in connection with the clinical trials for our product candidates.", "sentB": "At 12 months, we intend to conduct an interim analysis to test for non-inferiority to support an anticipated regulatory filing with the EMA.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "intend", "to", "use", "our", "manufacturing", "space", "to", "produce", "all", "of", "the", "drug", "substance", "needed", "in", "connection", "with", "the", "clinical", "trials", "for", "our", "product", "candidates.", "<tag2>", "At", "12", "months,", "we", "intend", "to", "conduct", "an", "interim", "analysis", "to", "test", "for", "non-inferiority", "to", "support", "an", "anticipated", "regulatory", "filing", "with", "the", "EMA.", "<tag3>"], "wordsA": ["In", "addition,", "we", "intend", "to", "use", "our", "manufacturing", "space", "to", "produce", "all", "of", "the", "drug", "substance", "needed", "in", "connection", "with", "the", "clinical", "trials", "for", "our", "product", "candidates."], "wordsB": ["At", "12", "months,", "we", "intend", "to", "conduct", "an", "interim", "analysis", "to", "test", "for", "non-inferiority", "to", "support", "an", "anticipated", "regulatory", "filing", "with", "the", "EMA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p120_s0", "idA": "1006281_16_item1_p129_s0", "sentA": "In addition, we are currently producing Fabry drug substance for our planned phase III trial as part of the process of converting our current approved manufacturing facility to an approved multi product facility, thereby introducing potentially significant operational savings.", "sentB": "In addition, we are currently producing Fabry drug substance for our phase III clinical trial as part of the process of converting our current approved manufacturing facility to an approved multi-product facility, thereby introducing potentially significant operational savings.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "are", "currently", "producing", "Fabry", "drug", "substance", "for", "our", "planned", "phase", "III", "trial", "as", "part", "of", "the", "process", "of", "converting", "our", "current", "approved", "manufacturing", "facility", "to", "an", "approved", "multi", "product", "facility,", "thereby", "introducing", "potentially", "significant", "operational", "savings.", "<tag2>", "In", "addition,", "we", "are", "currently", "producing", "Fabry", "drug", "substance", "for", "our", "phase", "III", "clinical", "trial", "as", "part", "of", "the", "process", "of", "converting", "our", "current", "approved", "manufacturing", "facility", "to", "an", "approved", "multi-product", "facility,", "thereby", "introducing", "potentially", "significant", "operational", "savings.", "<tag3>"], "wordsA": ["In", "addition,", "we", "are", "currently", "producing", "Fabry", "drug", "substance", "for", "our", "planned", "phase", "III", "trial", "as", "part", "of", "the", "process", "of", "converting", "our", "current", "approved", "manufacturing", "facility", "to", "an", "approved", "multi", "product", "facility,", "thereby", "introducing", "potentially", "significant", "operational", "savings."], "wordsB": ["In", "addition,", "we", "are", "currently", "producing", "Fabry", "drug", "substance", "for", "our", "phase", "III", "clinical", "trial", "as", "part", "of", "the", "process", "of", "converting", "our", "current", "approved", "manufacturing", "facility", "to", "an", "approved", "multi-product", "facility,", "thereby", "introducing", "potentially", "significant", "operational", "savings."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p13_s1", "idA": "1006281_16_item1_p12_s3", "sentA": "We completed a phase I clinical trial oPRX-106, which demonstrated that the drug was safe and well tolerated, showing biological activity in the gut and inducement of regulatory T cells.", "sentB": "OPRX-106 demonstrated a favorable safety and tolerability profile and biological activity in the gut in the phase I study.", "type": 2, "words": ["<tag1>", "We", "completed", "a", "phase", "I", "clinical", "trial", "oPRX-106,", "which", "demonstrated", "that", "the", "drug", "was", "safe", "and", "well", "tolerated,", "showing", "biological", "activity", "in", "the", "gut", "and", "inducement", "of", "regulatory", "T", "cells.", "<tag2>", "OPRX-106", "demonstrated", "a", "favorable", "safety", "and", "tolerability", "profile", "and", "biological", "activity", "in", "the", "gut", "in", "the", "phase", "I", "study.", "<tag3>"], "wordsA": ["We", "completed", "a", "phase", "I", "clinical", "trial", "oPRX-106,", "which", "demonstrated", "that", "the", "drug", "was", "safe", "and", "well", "tolerated,", "showing", "biological", "activity", "in", "the", "gut", "and", "inducement", "of", "regulatory", "T", "cells."], "wordsB": ["OPRX-106", "demonstrated", "a", "favorable", "safety", "and", "tolerability", "profile", "and", "biological", "activity", "in", "the", "gut", "in", "the", "phase", "I", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p92_s5", "idA": "1006281_16_item1_p12_s3", "sentA": "We completed a phase I clinical trial oPRX-106, which demonstrated that the drug was safe and well tolerated, showing biological activity in the gut and inducement of regulatory T cells.", "sentB": "Regulatory T cell activation showing biological activity in the gut was observed.", "type": 2, "words": ["<tag1>", "We", "completed", "a", "phase", "I", "clinical", "trial", "oPRX-106,", "which", "demonstrated", "that", "the", "drug", "was", "safe", "and", "well", "tolerated,", "showing", "biological", "activity", "in", "the", "gut", "and", "inducement", "of", "regulatory", "T", "cells.", "<tag2>", "Regulatory", "T", "cell", "activation", "showing", "biological", "activity", "in", "the", "gut", "was", "observed.", "<tag3>"], "wordsA": ["We", "completed", "a", "phase", "I", "clinical", "trial", "oPRX-106,", "which", "demonstrated", "that", "the", "drug", "was", "safe", "and", "well", "tolerated,", "showing", "biological", "activity", "in", "the", "gut", "and", "inducement", "of", "regulatory", "T", "cells."], "wordsB": ["Regulatory", "T", "cell", "activation", "showing", "biological", "activity", "in", "the", "gut", "was", "observed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p12_s3", "idA": "1006281_16_item1_p12_s4", "sentA": "We plan to initiate a proof of concept efficacy study for the treatment of ulcerative colitis in mid-year, 2016.", "sentB": "The first patient in our phase II proof of concept efficacy study of OPRX-106 for the treatment of ulcerative colitis was dosed in November 2016.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "for", "the", "treatment", "of", "ulcerative", "colitis", "in", "mid-year,", "2016.", "<tag2>", "The", "first", "patient", "in", "our", "phase", "II", "proof", "of", "concept", "efficacy", "study", "of", "OPRX-106", "for", "the", "treatment", "of", "ulcerative", "colitis", "was", "dosed", "in", "November", "2016.", "<tag3>"], "wordsA": ["We", "plan", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "for", "the", "treatment", "of", "ulcerative", "colitis", "in", "mid-year,", "2016."], "wordsB": ["The", "first", "patient", "in", "our", "phase", "II", "proof", "of", "concept", "efficacy", "study", "of", "OPRX-106", "for", "the", "treatment", "of", "ulcerative", "colitis", "was", "dosed", "in", "November", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p93_s0", "idA": "1006281_16_item1_p12_s4", "sentA": "We plan to initiate a proof of concept efficacy study for the treatment of ulcerative colitis in mid-year, 2016.", "sentB": "In November 2016, the first patient was enrolled in our phase IIa clinical trial of OPRX-106 for the treatment of ulcerative colitis.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "for", "the", "treatment", "of", "ulcerative", "colitis", "in", "mid-year,", "2016.", "<tag2>", "In", "November", "2016,", "the", "first", "patient", "was", "enrolled", "in", "our", "phase", "IIa", "clinical", "trial", "of", "OPRX-106", "for", "the", "treatment", "of", "ulcerative", "colitis.", "<tag3>"], "wordsA": ["We", "plan", "to", "initiate", "a", "proof", "of", "concept", "efficacy", "study", "for", "the", "treatment", "of", "ulcerative", "colitis", "in", "mid-year,", "2016."], "wordsB": ["In", "November", "2016,", "the", "first", "patient", "was", "enrolled", "in", "our", "phase", "IIa", "clinical", "trial", "of", "OPRX-106", "for", "the", "treatment", "of", "ulcerative", "colitis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p58_s1", "idA": "1006281_16_item1_p131_s0", "sentA": "Our current facility in Israel has been granted Approved Enterprise status, and we have elected to participate in the alternative benefits program.", "sentB": "Over 20 sites have been opened to participate in this trial.", "type": 2, "words": ["<tag1>", "Our", "current", "facility", "in", "Israel", "has", "been", "granted", "Approved", "Enterprise", "status,", "and", "we", "have", "elected", "to", "participate", "in", "the", "alternative", "benefits", "program.", "<tag2>", "Over", "20", "sites", "have", "been", "opened", "to", "participate", "in", "this", "trial.", "<tag3>"], "wordsA": ["Our", "current", "facility", "in", "Israel", "has", "been", "granted", "Approved", "Enterprise", "status,", "and", "we", "have", "elected", "to", "participate", "in", "the", "alternative", "benefits", "program."], "wordsB": ["Over", "20", "sites", "have", "been", "opened", "to", "participate", "in", "this", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p122_s1", "idA": "1006281_16_item1_p131_s1", "sentA": "Our facility is located in a Zone A location, and, therefore, our income from the Approved Enterprise will be tax exempt in Israel for a 10-year period commencing with the year in which we first generate taxable income from the relevant Approved Enterprise and after we use our NOLs.", "sentB": "Our facility is located in a Zone A location, and, therefore, our income from the Approved Enterprise will be tax exempt in Israel for a 10-year period commencing with the year in which we first generate taxable income from the relevant Approved Enterprise and after we use our net operating loss carryforwards, or NOLs.", "type": 2, "words": ["<tag1>", "Our", "facility", "is", "located", "in", "a", "Zone", "A", "location,", "and,", "therefore,", "our", "income", "from", "the", "Approved", "Enterprise", "will", "be", "tax", "exempt", "in", "Israel", "for", "a", "10-year", "period", "commencing", "with", "the", "year", "in", "which", "we", "first", "generate", "taxable", "income", "from", "the", "relevant", "Approved", "Enterprise", "and", "after", "we", "use", "our", "NOLs.", "<tag2>", "Our", "facility", "is", "located", "in", "a", "Zone", "A", "location,", "and,", "therefore,", "our", "income", "from", "the", "Approved", "Enterprise", "will", "be", "tax", "exempt", "in", "Israel", "for", "a", "10-year", "period", "commencing", "with", "the", "year", "in", "which", "we", "first", "generate", "taxable", "income", "from", "the", "relevant", "Approved", "Enterprise", "and", "after", "we", "use", "our", "net", "operating", "loss", "carryforwards,", "or", "NOLs.", "<tag3>"], "wordsA": ["Our", "facility", "is", "located", "in", "a", "Zone", "A", "location,", "and,", "therefore,", "our", "income", "from", "the", "Approved", "Enterprise", "will", "be", "tax", "exempt", "in", "Israel", "for", "a", "10-year", "period", "commencing", "with", "the", "year", "in", "which", "we", "first", "generate", "taxable", "income", "from", "the", "relevant", "Approved", "Enterprise", "and", "after", "we", "use", "our", "NOLs."], "wordsB": ["Our", "facility", "is", "located", "in", "a", "Zone", "A", "location,", "and,", "therefore,", "our", "income", "from", "the", "Approved", "Enterprise", "will", "be", "tax", "exempt", "in", "Israel", "for", "a", "10-year", "period", "commencing", "with", "the", "year", "in", "which", "we", "first", "generate", "taxable", "income", "from", "the", "relevant", "Approved", "Enterprise", "and", "after", "we", "use", "our", "net", "operating", "loss", "carryforwards,", "or", "NOLs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p63_s2", "idA": "1006281_16_item1_p131_s2", "sentA": "We expect to be entitled to similar tax benefits for a number of years thereafter.", "sentB": "We expect to enroll 22 patients in the BRIDGE Study during 2017.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "be", "entitled", "to", "similar", "tax", "benefits", "for", "a", "number", "of", "years", "thereafter.", "<tag2>", "We", "expect", "to", "enroll", "22", "patients", "in", "the", "BRIDGE", "Study", "during", "2017.", "<tag3>"], "wordsA": ["We", "expect", "to", "be", "entitled", "to", "similar", "tax", "benefits", "for", "a", "number", "of", "years", "thereafter."], "wordsB": ["We", "expect", "to", "enroll", "22", "patients", "in", "the", "BRIDGE", "Study", "during", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p8_s1", "idA": "1006281_16_item1_p131_s2", "sentA": "We expect to be entitled to similar tax benefits for a number of years thereafter.", "sentB": "The Brazilian MoH s order consists of a number of shipments during 2017 for a total of approximately $24.3 million.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "be", "entitled", "to", "similar", "tax", "benefits", "for", "a", "number", "of", "years", "thereafter.", "<tag2>", "The", "Brazilian", "MoH", "s", "order", "consists", "of", "a", "number", "of", "shipments", "during", "2017", "for", "a", "total", "of", "approximately", "$24.3", "million.", "<tag3>"], "wordsA": ["We", "expect", "to", "be", "entitled", "to", "similar", "tax", "benefits", "for", "a", "number", "of", "years", "thereafter."], "wordsB": ["The", "Brazilian", "MoH", "s", "order", "consists", "of", "a", "number", "of", "shipments", "during", "2017", "for", "a", "total", "of", "approximately", "$24.3", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p95_s1", "idA": "1006281_16_item1_p131_s2", "sentA": "We expect to be entitled to similar tax benefits for a number of years thereafter.", "sentB": "The Brazilian MoH s order consists of a number of shipments during 2017 for a total of approximately $24.3 million.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "be", "entitled", "to", "similar", "tax", "benefits", "for", "a", "number", "of", "years", "thereafter.", "<tag2>", "The", "Brazilian", "MoH", "s", "order", "consists", "of", "a", "number", "of", "shipments", "during", "2017", "for", "a", "total", "of", "approximately", "$24.3", "million.", "<tag3>"], "wordsA": ["We", "expect", "to", "be", "entitled", "to", "similar", "tax", "benefits", "for", "a", "number", "of", "years", "thereafter."], "wordsB": ["The", "Brazilian", "MoH", "s", "order", "consists", "of", "a", "number", "of", "shipments", "during", "2017", "for", "a", "total", "of", "approximately", "$24.3", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p123_s0", "idA": "1006281_16_item1_p132_s0", "sentA": "We believe that the raw materials that we require throughout the manufacturing process of Elelyso, PRX-102 and our other current and potential drug product candidates are widely available from numerous suppliers and are generally considered to be generic industrial biological supplies.", "sentB": "We believe that the raw materials that we require throughout the manufacturing process of Elelyso, PRX-102, alidornase alfa and OPRX-106 and our other current and potential drug product candidates are widely available from numerous suppliers and are generally considered to be generic industrial biological supplies.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "the", "raw", "materials", "that", "we", "require", "throughout", "the", "manufacturing", "process", "of", "Elelyso,", "PRX-102", "and", "our", "other", "current", "and", "potential", "drug", "product", "candidates", "are", "widely", "available", "from", "numerous", "suppliers", "and", "are", "generally", "considered", "to", "be", "generic", "industrial", "biological", "supplies.", "<tag2>", "We", "believe", "that", "the", "raw", "materials", "that", "we", "require", "throughout", "the", "manufacturing", "process", "of", "Elelyso,", "PRX-102,", "alidornase", "alfa", "and", "OPRX-106", "and", "our", "other", "current", "and", "potential", "drug", "product", "candidates", "are", "widely", "available", "from", "numerous", "suppliers", "and", "are", "generally", "considered", "to", "be", "generic", "industrial", "biological", "supplies.", "<tag3>"], "wordsA": ["We", "believe", "that", "the", "raw", "materials", "that", "we", "require", "throughout", "the", "manufacturing", "process", "of", "Elelyso,", "PRX-102", "and", "our", "other", "current", "and", "potential", "drug", "product", "candidates", "are", "widely", "available", "from", "numerous", "suppliers", "and", "are", "generally", "considered", "to", "be", "generic", "industrial", "biological", "supplies."], "wordsB": ["We", "believe", "that", "the", "raw", "materials", "that", "we", "require", "throughout", "the", "manufacturing", "process", "of", "Elelyso,", "PRX-102,", "alidornase", "alfa", "and", "OPRX-106", "and", "our", "other", "current", "and", "potential", "drug", "product", "candidates", "are", "widely", "available", "from", "numerous", "suppliers", "and", "are", "generally", "considered", "to", "be", "generic", "industrial", "biological", "supplies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p86_s0", "idA": "1006281_16_item1_p134_s0", "sentA": "The biotechnology and pharmaceutical industries are characterized by rapidly evolving technology and significant competition.", "sentB": "Auto-immune-mediated inflammatory disorders are conditions that are characterized by common pathways that lead to inflammation and are caused or triggered by a compromised or dysregulation of the normal immune response.", "type": 2, "words": ["<tag1>", "The", "biotechnology", "and", "pharmaceutical", "industries", "are", "characterized", "by", "rapidly", "evolving", "technology", "and", "significant", "competition.", "<tag2>", "Auto-immune-mediated", "inflammatory", "disorders", "are", "conditions", "that", "are", "characterized", "by", "common", "pathways", "that", "lead", "to", "inflammation", "and", "are", "caused", "or", "triggered", "by", "a", "compromised", "or", "dysregulation", "of", "the", "normal", "immune", "response.", "<tag3>"], "wordsA": ["The", "biotechnology", "and", "pharmaceutical", "industries", "are", "characterized", "by", "rapidly", "evolving", "technology", "and", "significant", "competition."], "wordsB": ["Auto-immune-mediated", "inflammatory", "disorders", "are", "conditions", "that", "are", "characterized", "by", "common", "pathways", "that", "lead", "to", "inflammation", "and", "are", "caused", "or", "triggered", "by", "a", "compromised", "or", "dysregulation", "of", "the", "normal", "immune", "response."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p126_s3", "idA": "1006281_16_item1_p135_s3", "sentA": "In addition, we are aware of other clinical stage, early clinical stage and experimental drugs which are being developed for the treatment of Fabry disease by Amicus Therapeutics, Inc. and other companies.", "sentB": "In addition, we are aware of other late clinical stage, early clinical stage and experimental drugs which are being developed for the treatment of Fabry disease by Amicus Therapeutics, Inc. and other companies.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "are", "aware", "of", "other", "clinical", "stage,", "early", "clinical", "stage", "and", "experimental", "drugs", "which", "are", "being", "developed", "for", "the", "treatment", "of", "Fabry", "disease", "by", "Amicus", "Therapeutics,", "Inc.", "and", "other", "companies.", "<tag2>", "In", "addition,", "we", "are", "aware", "of", "other", "late", "clinical", "stage,", "early", "clinical", "stage", "and", "experimental", "drugs", "which", "are", "being", "developed", "for", "the", "treatment", "of", "Fabry", "disease", "by", "Amicus", "Therapeutics,", "Inc.", "and", "other", "companies.", "<tag3>"], "wordsA": ["In", "addition,", "we", "are", "aware", "of", "other", "clinical", "stage,", "early", "clinical", "stage", "and", "experimental", "drugs", "which", "are", "being", "developed", "for", "the", "treatment", "of", "Fabry", "disease", "by", "Amicus", "Therapeutics,", "Inc.", "and", "other", "companies."], "wordsB": ["In", "addition,", "we", "are", "aware", "of", "other", "late", "clinical", "stage,", "early", "clinical", "stage", "and", "experimental", "drugs", "which", "are", "being", "developed", "for", "the", "treatment", "of", "Fabry", "disease", "by", "Amicus", "Therapeutics,", "Inc.", "and", "other", "companies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p126_s4", "idA": "1006281_16_item1_p135_s3", "sentA": "In addition, we are aware of other clinical stage, early clinical stage and experimental drugs which are being developed for the treatment of Fabry disease by Amicus Therapeutics, Inc. and other companies.", "sentB": "In addition, in May 2016, Galafold (migalastat), an oral small molecule pharmacological chaperone marketed by Amicus Therapeutics, Inc. was approved as a first line therapy for long-term treatment of adults and adolescents aged 16 years and older with a confirmed diagnosis of Fabry disease and who have an amenable mutation.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "are", "aware", "of", "other", "clinical", "stage,", "early", "clinical", "stage", "and", "experimental", "drugs", "which", "are", "being", "developed", "for", "the", "treatment", "of", "Fabry", "disease", "by", "Amicus", "Therapeutics,", "Inc.", "and", "other", "companies.", "<tag2>", "In", "addition,", "in", "May", "2016,", "Galafold", "(migalastat),", "an", "oral", "small", "molecule", "pharmacological", "chaperone", "marketed", "by", "Amicus", "Therapeutics,", "Inc.", "was", "approved", "as", "a", "first", "line", "therapy", "for", "long-term", "treatment", "of", "adults", "and", "adolescents", "aged", "16", "years", "and", "older", "with", "a", "confirmed", "diagnosis", "of", "Fabry", "disease", "and", "who", "have", "an", "amenable", "mutation.", "<tag3>"], "wordsA": ["In", "addition,", "we", "are", "aware", "of", "other", "clinical", "stage,", "early", "clinical", "stage", "and", "experimental", "drugs", "which", "are", "being", "developed", "for", "the", "treatment", "of", "Fabry", "disease", "by", "Amicus", "Therapeutics,", "Inc.", "and", "other", "companies."], "wordsB": ["In", "addition,", "in", "May", "2016,", "Galafold", "(migalastat),", "an", "oral", "small", "molecule", "pharmacological", "chaperone", "marketed", "by", "Amicus", "Therapeutics,", "Inc.", "was", "approved", "as", "a", "first", "line", "therapy", "for", "long-term", "treatment", "of", "adults", "and", "adolescents", "aged", "16", "years", "and", "older", "with", "a", "confirmed", "diagnosis", "of", "Fabry", "disease", "and", "who", "have", "an", "amenable", "mutation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p128_s1", "idA": "1006281_16_item1_p135_s3", "sentA": "In addition, we are aware of other clinical stage, early clinical stage and experimental drugs which are being developed for the treatment of Fabry disease by Amicus Therapeutics, Inc. and other companies.", "sentB": "In addition, we are aware of other clinical stage, early clinical stage and experimental antiTNF drugs.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "are", "aware", "of", "other", "clinical", "stage,", "early", "clinical", "stage", "and", "experimental", "drugs", "which", "are", "being", "developed", "for", "the", "treatment", "of", "Fabry", "disease", "by", "Amicus", "Therapeutics,", "Inc.", "and", "other", "companies.", "<tag2>", "In", "addition,", "we", "are", "aware", "of", "other", "clinical", "stage,", "early", "clinical", "stage", "and", "experimental", "antiTNF", "drugs.", "<tag3>"], "wordsA": ["In", "addition,", "we", "are", "aware", "of", "other", "clinical", "stage,", "early", "clinical", "stage", "and", "experimental", "drugs", "which", "are", "being", "developed", "for", "the", "treatment", "of", "Fabry", "disease", "by", "Amicus", "Therapeutics,", "Inc.", "and", "other", "companies."], "wordsB": ["In", "addition,", "we", "are", "aware", "of", "other", "clinical", "stage,", "early", "clinical", "stage", "and", "experimental", "antiTNF", "drugs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p127_s0", "idA": "1006281_16_item1_p136_s0", "sentA": "With respect to PRX-110 AIR DNase, we face competition from Genentech Inc., a member of the Roche Group, which markets Pulmozyme , and from the producers of CFTR protein potentiation such as Vertex Pharmaceuticals Incorporated (Kalydeco and Orkambi ).", "sentB": "With respect to alidornase alfa, we face competition from Genentech Inc., a member of the Roche Group, which markets Pulmozyme.", "type": 2, "words": ["<tag1>", "With", "respect", "to", "PRX-110", "AIR", "DNase,", "we", "face", "competition", "from", "Genentech", "Inc.,", "a", "member", "of", "the", "Roche", "Group,", "which", "markets", "Pulmozyme", ",", "and", "from", "the", "producers", "of", "CFTR", "protein", "potentiation", "such", "as", "Vertex", "Pharmaceuticals", "Incorporated", "(Kalydeco", "and", "Orkambi", ").", "<tag2>", "With", "respect", "to", "alidornase", "alfa,", "we", "face", "competition", "from", "Genentech", "Inc.,", "a", "member", "of", "the", "Roche", "Group,", "which", "markets", "Pulmozyme.", "<tag3>"], "wordsA": ["With", "respect", "to", "PRX-110", "AIR", "DNase,", "we", "face", "competition", "from", "Genentech", "Inc.,", "a", "member", "of", "the", "Roche", "Group,", "which", "markets", "Pulmozyme", ",", "and", "from", "the", "producers", "of", "CFTR", "protein", "potentiation", "such", "as", "Vertex", "Pharmaceuticals", "Incorporated", "(Kalydeco", "and", "Orkambi", ")."], "wordsB": ["With", "respect", "to", "alidornase", "alfa,", "we", "face", "competition", "from", "Genentech", "Inc.,", "a", "member", "of", "the", "Roche", "Group,", "which", "markets", "Pulmozyme."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p153_s0", "idA": "1006281_16_item1_p162_s0", "sentA": "The income of Protalix Ltd., other than income from Approved Enterprises, is taxed in Israel at the regular rates which were 25% in 2013 and 26.5% for 2014 and 2015.", "sentB": "The income of Protalix Ltd., other than income from Approved Enterprises, is taxed in Israel at the regular rates which were 26.5% for fiscal years 2014 through 2015, and 25% in 2016.", "type": 2, "words": ["<tag1>", "The", "income", "of", "Protalix", "Ltd.,", "other", "than", "income", "from", "Approved", "Enterprises,", "is", "taxed", "in", "Israel", "at", "the", "regular", "rates", "which", "were", "25%", "in", "2013", "and", "26.5%", "for", "2014", "and", "2015.", "<tag2>", "The", "income", "of", "Protalix", "Ltd.,", "other", "than", "income", "from", "Approved", "Enterprises,", "is", "taxed", "in", "Israel", "at", "the", "regular", "rates", "which", "were", "26.5%", "for", "fiscal", "years", "2014", "through", "2015,", "and", "25%", "in", "2016.", "<tag3>"], "wordsA": ["The", "income", "of", "Protalix", "Ltd.,", "other", "than", "income", "from", "Approved", "Enterprises,", "is", "taxed", "in", "Israel", "at", "the", "regular", "rates", "which", "were", "25%", "in", "2013", "and", "26.5%", "for", "2014", "and", "2015."], "wordsB": ["The", "income", "of", "Protalix", "Ltd.,", "other", "than", "income", "from", "Approved", "Enterprises,", "is", "taxed", "in", "Israel", "at", "the", "regular", "rates", "which", "were", "26.5%", "for", "fiscal", "years", "2014", "through", "2015,", "and", "25%", "in", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p154_s1", "idA": "1006281_16_item1_p163_s0", "sentA": "In January 2016, the Law for the Amendment of the Income Tax Ordinance (No. 216) was published, enacting a reduction of corporate tax rate beginning in 2016 and thereafter, from 26.5% to 25%.", "sentB": "In December 2016, the Economic Efficiency Law (Legislative Amendments for Implementing the Economic Policy for the 2017 and 2018 Budget Year), 2016 was published, introducing a gradual reduction in corporate tax rate from 25% to 23%.", "type": 2, "words": ["<tag1>", "In", "January", "2016,", "the", "Law", "for", "the", "Amendment", "of", "the", "Income", "Tax", "Ordinance", "(No.", "216)", "was", "published,", "enacting", "a", "reduction", "of", "corporate", "tax", "rate", "beginning", "in", "2016", "and", "thereafter,", "from", "26.5%", "to", "25%.", "<tag2>", "In", "December", "2016,", "the", "Economic", "Efficiency", "Law", "(Legislative", "Amendments", "for", "Implementing", "the", "Economic", "Policy", "for", "the", "2017", "and", "2018", "Budget", "Year),", "2016", "was", "published,", "introducing", "a", "gradual", "reduction", "in", "corporate", "tax", "rate", "from", "25%", "to", "23%.", "<tag3>"], "wordsA": ["In", "January", "2016,", "the", "Law", "for", "the", "Amendment", "of", "the", "Income", "Tax", "Ordinance", "(No.", "216)", "was", "published,", "enacting", "a", "reduction", "of", "corporate", "tax", "rate", "beginning", "in", "2016", "and", "thereafter,", "from", "26.5%", "to", "25%."], "wordsB": ["In", "December", "2016,", "the", "Economic", "Efficiency", "Law", "(Legislative", "Amendments", "for", "Implementing", "the", "Economic", "Policy", "for", "the", "2017", "and", "2018", "Budget", "Year),", "2016", "was", "published,", "introducing", "a", "gradual", "reduction", "in", "corporate", "tax", "rate", "from", "25%", "to", "23%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p154_s2", "idA": "1006281_16_item1_p164_s0", "sentA": "Capital gains on the sale of assets are subject to capital gain tax according to the corporate tax rate in effect in the year which the assets are sold.", "sentB": "However, the law also included a temporary provision setting the corporate tax rate in 2017 at 24%.", "type": 2, "words": ["<tag1>", "Capital", "gains", "on", "the", "sale", "of", "assets", "are", "subject", "to", "capital", "gain", "tax", "according", "to", "the", "corporate", "tax", "rate", "in", "effect", "in", "the", "year", "which", "the", "assets", "are", "sold.", "<tag2>", "However,", "the", "law", "also", "included", "a", "temporary", "provision", "setting", "the", "corporate", "tax", "rate", "in", "2017", "at", "24%.", "<tag3>"], "wordsA": ["Capital", "gains", "on", "the", "sale", "of", "assets", "are", "subject", "to", "capital", "gain", "tax", "according", "to", "the", "corporate", "tax", "rate", "in", "effect", "in", "the", "year", "which", "the", "assets", "are", "sold."], "wordsB": ["However,", "the", "law", "also", "included", "a", "temporary", "provision", "setting", "the", "corporate", "tax", "rate", "in", "2017", "at", "24%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p155_s0", "idA": "1006281_16_item1_p164_s0", "sentA": "Capital gains on the sale of assets are subject to capital gain tax according to the corporate tax rate in effect in the year which the assets are sold.", "sentB": "Capital gains on the sale of assets are subject to capital gains tax according to the corporate tax rate in effect in the year which the assets are sold.", "type": 2, "words": ["<tag1>", "Capital", "gains", "on", "the", "sale", "of", "assets", "are", "subject", "to", "capital", "gain", "tax", "according", "to", "the", "corporate", "tax", "rate", "in", "effect", "in", "the", "year", "which", "the", "assets", "are", "sold.", "<tag2>", "Capital", "gains", "on", "the", "sale", "of", "assets", "are", "subject", "to", "capital", "gains", "tax", "according", "to", "the", "corporate", "tax", "rate", "in", "effect", "in", "the", "year", "which", "the", "assets", "are", "sold.", "<tag3>"], "wordsA": ["Capital", "gains", "on", "the", "sale", "of", "assets", "are", "subject", "to", "capital", "gain", "tax", "according", "to", "the", "corporate", "tax", "rate", "in", "effect", "in", "the", "year", "which", "the", "assets", "are", "sold."], "wordsB": ["Capital", "gains", "on", "the", "sale", "of", "assets", "are", "subject", "to", "capital", "gains", "tax", "according", "to", "the", "corporate", "tax", "rate", "in", "effect", "in", "the", "year", "which", "the", "assets", "are", "sold."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p156_s0", "idA": "1006281_16_item1_p166_s0", "sentA": "The Law for the Encouragement of Capital Investments, 1959, or the Investment Law, provides certain incentives for capital investments in a production facility (or other eligible assets).", "sentB": "The Law for the Encouragement of Capital Investments, 1959, as amended or the Investment Law, provides certain incentives for capital investments in a production facility (or other eligible assets).", "type": 2, "words": ["<tag1>", "The", "Law", "for", "the", "Encouragement", "of", "Capital", "Investments,", "1959,", "or", "the", "Investment", "Law,", "provides", "certain", "incentives", "for", "capital", "investments", "in", "a", "production", "facility", "(or", "other", "eligible", "assets).", "<tag2>", "The", "Law", "for", "the", "Encouragement", "of", "Capital", "Investments,", "1959,", "as", "amended", "or", "the", "Investment", "Law,", "provides", "certain", "incentives", "for", "capital", "investments", "in", "a", "production", "facility", "(or", "other", "eligible", "assets).", "<tag3>"], "wordsA": ["The", "Law", "for", "the", "Encouragement", "of", "Capital", "Investments,", "1959,", "or", "the", "Investment", "Law,", "provides", "certain", "incentives", "for", "capital", "investments", "in", "a", "production", "facility", "(or", "other", "eligible", "assets)."], "wordsB": ["The", "Law", "for", "the", "Encouragement", "of", "Capital", "Investments,", "1959,", "as", "amended", "or", "the", "Investment", "Law,", "provides", "certain", "incentives", "for", "capital", "investments", "in", "a", "production", "facility", "(or", "other", "eligible", "assets)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p158_s0", "idA": "1006281_16_item1_p168_s0", "sentA": "Under the Investment Law prior to its amendment, a company that wished to receive benefits had to receive approval from the Investment Center of the Israeli Ministry of Industry, Trade and Labor, or the Investment Center.", "sentB": "Under the Investment Law prior to its amendment, a company that wished to receive benefits had to receive approval from the Authority for the Investment and Development of the Industry and Economy, or the Authority.", "type": 2, "words": ["<tag1>", "Under", "the", "Investment", "Law", "prior", "to", "its", "amendment,", "a", "company", "that", "wished", "to", "receive", "benefits", "had", "to", "receive", "approval", "from", "the", "Investment", "Center", "of", "the", "Israeli", "Ministry", "of", "Industry,", "Trade", "and", "Labor,", "or", "the", "Investment", "Center.", "<tag2>", "Under", "the", "Investment", "Law", "prior", "to", "its", "amendment,", "a", "company", "that", "wished", "to", "receive", "benefits", "had", "to", "receive", "approval", "from", "the", "Authority", "for", "the", "Investment", "and", "Development", "of", "the", "Industry", "and", "Economy,", "or", "the", "Authority.", "<tag3>"], "wordsA": ["Under", "the", "Investment", "Law", "prior", "to", "its", "amendment,", "a", "company", "that", "wished", "to", "receive", "benefits", "had", "to", "receive", "approval", "from", "the", "Investment", "Center", "of", "the", "Israeli", "Ministry", "of", "Industry,", "Trade", "and", "Labor,", "or", "the", "Investment", "Center."], "wordsB": ["Under", "the", "Investment", "Law", "prior", "to", "its", "amendment,", "a", "company", "that", "wished", "to", "receive", "benefits", "had", "to", "receive", "approval", "from", "the", "Authority", "for", "the", "Investment", "and", "Development", "of", "the", "Industry", "and", "Economy,", "or", "the", "Authority."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p71_s0", "idA": "1006281_16_item1_p171_s0", "sentA": "If a company has more than one Approved Enterprise program or if only a portion of its capital investments are approved, its effective tax rate is the result of a weighted combination of the applicable rates.", "sentB": "The study results showed improved stability and prolonged exposure to the enzyme, which we believe is the result of the PEGylation and cross linking we made to the enzyme.", "type": 2, "words": ["<tag1>", "If", "a", "company", "has", "more", "than", "one", "Approved", "Enterprise", "program", "or", "if", "only", "a", "portion", "of", "its", "capital", "investments", "are", "approved,", "its", "effective", "tax", "rate", "is", "the", "result", "of", "a", "weighted", "combination", "of", "the", "applicable", "rates.", "<tag2>", "The", "study", "results", "showed", "improved", "stability", "and", "prolonged", "exposure", "to", "the", "enzyme,", "which", "we", "believe", "is", "the", "result", "of", "the", "PEGylation", "and", "cross", "linking", "we", "made", "to", "the", "enzyme.", "<tag3>"], "wordsA": ["If", "a", "company", "has", "more", "than", "one", "Approved", "Enterprise", "program", "or", "if", "only", "a", "portion", "of", "its", "capital", "investments", "are", "approved,", "its", "effective", "tax", "rate", "is", "the", "result", "of", "a", "weighted", "combination", "of", "the", "applicable", "rates."], "wordsB": ["The", "study", "results", "showed", "improved", "stability", "and", "prolonged", "exposure", "to", "the", "enzyme,", "which", "we", "believe", "is", "the", "result", "of", "the", "PEGylation", "and", "cross", "linking", "we", "made", "to", "the", "enzyme."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p173_s1", "idA": "1006281_16_item1_p176_s1", "sentA": "This benefit is an incentive granted by the Israeli government regardless of whether the alternative benefits program is elected.", "sentB": "On January 1, 2016, the Israeli government established the National Authority for Technological Innovation, or NATI.", "type": 2, "words": ["<tag1>", "This", "benefit", "is", "an", "incentive", "granted", "by", "the", "Israeli", "government", "regardless", "of", "whether", "the", "alternative", "benefits", "program", "is", "elected.", "<tag2>", "On", "January", "1,", "2016,", "the", "Israeli", "government", "established", "the", "National", "Authority", "for", "Technological", "Innovation,", "or", "NATI.", "<tag3>"], "wordsA": ["This", "benefit", "is", "an", "incentive", "granted", "by", "the", "Israeli", "government", "regardless", "of", "whether", "the", "alternative", "benefits", "program", "is", "elected."], "wordsB": ["On", "January", "1,", "2016,", "the", "Israeli", "government", "established", "the", "National", "Authority", "for", "Technological", "Innovation,", "or", "NATI."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p168_s0", "idA": "1006281_16_item1_p178_s0", "sentA": "Under the Investment Law, the approval of the Investment Center is required only for Approved Enterprises that receive cash grants.", "sentB": "Under the Investment Law, the approval of the Authority is required only for Approved Enterprises that receive cash grants.", "type": 2, "words": ["<tag1>", "Under", "the", "Investment", "Law,", "the", "approval", "of", "the", "Investment", "Center", "is", "required", "only", "for", "Approved", "Enterprises", "that", "receive", "cash", "grants.", "<tag2>", "Under", "the", "Investment", "Law,", "the", "approval", "of", "the", "Authority", "is", "required", "only", "for", "Approved", "Enterprises", "that", "receive", "cash", "grants.", "<tag3>"], "wordsA": ["Under", "the", "Investment", "Law,", "the", "approval", "of", "the", "Investment", "Center", "is", "required", "only", "for", "Approved", "Enterprises", "that", "receive", "cash", "grants."], "wordsB": ["Under", "the", "Investment", "Law,", "the", "approval", "of", "the", "Authority", "is", "required", "only", "for", "Approved", "Enterprises", "that", "receive", "cash", "grants."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p25_s1", "idA": "1006281_16_item1_p17_s1", "sentA": "Mammalian cell-based systems were first introduced in the late 1980s and are currently used to produce many of the biotechnology industry s largest and most successful therapeutic proteins, including Epogen , Neupogen , Cerezyme , Rituxan , Humira , Enbrel , Neulasta , Remicade and Herceptin .", "sentB": "Many of the biotechnology industry s largest and most successful therapeutic proteins, including Epogen , Neupogen , Cerezyme , Rituxan , Humira , Enbrel , Neulasta , Remicade and Herceptin are produced through mammalian cell-based expression systems.", "type": 2, "words": ["<tag1>", "Mammalian", "cell-based", "systems", "were", "first", "introduced", "in", "the", "late", "1980s", "and", "are", "currently", "used", "to", "produce", "many", "of", "the", "biotechnology", "industry", "s", "largest", "and", "most", "successful", "therapeutic", "proteins,", "including", "Epogen", ",", "Neupogen", ",", "Cerezyme", ",", "Rituxan", ",", "Humira", ",", "Enbrel", ",", "Neulasta", ",", "Remicade", "and", "Herceptin", ".", "<tag2>", "Many", "of", "the", "biotechnology", "industry", "s", "largest", "and", "most", "successful", "therapeutic", "proteins,", "including", "Epogen", ",", "Neupogen", ",", "Cerezyme", ",", "Rituxan", ",", "Humira", ",", "Enbrel", ",", "Neulasta", ",", "Remicade", "and", "Herceptin", "are", "produced", "through", "mammalian", "cell-based", "expression", "systems.", "<tag3>"], "wordsA": ["Mammalian", "cell-based", "systems", "were", "first", "introduced", "in", "the", "late", "1980s", "and", "are", "currently", "used", "to", "produce", "many", "of", "the", "biotechnology", "industry", "s", "largest", "and", "most", "successful", "therapeutic", "proteins,", "including", "Epogen", ",", "Neupogen", ",", "Cerezyme", ",", "Rituxan", ",", "Humira", ",", "Enbrel", ",", "Neulasta", ",", "Remicade", "and", "Herceptin", "."], "wordsB": ["Many", "of", "the", "biotechnology", "industry", "s", "largest", "and", "most", "successful", "therapeutic", "proteins,", "including", "Epogen", ",", "Neupogen", ",", "Cerezyme", ",", "Rituxan", ",", "Humira", ",", "Enbrel", ",", "Neulasta", ",", "Remicade", "and", "Herceptin", "are", "produced", "through", "mammalian", "cell-based", "expression", "systems."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p173_s0", "idA": "1006281_16_item1_p183_s0", "sentA": "To date, Protalix Ltd. has received grants from the Office of the Chief Scientist of Israel s Ministry of Industry, Trade and Labor, or the OCS, for the financing of a portion of its research and development expenditures in Israel.", "sentB": "To date, Protalix Ltd. has received grants from the Office of the Chief Scientist, or the OCS, under the Israeli Law for the Encouragement of Industrial Research, Development and Technology Innovation, 1984, and related regulations, or the Research Law.", "type": 2, "words": ["<tag1>", "To", "date,", "Protalix", "Ltd.", "has", "received", "grants", "from", "the", "Office", "of", "the", "Chief", "Scientist", "of", "Israel", "s", "Ministry", "of", "Industry,", "Trade", "and", "Labor,", "or", "the", "OCS,", "for", "the", "financing", "of", "a", "portion", "of", "its", "research", "and", "development", "expenditures", "in", "Israel.", "<tag2>", "To", "date,", "Protalix", "Ltd.", "has", "received", "grants", "from", "the", "Office", "of", "the", "Chief", "Scientist,", "or", "the", "OCS,", "under", "the", "Israeli", "Law", "for", "the", "Encouragement", "of", "Industrial", "Research,", "Development", "and", "Technology", "Innovation,", "1984,", "and", "related", "regulations,", "or", "the", "Research", "Law.", "<tag3>"], "wordsA": ["To", "date,", "Protalix", "Ltd.", "has", "received", "grants", "from", "the", "Office", "of", "the", "Chief", "Scientist", "of", "Israel", "s", "Ministry", "of", "Industry,", "Trade", "and", "Labor,", "or", "the", "OCS,", "for", "the", "financing", "of", "a", "portion", "of", "its", "research", "and", "development", "expenditures", "in", "Israel."], "wordsB": ["To", "date,", "Protalix", "Ltd.", "has", "received", "grants", "from", "the", "Office", "of", "the", "Chief", "Scientist,", "or", "the", "OCS,", "under", "the", "Israeli", "Law", "for", "the", "Encouragement", "of", "Industrial", "Research,", "Development", "and", "Technology", "Innovation,", "1984,", "and", "related", "regulations,", "or", "the", "Research", "Law."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p174_s0", "idA": "1006281_16_item1_p183_s0", "sentA": "To date, Protalix Ltd. has received grants from the Office of the Chief Scientist of Israel s Ministry of Industry, Trade and Labor, or the OCS, for the financing of a portion of its research and development expenditures in Israel.", "sentB": "NATI grants are made available to finance of a portion of Protalix Ltd. s research and development expenditures in Israel.", "type": 2, "words": ["<tag1>", "To", "date,", "Protalix", "Ltd.", "has", "received", "grants", "from", "the", "Office", "of", "the", "Chief", "Scientist", "of", "Israel", "s", "Ministry", "of", "Industry,", "Trade", "and", "Labor,", "or", "the", "OCS,", "for", "the", "financing", "of", "a", "portion", "of", "its", "research", "and", "development", "expenditures", "in", "Israel.", "<tag2>", "NATI", "grants", "are", "made", "available", "to", "finance", "of", "a", "portion", "of", "Protalix", "Ltd.", "s", "research", "and", "development", "expenditures", "in", "Israel.", "<tag3>"], "wordsA": ["To", "date,", "Protalix", "Ltd.", "has", "received", "grants", "from", "the", "Office", "of", "the", "Chief", "Scientist", "of", "Israel", "s", "Ministry", "of", "Industry,", "Trade", "and", "Labor,", "or", "the", "OCS,", "for", "the", "financing", "of", "a", "portion", "of", "its", "research", "and", "development", "expenditures", "in", "Israel."], "wordsB": ["NATI", "grants", "are", "made", "available", "to", "finance", "of", "a", "portion", "of", "Protalix", "Ltd.", "s", "research", "and", "development", "expenditures", "in", "Israel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p174_s1", "idA": "1006281_16_item1_p183_s1", "sentA": "As of December 31, 2015, the OCS approved grants in respect of Protalix Ltd. s continuing operations totaling approximately $41.8 million, measured from inception.", "sentB": "As of December 31, 2016, NATI approved grants in respect of Protalix Ltd. s continuing operations totaling approximately $46.6 million, measured from inception.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2015,", "the", "OCS", "approved", "grants", "in", "respect", "of", "Protalix", "Ltd.", "s", "continuing", "operations", "totaling", "approximately", "$41.8", "million,", "measured", "from", "inception.", "<tag2>", "As", "of", "December", "31,", "2016,", "NATI", "approved", "grants", "in", "respect", "of", "Protalix", "Ltd.", "s", "continuing", "operations", "totaling", "approximately", "$46.6", "million,", "measured", "from", "inception.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2015,", "the", "OCS", "approved", "grants", "in", "respect", "of", "Protalix", "Ltd.", "s", "continuing", "operations", "totaling", "approximately", "$41.8", "million,", "measured", "from", "inception."], "wordsB": ["As", "of", "December", "31,", "2016,", "NATI", "approved", "grants", "in", "respect", "of", "Protalix", "Ltd.", "s", "continuing", "operations", "totaling", "approximately", "$46.6", "million,", "measured", "from", "inception."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p174_s2", "idA": "1006281_16_item1_p183_s2", "sentA": "Protalix Ltd. is required to repay up to 100% of grants actually received (plus interest at the LIBOR rate applied to the grants received on or after January 1, 1999) to the OCS through payments of royalties at a rate of 3% to 6% of the revenues generated from an OCS-funded project, depending on the period in which revenues were generated.", "sentB": "Protalix Ltd. is required to repay up to 100% of grants actually received (plus interest at the LIBOR rate applied to the grants received on or after January 1, 1999) to NATI through payments of royalties at a rate of 3% to 6% of the revenues generated from NATI-funded project, depending on the period in which revenues were generated.", "type": 2, "words": ["<tag1>", "Protalix", "Ltd.", "is", "required", "to", "repay", "up", "to", "100%", "of", "grants", "actually", "received", "(plus", "interest", "at", "the", "LIBOR", "rate", "applied", "to", "the", "grants", "received", "on", "or", "after", "January", "1,", "1999)", "to", "the", "OCS", "through", "payments", "of", "royalties", "at", "a", "rate", "of", "3%", "to", "6%", "of", "the", "revenues", "generated", "from", "an", "OCS-funded", "project,", "depending", "on", "the", "period", "in", "which", "revenues", "were", "generated.", "<tag2>", "Protalix", "Ltd.", "is", "required", "to", "repay", "up", "to", "100%", "of", "grants", "actually", "received", "(plus", "interest", "at", "the", "LIBOR", "rate", "applied", "to", "the", "grants", "received", "on", "or", "after", "January", "1,", "1999)", "to", "NATI", "through", "payments", "of", "royalties", "at", "a", "rate", "of", "3%", "to", "6%", "of", "the", "revenues", "generated", "from", "NATI-funded", "project,", "depending", "on", "the", "period", "in", "which", "revenues", "were", "generated.", "<tag3>"], "wordsA": ["Protalix", "Ltd.", "is", "required", "to", "repay", "up", "to", "100%", "of", "grants", "actually", "received", "(plus", "interest", "at", "the", "LIBOR", "rate", "applied", "to", "the", "grants", "received", "on", "or", "after", "January", "1,", "1999)", "to", "the", "OCS", "through", "payments", "of", "royalties", "at", "a", "rate", "of", "3%", "to", "6%", "of", "the", "revenues", "generated", "from", "an", "OCS-funded", "project,", "depending", "on", "the", "period", "in", "which", "revenues", "were", "generated."], "wordsB": ["Protalix", "Ltd.", "is", "required", "to", "repay", "up", "to", "100%", "of", "grants", "actually", "received", "(plus", "interest", "at", "the", "LIBOR", "rate", "applied", "to", "the", "grants", "received", "on", "or", "after", "January", "1,", "1999)", "to", "NATI", "through", "payments", "of", "royalties", "at", "a", "rate", "of", "3%", "to", "6%", "of", "the", "revenues", "generated", "from", "NATI-funded", "project,", "depending", "on", "the", "period", "in", "which", "revenues", "were", "generated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p174_s3", "idA": "1006281_16_item1_p183_s3", "sentA": "As of December 31, 2015, Protalix Ltd. either paid or accrued royalties payable of $7.8 million and Protalix Ltd. s contingent liability to the OCS with respect to grants received was approximately $33.3 million.", "sentB": "As of December 31, 2016, Protalix Ltd. either paid or accrued royalties payable of $8.1 million and Protalix Ltd. s contingent liability to NATI with respect to grants received was approximately $38.5 million.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2015,", "Protalix", "Ltd.", "either", "paid", "or", "accrued", "royalties", "payable", "of", "$7.8", "million", "and", "Protalix", "Ltd.", "s", "contingent", "liability", "to", "the", "OCS", "with", "respect", "to", "grants", "received", "was", "approximately", "$33.3", "million.", "<tag2>", "As", "of", "December", "31,", "2016,", "Protalix", "Ltd.", "either", "paid", "or", "accrued", "royalties", "payable", "of", "$8.1", "million", "and", "Protalix", "Ltd.", "s", "contingent", "liability", "to", "NATI", "with", "respect", "to", "grants", "received", "was", "approximately", "$38.5", "million.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2015,", "Protalix", "Ltd.", "either", "paid", "or", "accrued", "royalties", "payable", "of", "$7.8", "million", "and", "Protalix", "Ltd.", "s", "contingent", "liability", "to", "the", "OCS", "with", "respect", "to", "grants", "received", "was", "approximately", "$33.3", "million."], "wordsB": ["As", "of", "December", "31,", "2016,", "Protalix", "Ltd.", "either", "paid", "or", "accrued", "royalties", "payable", "of", "$8.1", "million", "and", "Protalix", "Ltd.", "s", "contingent", "liability", "to", "NATI", "with", "respect", "to", "grants", "received", "was", "approximately", "$38.5", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p175_s0", "idA": "1006281_16_item1_p184_s0", "sentA": "Under the Israeli Law for the Encouragement of Industrial Research and Development, 1984, and related regulations, or the Research Law, recipients of grants from the OCS are prohibited from manufacturing products developed using these grants outside of the State of Israel without special approvals, although the Research Law does enable companies to seek prior approval for conducting manufacturing activities outside of Israel without being subject to increased royalties.", "sentB": "Under the Research Law, recipients of grants from NATI are prohibited from manufacturing products developed using these grants outside of the State of Israel without special approvals, although the Research Law does enable companies to seek prior approval for conducting manufacturing activities outside of Israel without being subject to increased royalties.", "type": 2, "words": ["<tag1>", "Under", "the", "Israeli", "Law", "for", "the", "Encouragement", "of", "Industrial", "Research", "and", "Development,", "1984,", "and", "related", "regulations,", "or", "the", "Research", "Law,", "recipients", "of", "grants", "from", "the", "OCS", "are", "prohibited", "from", "manufacturing", "products", "developed", "using", "these", "grants", "outside", "of", "the", "State", "of", "Israel", "without", "special", "approvals,", "although", "the", "Research", "Law", "does", "enable", "companies", "to", "seek", "prior", "approval", "for", "conducting", "manufacturing", "activities", "outside", "of", "Israel", "without", "being", "subject", "to", "increased", "royalties.", "<tag2>", "Under", "the", "Research", "Law,", "recipients", "of", "grants", "from", "NATI", "are", "prohibited", "from", "manufacturing", "products", "developed", "using", "these", "grants", "outside", "of", "the", "State", "of", "Israel", "without", "special", "approvals,", "although", "the", "Research", "Law", "does", "enable", "companies", "to", "seek", "prior", "approval", "for", "conducting", "manufacturing", "activities", "outside", "of", "Israel", "without", "being", "subject", "to", "increased", "royalties.", "<tag3>"], "wordsA": ["Under", "the", "Israeli", "Law", "for", "the", "Encouragement", "of", "Industrial", "Research", "and", "Development,", "1984,", "and", "related", "regulations,", "or", "the", "Research", "Law,", "recipients", "of", "grants", "from", "the", "OCS", "are", "prohibited", "from", "manufacturing", "products", "developed", "using", "these", "grants", "outside", "of", "the", "State", "of", "Israel", "without", "special", "approvals,", "although", "the", "Research", "Law", "does", "enable", "companies", "to", "seek", "prior", "approval", "for", "conducting", "manufacturing", "activities", "outside", "of", "Israel", "without", "being", "subject", "to", "increased", "royalties."], "wordsB": ["Under", "the", "Research", "Law,", "recipients", "of", "grants", "from", "NATI", "are", "prohibited", "from", "manufacturing", "products", "developed", "using", "these", "grants", "outside", "of", "the", "State", "of", "Israel", "without", "special", "approvals,", "although", "the", "Research", "Law", "does", "enable", "companies", "to", "seek", "prior", "approval", "for", "conducting", "manufacturing", "activities", "outside", "of", "Israel", "without", "being", "subject", "to", "increased", "royalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p176_s0", "idA": "1006281_16_item1_p185_s0", "sentA": "Additionally, under the Research Law, Protalix Ltd. is prohibited from transferring the OCS-financed technologies and related intellectual property rights outside of the State of Israel, except under limited circumstances and only with the approval of the OCS Research Committee.", "sentB": "Additionally, under the Research Law, Protalix Ltd. is prohibited from transferring NATI-financed technologies and related intellectual property rights outside of the State of Israel, except under limited circumstances and only with the approval of NATI Council or the Research Committee.", "type": 2, "words": ["<tag1>", "Additionally,", "under", "the", "Research", "Law,", "Protalix", "Ltd.", "is", "prohibited", "from", "transferring", "the", "OCS-financed", "technologies", "and", "related", "intellectual", "property", "rights", "outside", "of", "the", "State", "of", "Israel,", "except", "under", "limited", "circumstances", "and", "only", "with", "the", "approval", "of", "the", "OCS", "Research", "Committee.", "<tag2>", "Additionally,", "under", "the", "Research", "Law,", "Protalix", "Ltd.", "is", "prohibited", "from", "transferring", "NATI-financed", "technologies", "and", "related", "intellectual", "property", "rights", "outside", "of", "the", "State", "of", "Israel,", "except", "under", "limited", "circumstances", "and", "only", "with", "the", "approval", "of", "NATI", "Council", "or", "the", "Research", "Committee.", "<tag3>"], "wordsA": ["Additionally,", "under", "the", "Research", "Law,", "Protalix", "Ltd.", "is", "prohibited", "from", "transferring", "the", "OCS-financed", "technologies", "and", "related", "intellectual", "property", "rights", "outside", "of", "the", "State", "of", "Israel,", "except", "under", "limited", "circumstances", "and", "only", "with", "the", "approval", "of", "the", "OCS", "Research", "Committee."], "wordsB": ["Additionally,", "under", "the", "Research", "Law,", "Protalix", "Ltd.", "is", "prohibited", "from", "transferring", "NATI-financed", "technologies", "and", "related", "intellectual", "property", "rights", "outside", "of", "the", "State", "of", "Israel,", "except", "under", "limited", "circumstances", "and", "only", "with", "the", "approval", "of", "NATI", "Council", "or", "the", "Research", "Committee."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p176_s1", "idA": "1006281_16_item1_p185_s1", "sentA": "Protalix Ltd. may not receive the required approvals for any proposed transfer and, if received, Protalix Ltd. may be required to pay the OCS a portion of the consideration that it receives upon any sale of such technology by a non-Israeli entity.", "sentB": "Protalix Ltd. may not receive the required approvals for any proposed transfer and, if received, Protalix Ltd. may be required to pay NATI a portion of the consideration that it receives upon any sale of such technology by a non-Israeli entity.", "type": 2, "words": ["<tag1>", "Protalix", "Ltd.", "may", "not", "receive", "the", "required", "approvals", "for", "any", "proposed", "transfer", "and,", "if", "received,", "Protalix", "Ltd.", "may", "be", "required", "to", "pay", "the", "OCS", "a", "portion", "of", "the", "consideration", "that", "it", "receives", "upon", "any", "sale", "of", "such", "technology", "by", "a", "non-Israeli", "entity.", "<tag2>", "Protalix", "Ltd.", "may", "not", "receive", "the", "required", "approvals", "for", "any", "proposed", "transfer", "and,", "if", "received,", "Protalix", "Ltd.", "may", "be", "required", "to", "pay", "NATI", "a", "portion", "of", "the", "consideration", "that", "it", "receives", "upon", "any", "sale", "of", "such", "technology", "by", "a", "non-Israeli", "entity.", "<tag3>"], "wordsA": ["Protalix", "Ltd.", "may", "not", "receive", "the", "required", "approvals", "for", "any", "proposed", "transfer", "and,", "if", "received,", "Protalix", "Ltd.", "may", "be", "required", "to", "pay", "the", "OCS", "a", "portion", "of", "the", "consideration", "that", "it", "receives", "upon", "any", "sale", "of", "such", "technology", "by", "a", "non-Israeli", "entity."], "wordsB": ["Protalix", "Ltd.", "may", "not", "receive", "the", "required", "approvals", "for", "any", "proposed", "transfer", "and,", "if", "received,", "Protalix", "Ltd.", "may", "be", "required", "to", "pay", "NATI", "a", "portion", "of", "the", "consideration", "that", "it", "receives", "upon", "any", "sale", "of", "such", "technology", "by", "a", "non-Israeli", "entity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p176_s2", "idA": "1006281_16_item1_p185_s2", "sentA": "The scope of the support received, the royalties that Protalix Ltd. has already paid to the OCS, the amount of time that has elapsed between the date on which the know-how was transferred and the date on which the OCS grants were received and the sale price and the form of transaction will be taken into account in order to calculate the amount of the payment to the OCS.", "sentB": "The scope of the support received, the royalties that Protalix Ltd. has already paid to NATI, the amount of time that has elapsed between the date on which the know-how was transferred and the date on which NATI grants were received and the sale price and the form of transaction will be taken into account in order to calculate the amount of the payment to NATI.", "type": 2, "words": ["<tag1>", "The", "scope", "of", "the", "support", "received,", "the", "royalties", "that", "Protalix", "Ltd.", "has", "already", "paid", "to", "the", "OCS,", "the", "amount", "of", "time", "that", "has", "elapsed", "between", "the", "date", "on", "which", "the", "know-how", "was", "transferred", "and", "the", "date", "on", "which", "the", "OCS", "grants", "were", "received", "and", "the", "sale", "price", "and", "the", "form", "of", "transaction", "will", "be", "taken", "into", "account", "in", "order", "to", "calculate", "the", "amount", "of", "the", "payment", "to", "the", "OCS.", "<tag2>", "The", "scope", "of", "the", "support", "received,", "the", "royalties", "that", "Protalix", "Ltd.", "has", "already", "paid", "to", "NATI,", "the", "amount", "of", "time", "that", "has", "elapsed", "between", "the", "date", "on", "which", "the", "know-how", "was", "transferred", "and", "the", "date", "on", "which", "NATI", "grants", "were", "received", "and", "the", "sale", "price", "and", "the", "form", "of", "transaction", "will", "be", "taken", "into", "account", "in", "order", "to", "calculate", "the", "amount", "of", "the", "payment", "to", "NATI.", "<tag3>"], "wordsA": ["The", "scope", "of", "the", "support", "received,", "the", "royalties", "that", "Protalix", "Ltd.", "has", "already", "paid", "to", "the", "OCS,", "the", "amount", "of", "time", "that", "has", "elapsed", "between", "the", "date", "on", "which", "the", "know-how", "was", "transferred", "and", "the", "date", "on", "which", "the", "OCS", "grants", "were", "received", "and", "the", "sale", "price", "and", "the", "form", "of", "transaction", "will", "be", "taken", "into", "account", "in", "order", "to", "calculate", "the", "amount", "of", "the", "payment", "to", "the", "OCS."], "wordsB": ["The", "scope", "of", "the", "support", "received,", "the", "royalties", "that", "Protalix", "Ltd.", "has", "already", "paid", "to", "NATI,", "the", "amount", "of", "time", "that", "has", "elapsed", "between", "the", "date", "on", "which", "the", "know-how", "was", "transferred", "and", "the", "date", "on", "which", "NATI", "grants", "were", "received", "and", "the", "sale", "price", "and", "the", "form", "of", "transaction", "will", "be", "taken", "into", "account", "in", "order", "to", "calculate", "the", "amount", "of", "the", "payment", "to", "NATI."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p178_s0", "idA": "1006281_16_item1_p187_s0", "sentA": "Under the Research Law, the Research Committee to allow the transfer outside of Israel of know-how derived from an approved program and the related manufacturing rights.", "sentB": "Under the Research Law and the regulations promulgated thereunder, NATI Council may allow the transfer outside of Israel of know-how derived from an approved program and the related manufacturing rights in limited circumstances which are currently as follows:", "type": 2, "words": ["<tag1>", "Under", "the", "Research", "Law,", "the", "Research", "Committee", "to", "allow", "the", "transfer", "outside", "of", "Israel", "of", "know-how", "derived", "from", "an", "approved", "program", "and", "the", "related", "manufacturing", "rights.", "<tag2>", "Under", "the", "Research", "Law", "and", "the", "regulations", "promulgated", "thereunder,", "NATI", "Council", "may", "allow", "the", "transfer", "outside", "of", "Israel", "of", "know-how", "derived", "from", "an", "approved", "program", "and", "the", "related", "manufacturing", "rights", "in", "limited", "circumstances", "which", "are", "currently", "as", "follows:", "<tag3>"], "wordsA": ["Under", "the", "Research", "Law,", "the", "Research", "Committee", "to", "allow", "the", "transfer", "outside", "of", "Israel", "of", "know-how", "derived", "from", "an", "approved", "program", "and", "the", "related", "manufacturing", "rights."], "wordsB": ["Under", "the", "Research", "Law", "and", "the", "regulations", "promulgated", "thereunder,", "NATI", "Council", "may", "allow", "the", "transfer", "outside", "of", "Israel", "of", "know-how", "derived", "from", "an", "approved", "program", "and", "the", "related", "manufacturing", "rights", "in", "limited", "circumstances", "which", "are", "currently", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p179_s0", "idA": "1006281_16_item1_p188_s0", "sentA": "in the event of a sale of know-how itself to a non-affiliated third party, provided that upon such sale the owner of the know-how pays to the OCS an amount, in cash, as set forth in the Research Law.", "sentB": "in the event of a sale of know-how itself to a non-affiliated third party, provided that upon such sale the owner of the know-how pays to NATI an amount, in cash, as set forth in the Research Law (and the regulations promulgated thereunder).", "type": 2, "words": ["<tag1>", "in", "the", "event", "of", "a", "sale", "of", "know-how", "itself", "to", "a", "non-affiliated", "third", "party,", "provided", "that", "upon", "such", "sale", "the", "owner", "of", "the", "know-how", "pays", "to", "the", "OCS", "an", "amount,", "in", "cash,", "as", "set", "forth", "in", "the", "Research", "Law.", "<tag2>", "in", "the", "event", "of", "a", "sale", "of", "know-how", "itself", "to", "a", "non-affiliated", "third", "party,", "provided", "that", "upon", "such", "sale", "the", "owner", "of", "the", "know-how", "pays", "to", "NATI", "an", "amount,", "in", "cash,", "as", "set", "forth", "in", "the", "Research", "Law", "(and", "the", "regulations", "promulgated", "thereunder).", "<tag3>"], "wordsA": ["in", "the", "event", "of", "a", "sale", "of", "know-how", "itself", "to", "a", "non-affiliated", "third", "party,", "provided", "that", "upon", "such", "sale", "the", "owner", "of", "the", "know-how", "pays", "to", "the", "OCS", "an", "amount,", "in", "cash,", "as", "set", "forth", "in", "the", "Research", "Law."], "wordsB": ["in", "the", "event", "of", "a", "sale", "of", "know-how", "itself", "to", "a", "non-affiliated", "third", "party,", "provided", "that", "upon", "such", "sale", "the", "owner", "of", "the", "know-how", "pays", "to", "NATI", "an", "amount,", "in", "cash,", "as", "set", "forth", "in", "the", "Research", "Law", "(and", "the", "regulations", "promulgated", "thereunder)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p180_s0", "idA": "1006281_16_item1_p189_s0", "sentA": "in the event of a sale of a company which is the owner of know-how, pursuant to which the company ceases to be an Israeli company, provided that upon such sale, the owner of the know-how makes a cash payment to the OCS as set forth in the Research Law.", "sentB": "in the event of a sale of a company which is the owner of know-how, pursuant to which the company ceases to be an Israeli company, provided that upon such sale, the owner of the know-how makes a cash payment to NATI as set forth in the Research Law (and the regulations promulgated thereunder).", "type": 2, "words": ["<tag1>", "in", "the", "event", "of", "a", "sale", "of", "a", "company", "which", "is", "the", "owner", "of", "know-how,", "pursuant", "to", "which", "the", "company", "ceases", "to", "be", "an", "Israeli", "company,", "provided", "that", "upon", "such", "sale,", "the", "owner", "of", "the", "know-how", "makes", "a", "cash", "payment", "to", "the", "OCS", "as", "set", "forth", "in", "the", "Research", "Law.", "<tag2>", "in", "the", "event", "of", "a", "sale", "of", "a", "company", "which", "is", "the", "owner", "of", "know-how,", "pursuant", "to", "which", "the", "company", "ceases", "to", "be", "an", "Israeli", "company,", "provided", "that", "upon", "such", "sale,", "the", "owner", "of", "the", "know-how", "makes", "a", "cash", "payment", "to", "NATI", "as", "set", "forth", "in", "the", "Research", "Law", "(and", "the", "regulations", "promulgated", "thereunder).", "<tag3>"], "wordsA": ["in", "the", "event", "of", "a", "sale", "of", "a", "company", "which", "is", "the", "owner", "of", "know-how,", "pursuant", "to", "which", "the", "company", "ceases", "to", "be", "an", "Israeli", "company,", "provided", "that", "upon", "such", "sale,", "the", "owner", "of", "the", "know-how", "makes", "a", "cash", "payment", "to", "the", "OCS", "as", "set", "forth", "in", "the", "Research", "Law."], "wordsB": ["in", "the", "event", "of", "a", "sale", "of", "a", "company", "which", "is", "the", "owner", "of", "know-how,", "pursuant", "to", "which", "the", "company", "ceases", "to", "be", "an", "Israeli", "company,", "provided", "that", "upon", "such", "sale,", "the", "owner", "of", "the", "know-how", "makes", "a", "cash", "payment", "to", "NATI", "as", "set", "forth", "in", "the", "Research", "Law", "(and", "the", "regulations", "promulgated", "thereunder)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p181_s0", "idA": "1006281_16_item1_p190_s0", "sentA": "in the event of an exchange of know-how such that in exchange for the transfer of know-how outside of Israel, the recipient of the know-how transfers other know-how to the company in Israel in a manner in which the OCS is convinced that the Israeli economy realizes a greater, overall benefit from the exchange of know-how.", "sentB": "in the event of an exchange of know-how such that in exchange for the transfer of know-how outside of Israel, the recipient of the know-how transfers other know-how to the company in Israel in a manner in which NATI is convinced that the Israeli economy realizes a greater, overall benefit from the exchange of know-how.", "type": 2, "words": ["<tag1>", "in", "the", "event", "of", "an", "exchange", "of", "know-how", "such", "that", "in", "exchange", "for", "the", "transfer", "of", "know-how", "outside", "of", "Israel,", "the", "recipient", "of", "the", "know-how", "transfers", "other", "know-how", "to", "the", "company", "in", "Israel", "in", "a", "manner", "in", "which", "the", "OCS", "is", "convinced", "that", "the", "Israeli", "economy", "realizes", "a", "greater,", "overall", "benefit", "from", "the", "exchange", "of", "know-how.", "<tag2>", "in", "the", "event", "of", "an", "exchange", "of", "know-how", "such", "that", "in", "exchange", "for", "the", "transfer", "of", "know-how", "outside", "of", "Israel,", "the", "recipient", "of", "the", "know-how", "transfers", "other", "know-how", "to", "the", "company", "in", "Israel", "in", "a", "manner", "in", "which", "NATI", "is", "convinced", "that", "the", "Israeli", "economy", "realizes", "a", "greater,", "overall", "benefit", "from", "the", "exchange", "of", "know-how.", "<tag3>"], "wordsA": ["in", "the", "event", "of", "an", "exchange", "of", "know-how", "such", "that", "in", "exchange", "for", "the", "transfer", "of", "know-how", "outside", "of", "Israel,", "the", "recipient", "of", "the", "know-how", "transfers", "other", "know-how", "to", "the", "company", "in", "Israel", "in", "a", "manner", "in", "which", "the", "OCS", "is", "convinced", "that", "the", "Israeli", "economy", "realizes", "a", "greater,", "overall", "benefit", "from", "the", "exchange", "of", "know-how."], "wordsB": ["in", "the", "event", "of", "an", "exchange", "of", "know-how", "such", "that", "in", "exchange", "for", "the", "transfer", "of", "know-how", "outside", "of", "Israel,", "the", "recipient", "of", "the", "know-how", "transfers", "other", "know-how", "to", "the", "company", "in", "Israel", "in", "a", "manner", "in", "which", "NATI", "is", "convinced", "that", "the", "Israeli", "economy", "realizes", "a", "greater,", "overall", "benefit", "from", "the", "exchange", "of", "know-how."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p183_s0", "idA": "1006281_16_item1_p192_s0", "sentA": "The State of Israel does not own intellectual property rights in technology developed with OCS funding and there is no restriction on the export of products manufactured using technology developed with OCS funding.", "sentB": "The State of Israel does not own intellectual property rights in technology developed with NATI funding and there is no restriction on the export of products manufactured using technology developed with NATI funding.", "type": 2, "words": ["<tag1>", "The", "State", "of", "Israel", "does", "not", "own", "intellectual", "property", "rights", "in", "technology", "developed", "with", "OCS", "funding", "and", "there", "is", "no", "restriction", "on", "the", "export", "of", "products", "manufactured", "using", "technology", "developed", "with", "OCS", "funding.", "<tag2>", "The", "State", "of", "Israel", "does", "not", "own", "intellectual", "property", "rights", "in", "technology", "developed", "with", "NATI", "funding", "and", "there", "is", "no", "restriction", "on", "the", "export", "of", "products", "manufactured", "using", "technology", "developed", "with", "NATI", "funding.", "<tag3>"], "wordsA": ["The", "State", "of", "Israel", "does", "not", "own", "intellectual", "property", "rights", "in", "technology", "developed", "with", "OCS", "funding", "and", "there", "is", "no", "restriction", "on", "the", "export", "of", "products", "manufactured", "using", "technology", "developed", "with", "OCS", "funding."], "wordsB": ["The", "State", "of", "Israel", "does", "not", "own", "intellectual", "property", "rights", "in", "technology", "developed", "with", "NATI", "funding", "and", "there", "is", "no", "restriction", "on", "the", "export", "of", "products", "manufactured", "using", "technology", "developed", "with", "NATI", "funding."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p184_s0", "idA": "1006281_16_item1_p193_s0", "sentA": "OCS approval is not required for the export of any products resulting from the research or development or for the licensing of any technology in the ordinary course of business.", "sentB": "NATI approval is not required for the export of any products resulting from the research or development or for the licensing of any technology in the ordinary course of business.", "type": 2, "words": ["<tag1>", "OCS", "approval", "is", "not", "required", "for", "the", "export", "of", "any", "products", "resulting", "from", "the", "research", "or", "development", "or", "for", "the", "licensing", "of", "any", "technology", "in", "the", "ordinary", "course", "of", "business.", "<tag2>", "NATI", "approval", "is", "not", "required", "for", "the", "export", "of", "any", "products", "resulting", "from", "the", "research", "or", "development", "or", "for", "the", "licensing", "of", "any", "technology", "in", "the", "ordinary", "course", "of", "business.", "<tag3>"], "wordsA": ["OCS", "approval", "is", "not", "required", "for", "the", "export", "of", "any", "products", "resulting", "from", "the", "research", "or", "development", "or", "for", "the", "licensing", "of", "any", "technology", "in", "the", "ordinary", "course", "of", "business."], "wordsB": ["NATI", "approval", "is", "not", "required", "for", "the", "export", "of", "any", "products", "resulting", "from", "the", "research", "or", "development", "or", "for", "the", "licensing", "of", "any", "technology", "in", "the", "ordinary", "course", "of", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p173_s2", "idA": "1006281_16_item1_p199_s1", "sentA": "These expenditures must relate to scientific research and development projects and must be approved by the OCS.", "sentB": "NATI has replaced many of the functions of the OCS.", "type": 2, "words": ["<tag1>", "These", "expenditures", "must", "relate", "to", "scientific", "research", "and", "development", "projects", "and", "must", "be", "approved", "by", "the", "OCS.", "<tag2>", "NATI", "has", "replaced", "many", "of", "the", "functions", "of", "the", "OCS.", "<tag3>"], "wordsA": ["These", "expenditures", "must", "relate", "to", "scientific", "research", "and", "development", "projects", "and", "must", "be", "approved", "by", "the", "OCS."], "wordsB": ["NATI", "has", "replaced", "many", "of", "the", "functions", "of", "the", "OCS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p173_s3", "idA": "1006281_16_item1_p199_s1", "sentA": "These expenditures must relate to scientific research and development projects and must be approved by the OCS.", "sentB": "For purposes of clarity, references to NATI will include the OCS.", "type": 2, "words": ["<tag1>", "These", "expenditures", "must", "relate", "to", "scientific", "research", "and", "development", "projects", "and", "must", "be", "approved", "by", "the", "OCS.", "<tag2>", "For", "purposes", "of", "clarity,", "references", "to", "NATI", "will", "include", "the", "OCS.", "<tag3>"], "wordsA": ["These", "expenditures", "must", "relate", "to", "scientific", "research", "and", "development", "projects", "and", "must", "be", "approved", "by", "the", "OCS."], "wordsB": ["For", "purposes", "of", "clarity,", "references", "to", "NATI", "will", "include", "the", "OCS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p190_s1", "idA": "1006281_16_item1_p199_s1", "sentA": "These expenditures must relate to scientific research and development projects and must be approved by the OCS.", "sentB": "These expenditures must relate to scientific research and development projects and must be approved by NATI.", "type": 2, "words": ["<tag1>", "These", "expenditures", "must", "relate", "to", "scientific", "research", "and", "development", "projects", "and", "must", "be", "approved", "by", "the", "OCS.", "<tag2>", "These", "expenditures", "must", "relate", "to", "scientific", "research", "and", "development", "projects", "and", "must", "be", "approved", "by", "NATI.", "<tag3>"], "wordsA": ["These", "expenditures", "must", "relate", "to", "scientific", "research", "and", "development", "projects", "and", "must", "be", "approved", "by", "the", "OCS."], "wordsB": ["These", "expenditures", "must", "relate", "to", "scientific", "research", "and", "development", "projects", "and", "must", "be", "approved", "by", "NATI."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p25_s0", "idA": "1006281_16_item1_p19_s0", "sentA": "Mammalian cell-based expression systems have become the dominant system for the expression of recombinant proteins due to their capacity for sophisticated, proper protein folding (which is necessary for proteins to carry out their intended biological activity), assembly and post-expression modification, such as glycosilation (the addition of sugar residues to a protein which is necessary to enable specific biological activity by the protein).", "sentB": "Mammalian cell-based expression technology is based on the introduction of a human gene encoding for a specific therapeutic protein into the genome of a mammalian cell, and such systems have become the dominant system for the expression of recombinant proteins due to their capacity for sophisticated, proper protein folding (which is necessary for proteins to carry out their intended biological activity), assembly and post-expression modification, such as glycosilation (the addition of sugar residues to a protein which is necessary to enable specific biological activity by the protein).", "type": 2, "words": ["<tag1>", "Mammalian", "cell-based", "expression", "systems", "have", "become", "the", "dominant", "system", "for", "the", "expression", "of", "recombinant", "proteins", "due", "to", "their", "capacity", "for", "sophisticated,", "proper", "protein", "folding", "(which", "is", "necessary", "for", "proteins", "to", "carry", "out", "their", "intended", "biological", "activity),", "assembly", "and", "post-expression", "modification,", "such", "as", "glycosilation", "(the", "addition", "of", "sugar", "residues", "to", "a", "protein", "which", "is", "necessary", "to", "enable", "specific", "biological", "activity", "by", "the", "protein).", "<tag2>", "Mammalian", "cell-based", "expression", "technology", "is", "based", "on", "the", "introduction", "of", "a", "human", "gene", "encoding", "for", "a", "specific", "therapeutic", "protein", "into", "the", "genome", "of", "a", "mammalian", "cell,", "and", "such", "systems", "have", "become", "the", "dominant", "system", "for", "the", "expression", "of", "recombinant", "proteins", "due", "to", "their", "capacity", "for", "sophisticated,", "proper", "protein", "folding", "(which", "is", "necessary", "for", "proteins", "to", "carry", "out", "their", "intended", "biological", "activity),", "assembly", "and", "post-expression", "modification,", "such", "as", "glycosilation", "(the", "addition", "of", "sugar", "residues", "to", "a", "protein", "which", "is", "necessary", "to", "enable", "specific", "biological", "activity", "by", "the", "protein).", "<tag3>"], "wordsA": ["Mammalian", "cell-based", "expression", "systems", "have", "become", "the", "dominant", "system", "for", "the", "expression", "of", "recombinant", "proteins", "due", "to", "their", "capacity", "for", "sophisticated,", "proper", "protein", "folding", "(which", "is", "necessary", "for", "proteins", "to", "carry", "out", "their", "intended", "biological", "activity),", "assembly", "and", "post-expression", "modification,", "such", "as", "glycosilation", "(the", "addition", "of", "sugar", "residues", "to", "a", "protein", "which", "is", "necessary", "to", "enable", "specific", "biological", "activity", "by", "the", "protein)."], "wordsB": ["Mammalian", "cell-based", "expression", "technology", "is", "based", "on", "the", "introduction", "of", "a", "human", "gene", "encoding", "for", "a", "specific", "therapeutic", "protein", "into", "the", "genome", "of", "a", "mammalian", "cell,", "and", "such", "systems", "have", "become", "the", "dominant", "system", "for", "the", "expression", "of", "recombinant", "proteins", "due", "to", "their", "capacity", "for", "sophisticated,", "proper", "protein", "folding", "(which", "is", "necessary", "for", "proteins", "to", "carry", "out", "their", "intended", "biological", "activity),", "assembly", "and", "post-expression", "modification,", "such", "as", "glycosilation", "(the", "addition", "of", "sugar", "residues", "to", "a", "protein", "which", "is", "necessary", "to", "enable", "specific", "biological", "activity", "by", "the", "protein)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p1_s0", "idA": "1006281_16_item1_p1_s0", "sentA": "The following table summarizes our current product candidates and our current projections regarding their respective stages of clinical development.", "sentB": "The following table summarizes our current product candidates and their respective stages of clinical development:", "type": 2, "words": ["<tag1>", "The", "following", "table", "summarizes", "our", "current", "product", "candidates", "and", "our", "current", "projections", "regarding", "their", "respective", "stages", "of", "clinical", "development.", "<tag2>", "The", "following", "table", "summarizes", "our", "current", "product", "candidates", "and", "their", "respective", "stages", "of", "clinical", "development:", "<tag3>"], "wordsA": ["The", "following", "table", "summarizes", "our", "current", "product", "candidates", "and", "our", "current", "projections", "regarding", "their", "respective", "stages", "of", "clinical", "development."], "wordsB": ["The", "following", "table", "summarizes", "our", "current", "product", "candidates", "and", "their", "respective", "stages", "of", "clinical", "development:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p191_s0", "idA": "1006281_16_item1_p200_s0", "sentA": "As of December 31, 2015, we had 223 employees, of whom 29 have a Ph.D. or an M.D.in their respective scientific fields.", "sentB": "As of December 31, 2016, we had 232 employees, of whom 29 have a Ph.D. or an M.D.in their respective scientific fields.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2015,", "we", "had", "223", "employees,", "of", "whom", "29", "have", "a", "Ph.D.", "or", "an", "M.D.in", "their", "respective", "scientific", "fields.", "<tag2>", "As", "of", "December", "31,", "2016,", "we", "had", "232", "employees,", "of", "whom", "29", "have", "a", "Ph.D.", "or", "an", "M.D.in", "their", "respective", "scientific", "fields.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2015,", "we", "had", "223", "employees,", "of", "whom", "29", "have", "a", "Ph.D.", "or", "an", "M.D.in", "their", "respective", "scientific", "fields."], "wordsB": ["As", "of", "December", "31,", "2016,", "we", "had", "232", "employees,", "of", "whom", "29", "have", "a", "Ph.D.", "or", "an", "M.D.in", "their", "respective", "scientific", "fields."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p193_s2", "idA": "1006281_16_item1_p202_s2", "sentA": "We were originally incorporated in the State of Florida in April 1992, and Protalix Ltd., our wholly-owned subsidiary and sole operating unit, is an Israeli company and was originally incorporated in Israel on December 27, 1993.", "sentB": "We were originally incorporated in the State of Florida in April 1992, and reincorporated in the State of Delaware in March 2016.", "type": 2, "words": ["<tag1>", "We", "were", "originally", "incorporated", "in", "the", "State", "of", "Florida", "in", "April", "1992,", "and", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary", "and", "sole", "operating", "unit,", "is", "an", "Israeli", "company", "and", "was", "originally", "incorporated", "in", "Israel", "on", "December", "27,", "1993.", "<tag2>", "We", "were", "originally", "incorporated", "in", "the", "State", "of", "Florida", "in", "April", "1992,", "and", "reincorporated", "in", "the", "State", "of", "Delaware", "in", "March", "2016.", "<tag3>"], "wordsA": ["We", "were", "originally", "incorporated", "in", "the", "State", "of", "Florida", "in", "April", "1992,", "and", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary", "and", "sole", "operating", "unit,", "is", "an", "Israeli", "company", "and", "was", "originally", "incorporated", "in", "Israel", "on", "December", "27,", "1993."], "wordsB": ["We", "were", "originally", "incorporated", "in", "the", "State", "of", "Florida", "in", "April", "1992,", "and", "reincorporated", "in", "the", "State", "of", "Delaware", "in", "March", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p194_s0", "idA": "1006281_16_item1_p202_s2", "sentA": "We were originally incorporated in the State of Florida in April 1992, and Protalix Ltd., our wholly-owned subsidiary and sole operating unit, is an Israeli company and was originally incorporated in Israel on December 27, 1993.", "sentB": "Protalix Ltd., our wholly-owned subsidiary and sole operating unit, is an Israeli company and was originally incorporated in Israel on December 27, 1993.", "type": 2, "words": ["<tag1>", "We", "were", "originally", "incorporated", "in", "the", "State", "of", "Florida", "in", "April", "1992,", "and", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary", "and", "sole", "operating", "unit,", "is", "an", "Israeli", "company", "and", "was", "originally", "incorporated", "in", "Israel", "on", "December", "27,", "1993.", "<tag2>", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary", "and", "sole", "operating", "unit,", "is", "an", "Israeli", "company", "and", "was", "originally", "incorporated", "in", "Israel", "on", "December", "27,", "1993.", "<tag3>"], "wordsA": ["We", "were", "originally", "incorporated", "in", "the", "State", "of", "Florida", "in", "April", "1992,", "and", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary", "and", "sole", "operating", "unit,", "is", "an", "Israeli", "company", "and", "was", "originally", "incorporated", "in", "Israel", "on", "December", "27,", "1993."], "wordsB": ["Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary", "and", "sole", "operating", "unit,", "is", "an", "Israeli", "company", "and", "was", "originally", "incorporated", "in", "Israel", "on", "December", "27,", "1993."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p25_s2", "idA": "1006281_16_item1_p20_s0", "sentA": "Due to their significant advantages, mammalian cell-based expression systems can produce proteins with superior quality and efficacy compared to proteins expressed in bacteria and yeast cell-based systems.", "sentB": "Mammalian cell-based expression systems can produce proteins with superior quality and efficacy compared to proteins expressed in bacteria and yeast cell-based systems.", "type": 2, "words": ["<tag1>", "Due", "to", "their", "significant", "advantages,", "mammalian", "cell-based", "expression", "systems", "can", "produce", "proteins", "with", "superior", "quality", "and", "efficacy", "compared", "to", "proteins", "expressed", "in", "bacteria", "and", "yeast", "cell-based", "systems.", "<tag2>", "Mammalian", "cell-based", "expression", "systems", "can", "produce", "proteins", "with", "superior", "quality", "and", "efficacy", "compared", "to", "proteins", "expressed", "in", "bacteria", "and", "yeast", "cell-based", "systems.", "<tag3>"], "wordsA": ["Due", "to", "their", "significant", "advantages,", "mammalian", "cell-based", "expression", "systems", "can", "produce", "proteins", "with", "superior", "quality", "and", "efficacy", "compared", "to", "proteins", "expressed", "in", "bacteria", "and", "yeast", "cell-based", "systems."], "wordsB": ["Mammalian", "cell-based", "expression", "systems", "can", "produce", "proteins", "with", "superior", "quality", "and", "efficacy", "compared", "to", "proteins", "expressed", "in", "bacteria", "and", "yeast", "cell-based", "systems."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p154_s3", "idA": "1006281_16_item1_p20_s1", "sentA": "As a result, the majority of currently approved therapeutic proteins, as well as those under development, are produced in mammalian cell-based systems.", "sentB": "As a result, the corporate tax rate will be 24% in 2017 and 23% in 2018 and thereafter.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "the", "majority", "of", "currently", "approved", "therapeutic", "proteins,", "as", "well", "as", "those", "under", "development,", "are", "produced", "in", "mammalian", "cell-based", "systems.", "<tag2>", "As", "a", "result,", "the", "corporate", "tax", "rate", "will", "be", "24%", "in", "2017", "and", "23%", "in", "2018", "and", "thereafter.", "<tag3>"], "wordsA": ["As", "a", "result,", "the", "majority", "of", "currently", "approved", "therapeutic", "proteins,", "as", "well", "as", "those", "under", "development,", "are", "produced", "in", "mammalian", "cell-based", "systems."], "wordsB": ["As", "a", "result,", "the", "corporate", "tax", "rate", "will", "be", "24%", "in", "2017", "and", "23%", "in", "2018", "and", "thereafter."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p37_s2", "idA": "1006281_16_item1_p23_s0", "sentA": "CHO cells and other mammalian cells are also susceptible to viral infections, including human viruses, and several cases of viral contamination have occurred recently.", "sentB": "Mammalian cells, to the contrary, are susceptible to viral infections, including human viruses, and several cases of viral contamination have occurred.", "type": 2, "words": ["<tag1>", "CHO", "cells", "and", "other", "mammalian", "cells", "are", "also", "susceptible", "to", "viral", "infections,", "including", "human", "viruses,", "and", "several", "cases", "of", "viral", "contamination", "have", "occurred", "recently.", "<tag2>", "Mammalian", "cells,", "to", "the", "contrary,", "are", "susceptible", "to", "viral", "infections,", "including", "human", "viruses,", "and", "several", "cases", "of", "viral", "contamination", "have", "occurred.", "<tag3>"], "wordsA": ["CHO", "cells", "and", "other", "mammalian", "cells", "are", "also", "susceptible", "to", "viral", "infections,", "including", "human", "viruses,", "and", "several", "cases", "of", "viral", "contamination", "have", "occurred", "recently."], "wordsB": ["Mammalian", "cells,", "to", "the", "contrary,", "are", "susceptible", "to", "viral", "infections,", "including", "human", "viruses,", "and", "several", "cases", "of", "viral", "contamination", "have", "occurred."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p36_s5", "idA": "1006281_16_item1_p23_s4", "sentA": "In addition, mammalian cell-based expression systems require large quantities of sophisticated and expensive growth medium to accelerate the expression process.", "sentB": "Mammalian cell-based expression systems require large quantities of sophisticated and expensive growth medium to accelerate the expression process.", "type": 2, "words": ["<tag1>", "In", "addition,", "mammalian", "cell-based", "expression", "systems", "require", "large", "quantities", "of", "sophisticated", "and", "expensive", "growth", "medium", "to", "accelerate", "the", "expression", "process.", "<tag2>", "Mammalian", "cell-based", "expression", "systems", "require", "large", "quantities", "of", "sophisticated", "and", "expensive", "growth", "medium", "to", "accelerate", "the", "expression", "process.", "<tag3>"], "wordsA": ["In", "addition,", "mammalian", "cell-based", "expression", "systems", "require", "large", "quantities", "of", "sophisticated", "and", "expensive", "growth", "medium", "to", "accelerate", "the", "expression", "process."], "wordsB": ["Mammalian", "cell-based", "expression", "systems", "require", "large", "quantities", "of", "sophisticated", "and", "expensive", "growth", "medium", "to", "accelerate", "the", "expression", "process."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p27_s0", "idA": "1006281_16_item1_p24_s0", "sentA": "Several companies and research institutions have explored alternatives to mammalian cell-based production technologies that overcome some of these disadvantages, focusing primarily on the expression of human proteins in genetically-modified organisms, or GMOs, such as transgenic field-grown, whole plants and transgenic animals.", "sentB": "Several companies and research institutions have been exploring the expression of human proteins in genetically-modified organisms, or GMOs, such as transgenic field-grown, whole plants and transgenic animals.", "type": 2, "words": ["<tag1>", "Several", "companies", "and", "research", "institutions", "have", "explored", "alternatives", "to", "mammalian", "cell-based", "production", "technologies", "that", "overcome", "some", "of", "these", "disadvantages,", "focusing", "primarily", "on", "the", "expression", "of", "human", "proteins", "in", "genetically-modified", "organisms,", "or", "GMOs,", "such", "as", "transgenic", "field-grown,", "whole", "plants", "and", "transgenic", "animals.", "<tag2>", "Several", "companies", "and", "research", "institutions", "have", "been", "exploring", "the", "expression", "of", "human", "proteins", "in", "genetically-modified", "organisms,", "or", "GMOs,", "such", "as", "transgenic", "field-grown,", "whole", "plants", "and", "transgenic", "animals.", "<tag3>"], "wordsA": ["Several", "companies", "and", "research", "institutions", "have", "explored", "alternatives", "to", "mammalian", "cell-based", "production", "technologies", "that", "overcome", "some", "of", "these", "disadvantages,", "focusing", "primarily", "on", "the", "expression", "of", "human", "proteins", "in", "genetically-modified", "organisms,", "or", "GMOs,", "such", "as", "transgenic", "field-grown,", "whole", "plants", "and", "transgenic", "animals."], "wordsB": ["Several", "companies", "and", "research", "institutions", "have", "been", "exploring", "the", "expression", "of", "human", "proteins", "in", "genetically-modified", "organisms,", "or", "GMOs,", "such", "as", "transgenic", "field-grown,", "whole", "plants", "and", "transgenic", "animals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p17_s0", "idA": "1006281_16_item1_p25_s1", "sentA": "We have developed ProCellEx based on our plant cell culture technology for the development, expression and manufacture of recombinant proteins.", "sentB": "We have developed our ProCellEx system based on our plant cell culture technology for the development, expression and manufacture of recombinant proteins.", "type": 2, "words": ["<tag1>", "We", "have", "developed", "ProCellEx", "based", "on", "our", "plant", "cell", "culture", "technology", "for", "the", "development,", "expression", "and", "manufacture", "of", "recombinant", "proteins.", "<tag2>", "We", "have", "developed", "our", "ProCellEx", "system", "based", "on", "our", "plant", "cell", "culture", "technology", "for", "the", "development,", "expression", "and", "manufacture", "of", "recombinant", "proteins.", "<tag3>"], "wordsA": ["We", "have", "developed", "ProCellEx", "based", "on", "our", "plant", "cell", "culture", "technology", "for", "the", "development,", "expression", "and", "manufacture", "of", "recombinant", "proteins."], "wordsB": ["We", "have", "developed", "our", "ProCellEx", "system", "based", "on", "our", "plant", "cell", "culture", "technology", "for", "the", "development,", "expression", "and", "manufacture", "of", "recombinant", "proteins."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p17_s2", "idA": "1006281_16_item1_p25_s2", "sentA": "ProCellEx consists of a comprehensive set of capabilities and proprietary technologies, including advanced genetic engineering and plant cell culture technology, which enables us to produce complex, proprietary and biologically equivalent proteins for a variety of human diseases.", "sentB": "Our ProCellEx system consists of a comprehensive set of capabilities and proprietary technologies, including advanced genetic engineering and plant cell culture technology, which enables us to produce complex, proprietary and biologically equivalent proteins for a variety of human diseases.", "type": 2, "words": ["<tag1>", "ProCellEx", "consists", "of", "a", "comprehensive", "set", "of", "capabilities", "and", "proprietary", "technologies,", "including", "advanced", "genetic", "engineering", "and", "plant", "cell", "culture", "technology,", "which", "enables", "us", "to", "produce", "complex,", "proprietary", "and", "biologically", "equivalent", "proteins", "for", "a", "variety", "of", "human", "diseases.", "<tag2>", "Our", "ProCellEx", "system", "consists", "of", "a", "comprehensive", "set", "of", "capabilities", "and", "proprietary", "technologies,", "including", "advanced", "genetic", "engineering", "and", "plant", "cell", "culture", "technology,", "which", "enables", "us", "to", "produce", "complex,", "proprietary", "and", "biologically", "equivalent", "proteins", "for", "a", "variety", "of", "human", "diseases.", "<tag3>"], "wordsA": ["ProCellEx", "consists", "of", "a", "comprehensive", "set", "of", "capabilities", "and", "proprietary", "technologies,", "including", "advanced", "genetic", "engineering", "and", "plant", "cell", "culture", "technology,", "which", "enables", "us", "to", "produce", "complex,", "proprietary", "and", "biologically", "equivalent", "proteins", "for", "a", "variety", "of", "human", "diseases."], "wordsB": ["Our", "ProCellEx", "system", "consists", "of", "a", "comprehensive", "set", "of", "capabilities", "and", "proprietary", "technologies,", "including", "advanced", "genetic", "engineering", "and", "plant", "cell", "culture", "technology,", "which", "enables", "us", "to", "produce", "complex,", "proprietary", "and", "biologically", "equivalent", "proteins", "for", "a", "variety", "of", "human", "diseases."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p21_s0", "idA": "1006281_16_item1_p28_s1", "sentA": "As a result, through our ProCellEx protein expression system, we believe that we can develop recombinant therapeutic proteins yielding substantial cost advantages, accelerated development and other competitive benefits when compared to mammalian cell-based protein expression systems.", "sentB": "We believe that our ProCellEx system will enable us to develop recombinant therapeutic proteins yielding substantial cost advantages, accelerated development and other competitive benefits when compared to mammalian cell-based protein expression systems.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "through", "our", "ProCellEx", "protein", "expression", "system,", "we", "believe", "that", "we", "can", "develop", "recombinant", "therapeutic", "proteins", "yielding", "substantial", "cost", "advantages,", "accelerated", "development", "and", "other", "competitive", "benefits", "when", "compared", "to", "mammalian", "cell-based", "protein", "expression", "systems.", "<tag2>", "We", "believe", "that", "our", "ProCellEx", "system", "will", "enable", "us", "to", "develop", "recombinant", "therapeutic", "proteins", "yielding", "substantial", "cost", "advantages,", "accelerated", "development", "and", "other", "competitive", "benefits", "when", "compared", "to", "mammalian", "cell-based", "protein", "expression", "systems.", "<tag3>"], "wordsA": ["As", "a", "result,", "through", "our", "ProCellEx", "protein", "expression", "system,", "we", "believe", "that", "we", "can", "develop", "recombinant", "therapeutic", "proteins", "yielding", "substantial", "cost", "advantages,", "accelerated", "development", "and", "other", "competitive", "benefits", "when", "compared", "to", "mammalian", "cell-based", "protein", "expression", "systems."], "wordsB": ["We", "believe", "that", "our", "ProCellEx", "system", "will", "enable", "us", "to", "develop", "recombinant", "therapeutic", "proteins", "yielding", "substantial", "cost", "advantages,", "accelerated", "development", "and", "other", "competitive", "benefits", "when", "compared", "to", "mammalian", "cell-based", "protein", "expression", "systems."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p2_s0", "idA": "1006281_16_item1_p2_s0", "sentA": "On May 1, 2012, the U.S. Food and Drug Administration, or the FDA, approved for sale our first commercial product, taliglucerase alfa for injection, an enzyme replacement therapy, or ERT, for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "sentB": "On May 1, 2012, the FDA approved for sale our first commercial product, taliglucerase alfa for injection, an enzyme replacement therapy, or ERT, for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease.", "type": 2, "words": ["<tag1>", "On", "May", "1,", "2012,", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag2>", "On", "May", "1,", "2012,", "the", "FDA", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease.", "<tag3>"], "wordsA": ["On", "May", "1,", "2012,", "the", "U.S.", "Food", "and", "Drug", "Administration,", "or", "the", "FDA,", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "wordsB": ["On", "May", "1,", "2012,", "the", "FDA", "approved", "for", "sale", "our", "first", "commercial", "product,", "taliglucerase", "alfa", "for", "injection,", "an", "enzyme", "replacement", "therapy,", "or", "ERT,", "for", "the", "long-term", "treatment", "of", "adult", "patients", "with", "a", "confirmed", "diagnosis", "of", "type", "1", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p3_s0", "idA": "1006281_16_item1_p2_s2", "sentA": "Taliglucerase alfa is being marketed under the name Uplyso TM in Brazil and certain other Latin American countries, and as Elelyso in all other territories.", "sentB": "Taliglucerase alfa is called alfataliglicerase in Brazil and certain other Latin American countries, where it is marketed under the name Uplyso TM .", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "and", "as", "Elelyso", "in", "all", "other", "territories.", "<tag2>", "Taliglucerase", "alfa", "is", "called", "alfataliglicerase", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "where", "it", "is", "marketed", "under", "the", "name", "Uplyso", "TM", ".", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "and", "as", "Elelyso", "in", "all", "other", "territories."], "wordsB": ["Taliglucerase", "alfa", "is", "called", "alfataliglicerase", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "where", "it", "is", "marketed", "under", "the", "name", "Uplyso", "TM", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p3_s1", "idA": "1006281_16_item1_p2_s2", "sentA": "Taliglucerase alfa is being marketed under the name Uplyso TM in Brazil and certain other Latin American countries, and as Elelyso in all other territories.", "sentB": "Taliglucerase alfa is marketed under the name Elelyso in other territories.", "type": 2, "words": ["<tag1>", "Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "and", "as", "Elelyso", "in", "all", "other", "territories.", "<tag2>", "Taliglucerase", "alfa", "is", "marketed", "under", "the", "name", "Elelyso", "in", "other", "territories.", "<tag3>"], "wordsA": ["Taliglucerase", "alfa", "is", "being", "marketed", "under", "the", "name", "Uplyso", "TM", "in", "Brazil", "and", "certain", "other", "Latin", "American", "countries,", "and", "as", "Elelyso", "in", "all", "other", "territories."], "wordsB": ["Taliglucerase", "alfa", "is", "marketed", "under", "the", "name", "Elelyso", "in", "other", "territories."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p21_s1", "idA": "1006281_16_item1_p30_s0", "sentA": "We believe that the ProCellEx system will enable us, in certain cases, to develop and commercialize recombinant proteins without infringing upon the method-based patents or other intellectual property rights of third parties.", "sentB": "In addition, our ProCellEx system may enable us, in certain cases, to develop and commercialize recombinant proteins without infringing upon the method-based patents or other intellectual property rights of third parties.", "type": 2, "words": ["<tag1>", "We", "believe", "that", "the", "ProCellEx", "system", "will", "enable", "us,", "in", "certain", "cases,", "to", "develop", "and", "commercialize", "recombinant", "proteins", "without", "infringing", "upon", "the", "method-based", "patents", "or", "other", "intellectual", "property", "rights", "of", "third", "parties.", "<tag2>", "In", "addition,", "our", "ProCellEx", "system", "may", "enable", "us,", "in", "certain", "cases,", "to", "develop", "and", "commercialize", "recombinant", "proteins", "without", "infringing", "upon", "the", "method-based", "patents", "or", "other", "intellectual", "property", "rights", "of", "third", "parties.", "<tag3>"], "wordsA": ["We", "believe", "that", "the", "ProCellEx", "system", "will", "enable", "us,", "in", "certain", "cases,", "to", "develop", "and", "commercialize", "recombinant", "proteins", "without", "infringing", "upon", "the", "method-based", "patents", "or", "other", "intellectual", "property", "rights", "of", "third", "parties."], "wordsB": ["In", "addition,", "our", "ProCellEx", "system", "may", "enable", "us,", "in", "certain", "cases,", "to", "develop", "and", "commercialize", "recombinant", "proteins", "without", "infringing", "upon", "the", "method-based", "patents", "or", "other", "intellectual", "property", "rights", "of", "third", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p23_s0", "idA": "1006281_16_item1_p32_s0", "sentA": "We have successfully demonstrated the feasibility of our ProCellEx system through: the FDA s approval of taliglucerase alfa, and its subsequent approval by other regulatory authorities; the clinical and preclinical studies we have performed to date, including the positive efficacy and safety data in our clinical trials for both Elelyso and PRX-102 for the treatment of Fabry disease; preclinical results in well-known models in our enzyme for each of Fabry disease, DNase and antiTNF; and by expressing, on an exploratory, research scale, many additional complex therapeutic proteins belonging to different drug classes, such as enzymes, hormones, monoclonal antibodies, cytokines and vaccines.", "sentB": "We have successfully demonstrated the feasibility of our ProCellEx system through: (i) the FDA s approval of taliglucerase alfa, and its subsequent approval by other regulatory authorities; (ii) the clinical and preclinical studies we have performed to date, including the positive efficacy and safety data in our clinical trials for taliglucerase alfa, PRX-102; (iii) alidornase alfa; OPRX-106 for the treatment of ulcerative colitis; (iv) preclinical results in well-known models in our enzyme for each of Fabry disease, DNase and antiTNF; and (v) by expressing, on an exploratory, research scale, many additional complex therapeutic proteins belonging to different drug classes, such as enzymes, hormones, monoclonal antibodies, cytokines and vaccines.", "type": 2, "words": ["<tag1>", "We", "have", "successfully", "demonstrated", "the", "feasibility", "of", "our", "ProCellEx", "system", "through:", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa,", "and", "its", "subsequent", "approval", "by", "other", "regulatory", "authorities;", "the", "clinical", "and", "preclinical", "studies", "we", "have", "performed", "to", "date,", "including", "the", "positive", "efficacy", "and", "safety", "data", "in", "our", "clinical", "trials", "for", "both", "Elelyso", "and", "PRX-102", "for", "the", "treatment", "of", "Fabry", "disease;", "preclinical", "results", "in", "well-known", "models", "in", "our", "enzyme", "for", "each", "of", "Fabry", "disease,", "DNase", "and", "antiTNF;", "and", "by", "expressing,", "on", "an", "exploratory,", "research", "scale,", "many", "additional", "complex", "therapeutic", "proteins", "belonging", "to", "different", "drug", "classes,", "such", "as", "enzymes,", "hormones,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines.", "<tag2>", "We", "have", "successfully", "demonstrated", "the", "feasibility", "of", "our", "ProCellEx", "system", "through:", "(i)", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa,", "and", "its", "subsequent", "approval", "by", "other", "regulatory", "authorities;", "(ii)", "the", "clinical", "and", "preclinical", "studies", "we", "have", "performed", "to", "date,", "including", "the", "positive", "efficacy", "and", "safety", "data", "in", "our", "clinical", "trials", "for", "taliglucerase", "alfa,", "PRX-102;", "(iii)", "alidornase", "alfa;", "OPRX-106", "for", "the", "treatment", "of", "ulcerative", "colitis;", "(iv)", "preclinical", "results", "in", "well-known", "models", "in", "our", "enzyme", "for", "each", "of", "Fabry", "disease,", "DNase", "and", "antiTNF;", "and", "(v)", "by", "expressing,", "on", "an", "exploratory,", "research", "scale,", "many", "additional", "complex", "therapeutic", "proteins", "belonging", "to", "different", "drug", "classes,", "such", "as", "enzymes,", "hormones,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines.", "<tag3>"], "wordsA": ["We", "have", "successfully", "demonstrated", "the", "feasibility", "of", "our", "ProCellEx", "system", "through:", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa,", "and", "its", "subsequent", "approval", "by", "other", "regulatory", "authorities;", "the", "clinical", "and", "preclinical", "studies", "we", "have", "performed", "to", "date,", "including", "the", "positive", "efficacy", "and", "safety", "data", "in", "our", "clinical", "trials", "for", "both", "Elelyso", "and", "PRX-102", "for", "the", "treatment", "of", "Fabry", "disease;", "preclinical", "results", "in", "well-known", "models", "in", "our", "enzyme", "for", "each", "of", "Fabry", "disease,", "DNase", "and", "antiTNF;", "and", "by", "expressing,", "on", "an", "exploratory,", "research", "scale,", "many", "additional", "complex", "therapeutic", "proteins", "belonging", "to", "different", "drug", "classes,", "such", "as", "enzymes,", "hormones,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines."], "wordsB": ["We", "have", "successfully", "demonstrated", "the", "feasibility", "of", "our", "ProCellEx", "system", "through:", "(i)", "the", "FDA", "s", "approval", "of", "taliglucerase", "alfa,", "and", "its", "subsequent", "approval", "by", "other", "regulatory", "authorities;", "(ii)", "the", "clinical", "and", "preclinical", "studies", "we", "have", "performed", "to", "date,", "including", "the", "positive", "efficacy", "and", "safety", "data", "in", "our", "clinical", "trials", "for", "taliglucerase", "alfa,", "PRX-102;", "(iii)", "alidornase", "alfa;", "OPRX-106", "for", "the", "treatment", "of", "ulcerative", "colitis;", "(iv)", "preclinical", "results", "in", "well-known", "models", "in", "our", "enzyme", "for", "each", "of", "Fabry", "disease,", "DNase", "and", "antiTNF;", "and", "(v)", "by", "expressing,", "on", "an", "exploratory,", "research", "scale,", "many", "additional", "complex", "therapeutic", "proteins", "belonging", "to", "different", "drug", "classes,", "such", "as", "enzymes,", "hormones,", "monoclonal", "antibodies,", "cytokines", "and", "vaccines."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p39_s2", "idA": "1006281_16_item1_p33_s1", "sentA": "In such method, an enzyme is naturally encapsulated within carrot cells genetically engineered to express the targeted enzyme.", "sentB": "In such method, an enzyme is naturally encapsulated within plant cells genetically engineered to express the targeted enzyme.", "type": 2, "words": ["<tag1>", "In", "such", "method,", "an", "enzyme", "is", "naturally", "encapsulated", "within", "carrot", "cells", "genetically", "engineered", "to", "express", "the", "targeted", "enzyme.", "<tag2>", "In", "such", "method,", "an", "enzyme", "is", "naturally", "encapsulated", "within", "plant", "cells", "genetically", "engineered", "to", "express", "the", "targeted", "enzyme.", "<tag3>"], "wordsA": ["In", "such", "method,", "an", "enzyme", "is", "naturally", "encapsulated", "within", "carrot", "cells", "genetically", "engineered", "to", "express", "the", "targeted", "enzyme."], "wordsB": ["In", "such", "method,", "an", "enzyme", "is", "naturally", "encapsulated", "within", "plant", "cells", "genetically", "engineered", "to", "express", "the", "targeted", "enzyme."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p40_s3", "idA": "1006281_16_item1_p34_s3", "sentA": "To date we have completed successful preclinical animal studies for oral GCD and oral antiTNF, and early clinical trials of oral GCD in Gaucher patients and oral antiTNF in a phase I clinical trial in healthy volunteers.", "sentB": "To date we have completed successful preclinical animal studies for oral GCD and oral antiTNF, and early clinical trials of oral GCD in Gaucher patients and oral antiTNF in a phase I clinical trial in healthy volunteers and a currently ongoing phase IIa proof of concept trial.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "antiTNF,", "and", "early", "clinical", "trials", "of", "oral", "GCD", "in", "Gaucher", "patients", "and", "oral", "antiTNF", "in", "a", "phase", "I", "clinical", "trial", "in", "healthy", "volunteers.", "<tag2>", "To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "antiTNF,", "and", "early", "clinical", "trials", "of", "oral", "GCD", "in", "Gaucher", "patients", "and", "oral", "antiTNF", "in", "a", "phase", "I", "clinical", "trial", "in", "healthy", "volunteers", "and", "a", "currently", "ongoing", "phase", "IIa", "proof", "of", "concept", "trial.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "antiTNF,", "and", "early", "clinical", "trials", "of", "oral", "GCD", "in", "Gaucher", "patients", "and", "oral", "antiTNF", "in", "a", "phase", "I", "clinical", "trial", "in", "healthy", "volunteers."], "wordsB": ["To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "antiTNF,", "and", "early", "clinical", "trials", "of", "oral", "GCD", "in", "Gaucher", "patients", "and", "oral", "antiTNF", "in", "a", "phase", "I", "clinical", "trial", "in", "healthy", "volunteers", "and", "a", "currently", "ongoing", "phase", "IIa", "proof", "of", "concept", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p40_s4", "idA": "1006281_16_item1_p34_s3", "sentA": "To date we have completed successful preclinical animal studies for oral GCD and oral antiTNF, and early clinical trials of oral GCD in Gaucher patients and oral antiTNF in a phase I clinical trial in healthy volunteers.", "sentB": "Our oral antiTNF product candidate is currently the subject of an ongoing phase IIa proof of concept trial and we have completed a phase I clinical trial of oral antiTNF in healthy volunteers.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "antiTNF,", "and", "early", "clinical", "trials", "of", "oral", "GCD", "in", "Gaucher", "patients", "and", "oral", "antiTNF", "in", "a", "phase", "I", "clinical", "trial", "in", "healthy", "volunteers.", "<tag2>", "Our", "oral", "antiTNF", "product", "candidate", "is", "currently", "the", "subject", "of", "an", "ongoing", "phase", "IIa", "proof", "of", "concept", "trial", "and", "we", "have", "completed", "a", "phase", "I", "clinical", "trial", "of", "oral", "antiTNF", "in", "healthy", "volunteers.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "antiTNF,", "and", "early", "clinical", "trials", "of", "oral", "GCD", "in", "Gaucher", "patients", "and", "oral", "antiTNF", "in", "a", "phase", "I", "clinical", "trial", "in", "healthy", "volunteers."], "wordsB": ["Our", "oral", "antiTNF", "product", "candidate", "is", "currently", "the", "subject", "of", "an", "ongoing", "phase", "IIa", "proof", "of", "concept", "trial", "and", "we", "have", "completed", "a", "phase", "I", "clinical", "trial", "of", "oral", "antiTNF", "in", "healthy", "volunteers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p29_s1", "idA": "1006281_16_item1_p36_s1", "sentA": "Significant advantages of ProCellEx over mammalian, bacterial, yeast and transgenic cell-based expression technologies, include the following:", "sentB": "Significant advantages of our ProCellEx system over mammalian, bacterial, yeast and transgenic cell-based expression technologies, include the following:", "type": 2, "words": ["<tag1>", "Significant", "advantages", "of", "ProCellEx", "over", "mammalian,", "bacterial,", "yeast", "and", "transgenic", "cell-based", "expression", "technologies,", "include", "the", "following:", "<tag2>", "Significant", "advantages", "of", "our", "ProCellEx", "system", "over", "mammalian,", "bacterial,", "yeast", "and", "transgenic", "cell-based", "expression", "technologies,", "include", "the", "following:", "<tag3>"], "wordsA": ["Significant", "advantages", "of", "ProCellEx", "over", "mammalian,", "bacterial,", "yeast", "and", "transgenic", "cell-based", "expression", "technologies,", "include", "the", "following:"], "wordsB": ["Significant", "advantages", "of", "our", "ProCellEx", "system", "over", "mammalian,", "bacterial,", "yeast", "and", "transgenic", "cell-based", "expression", "technologies,", "include", "the", "following:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p32_s3", "idA": "1006281_16_item1_p39_s3", "sentA": "Moreover, we expect to enjoy method-based patent protection for the proteins we develop using ProCellEx, although there can be no assurance that any such patents will be granted.", "sentB": "Moreover, we expect to enjoy method-based patent protection for the proteins we develop using our ProCellEx system, although there can be no assurance that any such patents will be granted.", "type": 2, "words": ["<tag1>", "Moreover,", "we", "expect", "to", "enjoy", "method-based", "patent", "protection", "for", "the", "proteins", "we", "develop", "using", "ProCellEx,", "although", "there", "can", "be", "no", "assurance", "that", "any", "such", "patents", "will", "be", "granted.", "<tag2>", "Moreover,", "we", "expect", "to", "enjoy", "method-based", "patent", "protection", "for", "the", "proteins", "we", "develop", "using", "our", "ProCellEx", "system,", "although", "there", "can", "be", "no", "assurance", "that", "any", "such", "patents", "will", "be", "granted.", "<tag3>"], "wordsA": ["Moreover,", "we", "expect", "to", "enjoy", "method-based", "patent", "protection", "for", "the", "proteins", "we", "develop", "using", "ProCellEx,", "although", "there", "can", "be", "no", "assurance", "that", "any", "such", "patents", "will", "be", "granted."], "wordsB": ["Moreover,", "we", "expect", "to", "enjoy", "method-based", "patent", "protection", "for", "the", "proteins", "we", "develop", "using", "our", "ProCellEx", "system,", "although", "there", "can", "be", "no", "assurance", "that", "any", "such", "patents", "will", "be", "granted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p4_s0", "idA": "1006281_16_item1_p3_s0", "sentA": "Since its approval by the FDA, taliglucerase alfa has been marketed mainly in the United States by Pfizer Inc., or Pfizer, as provided in the exclusive license and supply agreement by and between Protalix Ltd., our wholly-owned subsidiary, and Pfizer, which we refer to as the Pfizer Agreement.", "sentB": "Since its approval by the FDA, taliglucerase alfa has been marketed mainly in the United States by Pfizer, as provided in the exclusive license and supply agreement by and between Protalix Ltd., our wholly-owned subsidiary, and Pfizer, which we refer to as the Pfizer Agreement.", "type": 2, "words": ["<tag1>", "Since", "its", "approval", "by", "the", "FDA,", "taliglucerase", "alfa", "has", "been", "marketed", "mainly", "in", "the", "United", "States", "by", "Pfizer", "Inc.,", "or", "Pfizer,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement.", "<tag2>", "Since", "its", "approval", "by", "the", "FDA,", "taliglucerase", "alfa", "has", "been", "marketed", "mainly", "in", "the", "United", "States", "by", "Pfizer,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement.", "<tag3>"], "wordsA": ["Since", "its", "approval", "by", "the", "FDA,", "taliglucerase", "alfa", "has", "been", "marketed", "mainly", "in", "the", "United", "States", "by", "Pfizer", "Inc.,", "or", "Pfizer,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement."], "wordsB": ["Since", "its", "approval", "by", "the", "FDA,", "taliglucerase", "alfa", "has", "been", "marketed", "mainly", "in", "the", "United", "States", "by", "Pfizer,", "as", "provided", "in", "the", "exclusive", "license", "and", "supply", "agreement", "by", "and", "between", "Protalix", "Ltd.,", "our", "wholly-owned", "subsidiary,", "and", "Pfizer,", "which", "we", "refer", "to", "as", "the", "Pfizer", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p36_s0", "idA": "1006281_16_item1_p43_s0", "sentA": "Plant cells grow rapidly under a variety of conditions and are not as sensitive as mammalian cells are to temperature, pH and oxygen levels.", "sentB": "Plant cells grow rapidly under a variety of conditions and are not as sensitive as mammalian cells are to temperature, pH and oxygen levels which generally can only be grown under near perfect conditions.", "type": 2, "words": ["<tag1>", "Plant", "cells", "grow", "rapidly", "under", "a", "variety", "of", "conditions", "and", "are", "not", "as", "sensitive", "as", "mammalian", "cells", "are", "to", "temperature,", "pH", "and", "oxygen", "levels.", "<tag2>", "Plant", "cells", "grow", "rapidly", "under", "a", "variety", "of", "conditions", "and", "are", "not", "as", "sensitive", "as", "mammalian", "cells", "are", "to", "temperature,", "pH", "and", "oxygen", "levels", "which", "generally", "can", "only", "be", "grown", "under", "near", "perfect", "conditions.", "<tag3>"], "wordsA": ["Plant", "cells", "grow", "rapidly", "under", "a", "variety", "of", "conditions", "and", "are", "not", "as", "sensitive", "as", "mammalian", "cells", "are", "to", "temperature,", "pH", "and", "oxygen", "levels."], "wordsB": ["Plant", "cells", "grow", "rapidly", "under", "a", "variety", "of", "conditions", "and", "are", "not", "as", "sensitive", "as", "mammalian", "cells", "are", "to", "temperature,", "pH", "and", "oxygen", "levels", "which", "generally", "can", "only", "be", "grown", "under", "near", "perfect", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p40_s5", "idA": "1006281_16_item1_p46_s3", "sentA": "To date we have completed successful preclinical animal studies for oral GCD and oral anti TNF, and early clinical trials of oral GCD in Gaucher patients.", "sentB": "We have also completed an early clinical trial of oral GCD in Gaucher patients.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "anti", "TNF,", "and", "early", "clinical", "trials", "of", "oral", "GCD", "in", "Gaucher", "patients.", "<tag2>", "We", "have", "also", "completed", "an", "early", "clinical", "trial", "of", "oral", "GCD", "in", "Gaucher", "patients.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "completed", "successful", "preclinical", "animal", "studies", "for", "oral", "GCD", "and", "oral", "anti", "TNF,", "and", "early", "clinical", "trials", "of", "oral", "GCD", "in", "Gaucher", "patients."], "wordsB": ["We", "have", "also", "completed", "an", "early", "clinical", "trial", "of", "oral", "GCD", "in", "Gaucher", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p41_s3", "idA": "1006281_16_item1_p47_s3", "sentA": "In August 2014, the FDA approved Elelyso for injection for pediatric patients and in other jurisdictions thereafter.", "sentB": "In August 2014, the FDA approved Elelyso for injection for pediatric patients, and other jurisdictions, including Brazil, approved pediatric indications thereafter.", "type": 2, "words": ["<tag1>", "In", "August", "2014,", "the", "FDA", "approved", "Elelyso", "for", "injection", "for", "pediatric", "patients", "and", "in", "other", "jurisdictions", "thereafter.", "<tag2>", "In", "August", "2014,", "the", "FDA", "approved", "Elelyso", "for", "injection", "for", "pediatric", "patients,", "and", "other", "jurisdictions,", "including", "Brazil,", "approved", "pediatric", "indications", "thereafter.", "<tag3>"], "wordsA": ["In", "August", "2014,", "the", "FDA", "approved", "Elelyso", "for", "injection", "for", "pediatric", "patients", "and", "in", "other", "jurisdictions", "thereafter."], "wordsB": ["In", "August", "2014,", "the", "FDA", "approved", "Elelyso", "for", "injection", "for", "pediatric", "patients,", "and", "other", "jurisdictions,", "including", "Brazil,", "approved", "pediatric", "indications", "thereafter."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p82_s1", "idA": "1006281_16_item1_p54_s4", "sentA": "Finally, Zavesca (miglustat) is a small molecule drug for the treatment of Gaucher disease.", "sentB": "A commercially available small molecule CFTR modulator for the treatment of CF has reported a mean absolute increase in ppFEV1 of 2.5 from baseline in its registration clinical study.", "type": 2, "words": ["<tag1>", "Finally,", "Zavesca", "(miglustat)", "is", "a", "small", "molecule", "drug", "for", "the", "treatment", "of", "Gaucher", "disease.", "<tag2>", "A", "commercially", "available", "small", "molecule", "CFTR", "modulator", "for", "the", "treatment", "of", "CF", "has", "reported", "a", "mean", "absolute", "increase", "in", "ppFEV1", "of", "2.5", "from", "baseline", "in", "its", "registration", "clinical", "study.", "<tag3>"], "wordsA": ["Finally,", "Zavesca", "(miglustat)", "is", "a", "small", "molecule", "drug", "for", "the", "treatment", "of", "Gaucher", "disease."], "wordsB": ["A", "commercially", "available", "small", "molecule", "CFTR", "modulator", "for", "the", "treatment", "of", "CF", "has", "reported", "a", "mean", "absolute", "increase", "in", "ppFEV1", "of", "2.5", "from", "baseline", "in", "its", "registration", "clinical", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p48_s7", "idA": "1006281_16_item1_p54_s7", "sentA": "As a result, Zavesca s use has been limited with respect to treating Gaucher disease.", "sentB": "As a result, the use of Zavesca has been limited with respect to the treatment of Gaucher disease.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "Zavesca", "s", "use", "has", "been", "limited", "with", "respect", "to", "treating", "Gaucher", "disease.", "<tag2>", "As", "a", "result,", "the", "use", "of", "Zavesca", "has", "been", "limited", "with", "respect", "to", "the", "treatment", "of", "Gaucher", "disease.", "<tag3>"], "wordsA": ["As", "a", "result,", "Zavesca", "s", "use", "has", "been", "limited", "with", "respect", "to", "treating", "Gaucher", "disease."], "wordsB": ["As", "a", "result,", "the", "use", "of", "Zavesca", "has", "been", "limited", "with", "respect", "to", "the", "treatment", "of", "Gaucher", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p54_s0", "idA": "1006281_16_item1_p59_s1", "sentA": "PRX-102 has been shown to be taken up by Fabry patients cells where it localizes to the lysosome, in which Gb3 accumulates.", "sentB": "In clinical trials, PRX-102 has been shown to be taken up by Fabry patients cells where it localizes to the lysosome, in which Gb3 accumulates.", "type": 2, "words": ["<tag1>", "PRX-102", "has", "been", "shown", "to", "be", "taken", "up", "by", "Fabry", "patients", "cells", "where", "it", "localizes", "to", "the", "lysosome,", "in", "which", "Gb3", "accumulates.", "<tag2>", "In", "clinical", "trials,", "PRX-102", "has", "been", "shown", "to", "be", "taken", "up", "by", "Fabry", "patients", "cells", "where", "it", "localizes", "to", "the", "lysosome,", "in", "which", "Gb3", "accumulates.", "<tag3>"], "wordsA": ["PRX-102", "has", "been", "shown", "to", "be", "taken", "up", "by", "Fabry", "patients", "cells", "where", "it", "localizes", "to", "the", "lysosome,", "in", "which", "Gb3", "accumulates."], "wordsB": ["In", "clinical", "trials,", "PRX-102", "has", "been", "shown", "to", "be", "taken", "up", "by", "Fabry", "patients", "cells", "where", "it", "localizes", "to", "the", "lysosome,", "in", "which", "Gb3", "accumulates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p71_s1", "idA": "1006281_16_item1_p59_s1", "sentA": "PRX-102 has been shown to be taken up by Fabry patients cells where it localizes to the lysosome, in which Gb3 accumulates.", "sentB": "PRX-102 has been shown in clinical trials to have a half-life of approximately 80 hours and a substantially higher AUC compared to the other ERTs, demonstrating enzyme availability throughout the 2-week infusion intervals.", "type": 2, "words": ["<tag1>", "PRX-102", "has", "been", "shown", "to", "be", "taken", "up", "by", "Fabry", "patients", "cells", "where", "it", "localizes", "to", "the", "lysosome,", "in", "which", "Gb3", "accumulates.", "<tag2>", "PRX-102", "has", "been", "shown", "in", "clinical", "trials", "to", "have", "a", "half-life", "of", "approximately", "80", "hours", "and", "a", "substantially", "higher", "AUC", "compared", "to", "the", "other", "ERTs,", "demonstrating", "enzyme", "availability", "throughout", "the", "2-week", "infusion", "intervals.", "<tag3>"], "wordsA": ["PRX-102", "has", "been", "shown", "to", "be", "taken", "up", "by", "Fabry", "patients", "cells", "where", "it", "localizes", "to", "the", "lysosome,", "in", "which", "Gb3", "accumulates."], "wordsB": ["PRX-102", "has", "been", "shown", "in", "clinical", "trials", "to", "have", "a", "half-life", "of", "approximately", "80", "hours", "and", "a", "substantially", "higher", "AUC", "compared", "to", "the", "other", "ERTs,", "demonstrating", "enzyme", "availability", "throughout", "the", "2-week", "infusion", "intervals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p55_s0", "idA": "1006281_16_item1_p60_s0", "sentA": "Currently there are two drugs available on the market to treat Fabry disease.", "sentB": "Currently there are two enzyme replacement therapies drugs available on the market to treat Fabry disease.", "type": 2, "words": ["<tag1>", "Currently", "there", "are", "two", "drugs", "available", "on", "the", "market", "to", "treat", "Fabry", "disease.", "<tag2>", "Currently", "there", "are", "two", "enzyme", "replacement", "therapies", "drugs", "available", "on", "the", "market", "to", "treat", "Fabry", "disease.", "<tag3>"], "wordsA": ["Currently", "there", "are", "two", "drugs", "available", "on", "the", "market", "to", "treat", "Fabry", "disease."], "wordsB": ["Currently", "there", "are", "two", "enzyme", "replacement", "therapies", "drugs", "available", "on", "the", "market", "to", "treat", "Fabry", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p57_s0", "idA": "1006281_16_item1_p60_s0", "sentA": "Currently there are two drugs available on the market to treat Fabry disease.", "sentB": "In addition, there are other, non-ERT treatments for Fabry disease.", "type": 2, "words": ["<tag1>", "Currently", "there", "are", "two", "drugs", "available", "on", "the", "market", "to", "treat", "Fabry", "disease.", "<tag2>", "In", "addition,", "there", "are", "other,", "non-ERT", "treatments", "for", "Fabry", "disease.", "<tag3>"], "wordsA": ["Currently", "there", "are", "two", "drugs", "available", "on", "the", "market", "to", "treat", "Fabry", "disease."], "wordsB": ["In", "addition,", "there", "are", "other,", "non-ERT", "treatments", "for", "Fabry", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p55_s2", "idA": "1006281_16_item1_p60_s2", "sentA": "Sanofi reported 592 million (approximately $643 million) in worldwide sales of Fabrazyme in 2015.", "sentB": "Sanofi reported 674 million (approximately $709 million) in worldwide sales of Fabrazyme in 2016.", "type": 2, "words": ["<tag1>", "Sanofi", "reported", "592", "million", "(approximately", "$643", "million)", "in", "worldwide", "sales", "of", "Fabrazyme", "in", "2015.", "<tag2>", "Sanofi", "reported", "674", "million", "(approximately", "$709", "million)", "in", "worldwide", "sales", "of", "Fabrazyme", "in", "2016.", "<tag3>"], "wordsA": ["Sanofi", "reported", "592", "million", "(approximately", "$643", "million)", "in", "worldwide", "sales", "of", "Fabrazyme", "in", "2015."], "wordsB": ["Sanofi", "reported", "674", "million", "(approximately", "$709", "million)", "in", "worldwide", "sales", "of", "Fabrazyme", "in", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p68_s0", "idA": "1006281_16_item1_p61_s0", "sentA": "The other approved drug for the treatment of Fabry disease in the European Union is Replagal, which is marketed by Shire.", "sentB": "The detailed results, as a percentage of change from baseline, for both all patients and for the Classic Fabry disease patient subset are presented in the following chart:", "type": 2, "words": ["<tag1>", "The", "other", "approved", "drug", "for", "the", "treatment", "of", "Fabry", "disease", "in", "the", "European", "Union", "is", "Replagal,", "which", "is", "marketed", "by", "Shire.", "<tag2>", "The", "detailed", "results,", "as", "a", "percentage", "of", "change", "from", "baseline,", "for", "both", "all", "patients", "and", "for", "the", "Classic", "Fabry", "disease", "patient", "subset", "are", "presented", "in", "the", "following", "chart:", "<tag3>"], "wordsA": ["The", "other", "approved", "drug", "for", "the", "treatment", "of", "Fabry", "disease", "in", "the", "European", "Union", "is", "Replagal,", "which", "is", "marketed", "by", "Shire."], "wordsB": ["The", "detailed", "results,", "as", "a", "percentage", "of", "change", "from", "baseline,", "for", "both", "all", "patients", "and", "for", "the", "Classic", "Fabry", "disease", "patient", "subset", "are", "presented", "in", "the", "following", "chart:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p56_s1", "idA": "1006281_16_item1_p61_s1", "sentA": "Shire reported $442 million in sales of Replagal in 2015.", "sentB": "Shire reported $452 million in sales of Replagal in 2016.", "type": 2, "words": ["<tag1>", "Shire", "reported", "$442", "million", "in", "sales", "of", "Replagal", "in", "2015.", "<tag2>", "Shire", "reported", "$452", "million", "in", "sales", "of", "Replagal", "in", "2016.", "<tag3>"], "wordsA": ["Shire", "reported", "$442", "million", "in", "sales", "of", "Replagal", "in", "2015."], "wordsB": ["Shire", "reported", "$452", "million", "in", "sales", "of", "Replagal", "in", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p13_s0", "idA": "1006281_16_item1_p62_s0", "sentA": "In February 2015, we announced the completion of enrollment in our phase I/II clinical trial in adult Fabry patients.", "sentB": "In August 2015, we announced positive clinical study results from our phase I clinical trial of OPRX-106.", "type": 2, "words": ["<tag1>", "In", "February", "2015,", "we", "announced", "the", "completion", "of", "enrollment", "in", "our", "phase", "I/II", "clinical", "trial", "in", "adult", "Fabry", "patients.", "<tag2>", "In", "August", "2015,", "we", "announced", "positive", "clinical", "study", "results", "from", "our", "phase", "I", "clinical", "trial", "of", "OPRX-106.", "<tag3>"], "wordsA": ["In", "February", "2015,", "we", "announced", "the", "completion", "of", "enrollment", "in", "our", "phase", "I/II", "clinical", "trial", "in", "adult", "Fabry", "patients."], "wordsB": ["In", "August", "2015,", "we", "announced", "positive", "clinical", "study", "results", "from", "our", "phase", "I", "clinical", "trial", "of", "OPRX-106."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p59_s0", "idA": "1006281_16_item1_p62_s1", "sentA": "The phase I/II clinical trial is a worldwide, multi-center, open label, dose ranging study to evaluate the safety, tolerability, pharmacokinetics and exploratory efficacy parameters of PRX-102 in adult Fabry patients.", "sentB": "The phase III efficacy and safety clinical trial, which we refer to as the BALANCE Study, is a 24-month multi-center, randomized, double-blind, active control study of PRX-102 in Fabry patients with impaired renal function.", "type": 2, "words": ["<tag1>", "The", "phase", "I/II", "clinical", "trial", "is", "a", "worldwide,", "multi-center,", "open", "label,", "dose", "ranging", "study", "to", "evaluate", "the", "safety,", "tolerability,", "pharmacokinetics", "and", "exploratory", "efficacy", "parameters", "of", "PRX-102", "in", "adult", "Fabry", "patients.", "<tag2>", "The", "phase", "III", "efficacy", "and", "safety", "clinical", "trial,", "which", "we", "refer", "to", "as", "the", "BALANCE", "Study,", "is", "a", "24-month", "multi-center,", "randomized,", "double-blind,", "active", "control", "study", "of", "PRX-102", "in", "Fabry", "patients", "with", "impaired", "renal", "function.", "<tag3>"], "wordsA": ["The", "phase", "I/II", "clinical", "trial", "is", "a", "worldwide,", "multi-center,", "open", "label,", "dose", "ranging", "study", "to", "evaluate", "the", "safety,", "tolerability,", "pharmacokinetics", "and", "exploratory", "efficacy", "parameters", "of", "PRX-102", "in", "adult", "Fabry", "patients."], "wordsB": ["The", "phase", "III", "efficacy", "and", "safety", "clinical", "trial,", "which", "we", "refer", "to", "as", "the", "BALANCE", "Study,", "is", "a", "24-month", "multi-center,", "randomized,", "double-blind,", "active", "control", "study", "of", "PRX-102", "in", "Fabry", "patients", "with", "impaired", "renal", "function."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p63_s1", "idA": "1006281_16_item1_p62_s1", "sentA": "The phase I/II clinical trial is a worldwide, multi-center, open label, dose ranging study to evaluate the safety, tolerability, pharmacokinetics and exploratory efficacy parameters of PRX-102 in adult Fabry patients.", "sentB": "This supportive study, which we refer to as the BRIDGE Study, is designed to be an open-label, single-arm, switchover study to assess the efficacy and safety of PRX-102 in Fabry patients currently treated with Replagal.", "type": 2, "words": ["<tag1>", "The", "phase", "I/II", "clinical", "trial", "is", "a", "worldwide,", "multi-center,", "open", "label,", "dose", "ranging", "study", "to", "evaluate", "the", "safety,", "tolerability,", "pharmacokinetics", "and", "exploratory", "efficacy", "parameters", "of", "PRX-102", "in", "adult", "Fabry", "patients.", "<tag2>", "This", "supportive", "study,", "which", "we", "refer", "to", "as", "the", "BRIDGE", "Study,", "is", "designed", "to", "be", "an", "open-label,", "single-arm,", "switchover", "study", "to", "assess", "the", "efficacy", "and", "safety", "of", "PRX-102", "in", "Fabry", "patients", "currently", "treated", "with", "Replagal.", "<tag3>"], "wordsA": ["The", "phase", "I/II", "clinical", "trial", "is", "a", "worldwide,", "multi-center,", "open", "label,", "dose", "ranging", "study", "to", "evaluate", "the", "safety,", "tolerability,", "pharmacokinetics", "and", "exploratory", "efficacy", "parameters", "of", "PRX-102", "in", "adult", "Fabry", "patients."], "wordsB": ["This", "supportive", "study,", "which", "we", "refer", "to", "as", "the", "BRIDGE", "Study,", "is", "designed", "to", "be", "an", "open-label,", "single-arm,", "switchover", "study", "to", "assess", "the", "efficacy", "and", "safety", "of", "PRX-102", "in", "Fabry", "patients", "currently", "treated", "with", "Replagal."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p64_s1", "idA": "1006281_16_item1_p62_s1", "sentA": "The phase I/II clinical trial is a worldwide, multi-center, open label, dose ranging study to evaluate the safety, tolerability, pharmacokinetics and exploratory efficacy parameters of PRX-102 in adult Fabry patients.", "sentB": "The phase I/II clinical trial is a worldwide, multi-center, open label, dose ranging study to evaluate the safety, tolerability, pharmacokinetics, immunogenicity and efficacy parameters of PRX-102 in adult Fabry patients.", "type": 2, "words": ["<tag1>", "The", "phase", "I/II", "clinical", "trial", "is", "a", "worldwide,", "multi-center,", "open", "label,", "dose", "ranging", "study", "to", "evaluate", "the", "safety,", "tolerability,", "pharmacokinetics", "and", "exploratory", "efficacy", "parameters", "of", "PRX-102", "in", "adult", "Fabry", "patients.", "<tag2>", "The", "phase", "I/II", "clinical", "trial", "is", "a", "worldwide,", "multi-center,", "open", "label,", "dose", "ranging", "study", "to", "evaluate", "the", "safety,", "tolerability,", "pharmacokinetics,", "immunogenicity", "and", "efficacy", "parameters", "of", "PRX-102", "in", "adult", "Fabry", "patients.", "<tag3>"], "wordsA": ["The", "phase", "I/II", "clinical", "trial", "is", "a", "worldwide,", "multi-center,", "open", "label,", "dose", "ranging", "study", "to", "evaluate", "the", "safety,", "tolerability,", "pharmacokinetics", "and", "exploratory", "efficacy", "parameters", "of", "PRX-102", "in", "adult", "Fabry", "patients."], "wordsB": ["The", "phase", "I/II", "clinical", "trial", "is", "a", "worldwide,", "multi-center,", "open", "label,", "dose", "ranging", "study", "to", "evaluate", "the", "safety,", "tolerability,", "pharmacokinetics,", "immunogenicity", "and", "efficacy", "parameters", "of", "PRX-102", "in", "adult", "Fabry", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p80_s1", "idA": "1006281_16_item1_p62_s1", "sentA": "The phase I/II clinical trial is a worldwide, multi-center, open label, dose ranging study to evaluate the safety, tolerability, pharmacokinetics and exploratory efficacy parameters of PRX-102 in adult Fabry patients.", "sentB": "The trial is a 28-day switch-over study of 15 CF patients previously treated with Pulmozyme to evaluate the efficacy and safety of alidornase alfa in CF patients.", "type": 2, "words": ["<tag1>", "The", "phase", "I/II", "clinical", "trial", "is", "a", "worldwide,", "multi-center,", "open", "label,", "dose", "ranging", "study", "to", "evaluate", "the", "safety,", "tolerability,", "pharmacokinetics", "and", "exploratory", "efficacy", "parameters", "of", "PRX-102", "in", "adult", "Fabry", "patients.", "<tag2>", "The", "trial", "is", "a", "28-day", "switch-over", "study", "of", "15", "CF", "patients", "previously", "treated", "with", "Pulmozyme", "to", "evaluate", "the", "efficacy", "and", "safety", "of", "alidornase", "alfa", "in", "CF", "patients.", "<tag3>"], "wordsA": ["The", "phase", "I/II", "clinical", "trial", "is", "a", "worldwide,", "multi-center,", "open", "label,", "dose", "ranging", "study", "to", "evaluate", "the", "safety,", "tolerability,", "pharmacokinetics", "and", "exploratory", "efficacy", "parameters", "of", "PRX-102", "in", "adult", "Fabry", "patients."], "wordsB": ["The", "trial", "is", "a", "28-day", "switch-over", "study", "of", "15", "CF", "patients", "previously", "treated", "with", "Pulmozyme", "to", "evaluate", "the", "efficacy", "and", "safety", "of", "alidornase", "alfa", "in", "CF", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p93_s1", "idA": "1006281_16_item1_p62_s1", "sentA": "The phase I/II clinical trial is a worldwide, multi-center, open label, dose ranging study to evaluate the safety, tolerability, pharmacokinetics and exploratory efficacy parameters of PRX-102 in adult Fabry patients.", "sentB": "The phase IIa clinical trial is designed as a randomized, open label, 2-arm study of OPRX-106 in 20 patients with active mild to moderate ulcerative colitis.", "type": 2, "words": ["<tag1>", "The", "phase", "I/II", "clinical", "trial", "is", "a", "worldwide,", "multi-center,", "open", "label,", "dose", "ranging", "study", "to", "evaluate", "the", "safety,", "tolerability,", "pharmacokinetics", "and", "exploratory", "efficacy", "parameters", "of", "PRX-102", "in", "adult", "Fabry", "patients.", "<tag2>", "The", "phase", "IIa", "clinical", "trial", "is", "designed", "as", "a", "randomized,", "open", "label,", "2-arm", "study", "of", "OPRX-106", "in", "20", "patients", "with", "active", "mild", "to", "moderate", "ulcerative", "colitis.", "<tag3>"], "wordsA": ["The", "phase", "I/II", "clinical", "trial", "is", "a", "worldwide,", "multi-center,", "open", "label,", "dose", "ranging", "study", "to", "evaluate", "the", "safety,", "tolerability,", "pharmacokinetics", "and", "exploratory", "efficacy", "parameters", "of", "PRX-102", "in", "adult", "Fabry", "patients."], "wordsB": ["The", "phase", "IIa", "clinical", "trial", "is", "designed", "as", "a", "randomized,", "open", "label,", "2-arm", "study", "of", "OPRX-106", "in", "20", "patients", "with", "active", "mild", "to", "moderate", "ulcerative", "colitis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p64_s2", "idA": "1006281_16_item1_p62_s2", "sentA": "There were 18 adult Fabry patients (11 male and 7 female) enrolled in the trial, each in one of three dosing groups, 0.2 mg/kg, 1mg/kg and 2mg/kg.", "sentB": "Sixteen adult Fabry patients (9 male and 7 female) completed the trial, each in one of three dosing groups, 0.2 mg/kg, 1mg/kg and 2mg/kg.", "type": 2, "words": ["<tag1>", "There", "were", "18", "adult", "Fabry", "patients", "(11", "male", "and", "7", "female)", "enrolled", "in", "the", "trial,", "each", "in", "one", "of", "three", "dosing", "groups,", "0.2", "mg/kg,", "1mg/kg", "and", "2mg/kg.", "<tag2>", "Sixteen", "adult", "Fabry", "patients", "(9", "male", "and", "7", "female)", "completed", "the", "trial,", "each", "in", "one", "of", "three", "dosing", "groups,", "0.2", "mg/kg,", "1mg/kg", "and", "2mg/kg.", "<tag3>"], "wordsA": ["There", "were", "18", "adult", "Fabry", "patients", "(11", "male", "and", "7", "female)", "enrolled", "in", "the", "trial,", "each", "in", "one", "of", "three", "dosing", "groups,", "0.2", "mg/kg,", "1mg/kg", "and", "2mg/kg."], "wordsB": ["Sixteen", "adult", "Fabry", "patients", "(9", "male", "and", "7", "female)", "completed", "the", "trial,", "each", "in", "one", "of", "three", "dosing", "groups,", "0.2", "mg/kg,", "1mg/kg", "and", "2mg/kg."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p60_s0", "idA": "1006281_16_item1_p62_s3", "sentA": "Each patient receives intravenous infusions of PRX-102 every two weeks for 12 weeks, with a six-month efficacy follow up period.", "sentB": "Patients are to be treated via intravenous (IV) infusions every two weeks.", "type": 2, "words": ["<tag1>", "Each", "patient", "receives", "intravenous", "infusions", "of", "PRX-102", "every", "two", "weeks", "for", "12", "weeks,", "with", "a", "six-month", "efficacy", "follow", "up", "period.", "<tag2>", "Patients", "are", "to", "be", "treated", "via", "intravenous", "(IV)", "infusions", "every", "two", "weeks.", "<tag3>"], "wordsA": ["Each", "patient", "receives", "intravenous", "infusions", "of", "PRX-102", "every", "two", "weeks", "for", "12", "weeks,", "with", "a", "six-month", "efficacy", "follow", "up", "period."], "wordsB": ["Patients", "are", "to", "be", "treated", "via", "intravenous", "(IV)", "infusions", "every", "two", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p61_s0", "idA": "1006281_16_item1_p62_s3", "sentA": "Each patient receives intravenous infusions of PRX-102 every two weeks for 12 weeks, with a six-month efficacy follow up period.", "sentB": "All patients must have had treatment with a dose of 1 mg/kg agalsidase beta per infusion every two weeks for at least one year.", "type": 2, "words": ["<tag1>", "Each", "patient", "receives", "intravenous", "infusions", "of", "PRX-102", "every", "two", "weeks", "for", "12", "weeks,", "with", "a", "six-month", "efficacy", "follow", "up", "period.", "<tag2>", "All", "patients", "must", "have", "had", "treatment", "with", "a", "dose", "of", "1", "mg/kg", "agalsidase", "beta", "per", "infusion", "every", "two", "weeks", "for", "at", "least", "one", "year.", "<tag3>"], "wordsA": ["Each", "patient", "receives", "intravenous", "infusions", "of", "PRX-102", "every", "two", "weeks", "for", "12", "weeks,", "with", "a", "six-month", "efficacy", "follow", "up", "period."], "wordsB": ["All", "patients", "must", "have", "had", "treatment", "with", "a", "dose", "of", "1", "mg/kg", "agalsidase", "beta", "per", "infusion", "every", "two", "weeks", "for", "at", "least", "one", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p64_s3", "idA": "1006281_16_item1_p62_s3", "sentA": "Each patient receives intravenous infusions of PRX-102 every two weeks for 12 weeks, with a six-month efficacy follow up period.", "sentB": "Each patient received intravenous infusions of PRX-102 every two weeks for 12 weeks, with efficacy follow-up after six-month and twelve-month periods.", "type": 2, "words": ["<tag1>", "Each", "patient", "receives", "intravenous", "infusions", "of", "PRX-102", "every", "two", "weeks", "for", "12", "weeks,", "with", "a", "six-month", "efficacy", "follow", "up", "period.", "<tag2>", "Each", "patient", "received", "intravenous", "infusions", "of", "PRX-102", "every", "two", "weeks", "for", "12", "weeks,", "with", "efficacy", "follow-up", "after", "six-month", "and", "twelve-month", "periods.", "<tag3>"], "wordsA": ["Each", "patient", "receives", "intravenous", "infusions", "of", "PRX-102", "every", "two", "weeks", "for", "12", "weeks,", "with", "a", "six-month", "efficacy", "follow", "up", "period."], "wordsB": ["Each", "patient", "received", "intravenous", "infusions", "of", "PRX-102", "every", "two", "weeks", "for", "12", "weeks,", "with", "efficacy", "follow-up", "after", "six-month", "and", "twelve-month", "periods."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p64_s4", "idA": "1006281_16_item1_p62_s4", "sentA": "All patients that completed the trial have opted to continue to receive PRX-102 in an open-label extension trial.", "sentB": "All patients that completed the trial have opted to continue to receive 1 mg/kg of PRX-102 in an open-label extension trial, 60-month extension study under which all patients have been switched to receive 1 mg/kg of the drug, the selected dose for our phase III studies of PRX-102.", "type": 2, "words": ["<tag1>", "All", "patients", "that", "completed", "the", "trial", "have", "opted", "to", "continue", "to", "receive", "PRX-102", "in", "an", "open-label", "extension", "trial.", "<tag2>", "All", "patients", "that", "completed", "the", "trial", "have", "opted", "to", "continue", "to", "receive", "1", "mg/kg", "of", "PRX-102", "in", "an", "open-label", "extension", "trial,", "60-month", "extension", "study", "under", "which", "all", "patients", "have", "been", "switched", "to", "receive", "1", "mg/kg", "of", "the", "drug,", "the", "selected", "dose", "for", "our", "phase", "III", "studies", "of", "PRX-102.", "<tag3>"], "wordsA": ["All", "patients", "that", "completed", "the", "trial", "have", "opted", "to", "continue", "to", "receive", "PRX-102", "in", "an", "open-label", "extension", "trial."], "wordsB": ["All", "patients", "that", "completed", "the", "trial", "have", "opted", "to", "continue", "to", "receive", "1", "mg/kg", "of", "PRX-102", "in", "an", "open-label", "extension", "trial,", "60-month", "extension", "study", "under", "which", "all", "patients", "have", "been", "switched", "to", "receive", "1", "mg/kg", "of", "the", "drug,", "the", "selected", "dose", "for", "our", "phase", "III", "studies", "of", "PRX-102."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p72_s1", "idA": "1006281_16_item1_p69_s0", "sentA": "The interim analysis includes six patients enrolled in the 1mg/kg dose group at six months of treatment.", "sentB": "Three of the 16 patients treated developed ADA, which turned to be negative after 12 months of treatment.", "type": 2, "words": ["<tag1>", "The", "interim", "analysis", "includes", "six", "patients", "enrolled", "in", "the", "1mg/kg", "dose", "group", "at", "six", "months", "of", "treatment.", "<tag2>", "Three", "of", "the", "16", "patients", "treated", "developed", "ADA,", "which", "turned", "to", "be", "negative", "after", "12", "months", "of", "treatment.", "<tag3>"], "wordsA": ["The", "interim", "analysis", "includes", "six", "patients", "enrolled", "in", "the", "1mg/kg", "dose", "group", "at", "six", "months", "of", "treatment."], "wordsB": ["Three", "of", "the", "16", "patients", "treated", "developed", "ADA,", "which", "turned", "to", "be", "negative", "after", "12", "months", "of", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p81_s0", "idA": "1006281_16_item1_p69_s0", "sentA": "The interim analysis includes six patients enrolled in the 1mg/kg dose group at six months of treatment.", "sentB": "In January 2017, we announced positive interim results from the phase IIa clinical trial for the first 13 CF patients enrolled in the study.", "type": 2, "words": ["<tag1>", "The", "interim", "analysis", "includes", "six", "patients", "enrolled", "in", "the", "1mg/kg", "dose", "group", "at", "six", "months", "of", "treatment.", "<tag2>", "In", "January", "2017,", "we", "announced", "positive", "interim", "results", "from", "the", "phase", "IIa", "clinical", "trial", "for", "the", "first", "13", "CF", "patients", "enrolled", "in", "the", "study.", "<tag3>"], "wordsA": ["The", "interim", "analysis", "includes", "six", "patients", "enrolled", "in", "the", "1mg/kg", "dose", "group", "at", "six", "months", "of", "treatment."], "wordsB": ["In", "January", "2017,", "we", "announced", "positive", "interim", "results", "from", "the", "phase", "IIa", "clinical", "trial", "for", "the", "first", "13", "CF", "patients", "enrolled", "in", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p69_s0", "idA": "1006281_16_item1_p70_s0", "sentA": "Based on an analysis of kidney biopsies with randomized blinded scoring (n=4), PRX-102 demonstrated a reduction in renal peritubular capillary Gb3 of 86% using a quantitative Barisoni Lipid Inclusion Scoring System (BLISS).", "sentB": "Based on an analysis of kidney biopsies with randomized blinded scoring, PRX-102 demonstrated a major reduction from baseline in renal peritubular capillary Gb3 using the quantitative Barisoni Lipid Inclusion Scoring System (BLISS).", "type": 2, "words": ["<tag1>", "Based", "on", "an", "analysis", "of", "kidney", "biopsies", "with", "randomized", "blinded", "scoring", "(n=4),", "PRX-102", "demonstrated", "a", "reduction", "in", "renal", "peritubular", "capillary", "Gb3", "of", "86%", "using", "a", "quantitative", "Barisoni", "Lipid", "Inclusion", "Scoring", "System", "(BLISS).", "<tag2>", "Based", "on", "an", "analysis", "of", "kidney", "biopsies", "with", "randomized", "blinded", "scoring,", "PRX-102", "demonstrated", "a", "major", "reduction", "from", "baseline", "in", "renal", "peritubular", "capillary", "Gb3", "using", "the", "quantitative", "Barisoni", "Lipid", "Inclusion", "Scoring", "System", "(BLISS).", "<tag3>"], "wordsA": ["Based", "on", "an", "analysis", "of", "kidney", "biopsies", "with", "randomized", "blinded", "scoring", "(n=4),", "PRX-102", "demonstrated", "a", "reduction", "in", "renal", "peritubular", "capillary", "Gb3", "of", "86%", "using", "a", "quantitative", "Barisoni", "Lipid", "Inclusion", "Scoring", "System", "(BLISS)."], "wordsB": ["Based", "on", "an", "analysis", "of", "kidney", "biopsies", "with", "randomized", "blinded", "scoring,", "PRX-102", "demonstrated", "a", "major", "reduction", "from", "baseline", "in", "renal", "peritubular", "capillary", "Gb3", "using", "the", "quantitative", "Barisoni", "Lipid", "Inclusion", "Scoring", "System", "(BLISS)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p67_s5", "idA": "1006281_16_item1_p71_s0", "sentA": "Reductions of plasma Lyso-Gb3 and plasma Gb3 concentrations were also observed.", "sentB": "After one year of treatment, average reduction of plasma Lyso-Gb3 were 48.9% in all patients and 57.6% in Classic Fabry patients.", "type": 2, "words": ["<tag1>", "Reductions", "of", "plasma", "Lyso-Gb3", "and", "plasma", "Gb3", "concentrations", "were", "also", "observed.", "<tag2>", "After", "one", "year", "of", "treatment,", "average", "reduction", "of", "plasma", "Lyso-Gb3", "were", "48.9%", "in", "all", "patients", "and", "57.6%", "in", "Classic", "Fabry", "patients.", "<tag3>"], "wordsA": ["Reductions", "of", "plasma", "Lyso-Gb3", "and", "plasma", "Gb3", "concentrations", "were", "also", "observed."], "wordsB": ["After", "one", "year", "of", "treatment,", "average", "reduction", "of", "plasma", "Lyso-Gb3", "were", "48.9%", "in", "all", "patients", "and", "57.6%", "in", "Classic", "Fabry", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p67_s4", "idA": "1006281_16_item1_p72_s0", "sentA": "Furthermore, all patients had stable cardiac function after only six months, as measured by left ventricular mass (LVM), left ventricular mass index (LVMI) and ejection fraction (EF).", "sentB": "All patients had stable cardiac function as measured by left ventricular mass (LVM) and left ventricular mass index (LVMI), via MRI.", "type": 2, "words": ["<tag1>", "Furthermore,", "all", "patients", "had", "stable", "cardiac", "function", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI)", "and", "ejection", "fraction", "(EF).", "<tag2>", "All", "patients", "had", "stable", "cardiac", "function", "as", "measured", "by", "left", "ventricular", "mass", "(LVM)", "and", "left", "ventricular", "mass", "index", "(LVMI),", "via", "MRI.", "<tag3>"], "wordsA": ["Furthermore,", "all", "patients", "had", "stable", "cardiac", "function", "after", "only", "six", "months,", "as", "measured", "by", "left", "ventricular", "mass", "(LVM),", "left", "ventricular", "mass", "index", "(LVMI)", "and", "ejection", "fraction", "(EF)."], "wordsB": ["All", "patients", "had", "stable", "cardiac", "function", "as", "measured", "by", "left", "ventricular", "mass", "(LVM)", "and", "left", "ventricular", "mass", "index", "(LVMI),", "via", "MRI."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p67_s0", "idA": "1006281_16_item1_p72_s1", "sentA": "Stable kidney function was also observed, as measured by estimated glomerular filtration rate (eGFR) and urine protein.", "sentB": "Stable kidney function was observed in the trial, as measured by estimated glomerular filtration rate (eGFR), with mean change from mean eGFR value of 110.78 at base-line to 110.23 after 12 months for all patients, and from mean eGFR value of 117.37 to 117.36 for Classic Fabry patients.", "type": 2, "words": ["<tag1>", "Stable", "kidney", "function", "was", "also", "observed,", "as", "measured", "by", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein.", "<tag2>", "Stable", "kidney", "function", "was", "observed", "in", "the", "trial,", "as", "measured", "by", "estimated", "glomerular", "filtration", "rate", "(eGFR),", "with", "mean", "change", "from", "mean", "eGFR", "value", "of", "110.78", "at", "base-line", "to", "110.23", "after", "12", "months", "for", "all", "patients,", "and", "from", "mean", "eGFR", "value", "of", "117.37", "to", "117.36", "for", "Classic", "Fabry", "patients.", "<tag3>"], "wordsA": ["Stable", "kidney", "function", "was", "also", "observed,", "as", "measured", "by", "estimated", "glomerular", "filtration", "rate", "(eGFR)", "and", "urine", "protein."], "wordsB": ["Stable", "kidney", "function", "was", "observed", "in", "the", "trial,", "as", "measured", "by", "estimated", "glomerular", "filtration", "rate", "(eGFR),", "with", "mean", "change", "from", "mean", "eGFR", "value", "of", "110.78", "at", "base-line", "to", "110.23", "after", "12", "months", "for", "all", "patients,", "and", "from", "mean", "eGFR", "value", "of", "117.37", "to", "117.36", "for", "Classic", "Fabry", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p70_s0", "idA": "1006281_16_item1_p73_s0", "sentA": "PRX-102 was well tolerated, with the majority of adverse events being mild and moderate.", "sentB": "With respect to safety, PRX-102 was found to be safe and well tolerated, with a majority of adverse events being mild and moderate in severity with very limited formation of antibodies, which all seroconvert to be antibody negative after 12 months of treatment.", "type": 2, "words": ["<tag1>", "PRX-102", "was", "well", "tolerated,", "with", "the", "majority", "of", "adverse", "events", "being", "mild", "and", "moderate.", "<tag2>", "With", "respect", "to", "safety,", "PRX-102", "was", "found", "to", "be", "safe", "and", "well", "tolerated,", "with", "a", "majority", "of", "adverse", "events", "being", "mild", "and", "moderate", "in", "severity", "with", "very", "limited", "formation", "of", "antibodies,", "which", "all", "seroconvert", "to", "be", "antibody", "negative", "after", "12", "months", "of", "treatment.", "<tag3>"], "wordsA": ["PRX-102", "was", "well", "tolerated,", "with", "the", "majority", "of", "adverse", "events", "being", "mild", "and", "moderate."], "wordsB": ["With", "respect", "to", "safety,", "PRX-102", "was", "found", "to", "be", "safe", "and", "well", "tolerated,", "with", "a", "majority", "of", "adverse", "events", "being", "mild", "and", "moderate", "in", "severity", "with", "very", "limited", "formation", "of", "antibodies,", "which", "all", "seroconvert", "to", "be", "antibody", "negative", "after", "12", "months", "of", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p84_s0", "idA": "1006281_16_item1_p73_s0", "sentA": "PRX-102 was well tolerated, with the majority of adverse events being mild and moderate.", "sentB": "No serious adverse events were reported, and all adverse events that occurred during the study were mild and transient in nature.", "type": 2, "words": ["<tag1>", "PRX-102", "was", "well", "tolerated,", "with", "the", "majority", "of", "adverse", "events", "being", "mild", "and", "moderate.", "<tag2>", "No", "serious", "adverse", "events", "were", "reported,", "and", "all", "adverse", "events", "that", "occurred", "during", "the", "study", "were", "mild", "and", "transient", "in", "nature.", "<tag3>"], "wordsA": ["PRX-102", "was", "well", "tolerated,", "with", "the", "majority", "of", "adverse", "events", "being", "mild", "and", "moderate."], "wordsB": ["No", "serious", "adverse", "events", "were", "reported,", "and", "all", "adverse", "events", "that", "occurred", "during", "the", "study", "were", "mild", "and", "transient", "in", "nature."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p82_s2", "idA": "1006281_16_item1_p73_s1", "sentA": "Only one of the patients evaluated for safety experienced hypersensitivity, and only three patients, or approximately 19%, developed antibodies.", "sentB": "This score was achieved while 74% of the patients participating in the trial of the CFTR modulator were also treated with Pulmozyme on top of the modulator.", "type": 2, "words": ["<tag1>", "Only", "one", "of", "the", "patients", "evaluated", "for", "safety", "experienced", "hypersensitivity,", "and", "only", "three", "patients,", "or", "approximately", "19%,", "developed", "antibodies.", "<tag2>", "This", "score", "was", "achieved", "while", "74%", "of", "the", "patients", "participating", "in", "the", "trial", "of", "the", "CFTR", "modulator", "were", "also", "treated", "with", "Pulmozyme", "on", "top", "of", "the", "modulator.", "<tag3>"], "wordsA": ["Only", "one", "of", "the", "patients", "evaluated", "for", "safety", "experienced", "hypersensitivity,", "and", "only", "three", "patients,", "or", "approximately", "19%,", "developed", "antibodies."], "wordsB": ["This", "score", "was", "achieved", "while", "74%", "of", "the", "patients", "participating", "in", "the", "trial", "of", "the", "CFTR", "modulator", "were", "also", "treated", "with", "Pulmozyme", "on", "top", "of", "the", "modulator."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p83_s0", "idA": "1006281_16_item1_p73_s1", "sentA": "Only one of the patients evaluated for safety experienced hypersensitivity, and only three patients, or approximately 19%, developed antibodies.", "sentB": "Sputa available DNA samples were analyzed for approximately half of the patients in the phase II trial.", "type": 2, "words": ["<tag1>", "Only", "one", "of", "the", "patients", "evaluated", "for", "safety", "experienced", "hypersensitivity,", "and", "only", "three", "patients,", "or", "approximately", "19%,", "developed", "antibodies.", "<tag2>", "Sputa", "available", "DNA", "samples", "were", "analyzed", "for", "approximately", "half", "of", "the", "patients", "in", "the", "phase", "II", "trial.", "<tag3>"], "wordsA": ["Only", "one", "of", "the", "patients", "evaluated", "for", "safety", "experienced", "hypersensitivity,", "and", "only", "three", "patients,", "or", "approximately", "19%,", "developed", "antibodies."], "wordsB": ["Sputa", "available", "DNA", "samples", "were", "analyzed", "for", "approximately", "half", "of", "the", "patients", "in", "the", "phase", "II", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p92_s4", "idA": "1006281_16_item1_p76_s1", "sentA": "After dosing with 0.2mg/kg of PRX-102 for 12 months, a majority of the patients (4/6) experienced a stabilization or improvement in kidney function; a reversal of the decline shown by annualized eGFR slope was observed.", "sentB": "No major side effects were noted, and no suppression of the immune system was observed.", "type": 2, "words": ["<tag1>", "After", "dosing", "with", "0.2mg/kg", "of", "PRX-102", "for", "12", "months,", "a", "majority", "of", "the", "patients", "(4/6)", "experienced", "a", "stabilization", "or", "improvement", "in", "kidney", "function;", "a", "reversal", "of", "the", "decline", "shown", "by", "annualized", "eGFR", "slope", "was", "observed.", "<tag2>", "No", "major", "side", "effects", "were", "noted,", "and", "no", "suppression", "of", "the", "immune", "system", "was", "observed.", "<tag3>"], "wordsA": ["After", "dosing", "with", "0.2mg/kg", "of", "PRX-102", "for", "12", "months,", "a", "majority", "of", "the", "patients", "(4/6)", "experienced", "a", "stabilization", "or", "improvement", "in", "kidney", "function;", "a", "reversal", "of", "the", "decline", "shown", "by", "annualized", "eGFR", "slope", "was", "observed."], "wordsB": ["No", "major", "side", "effects", "were", "noted,", "and", "no", "suppression", "of", "the", "immune", "system", "was", "observed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p67_s3", "idA": "1006281_16_item1_p76_s2", "sentA": "Throughout the study, continuous and durable reduction of up to 61.8% of plasma lyso-Gb3 levels from base line was observed in patients in the 0.2mg/kg cohort.", "sentB": "According to a published report, an annualized rate of eGFR change of -3.8 (BL 49-170) was observed in a study of the effect of Fabrazymeon the Classic Fabry patient population using CKD-EPI analysis with similar base line of eGFR.", "type": 2, "words": ["<tag1>", "Throughout", "the", "study,", "continuous", "and", "durable", "reduction", "of", "up", "to", "61.8%", "of", "plasma", "lyso-Gb3", "levels", "from", "base", "line", "was", "observed", "in", "patients", "in", "the", "0.2mg/kg", "cohort.", "<tag2>", "According", "to", "a", "published", "report,", "an", "annualized", "rate", "of", "eGFR", "change", "of", "-3.8", "(BL", "49-170)", "was", "observed", "in", "a", "study", "of", "the", "effect", "of", "Fabrazymeon", "the", "Classic", "Fabry", "patient", "population", "using", "CKD-EPI", "analysis", "with", "similar", "base", "line", "of", "eGFR.", "<tag3>"], "wordsA": ["Throughout", "the", "study,", "continuous", "and", "durable", "reduction", "of", "up", "to", "61.8%", "of", "plasma", "lyso-Gb3", "levels", "from", "base", "line", "was", "observed", "in", "patients", "in", "the", "0.2mg/kg", "cohort."], "wordsB": ["According", "to", "a", "published", "report,", "an", "annualized", "rate", "of", "eGFR", "change", "of", "-3.8", "(BL", "49-170)", "was", "observed", "in", "a", "study", "of", "the", "effect", "of", "Fabrazymeon", "the", "Classic", "Fabry", "patient", "population", "using", "CKD-EPI", "analysis", "with", "similar", "base", "line", "of", "eGFR."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p72_s0", "idA": "1006281_16_item1_p77_s1", "sentA": "This resulted in low incidence of antibody formation with low titers in general, and moreover, in antibody positive patients it resulted in a transient and reversible shift of overall drug availability.", "sentB": "The data demonstrated a low incidence of treatment induced anti-drug antibodies, or ADA.", "type": 2, "words": ["<tag1>", "This", "resulted", "in", "low", "incidence", "of", "antibody", "formation", "with", "low", "titers", "in", "general,", "and", "moreover,", "in", "antibody", "positive", "patients", "it", "resulted", "in", "a", "transient", "and", "reversible", "shift", "of", "overall", "drug", "availability.", "<tag2>", "The", "data", "demonstrated", "a", "low", "incidence", "of", "treatment", "induced", "anti-drug", "antibodies,", "or", "ADA.", "<tag3>"], "wordsA": ["This", "resulted", "in", "low", "incidence", "of", "antibody", "formation", "with", "low", "titers", "in", "general,", "and", "moreover,", "in", "antibody", "positive", "patients", "it", "resulted", "in", "a", "transient", "and", "reversible", "shift", "of", "overall", "drug", "availability."], "wordsB": ["The", "data", "demonstrated", "a", "low", "incidence", "of", "treatment", "induced", "anti-drug", "antibodies,", "or", "ADA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p63_s0", "idA": "1006281_16_item1_p79_s1", "sentA": "Official FDA meeting minutes indicate the FDA s acceptance of our path forward for a phase III clinical trial to support a full BLA approval.", "sentB": "In addition, we are preparing for a supportive phase III clinical trial of PRX-102, which shall be run at the same time as the BALANCE Study.", "type": 2, "words": ["<tag1>", "Official", "FDA", "meeting", "minutes", "indicate", "the", "FDA", "s", "acceptance", "of", "our", "path", "forward", "for", "a", "phase", "III", "clinical", "trial", "to", "support", "a", "full", "BLA", "approval.", "<tag2>", "In", "addition,", "we", "are", "preparing", "for", "a", "supportive", "phase", "III", "clinical", "trial", "of", "PRX-102,", "which", "shall", "be", "run", "at", "the", "same", "time", "as", "the", "BALANCE", "Study.", "<tag3>"], "wordsA": ["Official", "FDA", "meeting", "minutes", "indicate", "the", "FDA", "s", "acceptance", "of", "our", "path", "forward", "for", "a", "phase", "III", "clinical", "trial", "to", "support", "a", "full", "BLA", "approval."], "wordsB": ["In", "addition,", "we", "are", "preparing", "for", "a", "supportive", "phase", "III", "clinical", "trial", "of", "PRX-102,", "which", "shall", "be", "run", "at", "the", "same", "time", "as", "the", "BALANCE", "Study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p59_s1", "idA": "1006281_16_item1_p79_s3", "sentA": "We anticipate a small sample size of patients will be needed to achieve statistical significance with a study duration of approximately six months.", "sentB": "The trial is designed to enroll 78 patients previously treated with Fabrazyme (agalsidase beta) with a stable dose for at least six months.", "type": 2, "words": ["<tag1>", "We", "anticipate", "a", "small", "sample", "size", "of", "patients", "will", "be", "needed", "to", "achieve", "statistical", "significance", "with", "a", "study", "duration", "of", "approximately", "six", "months.", "<tag2>", "The", "trial", "is", "designed", "to", "enroll", "78", "patients", "previously", "treated", "with", "Fabrazyme", "(agalsidase", "beta)", "with", "a", "stable", "dose", "for", "at", "least", "six", "months.", "<tag3>"], "wordsA": ["We", "anticipate", "a", "small", "sample", "size", "of", "patients", "will", "be", "needed", "to", "achieve", "statistical", "significance", "with", "a", "study", "duration", "of", "approximately", "six", "months."], "wordsB": ["The", "trial", "is", "designed", "to", "enroll", "78", "patients", "previously", "treated", "with", "Fabrazyme", "(agalsidase", "beta)", "with", "a", "stable", "dose", "for", "at", "least", "six", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p63_s3", "idA": "1006281_16_item1_p79_s3", "sentA": "We anticipate a small sample size of patients will be needed to achieve statistical significance with a study duration of approximately six months.", "sentB": "The objective of the study is to generate safety and efficacy data of patients switched from Replagal to PRX-102 over a 12-month period, with interim results at six months.", "type": 2, "words": ["<tag1>", "We", "anticipate", "a", "small", "sample", "size", "of", "patients", "will", "be", "needed", "to", "achieve", "statistical", "significance", "with", "a", "study", "duration", "of", "approximately", "six", "months.", "<tag2>", "The", "objective", "of", "the", "study", "is", "to", "generate", "safety", "and", "efficacy", "data", "of", "patients", "switched", "from", "Replagal", "to", "PRX-102", "over", "a", "12-month", "period,", "with", "interim", "results", "at", "six", "months.", "<tag3>"], "wordsA": ["We", "anticipate", "a", "small", "sample", "size", "of", "patients", "will", "be", "needed", "to", "achieve", "statistical", "significance", "with", "a", "study", "duration", "of", "approximately", "six", "months."], "wordsB": ["The", "objective", "of", "the", "study", "is", "to", "generate", "safety", "and", "efficacy", "data", "of", "patients", "switched", "from", "Replagal", "to", "PRX-102", "over", "a", "12-month", "period,", "with", "interim", "results", "at", "six", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p7_s0", "idA": "1006281_16_item1_p7_s0", "sentA": "On June 18, 2013, we entered into a Supply and Technology Transfer Agreement, or the Brazil Agreement, with Fiocruz, an arm of the Brazilian Ministry of Health for taliglucerase alfa.", "sentB": "On June 18, 2013, we entered into a Supply and Technology Transfer Agreement, or the Brazil Agreement, with Fiocruz, an arm of the Brazilian Brazilian MoH, for taliglucerase alfa.", "type": 2, "words": ["<tag1>", "On", "June", "18,", "2013,", "we", "entered", "into", "a", "Supply", "and", "Technology", "Transfer", "Agreement,", "or", "the", "Brazil", "Agreement,", "with", "Fiocruz,", "an", "arm", "of", "the", "Brazilian", "Ministry", "of", "Health", "for", "taliglucerase", "alfa.", "<tag2>", "On", "June", "18,", "2013,", "we", "entered", "into", "a", "Supply", "and", "Technology", "Transfer", "Agreement,", "or", "the", "Brazil", "Agreement,", "with", "Fiocruz,", "an", "arm", "of", "the", "Brazilian", "Brazilian", "MoH,", "for", "taliglucerase", "alfa.", "<tag3>"], "wordsA": ["On", "June", "18,", "2013,", "we", "entered", "into", "a", "Supply", "and", "Technology", "Transfer", "Agreement,", "or", "the", "Brazil", "Agreement,", "with", "Fiocruz,", "an", "arm", "of", "the", "Brazilian", "Ministry", "of", "Health", "for", "taliglucerase", "alfa."], "wordsB": ["On", "June", "18,", "2013,", "we", "entered", "into", "a", "Supply", "and", "Technology", "Transfer", "Agreement,", "or", "the", "Brazil", "Agreement,", "with", "Fiocruz,", "an", "arm", "of", "the", "Brazilian", "Brazilian", "MoH,", "for", "taliglucerase", "alfa."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p62_s0", "idA": "1006281_16_item1_p82_s1", "sentA": "The primary endpoint for this head-to-head trial will be an improvement in eGFR.", "sentB": "The primary endpoint for the BALANCE study, which was agreed with both the FDA and the EMA, is the comparison in the rate of decline of eGFR slope between Fabrazyme and PRX 102.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "for", "this", "head-to-head", "trial", "will", "be", "an", "improvement", "in", "eGFR.", "<tag2>", "The", "primary", "endpoint", "for", "the", "BALANCE", "study,", "which", "was", "agreed", "with", "both", "the", "FDA", "and", "the", "EMA,", "is", "the", "comparison", "in", "the", "rate", "of", "decline", "of", "eGFR", "slope", "between", "Fabrazyme", "and", "PRX", "102.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "for", "this", "head-to-head", "trial", "will", "be", "an", "improvement", "in", "eGFR."], "wordsB": ["The", "primary", "endpoint", "for", "the", "BALANCE", "study,", "which", "was", "agreed", "with", "both", "the", "FDA", "and", "the", "EMA,", "is", "the", "comparison", "in", "the", "rate", "of", "decline", "of", "eGFR", "slope", "between", "Fabrazyme", "and", "PRX", "102."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p93_s3", "idA": "1006281_16_item1_p82_s1", "sentA": "The primary endpoint for this head-to-head trial will be an improvement in eGFR.", "sentB": "The primary endpoint of the study is safety, including monitoring for adverse events following daily administration of the drug.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "for", "this", "head-to-head", "trial", "will", "be", "an", "improvement", "in", "eGFR.", "<tag2>", "The", "primary", "endpoint", "of", "the", "study", "is", "safety,", "including", "monitoring", "for", "adverse", "events", "following", "daily", "administration", "of", "the", "drug.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "for", "this", "head-to-head", "trial", "will", "be", "an", "improvement", "in", "eGFR."], "wordsB": ["The", "primary", "endpoint", "of", "the", "study", "is", "safety,", "including", "monitoring", "for", "adverse", "events", "following", "daily", "administration", "of", "the", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p59_s2", "idA": "1006281_16_item1_p82_s2", "sentA": "The trial will enroll patients who are currently treated with Fabrazyme; such patients will be treated with 1mg/kg of PRX-102 for a two-year period.", "sentB": "Enrolled patients will be randomized to continue treatment with 1 mg/kg of either Fabrazyme or PRX-102, at a 2:1 ratio of PRX-102 to Fabrazyme, respectively.", "type": 2, "words": ["<tag1>", "The", "trial", "will", "enroll", "patients", "who", "are", "currently", "treated", "with", "Fabrazyme;", "such", "patients", "will", "be", "treated", "with", "1mg/kg", "of", "PRX-102", "for", "a", "two-year", "period.", "<tag2>", "Enrolled", "patients", "will", "be", "randomized", "to", "continue", "treatment", "with", "1", "mg/kg", "of", "either", "Fabrazyme", "or", "PRX-102,", "at", "a", "2:1", "ratio", "of", "PRX-102", "to", "Fabrazyme,", "respectively.", "<tag3>"], "wordsA": ["The", "trial", "will", "enroll", "patients", "who", "are", "currently", "treated", "with", "Fabrazyme;", "such", "patients", "will", "be", "treated", "with", "1mg/kg", "of", "PRX-102", "for", "a", "two-year", "period."], "wordsB": ["Enrolled", "patients", "will", "be", "randomized", "to", "continue", "treatment", "with", "1", "mg/kg", "of", "either", "Fabrazyme", "or", "PRX-102,", "at", "a", "2:1", "ratio", "of", "PRX-102", "to", "Fabrazyme,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p62_s2", "idA": "1006281_16_item1_p82_s2", "sentA": "The trial will enroll patients who are currently treated with Fabrazyme; such patients will be treated with 1mg/kg of PRX-102 for a two-year period.", "sentB": "Patients enrolled in the study will continue to be treated for a total of 24 months, at which point the data will be analyzed to test for superiority to support an FDA filing.", "type": 2, "words": ["<tag1>", "The", "trial", "will", "enroll", "patients", "who", "are", "currently", "treated", "with", "Fabrazyme;", "such", "patients", "will", "be", "treated", "with", "1mg/kg", "of", "PRX-102", "for", "a", "two-year", "period.", "<tag2>", "Patients", "enrolled", "in", "the", "study", "will", "continue", "to", "be", "treated", "for", "a", "total", "of", "24", "months,", "at", "which", "point", "the", "data", "will", "be", "analyzed", "to", "test", "for", "superiority", "to", "support", "an", "FDA", "filing.", "<tag3>"], "wordsA": ["The", "trial", "will", "enroll", "patients", "who", "are", "currently", "treated", "with", "Fabrazyme;", "such", "patients", "will", "be", "treated", "with", "1mg/kg", "of", "PRX-102", "for", "a", "two-year", "period."], "wordsB": ["Patients", "enrolled", "in", "the", "study", "will", "continue", "to", "be", "treated", "for", "a", "total", "of", "24", "months,", "at", "which", "point", "the", "data", "will", "be", "analyzed", "to", "test", "for", "superiority", "to", "support", "an", "FDA", "filing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p74_s0", "idA": "1006281_16_item1_p84_s0", "sentA": "PRX-110, or AIR DNase, is our plant cell recombinant form of human deoxyribonuclease I (DNase I) that we are developing for the treatment of CF to be administered by inhalation.", "sentB": "alidornase alfa is our proprietary plant cell recombinant form of human deoxyribonuclease I (DNase I) that we are developing for the treatment of CF, to be administered by inhalation.", "type": 2, "words": ["<tag1>", "PRX-110,", "or", "AIR", "DNase,", "is", "our", "plant", "cell", "recombinant", "form", "of", "human", "deoxyribonuclease", "I", "(DNase", "I)", "that", "we", "are", "developing", "for", "the", "treatment", "of", "CF", "to", "be", "administered", "by", "inhalation.", "<tag2>", "alidornase", "alfa", "is", "our", "proprietary", "plant", "cell", "recombinant", "form", "of", "human", "deoxyribonuclease", "I", "(DNase", "I)", "that", "we", "are", "developing", "for", "the", "treatment", "of", "CF,", "to", "be", "administered", "by", "inhalation.", "<tag3>"], "wordsA": ["PRX-110,", "or", "AIR", "DNase,", "is", "our", "plant", "cell", "recombinant", "form", "of", "human", "deoxyribonuclease", "I", "(DNase", "I)", "that", "we", "are", "developing", "for", "the", "treatment", "of", "CF", "to", "be", "administered", "by", "inhalation."], "wordsB": ["alidornase", "alfa", "is", "our", "proprietary", "plant", "cell", "recombinant", "form", "of", "human", "deoxyribonuclease", "I", "(DNase", "I)", "that", "we", "are", "developing", "for", "the", "treatment", "of", "CF,", "to", "be", "administered", "by", "inhalation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p82_s3", "idA": "1006281_16_item1_p84_s1", "sentA": "DNase I cleaves extracellular DNA and thins the thick mucus that accumulates in the lungs of CF patients.", "sentB": "While this marketed CFTR addresses a certain mutation applicable to less than 50% of CF patients, we are developing alidornase alfa to treat all CF patients.", "type": 2, "words": ["<tag1>", "DNase", "I", "cleaves", "extracellular", "DNA", "and", "thins", "the", "thick", "mucus", "that", "accumulates", "in", "the", "lungs", "of", "CF", "patients.", "<tag2>", "While", "this", "marketed", "CFTR", "addresses", "a", "certain", "mutation", "applicable", "to", "less", "than", "50%", "of", "CF", "patients,", "we", "are", "developing", "alidornase", "alfa", "to", "treat", "all", "CF", "patients.", "<tag3>"], "wordsA": ["DNase", "I", "cleaves", "extracellular", "DNA", "and", "thins", "the", "thick", "mucus", "that", "accumulates", "in", "the", "lungs", "of", "CF", "patients."], "wordsB": ["While", "this", "marketed", "CFTR", "addresses", "a", "certain", "mutation", "applicable", "to", "less", "than", "50%", "of", "CF", "patients,", "we", "are", "developing", "alidornase", "alfa", "to", "treat", "all", "CF", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p74_s2", "idA": "1006281_16_item1_p84_s2", "sentA": "Currently, Pulmozyme is the only DNase I commercially available, with annual sales of approximately CHF 652 million (approximately $652 million) in sales for 2015, an increase of 10%, according to public reports by F. Hoffman-La Roche Ltd.", "sentB": "Currently, Pulmozyme is the only DNase I commercially available, with annual sales of approximately CHF 685 million (approximately $671 million) in sales for 2016 according to public reports by F. Hoffman-La Roche Ltd.", "type": 2, "words": ["<tag1>", "Currently,", "Pulmozyme", "is", "the", "only", "DNase", "I", "commercially", "available,", "with", "annual", "sales", "of", "approximately", "CHF", "652", "million", "(approximately", "$652", "million)", "in", "sales", "for", "2015,", "an", "increase", "of", "10%,", "according", "to", "public", "reports", "by", "F.", "Hoffman-La", "Roche", "Ltd.", "<tag2>", "Currently,", "Pulmozyme", "is", "the", "only", "DNase", "I", "commercially", "available,", "with", "annual", "sales", "of", "approximately", "CHF", "685", "million", "(approximately", "$671", "million)", "in", "sales", "for", "2016", "according", "to", "public", "reports", "by", "F.", "Hoffman-La", "Roche", "Ltd.", "<tag3>"], "wordsA": ["Currently,", "Pulmozyme", "is", "the", "only", "DNase", "I", "commercially", "available,", "with", "annual", "sales", "of", "approximately", "CHF", "652", "million", "(approximately", "$652", "million)", "in", "sales", "for", "2015,", "an", "increase", "of", "10%,", "according", "to", "public", "reports", "by", "F.", "Hoffman-La", "Roche", "Ltd."], "wordsB": ["Currently,", "Pulmozyme", "is", "the", "only", "DNase", "I", "commercially", "available,", "with", "annual", "sales", "of", "approximately", "CHF", "685", "million", "(approximately", "$671", "million)", "in", "sales", "for", "2016", "according", "to", "public", "reports", "by", "F.", "Hoffman-La", "Roche", "Ltd."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p77_s1", "idA": "1006281_16_item1_p87_s1", "sentA": "As demonstrated in Figure 1, the activity of AIR DNase remains almost with no change in the relevant actin concentration found in CF patients while Pulmozyme is degraded significantly.", "sentB": "As demonstrated in Figure 1, the activity of alidornase alfa, as demonstrated in in vitro studies, remains almost with no change in the relevant actin concentration found in CF patients while Pulmozyme is degraded significantly.", "type": 2, "words": ["<tag1>", "As", "demonstrated", "in", "Figure", "1,", "the", "activity", "of", "AIR", "DNase", "remains", "almost", "with", "no", "change", "in", "the", "relevant", "actin", "concentration", "found", "in", "CF", "patients", "while", "Pulmozyme", "is", "degraded", "significantly.", "<tag2>", "As", "demonstrated", "in", "Figure", "1,", "the", "activity", "of", "alidornase", "alfa,", "as", "demonstrated", "in", "in", "vitro", "studies,", "remains", "almost", "with", "no", "change", "in", "the", "relevant", "actin", "concentration", "found", "in", "CF", "patients", "while", "Pulmozyme", "is", "degraded", "significantly.", "<tag3>"], "wordsA": ["As", "demonstrated", "in", "Figure", "1,", "the", "activity", "of", "AIR", "DNase", "remains", "almost", "with", "no", "change", "in", "the", "relevant", "actin", "concentration", "found", "in", "CF", "patients", "while", "Pulmozyme", "is", "degraded", "significantly."], "wordsB": ["As", "demonstrated", "in", "Figure", "1,", "the", "activity", "of", "alidornase", "alfa,", "as", "demonstrated", "in", "in", "vitro", "studies,", "remains", "almost", "with", "no", "change", "in", "the", "relevant", "actin", "concentration", "found", "in", "CF", "patients", "while", "Pulmozyme", "is", "degraded", "significantly."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p78_s0", "idA": "1006281_16_item1_p88_s0", "sentA": "In addition, the product candidate has demonstrated improved disease parameters in human models sputum testing when compared to the currently marketed product.", "sentB": "In addition, alidornase alfa has demonstrated improved disease parameters in human models sputum testing when compared to the currently marketed product.", "type": 2, "words": ["<tag1>", "In", "addition,", "the", "product", "candidate", "has", "demonstrated", "improved", "disease", "parameters", "in", "human", "models", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product.", "<tag2>", "In", "addition,", "alidornase", "alfa", "has", "demonstrated", "improved", "disease", "parameters", "in", "human", "models", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product.", "<tag3>"], "wordsA": ["In", "addition,", "the", "product", "candidate", "has", "demonstrated", "improved", "disease", "parameters", "in", "human", "models", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product."], "wordsB": ["In", "addition,", "alidornase", "alfa", "has", "demonstrated", "improved", "disease", "parameters", "in", "human", "models", "sputum", "testing", "when", "compared", "to", "the", "currently", "marketed", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p78_s1", "idA": "1006281_16_item1_p88_s1", "sentA": "In particular, AIR DNase has demonstrated a reduction in mucus viscosity in human sputum sample when compared to the currently marketed product.", "sentB": "In particular, alidornase alfa has demonstrated a reduction in mucus viscosity in human sputum samples when compared to the currently marketed product.", "type": 2, "words": ["<tag1>", "In", "particular,", "AIR", "DNase", "has", "demonstrated", "a", "reduction", "in", "mucus", "viscosity", "in", "human", "sputum", "sample", "when", "compared", "to", "the", "currently", "marketed", "product.", "<tag2>", "In", "particular,", "alidornase", "alfa", "has", "demonstrated", "a", "reduction", "in", "mucus", "viscosity", "in", "human", "sputum", "samples", "when", "compared", "to", "the", "currently", "marketed", "product.", "<tag3>"], "wordsA": ["In", "particular,", "AIR", "DNase", "has", "demonstrated", "a", "reduction", "in", "mucus", "viscosity", "in", "human", "sputum", "sample", "when", "compared", "to", "the", "currently", "marketed", "product."], "wordsB": ["In", "particular,", "alidornase", "alfa", "has", "demonstrated", "a", "reduction", "in", "mucus", "viscosity", "in", "human", "sputum", "samples", "when", "compared", "to", "the", "currently", "marketed", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p79_s0", "idA": "1006281_16_item1_p89_s0", "sentA": "AIR DNase is the subject of a phase I clinical trial involving 18 healthy volunteers.", "sentB": "We completed a phase I clinical trial of alidornase alfa with 18 healthy volunteers in which alidornase alfa was found to be safe and tolerable.", "type": 2, "words": ["<tag1>", "AIR", "DNase", "is", "the", "subject", "of", "a", "phase", "I", "clinical", "trial", "involving", "18", "healthy", "volunteers.", "<tag2>", "We", "completed", "a", "phase", "I", "clinical", "trial", "of", "alidornase", "alfa", "with", "18", "healthy", "volunteers", "in", "which", "alidornase", "alfa", "was", "found", "to", "be", "safe", "and", "tolerable.", "<tag3>"], "wordsA": ["AIR", "DNase", "is", "the", "subject", "of", "a", "phase", "I", "clinical", "trial", "involving", "18", "healthy", "volunteers."], "wordsB": ["We", "completed", "a", "phase", "I", "clinical", "trial", "of", "alidornase", "alfa", "with", "18", "healthy", "volunteers", "in", "which", "alidornase", "alfa", "was", "found", "to", "be", "safe", "and", "tolerable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p9_s1", "idA": "1006281_16_item1_p8_s1", "sentA": "The strategy centers around prioritizing existing and new pipeline candidates to focus on products that offer a clear competitive advantage over existing treatments.", "sentB": "The strategy centers around prioritizing existing and new pipeline candidates to focus on products that we believe offer a clear competitive advantage over existing treatments.", "type": 2, "words": ["<tag1>", "The", "strategy", "centers", "around", "prioritizing", "existing", "and", "new", "pipeline", "candidates", "to", "focus", "on", "products", "that", "offer", "a", "clear", "competitive", "advantage", "over", "existing", "treatments.", "<tag2>", "The", "strategy", "centers", "around", "prioritizing", "existing", "and", "new", "pipeline", "candidates", "to", "focus", "on", "products", "that", "we", "believe", "offer", "a", "clear", "competitive", "advantage", "over", "existing", "treatments.", "<tag3>"], "wordsA": ["The", "strategy", "centers", "around", "prioritizing", "existing", "and", "new", "pipeline", "candidates", "to", "focus", "on", "products", "that", "offer", "a", "clear", "competitive", "advantage", "over", "existing", "treatments."], "wordsB": ["The", "strategy", "centers", "around", "prioritizing", "existing", "and", "new", "pipeline", "candidates", "to", "focus", "on", "products", "that", "we", "believe", "offer", "a", "clear", "competitive", "advantage", "over", "existing", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p9_s2", "idA": "1006281_16_item1_p8_s2", "sentA": "The strategy was the culmination of two months of intensive review by our management of the company s internal resources and of the markets in which we think we can operate.", "sentB": "The strategy was the culmination of two months of intensive review by our management of our internal resources and of the markets in which we expect we can operate.", "type": 2, "words": ["<tag1>", "The", "strategy", "was", "the", "culmination", "of", "two", "months", "of", "intensive", "review", "by", "our", "management", "of", "the", "company", "s", "internal", "resources", "and", "of", "the", "markets", "in", "which", "we", "think", "we", "can", "operate.", "<tag2>", "The", "strategy", "was", "the", "culmination", "of", "two", "months", "of", "intensive", "review", "by", "our", "management", "of", "our", "internal", "resources", "and", "of", "the", "markets", "in", "which", "we", "expect", "we", "can", "operate.", "<tag3>"], "wordsA": ["The", "strategy", "was", "the", "culmination", "of", "two", "months", "of", "intensive", "review", "by", "our", "management", "of", "the", "company", "s", "internal", "resources", "and", "of", "the", "markets", "in", "which", "we", "think", "we", "can", "operate."], "wordsB": ["The", "strategy", "was", "the", "culmination", "of", "two", "months", "of", "intensive", "review", "by", "our", "management", "of", "our", "internal", "resources", "and", "of", "the", "markets", "in", "which", "we", "expect", "we", "can", "operate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p86_s2", "idA": "1006281_16_item1_p92_s0", "sentA": "antiTNFs are used to treat a number of indications including rheumatoid arthritis, psoriasis, crohn s disease and others.", "sentB": "Common auto-immune diseases include rheumatoid arthritis, inflammatory bowel disease (IBD) such as ulcerative colitis and crohn s disease, psoriasis, and others.", "type": 2, "words": ["<tag1>", "antiTNFs", "are", "used", "to", "treat", "a", "number", "of", "indications", "including", "rheumatoid", "arthritis,", "psoriasis,", "crohn", "s", "disease", "and", "others.", "<tag2>", "Common", "auto-immune", "diseases", "include", "rheumatoid", "arthritis,", "inflammatory", "bowel", "disease", "(IBD)", "such", "as", "ulcerative", "colitis", "and", "crohn", "s", "disease,", "psoriasis,", "and", "others.", "<tag3>"], "wordsA": ["antiTNFs", "are", "used", "to", "treat", "a", "number", "of", "indications", "including", "rheumatoid", "arthritis,", "psoriasis,", "crohn", "s", "disease", "and", "others."], "wordsB": ["Common", "auto-immune", "diseases", "include", "rheumatoid", "arthritis,", "inflammatory", "bowel", "disease", "(IBD)", "such", "as", "ulcerative", "colitis", "and", "crohn", "s", "disease,", "psoriasis,", "and", "others."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p40_s1", "idA": "1006281_16_item1_p93_s2", "sentA": "The plant cell itself serves as a delivery vehicle, once released and absorbed, to transport the enzyme in active form to the bloodstream.", "sentB": "The plant cell itself serves as a delivery vehicle, once released and absorbed, to transport an enzyme in active form to the bloodstream.", "type": 2, "words": ["<tag1>", "The", "plant", "cell", "itself", "serves", "as", "a", "delivery", "vehicle,", "once", "released", "and", "absorbed,", "to", "transport", "the", "enzyme", "in", "active", "form", "to", "the", "bloodstream.", "<tag2>", "The", "plant", "cell", "itself", "serves", "as", "a", "delivery", "vehicle,", "once", "released", "and", "absorbed,", "to", "transport", "an", "enzyme", "in", "active", "form", "to", "the", "bloodstream.", "<tag3>"], "wordsA": ["The", "plant", "cell", "itself", "serves", "as", "a", "delivery", "vehicle,", "once", "released", "and", "absorbed,", "to", "transport", "the", "enzyme", "in", "active", "form", "to", "the", "bloodstream."], "wordsB": ["The", "plant", "cell", "itself", "serves", "as", "a", "delivery", "vehicle,", "once", "released", "and", "absorbed,", "to", "transport", "an", "enzyme", "in", "active", "form", "to", "the", "bloodstream."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p88_s3", "idA": "1006281_16_item1_p94_s0", "sentA": "If proven effective, our experimental oral antiTNF would be the first protein to be administered orally rather than through injectable therapy.", "sentB": "If proven effective, our experimental oral antiTNF would be the first protein to be administered orally rather than through injection.", "type": 2, "words": ["<tag1>", "If", "proven", "effective,", "our", "experimental", "oral", "antiTNF", "would", "be", "the", "first", "protein", "to", "be", "administered", "orally", "rather", "than", "through", "injectable", "therapy.", "<tag2>", "If", "proven", "effective,", "our", "experimental", "oral", "antiTNF", "would", "be", "the", "first", "protein", "to", "be", "administered", "orally", "rather", "than", "through", "injection.", "<tag3>"], "wordsA": ["If", "proven", "effective,", "our", "experimental", "oral", "antiTNF", "would", "be", "the", "first", "protein", "to", "be", "administered", "orally", "rather", "than", "through", "injectable", "therapy."], "wordsB": ["If", "proven", "effective,", "our", "experimental", "oral", "antiTNF", "would", "be", "the", "first", "protein", "to", "be", "administered", "orally", "rather", "than", "through", "injection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p92_s3", "idA": "1006281_16_item1_p95_s4", "sentA": "Additionally, oral administration of OPRX-106 alleviated immune mediated colitis in a well-established mouse model, promoting serum levels of anti-inflammatory IL-10 and regulatory T-cells.", "sentB": "The results demonstrated that oral administration of OPRX-106 is safe and well tolerated.", "type": 2, "words": ["<tag1>", "Additionally,", "oral", "administration", "of", "OPRX-106", "alleviated", "immune", "mediated", "colitis", "in", "a", "well-established", "mouse", "model,", "promoting", "serum", "levels", "of", "anti-inflammatory", "IL-10", "and", "regulatory", "T-cells.", "<tag2>", "The", "results", "demonstrated", "that", "oral", "administration", "of", "OPRX-106", "is", "safe", "and", "well", "tolerated.", "<tag3>"], "wordsA": ["Additionally,", "oral", "administration", "of", "OPRX-106", "alleviated", "immune", "mediated", "colitis", "in", "a", "well-established", "mouse", "model,", "promoting", "serum", "levels", "of", "anti-inflammatory", "IL-10", "and", "regulatory", "T-cells."], "wordsB": ["The", "results", "demonstrated", "that", "oral", "administration", "of", "OPRX-106", "is", "safe", "and", "well", "tolerated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p91_s0", "idA": "1006281_16_item1_p97_s0", "sentA": "We have concluded a phase I clinical trial of OPRX-106, which demonstrated that the drug was safe and well tolerated, showing biological activity in the gut and inducement of regulatory T cells.", "sentB": "We have concluded a phase I clinical trial of OPRX-106, which demonstrated that the drug was safe and well tolerated, showing biological activity in the gut.", "type": 2, "words": ["<tag1>", "We", "have", "concluded", "a", "phase", "I", "clinical", "trial", "of", "OPRX-106,", "which", "demonstrated", "that", "the", "drug", "was", "safe", "and", "well", "tolerated,", "showing", "biological", "activity", "in", "the", "gut", "and", "inducement", "of", "regulatory", "T", "cells.", "<tag2>", "We", "have", "concluded", "a", "phase", "I", "clinical", "trial", "of", "OPRX-106,", "which", "demonstrated", "that", "the", "drug", "was", "safe", "and", "well", "tolerated,", "showing", "biological", "activity", "in", "the", "gut.", "<tag3>"], "wordsA": ["We", "have", "concluded", "a", "phase", "I", "clinical", "trial", "of", "OPRX-106,", "which", "demonstrated", "that", "the", "drug", "was", "safe", "and", "well", "tolerated,", "showing", "biological", "activity", "in", "the", "gut", "and", "inducement", "of", "regulatory", "T", "cells."], "wordsB": ["We", "have", "concluded", "a", "phase", "I", "clinical", "trial", "of", "OPRX-106,", "which", "demonstrated", "that", "the", "drug", "was", "safe", "and", "well", "tolerated,", "showing", "biological", "activity", "in", "the", "gut."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p92_s0", "idA": "1006281_16_item1_p97_s1", "sentA": "The primary objective of the phase I clinical trial was to test the safety and pharmacokinetics of OPRX-106 in healthy volunteers, with an exploratory objective of analyzing the immunomodulatory effect.", "sentB": "The phase I clinical trial was a randomized, parallel-design, open-label study designed to evaluate the safety and pharmacokinetics of OPRX-106 in healthy volunteers.", "type": 2, "words": ["<tag1>", "The", "primary", "objective", "of", "the", "phase", "I", "clinical", "trial", "was", "to", "test", "the", "safety", "and", "pharmacokinetics", "of", "OPRX-106", "in", "healthy", "volunteers,", "with", "an", "exploratory", "objective", "of", "analyzing", "the", "immunomodulatory", "effect.", "<tag2>", "The", "phase", "I", "clinical", "trial", "was", "a", "randomized,", "parallel-design,", "open-label", "study", "designed", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "OPRX-106", "in", "healthy", "volunteers.", "<tag3>"], "wordsA": ["The", "primary", "objective", "of", "the", "phase", "I", "clinical", "trial", "was", "to", "test", "the", "safety", "and", "pharmacokinetics", "of", "OPRX-106", "in", "healthy", "volunteers,", "with", "an", "exploratory", "objective", "of", "analyzing", "the", "immunomodulatory", "effect."], "wordsB": ["The", "phase", "I", "clinical", "trial", "was", "a", "randomized,", "parallel-design,", "open-label", "study", "designed", "to", "evaluate", "the", "safety", "and", "pharmacokinetics", "of", "OPRX-106", "in", "healthy", "volunteers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p92_s1", "idA": "1006281_16_item1_p97_s2", "sentA": "The study consisted of 15 healthy volunteers divided into three dosing cohorts, equivalent to 2mg, 8mg or 16mg Tumor Necrosis Factor receptor-Fc fusion protein.", "sentB": "The trial enrolled 14 subjects that were randomized to one of three dosing cohorts receiving OPRX-106 doses equivalent to 2mg, 8mg or 16mg Tumor Necrosis Factor receptor-Fc fusion protein.", "type": 2, "words": ["<tag1>", "The", "study", "consisted", "of", "15", "healthy", "volunteers", "divided", "into", "three", "dosing", "cohorts,", "equivalent", "to", "2mg,", "8mg", "or", "16mg", "Tumor", "Necrosis", "Factor", "receptor-Fc", "fusion", "protein.", "<tag2>", "The", "trial", "enrolled", "14", "subjects", "that", "were", "randomized", "to", "one", "of", "three", "dosing", "cohorts", "receiving", "OPRX-106", "doses", "equivalent", "to", "2mg,", "8mg", "or", "16mg", "Tumor", "Necrosis", "Factor", "receptor-Fc", "fusion", "protein.", "<tag3>"], "wordsA": ["The", "study", "consisted", "of", "15", "healthy", "volunteers", "divided", "into", "three", "dosing", "cohorts,", "equivalent", "to", "2mg,", "8mg", "or", "16mg", "Tumor", "Necrosis", "Factor", "receptor-Fc", "fusion", "protein."], "wordsB": ["The", "trial", "enrolled", "14", "subjects", "that", "were", "randomized", "to", "one", "of", "three", "dosing", "cohorts", "receiving", "OPRX-106", "doses", "equivalent", "to", "2mg,", "8mg", "or", "16mg", "Tumor", "Necrosis", "Factor", "receptor-Fc", "fusion", "protein."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p92_s2", "idA": "1006281_16_item1_p97_s3", "sentA": "Study subjects received daily oral administration for five consecutive days.", "sentB": "Subjects received once daily oral administrations for five consecutive days.", "type": 2, "words": ["<tag1>", "Study", "subjects", "received", "daily", "oral", "administration", "for", "five", "consecutive", "days.", "<tag2>", "Subjects", "received", "once", "daily", "oral", "administrations", "for", "five", "consecutive", "days.", "<tag3>"], "wordsA": ["Study", "subjects", "received", "daily", "oral", "administration", "for", "five", "consecutive", "days."], "wordsB": ["Subjects", "received", "once", "daily", "oral", "administrations", "for", "five", "consecutive", "days."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p94_s4", "idA": "1006281_16_item1_p99_s5", "sentA": "If Fiocruz fails to comply with certain of its purchase commitments under the agreement, we may terminate the agreement, and all of our rights to the technology will be returned.", "sentB": "If Fiocruz fails to comply with the purchase commitments, we may terminate the agreement, and all of our rights to the technology will be returned.", "type": 2, "words": ["<tag1>", "If", "Fiocruz", "fails", "to", "comply", "with", "certain", "of", "its", "purchase", "commitments", "under", "the", "agreement,", "we", "may", "terminate", "the", "agreement,", "and", "all", "of", "our", "rights", "to", "the", "technology", "will", "be", "returned.", "<tag2>", "If", "Fiocruz", "fails", "to", "comply", "with", "the", "purchase", "commitments,", "we", "may", "terminate", "the", "agreement,", "and", "all", "of", "our", "rights", "to", "the", "technology", "will", "be", "returned.", "<tag3>"], "wordsA": ["If", "Fiocruz", "fails", "to", "comply", "with", "certain", "of", "its", "purchase", "commitments", "under", "the", "agreement,", "we", "may", "terminate", "the", "agreement,", "and", "all", "of", "our", "rights", "to", "the", "technology", "will", "be", "returned."], "wordsB": ["If", "Fiocruz", "fails", "to", "comply", "with", "the", "purchase", "commitments,", "we", "may", "terminate", "the", "agreement,", "and", "all", "of", "our", "rights", "to", "the", "technology", "will", "be", "returned."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1006281_17_item1_p58_s0", "idA": "1006281_16_item1_p9_s0", "sentA": "PRX-102 for the Treatment of Fabry disease .", "sentB": "In October 2016, the first patient was dosed in our global phase III clinical trial of PRX-102 for the treatment of Fabry disease.", "type": 2, "words": ["<tag1>", "PRX-102", "for", "the", "Treatment", "of", "Fabry", "disease", ".", "<tag2>", "In", "October", "2016,", "the", "first", "patient", "was", "dosed", "in", "our", "global", "phase", "III", "clinical", "trial", "of", "PRX-102", "for", "the", "treatment", "of", "Fabry", "disease.", "<tag3>"], "wordsA": ["PRX-102", "for", "the", "Treatment", "of", "Fabry", "disease", "."], "wordsB": ["In", "October", "2016,", "the", "first", "patient", "was", "dosed", "in", "our", "global", "phase", "III", "clinical", "trial", "of", "PRX-102", "for", "the", "treatment", "of", "Fabry", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
